Citrus Sinensis ID: 022887

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290
Protein Sequence
MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT
Secondary Structure (PSIPRED)
ccHHHHHHHHHHcccEEcEEccccccccccEEEEccccEEEEccccccccccEEEEccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEcccccccHHHHHHHHHHHHHHHcccccccHHcccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHcccEEEEEEEcccccccEEEEEEccHEcHHHccccccccEEEEEEcccHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccEcHHHHHHHHcccccccccccccccccEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEEEcHHccccccHHHHHHHHHHHHHHHHHHHHccHcccEcccccHHHEEEcccccEEEccccccEEccHHcccccccEEccc
Coil and Loop (DISEMBL)
mnlnqcqakclkncscrayanskltgggsgclmwfgdlidlrkpisnftgqsvyirvpapeqgnkKLLWIIVVLVLPvvllpsfyiFRRRRRKhkekdgegndkskdswlplFSLASVSAATENFstqcklgeggfgpvykgrllnGQEVAVKRLsnqsgqgltEFKNEMMLIAKLQHRHLVRLFGCCieqgeniliyeympnksldvflfypkkkrllGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASnilldsdmnpkisdfgmarifggdelqgntkrivgt
Flexible Loop (DISEMBL)
MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQGNKKLLWIIVVLVLpvvllpsfyifrrrrrkhkekdgegndkskdswlPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARifggdelqgntkrivgt
Low Complexity Region (SEG)
MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQGNKKllwiivvlvlpvvllpSFYIFRRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT
Disordered region (IsUnstruct)
*****CQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQGNKKLLWIIVVLVLPVVLLPSFYIFRR*******************WLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLS***GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG*************
Disordered Region (DISOPRED)
MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQGNKKLLWIIVVLVLPVVLLPSFYIFRR********************LPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT
Disordered Region (DISEMBL)
MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQGNKKLLWIIVVLVLPVVLLPSFYIFRRRR*************SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT
Disordered Region (DISPRO)
MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKE**********DSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL**********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	290	2.2.26 [Sep-21-2011]
Q9ZT07	833	G-type lectin S-receptor-	yes	no	0.993	0.345	0.510	2e-85
O81832	783	G-type lectin S-receptor-	no	no	0.903	0.334	0.541	2e-81
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.993	0.340	0.496	9e-81
O81833	815	G-type lectin S-receptor-	no	no	0.993	0.353	0.542	2e-80
O81906	849	G-type lectin S-receptor-	no	no	0.965	0.329	0.492	1e-79
Q9LW83	850	G-type lectin S-receptor-	no	no	0.958	0.327	0.480	2e-78
Q9S972	847	Receptor-like serine/thre	no	no	0.993	0.340	0.490	2e-77
O64793	818	G-type lectin S-receptor-	no	no	0.972	0.344	0.480	6e-77
O81905	850	Receptor-like serine/thre	no	no	0.993	0.338	0.482	1e-76
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.962	0.331	0.478	5e-76

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  315 bits (808), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 163/319 (51%), Positives = 218/319 (68%), Gaps = 31/319 (9%)

Query: 1   MNLNQCQAKCLKNCSCRAYANS--KLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVP 58
           + L +C+ +CLKNCSC AYA++  +   G  GCL W G ++D R  ++  +GQ  YIRV 
Sbjct: 364 ITLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVD 421

Query: 59  APE---------QGNKKLLWIIVVLVLPVVLLPS--FYIFRRRRRKHKEKDGEGN----- 102
             E          G +++L I++ L+  V+LL    F + R RR+ ++ +    N     
Sbjct: 422 KEELARWNRNGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVP 481

Query: 103 -----------DKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVA 151
                      DK+++  LPLF L ++ AAT NFS+Q KLG GGFGPVYKG L N  E+A
Sbjct: 482 FDFDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIA 541

Query: 152 VKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLF 211
           VKRLS  SGQG+ EFKNE+ LI+KLQHR+LVR+ GCC+E  E +L+YEY+PNKSLD F+F
Sbjct: 542 VKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIF 601

Query: 212 YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
           + +++  L W  R+ I+ GIA+G+LYLHQ SRLRIIHRDLKASNILLDS+M PKISDFGM
Sbjct: 602 HEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGM 661

Query: 272 ARIFGGDELQGNTKRIVGT 290
           ARIFGG++++G T R+VGT
Sbjct: 662 ARIFGGNQMEGCTSRVVGT 680

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4

 Score =  302 bits (773), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 157/290 (54%), Positives = 198/290 (68%), Gaps = 28/290 (9%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
           M+LN+C+  CL+NC+C AY+   +  GG GC++WFGDLID+R+   N  GQ +Y+R+ + 
Sbjct: 369 MDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE--YNENGQDLYVRLASS 426

Query: 61  EQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSA 120
           E         I  L      + S        RK +E+D E         LP   L +VS 
Sbjct: 427 E---------IETLQRESSRVSS--------RKQEEEDLE---------LPFLDLDTVSE 460

Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 180
           AT  FS   KLG+GGFGPVYKG L  GQEVAVKRLS  S QG+ EFKNE+ LIAKLQHR+
Sbjct: 461 ATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRN 520

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           LV++ G C+++ E +LIYEY PNKSLD F+F  +++R L W  RV II+GIA+G+LYLH+
Sbjct: 521 LVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHE 580

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            SRLRIIHRDLKASN+LLDSDMN KISDFG+AR  GGDE + NT R+VGT
Sbjct: 581 DSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGT 630

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  300 bits (768), Expect = 9e-81,   Method: Compositional matrix adjust.
 Identities = 161/324 (49%), Positives = 221/324 (68%), Gaps = 36/324 (11%)

Query: 1   MNLNQCQAKCLKNCSCRAYANS--KLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVP 58
           + L +C+ +CLKNCSC AYA++  +   G  GCL W G+++D R  +S  +GQ  Y+RV 
Sbjct: 367 ITLKECEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLS--SGQDFYLRVD 424

Query: 59  APE---------QGNKKLLWIIVVLVLPVVLL-PSFYIFRRRRRKHKEKD---------- 98
             E          G K+L+ I++ L+  V+LL  SF+ + R+RR+  + +          
Sbjct: 425 KSELARWNGNGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFA 484

Query: 99  ------------GEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLN 146
                        E  DKS+   LPLF L++++ AT NF+ Q KLG GGFGPVYKG L N
Sbjct: 485 PSSFDLEDSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQN 544

Query: 147 GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 206
           G E+AVKRLS  SGQG+ EFKNE+ LI+KLQHR+LVR+ GCC+E  E +L+YEY+PNKSL
Sbjct: 545 GMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSL 604

Query: 207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 266
           D F+F+ +++  L W  R+ II GI +G+LYLHQ SRLRIIHRDLKASN+LLD++M PKI
Sbjct: 605 DYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKI 664

Query: 267 SDFGMARIFGGDELQGNTKRIVGT 290
           +DFG+ARIFGG++++G+T R+VGT
Sbjct: 665 ADFGLARIFGGNQIEGSTNRVVGT 688

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1

 Score =  298 bits (764), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 160/295 (54%), Positives = 211/295 (71%), Gaps = 7/295 (2%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRV--P 58
           M L  C+ KC  NCSC AYAN+ +  GG GCL+WFGDL+D+R+  S+F GQ VYIR+   
Sbjct: 373 MTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMRE-YSSF-GQDVYIRMGFA 430

Query: 59  APEQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKDGEGNDK---SKDSWLPLFSL 115
             E   ++++ ++V  V+ + ++        R++  K   GE   K    +D  LP+F  
Sbjct: 431 KIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLPIFDR 490

Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
            ++S AT++FS    LG GGFGPVYKG+L +GQE+AVKRLS  SGQG+ EFKNE+ LIAK
Sbjct: 491 KTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAK 550

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           LQHR+LVRL GCCI+  E +LIYEYMPNKSLD F+F  ++   L W+ R+ II G+A+G+
Sbjct: 551 LQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGI 610

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           LYLHQ SRLRIIHRDLKA N+LLD+DMNPKISDFG+A+ FGGD+ + +T R+VGT
Sbjct: 611 LYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGT 665

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  296 bits (759), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 158/321 (49%), Positives = 212/321 (66%), Gaps = 41/321 (12%)

Query: 5   QCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQGN 64
            C+ +CL+NCSC AY+      GG GC++W  DL+DL++  +   G S++IR+   E G 
Sbjct: 380 DCRERCLRNCSCNAYS----LVGGIGCMIWNQDLVDLQQFEAG--GSSLHIRLADSEVGE 433

Query: 65  --KKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKDGEGNDKSKD--------------- 107
             K  + +IV +++ V+L+  F +   R ++ K+  G    K+ D               
Sbjct: 434 NRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETT 493

Query: 108 ------------------SWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQE 149
                             S LP+FSL +++ AT +F  + +LG GGFGPVYKG L +G+E
Sbjct: 494 SAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGRE 553

Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVF 209
           +AVKRLS +SGQG+ EFKNE++LIAKLQHR+LVRL GCC E  E +L+YEYMPNKSLD F
Sbjct: 554 IAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFF 613

Query: 210 LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 269
           LF   K+ L+ W+ R  IIEGIA+GLLYLH+ SRLRIIHRDLK SN+LLD++MNPKISDF
Sbjct: 614 LFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDF 673

Query: 270 GMARIFGGDELQGNTKRIVGT 290
           GMARIFGG++ + NT R+VGT
Sbjct: 674 GMARIFGGNQNEANTVRVVGT 694

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2

 Score =  292 bits (747), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 161/335 (48%), Positives = 211/335 (62%), Gaps = 57/335 (17%)

Query: 5   QCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPEQGN 64
            C  KCL+NCSC AYA++   G G+GC +W  D  +  +  ++   +++YIR+    +G+
Sbjct: 366 DCYVKCLQNCSCVAYASTN--GDGTGCEIWNTDPTN--ENSASHHPRTIYIRI----KGS 417

Query: 65  K-KLLWIIVV----LVLPVVLLPSFYIFRR------------------------RRRKHK 95
           K    W++VV    L++PV  L  + + R+                         +R   
Sbjct: 418 KLAATWLVVVASLFLIIPVTWLIIYLVLRKFKIKGTNFVSESLKMISSQSCSLTNKRLST 477

Query: 96  EKDGEGNDK--------------------SKDSWLPLFSLASVSAATENFSTQCKLGEGG 135
            + G   D+                    + ++ L +FS  SV+ AT+ FS   KLGEGG
Sbjct: 478 LRVGSTIDQEMLLLELGIERRRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGG 537

Query: 136 FGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI 195
           FGPVYKGRL++G+EVA+KRLS  SGQGL EFKNE MLIAKLQH +LV+L GCC+E+ E +
Sbjct: 538 FGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKM 597

Query: 196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN 255
           LIYEYMPNKSLD FLF P +K +L W+ R RI+EGI QGLLYLH+YSRL++IHRD+KA N
Sbjct: 598 LIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGN 657

Query: 256 ILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           ILLD DMNPKISDFGMARIFG  E + NTKR+ GT
Sbjct: 658 ILLDEDMNPKISDFGMARIFGAQESKANTKRVAGT 692

Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  288 bits (738), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 157/320 (49%), Positives = 205/320 (64%), Gaps = 32/320 (10%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
           + L +C+ +CLK C+C A+AN+ +  GGSGC++W G L D+R       GQ +Y+RV A 
Sbjct: 371 IGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKG--GQDLYVRVAAG 428

Query: 61  EQGNKKLLWIIVV---LVLPVVLLPSFYIFRRRRRKHK--------------EKDGEGND 103
           +  +K++    ++   + + ++LL SF IF   +RK K               +D   N+
Sbjct: 429 DLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNE 488

Query: 104 KSKDS-------------WLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEV 150
             K S              LPL    +++ AT NFST  KLG+GGFG VYKG LL+G+E+
Sbjct: 489 LVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEI 548

Query: 151 AVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL 210
           AVKRLS  S QG  EF NE+ LIAKLQH +LVRL GCC+++GE +LIYEY+ N SLD  L
Sbjct: 549 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 608

Query: 211 FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
           F   +   L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFG
Sbjct: 609 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 668

Query: 271 MARIFGGDELQGNTKRIVGT 290
           MARIFG +E + NT+R+VGT
Sbjct: 669 MARIFGREETEANTRRVVGT 688

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3

 Score =  287 bits (735), Expect = 6e-77,   Method: Compositional matrix adjust.
 Identities = 162/337 (48%), Positives = 209/337 (62%), Gaps = 55/337 (16%)

Query: 5   QCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIR-------- 56
            C A CL+N SC AYA+++    G+GC +W  +     K  ++ + +++YIR        
Sbjct: 329 DCSAICLQNSSCLAYASTE--PDGTGCEIW--NTYPTNKGSASHSPRTIYIRGNENKKVA 384

Query: 57  ----VPAPEQGNKKLLWIIVVLVL--------------------PVVLLPSFYIFRRRR- 91
               V A       ++W I+ LVL                     +V L +   F RRR 
Sbjct: 385 AWHIVVATLFLMTPIIWFIIYLVLRKFNVKGRNCIRITHKTVLVSMVFLLTMIGFIRRRI 444

Query: 92  ---RKHKEKDGE---------------GNDKSKDSWLPLFSLASVSAATENFSTQCKLGE 133
              R     D E                N++  ++ L +FS  SV +AT++FS + KLGE
Sbjct: 445 LSLRFGSTIDQEMLLRELGIDRSCIHKRNERKSNNELQIFSFESVVSATDDFSDENKLGE 504

Query: 134 GGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 193
           GGFGPVYKG+LLNG+EVA+KRLS  SGQGL EFKNE +LIAKLQH +LV++ GCCIE+ E
Sbjct: 505 GGFGPVYKGKLLNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDE 564

Query: 194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKA 253
            +LIYEYM NKSLD FLF P +K +L W  R RI+EGI QGLLYLH+YSRL++IHRD+KA
Sbjct: 565 KMLIYEYMQNKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKA 624

Query: 254 SNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           SNILLD DMNPKISDFG+ARIFG +E + NTKR+ GT
Sbjct: 625 SNILLDEDMNPKISDFGLARIFGAEETRANTKRVAGT 661

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  286 bits (732), Expect = 1e-76,   Method: Compositional matrix adjust.
 Identities = 155/321 (48%), Positives = 199/321 (61%), Gaps = 33/321 (10%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
           + + +C+ KCL++C+C A+AN+ + G GSGC+ W G+L D+R       GQ +Y+R+ A 
Sbjct: 373 IGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKG--GQDLYVRLAAT 430

Query: 61  E---QGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKE--------------------- 96
           +   + N+    I   + + V+LL SF IF   +RK K                      
Sbjct: 431 DLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMN 490

Query: 97  -------KDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQE 149
                  +     + + D  LPL     V+ AT NFS   KLG+GGFG VYKG+LL+GQE
Sbjct: 491 EVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQE 550

Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVF 209
           +AVKRLS  S QG  EFKNE+ LIA+LQH +LVRL  CC++ GE +LIYEY+ N SLD  
Sbjct: 551 MAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSH 610

Query: 210 LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 269
           LF   +   L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASNILLD  M PKISDF
Sbjct: 611 LFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDF 670

Query: 270 GMARIFGGDELQGNTKRIVGT 290
           GMARIFG DE + NT+++VGT
Sbjct: 671 GMARIFGRDETEANTRKVVGT 691

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  284 bits (727), Expect = 5e-76,   Method: Compositional matrix adjust.
 Identities = 147/307 (47%), Positives = 207/307 (67%), Gaps = 28/307 (9%)

Query: 6   CQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPE-QGN 64
           C   CL NCSC AYA  +    G GC++W GDL+D++  +   +G  ++IRV   E + +
Sbjct: 389 CPKVCLDNCSCTAYAYDR----GIGCMLWSGDLVDMQSFLG--SGIDLFIRVAHSELKTH 442

Query: 65  KKLLWIIVVLVLPVVLLPSFYI------FRRRRRKHKEKDGE---------------GND 103
             L  +I   V+ V+L+ +  +      +++R    K++  E                ++
Sbjct: 443 SNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFKRMEALTSDNESASN 502

Query: 104 KSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL 163
           + K   LPLF    ++ +T++FS + KLG+GGFGPVYKG+L  GQE+AVKRLS +SGQGL
Sbjct: 503 QIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGL 562

Query: 164 TEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQA 223
            E  NE+++I+KLQHR+LV+L GCCIE  E +L+YEYMP KSLD +LF P K+++L W+ 
Sbjct: 563 EELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKT 622

Query: 224 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN 283
           R  I+EGI +GLLYLH+ SRL+IIHRDLKASNILLD ++NPKISDFG+ARIF  +E + N
Sbjct: 623 RFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEAN 682

Query: 284 TKRIVGT 290
           T+R+VGT
Sbjct: 683 TRRVVGT 689

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	290
224111422	304	predicted protein [Populus trichocarpa]	0.989	0.944	0.576	8e-92
359493713	1988	PREDICTED: uncharacterized protein LOC10	0.955	0.139	0.582	3e-91
356514913	829	PREDICTED: G-type lectin S-receptor-like	0.993	0.347	0.570	1e-90
449458261	814	PREDICTED: receptor-like serine/threonin	0.989	0.352	0.566	3e-90
356514897	821	PREDICTED: G-type lectin S-receptor-like	0.993	0.350	0.579	5e-90
449476944	1267	PREDICTED: receptor-like serine/threonin	0.989	0.226	0.566	7e-90
224122858	831	predicted protein [Populus trichocarpa]	0.993	0.346	0.569	2e-89
224122958	812	predicted protein [Populus trichocarpa]	0.993	0.354	0.555	3e-89
224122966	783	predicted protein [Populus trichocarpa]	0.903	0.334	0.573	3e-88
302143128	692	unnamed protein product [Vitis vinifera]	0.975	0.408	0.566	3e-88

>gi|224111422|ref|XP_002332932.1| predicted protein [Populus trichocarpa] gi|222837503|gb|EEE75882.1| predicted protein [Populus trichocarpa]

 Score =  342 bits (878), Expect = 8e-92,   Method: Compositional matrix adjust.
 Identities = 177/307 (57%), Positives = 218/307 (71%), Gaps = 20/307 (6%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPA- 59
           M+L +C+  CL NCSC AY+   +T G +GCL+WF DL+D+R+     TGQ  YIR+ A 
Sbjct: 1   MDLEECRRVCLMNCSCTAYSTLNITDG-TGCLLWFEDLLDIREYTE--TGQDFYIRLSAS 57

Query: 60  ---PEQGNKKL--LWIIVV--LVLPVVLLPSFYIFRRRRRKHK---------EKDGEGND 103
              P +  K+   +WII +  LV  + +L    +F  RRRK K         E+D   N 
Sbjct: 58  DLEPTRSPKRTTRVWIIAICLLVAGITILGFCLLFLMRRRKMKTAARMVSMQERDYSINS 117

Query: 104 KSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL 163
             KD  LP+F  A+++ AT NFS   KLGEGGFGPVYKG+L +GQE+AVKRLS  S QGL
Sbjct: 118 TGKDLELPVFDFATIAIATSNFSGANKLGEGGFGPVYKGKLEDGQEIAVKRLSKTSTQGL 177

Query: 164 TEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQA 223
            EFKNE++ IAKLQHR+LV+L GCCIE  E +L+YEYMPNKSLD F+F  K+ +LL W  
Sbjct: 178 DEFKNEVICIAKLQHRNLVKLLGCCIESEETMLVYEYMPNKSLDAFIFDQKQSKLLDWSM 237

Query: 224 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN 283
           R  II G+A+GLLYLHQ SRLRIIHRDLKASNIL+D DMNPKISDFGMAR FGG+E+QGN
Sbjct: 238 RYNIINGVARGLLYLHQDSRLRIIHRDLKASNILVDYDMNPKISDFGMARSFGGNEIQGN 297

Query: 284 TKRIVGT 290
           TKR+VGT
Sbjct: 298 TKRVVGT 304

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493713|ref|XP_002281009.2| PREDICTED: uncharacterized protein LOC100265866 [Vitis vinifera]

 Score =  341 bits (874), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 173/297 (58%), Positives = 221/297 (74%), Gaps = 20/297 (6%)

Query: 3    LNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAPE- 61
            L +C+A+CLKNCSC AYANS ++ GGSGCLMWFG+LID+R+  +  + Q+VY+R+PA E 
Sbjct: 1703 LRECRAECLKNCSCTAYANSNISKGGSGCLMWFGNLIDVREFHAQESEQTVYVRMPASEL 1762

Query: 62   -------QGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKDGEGNDKSKDSW-LPLF 113
                   Q  K L+ +++V +  VVL+     +             G +  KD +  PLF
Sbjct: 1763 ESRRNSSQKRKHLVIVVLVSMASVVLILGLVFWYT-----------GPEMQKDEFESPLF 1811

Query: 114  SLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLI 173
            SLA+V++AT NFS    +GEGGFGPVYKG L  GQE+AVKRLSN SGQGL EFKNE++LI
Sbjct: 1812 SLATVASATNNFSCANMIGEGGFGPVYKGTLGTGQEIAVKRLSNNSGQGLQEFKNEVILI 1871

Query: 174  AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
            ++LQHR+LVRL GCCIE+ E +LIYEYMPN+SLD F+F   ++ LL WQ R+ II GIA+
Sbjct: 1872 SRLQHRNLVRLLGCCIEREERMLIYEYMPNRSLDYFIFDQMRRVLLPWQKRLDIILGIAR 1931

Query: 234  GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            GLLYLHQ SRLRIIHRDLK SNILLDS++ PKISDFG+ARIFGGD+++  TKR++GT
Sbjct: 1932 GLLYLHQDSRLRIIHRDLKTSNILLDSELTPKISDFGIARIFGGDQIEAKTKRVIGT 1988

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356514913|ref|XP_003526146.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max]

 Score =  339 bits (869), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 173/303 (57%), Positives = 219/303 (72%), Gaps = 15/303 (4%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVP-- 58
           M L +C+ KC +NCSC AYAN  + G GSGC +WFGDLIDL+  + + +GQ +YIR+   
Sbjct: 377 MTLEECKVKCWENCSCTAYANLDIRGAGSGCSIWFGDLIDLK--VVSQSGQYLYIRMADS 434

Query: 59  ---APEQGNKKLLWIIVVLVLPVVL---LPSFYIFRRRRRKHKE-----KDGEGNDKSKD 107
              A +   KK L +I  +V P+VL   L  FY ++R+R+  +E     K  E   +   
Sbjct: 435 QTDAKDAHKKKELLLIGTIVPPIVLVILLAIFYSYKRKRKYEEENVSVVKKDEAGGQEHS 494

Query: 108 SWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFK 167
             LPLF LA++  AT NFST  KLG+GGFGPVYKG L  GQE+AVKRLS  SGQGLTEFK
Sbjct: 495 MELPLFDLATLVNATNNFSTDNKLGQGGFGPVYKGVLAGGQEIAVKRLSRSSGQGLTEFK 554

Query: 168 NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI 227
           NE++L AKLQHR+LV++ GCCIE+ E +L+YEYMPNKSLD FLF   K ++L W  R  I
Sbjct: 555 NEVILCAKLQHRNLVKVLGCCIEEEEKMLLYEYMPNKSLDSFLFDSTKSKILDWSKRFHI 614

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRI 287
           +   A+GLLYLHQ SRLRIIHRDLKASNILLD+++NPKISDFG+AR+ GGD+++GNT R+
Sbjct: 615 LCATARGLLYLHQDSRLRIIHRDLKASNILLDNNLNPKISDFGLARMCGGDQIEGNTNRV 674

Query: 288 VGT 290
           VGT
Sbjct: 675 VGT 677

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus]

 Score =  337 bits (864), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 170/300 (56%), Positives = 221/300 (73%), Gaps = 13/300 (4%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
           M+LN+C+ KCL+NCSC A+AN+ + G GSGC +WFG+L+D++  +    GQ +Y+R+ A 
Sbjct: 366 MSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIK--VVRRGGQDLYVRMLAS 423

Query: 61  EQGNKKLLWIIVVLVLPVVLLPS-------FYIFRRRRRKHKEKDGEGND---KSKDSWL 110
           E   KK   + V +++    L         FY+ R +RRK  E  G G D   +  D  L
Sbjct: 424 ELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKL-EATGAGKDLEGQEDDLEL 482

Query: 111 PLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEM 170
           PLF+LA++S AT+NFS   KLGEGGFG V++GRL +G+E+AVKRLS+ S QG  EFKNE+
Sbjct: 483 PLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGTDEFKNEV 542

Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG 230
           +LIAKLQHR+LV+L GCCI+  E +LIYEYMPNKSLD F+F   +K+LL W  R  II G
Sbjct: 543 ILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSKRFNIICG 602

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           +A+G+LYLHQ SRLRIIHRDLKASN+LLD D+NPKISDFGMAR FGGD+ +GNT+R+VGT
Sbjct: 603 VARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGNTRRVVGT 662

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356514897|ref|XP_003526138.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max]

 Score =  337 bits (863), Expect = 5e-90,   Method: Compositional matrix adjust.
 Identities = 175/302 (57%), Positives = 217/302 (71%), Gaps = 14/302 (4%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
           M L +C+ KC +NCSC AYANS + G GSGC +WFGDL+D+R  +SN  GQ +YIR+   
Sbjct: 370 MTLEECKHKCTENCSCMAYANSDIRGEGSGCAIWFGDLLDIRL-MSN-AGQDLYIRLAMS 427

Query: 61  EQGN---------KKLLWIIVVLVLPVV--LLPSFYIFRRRRRKHKEKDGEGNDKSKDSW 109
           E  +         KK + +I   +  V+  LL   +I+ R   K+ E +G  N   ++ +
Sbjct: 428 ETAHQDQDEKDSSKKKVVVIASSISSVIAMLLIFIFIYWRYTNKNNEIEGTKNQSQQEDF 487

Query: 110 -LPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKN 168
            LPLF LASV+ AT NFS   KLGEGGFGPVYKG L NGQEVAVKRLS  S QGL EFKN
Sbjct: 488 ELPLFDLASVAHATSNFSNDKKLGEGGFGPVYKGTLPNGQEVAVKRLSQTSRQGLKEFKN 547

Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ML A+LQHR+LV++ GCCI+  E +LIYEYM NKSLDVFLF   + +LL W  R  II
Sbjct: 548 EVMLCAELQHRNLVKVLGCCIQDDEKLLIYEYMANKSLDVFLFDSSQSKLLDWPMRFGII 607

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
            GIA+GLLYLHQ SRLRIIHRDLKASN+LLD++MNPKISDFG+AR+ GGD+++G T R+V
Sbjct: 608 NGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGLARMCGGDQIEGETSRVV 667

Query: 289 GT 290
           GT
Sbjct: 668 GT 669

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449476944|ref|XP_004154883.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus]

 Score =  336 bits (861), Expect = 7e-90,   Method: Compositional matrix adjust.
 Identities = 170/300 (56%), Positives = 221/300 (73%), Gaps = 13/300 (4%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
           M+LN+C+ KCL+NCSC A+AN+ + G GSGC +WFG+L+D++  +    GQ +Y+R+ A 
Sbjct: 366 MSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIK--VVRRGGQDLYVRMLAS 423

Query: 61  EQGNKKLLWIIVVLVLPVVLLPS-------FYIFRRRRRKHKEKDGEGND---KSKDSWL 110
           E   KK   + V +++    L         FY+ R +RRK  E  G G D   +  D  L
Sbjct: 424 ELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKL-EATGAGKDLEGQEDDLEL 482

Query: 111 PLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEM 170
           PLF+LA++S AT+NFS   KLGEGGFG V++GRL +G+E+AVKRLS+ S QG  EFKNE+
Sbjct: 483 PLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGTDEFKNEV 542

Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG 230
           +LIAKLQHR+LV+L GCCI+  E +LIYEYMPNKSLD F+F   +K+LL W  R  II G
Sbjct: 543 ILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSKRFNIICG 602

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           +A+G+LYLHQ SRLRIIHRDLKASN+LLD D+NPKISDFGMAR FGGD+ +GNT+R+VGT
Sbjct: 603 VARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGNTRRVVGT 662

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa]

 Score =  335 bits (858), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 177/311 (56%), Positives = 220/311 (70%), Gaps = 23/311 (7%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRV--- 57
           +NL +C+  CLKNCSC AYAN  +  GGSGC++WFGDLID+R+   N  GQ +YIR+   
Sbjct: 371 INLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQ--YNENGQDIYIRIAAS 428

Query: 58  ----PAPEQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHKEKD--GEGN-------DK 104
               P   +G K++  I++ + L    L +  +F R  RK+K++    EGN       D+
Sbjct: 429 VIDKPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPEQDR 488

Query: 105 SKDS-----WLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS 159
           +K+S      LPLF LA+++ AT  FS   KLG+GGFGPVYKG L +GQE+AVKRLS +S
Sbjct: 489 TKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQDGQEIAVKRLSKRS 548

Query: 160 GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL 219
            QG+ EF+NE++ IAKLQHR+LV+L GCCIE  E +LIYEYMPNKSLD F+F  ++  LL
Sbjct: 549 RQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKSLDSFIFDKRRNMLL 608

Query: 220 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            W  R  II GIA+GLLYLHQ SRLRIIHRDLKASNILLD +MNPKISDFGMAR FGGDE
Sbjct: 609 DWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPKISDFGMARSFGGDE 668

Query: 280 LQGNTKRIVGT 290
              NT RIVGT
Sbjct: 669 TSANTSRIVGT 679

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa]

 Score =  334 bits (856), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 166/299 (55%), Positives = 215/299 (71%), Gaps = 11/299 (3%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
            +L +C+  C++NCSC AYAN    G GSGCL WFGDLID R+      GQ +YIR+ A 
Sbjct: 363 FSLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEG--GQDIYIRLAAS 420

Query: 61  EQG-------NKKLLWIIV--VLVLPVVLLPSFYIFRRRRRKHKEKDGEGNDKSKDSWLP 111
           + G        KK    ++   ++L   +L    +F  RRRKH++     + K ++  LP
Sbjct: 421 QSGVTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNGNFEDRKEEEMELP 480

Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMM 171
           +  L ++  AT+NFS+  KLGEGGFG VYKG L+ GQE+AVKRLS  SGQGL EFKNE++
Sbjct: 481 MLDLTTIEHATDNFSSSKKLGEGGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVL 540

Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           LIAKLQHR+LV+L GCCI + E +LIYEYMPN+SLD F+F P +++ L W  R  II+GI
Sbjct: 541 LIAKLQHRNLVKLLGCCIHEDEKMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGI 600

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           A+GLLYLHQ SRLRIIHRD+KASNILLD+++NPKISDFG+AR+FGGD+ + NTKR+VGT
Sbjct: 601 ARGLLYLHQDSRLRIIHRDIKASNILLDNELNPKISDFGLARMFGGDQTEANTKRVVGT 659

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122966|ref|XP_002330408.1| predicted protein [Populus trichocarpa] gi|222871793|gb|EEF08924.1| predicted protein [Populus trichocarpa]

 Score =  330 bits (847), Expect = 3e-88,   Method: Compositional matrix adjust.
 Identities = 167/291 (57%), Positives = 214/291 (73%), Gaps = 29/291 (9%)

Query: 1   MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
           M+L +C+  CLKNCSC AYANS +TG  SGC++WFG+L+D+R+  +   GQ +YIR+P P
Sbjct: 369 MSLVECKDMCLKNCSCTAYANSNITGEASGCILWFGELVDMREFSTG--GQDLYIRMPPP 426

Query: 61  EQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRRKHK-EKDGEGNDKSKDSWLPLFSLASVS 119
            +                    +FYI+R+++RK + E+D E         LP F LA++ 
Sbjct: 427 LKTGL-----------------TFYIWRKKQRKQEIEEDME---------LPSFHLATIV 460

Query: 120 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR 179
            AT+NFS+  KLG+GGFGPVYKG L++GQE+AVKRLS  S QGLTEFKNE++LIAKLQHR
Sbjct: 461 KATDNFSSNNKLGQGGFGPVYKGTLIDGQEIAVKRLSKSSRQGLTEFKNEVILIAKLQHR 520

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           +LV+L GCCI+  E +LIYE+MPNKSLD F+F   + + L WQ R  II GIA+GLLYLH
Sbjct: 521 NLVKLLGCCIQGDEVMLIYEFMPNKSLDYFIFDQTRNKFLDWQRRNLIIGGIARGLLYLH 580

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           Q SRLRIIHRDLKASNILLD DMNPKISDFGMAR+FG D+++ +T ++VGT
Sbjct: 581 QDSRLRIIHRDLKASNILLDKDMNPKISDFGMARLFGVDQIEADTNKVVGT 631

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera]

 Score =  330 bits (847), Expect = 3e-88,   Method: Compositional matrix adjust.
 Identities = 183/323 (56%), Positives = 224/323 (69%), Gaps = 40/323 (12%)

Query: 2   NLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRK-PISNFTGQSVYIRVPAP 60
           ++  C+  CL  CSC AYA++        CLMW   L++L++    +  G+++Y+++ A 
Sbjct: 224 SIETCKMTCLNKCSCNAYAHN------GSCLMWDQILLNLQQLSKKDPDGRTLYLKLAAS 277

Query: 61  EQGN----KKLLWII--VVLVLPVVLLPSFYIFRRRRRKHKEKD---------------- 98
           E  N    K   W+I  VV+ + V+LL S+  +R+ +R    ++                
Sbjct: 278 ELQNSRESKMPRWVIGMVVVAVLVLLLASYICYRQMKRVQDREEMTTSQDILLYEFGMGS 337

Query: 99  -------GEGN----DKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNG 147
                   EGN    DK+KD+WLPLFS ASVSAATE+FST+ KLG+GGFGPVYKG L NG
Sbjct: 338 KATENELNEGNRVGKDKNKDAWLPLFSFASVSAATEHFSTENKLGQGGFGPVYKGELFNG 397

Query: 148 QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD 207
           QE+AVKRLS  SGQGL E KNE +L+A+LQHR+LVRL GCCIEQGE ILIYEYMPNKSLD
Sbjct: 398 QEIAVKRLSRSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLD 457

Query: 208 VFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 267
            FLF P K+  L W  RV IIEGIAQGLLYLH+YSRLRIIHRDLKASNILLD+DMNPKIS
Sbjct: 458 SFLFDPNKRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKIS 517

Query: 268 DFGMARIFGGDELQGNTKRIVGT 290
           DFGMAR+FGG+E   NT RIVGT
Sbjct: 518 DFGMARMFGGNESYANTNRIVGT 540

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	290
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.993	0.353	0.528	6.2e-78
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.644	0.238	0.647	4.1e-77
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.675	0.230	0.658	9.6e-76
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.648	0.221	0.691	9.7e-74
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.624	0.213	0.646	2.1e-73
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.686	0.236	0.609	2.5e-73
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.672	0.229	0.608	5.4e-73
TAIR|locus:2200888	804	AT1G61500 [Arabidopsis thalian	0.979	0.353	0.501	8e-69
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.624	0.214	0.662	6e-68
TAIR|locus:2137010	849	AT4G11900 [Arabidopsis thalian	0.696	0.237	0.6	2e-67

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 784 (281.0 bits), Expect = 6.2e-78, P = 6.2e-78
 Identities = 156/295 (52%), Positives = 207/295 (70%)

Query:     1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
             M L  C+ KC  NCSC AYAN+ +  GG GCL+WFGDL+D+R+  S+F GQ VYIR+   
Sbjct:   373 MTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMRE-YSSF-GQDVYIRMGFA 430

Query:    61 E---QGNKKXXXXXXXXXXXXXXXXS-FYIFRRR-RRKHKEKDGEGNDKSKDSWLPLFSL 115
             +   +G +                   F  FR++  ++++ ++     + +D  LP+F  
Sbjct:   431 KIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLPIFDR 490

Query:   116 ASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
              ++S AT++FS    LG GGFGPVYKG+L +GQE+AVKRLS  SGQG+ EFKNE+ LIAK
Sbjct:   491 KTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAK 550

Query:   176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
             LQHR+LVRL GCCI+  E +LIYEYMPNKSLD F+F  ++   L W+ R+ II G+A+G+
Sbjct:   551 LQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGI 610

Query:   236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
             LYLHQ SRLRIIHRDLKA N+LLD+DMNPKISDFG+A+ FGGD+ + +T R+VGT
Sbjct:   611 LYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGT 665

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 620 (223.3 bits), Expect = 4.1e-77, Sum P(2) = 4.1e-77
 Identities = 121/187 (64%), Positives = 146/187 (78%)

Query:   104 KSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL 163
             + +D  LP   L +VS AT  FS   KLG+GGFGPVYKG L  GQEVAVKRLS  S QG+
Sbjct:   444 EEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGV 503

Query:   164 TEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQA 223
              EFKNE+ LIAKLQHR+LV++ G C+++ E +LIYEY PNKSLD F+F  +++R L W  
Sbjct:   504 EEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPK 563

Query:   224 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN 283
             RV II+GIA+G+LYLH+ SRLRIIHRDLKASN+LLDSDMN KISDFG+AR  GGDE + N
Sbjct:   564 RVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEAN 623

Query:   284 TKRIVGT 290
             T R+VGT
Sbjct:   624 TTRVVGT 630

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 682 (245.1 bits), Expect = 9.6e-76, Sum P(2) = 9.6e-76
 Identities = 129/196 (65%), Positives = 159/196 (81%)

Query:    95 KEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKR 154
             + + G+ + ++ ++ L +FS  SV+ AT+ FS   KLGEGGFGPVYKGRL++G+EVA+KR
Sbjct:   497 RRRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKR 556

Query:   155 LSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPK 214
             LS  SGQGL EFKNE MLIAKLQH +LV+L GCC+E+ E +LIYEYMPNKSLD FLF P 
Sbjct:   557 LSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPL 616

Query:   215 KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
             +K +L W+ R RI+EGI QGLLYLH+YSRL++IHRD+KA NILLD DMNPKISDFGMARI
Sbjct:   617 RKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARI 676

Query:   275 FGGDELQGNTKRIVGT 290
             FG  E + NTKR+ GT
Sbjct:   677 FGAQESKANTKRVAGT 692

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 670 (240.9 bits), Expect = 9.7e-74, Sum P(2) = 9.7e-74
 Identities = 130/188 (69%), Positives = 151/188 (80%)

Query:   103 DKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG 162
             +  K   L ++SL  +  AT NFS   KLGEGGFGPVY G L  G+EVAVKRL   SGQG
Sbjct:   508 EDGKSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQG 567

Query:   163 LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ 222
             L EFKNE++LIAKLQHR+LVRL GCCI + E IL+YEYMPNKSLD FLF P+K+RLL W+
Sbjct:   568 LEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWK 627

Query:   223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
              R  IIEGIA+GLLYLH+ SRLR++HRDLKASNILLD+DM PKISDFGMAR+FGGD+ Q 
Sbjct:   628 KRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQF 687

Query:   283 NTKRIVGT 290
             NT R+VGT
Sbjct:   688 NTNRVVGT 695

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 596 (214.9 bits), Expect = 2.1e-73, Sum P(2) = 2.1e-73
 Identities = 117/181 (64%), Positives = 139/181 (76%)

Query:   110 LPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE 169
             LPL    +++ AT NFST  KLG+GGFG VYKG LL+G+E+AVKRLS  S QG  EF NE
Sbjct:   508 LPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNE 567

Query:   170 MMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE 229
             + LIAKLQH +LVRL GCC+++GE +LIYEY+ N SLD  LF   +   L WQ R  II 
Sbjct:   568 VRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIIN 627

Query:   230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
             GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFGMARIFG +E + NT+R+VG
Sbjct:   628 GIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVG 687

Query:   290 T 290
             T
Sbjct:   688 T 688

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 607 (218.7 bits), Expect = 2.5e-73, Sum P(2) = 2.5e-73
 Identities = 125/205 (60%), Positives = 149/205 (72%)

Query:    86 IFRRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLL 145
             +  RR    KEK      KS+   LPL  L +++ AT NFS   KLG+GGFG VYKGRLL
Sbjct:   486 VVSRRGYTSKEK------KSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLL 539

Query:   146 NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKS 205
             +G+E+AVKRLS  S QG  EF NE+ LIAKLQH +LVRL GCC+++GE +LIYEY+ N S
Sbjct:   540 DGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLS 599

Query:   206 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 265
             LD  LF   +   L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PK
Sbjct:   600 LDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPK 659

Query:   266 ISDFGMARIFGGDELQGNTKRIVGT 290
             ISDFGMARIFG +E + NT+R+VGT
Sbjct:   660 ISDFGMARIFGREETEANTRRVVGT 684

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 595 (214.5 bits), Expect = 5.4e-73, Sum P(2) = 5.4e-73
 Identities = 121/199 (60%), Positives = 143/199 (71%)

Query:    92 RKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVA 151
             R+H  ++   +D      LPL     V+ AT NFS   KLG+GGFG VYKG+LL+GQE+A
Sbjct:   497 RRHISRENNTDDLE----LPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMA 552

Query:   152 VKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLF 211
             VKRLS  S QG  EFKNE+ LIA+LQH +LVRL  CC++ GE +LIYEY+ N SLD  LF
Sbjct:   553 VKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLF 612

Query:   212 YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
                +   L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASNILLD  M PKISDFGM
Sbjct:   613 DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGM 672

Query:   272 ARIFGGDELQGNTKRIVGT 290
             ARIFG DE + NT+++VGT
Sbjct:   673 ARIFGRDETEANTRKVVGT 691

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)]

 Score = 698 (250.8 bits), Expect = 8.0e-69, P = 8.0e-69
 Identities = 150/299 (50%), Positives = 195/299 (65%)

Query:     1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVPAP 60
             +N  +C  +C+ NCSC A+A  K    G GCL+W  DL+D  +   + TG+ + IR+   
Sbjct:   364 VNAEECHQRCVHNCSCLAFAYIK----GIGCLVWNQDLMDAVQ--FSATGELLSIRLARS 417

Query:    61 E-QGNKKXXXXXXXXXXXXXXX----XSFYIFRRRRRK--HKEKDGEGND-KSKD-SWLP 111
             E  GNK+                    +F ++R R     H  KD   ND K +D   L 
Sbjct:   418 ELDGNKRKKTIVASIVSLTLFMILGFTAFGVWRCRVEHIAHISKDAWKNDLKPQDVPGLD 477

Query:   112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMM 171
              F + ++  AT NFS   KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG  EF NE++
Sbjct:   478 FFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIV 537

Query:   172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
             LI+KLQHR+LVR+ GCCIE+ E +LIYE+M NKSLD FLF  +K+  + W  R  II+GI
Sbjct:   538 LISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQGI 597

Query:   232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
             A+GLLYLH  SRLR+IHRDLK SNILLD  MNPKISDFG+AR++ G E Q NT+R+VGT
Sbjct:   598 ARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGT 656

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 611 (220.1 bits), Expect = 6.0e-68, Sum P(2) = 6.0e-68
 Identities = 120/181 (66%), Positives = 145/181 (80%)

Query:   110 LPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE 169
             LP+FS  SV++AT +F+ + KLG+GGFG VYKG    G+E+AVKRLS +S QGL EFKNE
Sbjct:   510 LPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNE 569

Query:   170 MMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE 229
             ++LIAKLQHR+LVRL GCCIE  E +L+YEYMPNKSLD FLF   K+  L W+ R  +I 
Sbjct:   570 ILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIG 629

Query:   230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
             GIA+GLLYLH+ SRL+IIHRDLKASNILLD++MNPKISDFGMARIF   +   NT R+VG
Sbjct:   630 GIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVG 689

Query:   290 T 290
             T
Sbjct:   690 T 690

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2137010 AT4G11900 [Arabidopsis thaliana (taxid:3702)]

 Score = 609 (219.4 bits), Expect = 2.0e-67, Sum P(2) = 2.0e-67
 Identities = 123/205 (60%), Positives = 153/205 (74%)

Query:    88 RRRRRKHKEKDGEGN--DKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLL 145
             ++R  KH  +  EG   D + ++   L +L  +  AT +FS + KLGEGGFGPVYKG+L 
Sbjct:   499 KQRDEKHSRELLEGGLIDDAGENMCYL-NLHDIMVATNSFSRKKKLGEGGFGPVYKGKLP 557

Query:   146 NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKS 205
             NG EVA+KRLS +S QGLTEFKNE++LI KLQH++LVRL G C+E  E +LIYEYM NKS
Sbjct:   558 NGMEVAIKRLSKKSSQGLTEFKNEVVLIIKLQHKNLVRLLGYCVEGDEKLLIYEYMSNKS 617

Query:   206 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 265
             LD  LF   K R L W+ R++I+ G  +GL YLH+YSRLRIIHRDLKASNILLD +MNPK
Sbjct:   618 LDGLLFDSLKSRELDWETRMKIVNGTTRGLQYLHEYSRLRIIHRDLKASNILLDDEMNPK 677

Query:   266 ISDFGMARIFGGDELQGNTKRIVGT 290
             ISDFG ARIFG  ++  +T+RIVGT
Sbjct:   678 ISDFGTARIFGCKQIDDSTQRIVGT 702

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	290
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-42
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-41
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-40
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-37
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-37
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-23
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-18
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	7e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-16
pfam08276	66	pfam08276, PAN_2, PAN-like domain	2e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-15
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-07
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	8e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.001
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.001
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.001
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.001
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.001
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.001
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.001
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.002
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  148 bits (375), Expect = 3e-43
 Identities = 58/150 (38%), Positives = 79/150 (52%), Gaps = 11/150 (7%)

Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           KLGEG FG VYKG+L         EVAVK L  + S Q + EF  E  ++ KL H ++V+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
           L G C E+    ++ EYM    L  +L   K +  L     +     IA+G+ YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              IHRDL A N L+  ++  KISDFG++R
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR 150

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  147 bits (373), Expect = 5e-43
 Identities = 59/150 (39%), Positives = 80/150 (53%), Gaps = 10/150 (6%)

Query: 130 KLGEGGFGPVYKGRLLNG-----QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           KLGEG FG VYKG L         EVAVK L  + S Q + EF  E  ++ KL H ++V+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
           L G C E+   +++ EYMP   L  +L   + K  L     +     IA+G+ YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE---S 121

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              IHRDL A N L+  ++  KISDFG++R
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR 151

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  146 bits (370), Expect = 2e-42
 Identities = 56/150 (37%), Positives = 78/150 (52%), Gaps = 11/150 (7%)

Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVR 183
           KLGEG FG VYKG L         +VAVK L   +  +   EF  E  ++ KL H ++VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
           L G C +     ++ EYMP   L  FL   K    L  +  +++   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +HRDL A N L+  ++  KISDFG++R
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  143 bits (362), Expect = 3e-41
 Identities = 59/155 (38%), Positives = 80/155 (51%), Gaps = 14/155 (9%)

Query: 130 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRL 184
           KLGEG FG VYKG+L        EVAVK L    S +   +F  E  ++ KL H ++VRL
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            G C E+    L+ EYM    L  +L      F   +K  L  +  +     IA+G+ YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                 + +HRDL A N L+  D+  KISDFG++R
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  139 bits (353), Expect = 2e-40
 Identities = 62/163 (38%), Positives = 88/163 (53%), Gaps = 10/163 (6%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           LGEGGFG VY  R    G++VA+K +    S   L E   E+ ++ KL H ++V+L+G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
            ++    L+ EY    SL       + +  L     +RI+  I +GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSL--KDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 249 RDLKASNILLDSD-MNPKISDFGMARIFGGDELQGNTKRIVGT 290
           RDLK  NILLDSD    K++DFG++++   D+    T  IVGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  132 bits (335), Expect = 2e-37
 Identities = 55/164 (33%), Positives = 79/164 (48%), Gaps = 11/164 (6%)

Query: 130 KLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           KLG G FG VYK +    G+ VAVK L   ++  +     + E+ ++ +L H ++VRL  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
              ++    L+ EY     L  +L    +   L      +I   I +GL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119

Query: 247 IHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           IHRDLK  NILLD +   KI+DFG+A+         +    VGT
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGT 161

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  131 bits (331), Expect = 8e-37
 Identities = 59/168 (35%), Positives = 84/168 (50%), Gaps = 11/168 (6%)

Query: 125 FSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLV 182
           +    KLGEG FG VY  R    G+ VA+K +  +  +   E    E+ ++ KL+H ++V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+    ++ +  L+ EY     L   L   K+ RL   +AR   +  I   L YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR-FYLRQILSALEYLHS-- 115

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              I+HRDLK  NILLD D + K++DFG+AR     E        VGT
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  118 bits (297), Expect = 1e-31
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 13/153 (8%)

Query: 130 KLGEGGFGPVYKGRLLN-----GQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           +LGEG FG V   R        G++VAVK L+ +   Q  ++F+ E+ ++  L H ++V+
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 184 LFGCCIEQGENI--LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
             G C + G     LI EY+P+ SL  +L   + +  +  +  +     I +G+ YL   
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS- 127

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
              R IHRDL A NIL++S+   KISDFG+A++
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKV 158

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  114 bits (288), Expect = 2e-30
 Identities = 60/168 (35%), Positives = 88/168 (52%), Gaps = 13/168 (7%)

Query: 129 CKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
             LG G FG VY       G+ +AVK   LS  S + L   + E+ +++ LQH ++VR +
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 186 GCCIEQGEN-ILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRI-IEGIAQGLLYLHQYS 242
           G   ++ +N + I+ EY+   SL   L   KK   L  +  +R     I +GL YLH   
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLP-EPVIRKYTRQILEGLAYLH--- 118

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              I+HRD+K +NIL+DSD   K++DFG A+  G  E    T  + GT
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 2e-28
 Identities = 56/171 (32%), Positives = 83/171 (48%), Gaps = 13/171 (7%)

Query: 124 NFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLTEFKNEMMLIAKLQHRH 180
           N+     +G G FG VYKG  L  G  VA+K++S      + L     E+ L+  L+H +
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 181 LVRLFGCCIEQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           +V+  G  IE  +++ I  EY  N SL   +   KK            +  + QGL YLH
Sbjct: 61  IVKYIGS-IETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLH 116

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           +     +IHRD+KA+NIL   D   K++DFG+A           +  +VGT
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  107 bits (268), Expect = 1e-27
 Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 18/159 (11%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E F+ + KLG G FG V++G   N   VA+K L +       +F+ E+  + +L+H+HL+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------LGWQARVRIIEGIAQGL 235
            LF  C       +I E M   SL  FL  P+ + L       +  Q        +A+G+
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
            YL +      IHRDL A NIL+  D+  K++DFG+AR+
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARL 153

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  103 bits (258), Expect = 4e-26
 Identities = 53/170 (31%), Positives = 90/170 (52%), Gaps = 15/170 (8%)

Query: 125 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           F    K+G+GGFG VYK R    G+EVA+K +  +S +   +  NE+ ++ K +H ++V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 184 LFGCCIEQGENILIYEYMPNKSL-DVFLFYPKK--KRLLGWQARVRIIEGIAQGLLYLHQ 240
            +G  +++ E  ++ E+    SL D+     +   +  + +     + + + +GL YLH 
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-----VCKELLKGLEYLHS 116

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                IIHRD+KA+NILL SD   K+ DFG++              +VGT
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  101 bits (253), Expect = 4e-25
 Identities = 51/165 (30%), Positives = 82/165 (49%), Gaps = 15/165 (9%)

Query: 130 KLGEGGFGPVYKG-RLLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           K+GEG  G VYK      G+EVA+K  RL  Q+ + +    NE++++   +H ++V  + 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYD 82

Query: 187 CCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
             +   E  ++ EYM   SL D+      +   +       +   + QGL YLH      
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVR---MNEPQIAYVCREVLQGLEYLHS---QN 136

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           +IHRD+K+ NILL  D + K++DFG A      + +     +VGT
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 4e-25
 Identities = 58/151 (38%), Positives = 77/151 (50%), Gaps = 7/151 (4%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           KLG G FG V+ G      +VAVK L          F  E  ++ KL+H  LV+L+  C 
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC- 70

Query: 190 EQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
            + E I I  EYM   SL  FL   + K+L      V +   IA+G+ YL        IH
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SRNYIH 126

Query: 249 RDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           RDL A NIL+  ++  KI+DFG+AR+   DE
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDE 157

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =   99 bits (250), Expect = 1e-24
 Identities = 53/171 (30%), Positives = 92/171 (53%), Gaps = 15/171 (8%)

Query: 125 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEF----KNEMMLIAKLQHR 179
           +    ++GEG +G VYK R    G+ VA+K++  ++ +    F      E+ L+ KL+H 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHP 58

Query: 180 HLVRLFGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           ++VRL      +G+    +++EYM +  L   L  P+ K     Q +   ++ + +GL Y
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES-QIK-CYMKQLLEGLQY 115

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
           LH      I+HRD+K SNIL+++D   K++DFG+AR +        T R++
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.8 bits (247), Expect = 2e-24
 Identities = 46/154 (29%), Positives = 78/154 (50%), Gaps = 7/154 (4%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRH 180
            +      LG+G  G VYK R    G+  A+K++  +   +   +   E+  +   +  +
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V+ +G   ++GE  ++ EYM   SL   L   KK   +       I   I +GL YLH 
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
             +  IIHRD+K SN+L++S    KI+DFG++++
Sbjct: 118 --KRHIIHRDIKPSNLLINSKGEVKIADFGISKV 149

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 2e-24
 Identities = 52/155 (33%), Positives = 82/155 (52%), Gaps = 12/155 (7%)

Query: 131 LGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +         VA+K L  ++  +   E  +E  ++A + H H+VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+   +  LI + MP   L  ++   K    +G Q  +     IA+G+ YL +    
Sbjct: 75  LGICLSS-QVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEK--- 128

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++   DE
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 97.9 bits (244), Expect = 6e-24
 Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 21/161 (13%)

Query: 131 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVR 183
           LGEG FG V+ G   + +       VAVK L   +     + F+ E  L+   QH ++V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPKKKRLLGWQARVRIIEGIA 232
            +G C E    I+++EYM +  L+ FL                   L     ++I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            G++YL   +    +HRDL   N L+  D+  KI DFGM+R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 96.4 bits (240), Expect = 2e-23
 Identities = 58/169 (34%), Positives = 81/169 (47%), Gaps = 24/169 (14%)

Query: 131 LGEGGFGPVYKGRL--LNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           LGEG FG VYKG L   N +     VA+K L  N   +   EF+ E  L++ LQH ++V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLF-------------YPKKKRLLGWQARVRIIEG 230
           L G C ++    +++EY+ +  L  FL                  K  L     + I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
           IA G+ YL   S    +HRDL A N L+   +  KISDFG++R I+  D
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 95.5 bits (238), Expect = 3e-23
 Identities = 58/160 (36%), Positives = 87/160 (54%), Gaps = 10/160 (6%)

Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG V +GRL L G++   VA+K L +  S +   +F  E  ++ +  H +++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G   +    ++I EYM N SLD FL     K        V ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTK 285
            +HRDL A NIL++S++  K+SDFG++R     E    TK
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 96.3 bits (238), Expect = 9e-23
 Identities = 56/176 (31%), Positives = 86/176 (48%), Gaps = 14/176 (7%)

Query: 124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH-R 179
           ++    KLGEG FG VY  R  + + VA+K L+ +     + +  F  E+ ++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++V+L+    ++G   L+ EY+   SL+  L    +K  L     + I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 240 QYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARIFGGD----ELQGNTKRIVGT 290
                 IIHRD+K  NILLD D    K+ DFG+A++         +       VGT
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Length = 384

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.9 bits (233), Expect = 1e-22
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 6/155 (3%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG V+ G  L  ++VA+K +  +      +F  E  ++ KL H  LV+L+G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           E+    L++E+M +  L  +L    ++     +  + +   + +G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L+  +   K+SDFGM R    D+   +T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 93.5 bits (233), Expect = 1e-22
 Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 12/170 (7%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           E F    KLGEG +G VYK      GQ VA+K +  +    L E   E+ ++ +    ++
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYI 60

Query: 182 VRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           V+ +G   +  +  ++ EY    S  D  +     K L   +    I+    +GL YLH 
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAA-ILYQTLKGLEYLHS 117

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
               + IHRD+KA NILL+ +   K++DFG++        + NT  ++GT
Sbjct: 118 ---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 94.2 bits (234), Expect = 2e-22
 Identities = 63/151 (41%), Positives = 82/151 (54%), Gaps = 15/151 (9%)

Query: 131 LGEGGFGPV--YKGRLLN---GQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRL 184
           LGEG FG V  Y     N   G+ VAVK L  + GQ  T  +K E+ ++  L H ++V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 185 FGCCIEQGENI--LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            GCC EQG     LI EY+P  SL  +L  PK K  L     +   + I +G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHK--LNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               IHRDL A N+LLD+D   KI DFG+A+
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 92.9 bits (232), Expect = 3e-22
 Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 25/158 (15%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGLTEFKN---EMMLIAKLQHRHLVRL 184
           KLGEG +G VYK R    G+ VA+K++  +   +G+        E+ L+ +L+H ++V+L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKL 63

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                 + +  L++EY  +  L  +L        P   + + +Q        + +GL Y 
Sbjct: 64  LDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQ--------LLRGLAYC 114

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           H +   RI+HRDLK  NIL++ D   K++DFG+AR FG
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFG 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 91.8 bits (228), Expect = 6e-22
 Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 15/173 (8%)

Query: 124 NFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQHRH 180
           +F    K+G+G FG V+K  R  + +  A+K+  LS  + +   E  +E  ++AKL   +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL---LGWQARVRIIEGIAQGLLY 237
           ++R +   +++G+  ++ EY  N  L   L   + + L     W    R    I  GL +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           LH     +I+HRD+K+ N+ LD+  N KI D G+A++   +    NT  IVGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 92.4 bits (229), Expect = 9e-22
 Identities = 59/159 (37%), Positives = 90/159 (56%), Gaps = 12/159 (7%)

Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L+  +G +   EF +E +++A + H HLVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      L+ + MP+  L    +  + K  +G Q  +     IA+G++YL +    
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCL--LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN 283
           R++HRDL A N+L+ S  + KI+DFG+AR+  GDE + N
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 90.6 bits (226), Expect = 2e-21
 Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 25/173 (14%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           ++G+G FG VY  R   +G+   +K   LSN S +   +  NE+ ++ KL H ++++ + 
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 187 CCIEQGENILIYEYMPNKSLDVFL-------FYPKKKRLLGW--QARVRIIEGIAQGLLY 237
              E+G+  ++ EY     L   +           ++++L W  Q        +   L Y
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--------LCLALKY 118

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           LH  SR +I+HRD+K  NI L S+   K+ DFG++++         T  +VGT
Sbjct: 119 LH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 2e-21
 Identities = 59/158 (37%), Positives = 79/158 (50%), Gaps = 20/158 (12%)

Query: 131 LGEGGFGPVYKG--RLLNGQE--VAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           LG G FG V KG   + +G+E  VAVK L       G  EF  E  ++A+L H  +VRL 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 186 GCCIEQGEN-ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE---GIAQGLLYLHQY 241
           G C  +GE  +L+ E  P   L  +L   KK+R +       + E    +A G+ YL   
Sbjct: 63  GVC--KGEPLMLVMELAPLGPLLKYL---KKRREI---PVSDLKELAHQVAMGMAYLES- 113

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
                +HRDL A N+LL +    KISDFGM+R  G   
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 89.5 bits (222), Expect = 5e-21
 Identities = 56/150 (37%), Positives = 80/150 (53%), Gaps = 6/150 (4%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           KLG G FG V+ G      +VA+K L  Q       F  E  L+ +LQH  LVRL+    
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           ++   I I EYM N SL  FL  P+  +L      + +   IA+G+ ++    R   IHR
Sbjct: 72  QEPIYI-ITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE---RKNYIHR 126

Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   +  KI+DFG+AR+   +E
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNE 156

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 89.5 bits (222), Expect = 6e-21
 Identities = 53/164 (32%), Positives = 82/164 (50%), Gaps = 19/164 (11%)

Query: 131 LGEGGFGPVYKGRL----LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LGEG FG V +G+L     +  +VAVK  +L   +   + EF +E   +    H ++++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 185 FGCCIEQGEN------ILIYEYMPNKSLDVFLFYPKKKRL---LGWQARVRIIEGIAQGL 235
            G C E          ++I  +M +  L  FL Y +   L   L  Q  ++ +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
            YL   S    IHRDL A N +L  DM   ++DFG+++ I+ GD
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 22/159 (13%)

Query: 129 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN-----EMMLIAKLQHRHLV 182
            KLGEG +  VYK R    G+ VA+K++     +   +  N     E+ L+ +L+H +++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 183 RL---FGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVR-IIEGIAQGLLY 237
            L   FG       NI L++E+M    L+  +   K K ++   A ++  +    +GL Y
Sbjct: 66  GLLDVFG----HKSNINLVFEFMET-DLEKVI---KDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           LH      I+HRDLK +N+L+ SD   K++DFG+AR FG
Sbjct: 118 LHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 88.9 bits (220), Expect = 1e-20
 Identities = 60/168 (35%), Positives = 84/168 (50%), Gaps = 22/168 (13%)

Query: 130 KLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           +LGEG FG V+      LL  Q+   VAVK L   S     +F+ E  L+  LQH+H+VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRL----------LGWQARVRIIEGI 231
            +G C E    ++++EYM +  L+ FL    P  K L          L     + I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R I+  D
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 3e-20
 Identities = 45/143 (31%), Positives = 76/143 (53%), Gaps = 6/143 (4%)

Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 190
           +G+G FG V  G    GQ+VAVK L + S      F  E  ++  L+H +LV+L G  ++
Sbjct: 14  IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 191 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRD 250
                ++ EYM   SL  +L   + + ++    ++     + +G+ YL +      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 251 LKASNILLDSDMNPKISDFGMAR 273
           L A N+L+  D+  K+SDFG+A+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 4e-20
 Identities = 49/149 (32%), Positives = 77/149 (51%), Gaps = 6/149 (4%)

Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 190
           LG G FG V+ G+     +VA+K +  +      +F  E  ++ KL H +LV+L+G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 191 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRD 250
           Q    ++ EYM N  L  +L   ++K  LG +  + +   + + + YL        IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 251 LKASNILLDSDMNPKISDFGMARIFGGDE 279
           L A N L+  D   K+SDFG+AR    D+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 5e-20
 Identities = 51/151 (33%), Positives = 74/151 (49%), Gaps = 7/151 (4%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           KLG G FG V++G   N   VAVK L   +     +F  E  ++ KL+H  L++L+  C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 190 EQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
              E I I  E M   SL  +L      R L     + +   +A G+ YL   +    IH
Sbjct: 72  -LEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126

Query: 249 RDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           RDL A N+L+  +   K++DFG+AR+   D 
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDI 157

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 86.8 bits (215), Expect = 6e-20
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 30/180 (16%)

Query: 131 LGEGGFGPVYKGR---LLNGQE---VAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           +G+G FG V++ R   LL  +    VAVK L  + S     +F+ E  L+A+  H ++V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL-------------------FYPKKKRLLGWQAR 224
           L G C       L++EYM    L+ FL                           L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDELQGN 283
           + I + +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R I+  D  + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.1 bits (211), Expect = 3e-19
 Identities = 47/154 (30%), Positives = 87/154 (56%), Gaps = 13/154 (8%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLF 185
           K+GEG +G VYK R  L G+ VA+K++     +     K    E+ L+ +L H ++++L 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIK-LRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR-IIEGIAQGLLYLHQYSRL 244
                +G+  L++E+M     D++     ++R L  ++ ++  +  + QGL + H +   
Sbjct: 65  DVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHSH--- 117

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
            I+HRDLK  N+L++++   K++DFG+AR FG  
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 3e-19
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 32/162 (19%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           K+GEG +G VYK R  L G+ VA+K++   +   G   T  + E+ L+ +L H ++VRL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLL 64

Query: 186 GCCIEQGENILIYEYM-----------PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
                + +  L++E++           P   LD  L    K  L  +Q    +++GIA  
Sbjct: 65  DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSYL--YQ----LLQGIA-- 113

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
             Y H +   R++HRDLK  N+L+D +   K++DFG+AR FG
Sbjct: 114 --YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.8 bits (207), Expect = 6e-19
 Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 26/175 (14%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLT--EFKNEMMLIAKLQHRHLVR 183
           LG G F   Y+ R +  G  +AVK+++      S Q       + E+ L+A+L H H++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           + G   E     L  E+M   S+   L  +   K+ ++     +   E + +GL YLH+ 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122

Query: 242 SRLRIIHRDLKASNILLDSD-MNPKISDFGMA-----RIFGGDELQGNTKRIVGT 290
              +IIHRD+K +N+L+DS     +I+DFG A     +  G  E QG   +++GT
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGT 171

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 83.7 bits (207), Expect = 6e-19
 Identities = 53/145 (36%), Positives = 77/145 (53%), Gaps = 6/145 (4%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLFGCC 188
           K+G+G FG VYKG L    EVAVK   +     L   F  E  ++ +  H ++V+L G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
           +++    ++ E +P  SL  FL   KKK  L  +  +++    A G+ YL   +    IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116

Query: 249 RDLKASNILLDSDMNPKISDFGMAR 273
           RDL A N L+  +   KISDFGM+R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 84.0 bits (208), Expect = 7e-19
 Identities = 55/154 (35%), Positives = 88/154 (57%), Gaps = 15/154 (9%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           K+GEG +G VYKGR    GQ VA+K++   S + G   T  + E+ L+ +LQH ++V L 
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCLQ 65

Query: 186 GCCIEQGENILIYEYMP---NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
              +++    LI+E++     K LD     PK + +     +  + + I QG+L+ H   
Sbjct: 66  DVLMQESRLYLIFEFLSMDLKKYLDSL---PKGQYMDAELVKSYLYQ-ILQGILFCH--- 118

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
             R++HRDLK  N+L+D+    K++DFG+AR FG
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 83.3 bits (206), Expect = 1e-18
 Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 24/162 (14%)

Query: 131 LGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 186 GCCIEQGEN--ILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLY 237
           G C   G     L+ EY+P  SL  +L         +K  L   Q        I +G+ Y
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           L      R +HRDL   NIL++S+   KI DFG+ ++   D+
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 1e-18
 Identities = 52/158 (32%), Positives = 90/158 (56%), Gaps = 18/158 (11%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQ---HRHLVR 183
           +GEG +G VYK R L  G+ VA+K++    ++ G  L+  + E+ L+ +L+   H ++VR
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVR 65

Query: 184 LFGCC-IEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
           L   C   + +      L++E++ ++ L  +L    K  L     +  ++  + +G+ +L
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFL 123

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           H +   RI+HRDLK  NIL+ SD   KI+DFG+ARI+ 
Sbjct: 124 HSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 27/177 (15%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLF 185
           KLGEG FG VYK R +  G+ VA+K++   +   G  +T  + E+ ++ KL+H ++V L 
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLI 73

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKR----LLGWQARVR--------IIEGIAQ 233
              +E+ +          K   V++  P        LL     V+         +  + +
Sbjct: 74  DMAVERPDKSK------RKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYMLQLLE 126

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G+ YLH+     I+HRD+KA+NIL+D+    KI+DFG+AR + G           GT
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.8 bits (204), Expect = 2e-18
 Identities = 54/150 (36%), Positives = 79/150 (52%), Gaps = 5/150 (3%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           KLG G FG V+ G   N  +VAVK L   +   +  F  E  L+  LQH  LVRL+    
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           ++    +I EYM   SL  FL   +  ++L     +     IA+G+ Y+    R   IHR
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 127

Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+N+L+   +  KI+DFG+AR+   +E
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE 157

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 83.2 bits (205), Expect = 2e-18
 Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 19/166 (11%)

Query: 124 NFSTQCKLGEGGFGPVYKGRLLN---GQE---VAVKRLSNQSGQGLTEFKNEMMLIAKLQ 177
           N   + +LGEG FG V+     N    Q+   VAVK L + S     +F  E  L+  LQ
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR----------VRI 227
           H H+V+ +G C+E    I+++EYM +  L+ FL       +L  +            + I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            + IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 82.6 bits (205), Expect = 2e-18
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 17/163 (10%)

Query: 131 LGEGGFGPVYKGRLL-NGQEVAVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +GEG F  V   +     +E A+K L         +      E K  +  +    H  ++
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE-KEVLTRLN--GHPGII 65

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L+    ++     + EY PN  L   L Y +K   L  +        I   L YLH   
Sbjct: 66  KLYYTFQDEENLYFVLEYAPNGEL---LQYIRKYGSLDEKCTRFYAAEILLALEYLHS-- 120

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTK 285
              IIHRDLK  NILLD DM+ KI+DFG A++   +    + K
Sbjct: 121 -KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.4 bits (204), Expect = 2e-18
 Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 16/151 (10%)

Query: 130 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH---LVRLF 185
           +LG G  G V K      G+ +AVK +  +        K  +  +  L   +   +V  +
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKK---KRLLGWQARVRIIEGIAQGLLYLHQYS 242
           G     G+  +  EYM   SLD  L   +    +R+LG     +I   + +GL YLH   
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--E 118

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           + +IIHRD+K SNIL++S    K+ DFG++ 
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 81.1 bits (200), Expect = 5e-18
 Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 6/150 (4%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G+     +VA+K + N+      +F  E  ++ KL H  LV+L+G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +Q    ++ E+M N  L  +L   +++  L     + + + + +G+ YL + S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL A N L+ S    K+SDFGM R    DE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 76.3 bits (188), Expect = 7e-18
 Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 5/58 (8%)

Query: 1  MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVP 58
          ++L +C+  CL NCSC AYA +    G  GCL+W G L +LR    +  G ++Y+R+ 
Sbjct: 32 ISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSL--SSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 80.5 bits (199), Expect = 7e-18
 Identities = 52/152 (34%), Positives = 69/152 (45%), Gaps = 16/152 (10%)

Query: 130 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRL 184
           KLG+G FG V +G           VAVK L +      + +F  E  ++  L H +L+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG---WQARVRIIEGIAQGLLYLHQY 241
           +G  +     +++ E  P  SL   L        L        V+I    A G+ YL   
Sbjct: 62  YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              R IHRDL A NILL SD   KI DFG+ R
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 9e-18
 Identities = 47/163 (28%), Positives = 70/163 (42%), Gaps = 29/163 (17%)

Query: 131 LGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG+G FG VY+G             VA+K ++ N S +   EF NE  ++ +    H+VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 184 LFGCCIEQGENILIYEYM-------------PNKSLDVFLFYPKKKRLLGWQARVRIIEG 230
           L G        +++ E M             P    +  L  P  ++ +   A       
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE------ 127

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           IA G+ YL      + +HRDL A N ++  D+  KI DFGM R
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 9e-18
 Identities = 51/155 (32%), Positives = 82/155 (52%), Gaps = 24/155 (15%)

Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+G FG VY    ++ G+E+AVK+      S ++ + +   + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 185 FGCCIEQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-----IAQGLLYL 238
           +GC +   E + I+ EYMP  S+        K +L  + A    +       I +G+ YL
Sbjct: 70  YGC-LRDDETLSIFMEYMPGGSV--------KDQLKAYGALTETVTRKYTRQILEGVEYL 120

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           H      I+HRD+K +NIL DS  N K+ DFG ++
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 80.4 bits (198), Expect = 1e-17
 Identities = 54/157 (34%), Positives = 87/157 (55%), Gaps = 18/157 (11%)

Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIAKLQHRHL 181
           +G G FG V++G L + G++   VA+K L      G TE     F +E  ++ +  H ++
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLK----PGYTEKQRQDFLSEASIMGQFSHHNI 68

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL G   +    ++I EYM N +LD +L          +Q  V ++ GIA G+ YL   
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQL-VGMLRGIAAGMKYL--- 123

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           S +  +HRDL A NIL++S++  K+SDFG++R+   D
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.8 bits (200), Expect = 1e-17
 Identities = 46/162 (28%), Positives = 83/162 (51%), Gaps = 9/162 (5%)

Query: 130 KLGEGGFGPVYKGRLL-NGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           ++GEG  G V+K +    G+ VA+K+  L    G    +   E+  +   QH ++V+L  
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
                   +L+ EYMP+   +V     +   L   Q +   +  + +G+ Y+H      I
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERP--LPEAQVK-SYMRMLLKGVAYMHA---NGI 120

Query: 247 IHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
           +HRDLK +N+L+ +D   KI+DFG+AR+F  +E +  + ++ 
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 80.3 bits (198), Expect = 1e-17
 Identities = 53/152 (34%), Positives = 84/152 (55%), Gaps = 18/152 (11%)

Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG V +GRL L G+    VA+K L S  + +   +F +E  ++ +  H +++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ----ARVRIIEGIAQGLLYLHQY 241
           G   +    ++I E+M N +LD FL      R    Q      V ++ GIA G+ YL   
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL------RQNDGQFTVIQLVGMLRGIAAGMKYL--- 122

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           S +  +HRDL A NIL++S++  K+SDFG++R
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.8 bits (199), Expect = 1e-17
 Identities = 53/163 (32%), Positives = 81/163 (49%), Gaps = 22/163 (13%)

Query: 130 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           +LGEG FG V+     N         VAVK L + +     +F+ E  L+  LQH H+V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLF------------YPKK-KRLLGWQARVRIIEG 230
            +G C +    I+++EYM +  L+ FL              P++ K  LG    + I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 80.4 bits (198), Expect = 1e-17
 Identities = 55/165 (33%), Positives = 88/165 (53%), Gaps = 28/165 (16%)

Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG V+KG  +   +     VA+K + ++SG Q   E  + M+ +  L H ++VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 185 FGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKR-------LLGWQARVRIIEGIAQGLL 236
            G C   G ++ L+ +  P  SL   L + ++ R       LL W  +      IA+G+ 
Sbjct: 75  LGIC--PGASLQLVTQLSPLGSL---LDHVRQHRDSLDPQRLLNWCVQ------IAKGMY 123

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
           YL ++   R++HR+L A NILL SD   +I+DFG+A +   D+ +
Sbjct: 124 YLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 80.2 bits (198), Expect = 2e-17
 Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 16/164 (9%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQG-LTEFKNEMMLIAK 175
            N      LG G FG V+  +    +E      V VK L     +   +EF+ E+ +  K
Sbjct: 5   SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL------LGWQARVRIIE 229
           L H+++VRL G C E   + +I EY     L  FL   K K        L  + +V +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            IA G+ +L   S  R +HRDL A N L+ S    K+S   +++
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 79.9 bits (197), Expect = 2e-17
 Identities = 54/160 (33%), Positives = 76/160 (47%), Gaps = 20/160 (12%)

Query: 131 LGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLV 182
           LG G FG VY+G   +          VAVK L   +  Q   EF  E  L++   H ++V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKR----LLGWQARVRIIEGIAQGLLYL 238
           +L G C+      +I E M    L  +L   + +R    LL  +  + I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 239 HQYSRLRIIHRDLKASNILL-----DSDMNPKISDFGMAR 273
            Q   +  IHRDL A N L+     D+D   KI DFG+AR
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 79.7 bits (196), Expect = 2e-17
 Identities = 52/163 (31%), Positives = 89/163 (54%), Gaps = 18/163 (11%)

Query: 131 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           LGEG FG V +G+L       +VAVK  +++  +   + +F +E + + +  H +++RL 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 186 GCCIEQGEN------ILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLL 236
           G C++  E+      ++I  +M +  L  FL Y +     + L  Q  V+ +  IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RIFGGD 278
           YL   S    IHRDL A N +L+ +MN  ++DFG++ +I+ GD
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 45/159 (28%), Positives = 83/159 (52%), Gaps = 16/159 (10%)

Query: 130 KLGEGGFGPVYKGRLLN---GQEVAVKRL--SNQSGQGLTEFK-NEMMLIAKLQHRHLVR 183
            +G G +G VYK +  N   G+E A+K+     +   G+++    E+ L+ +L+H ++V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 184 LFGCCIEQGENI--LIYEYMPNKSLDVFLFYPKKKRLLGWQARVR-IIEGIAQGLLYLHQ 240
           L    +E  +    L+++Y  +    +  F+ + KR+    + V+ ++  I  G+ YLH 
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126

Query: 241 YSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIF 275
                ++HRDLK +NIL+  +       KI D G+AR+F
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.8 bits (197), Expect = 2e-17
 Identities = 54/163 (33%), Positives = 80/163 (49%), Gaps = 18/163 (11%)

Query: 131 LGEGGFGPVYKG--RLLNG----QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G  R  +G     +VAVK L  + S Q  ++F  E ++++K  H+++VR
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLF----YPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           L G   E+    ++ E M    L  FL      P++   L  +  +     +A+G  YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 240 QYSRLRIIHRDLKASNILLDS---DMNPKISDFGMAR-IFGGD 278
           +      IHRD+ A N LL         KI+DFGMAR I+   
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 79.1 bits (196), Expect = 2e-17
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 16/166 (9%)

Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+G FG V   R  + G+  A+K L  +     + +     E  +++++ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 187 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQGLLYLHQYSRL 244
              +  E + L+ EY P   L     +  K+     + R R     I   L YLH    L
Sbjct: 60  YAFQTEEKLYLVLEYAPGGEL---FSHLSKEGRFS-EERARFYAAEIVLALEYLH---SL 112

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            II+RDLK  NILLD+D + K++DFG+A+    +  + NT    GT
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 79.6 bits (196), Expect = 3e-17
 Identities = 58/165 (35%), Positives = 85/165 (51%), Gaps = 18/165 (10%)

Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIAKLQHRHL 181
           +G G FG V  GRL L G+    VA+K L      G TE     F +E  ++ +  H ++
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLK----AGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           + L G   +    +++ EYM N SLD FL   K          V ++ GIA G+ YL   
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYL--- 122

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 78.8 bits (194), Expect = 3e-17
 Identities = 52/146 (35%), Positives = 81/146 (55%), Gaps = 10/146 (6%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
            +GEG FG V +G    GQ+VAVK +  + + Q    F  E  ++ KL H++LVRL G  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
           +  G  I++ E M   +L  FL   + + L+     ++    +A+G+ YL      +++H
Sbjct: 69  LHNGLYIVM-ELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 249 RDLKASNILLDSDMNPKISDFGMARI 274
           RDL A NIL+  D   K+SDFG+AR+
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV 149

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.9 bits (197), Expect = 3e-17
 Identities = 48/149 (32%), Positives = 76/149 (51%), Gaps = 10/149 (6%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           ++G G FG VY  R +   + VA+K++S    QS +   +   E+  + +L+H + +   
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           GC + +    L+ EY    + D+   + K  + +   A   I  G  QGL YLH + R  
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA---ICHGALQGLAYLHSHER-- 136

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARI 274
            IHRD+KA NILL      K++DFG A +
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASL 164

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 5e-17
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 12/154 (7%)

Query: 125 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQ-HRH 180
           +    +LG+G FG VY  R    G+ VA+K++  +  S +     + E+  + KL  H +
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPN 59

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR-IIEGIAQGLLYLH 239
           +V+L     E  E   ++EYM     +++     +K     ++ +R II  I QGL ++H
Sbjct: 60  IVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +    HRDLK  N+L+      KI+DFG+AR
Sbjct: 117 ---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.8 bits (194), Expect = 5e-17
 Identities = 56/159 (35%), Positives = 87/159 (54%), Gaps = 17/159 (10%)

Query: 131 LGEGGFGPV----YKGRLLN-GQEVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRL 184
           LGEG FG V    Y     N G++VAVK L  +SG   + + K E+ ++  L H ++V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 185 FGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL--HQ 240
            G C E G N   LI E++P+ SL  +L  P+ K  +  + +++    I +G+ YL   Q
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           Y     +HRDL A N+L++S+   KI DFG+ +    D+
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 77.5 bits (191), Expect = 9e-17
 Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 18/152 (11%)

Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLS----NQSGQG-LTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VY+G  L +G   AVK +S     Q+GQ  + + + E+ L++KLQH ++V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 185 FGCCIEQGENILIY-EYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
            G   E  +N+ I+ E +P  SL   L  +    + ++    R      I  GL YLH  
Sbjct: 68  LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH-- 119

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            R   +HRD+K +NIL+D++   K++DFGMA+
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 77.2 bits (190), Expect = 1e-16
 Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 10/152 (6%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V  G+     +VA+K +   S     EF  E  ++ KL H  LV+L+G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL--HQYSRLRII 247
           +Q    ++ EYM N  L  +L    K+        + + + + +G+ YL   Q+     I
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESKQF-----I 122

Query: 248 HRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           HRDL A N L+D     K+SDFG++R    DE
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 1e-16
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 23/161 (14%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN----EMMLIAKLQ 177
             +     +GEG +G V K R    G+ VA+K+   +  +   + K     E+ ++ +L+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPK-----KKRLLGWQARVRIIEGIA 232
           H ++V L      +G   L++EY+    L++    P        R   WQ        + 
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LL 110

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           Q + Y H      IIHRD+K  NIL+      K+ DFG AR
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.4 bits (191), Expect = 1e-16
 Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 7/167 (4%)

Query: 128 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
              +G G    VY    L N ++VA+KR+   +    + E + E+  +++  H ++V+ +
Sbjct: 6   IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
              +   E  L+  Y+   SL   +     +  L       +++ + +GL YLH   +  
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 246 IIHRDLKASNILLDSDMNPKISDFGM-ARIF-GGDELQGNTKRIVGT 290
            IHRD+KA NILL  D + KI+DFG+ A +  GGD  +   K  VGT
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 77.2 bits (190), Expect = 2e-16
 Identities = 54/158 (34%), Positives = 88/158 (55%), Gaps = 23/158 (14%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGL--TEFKNEMMLIAKLQHRHLVRLF 185
           K+GEG +G VYK R  +  + +A+K++   Q  +G+  T  + E+ L+ ++QH ++VRL 
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQ 67

Query: 186 GCCIEQGENILIYEYMP---NKSLDVFLFYPKKKRLLG---WQARVRIIEGIAQGLLYLH 239
                +    L++EY+     K +D    + K  RL+    +Q    I+ GIA    Y H
Sbjct: 68  DVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----YCH 119

Query: 240 QYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFG 276
            +   R++HRDLK  N+L+D   N  K++DFG+AR FG
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154

Length = 294

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 77.1 bits (190), Expect = 2e-16
 Identities = 52/163 (31%), Positives = 84/163 (51%), Gaps = 22/163 (13%)

Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRH 180
           NF    KLGEG +  VYKGR    G+ VA+K   L  + G   T  + E+ L+ +L+H +
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59

Query: 181 LVRLFGCCIEQGENILIYEYMPN---KSLDVF----LFYPKKKRLLGWQARVRIIEGIAQ 233
           +VRL      + + +L++EYM     K +D         P   +   +Q        + +
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLK 111

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           G+ + H+    R++HRDLK  N+L++     K++DFG+AR FG
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score = 71.5 bits (176), Expect = 2e-16
 Identities = 21/41 (51%), Positives = 31/41 (75%), Gaps = 1/41 (2%)

Query: 1  MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDL 41
          + L +C+ +CL NCSC AYA + +  GGSGCL+W G+L+D+
Sbjct: 27 IGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIWTGELVDM 66

Length = 66

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.1 bits (190), Expect = 2e-16
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGL-TEFKNEMMLIAKLQHRH 180
           E      +LGEG  G V K RL N   + A+K ++      L  +   E+ +    +  +
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 181 LVRLFGCCI-EQGENILI-YEYMPNKSLDVFLFYPKKKRLLGWQARV------RIIEGIA 232
           +V+ +G  + E   +I I  EY    SLD        K++     R+      +I E + 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY-----KKVKKRGGRIGEKVLGKIAESVL 115

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
           +GL YLH     +IIHRD+K SNILL      K+ DFG
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 57/178 (32%), Positives = 87/178 (48%), Gaps = 26/178 (14%)

Query: 130 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRHLV 182
           +LGE  FG VYKG L         Q VA+K L +++   L  EFK+E M+ ++LQH ++V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIE 229
            L G   ++    +I+ Y  +  L  FL                  K  L     V I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD--ELQGNT 284
            IA G+ +L   S   ++H+DL   N+L+   +N KISD G+ R ++  D  +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 50/170 (29%), Positives = 73/170 (42%), Gaps = 29/170 (17%)

Query: 130 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLTEFKNEMM 171
           KLGEG FG V+       Q+                 VAVK L  + S     +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFY--------PKKKRLLGWQA 223
           ++++L   ++ RL G C       +I EYM N  L+ FL              + L +  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 224 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            + +   IA G+ YL     L  +HRDL   N L+  +   KI+DFGM+R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.4 bits (188), Expect = 3e-16
 Identities = 50/157 (31%), Positives = 89/157 (56%), Gaps = 10/157 (6%)

Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQS-GQGLTEFKNEMMLIAKLQHR 179
           NF    K+GEG +G VYK R  L G+ VA+K  RL  ++ G   T  + E+ L+ +L H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++V+L      + +  L++E++ ++ L  F+       +     +  + + + QGL + H
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQ-LLQGLAFCH 117

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.8 bits (186), Expect = 4e-16
 Identities = 51/144 (35%), Positives = 74/144 (51%), Gaps = 6/144 (4%)

Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT-EFKNEMMLIAKLQHRHLVRLFGCCI 189
           LG+G FG V+KG L +   VAVK       Q L  +F +E  ++ +  H ++V+L G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           ++    ++ E +P    D   F  KKK  L  +  V+     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 250 DLKASNILLDSDMNPKISDFGMAR 273
           DL A N L+  +   KISDFGM+R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 76.3 bits (188), Expect = 4e-16
 Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 16/169 (9%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL 176
           +  +    L EG FG ++ G L++      +EV VK + + + +  +T    E  L+  L
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 177 QHRHLVRLFGCCIEQGEN-ILIYEYMPNKSLDVFLFYPK-----KKRLLGWQARVRIIEG 230
            H++++ +   CIE GE   ++Y YM   +L +FL   +       + L  Q  V +   
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
           IA G+ YLH   +  +IH+D+ A N ++D ++  KI+D  ++R +F  D
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 75.7 bits (186), Expect = 5e-16
 Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 6/150 (4%)

Query: 130 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           KLG G +G VY+G        VAVK L   +   + EF  E  ++ +++H +LV+L G C
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
             +    +I E+M   +L  +L     ++ +     + +   I+  + YL + +    IH
Sbjct: 72  TREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127

Query: 249 RDLKASNILLDSDMNPKISDFGMARIFGGD 278
           RDL A N L+  +   K++DFG++R+  GD
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGD 157

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 9e-16
 Identities = 41/151 (27%), Positives = 76/151 (50%), Gaps = 11/151 (7%)

Query: 125 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           F+    +G+G FG VYK       Q VA+K +   ++   + + + E+  +++ +  ++ 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 183 RLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           + +G  ++  +  +I EY    S LD+          L       I+  +  GL YLH+ 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK-----LDETYIAFILREVLLGLEYLHEE 117

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
                IHRD+KA+NILL  + + K++DFG++
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.8 bits (186), Expect = 9e-16
 Identities = 55/162 (33%), Positives = 83/162 (51%), Gaps = 26/162 (16%)

Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKR-------LLGWQARVRIIEGIAQGLLY 237
            G C+      LI + MP   L   L Y ++ +       LL W  +      IA+G+ Y
Sbjct: 75  LGICLTSTVQ-LITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQ------IAKGMNY 124

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           L +    R++HRDL A N+L+ +  + KI+DFG+A++ G DE
Sbjct: 125 LEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 74.7 bits (183), Expect = 1e-15
 Identities = 54/158 (34%), Positives = 84/158 (53%), Gaps = 8/158 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHL 181
           E+   + KLG+G FG V+ G       VA+K L  + G    E F  E  ++ KL+H  L
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 63

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V+L+    E+   I + EYM   SL  FL   +  + L     V +   IA G+ Y+   
Sbjct: 64  VQLYAVVSEEPIYI-VTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE-- 119

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 120 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 74.8 bits (184), Expect = 1e-15
 Identities = 48/155 (30%), Positives = 85/155 (54%), Gaps = 7/155 (4%)

Query: 124 NFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQHRH 180
           +F    KLG+G +G VYK  RL + Q  A+K   L + S +   +  NE+ ++A + H +
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKK-KRLLGWQARVRIIEGIAQGLLYLH 239
           ++      ++  +  ++ EY P   L   +   KK ++L+  Q   RI   + +GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
           +    +I+HRDLK++NILL ++   KI D G++++
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKV 152

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.5 bits (183), Expect = 1e-15
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 35/164 (21%)

Query: 131 LGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           LG+G +G VY  R L+ Q  +A+K +  +  + +     E+ L + L+HR++V+  G   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 190 EQGENILIYEYMPNKSLDVFL---------------FYPKKKRLLGWQARVRIIEGIAQG 234
           E G   +  E +P  SL   L               FY K+               I +G
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ---------------ILEG 120

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFGG 277
           L YLH     +I+HRD+K  N+L+++     KISDFG ++   G
Sbjct: 121 LKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.3 bits (182), Expect = 2e-15
 Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 14/151 (9%)

Query: 131 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+G FG VY       GR L  ++V     S ++ + ++  + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 185 FGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +GC  ++ E  L    EYMP  S+   L   K    L      +    I +G+ YLH   
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN- 125

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              I+HRD+K +NIL DS  N K+ DFG ++
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 74.7 bits (183), Expect = 2e-15
 Identities = 47/144 (32%), Positives = 80/144 (55%), Gaps = 6/144 (4%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           +LG+G FG VYK +    G   A K +  +S + L ++  E+ ++A   H ++V+L G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
              G+  ++ E+ P  ++D  +     + L   Q +V I   + + L YLH    ++IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIML-ELDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133

Query: 249 RDLKASNILLDSDMNPKISDFGMA 272
           RDLKA N+LL  D + K++DFG++
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 24/172 (13%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRL-SNQSGQGLTEFKNEMMLIAK 175
           +  +    LGEG FG V K   +          VAVK L  + + + L++  +EM ++  
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 176 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG---- 230
           + +H++++ L G C ++G   ++ EY  + +L  FL   +           R  E     
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 231 ---------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                    +A+G+ +L      + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 74.6 bits (183), Expect = 2e-15
 Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 40/190 (21%)

Query: 130 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLTEFKNEMM 171
           KLGEG FG V+   ++N Q+                 VAVK L  + +     +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFY--------------PKKKR 217
           ++++L+  +++RL G C+++    +I EYM N  L+ FL                P    
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 218 LL--GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-I 274
           L    + + + +   IA G+ YL   S L  +HRDL   N L+  ++  KI+DFGM+R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 275 FGGD--ELQG 282
           + GD   +QG
Sbjct: 189 YAGDYYRIQG 198

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 73.5 bits (180), Expect = 3e-15
 Identities = 55/151 (36%), Positives = 80/151 (52%), Gaps = 8/151 (5%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLFGCC 188
           KLG G FG V+ G      +VAVK L  + G    E F  E  ++ KL+H  LV+L+   
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
            E+   I + EYM   SL  FL    + R L     V +   +A G+ Y+    R+  IH
Sbjct: 71  SEEPIYI-VTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 249 RDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           RDL+++NIL+   +  KI+DFG+AR+   +E
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNE 156

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 74.3 bits (182), Expect = 3e-15
 Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 10/154 (6%)

Query: 125 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQHRH 180
           FS   ++G G FG VY  R + N + VA+K++S    QS +   +   E+  + KL+H +
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
            ++  GC + +    L+ EY    + D+   + K  + +   A   +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHS 133

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
           ++   +IHRD+KA NILL      K+ DFG A I
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 3e-15
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 12/154 (7%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           E++    ++G G +G VYK R +  G+ VA+K +  + G      + E+ ++ + +H ++
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 182 VRLFGCCIEQGENILIYEYMPNKSL-DVF--LFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
           V  FG  + + +  ++ EY    SL D++     P  +  + +  R  +     +GL YL
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYL 117

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
           H+      IHRD+K +NILL  D + K++DFG++
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 73.3 bits (180), Expect = 4e-15
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 26/158 (16%)

Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQG-------LTEFKNEMMLIAKLQHRH 180
           +G G FG VY G    +G+ +AVK+  L + S          L     E+ L+ +LQH +
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 181 LVRLFGCCIEQGENILIYEYMPNKS----LDVFLFYPKKKRLLGWQARVR-IIEGIAQGL 235
           +V+  G  ++     +  EY+P  S    L+ +  +         +  VR  +  I +GL
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE--------ETLVRNFVRQILKGL 119

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            YLH  +R  IIHRD+K +NIL+D+    KISDFG+++
Sbjct: 120 NYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.8 bits (178), Expect = 6e-15
 Identities = 57/158 (36%), Positives = 84/158 (53%), Gaps = 8/158 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHL 181
           E+     KLG+G FG V+ G      +VA+K L  + G  + E F  E  ++ KL+H  L
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V L+    E+   I + E+M   SL  FL     K L   Q  V +   IA G+ Y+   
Sbjct: 64  VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            R+  IHRDL+A+NIL+  ++  KI+DFG+AR+   +E
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 73.2 bits (179), Expect = 7e-15
 Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 10/154 (6%)

Query: 125 FSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS---NQSGQGLTEFKNEMMLIAKLQHRH 180
           F+   ++G G FG VY  R +   EV A+K++S    QS +   +   E+  + +++H +
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
            +   GC + +    L+ EY    + D+   + K  + +   A   I  G  QGL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHS 143

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
           ++   +IHRD+KA NILL      K++DFG A I
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 8e-15
 Identities = 43/143 (30%), Positives = 79/143 (55%), Gaps = 6/143 (4%)

Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           LG+G FG VYK +    G   A K +  +S + L +F  E+ ++++ +H ++V L+    
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            + +  ++ E+    +LD  +    ++ L   Q R  +   + + L +LH +   ++IHR
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHR 127

Query: 250 DLKASNILLDSDMNPKISDFGMA 272
           DLKA NILL  D + K++DFG++
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 26/178 (14%)

Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVR 183
           +LGE  FG +YKG L      + Q VA+K L +  + Q   EF+ E  L+A+L H ++V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR--------------VRIIE 229
           L G   ++    +++EY+    L  FL        +G  +               + I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD--ELQGNT 284
            IA G+ YL  +     +H+DL A NIL+   ++ KISD G++R I+  D   +Q  +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 72.1 bits (177), Expect = 1e-14
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 38/177 (21%)

Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLS---------NQSGQGLTE-FKNEMMLIAKLQHR 179
           +G+G +G VY    +  G+ +AVK++          +   + + +  ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 180 HLVRLFGCCIEQGENIL-IY-EYMPNKSLDVFL-----FYPKKKRLLGWQARVRIIEGIA 232
           ++V+  G   E  E  L I+ EY+P  S+   L     F  +  R    Q        + 
Sbjct: 69  NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VL 118

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR----IFGGDE---LQG 282
           +GL YLH      I+HRDLKA N+L+D+D   KISDFG+++    I+  D+   +QG
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 71.7 bits (176), Expect = 1e-14
 Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 18/178 (10%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLTEFKNEMMLI 173
             NF  + K+G+G F  VYK   LL+G+ VA+K++       +      L E      L+
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56

Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKK-KRLLGWQARVRIIEGIA 232
            +L H ++++     IE  E  ++ E      L   + + KK KRL+  +   +    + 
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
             L ++H     RI+HRD+K +N+ + +    K+ D G+ R F       ++   VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.5 bits (175), Expect = 1e-14
 Identities = 51/158 (32%), Positives = 85/158 (53%), Gaps = 18/158 (11%)

Query: 130 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR----HLV 182
           +LG G FG V KG  ++   Q +VA+K L N++ + + +   EMM  A++ H+    ++V
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD---EMMREAEIMHQLDNPYIV 58

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           R+ G C  + E + L+ E      L+ FL    KK  +     V ++  ++ G+ YL   
Sbjct: 59  RMIGVC--EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGK 114

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           +    +HRDL A N+LL +    KISDFG+++  G D+
Sbjct: 115 N---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 31/181 (17%)

Query: 130 KLGEGGFGPVYKGRLLNGQE---------------VAVKRL-SNQSGQGLTEFKNEMMLI 173
           KLGEG FG V+        E               VAVK L ++ +     +F  E+ ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL---------GWQAR 224
           ++L++ +++RL G C+      +I EYM N  L+ FL   + +                 
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD--ELQ 281
           + +   IA G+ YL   + L  +HRDL   N L+ +    KI+DFGM+R ++ GD   +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 282 G 282
           G
Sbjct: 189 G 189

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 47/179 (26%)

Query: 131 LGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           LGEG FG V K     L G+     VAVK L  N S   L +  +E  L+ ++ H H+++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----------------------FYPKKKRL--- 218
           L+G C + G  +LI EY    SL  FL                        P ++ L   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 219 ----LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                 WQ        I++G+ YL   + ++++HRDL A N+L+      KISDFG++R
Sbjct: 128 DLISFAWQ--------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (174), Expect = 2e-14
 Identities = 51/151 (33%), Positives = 73/151 (48%), Gaps = 14/151 (9%)

Query: 131 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VY       GR L  ++V     S ++ + +   + E+ L+  L+H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 185 FGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +GC  +  E  L    EYMP  S+   L   K    L      R    I QG+ YLH   
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLHSN- 125

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              I+HRD+K +NIL DS  N K+ DFG ++
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 71.2 bits (174), Expect = 3e-14
 Identities = 54/158 (34%), Positives = 84/158 (53%), Gaps = 14/158 (8%)

Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L  N S +   E  +E  ++A +   ++ RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKR-LLGWQARVRIIEGIAQGLLYLHQYSR 243
            G C+      L+ + MP   L   L Y ++ +  +G Q  +     IA+G+ YL +   
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCL---LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE--- 127

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
           +R++HRDL A N+L+ S  + KI+DFG+AR+   DE +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.4 bits (176), Expect = 3e-14
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 39/169 (23%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMMLIAKLQHRH 180
           +G G +G V        G++VA+K++SN        F +         E+ L+  L+H +
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYP----------KKKRLLGWQARVRIIEG 230
           ++ L         +IL      + + DV++             K  + L        +  
Sbjct: 61  IIGLL--------DILRPPSPEDFN-DVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQ 111

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           I +GL YLH      +IHRDLK SNIL++S+ + KI DFG+AR    DE
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 70.1 bits (171), Expect = 5e-14
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 16/162 (9%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E+   + KLG G FG V+        +VAVK +   S   +  F  E  ++  LQH  LV
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKR-----LLGWQARVRIIEGIAQGLLY 237
           +L     ++   I I E+M   SL  FL   +  +     L+ + A+      IA+G+ +
Sbjct: 65  KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF 117

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           + Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+   +E
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 70.1 bits (172), Expect = 7e-14
 Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 19/158 (12%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQGL--TEFKNEMMLIAKLQHRHLVRLF 185
           K+G+G FG V+K R     Q VA+K+ L     +G   T  + E+ ++  L+H ++V L 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 77

Query: 186 GCC--IEQGEN------ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
             C       N       L++E+  +  L   L     K  L      ++++ +  GL Y
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS--EIKKVMKMLLNGLYY 134

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           +H   R +I+HRD+KA+NIL+  D   K++DFG+AR F
Sbjct: 135 IH---RNKILHRDMKAANILITKDGILKLADFGLARAF 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 69.7 bits (170), Expect = 7e-14
 Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 14/151 (9%)

Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRL-----SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+G FG VY     + G+E+AVK++     S ++ + +   + E+ L+  L H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 185 FGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +GC  +  E  L    E+MP  S+   L   K    L      +    I +G+ YLH   
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSN- 125

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              I+HRD+K +NIL DS  N K+ DFG ++
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 69.3 bits (170), Expect = 8e-14
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 9/148 (6%)

Query: 130 KLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG--LTEFKNEMMLIAKLQHRHLVRLFG 186
           K+G G FG VY    L+  E+ AVK +  Q      + E  +EM ++  L+H +LV+ +G
Sbjct: 7   KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
             + + +  +  EY    +L+  L +    R+L           + +GL YLH +    I
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSH---GI 120

Query: 247 IHRDLKASNILLDSDMNPKISDFGMARI 274
           +HRD+K +NI LD +   K+ DFG A  
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVK 148

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 19/155 (12%)

Query: 130 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-NQSGQGLTEFK-NEMMLIAKLQHRHLVRLFG 186
           K+GEG +G V+K +     E VA+KR+  +   +G+      E+ L+ +L+H+++VRL+ 
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 187 CCIEQGENILIYEYMPN---KSLDVFLFYPKKK--RLLGWQARVRIIEGIAQGLLYLHQY 241
                 +  L++EY      K  D        +  +   +Q        + +GL + H +
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHSH 118

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
               ++HRDLK  N+L++ +   K++DFG+AR FG
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 69.2 bits (169), Expect = 1e-13
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 8/152 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +       +G+G FG V  G    G +VAVK + N +      F  E  ++ +L+H +LV
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62

Query: 183 RLFGCCIEQ-GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +L G  +E+ G   ++ EYM   SL  +L   + + +LG    ++    + + + YL   
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +    +HRDL A N+L+  D   K+SDFG+ +
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 69.3 bits (169), Expect = 1e-13
 Identities = 49/172 (28%), Positives = 90/172 (52%), Gaps = 31/172 (18%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS---GQGLTEFKNEMML--IAK 175
           + +    ++GEG +G V+K R L   G+ VA+KR+  Q+   G  L+  +   +L  +  
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 176 LQHRHLVRLFGCCI-----EQGENILIYEYMPNKSLDVFL-------FYPKKKRLLGWQA 223
            +H ++VRLF  C       + +  L++E++ ++ L  +L          +  + + +Q 
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ- 118

Query: 224 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
                  + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+ARI+
Sbjct: 119 -------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.0 bits (169), Expect = 1e-13
 Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 11/149 (7%)

Query: 130 KLGEGGFGPVYKG--RLLNGQE--VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRL 184
            +GEG FG VY+G       ++  VAVK   N +   + E F  E  ++ +  H H+V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G   E    I + E  P   L  +L     K  L   + +     ++  L YL      
Sbjct: 73  IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMAR 273
           R +HRD+ A N+L+ S    K+ DFG++R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 69.3 bits (169), Expect = 1e-13
 Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 27/164 (16%)

Query: 131 LGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LTEFKNEMMLIAKL-QHRHLVRLF 185
           +GEG FG V K R+       + A+KR+   + +    +F  E+ ++ KL  H +++ L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL----------------GWQARVRIIE 229
           G C  +G   L  EY P+ +L  FL   +K R+L                  Q  +    
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +A+G+ YL Q    + IHRDL A NIL+  +   KI+DFG++R
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 66  KLLWIIV---VLVLPVVLLPSF-YIFRRRRRKHKEKDGEGNDKSKDSWLPLF--SLASVS 119
              W  +   +    V+ L +F ++F R R   + K  E  D    +W   F  S  S S
Sbjct: 626 PSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENED---GTWELQFFDSKVSKS 682

Query: 120 AATENFSTQCK----LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIA 174
               +  +  K    +  G  G  YKG+ + NG +  VK +++ +    +E  +    + 
Sbjct: 683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MG 738

Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           KLQH ++V+L G C  +    LI+EY+  K+L   L      R L W+ R +I  GIA+ 
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKA 792

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 266
           L +LH      ++  +L    I++D    P +
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 25/158 (15%)

Query: 131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCC 188
           +GEG +G VYK R    GQ VA+K +         E K E  ++ K   H ++   +G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 189 IEQGENI------LIYEYMPNKSL-DVFLFYPKKKRLLGWQARVR------IIEGIAQGL 235
           I++          L+ E     S+ D+       K L     R++      I+    +GL
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRGL 126

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            YLH+    ++IHRD+K  NILL  +   K+ DFG++ 
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 16/172 (9%)

Query: 130 KLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
            +G+G FG V K      G++L  +E+    ++ +  Q L    +E+ ++ +L+H ++VR
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVR 63

Query: 184 LFGCCI-EQGENILIY-EYMPNKSLDVFL-FYPKKKRLLGWQARVRIIEGIAQGLLYLH- 239
            +   I    + + I  EY     L   +    K+++ +  +   RI+  +   L   H 
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 240 -QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                  ++HRDLK +NI LD++ N K+ DFG+A+I G D      K  VGT
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGT 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 68.3 bits (167), Expect = 3e-13
 Identities = 52/178 (29%), Positives = 91/178 (51%), Gaps = 21/178 (11%)

Query: 125 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ-SGQGLTEFKNEMMLIAKLQHRH 180
           F    ++GEG +G VYK R    G+ VA+K  RL N+  G  +T  + E+ ++ +L HR+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67

Query: 181 LVRLFGCCI----------EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG 230
           +V L               ++G   L++EYM +   D+                   ++ 
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH---DLMGLLESGLVHFSEDHIKSFMKQ 124

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
           + +GL Y H+ + L   HRD+K SNILL++    K++DFG+AR++  +E +  T +++
Sbjct: 125 LLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 67.6 bits (165), Expect = 4e-13
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 19/164 (11%)

Query: 131 LGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+G FG V + +L     + Q+VAVK L     S   + EF  E   + +  H ++++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 185 FGCCIEQGEN------ILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGL 235
            G  +           ++I  +M +  L  FL   +   +   L  Q  VR +  IA G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
            YL   S    IHRDL A N +L+ +M   ++DFG+++ I+ GD
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 22/160 (13%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           E +    KLGEG +  VYKGR  L GQ VA+K  RL ++ G   T  + E  L+  L+H 
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHA 63

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQ 233
           ++V L      +    L++EY+ +  L  ++            RL  +Q        + +
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLR 114

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           GL Y HQ    R++HRDLK  N+L+      K++DFG+AR
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 67.1 bits (164), Expect = 5e-13
 Identities = 47/153 (30%), Positives = 81/153 (52%), Gaps = 19/153 (12%)

Query: 131 LGEGGFGPVYKGRLL--NGQEV--AVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G+G FG VY G L+  +GQ++  AVK L+  +  + + +F  E +++    H +++ L 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 186 GCCIEQ-GENILIYEYMPNKSLDVFLFYPKK----KRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+   G  +++  YM +  L  F+         K L+G+  +V      A+G+ YL  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               + +HRDL A N +LD     K++DFG+AR
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 67.6 bits (165), Expect = 5e-13
 Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 32/182 (17%)

Query: 130 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLTEFKNEMM 171
           KLGEG FG V+       ++                 VAVK L  + +     +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--------FYPKKKRLLGWQA 223
           ++++L+  +++RL   CI      +I EYM N  L+ FL                + +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 224 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD--EL 280
            + +   IA G+ YL   S L  +HRDL   N L+  +   KI+DFGM+R ++ GD   +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 281 QG 282
           QG
Sbjct: 189 QG 190

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 66.9 bits (163), Expect = 5e-13
 Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 18/158 (11%)

Query: 130 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSNQSGQGLTEFKNEMMLIAK----LQHRHLV 182
           +LG G FG V KG  ++   ++ VAVK L N +       K+E++  A     L + ++V
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59

Query: 183 RLFGCCIEQGEN-ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           R+ G C  + E+ +L+ E      L+ FL   +K + +  +    ++  ++ G+ YL + 
Sbjct: 60  RMIGIC--EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEET 114

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           +    +HRDL A N+LL +    KISDFG+++  G DE
Sbjct: 115 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 67.4 bits (164), Expect = 7e-13
 Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 10/149 (6%)

Query: 130 KLGEGGFGPVYKGRLLNGQE-VAVKRLS---NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           ++G G FG VY     +  E VAVK++S    Q+ +   +   E+  + +L+H + +   
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           GC +++    L+ EY    + D+   + K  + +   A   I  G  QGL YLH ++   
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSHN--- 141

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARI 274
           +IHRD+KA NILL      K++DFG A  
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASK 170

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 66.4 bits (162), Expect = 8e-13
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 9/149 (6%)

Query: 130 KLGEGGFGPVYKG---RLLNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLF 185
           ++G G FG V  G   R ++   V VK L   +       F  E+    +L H ++++  
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLYLHQYSR 243
           G CIE    +L+ E+ P   L  +L   +       Q  V  R+   +A GLL+LHQ   
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMA 272
              IH DL   N  L +D++ KI D+G+A
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.6 bits (162), Expect = 8e-13
 Identities = 51/171 (29%), Positives = 92/171 (53%), Gaps = 13/171 (7%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRH 180
           E F+   ++G+G FG VYKG     +EV A+K +  +  +  + + + E+ ++++    +
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 181 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           + R +G  ++  +  +I EY+   S LD+    P ++  +       I+  I +GL YLH
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLH 118

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                R IHRD+KA+N+LL    + K++DFG+A      +++ NT   VGT
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 55/166 (33%), Positives = 81/166 (48%), Gaps = 26/166 (15%)

Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K R      VAVK L  N + + L +  +EM L+  + +H++
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRI 227
           ++ L G C ++G   +I EY    +L  FL   +              +  L ++  V  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   SR R IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 140 AYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 37/173 (21%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQH 178
           + +    ++ EG +G VY+ R    G+ VA+K+L     + G  +T  + E+ ++ KLQH
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63

Query: 179 RHLVRL----FGCCIEQGENILIY---EYMPN--KSL-----DVFLFYPKKKRLLGWQAR 224
            ++V +     G  +++     IY   EY+ +  KSL       FL   + K L+     
Sbjct: 64  PNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSLMETMKQPFL-QSEVKCLM----- 112

Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 277
           ++++ G+A    +LH      I+HRDLK SN+LL++    KI DFG+AR +G 
Sbjct: 113 LQLLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.1 bits (161), Expect = 1e-12
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 16/151 (10%)

Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT------EFKNEMMLIAKLQHRHLVRL 184
           LG+G +G VY G    GQ +AVK++   +   L       + + E+ L+  L+H ++V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C++     +  E++P  S+   L  F P  + +       +  + I  G+ YLH   
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF-----CKYTKQILDGVAYLHNNC 122

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              ++HRD+K +N++L  +   K+ DFG AR
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 66.1 bits (161), Expect = 1e-12
 Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 9/149 (6%)

Query: 130 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           ++G G FG V  G +       +V VK L  + S Q   +F  E      LQH +L++  
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLYLHQYSR 243
           G C E    +L+ E+ P   L  +L   +K  L+        R+   IA GLL+LH+ + 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMA 272
              IH DL   N LL +D+  KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.4 bits (163), Expect = 1e-12
 Identities = 56/178 (31%), Positives = 91/178 (51%), Gaps = 24/178 (13%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL----SNQSGQGLTEFKNEMMLIAKL- 176
             +    KLG+G +G V+K       + VA+K++     N +    T F+ E+M + +L 
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT-FR-EIMFLQELG 64

Query: 177 QHRHLVRLFGCCIEQGEN----ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 232
            H ++V+L    + + EN     L++EYM     +  L    +  +L    +  I+  + 
Sbjct: 65  DHPNIVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLL 117

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           + L Y+H  S   +IHRDLK SNILL+SD   K++DFG+AR     EL+ N +  V T
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLT 170

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.9 bits (161), Expect = 1e-12
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 15/152 (9%)

Query: 129 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMM-LIAKLQHRH---LVR 183
            +LG G +G V K R +  G  +AVKR+         E K  +M L   ++       V 
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVT 64

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLLYLHQ 240
            +G    +G+  +  E M + SLD F  Y K   K   +      +I   I + L YLH 
Sbjct: 65  FYGALFREGDVWICMEVM-DTSLDKF--YKKVYDKGLTIPEDILGKIAVSIVKALEYLH- 120

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            S+L +IHRD+K SN+L++ +   K+ DFG++
Sbjct: 121 -SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 43/153 (28%), Positives = 84/153 (54%), Gaps = 11/153 (7%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           E+F    ++G G +G VYK R +N G+  A+K +  + G+     + E++++   +H ++
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 182 VRLFGCCIEQGENILIYEYMPNKSL-DVF-LFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           V  FG  + + +  +  E+    SL D++ +  P  +  + + +R  +     QGL YLH
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
              +   +HRD+K +NILL  + + K++DFG++
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 10/163 (6%)

Query: 115 LASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN--EMM 171
             +V   T  +     +G G FG V   R  L GQ VA+K++       +   +   E+ 
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           L+  L+H +++ L    I   E+I     +    L   L      R L  Q     +  I
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQI 117

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
            +GL Y+H      ++HRDLK SNIL++ + + KI DFG+ARI
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 65.7 bits (160), Expect = 2e-12
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 19/161 (11%)

Query: 128 QCKLGEGGFGPVY---------KGRLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQ 177
           Q +LG+G FG VY         + RL   +E+ V  L+ N++ Q       E  L++KL 
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLSKLD 60

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLF-YPKKKRLLGWQARVRIIEGIAQGLL 236
           H  +V+     +E+    +I EY   + LD  L       + L   +  ++ E   Q LL
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL---SENQVCEWFIQLLL 117

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 277
            +H   + RI+HRDLKA NI L +++  KI DFG++R+  G
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG 157

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 50/153 (32%), Positives = 81/153 (52%), Gaps = 22/153 (14%)

Query: 130 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           KLGEG +  VYKG+  +NG+ VA+K  RL  + G   T  + E  L+  L+H ++V L  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 187 CCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
               +    L++EY+ +  L  ++       +P+  +L  +Q        + +GL Y+HQ
Sbjct: 71  IIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ--------LLRGLSYIHQ 121

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                I+HRDLK  N+L+      K++DFG+AR
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.2 bits (159), Expect = 4e-12
 Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 32/176 (18%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-GLTEFKN-------------EMMLIAK 175
           LGEG +G V K    L G+ VA+K++        +T+ +              E+ ++ +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPN---KSLD--VFLFYPKKKRLLGWQARVRIIEG 230
           ++H +++ L    +E     L+ + M +   K +D  + L   + K +L  Q        
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ-------- 127

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           I  GL  LH++     +HRDL  +NI ++S    KI+DFG+AR +G         +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Length = 335

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 64.6 bits (157), Expect = 5e-12
 Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 22/153 (14%)

Query: 130 KLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRLFG 186
           KLGEG +  VYKG   +NGQ VA+K +S ++ +G+  T  + E  L+  L+H ++V L  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 187 CCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
               +     ++EYM +  L  ++       +P   RL  +Q        + +GL Y+H 
Sbjct: 71  IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ--------LLRGLAYIH- 120

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                I+HRDLK  N+L+      K++DFG+AR
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 64.2 bits (157), Expect = 5e-12
 Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 28/173 (16%)

Query: 134 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           G +G V+  +    G   A+K +          + +   E  ++++ Q  ++V+L+    
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62

Query: 190 EQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGW----QARVRIIEGIAQGLLYLHQYSRL 244
           +  +N+ L+ EY+P   L   L        +G      AR+ I E I   L YLH     
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLL------ENVGSLDEDVARIYIAE-IVLALEYLHSNG-- 113

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN-------TKRIVGT 290
            IIHRDLK  NIL+DS+ + K++DFG+++  G    Q N        KRIVGT
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGT 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.3 bits (156), Expect = 5e-12
 Identities = 44/146 (30%), Positives = 79/146 (54%), Gaps = 11/146 (7%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           ++G G +G VYK R L  G+  AVK +  + G   +  + E+ ++ + +H ++V  FG  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 189 IEQGENILIYEYMPNKSL-DVF-LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
           + + +  +  EY    SL D++ +  P  +  + +  R  +     QGL YLH   ++  
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM-- 128

Query: 247 IHRDLKASNILLDSDMNPKISDFGMA 272
            HRD+K +NILL  + + K++DFG+A
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 5e-12
 Identities = 47/176 (26%), Positives = 74/176 (42%), Gaps = 11/176 (6%)

Query: 98  DGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN 157
             E +D   D  +P    A    A+  ++    L  G  G V+      GQ   V     
Sbjct: 41  ASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVVLKIG 99

Query: 158 QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKR 217
           Q G  L E     ML+  + H  ++R+    +      ++   +P+ S D++ +  K+ R
Sbjct: 100 QKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSR 152

Query: 218 LLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            L     + I + I +GL YLH     RIIHRD+K  NI ++      I D G A+
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.3 bits (156), Expect = 6e-12
 Identities = 44/144 (30%), Positives = 77/144 (53%), Gaps = 6/144 (4%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           +LG+G FG VYK +    G   A K +  +S + L ++  E+ ++A   H ++V+L    
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
             +    ++ E+    ++D  +    ++ L   Q RV + +   + L YLH+    +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126

Query: 249 RDLKASNILLDSDMNPKISDFGMA 272
           RDLKA NIL   D + K++DFG++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 64.3 bits (156), Expect = 8e-12
 Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 22/153 (14%)

Query: 130 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           KLGEG +  VYKGR  L    VA+K  RL ++ G   T  + E+ L+  L+H ++V L  
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 187 CCIEQGENILIYEYMPNKSLDVFL------FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
               +    L++EY+ +K L  +L            +L  +Q        + +GL Y H 
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ--------LLRGLNYCH- 121

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             R +++HRDLK  N+L++     K++DFG+AR
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 9e-12
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 12/153 (7%)

Query: 125 FSTQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLTEFK---NEMMLIAKLQHRH 180
           F    ++G+GG+G V+  +  +  E VA+KR+       L E +    E  ++   +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 181 LVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           LV+L     +  E + L  EY+P       L       L    AR  + E     +  LH
Sbjct: 63  LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALH 118

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
               L  IHRDLK  N L+D+  + K++DFG++
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.0 bits (153), Expect = 1e-11
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 8/150 (5%)

Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE---FKNEMMLIAKLQHRHLVRLFGC 187
           +G G FG V+  R    Q++ + +          E    +NE  ++  L H +++  +  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 188 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 247
            +E    +++ EY P  +L  ++    +KR         I+    Q LL LH      I+
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYI----QKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123

Query: 248 HRDLKASNILLDS-DMNPKISDFGMARIFG 276
           HRDLK  NILLD   M  KI DFG+++I  
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILS 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 26/181 (14%)

Query: 110 LPLFSLASVSAATENFSTQC--------------KLGEGGFGPVYKGRLL-NGQEVAVKR 154
           LP  S +S S+++ + S                 ++G G  G VYK      G+  A+K 
Sbjct: 47  LPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKV 106

Query: 155 L-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYP 213
           +  N       +   E+ ++  + H ++V+        GE  ++ E+M   SL+    + 
Sbjct: 107 IYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT--HI 164

Query: 214 KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             ++ L   AR +I+ GIA    YLH   R  I+HRD+K SN+L++S  N KI+DFG++R
Sbjct: 165 ADEQFLADVAR-QILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216

Query: 274 I 274
           I
Sbjct: 217 I 217

Length = 353

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 7/146 (4%)

Query: 130 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRHLVRLFGC 187
           ++G G FG V+ GRL  +   VAVK         L  +F  E  ++ +  H ++VRL G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 188 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 247
           C ++    ++ E +  +  D   F   +   L  +  ++++E  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 248 HRDLKASNILLDSDMNPKISDFGMAR 273
           HRDL A N L+      KISDFGM+R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.5 bits (152), Expect = 2e-11
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 23/160 (14%)

Query: 131 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSNQSGQGLTEFKNEMMLIAKLQHRH 180
           LG+G F  +YKG L           GQEV+V   +     +    F     L+++L H+H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           LV+L+G C+   ENI++ EY+    LDVFL   K    L W+  V   + +A  L YL  
Sbjct: 63  LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119

Query: 241 YSRLRIIHRDLKASNILL---DSDMNP----KISDFGMAR 273
               +++H ++   NIL+     +       K+SD G+  
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 10/147 (6%)

Query: 130 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           KLGEG +  V+KGR  L    VA+K  RL ++ G   T  + E+ L+  L+H ++V L  
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70

Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
               +    L++EY+ +   D+  +      L+        +  + +GL Y H   + +I
Sbjct: 71  IIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKI 124

Query: 247 IHRDLKASNILLDSDMNPKISDFGMAR 273
           +HRDLK  N+L++     K++DFG+AR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 18/158 (11%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQ---HRHLV 182
           ++G G +G VYK R   +G  VA+K +   +N+ G  L+  + E+ L+ +L+   H ++V
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65

Query: 183 RLFGCCI-----EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           RL   C       + +  L++E++ ++ L  +L       L     +  ++    +GL +
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK-DLMRQFLRGLDF 123

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           LH      I+HRDLK  NIL+ S    K++DFG+ARI+
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 17/158 (10%)

Query: 130 KLGEGGFGPVYKG---RLLNGQ---EVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +LG+G FG VY+G    ++ G+    VAVK ++ + S +   EF NE  ++      H+V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLG-----WQARVRIIEGIAQGL 235
           RL G   +    +++ E M +  L  +L    P+ +   G      Q  +++   IA G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 45/176 (25%), Positives = 86/176 (48%), Gaps = 18/176 (10%)

Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQHR 179
           NF  + K+G G F  VY+   LL+ + VA+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLD-VFLFYPKKKRLLG----WQARVRIIEGIAQG 234
           ++++     IE  E  ++ E      L  +  ++ K+KRL+     W+  V++   +   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
               H +SR R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 62.1 bits (151), Expect = 3e-11
 Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 9/106 (8%)

Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVR 226
           E+ ++ + +  ++V  +G  + +    +  E+M   SLD       P    +LG     +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----K 107

Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
           I   + +GL YL  Y+  RI+HRD+K SNIL++S    K+ DFG++
Sbjct: 108 IAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.0 bits (151), Expect = 3e-11
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 11/159 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFK---NEMMLIAKLQH 178
           E +    K+GEG +G V+K R    GQ VA+K+   +S       K    E+ ++ +L+H
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV-ESEDDPVIKKIALREIRMLKQLKH 59

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            +LV L      + +  L++EY  +  L+     P+    +      +II    Q + + 
Sbjct: 60  PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFC 116

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 277
           H+++    IHRD+K  NIL+      K+ DFG ARI  G
Sbjct: 117 HKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 62.1 bits (151), Expect = 3e-11
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 20/160 (12%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           K+GEG +G VYK R    G+ VA+K+     ++ G   T  +   +L    +  ++VRL 
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 186 GCCIEQGEN-------ILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGLL 236
              +E  E         L++EY+ +  L  F+        R L  +     +  + +G+ 
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIF 275
           + H++    ++HRDLK  N+L+D      KI+D G+ R F
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 27/172 (15%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LTEFKNEMMLIAKL-Q 177
           E+   +  +GEG FG V +  +         A+K L   + +    +F  E+ ++ KL  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL----------------GW 221
           H +++ L G C  +G   +  EY P  +L  FL   +K R+L                  
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTS 118

Query: 222 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           Q  ++    +A G+ YL   S  + IHRDL A N+L+  ++  KI+DFG++R
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 10/147 (6%)

Query: 130 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           KLGEG +  V+KGR  L    VA+K  RL ++ G   T  + E+ L+  L+H ++V L  
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
                    L++EY+     D+  +      ++        +  I +GL Y H   R ++
Sbjct: 72  IVHTDKSLTLVFEYLDK---DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKV 125

Query: 247 IHRDLKASNILLDSDMNPKISDFGMAR 273
           +HRDLK  N+L++     K++DFG+AR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 61.5 bits (149), Expect = 4e-11
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 28/166 (16%)

Query: 124 NFSTQCKLGEGGFGPVY--KGRLLNGQ----EVAVKRLSNQSGQGLTEFKNEMMLIAKLQ 177
            +    K+GEG FG +Y  K +  +      E+ + ++  +  +     K E++L+AK++
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEA---SKKEVILLAKMK 57

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSL-------DVFLFYPKKKRLLGWQARVRIIEG 230
           H ++V  F    E G   ++ EY     L          LF   + ++L W  +      
Sbjct: 58  HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ 109

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIF 275
           I+ GL ++H     +I+HRD+K+ NI L  + M  K+ DFG+AR  
Sbjct: 110 ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 61.8 bits (151), Expect = 5e-11
 Identities = 55/165 (33%), Positives = 76/165 (46%), Gaps = 17/165 (10%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ----SGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           LG G FG V   R     +  A+K LS        Q +    NE  ++  ++H  LV L+
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G   +     L+ EY+P   L  F    K  R     AR    + +   L YLH    L 
Sbjct: 68  GSFQDDSNLYLVMEYVPGGEL--FSHLRKSGRFPEPVARFYAAQ-VVLALEYLHS---LD 121

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           I++RDLK  N+LLDSD   KI+DFG A+      ++G T  + GT
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 5e-11
 Identities = 45/168 (26%), Positives = 89/168 (52%), Gaps = 20/168 (11%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQH---RHLVRLF 185
           +G G +G VY+G+ +  G+ VA+K ++ +     +++ + E+ L+++L+     ++ + +
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 186 GCCIEQGENILIYEYMPNKSLDVFL-FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
           G  ++     +I EY    S+   +   P  ++ +       II  +   L Y+H+    
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALKYIHKVG-- 121

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRI--VGT 290
            +IHRD+KA+NIL+ +  N K+ DFG+A +      Q ++KR   VGT
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGT 164

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 61.7 bits (149), Expect = 5e-11
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 13/167 (7%)

Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCI 189
           +G G +G VYKGR +   ++A  ++ + +G    E K E+ ++ K   HR++   +G  I
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 190 EQG------ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
           ++       +  L+ E+    S+   L    K   L  +    I   I +GL +LHQ+  
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            ++IHRD+K  N+LL  +   K+ DFG++     D   G     +GT
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 174

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 5e-11
 Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 19/174 (10%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE---FKNEMMLIAKLQH 178
           ++      +G G FG V+  R  ++    A+K ++      L +     NE  ++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 179 RHLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
             ++RLF    E  +  L  + EY+P   L  F +     R           E I   L 
Sbjct: 61  PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALE 115

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           YLH      I++RDLK  NILLD + + K++DFG A+     +L+  T  + GT
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 61.3 bits (149), Expect = 6e-11
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 9/154 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTE--FKNEMMLIAKLQHR 179
           E +     +GEG +G V K +    GQ VA+K+        + +     E+ ++ +L+H 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           +LV L      +    L++E++ +  LD    YP     L      + +  I +G+ + H
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            ++   IIHRD+K  NIL+      K+ DFG AR
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 61.6 bits (150), Expect = 6e-11
 Identities = 45/147 (30%), Positives = 74/147 (50%), Gaps = 8/147 (5%)

Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQH-RHLVRLFGC 187
           +G G FG V K      G  +AVKR+ S    +       ++ ++ +     ++V+ +G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 188 CIEQGENILIYEYMPNKSLDVF--LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
              +G+  +  E M + SLD F    Y   K ++  +   +I     + L YL +   L+
Sbjct: 72  LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELK 128

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMA 272
           IIHRD+K SNILLD + N K+ DFG++
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 61.6 bits (150), Expect = 6e-11
 Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 37/171 (21%)

Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGL--TEFKNEMMLIAKLQHR 179
            F    ++GEG +G VY+ R   +G+ VA+K++  +    G+  +  + E+ L+  L+H 
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66

Query: 180 HLVRLFGCCI-EQGENI-LIYEY-----------MPNKSLDVFLFYPKKKRLLGWQARVR 226
           ++V L    + +  ++I L+ EY           MP        F          +++V+
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP------FS---------ESQVK 111

Query: 227 -IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            ++  + +GL YLH+     IIHRDLK SN+LL      KI+DFG+AR +G
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 61.6 bits (149), Expect = 7e-11
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 26/166 (15%)

Query: 131 LGEGGFGPVYKGRLLNGQE--------VAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V     +   +        VAVK L S+ + + L++  +EM ++  + +H++
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPKK--KRLLGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L           + P +  +  L ++  V  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 60.8 bits (147), Expect = 9e-11
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 18/162 (11%)

Query: 127 TQCK-LGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-SGQGLTEFKNEMMLIAKLQH 178
           T  + LG+G FG VY    KG + +  E  VA+K ++   S +   EF NE  ++ +   
Sbjct: 9   TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 68

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKR-----LLGWQARVRIIEGI 231
            H+VRL G   +    ++I E M    L  +L    P+ +          +  +++   I
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           A G+ YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.2 bits (149), Expect = 9e-11
 Identities = 51/160 (31%), Positives = 75/160 (46%), Gaps = 33/160 (20%)

Query: 131 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +G G +G V        G++VA+K+LS         F++ +   AK  +R L RL     
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSR-------PFQSAIH--AKRTYREL-RLLKHM- 71

Query: 190 EQGENI--LIYEYMPNKSL----DVFLFYP----------KKKRLLGWQARVRIIEGIAQ 233
              EN+  L+  + P  SL    DV+L             K ++L     +  ++  I +
Sbjct: 72  -DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILR 129

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           GL Y+H      IIHRDLK SNI ++ D   KI DFG+AR
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 46/176 (26%), Positives = 86/176 (48%), Gaps = 18/176 (10%)

Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQHR 179
           NF  + K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFL-FYPKKKRLLG----WQARVRIIEGIAQG 234
           ++++ +   IE  E  ++ E      L   +  + K+KRL+     W+  V++   +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
               H +SR R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 47/171 (27%), Positives = 92/171 (53%), Gaps = 13/171 (7%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRH 180
           E F+   ++G+G FG V+KG     Q+V A+K +  +  +  + + + E+ ++++    +
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 181 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           + + +G  ++  +  +I EY+   S LD+    P  +  +       +++ I +GL YLH
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLH 118

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              +   IHRD+KA+N+LL    + K++DFG+A      +++ NT   VGT
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.2 bits (143), Expect = 3e-10
 Identities = 45/145 (31%), Positives = 75/145 (51%), Gaps = 10/145 (6%)

Query: 131 LGEGGFGPVYKG--RLLNGQE--VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           LG G FG + +G  +L + +E  VA+  L +  S +    F  E + + +  H ++VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G        +++ EYM N +LD FL   K +  L     + ++ G+A G+ YL   S + 
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127

Query: 246 IIHRDLKASNILLDSDMNPKISDFG 270
            +H+ L A  +L++SD+  KIS F 
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 31/167 (18%)

Query: 123 ENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
             +     +GEG +G V        G +VA+K++S         F+++      L+   +
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS--------PFEHQTFCQRTLREIKI 56

Query: 182 VRLFGCCIEQGENIL-IYEYMPNKSLDVF-------------LFYPKKKRLLGWQARVRI 227
           +R F       ENI+ I + +   S + F             L+   K + L        
Sbjct: 57  LRRFKH-----ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYF 111

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
           +  I +GL Y+H  +   ++HRDLK SN+LL+++ + KI DFG+ARI
Sbjct: 112 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 26/166 (15%)

Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L +  + + L++  +EM ++  + +H++
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   ++ EY    +L  +L   +   +             L ++  V  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 58.9 bits (142), Expect = 4e-10
 Identities = 48/171 (28%), Positives = 89/171 (52%), Gaps = 13/171 (7%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRH 180
           E F+   K+G+G FG V+KG     Q+V A+K +  +  +  + + + E+ ++++    +
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 181 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           + + +G  ++  +  +I EY+   S LD+    P  +  +       I+  I +GL YLH
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 118

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              +   IHRD+KA+N+LL      K++DFG+A      +++ N    VGT
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 58.8 bits (143), Expect = 4e-10
 Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 16/152 (10%)

Query: 129 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN--EMMLIAKLQ-HRHLVRL 184
            K+GEG F  V K +    G+  A+K +  +  + L +  N  E+  + +L  H +++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 185 FGCCIEQ--GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR-IIEGIAQGLLYLHQY 241
                ++  G   L++E M    ++++     +KR L  + RV+  +  + + L ++H  
Sbjct: 64  IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH-- 117

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            R  I HRD+K  NIL+  D   K++DFG  R
Sbjct: 118 -RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 58.9 bits (143), Expect = 4e-10
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 12/162 (7%)

Query: 124 NFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLTEFKNEMMLIAKLQHR 179
           +F     +G+G FG V   +  + +++ A+K ++ Q       +    NE  ++ +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 180 HLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            LV L+    +  EN+ L+ + +    L   L   +K +    Q +  I E I   L YL
Sbjct: 61  FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYL 116

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
           H      IIHRD+K  NILLD   +  I+DF +A     D L
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.7 bits (142), Expect = 4e-10
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 21/158 (13%)

Query: 131 LGEGGFGPVYKG--------RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           LG+G F  ++KG          L+  EV +K L          F     ++++L H+HLV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
             +G C+   E+I++ EY+   SLD +L   K K L+    ++ + + +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 243 RLRIIHRDLKASNILL-----DSDMNP---KISDFGMA 272
              + H ++ A N+LL         NP   K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 58.6 bits (142), Expect = 5e-10
 Identities = 43/170 (25%), Positives = 81/170 (47%), Gaps = 23/170 (13%)

Query: 131 LGEGGFGP--VYK----GRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+G FG   +Y+      L+  +EV + RLS +      +  NE+++++ LQH +++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKK----RLLGWQARVRIIEGIAQGLLYLHQ 240
           +   ++    ++  EY    +L   +   K +     ++ W      +  I   + Y+H+
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHK 119

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                I+HRD+K  NI L      K+ DFG+++I G +     T  +VGT
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 32/169 (18%)

Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L  + + + L++  +EM ++  + +H++
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG----------------WQAR 224
           ++ L G C + G   +I EY    +L  +L   + +R  G                ++  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           V     +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 58.3 bits (141), Expect = 8e-10
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)

Query: 131 LGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSGQGLTE-FKNEMMLIAKL-QHRHLV 182
           LG G FG V +     L       +VAVK L   +     E   +E+ +++ L  H ++V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            L G C   G  ++I EY     L  FL   K++  L  +  +     +A+G+ +L   +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               IHRDL A N+LL      KI DFG+AR
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 57.9 bits (140), Expect = 8e-10
 Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 13/165 (7%)

Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGFG V   ++   G+  A K+L  +     +G     NE  ++ K+  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQGLLYLHQYSRLR 245
               + +  L+   M    L  +  Y   +     +AR       I  GL +LHQ    R
Sbjct: 61  AFETKDDLCLVMTLMNGGDLK-YHIYNVGEPGFP-EARAIFYAAQIICGLEHLHQ---RR 115

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           I++RDLK  N+LLD   N +ISD G+A    G       K   GT
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 57.8 bits (139), Expect = 9e-10
 Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 27/164 (16%)

Query: 131 LGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LTEFKNEMMLIAKL-QHRHLVRLF 185
           +GEG FG V K R+       + A+KR+   + +    +F  E+ ++ KL  H +++ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL----------------GWQARVRIIE 229
           G C  +G   L  EY P+ +L  FL   +K R+L                  Q  +    
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R
Sbjct: 120 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 57.8 bits (140), Expect = 9e-10
 Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 10/150 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
                  K+GEG  G V      + G++VAVK++  +  Q      NE++++   QH ++
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 182 VRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           V ++   +   E  ++ E++   +L D+        R+   Q    +   + + L +LH 
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQI-ATVCLAVLKALSFLHA 133

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFG 270
                +IHRD+K+ +ILL SD   K+SDFG
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           K+GEG  G V   R   +G++VAVK +  +  Q      NE++++   QH+++V ++   
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
           +   E  ++ E++   +L   +    + RL   Q    + E + Q L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV---SQTRLNEEQI-ATVCESVLQALCYLHSQG---VIH 140

Query: 249 RDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           RD+K+ +ILL  D   K+SDFG       D  +   K +VGT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGT 180

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 12/145 (8%)

Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           LG G  G VYK   LL  + +AVK +  + + +   +  +E+ ++ K    +++  +G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
             +    +  E+M   SLDV+   P+   +LG     RI   + +GL YL     L+I+H
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEH--VLG-----RIAVAVVKGLTYLWS---LKILH 118

Query: 249 RDLKASNILLDSDMNPKISDFGMAR 273
           RD+K SN+L+++    K+ DFG++ 
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 55/173 (31%), Positives = 78/173 (45%), Gaps = 29/173 (16%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS----NQSGQ---GLTEFKNEMMLIAKLQHRH-- 180
           LG+G FG V    L    E+ AVK L      Q       +TE +     +  L  +H  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKR-----VLALAGKHPF 57

Query: 181 LVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           L +L   C +  + +  + EY+     D+     +  R    +AR    E I  GL +LH
Sbjct: 58  LTQLH-SCFQTKDRLFFVMEYV--NGGDLMFHIQRSGRFDEPRARFYAAE-IVLGLQFLH 113

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGDELQGNTKRIVGT 290
           +     II+RDLK  N+LLDS+ + KI+DFGM +  I GG      T    GT
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGT 159

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 38/119 (31%), Positives = 56/119 (47%), Gaps = 20/119 (16%)

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++V  +G     GE  +  E+M   SLD  L   KK   +      +I   + +GL YL 
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLR 116

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGG-------DELQGN 283
           +  + +I+HRD+K SNIL++S    K+ DFG        MA  F G       + LQG 
Sbjct: 117 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 173

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 56.5 bits (136), Expect = 3e-09
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 12/162 (7%)

Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFK-NE 169
           L ++ SV    + ++   K+G+G  G VY    +  GQEVA+K++ N   Q   E   NE
Sbjct: 8   LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINE 66

Query: 170 MMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRII 228
           ++++ + +H ++V      +   E  ++ EY+   SL DV       +  +    R    
Sbjct: 67  ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 122

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
               Q L +LH     ++IHRD+K+ NILL  D + K++DFG
Sbjct: 123 -ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 28/62 (45%), Positives = 38/62 (61%), Gaps = 9/62 (14%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGDELQGNTKRIV 288
           IA GL +LH      II+RDLK  N++LD++ + KI+DFGM +  IFGG      T+   
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162

Query: 289 GT 290
           GT
Sbjct: 163 GT 164

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.4 bits (136), Expect = 4e-09
 Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 17/156 (10%)

Query: 131 LGEGGFGPVYKGRLL-NGQEVAVKRLSN----QSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           LG+G FG V   RL  +G+  AVK L      Q          + +L     H  L +L+
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 186 GCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQGLLYLHQYSR 243
            CC +  + +  + E++    L   +F+ +K R    +AR R     I   L++LH    
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG- 116

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGG 277
             II+RDLK  N+LLD + + K++DFGM +  IF G
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 44/166 (26%)

Query: 130 KLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL--VRLFG 186
            +G G +G V       +G++VA+K++ +           ++  +AK   R L  +R F 
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTLRELKILRHF- 61

Query: 187 CCIEQGENIL-IYE-YMPNKSL--DVFLFYPKKKRLLGWQARVRIIEG------------ 230
               + +NI+ I +   P  +   DV++     +  L       II              
Sbjct: 62  ----KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLH-----HIIHSDQPLTEEHIRYF 112

Query: 231 ---IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              + +GL Y+H  +   +IHRDLK SN+L++ D   +I DFGMAR
Sbjct: 113 LYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 55.6 bits (134), Expect = 5e-09
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 16/157 (10%)

Query: 131 LGEGGFGPVYK-------GRLLNGQEVAVKRLS-----NQSGQGLTEFKNEMMLIAK-LQ 177
           LG G FG VYK         LL  +E+ V   +      +  + + +  +E+ +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
           H ++VR +   +E     ++ + +    L + F    +KK+    +    I   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           YLH+  R  I+HRDL  +NI+L  D    I+DFG+A+
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.5 bits (133), Expect = 7e-09
 Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 10/162 (6%)

Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNEM 170
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+K+++ Q         NE+
Sbjct: 8   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67

Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 229
           +++ + ++ ++V      +   E  ++ EY+   SL DV       +  +       +  
Sbjct: 68  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 122

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
              Q L +LH     ++IHRD+K+ NILL  D + K++DFG 
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 38/143 (26%), Positives = 72/143 (50%), Gaps = 23/143 (16%)

Query: 147 GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI----------- 195
            + VAVK++     Q +     E+ +I +L H ++V+++      G ++           
Sbjct: 30  DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89

Query: 196 ---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK 252
              ++ EYM    L   L   ++  L    AR+ + + + +GL Y+H  +   ++HRDLK
Sbjct: 90  SVYIVQEYM-ETDLANVL---EQGPLSEEHARLFMYQ-LLRGLKYIHSAN---VLHRDLK 141

Query: 253 ASNILLDS-DMNPKISDFGMARI 274
            +N+ +++ D+  KI DFG+ARI
Sbjct: 142 PANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 15/168 (8%)

Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCI 189
           +G G +G VYKGR +   ++A  ++ + +     E K E+ ++ K   HR++   +G  I
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 190 EQG------ENILIYEYMPNKSLDVFLFYPKKKRLL-GWQARVRIIEGIAQGLLYLHQYS 242
           ++       +  L+ E+    S+   +   K   L   W A   I   I +GL +LH + 
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH- 140

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
             ++IHRD+K  N+LL  +   K+ DFG++     D   G     +GT
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 184

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 10/162 (6%)

Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEM 170
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q         NE+
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68

Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 229
           +++ + ++ ++V      +   E  ++ EY+   SL DV       +  +       +  
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 123

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
              Q L +LH     ++IHRD+K+ NILL  D + K++DFG 
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 15/165 (9%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQS--GQGLTE-FKNEMMLIAKLQHRHLVRLFG 186
           LG GGFG V   ++ +     A+K +  +     G  E   +E  ++ +  H  +V+L+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG-WQARVRIIEGIAQGLLYLHQYSRLR 245
              ++    ++ EY     L   L   + + L   + AR   I  +     YLH      
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARF-YIACVVLAFEYLH---NRG 113

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           II+RDLK  N+LLDS+   K+ DFG A+     +    T    GT
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 48/157 (30%), Positives = 68/157 (43%), Gaps = 32/157 (20%)

Query: 131 LGEGGFGPV----YKGRLLNGQEVAVKRL------SNQSGQGLTEFKNEMMLIAKLQHRH 180
           LG G FG V    YK     G+  A+K L      +    + L   K         +H  
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           LV LF C   +     + EY     L      DVF     + R + + A V +      G
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAACVVL------G 113

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
           L YLH+    +I++RDLK  N+LLD++   KI+DFG+
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.3 bits (130), Expect = 1e-08
 Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 10/162 (6%)

Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEM 170
           L ++ S+    + ++   K+G+G  G V+    +  GQEVA+K+++ Q         NE+
Sbjct: 8   LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67

Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 229
           +++ +L++ ++V      +   E  ++ EY+   SL DV       +  +       +  
Sbjct: 68  LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCR 122

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
              Q L +LH     ++IHRD+K+ N+LL  D + K++DFG 
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 14/150 (9%)

Query: 131 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+GGFG V        G+L   +++  KRL  +  +G      E  ++AK+  R +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII--EGIAQGLLYLHQYS 242
                +   ++ +   + N     +  Y   +   G+           I  GL +LHQ  
Sbjct: 59  -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             RII+RDLK  N+LLD+D N +ISD G+A
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 13/165 (7%)

Query: 131 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRHLVRLF 185
           +G+G FG V    R  +G   AVK L  ++     E  + M    +L+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
                  +   + +Y+    L  F    +++  L  +AR    E +A  + YLH    L 
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS---LN 116

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           II+RDLK  NILLDS  +  ++DFG+ +   G E +  T    GT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 15/178 (8%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRH 180
           ++F    +LG G  G V K +      +  ++L +   +     +   E+ ++ +    +
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V  +G     GE  +  E+M   SLD  L   K+ + +  +   ++   + +GL YL +
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE 121

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDELQGNTKRIVGT 290
             + +I+HRD+K SNIL++S    K+ DFG        MA  F G     + +R+ GT
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 13/165 (7%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRHLVRLF 185
           +G+G FG V   +   +G+  AVK L  ++     E K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
                  +   + +Y+    L  F    +++     +AR    E IA  L YLH    L 
Sbjct: 63  YSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---LN 116

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           II+RDLK  NILLDS  +  ++DFG+ +   G E    T    GT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 17/160 (10%)

Query: 129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLVRLFGC 187
           CK+G G +G VYK +  +G++     L    G G++     E+ L+ +L+H +++ L   
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 188 CIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQ 240
            +   +    L+++Y  +    +  F+   K     +  V++  G+ + LLY     +H 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 241 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARIF 275
                ++HRDLK +NIL+  +  P     KI+D G AR+F
Sbjct: 124 LHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 21/153 (13%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQS-------GQGLTEFKNEMMLIAKLQHRHLV 182
           LG+G FG V    L    EV A+K L              +TE K  + L AK  H  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTE-KRILALAAK--HPFLT 59

Query: 183 RLFGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQGLLYLHQ 240
            L  CC +  + +  + EY+    L   +F  ++ R    + R R     +   L++LH+
Sbjct: 60  ALH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHR 114

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +    +I+RDLK  NILLD++ + K++DFGM +
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 52.0 bits (125), Expect = 2e-08
 Identities = 31/146 (21%), Positives = 55/146 (37%), Gaps = 13/146 (8%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCC 188
            L  G    VY       ++  +K   ++      E +  ++ +   +    V ++    
Sbjct: 5   LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
              G + L+ E++  ++LD      K+           I E +A+ L  LHQ   L + H
Sbjct: 63  ESDGWSYLLMEWIEGETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLVLCH 112

Query: 249 RDLKASNILLDSDMNPKISDFGMARI 274
            DL   NIL+D      I D+  A  
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 45/147 (30%), Positives = 69/147 (46%), Gaps = 31/147 (21%)

Query: 147 GQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 203
           GQ VA+K+LS +  Q +T  K    E++L+  + H++++ L               + P 
Sbjct: 41  GQNVAIKKLS-RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQ 87

Query: 204 KSL----DVFLFYPKK--------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDL 251
           KSL    DV+L             +  L  +    ++  +  G+ +LH      IIHRDL
Sbjct: 88  KSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 144

Query: 252 KASNILLDSDMNPKISDFGMARIFGGD 278
           K SNI++ SD   KI DFG+AR  G  
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTAGTS 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.4 bits (128), Expect = 3e-08
 Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 22/162 (13%)

Query: 123 ENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHR 179
           E +++  ++G G +G V        G++VA+K+LS   QS         E+ L+  +QH 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 180 HLVRLFGCCIEQ--GENIL-IYEYMPNKSLDV-----FLFYPKKKRLLGWQARVRIIEGI 231
           +++ L         G+     Y  MP    D+           K + L +Q        +
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ--------M 126

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 25/58 (43%), Positives = 37/58 (63%), Gaps = 3/58 (5%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
           I +GL YLH      I+HRD+K  N+L++S+   KI DFG+AR+   DE +  T+ +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.8 bits (126), Expect = 5e-08
 Identities = 44/160 (27%), Positives = 81/160 (50%), Gaps = 17/160 (10%)

Query: 129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLVRLFGC 187
           CK+G G +G VYK +  +G++     L    G G++     E+ L+ +L+H +++ L   
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 188 CIEQGEN--ILIYEYMPNKSLDVFLFY----PKKKRLLGWQARVR-IIEGIAQGLLYLHQ 240
            +   +    L+++Y  +    +  F+      KK +   ++ V+ ++  I  G+ YLH 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 241 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARIF 275
                ++HRDLK +NIL+  +  P     KI+D G AR+F
Sbjct: 127 N---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 52.9 bits (127), Expect = 5e-08
 Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 12/149 (8%)

Query: 131 LGEGGFGPVYKGRLLN----GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+G FG V+  R +     GQ  A+K L   +   +     K E  ++A++ H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
                 +G+  LI +++  +  D+F    K+        +  + E +A  L +LH    L
Sbjct: 64  HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLH---SL 117

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMAR 273
            II+RDLK  NILLD + + K++DFG+++
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 52.3 bits (125), Expect = 6e-08
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 8/142 (5%)

Query: 130 KLGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           K+GEG  G V        G++VAVK++  +  Q      NE++++    H ++V ++   
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
           +   E  ++ E++   +L   + + +    +  +    +   + + L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 249 RDLKASNILLDSDMNPKISDFG 270
           RD+K+ +ILL SD   K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 10/128 (7%)

Query: 146 NGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN 203
               VAVK+  L + S + L   + E++   +LQH +++      I   E  ++   M  
Sbjct: 24  TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83

Query: 204 KSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 261
            S +  L   +P+    L   A   I++ +   L Y+H       IHR +KAS+ILL  D
Sbjct: 84  GSCEDLLKTHFPEG---LPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGD 137

Query: 262 MNPKISDF 269
               +S  
Sbjct: 138 GKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 52.1 bits (125), Expect = 8e-08
 Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 20/159 (12%)

Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLS------NQSGQGLTEFKNEMMLIAKLQHRH 180
           LG+GG+G V++ R + G +     A+K L       NQ     T  K E  ++  ++H  
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT--KAERNILEAVKHPF 61

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V L       G+  LI EY+    L  F+   ++   +   A   + E I+  L +LHQ
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSE-ISLALEHLHQ 118

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGG 277
                II+RDLK  NILLD+  + K++DFG+ +  I  G
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.1 bits (125), Expect = 8e-08
 Identities = 23/60 (38%), Positives = 40/60 (66%), Gaps = 2/60 (3%)

Query: 222 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
           ++ VR+   IA+ +L L    +L II+RD+K  NILLDS+ +  ++DFG+++ F  +E +
Sbjct: 104 ESEVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 20/150 (13%)

Query: 131 LGEGGFGPVYKGRL----LNGQEVAVKRLSN----QSGQGLTEFKNEMMLIAKLQHRHLV 182
           +G G FG V   RL      G   A+K+L      +  Q +   + E  ++A+  +  +V
Sbjct: 9   IGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVV 64

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +L+    +    + LI EY+P   +   L   KK      + R  I E I    L +   
Sbjct: 65  KLY-YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETI----LAIDSI 117

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGM 271
            +L  IHRD+K  N+LLD+  + K+SDFG+
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 9e-08
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 32/157 (20%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +G G FG V+  R  +  +V A+K L        NQ      E   +++  A      +V
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE--RDILADAD--SPWIV 64

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG------IAQGL 235
           +L+    +  E++ L+ EYMP   L            +    R  +         IA+ +
Sbjct: 65  KLY-YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELV 111

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
           L L    +L  IHRD+K  NIL+D+D + K++DFG+ 
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 16/149 (10%)

Query: 131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH----LVRLF 185
           +G G  G VYK R    G  +AVK++     +   E K  +M +  +   H    +V+ +
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCY 80

Query: 186 GCCIEQGENILIYEYMPN--KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
           G  I   +  +  E M      L   +  P  + +LG     ++   I + L YL +  +
Sbjct: 81  GYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKE--K 133

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMA 272
             +IHRD+K SNILLD+  N K+ DFG++
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 10/148 (6%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           +LG+G +G VYK      G  +A+K  RL     +   +   E+ ++ K    ++V  +G
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66

Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLYLHQYSRL 244
               +G   +  EYM   SLD    Y       G    V  RI   + +GL +L +    
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKL--YAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMA 272
            IIHRD+K +N+L++ +   K+ DFG++
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 50.3 bits (120), Expect = 3e-07
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 14/150 (9%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           ++G G FG V    +     VA   VK L +N S +   EF  +      LQH ++++  
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKR----LLGWQARVRIIEGIAQGLLYLHQY 241
           G C+E    +L++EY     L  +L   +  R    LL  Q   R+   IA G+ ++H  
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH-- 116

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGM 271
            +   +H DL   N  L SD+  K+ D+G+
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 12/148 (8%)

Query: 131 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+GGFG V        G++   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
                 +    L+   M    L   +++  +      +A     E I  GL  LHQ    
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQE--- 121

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMA 272
           RI++RDLK  NILLD   + +ISD G+A
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 50/193 (25%), Positives = 81/193 (41%), Gaps = 20/193 (10%)

Query: 87  FRRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLN 146
           F +  + HK+KD +   + K                E+F+    LG G FG V      N
Sbjct: 3   FLKNLQLHKKKDSDSTKEPK---------RKNKMKYEDFNFIRTLGTGSFGRVILATYKN 53

Query: 147 GQ--EVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 201
                VA+KR         + +    +E  ++  + H   V L+G   ++    L+ E++
Sbjct: 54  EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV 113

Query: 202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 261
                + F F  + KR   +   V      AQ +L       L I++RDLK  N+LLD D
Sbjct: 114 IGG--EFFTFLRRNKR---FPNDVGCFYA-AQIVLIFEYLQSLNIVYRDLKPENLLLDKD 167

Query: 262 MNPKISDFGMARI 274
              K++DFG A++
Sbjct: 168 GFIKMTDFGFAKV 180

Length = 340

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 49.4 bits (118), Expect = 5e-07
 Identities = 37/152 (24%), Positives = 75/152 (49%), Gaps = 13/152 (8%)

Query: 130 KLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           K+GEG FG          G+    +E+ + ++S +  +   E + E+ +++ ++H ++V+
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQ 63

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
                 E G   ++ +Y      D++     ++ +L +    +I++   Q  L L     
Sbjct: 64  YQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVL-FPED-QILDWFVQICLALKHVHD 119

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
            +I+HRD+K+ NI L  D   K+ DFG+AR+ 
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 16/168 (9%)

Query: 123 ENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHR 179
           E +     +G G +G V        G  VAVK+LS   QS         E+ L+  ++H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 180 HLVRLF-----GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +++ L         +E+  ++ +  ++    L+  +   K ++L     +  I + I +G
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQ-ILRG 132

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
           L Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 176

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 49.7 bits (119), Expect = 5e-07
 Identities = 20/43 (46%), Positives = 32/43 (74%), Gaps = 3/43 (6%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           + +GL Y+H  +   ++HRDLK SN+LL+++ + KI DFG+AR
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 5e-07
 Identities = 26/87 (29%), Positives = 49/87 (56%), Gaps = 5/87 (5%)

Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           L++++ H HL  + G C+   ENI++ E++ +  LDV L   K +  + W  ++ + + +
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILL 258
           A  L YL   +   ++H ++ A NILL
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 49.6 bits (118), Expect = 5e-07
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 23/164 (14%)

Query: 131 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+GGFG V        G++   + +  KR+  + G+ +    NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYP-----KKKRLLGWQARVRIIEGIAQGLLYLH 239
                 +    L+   M    L   ++       +++R L + A       I  GL  LH
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLH 119

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RIFGGDELQG 282
           + +    ++RDLK  NILLD   + +ISD G+A +I  G+ ++G
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 37/142 (26%), Positives = 71/142 (50%), Gaps = 8/142 (5%)

Query: 130 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           K+GEG  G V    +  +G+ VAVK++  +  Q      NE++++   QH ++V ++   
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
           +   E  ++ E++   +L   + + +    +  +    +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 249 RDLKASNILLDSDMNPKISDFG 270
           RD+K+ +ILL  D   K+SDFG
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 7e-07
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 20/162 (12%)

Query: 131 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G +G V   Y  RL   Q+VAVK+LS   QS         E+ L+  ++H +++ L 
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 186 -----GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
                   IE    + +   +    L+  +   K ++L     +  I + + +GL Y+H 
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLSDEHVQFLIYQ-LLRGLKYIHS 136

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
                IIHRDLK SN+ ++ D   +I DFG+AR    DE+ G
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG 174

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 15/139 (10%)

Query: 147 GQEVAVKRLSNQSGQGLTE---FKNEMMLIAKLQHRHLVRLF--GCCIEQGENILIYEYM 201
           G EVA+K L   + +   +   F+ E  L A+L H ++V L   G     G    ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--- 258
           P ++L   L        L      R++  +   L   H      I+HRDLK  NI++   
Sbjct: 62  PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115

Query: 259 DSDMNPKISDFGMARIFGG 277
               + K+ DFG+  +  G
Sbjct: 116 GVRPHAKVLDFGIGTLLPG 134

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 49.3 bits (117), Expect = 8e-07
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)

Query: 147 GQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGC-----CIEQGENI-LI 197
           G  VAVK+LS +  Q  T  K    E++L+  + H++++ L         +E+ +++ L+
Sbjct: 46  GINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104

Query: 198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 257
            E M      V       +R+        ++  +  G+ +LH      IIHRDLK SNI+
Sbjct: 105 MELMDANLCQVIHMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 155

Query: 258 LDSDMNPKISDFGMAR 273
           + SD   KI DFG+AR
Sbjct: 156 VKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 45.6 bits (108), Expect = 8e-07
 Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 7/59 (11%)

Query: 1  MNLNQCQAKCLK-NCSCRAYANSKLTGGGSGCLMW-FGDLIDLRKPISNFTGQSVYIRV 57
           +L +C +KCL  NCSCR++  +    G  GCL+W    L D R       G  +Y ++
Sbjct: 25 ASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARL--FPSGGVDLYEKI 78

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 49.2 bits (117), Expect = 9e-07
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 11/148 (7%)

Query: 131 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRHLVRLF 185
           +G+G FG V    R L+G+  AVK L  +      E K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
                  +   + +++    L  F    +++     +AR    E IA  L YLH    + 
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---IN 116

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
           I++RDLK  NILLDS  +  ++DFG+ +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 49.3 bits (117), Expect = 9e-07
 Identities = 39/130 (30%), Positives = 64/130 (49%), Gaps = 13/130 (10%)

Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ ++ +    ++V  +G     GE  +  E+M   SLD  L   KK   +  Q   ++ 
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVS 109

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDEL 280
             + +GL YL +  + +I+HRD+K SNIL++S    K+ DFG        MA  F G   
Sbjct: 110 IAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167

Query: 281 QGNTKRIVGT 290
             + +R+ GT
Sbjct: 168 YMSPERLQGT 177

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 51/161 (31%), Positives = 78/161 (48%), Gaps = 35/161 (21%)

Query: 131 LGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +G G +G V        G +VA+K+L          F++E  L AK  +R L RL     
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYR-------PFQSE--LFAKRAYREL-RLLKHM- 71

Query: 190 EQGENI--LIYEYMPNKSLDVF----LFYP----------KKKRLLGWQARVR-IIEGIA 232
            + EN+  L+  + P+ SLD F    L  P          K ++L   + R++ ++  + 
Sbjct: 72  -KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL--SEDRIQFLVYQML 128

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 13/148 (8%)

Query: 131 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLTEFKN----EMMLIAKLQHRHLVRLF 185
           +GEG +G V K R    +E VA+K+  +       E K     E+ ++  L+  ++V L 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
                +G+  L++EY+    L++    P          +VR    I Q +  +H   +  
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP----PEKVR--SYIYQLIKAIHWCHKND 120

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
           I+HRD+K  N+L+  +   K+ DFG AR
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 13/165 (7%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTEFKNEM----MLIAKLQHRHLVRLF 185
           +G+G FG V   R    ++  AVK L  ++     E K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
                  +   + +Y+    L  F    +++  L  +AR    E IA  L YLH    L 
Sbjct: 63  FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---LN 116

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           I++RDLK  NILLDS  +  ++DFG+ +     E  G T    GT
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 44/161 (27%), Positives = 82/161 (50%), Gaps = 20/161 (12%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLTE-FKNEMMLIAKLQH 178
           E F     +  G FG VY GR   N +  AVK  + ++   + +    + E   +A  + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 179 RHLVRLFGCCIEQGENI-LIYEYMPN---KSL-DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
             +V L+   ++   N+ L+ EY+     KSL  ++ ++ +       +  V+ I  +A 
Sbjct: 64  PFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE-------EMAVKYISEVAL 115

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
            L YLH++    IIHRDLK  N+L+ ++ + K++DFG++++
Sbjct: 116 ALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 22/153 (14%)

Query: 131 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+GGFG V        G++   +++  KRL  +SG+ +   + E++   K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKK-----RLLGWQARVRIIEGIAQGLLYLH 239
                 +    L+   M    L   ++   ++     R++ + A+      I  G+L+LH
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH 112

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
               + I++RD+K  N+LLD   N ++SD G+A
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 12/107 (11%)

Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++ ++ H+H+V L+G C+   ENI++ E++    LD  LF  +K  +L    + ++ + +
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQL 114

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILL-----DSDMNP--KISDFGM 271
           A  L YL       ++H ++   NILL     D +  P  K+SD G+
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 8/104 (7%)

Query: 171 MLIAKLQHRHLVRLFGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE 229
           +L    +H  L  LF C  +  E++  + EY+     D+        R    +AR    E
Sbjct: 48  VLALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGG--DLMFHIQSSGRFDEARARFYAAE 104

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            I  GL +LH+     II+RDLK  N+LLD D + KI+DFGM +
Sbjct: 105 -IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 56/192 (29%), Positives = 87/192 (45%), Gaps = 24/192 (12%)

Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKNEM 170
           +  L S+   T+ +     +G+G +G VYK     +G   AVK L   S     E + E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69

Query: 171 MLIAKL-QHRHLVRLFGCCIEQ-----GENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            ++  L  H ++V+ +G   +      G+  L+ E     S+   +     K LL    R
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124

Query: 225 VR------IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +       I+ G   GL +LH     RIIHRD+K +NILL ++   K+ DFG++      
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Query: 279 ELQGNTKRIVGT 290
            L+ NT   VGT
Sbjct: 182 RLRRNTS--VGT 191

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 2e-06
 Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 27/172 (15%)

Query: 131 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+GGFG V        G++   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYP-----KKKRLLGWQARVRIIEGIAQGLLYLH 239
                 +    L+   M    L   ++        ++R + + A       I  GL  LH
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE------ITCGLEDLH 119

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RIFGGDELQGNTKRIVGT 290
              R RI++RDLK  NILLD   + +ISD G+A  I  G+ ++G     VGT
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGT 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 46/151 (30%), Positives = 68/151 (45%), Gaps = 17/151 (11%)

Query: 131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAK------LQHRHLVR 183
           LG+G FG V+   L    Q  A+K L       L +   E  ++ K       +H  L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 184 LFGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           L+ C  +  EN+  + EY+    L   +F+ +                I  GL +LH   
Sbjct: 61  LY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              I++RDLK  NILLD+D + KI+DFGM +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 15/167 (8%)

Query: 124 NFSTQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLTEFKNEMMLIAK 175
           NF     LG G +G V+  R ++G +     A+K L      Q  +     + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 176 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           + Q   LV L        +  LI +Y+    L  F    +++R    + ++   E I   
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGE-IVLA 117

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
           L +LH   +L II+RD+K  NILLDS+ +  ++DFG+++ F  DE++
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 46/172 (26%)

Query: 131 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---- 184
           +G G FG VY+   ++  E VA+K++         ++KN E++++  L H +++ L    
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128

Query: 185 FGCCIEQGE-NI---LIYEYMP-------------NKSLDVFLFYPKKKRLLGWQARVRI 227
           +  C ++ E NI   ++ E++P             N +L +FL      +L  +Q     
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ----- 178

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMAR-IFGG 277
              + + L Y+H  S+  I HRDLK  N+L+D + +  K+ DFG A+ +  G
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224

Length = 440

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 46.9 bits (111), Expect = 4e-06
 Identities = 36/147 (24%), Positives = 73/147 (49%), Gaps = 6/147 (4%)

Query: 131 LGEGGFG-PVYKGRLLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           +GEG FG  +    + + Q+ A+K +   +S   + + + E +L+AK++H ++V      
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
              G   ++ EY     L +     ++ +L      ++    +  G+ ++H+    R++H
Sbjct: 68  EADGHLYIVMEYCDGGDL-MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLH 123

Query: 249 RDLKASNILLDSDMNPKISDFGMARIF 275
           RD+K+ NI L  +   K+ DFG AR+ 
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLL 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.0 bits (111), Expect = 4e-06
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 6/96 (6%)

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H  LV L  C   +     + EY+     D+     ++++L    AR    E I+  L Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALNY 111

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           LH+     II+RDLK  N+LLDS+ + K++D+GM +
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 4e-06
 Identities = 47/172 (27%), Positives = 72/172 (41%), Gaps = 40/172 (23%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAK 175
           E+F T   +G+G FG V   RL+     G+  A+K L          L   K E  ++A+
Sbjct: 1   EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSL------------DVFLFYPKKKRLLGWQA 223
                +V L+    +     LI E++P   L            DV  FY           
Sbjct: 58  SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY----------- 106

Query: 224 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
                  +A+ +L +    +L  IHRD+K  NIL+D   + K+SDFG++  F
Sbjct: 107 -------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 46.7 bits (111), Expect = 5e-06
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 8/97 (8%)

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRIIEGIAQGLL 236
           H  LV L  C   +     + E++    L   +F+ +++R L  + AR    E I+  L 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 110

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +LH+     II+RDLK  N+LLD++ + K++D+GM +
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 46.6 bits (111), Expect = 5e-06
 Identities = 21/45 (46%), Positives = 30/45 (66%), Gaps = 3/45 (6%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           I  GL Y+H  +   ++HRDLK  N+L+++D   KI DFG+AR F
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 16/156 (10%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAK 175
           E+F +   +G G FG V   RL+     G   A+K L        + +   + E  ++ +
Sbjct: 1   EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
                +V++F    ++    LI E++P   +   L   KK  L   + +  I    A+ +
Sbjct: 58  ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYI----AETV 111

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
           L +    +L  IHRD+K  N+LLDS  + K+SDFG+
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 46.5 bits (110), Expect = 6e-06
 Identities = 49/167 (29%), Positives = 76/167 (45%), Gaps = 17/167 (10%)

Query: 131 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+GGFG V        G++   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
                 +    L+   M    L  F  Y         Q  +     +  GL  L    R 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLK-FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RE 121

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMA-RIFGGDELQGNTKRIVGT 290
           RI++RDLK  NILLD   + +ISD G+A +I  G+ ++G     VGT
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGT 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 7e-06
 Identities = 37/133 (27%), Positives = 63/133 (47%), Gaps = 23/133 (17%)

Query: 153 KRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE---YMPNKSLDVF 209
           KR+   S +   + +NE++ + +L H +++++        E IL  E   YM  +  D  
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFD 248

Query: 210 LF-------YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 262
           L+       +  K R L  Q R  I++ +   + Y+H     ++IHRD+K  NI L+ D 
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304

Query: 263 NPKISDFGMARIF 275
              + DFG A  F
Sbjct: 305 KIVLGDFGTAMPF 317

Length = 501

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 46.6 bits (110), Expect = 7e-06
 Identities = 39/137 (28%), Positives = 67/137 (48%), Gaps = 17/137 (12%)

Query: 148 QEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLFGC-----CIEQGENI-LIYE 199
           + VA+K+LS   Q+         E++L+  + H++++ L         +E+ +++ L+ E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102

Query: 200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 259
            M      V       +R+        ++  +  G+ +LH      IIHRDLK SNI++ 
Sbjct: 103 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153

Query: 260 SDMNPKISDFGMARIFG 276
           SD   KI DFG+AR  G
Sbjct: 154 SDCTLKILDFGLARTAG 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 22/43 (51%), Positives = 31/43 (72%), Gaps = 3/43 (6%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           I+ GL +LH   R  II+RDLK  N++LDS+ + KI+DFGM +
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 19/163 (11%)

Query: 134 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN----EMMLIAKLQHRHLVRLFGCC 188
           G FG VY  +    G   A+K L         +  N      +++ + +  ++ +L+   
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY-YS 65

Query: 189 IEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 247
            +  + + L+ EY+        +   K    L      + I  +  G+  LHQ     II
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119

Query: 248 HRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           HRD+K  N+L+D   + K++DFG++R   G E     K+ VGT
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGT 156

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           IA GL +LH      II+RDLK  N++LDS+ + KI+DFGM +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 18/37 (48%), Positives = 25/37 (67%), Gaps = 3/37 (8%)

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           YLH      II+RDLK  N+LLD+  + K++DFG A+
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 8/94 (8%)

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRIIEGIAQGLLYLH 239
           LV L  C        L+ EY+    L   +F+ +++R L  + AR    E I   L +LH
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLH 113

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +     II+RDLK  N+LLD+D + K++D+GM +
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 45/138 (32%), Positives = 63/138 (45%), Gaps = 19/138 (13%)

Query: 148 QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL- 206
           + VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL 
Sbjct: 50  RNVAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99

Query: 207 ---DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILL 258
              DV++        L    ++ +       LLY     +       IIHRDLK SNI++
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

Query: 259 DSDMNPKISDFGMARIFG 276
            SD   KI DFG+AR  G
Sbjct: 160 KSDCTLKILDFGLARTAG 177

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 17/166 (10%)

Query: 124 NFSTQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLTEFKNEMMLIAK 175
           NF     LG G +G V+  R + G +     A+K L      Q  + +   + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 176 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQ 233
           + Q   LV L      + +  LI +Y+    +   L+    +R    +  VR   G I  
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIIL 116

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            L +LH   +L I++RD+K  NILLDS+ +  ++DFG+++ F  +E
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
           + L Y+H  +   + HRDLK  NIL ++D   KI DFG+AR+
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.9 bits (103), Expect = 5e-05
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 16/156 (10%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAK 175
           ++F +   +G G FG V   RL+     G   A+K L        + +   + E  ++ +
Sbjct: 1   DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
                +V++F    ++    LI E++P   +   L   KK  L     +  I E +    
Sbjct: 58  ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETV---- 111

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
           L +    +L  IHRD+K  N+LLD+  + K+SDFG+
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 32/113 (28%), Positives = 47/113 (41%), Gaps = 25/113 (22%)

Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEY---------MPNKSLDVFLFYPKKKRLL 219
           E+ ++  + HR ++ L            I+ Y         MP    D+F  Y  +   L
Sbjct: 136 EIDILKTISHRAIINL------------IHAYRWKSTVCMVMPKYKCDLFT-YVDRSGPL 182

Query: 220 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             +  + I   + + L YLH      IIHRD+K  NI LD   N  + DFG A
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 43.4 bits (102), Expect = 5e-05
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 10/150 (6%)

Query: 131 LGEGGFGPV--YKGRLLNGQEVAVK-RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           +G+G +G V   + R    Q V  K  L N S +     + E  L+++L+H ++V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 188 CIEQGENILIYEYMP-NKSLDVF-LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
              +GE+ L+Y  M   +  D++     +K +LL     V     IA  L YLH+     
Sbjct: 68  W--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIF 275
           I+HRDLK  N+ L      K+ D G+AR+ 
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 43.6 bits (103), Expect = 7e-05
 Identities = 47/160 (29%), Positives = 67/160 (41%), Gaps = 43/160 (26%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTEFKNEMM-------------LIAKL 176
           +G G FG V   R  + ++V A+K LS          K EM+             ++A  
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWEERDIMAHA 100

Query: 177 QHRHLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLF----YPKKKRLLGWQARVRIIEG 230
               +V+L      Q +  L  + EYMP   L V L      P+K     W AR    E 
Sbjct: 101 NSEWIVQL--HYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEK-----W-ARFYTAE- 150

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
           +   L  +H       IHRD+K  N+LLD   + K++DFG
Sbjct: 151 VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 43.1 bits (101), Expect = 7e-05
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 14/168 (8%)

Query: 131 LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCC 188
           +G+G +G V+K     NG + AVK L         E + E  ++  L  H ++V+ +G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 189 ----IEQGENI-LIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               ++ G+ + L+ E     S+ D+   + K+   +       I+     GL +LH   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
             + IHRD+K +NILL ++   K+ DFG++       L+ NT   VGT
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 187

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 43.3 bits (102), Expect = 8e-05
 Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           I   L YLH      +++RDLK  N++LD D + KI+DFG+ +
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 23/48 (47%), Positives = 31/48 (64%), Gaps = 5/48 (10%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFG 276
           I  GL +LH      II+RDLK  N++LD D + KI+DFGM +  +FG
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 26/153 (16%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +G G FG V   R ++   + A+K L        NQ+       K E  ++A+  +  +V
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH----VKAERDILAEADNEWVV 64

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLF----YPKKKRLLGWQARVRIIEGIAQGLLYL 238
           +L+    ++     + +Y+P   +   L     + +        AR  I E +   +  +
Sbjct: 65  KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED------LARFYIAE-LTCAIESV 117

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
           H   ++  IHRD+K  NIL+D D + K++DFG+
Sbjct: 118 H---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 18/43 (41%), Positives = 29/43 (67%)

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           Q LL +H      +IHRD+K++NILL S+   K+ DFG ++++
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193

Length = 496

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 19/40 (47%), Positives = 28/40 (70%), Gaps = 3/40 (7%)

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
           L YLH Y    I+HRDLK  N+L+ S  + K++DFG+++I
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 42.4 bits (99), Expect = 1e-04
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 12/148 (8%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+G FG V   R   +G+  A+K L  +   +   +     E  ++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQGLLYLHQYSRLR 245
               +     + EY+    L    F+  ++R+   + R R     I   L YLH     +
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG---K 115

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
           I++RDLK  N++LD D + KI+DFG+ +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 6/78 (7%)

Query: 196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN 255
           L+ +YM    L  F    K+ R    +A+  I E +   L +LH+Y    I++RDLK  N
Sbjct: 73  LVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAE-LVLALEHLHKYD---IVYRDLKPEN 126

Query: 256 ILLDSDMNPKISDFGMAR 273
           ILLD+  +  + DFG+++
Sbjct: 127 ILLDATGHIALCDFGLSK 144

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.4 bits (98), Expect = 2e-04
 Identities = 26/100 (26%), Positives = 49/100 (49%), Gaps = 7/100 (7%)

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           + + ++L+        ++LI +Y+ +  L   L   KK+  L      +II  + + L  
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL---KKEGKLSEAEVKKIIRQLVEALND 124

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFG 276
           LH++    IIH D+K  N+L D   +   + D+G+ +I G
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161

Length = 267

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 27/104 (25%), Positives = 49/104 (47%), Gaps = 7/104 (6%)

Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E  ++  + H  +++L G         LI   +P    D++ +   K+ +      + I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIE 188

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             + + + YLH+    RIIHRD+KA NI ++   +  + DFG A
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +A+G+ +L   SR + IHRDL A NILL  +   KI DFG+AR
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 18/153 (11%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG G FG V     ++   + A+K L  +   +   +   K E  ++A+  +  +V+L+ 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 187 CCIEQGENILIYEYMPNKSLDVFLF----YPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
              ++     + +Y+P   +   L     +P+        AR  I    A+  L +    
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV------LARFYI----AELTLAIESVH 118

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           ++  IHRD+K  NIL+D D + K++DFG+   F
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 37/166 (22%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           ++F     +G G FG           EVAV ++ +      TE    M ++ K +   L 
Sbjct: 1   DDFEIIKVIGRGAFG-----------EVAVVKMKH------TERIYAMKILNKWEM--LK 41

Query: 183 RLFGCCIEQGENILI-----------YEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIE 229
           R    C  +  N+L+           Y +     L + + Y     LL   ++   R+ E
Sbjct: 42  RAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPE 101

Query: 230 G-----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
                 IA+ +L +H   +L  +HRD+K  N+LLD + + +++DFG
Sbjct: 102 DMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 19/43 (44%), Positives = 26/43 (60%), Gaps = 3/43 (6%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 40.4 bits (94), Expect = 6e-04
 Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 2/43 (4%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           I   L YLH  S   +++RDLK  N++LD D + KI+DFG+ +
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 7e-04
 Identities = 39/153 (25%), Positives = 69/153 (45%), Gaps = 18/153 (11%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG G FG V   R ++ + + A+K L  +       +   K E  ++A+  +  +VRL+ 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 187 CCIEQGENILIYEYMPNKSLDVFLF----YPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
              ++     + +Y+P   +   L     +P+        AR  I E        +    
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED------LARFYIAELTCA----VESVH 118

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           ++  IHRD+K  NIL+D D + K++DFG+   F
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 40.0 bits (93), Expect = 8e-04
 Identities = 17/43 (39%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           I   L YLH      +++RD+K  N++LD D + KI+DFG+ +
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.9 bits (93), Expect = 9e-04
 Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 6/58 (10%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQGNTK 285
           +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++GN +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 25/159 (15%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSN-----QSGQGLTEFKNEMMLIAKL 176
           E++     +G G FG V   R  + Q+V A+K LS      +S      F  E  ++A  
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFA 100

Query: 177 QHRHLVRLFGCCIEQGENIL--IYEYMPNKSL-DVFLFY--PKKKRLLGWQARVRIIEGI 231
               +V+LF  C  Q +  L  + EYMP   L ++   Y  P+K     W          
Sbjct: 101 NSPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFY-----T 148

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
           A+ +L L     + +IHRD+K  N+LLD   + K++DFG
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 14/40 (35%), Positives = 27/40 (67%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
           +A+ +L +    +L  +HRD+K  N+LLD + + +++DFG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 46/175 (26%), Positives = 71/175 (40%), Gaps = 41/175 (23%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFK-------NEMMLIAKLQHRHL 181
            +G+GG G VY     +  + VA+K++     + L+E          E  + A L H  +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIR----EDLSENPLLKKRFLREAKIAADLIHPGI 64

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG--WQ---------------AR 224
           V ++  C   G+   +Y  MP      ++     K LL   WQ               A 
Sbjct: 65  VPVYSIC-SDGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115

Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           + I   I   + Y+H  S+  ++HRDLK  NILL       I D+G A     +E
Sbjct: 116 LSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167

Length = 932

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +A+G+ +L   SR + IHRDL A NILL  +   KI DFG+AR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 0.001
 Identities = 45/145 (31%), Positives = 63/145 (43%), Gaps = 10/145 (6%)

Query: 130 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLF 185
            LG+G  G V+  RL   G+  A+K L  +      + K    E  ++A L H  L  L+
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 186 GCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
               +    + L+ +Y P   L   L     K L    AR    E +   L YLH    L
Sbjct: 68  -ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHL---L 122

Query: 245 RIIHRDLKASNILLDSDMNPKISDF 269
            I++RDLK  NILL    +  +SDF
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDF 147

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +A+G+ +L   SR + IHRDL A NILL  +   KI DFG+AR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 19/54 (35%), Positives = 30/54 (55%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
            A+ L  L    +  +I+RDLK  NILLD   +  + DFG+ ++   D+ + NT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 7/61 (11%)

Query: 213 PKKKRLLGWQARVRIIEGIA-QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
           P+ KR       + +I+G+  Q L  L +  R+ I+HRD+K  N+L+  D   KI DFG 
Sbjct: 302 PQDKR------DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGA 355

Query: 272 A 272
           A
Sbjct: 356 A 356

Length = 507

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 38.2 bits (89), Expect = 0.004
 Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 32/189 (16%)

Query: 111 PLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLTE 165
           PL  L   S   ++F    KLGEG FG VYK  L+N       +  +K+ +     G  E
Sbjct: 120 PLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE---YGAVE 176

Query: 166 -FKNEMML------IAKLQHRHLVRLFGCCIEQGENILIYEY---------MPNK----S 205
            + NE +        A   +  L  +     ++ E  L++ Y         M +K    +
Sbjct: 177 IWMNERVRRACPNSCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYN 234

Query: 206 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-LHQYSRLRIIHRDLKASNILLDSDMNP 264
           ++ +L    +    G +   +II+ I + +L+ L       I+HRD+K  NI+       
Sbjct: 235 VEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS 294

Query: 265 -KISDFGMA 272
            KI D G A
Sbjct: 295 FKIIDLGAA 303

Length = 566

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	290
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.98
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.97
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.96
KOG0198	313	consensus MEKK and related serine/threonine protei	99.96
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.96
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.96
KOG0605	550	consensus NDR and related serine/threonine kinases	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.96
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.96
KOG0578	550	consensus p21-activated serine/threonine protein k	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.96
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.96
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.95
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.95
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.95
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.95
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.95
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.95
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.95
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.95
PTZ00267	478	NIMA-related protein kinase; Provisional	99.95
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.95
KOG0589	426	consensus Serine/threonine protein kinase [General	99.95
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.95
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.95
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.95
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.95
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.95
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.95
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.95
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.95
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.95
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.95
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.95
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.95
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.95
PHA03212	391	serine/threonine kinase US3; Provisional	99.94
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.94
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.94
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.94
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.94
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.94
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.94
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.94
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.94
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.94
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.94
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.94
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.94
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.94
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.94
PTZ00283	496	serine/threonine protein kinase; Provisional	99.94
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.94
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.94
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.94
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.94
PHA02988	283	hypothetical protein; Provisional	99.94
PHA03211	461	serine/threonine kinase US3; Provisional	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.94
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.94
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.94
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.94
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.94
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.94
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.94
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.94
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.94
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.94
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.94
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.94
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.94
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.94
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.94
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.94
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.94
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.94
KOG0610	459	consensus Putative serine/threonine protein kinase	99.94
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.94
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.94
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.94
KOG0586	596	consensus Serine/threonine protein kinase [General	99.94
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.94
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.94
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.94
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.94
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.94
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.94
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.93
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.93
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.93
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.93
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.93
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.93
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.93
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.93
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.93
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.93
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.93
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.93
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.93
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.93
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.93
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.93
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.93
PTZ00036	440	glycogen synthase kinase; Provisional	99.93
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.93
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.93
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.93
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.93
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.93
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.93
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.93
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.93
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.93
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.93
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.93
PHA03207	392	serine/threonine kinase US3; Provisional	99.93
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.93
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.93
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.93
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.93
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.93
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.93
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.93
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.93
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.93
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.93
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.93
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.93
PHA03209	357	serine/threonine kinase US3; Provisional	99.93
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.93
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.93
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.93
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.93
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.93
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.93
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.93
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.93
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.93
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.93
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.93
KOG0584	632	consensus Serine/threonine protein kinase [General	99.93
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.93
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.93
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.93
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.93
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.93
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.93
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.93
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.93
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.93
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.93
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.93
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.93
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.93
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.93
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.93
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.93
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.93
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.93
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.93
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.93
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.93
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.93
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.93
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.93
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.93
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.93
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.93
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.92
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.92
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.92
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.92
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.92
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.92
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.92
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.92
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.92
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.92
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.92
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.92
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.92
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.92
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.92
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.92
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.92
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.92
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.92
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.92
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.92
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.92
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.92
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.92
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.92
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.92
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.92
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.92
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.92
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.92
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.92
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.92
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.92
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.92
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.92
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.92
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.92
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.92
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.92
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.92
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.92
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.92
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.92
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.92
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.92
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.92
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.92
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.92
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.92
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.92
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.91
PHA03210	501	serine/threonine kinase US3; Provisional	99.91
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.91
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.91
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.91
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.91
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.91
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.91
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.91
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.91
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.91
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.91
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.91
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.91
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.91
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.91
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.91
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.91
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.91
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.91
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.91
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.91
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.91
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.91
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.91
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.91
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.91
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.91
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.91
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.91
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.91
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.91
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.91
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.9
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.9
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.9
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.9
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.9
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.9
PLN00009	294	cyclin-dependent kinase A; Provisional	99.9
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.9
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.9
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.9
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.9
PTZ00284	467	protein kinase; Provisional	99.9
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.9
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.9
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.9
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.9
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.9
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.9
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.9
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.9
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.9
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.9
KOG1152	772	consensus Signal transduction serine/threonine kin	99.9
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.9
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.9
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.9
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.89
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.89
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.89
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.89
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.89
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.89
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.89
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.89
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.89
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.89
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.89
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.89
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.89
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.89
PHA02882	294	putative serine/threonine kinase; Provisional	99.89
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.89
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.89
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.89
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.89
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.89
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.89
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.88
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.88
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.88
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.88
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.88
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.87
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.87
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.87
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.87
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.87
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.86
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.86
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.85
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.85
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.85
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.84
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.84
smart00090	237	RIO RIO-like kinase.	99.84
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.84
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.83
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.8
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.79
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.78
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.77
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.74
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.72
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.71
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.69
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.67
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.51
PLN00181	793	protein SPA1-RELATED; Provisional	99.45
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.43
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.4
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.36
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.34
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.31
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.27
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.25
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.25
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.23
KOG3087	229	consensus Serine/threonine protein kinase [General	99.21
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.11
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.1
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.03
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.96
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.93
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.89
KOG1243	690	consensus Protein kinase [General function predict	98.83
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.82
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.76
PRK09902	216	hypothetical protein; Provisional	98.72
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.69
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.67
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.66
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.66
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.65
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.63
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.57
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.53
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.52
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.51
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.5
PF01636	239	APH: Phosphotransferase enzyme family This family	98.49
PLN02876	822	acyl-CoA dehydrogenase	98.41
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.19
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.18
PRK10593	297	hypothetical protein; Provisional	98.17
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.11
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.09
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.09
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.08
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	97.95
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.93
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.91
PRK05231	319	homoserine kinase; Provisional	97.85
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.6
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.5
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.5
KOG2270	520	consensus Serine/threonine protein kinase involved	97.49
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.45
PLN02236	344	choline kinase	97.37
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.33
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	96.9
PLN02756	418	S-methyl-5-thioribose kinase	96.79
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.75
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.75
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	96.66
PRK06148	1013	hypothetical protein; Provisional	96.66
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.59
COG2334	331	Putative homoserine kinase type II (protein kinase	96.52
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.4
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.37
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.32
PRK12396	409	5-methylribose kinase; Reviewed	96.12
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.81
PRK11768	325	serine/threonine protein kinase; Provisional	95.69
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.36
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.19
PTZ00384	383	choline kinase; Provisional	95.04
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	94.71

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=302.86  Aligned_cols=168  Identities=51%  Similarity=0.826  Sum_probs=154.3

Q ss_pred             CCCcccHHhHHHHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEE
Q 022887          109 WLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC  188 (290)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  188 (290)
                      ....|++.++..+|++|+..+.||+|+||.||+|.+.++..||||++.....+...+|.+|+.++++++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            46679999999999999999999999999999999999999999988764433156799999999999999999999999


Q ss_pred             EeCC-eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEe
Q 022887          189 IEQG-ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       189 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                      .+.+ +.+||||||++|+|+++|+..... .++|.+|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999875544 88999999999999999999999988899999999999999999999999


Q ss_pred             eccCceeeCC
Q 022887          268 DFGMARIFGG  277 (290)
Q Consensus       268 DfGla~~~~~  277 (290)
                      |||+|+....
T Consensus       220 DFGLa~~~~~  229 (361)
T KOG1187|consen  220 DFGLAKLGPE  229 (361)
T ss_pred             CccCcccCCc
Confidence            9999976654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=253.72  Aligned_cols=153  Identities=31%  Similarity=0.529  Sum_probs=137.0

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..+|...+.||+|+|+.||+|++. ++.+||||.+...  ..+..+.+..|+.+|+.++|||||.+++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            358888899999999999999884 4789999999765  4455677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC------CCeEEeeccCc
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD------MNPKISDFGMA  272 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~------~~~kl~DfGla  272 (290)
                      |||.+|+|..|+..   .+.+++.+...+..|+|.||++||+++   ||||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999943   457899999999999999999999988   9999999999999764      45899999999


Q ss_pred             eeeCCCcc
Q 022887          273 RIFGGDEL  280 (290)
Q Consensus       273 ~~~~~~~~  280 (290)
                      |.+.++..
T Consensus       163 R~L~~~~~  170 (429)
T KOG0595|consen  163 RFLQPGSM  170 (429)
T ss_pred             hhCCchhH
Confidence            99987654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=249.06  Aligned_cols=152  Identities=39%  Similarity=0.616  Sum_probs=133.9

Q ss_pred             CCCccceecccCCccEEEEEEcCCcEEEEEEeccccccC--HHHHHHHHHHHcccCCCCcceeEEEEEeCC-eeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG--LTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-ENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  200 (290)
                      ++...+.||+|+||+||+|.+.+...||||++.......  ..+|.+|+.++.+++|||||+++|+|.+.. ...+||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            444556699999999999999766569999997643222  569999999999999999999999999988 78999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-CeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~~~  278 (290)
                      |++|+|..+++.. ....+++..+++++.|||+||.|||++.+  ||||||||+|||++.++ ++||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999654 46779999999999999999999998764  99999999999999997 9999999999987653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-34  Score=242.10  Aligned_cols=161  Identities=28%  Similarity=0.446  Sum_probs=136.4

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccccc-------CHHHHHHHHHHHcccCCCCcceeEEEEEeCC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ-------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  192 (290)
                      ..+.|...+.||+|+||.|-+|.. .+++.||||.+.+....       ......+|+++|.+|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            345677889999999999999965 56999999999754211       2334679999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC---CCeEEeec
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDF  269 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Df  269 (290)
                      ..||||||+++|.|-+++..   ...+.+..-..++.|++.|+.|||+++   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999888743   455777778899999999999999998   9999999999999765   78999999


Q ss_pred             cCceeeCCCccccCcceeecC
Q 022887          270 GMARIFGGDELQGNTKRIVGT  290 (290)
Q Consensus       270 Gla~~~~~~~~~~~~~~~~Gt  290 (290)
                      |||++.+....   +.+..||
T Consensus       324 GlAK~~g~~sf---m~TlCGT  341 (475)
T KOG0615|consen  324 GLAKVSGEGSF---MKTLCGT  341 (475)
T ss_pred             chhhcccccee---hhhhcCC
Confidence            99999975543   3445665

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-34  Score=246.92  Aligned_cols=156  Identities=38%  Similarity=0.617  Sum_probs=139.6

Q ss_pred             HHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ...+.+...+.||+|.||.||.|.+.+...||+|.++.. ......|.+|+.+|.+|+|+|||+++|+|..++..+||||
T Consensus       203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            334456667899999999999999988889999999864 3445789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      ||+.|+|.++|.. ..+..+...+.+.++.|||+||+||+++.   +|||||.++||||+++..+||+||||||.+..++
T Consensus       282 ~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  282 YMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             ecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            9999999999954 34567889999999999999999999888   9999999999999999999999999999776654


Q ss_pred             c
Q 022887          280 L  280 (290)
Q Consensus       280 ~  280 (290)
                      -
T Consensus       358 Y  358 (468)
T KOG0197|consen  358 Y  358 (468)
T ss_pred             e
Confidence            3

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-33  Score=242.31  Aligned_cols=161  Identities=30%  Similarity=0.471  Sum_probs=138.2

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  196 (290)
                      .+.|+.+++||+|.||.||+|+. .+|..||+|++....  .....-..+||.+|++|+||||++|.+..++.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            45688899999999999999976 568999999997433  44556678999999999999999999999987  68999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |+|||++. |.-++.  ...-.++..+...++.|++.||+|+|.++   |+|||||.+|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdhD-L~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDHD-LSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccch-hhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            99999884 444442  23446899999999999999999999988   9999999999999999999999999999998


Q ss_pred             CCccccCcceee
Q 022887          277 GDELQGNTKRIV  288 (290)
Q Consensus       277 ~~~~~~~~~~~~  288 (290)
                      .+.....|.+++
T Consensus       270 ~~~~~~~T~rVv  281 (560)
T KOG0600|consen  270 PSGSAPYTSRVV  281 (560)
T ss_pred             CCCCcccccceE
Confidence            887666666654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-33  Score=246.67  Aligned_cols=160  Identities=31%  Similarity=0.477  Sum_probs=145.1

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..|...+.||+|+|+.+|+++. ..|+.||+|++.+.   .........+|+++.+.|+|||||+++++|.+.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999998 77999999999753   3445678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+|++++|..++.   .++.+++.+...+..||+.||.|||+.+   |+|||||..|++|+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999883   5678999999999999999999999988   999999999999999999999999999999877


Q ss_pred             ccccCcceeecC
Q 022887          279 ELQGNTKRIVGT  290 (290)
Q Consensus       279 ~~~~~~~~~~Gt  290 (290)
                      +.+..|  +.||
T Consensus       172 ~Erk~T--lCGT  181 (592)
T KOG0575|consen  172 GERKKT--LCGT  181 (592)
T ss_pred             ccccce--ecCC
Confidence            655444  6776

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-33  Score=238.59  Aligned_cols=161  Identities=34%  Similarity=0.531  Sum_probs=139.1

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHH--cccCCCCcceeEEEEEeCC----eeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLI--AKLQHRHLVRLFGCCIEQG----ENI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l--~~l~h~niv~l~~~~~~~~----~~~  195 (290)
                      .......++||+|+||.||+|.+.+ +.||||++...   ....|.+|-.+.  -.++|+||+++++.-...+    +.+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            3456677899999999999999954 89999999653   345666665554  4678999999999876655    789


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------CCCCceecCCCCCCEEEcCCCCeEEeec
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY------SRLRIIHRDLKASNILLDSDMNPKISDF  269 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------~~~~iiH~dlk~~Nill~~~~~~kl~Df  269 (290)
                      ||+||.++|+|.++|    ....++|....+|+..+++||+|||+.      .+++|+|||||++|||+.+|+++.|+||
T Consensus       285 LVt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EEeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            999999999999999    346799999999999999999999974      3467999999999999999999999999


Q ss_pred             cCceeeCCCccccCcceeecC
Q 022887          270 GMARIFGGDELQGNTKRIVGT  290 (290)
Q Consensus       270 Gla~~~~~~~~~~~~~~~~Gt  290 (290)
                      |||..+..+...+.+.+.+||
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT  381 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGT  381 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhh
Confidence            999999998888888888998

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=230.41  Aligned_cols=159  Identities=31%  Similarity=0.416  Sum_probs=137.6

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe-eEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-NILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e  199 (290)
                      .+++..+.||+|..|+||++.+. ++..+|+|.+... .+...+++.+|++++...+||+||.++|.|...+. ..++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            45667789999999999999885 5778999999532 34556889999999999999999999999999994 999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      ||.+|+|+.++..   .+.+++...-+|+.+|++||.|||+.  ..||||||||+|+|++..|++||+|||.++.+.+. 
T Consensus       159 YMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999999843   35688999999999999999999962  24999999999999999999999999999988654 


Q ss_pred             cccCcceeecC
Q 022887          280 LQGNTKRIVGT  290 (290)
Q Consensus       280 ~~~~~~~~~Gt  290 (290)
                         +..+++||
T Consensus       233 ---~a~tfvGT  240 (364)
T KOG0581|consen  233 ---IANTFVGT  240 (364)
T ss_pred             ---hccccccc
Confidence               34456776

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.98  E-value=2.8e-32  Score=227.81  Aligned_cols=162  Identities=28%  Similarity=0.394  Sum_probs=140.2

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ..++|+.+++||+|+||+||.++. ++++.+|+|.+++..   ....+....|..++.+++||+||.++-.|++.+..|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            357899999999999999999976 458889999997642   3346778899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |+||+.+|.|..+|.   ..+.+++....-++..|+.||.|||+++   ||||||||+|||||++|.++|+||||++..-
T Consensus       103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999988883   3556888877888888999999999998   9999999999999999999999999999664


Q ss_pred             CCccccCcceeecC
Q 022887          277 GDELQGNTKRIVGT  290 (290)
Q Consensus       277 ~~~~~~~~~~~~Gt  290 (290)
                      .++..  |.+++||
T Consensus       177 ~~~~~--t~tfcGT  188 (357)
T KOG0598|consen  177 KDGDA--TRTFCGT  188 (357)
T ss_pred             cCCCc--cccccCC
Confidence            44332  4457887

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=9.6e-32  Score=215.23  Aligned_cols=150  Identities=33%  Similarity=0.541  Sum_probs=132.3

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .+|...+.+|+|.||.||+|+. .+|+.||||+++....  .......+|++.|+.++|+||+.+++++.+.+..-+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677889999999999999986 5689999999975422  234578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+- +|...+.  .....++..+...++.++++|++|||++.   |+||||||.|+|+++++.+||+|||+|+.+.+.
T Consensus        82 fm~t-dLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9965 6777663  34567899999999999999999999988   999999999999999999999999999999753

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=7.5e-32  Score=245.94  Aligned_cols=152  Identities=34%  Similarity=0.547  Sum_probs=134.2

Q ss_pred             HhcCCCccceecccCCccEEEEEEc------CCcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      ...+....+.||+|+||+||+|+..      +...||||.++..... ...+|++|++++..++|||||+|+|.|.+++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3456667789999999999999763      2457999999876554 77899999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC
Q 022887          194 NILIYEYMPNKSLDVFLFYPKK-----------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~  262 (290)
                      .+||+|||..|+|.+||.....           ...++..+.+.||.|||.||+||-++.   +|||||..+|+|+.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence            9999999999999999864211           234889999999999999999999877   99999999999999999


Q ss_pred             CeEEeeccCceee
Q 022887          263 NPKISDFGMARIF  275 (290)
Q Consensus       263 ~~kl~DfGla~~~  275 (290)
                      .|||+||||+|.+
T Consensus       641 ~VKIsDfGLsRdi  653 (774)
T KOG1026|consen  641 VVKISDFGLSRDI  653 (774)
T ss_pred             EEEecccccchhh
Confidence            9999999999765

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.1e-33  Score=225.56  Aligned_cols=167  Identities=26%  Similarity=0.443  Sum_probs=141.0

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecc--ccccCHHHHHHHHHHHcccCCCCcceeEEE-EEeCCe-eEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLFGC-CIEQGE-NIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~l  196 (290)
                      ..+|.+++.||+|+||.||++.. .++..||.|.+.-  ...+.......|+.+|++|+|||||+.+++ +.++++ .++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            35788899999999999999964 7899999998862  234556789999999999999999999994 445554 789


Q ss_pred             EEEecCCCChhhhhhC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC-CCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          197 IYEYMPNKSLDVFLFY-PKKKRLLGWQARVRIIEGIAQGLLYLHQYSR-LRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ||||+..|+|..++.. +...+.+++.+.++++.|+++||..+|++-+ ..|+||||||.||+++.+|.+||+||||+++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999988754 3456789999999999999999999998421 2399999999999999999999999999999


Q ss_pred             eCCCccccCcceeecC
Q 022887          275 FGGDELQGNTKRIVGT  290 (290)
Q Consensus       275 ~~~~~~~~~~~~~~Gt  290 (290)
                      +....+.  +++.+||
T Consensus       178 l~s~~tf--A~S~VGT  191 (375)
T KOG0591|consen  178 LSSKTTF--AHSLVGT  191 (375)
T ss_pred             hcchhHH--HHhhcCC
Confidence            9776543  4456777

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=231.96  Aligned_cols=153  Identities=31%  Similarity=0.437  Sum_probs=134.4

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  195 (290)
                      ..++|...+.||+|+|++|++|+. ..+.++|||++.+.   .....+-+..|-..|.+| .||.|++|+-.|.++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            346899999999999999999976 45889999998653   223334566777888888 8999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +|+||.++|+|-.++.   ..+.+++.....++.+|+.||+|||+.+   ||||||||+|||||+|+.+||+|||.|+++
T Consensus       151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999884   3467888889999999999999999988   999999999999999999999999999999


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      ++.+
T Consensus       225 ~~~~  228 (604)
T KOG0592|consen  225 SPSQ  228 (604)
T ss_pred             Chhh
Confidence            7643

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-32  Score=242.99  Aligned_cols=163  Identities=32%  Similarity=0.511  Sum_probs=142.9

Q ss_pred             cccHHhHHHHhcC---------CCccceecccCCccEEEEEEcC----CcEEEEEEecccc-ccCHHHHHHHHHHHcccC
Q 022887          112 LFSLASVSAATEN---------FSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQ  177 (290)
Q Consensus       112 ~~~~~~~~~~~~~---------~~~~~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~  177 (290)
                      .++|++...+...         ..+.++||.|.||.|++|+++-    ...||||.++... ++...+|+.|..+|++.+
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd  688 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD  688 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence            4677776655443         3467899999999999998743    3469999998653 456789999999999999


Q ss_pred             CCCcceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEE
Q 022887          178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  257 (290)
Q Consensus       178 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nil  257 (290)
                      ||||++|.|+.+.....++|.|||+||+|+.||..  ....+++.+...+..+||.||.||.+.+   +|||||.++|||
T Consensus       689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNIL  763 (996)
T KOG0196|consen  689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNIL  763 (996)
T ss_pred             CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhhee
Confidence            99999999999999999999999999999999954  3456999999999999999999999877   999999999999


Q ss_pred             EcCCCCeEEeeccCceeeCCCc
Q 022887          258 LDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       258 l~~~~~~kl~DfGla~~~~~~~  279 (290)
                      ++.+..+||+||||+|++.+|.
T Consensus       764 VNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             eccceEEEeccccceeecccCC
Confidence            9999999999999999997765

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.97  E-value=6.4e-32  Score=219.99  Aligned_cols=149  Identities=26%  Similarity=0.400  Sum_probs=131.9

Q ss_pred             cCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      +.|+.+.++|+|+||.||+++..+ |+.||||++.....  ...+-..+|+.++++++|||+|.++.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            467888899999999999999854 89999999975433  234567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |++..-|+++-.   ....++......+..|+++|+.|+|+++   +|||||||+|||++.++.+||+|||+|+.+..
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            999988877653   2344778889999999999999999988   99999999999999999999999999999973

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-31  Score=231.06  Aligned_cols=149  Identities=33%  Similarity=0.529  Sum_probs=131.8

Q ss_pred             CCCccceecccCCccEEEEEEcCCcEEEEEEeccccccC-HHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      ...+.++||+|.||+|.++...++..||||.++...... ..+|..|+++|.+++||||++++|.|..++..++++|||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            445668999999999999999888999999998765443 5899999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +|+|..|+..... ..+.-....+|+.||+.||+||.+..   +||||+.++|+|+|.++++||+||||+|-+-
T Consensus       619 nGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  619 NGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             cCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence            9999999854322 22455667789999999999999877   9999999999999999999999999998553

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=210.96  Aligned_cols=158  Identities=32%  Similarity=0.468  Sum_probs=138.8

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||.|+||.|.+++.. ++.-+|+|.+.+...   +..+...+|..+|+.+.||+++++++.+.+.+..+||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            358899999999999999999874 478899999976532   2345678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||.++|.|..++   +..+.+++....-+|.||+.||+|||+.+   |++|||||+|||+|.+|.+||+|||+|+....
T Consensus       123 meyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999998   34556899999999999999999999988   99999999999999999999999999998754


Q ss_pred             CccccCcceeecC
Q 022887          278 DELQGNTKRIVGT  290 (290)
Q Consensus       278 ~~~~~~~~~~~Gt  290 (290)
                      .     |.++.||
T Consensus       197 r-----T~TlCGT  204 (355)
T KOG0616|consen  197 R-----TWTLCGT  204 (355)
T ss_pred             c-----EEEecCC
Confidence            3     4456666

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-30  Score=219.72  Aligned_cols=152  Identities=30%  Similarity=0.451  Sum_probs=129.6

Q ss_pred             HHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc--------------cCHHHHHHHHHHHcccCCCCccee
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--------------QGLTEFKNEMMLIAKLQHRHLVRL  184 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l  184 (290)
                      .-.++|+..+.||+|.||.|-+|+. .+++.||||.+.+...              ...+..++|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3457899999999999999999987 4588999999864311              123578999999999999999999


Q ss_pred             EEEEEeC--CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC
Q 022887          185 FGCCIEQ--GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       185 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~  262 (290)
                      +.+..+.  +..|||+||+..|.+...-   .....++..+.+.++.++..||+|||.++   ||||||||+|+||++++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            9998765  5789999999999875432   22233899999999999999999999998   99999999999999999


Q ss_pred             CeEEeeccCceeeCC
Q 022887          263 NPKISDFGMARIFGG  277 (290)
Q Consensus       263 ~~kl~DfGla~~~~~  277 (290)
                      ++||+|||.+..+..
T Consensus       248 ~VKIsDFGVs~~~~~  262 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQ  262 (576)
T ss_pred             cEEeeccceeeeccc
Confidence            999999999988743

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-30  Score=227.58  Aligned_cols=150  Identities=35%  Similarity=0.520  Sum_probs=131.2

Q ss_pred             hcCCCccceecccCCccEEEEEEcC--C---cEEEEEEecc---ccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN--G---QEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~--~---~~vavK~l~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      -++....++||+|+||.||+|++..  +   ..||||..+.   .......+|..|.+++..++|||||+++|++..+.+
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3455566899999999999998733  2   2389998874   234456899999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++|||++++|+|+++|...  ...++..++..++.+.|.||+|||+++   +|||||.++|+|++.++.+||+||||++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence            99999999999999999432  336999999999999999999999988   9999999999999999999999999988


Q ss_pred             eeC
Q 022887          274 IFG  276 (290)
Q Consensus       274 ~~~  276 (290)
                      .-.
T Consensus       311 ~~~  313 (474)
T KOG0194|consen  311 AGS  313 (474)
T ss_pred             CCc
Confidence            554

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=8.8e-31  Score=221.01  Aligned_cols=152  Identities=26%  Similarity=0.518  Sum_probs=137.3

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .+|++.+.||+|.||+|-++.. ..|+.||||.+++..   .+..-.+++|+++|+.|+||||+.++.+|...+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4788889999999999999965 679999999987643   344556889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||..+|.|.+|+.   ..+.+++.+..+++.||..|+.|+|.+.   ++|||||.+|||||.|+++||+||||+.++..+
T Consensus       133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            9999999999984   4567999999999999999999999877   999999999999999999999999999988766


Q ss_pred             cc
Q 022887          279 EL  280 (290)
Q Consensus       279 ~~  280 (290)
                      .+
T Consensus       207 kf  208 (668)
T KOG0611|consen  207 KF  208 (668)
T ss_pred             cH
Confidence            54

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=220.55  Aligned_cols=151  Identities=28%  Similarity=0.452  Sum_probs=133.5

Q ss_pred             HHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc----cc-cCHHHHHHHHHHHcccC-CCCcceeEEEEEeCC
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ----SG-QGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQG  192 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  192 (290)
                      ...++|...+.||+|+||+|+.|.. .+++.||+|.+...    .. .....+.+|+.++.+++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999976 45799999976553    12 23456678999999999 999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC-CCeEEeeccC
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGM  271 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGl  271 (290)
                      ..++||||+.+|+|.+++..   ...+.+.+...++.|++.|++|+|+.+   |+||||||+|+|++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999843   456888999999999999999999988   9999999999999999 9999999999


Q ss_pred             ceeeC
Q 022887          272 ARIFG  276 (290)
Q Consensus       272 a~~~~  276 (290)
                      +....
T Consensus       168 s~~~~  172 (370)
T KOG0583|consen  168 SAISP  172 (370)
T ss_pred             ccccC
Confidence            99884

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-29  Score=213.13  Aligned_cols=151  Identities=30%  Similarity=0.486  Sum_probs=131.5

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC--eeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG--ENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  198 (290)
                      ..++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|......  ...+.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3467788999999999999998854 8899999887643333677999999999999999999999855444  588999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-CCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~~  277 (290)
                      ||+++|+|.+++.....  .+++.....+..|+++||+|||+++   ++||||||+|||++. ++.+||+|||+++....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999854322  6999999999999999999999888   999999999999999 79999999999998874

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.96  E-value=5.9e-30  Score=211.01  Aligned_cols=152  Identities=28%  Similarity=0.401  Sum_probs=129.8

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENI  195 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  195 (290)
                      ..++|+.++.|++|.||.||+|++ .+++.||+|+++....  ...-...+|+.+|.+.+|||||.+-.+....  +..|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            346788999999999999999988 4578899999975432  2234568999999999999999998887654  5789


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||+++ +|...+...  ...+...+..-+..|+++|++|||...   |+|||||++|+|++..|.+||+||||||.+
T Consensus       154 ~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence            99999988 677766543  356888889999999999999999888   999999999999999999999999999999


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      +..
T Consensus       228 gsp  230 (419)
T KOG0663|consen  228 GSP  230 (419)
T ss_pred             cCC
Confidence            764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=224.02  Aligned_cols=150  Identities=29%  Similarity=0.460  Sum_probs=130.6

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHH--HHHHHHHcccC-CCCcceeEEEEEeCC-eeE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEF--KNEMMLIAKLQ-HRHLVRLFGCCIEQG-ENI  195 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~--~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~  195 (290)
                      ..++|...++||.|.||.||+|+. .+++.||||++++.- ..+++.  .+|+..|.+|+ ||||+++.+.+.+.+ ..+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            456899999999999999999976 458899999997642 223443  68999999998 999999999999988 899


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +|||||+. +|..++..  .++.+++.+...|+.||++||+|+|.++   +.|||+||+|||+..+..+||+||||||-+
T Consensus        87 fVfE~Md~-NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhhh-hHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            99999976 56666543  3788999999999999999999999888   999999999999999999999999999987


Q ss_pred             CC
Q 022887          276 GG  277 (290)
Q Consensus       276 ~~  277 (290)
                      ..
T Consensus       161 ~S  162 (538)
T KOG0661|consen  161 RS  162 (538)
T ss_pred             cc
Confidence            54

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.96  E-value=2.9e-29  Score=218.34  Aligned_cols=151  Identities=26%  Similarity=0.393  Sum_probs=134.4

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ..++|+.+..||+|+||.||+++- ++|..+|+|++++..   ......++.|-.+|...++|.||+|+-.|.+.+++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            357899999999999999999975 568999999998653   3345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|++..+|.   ....|++.....++.+++.|++.+|..+   +|||||||+|+|||..|.+||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999884   3466888888888888999999999888   9999999999999999999999999997664


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       293 ~  293 (550)
T KOG0605|consen  293 K  293 (550)
T ss_pred             h
Confidence            4

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=6e-30  Score=225.27  Aligned_cols=155  Identities=35%  Similarity=0.583  Sum_probs=136.8

Q ss_pred             cHHhHHHHhcCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC
Q 022887          114 SLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ  191 (290)
Q Consensus       114 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  191 (290)
                      +..+++...+.+...+.||+|+||+||+|+|.+  .||||.++...  ....+.|+.|+..+++-+|.||+=+.|+|..+
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            335566667778888999999999999999853  79999997543  34568999999999999999999999999998


Q ss_pred             CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccC
Q 022887          192 GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl  271 (290)
                      +. .+|+.++++.+|..+++..+  ..++..+...||.||++||.|||.++   |||||||+.||++.+++.|||+||||
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence            77 99999999999999987543  45888999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeC
Q 022887          272 ARIFG  276 (290)
Q Consensus       272 a~~~~  276 (290)
                      +..-.
T Consensus       535 atvk~  539 (678)
T KOG0193|consen  535 ATVKT  539 (678)
T ss_pred             eeeee
Confidence            97653

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.96  E-value=8.2e-30  Score=222.80  Aligned_cols=159  Identities=30%  Similarity=0.458  Sum_probs=139.8

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|...+.||+|+||.||||+.+ +.+.||+|.+.+..  .+..+.+.+|++++..++||||+.++++|....+.|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999764 57889999997543  3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      |+.+ +|..++.   ....++++....++.+++.||.|||+..   |+|||+||.|||++.++.+|++|||+||..+.+.
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9987 9988884   4566999999999999999999999887   9999999999999999999999999999987754


Q ss_pred             cccCcceeecC
Q 022887          280 LQGNTKRIVGT  290 (290)
Q Consensus       280 ~~~~~~~~~Gt  290 (290)
                      .  ..+++.||
T Consensus       155 ~--vltsikGt  163 (808)
T KOG0597|consen  155 S--VLTSIKGT  163 (808)
T ss_pred             e--eeeeccCc
Confidence            3  33456665

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=1.5e-28  Score=212.06  Aligned_cols=153  Identities=31%  Similarity=0.520  Sum_probs=130.9

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-----------------CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcce
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVR  183 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~  183 (290)
                      .++|...+.||+|+||.||++.+.+                 +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578888999999999999997532                 2369999887543 223467999999999999999999


Q ss_pred             eEEEEEeCCeeEEEEEecCCCChhhhhhCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCce
Q 022887          184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPK----------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII  247 (290)
Q Consensus       184 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ii  247 (290)
                      +++++.+.+..++||||+++|+|.+++....                ....++|...+.++.|++.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999998874321                1235788999999999999999999887   99


Q ss_pred             ecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          248 HRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       248 H~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||||||+|||+++++.+||+|||+++.+..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~  190 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYA  190 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceeccc
Confidence            999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.3e-29  Score=212.20  Aligned_cols=149  Identities=28%  Similarity=0.440  Sum_probs=127.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHc--ccCCCCcceeEEEEEeCC----eeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIA--KLQHRHLVRLFGCCIEQG----ENI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~  195 (290)
                      .++....+.||+|.||.||+|.+ .|+.||||.+...++   ....+|.++..  .|+|+||+.+++.-..++    ++|
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            45777889999999999999999 568999999975433   34555655554  469999999998765543    679


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-----YSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-----~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                      ||.+|.++|||.+||.    ...++....++++..+|.||++||.     ++.+.|.|||||+.|||+.+++++.|+|+|
T Consensus       286 LvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            9999999999999993    3668899999999999999999994     578889999999999999999999999999


Q ss_pred             CceeeCCC
Q 022887          271 MARIFGGD  278 (290)
Q Consensus       271 la~~~~~~  278 (290)
                      ||-..+.+
T Consensus       362 LAv~h~~~  369 (513)
T KOG2052|consen  362 LAVRHDSD  369 (513)
T ss_pred             eeEEeccc
Confidence            99888665

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.96  E-value=9.3e-29  Score=216.44  Aligned_cols=154  Identities=29%  Similarity=0.419  Sum_probs=129.4

Q ss_pred             HhcCCCccceecccCCccEEEEEE------cCCcEEEEEEeccccc-cCHHHHHHHHHHHccc-CCCCcceeEEEEEeCC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  192 (290)
                      +.++|+..+.||+|+||.||+|.+      .++..||+|++..... .....+..|+.++..+ +||||+++++++...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            456899999999999999999974      2246799999875332 2346789999999999 8999999999988654


Q ss_pred             -eeEEEEEecCCCChhhhhhCCCC--------------------------------------------------------
Q 022887          193 -ENILIYEYMPNKSLDVFLFYPKK--------------------------------------------------------  215 (290)
Q Consensus       193 -~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  215 (290)
                       ..+++|||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             57899999999999988753211                                                        


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          216 ---KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       216 ---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                         ...+++.+...++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~  226 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK  226 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence               134788899999999999999999887   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.6e-29  Score=217.12  Aligned_cols=160  Identities=31%  Similarity=0.480  Sum_probs=141.0

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ...|..-..||+|+.|.||.+.- .+++.||||++........+-+.+|+.+|...+|+|||.++..+...++.|.||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            34677788999999999999965 56889999999876555566789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCcc
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL  280 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~  280 (290)
                      |++|+|.+..    ....+++.+...|+.++++||+|||.++   |+|||||.+|||++.++.+||+|||++..+.....
T Consensus       352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            9999998887    3345899999999999999999999998   99999999999999999999999999999977665


Q ss_pred             ccCcceeecC
Q 022887          281 QGNTKRIVGT  290 (290)
Q Consensus       281 ~~~~~~~~Gt  290 (290)
                      ...  ..+||
T Consensus       425 KR~--TmVGT  432 (550)
T KOG0578|consen  425 KRS--TMVGT  432 (550)
T ss_pred             ccc--cccCC
Confidence            332  35676

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=1.6e-28  Score=204.92  Aligned_cols=151  Identities=31%  Similarity=0.484  Sum_probs=127.7

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCC-cceeEEEEEeCC-----
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRH-LVRLFGCCIEQG-----  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~-----  192 (290)
                      ...|...+.||+|.||.||+|+. .+|+.||+|++.-...  .......+|+.++..++|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45677778999999999999986 4578999999975432  23456789999999999999 999999999877     


Q ss_pred             -eeEEEEEecCCCChhhhhhCCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          193 -ENILIYEYMPNKSLDVFLFYPKKK-RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       193 -~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                       ..++|+||+.. +|..++...... ..++......+..|+++||+|||+++   |+||||||.|||+++++.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             78899999965 677776443211 34666889999999999999999988   9999999999999999999999999


Q ss_pred             CceeeC
Q 022887          271 MARIFG  276 (290)
Q Consensus       271 la~~~~  276 (290)
                      +|+.+.
T Consensus       166 lAra~~  171 (323)
T KOG0594|consen  166 LARAFS  171 (323)
T ss_pred             hHHHhc
Confidence            999765

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=3.3e-28  Score=215.07  Aligned_cols=148  Identities=26%  Similarity=0.387  Sum_probs=131.5

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++... +++.||+|.+....   ......+..|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999874 57899999986532   223456888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||+++|+|.+++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999999998843   356899999999999999999999887   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.9e-28  Score=211.49  Aligned_cols=149  Identities=24%  Similarity=0.392  Sum_probs=132.2

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||+|... +++.||+|.+....   ......+..|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46888999999999999999885 47899999987532   223467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999998843   345889999999999999999999887   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.96  E-value=4.9e-29  Score=208.15  Aligned_cols=149  Identities=32%  Similarity=0.496  Sum_probs=120.9

Q ss_pred             CCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe-----eEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-----NILI  197 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~lv  197 (290)
                      .|+..+++|+|+||.||+|.... +++||||+......    --.+|+++|..++|||||+|.-++.....     ..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            56777899999999999998744 68999999865432    23568899999999999999988875432     3489


Q ss_pred             EEecCCCChhhhhh-CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC-CCeEEeeccCceee
Q 022887          198 YEYMPNKSLDVFLF-YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIF  275 (290)
Q Consensus       198 ~e~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGla~~~  275 (290)
                      |||||. +|...+. ....+..++.....-+..|+.+||.|||+.+   |+||||||.|+|+|.+ +.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999988 5555553 2223455677777788999999999999877   9999999999999966 89999999999999


Q ss_pred             CCCcc
Q 022887          276 GGDEL  280 (290)
Q Consensus       276 ~~~~~  280 (290)
                      ..++-
T Consensus       177 ~~~ep  181 (364)
T KOG0658|consen  177 VKGEP  181 (364)
T ss_pred             ccCCC
Confidence            77654

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.6e-28  Score=214.87  Aligned_cols=149  Identities=25%  Similarity=0.391  Sum_probs=132.4

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++... +++.||||.+....   ......+..|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999874 58899999996432   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++|+|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999998843   345899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=4.5e-28  Score=214.46  Aligned_cols=150  Identities=25%  Similarity=0.296  Sum_probs=132.0

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ..++|+..+.||+|+||.||++... +++.+|+|.+...   .......+.+|+.++..++||||+++++++...+..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3468999999999999999999875 4788999998642   12234567889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|+|..++..    ..+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+.
T Consensus       121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999998832    34788889999999999999999887   9999999999999999999999999998875


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       194 ~  194 (370)
T cd05621         194 E  194 (370)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.2e-28  Score=214.85  Aligned_cols=147  Identities=27%  Similarity=0.370  Sum_probs=130.0

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++.. .+++.||||.+....   ......+..|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4788899999999999999977 458899999986432   223467888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ||+++|+|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999999988743   345888889999999999999999887   999999999999999999999999999743

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.95  E-value=6.8e-28  Score=211.02  Aligned_cols=150  Identities=27%  Similarity=0.380  Sum_probs=132.1

Q ss_pred             hcCCCccceecccCCccEEEEEEcC--CcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~--~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||+|.+.+  +..||+|.+....   ......+..|+.++..++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4579999999999999999998643  3689999886432   2335678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999988843   345889999999999999999999987   9999999999999999999999999998775


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       183 ~  183 (340)
T PTZ00426        183 T  183 (340)
T ss_pred             C
Confidence            4

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.95  E-value=6.6e-28  Score=210.33  Aligned_cols=149  Identities=24%  Similarity=0.356  Sum_probs=132.6

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++.+++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57889999999999999999875 57899999986432   233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999988743   345788889999999999999999987   99999999999999999999999999987754

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.95  E-value=6.4e-28  Score=214.51  Aligned_cols=146  Identities=24%  Similarity=0.366  Sum_probs=129.5

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .|..++.||+|+||.||+|.. .+++.||+|.+....   ......+..|+.++..++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            688889999999999999987 457899999996532   2234578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            9999999988743   345788888999999999999999887   999999999999999999999999998755

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=6.8e-29  Score=196.17  Aligned_cols=152  Identities=32%  Similarity=0.426  Sum_probs=134.0

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|-||.||.|+.+ ++-.||+|++.+..   .+....+.+|+++-+.|+||||+++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            468999999999999999999874 46789999997542   34457899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +||.++|++...|... ....+++.....+..|+|.|+.|+|...   +|||||||+|+|++.++..||+|||-+..-+.
T Consensus       101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            9999999998888532 3345788888999999999999999877   99999999999999999999999999986653

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=204.56  Aligned_cols=153  Identities=26%  Similarity=0.358  Sum_probs=135.5

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..++|+..+.||.|..+.||+|+. ..++.||||++.-+.. ...++++.|+..++.++||||++.+..|..+...|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            357899999999999999999975 5679999999975443 34689999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      .||.+||+.+++...- ...+++.....|..++++||.|||.++   .||||||+.||||+++|.+||+|||.+.-+-.
T Consensus       104 pfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            9999999998875432 234888999999999999999999988   99999999999999999999999998865543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=1.3e-27  Score=207.95  Aligned_cols=141  Identities=27%  Similarity=0.321  Sum_probs=124.8

Q ss_pred             ceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCC
Q 022887          129 CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK  204 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  204 (290)
                      +.||+|+||.||++.. .+++.||+|.+....   ......+..|+.++.+++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999987 458899999987532   223456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       205 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            99888743   456899999999999999999999887   999999999999999999999999999854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.6e-28  Score=207.77  Aligned_cols=149  Identities=27%  Similarity=0.357  Sum_probs=131.7

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999875 58899999986432   223456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++|+|.+++..   ...+++.....++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++.+..
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999988843   346889999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.95  E-value=1.9e-27  Score=203.30  Aligned_cols=150  Identities=27%  Similarity=0.350  Sum_probs=130.3

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .|+..+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++..++|+|++++.+.+.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999986 568899999886432   2233467889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |+++|+|..++... ....+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++..+..
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            99999998776432 2345889999999999999999999887   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=1.7e-27  Score=217.45  Aligned_cols=152  Identities=19%  Similarity=0.219  Sum_probs=131.8

Q ss_pred             CCCccceecccCCccEEEEEEc-C-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .|...+.||+|+||.||++... + ++.||+|.+..........+..|+.++..++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888899999999999999763 3 5778888775444444567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          202 PNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       202 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++|+|..++... .....+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            999999877532 23446889999999999999999999887   999999999999999999999999999987543

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.95  E-value=1.4e-27  Score=211.98  Aligned_cols=147  Identities=24%  Similarity=0.382  Sum_probs=129.8

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+....   ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            37889999999999999999874 47899999986432   223466889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ||+++|+|.+++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|..+
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            99999999998843   345788888899999999999999887   999999999999999999999999998644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=1.7e-28  Score=213.02  Aligned_cols=163  Identities=26%  Similarity=0.422  Sum_probs=141.6

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe-eEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-NILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv  197 (290)
                      .++|..++++|+|+||.++..+.. ++..+++|.+.-.  .....+...+|+.++++++|||||...+.|..++. .++|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            357889999999999999998764 4678999988643  33445678999999999999999999999999988 8999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |+|+++|++...+...+ +..++++....|+.|++.|+.|||++.   |+|||||+.||+++.+..+||.|||+|+.+++
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999886543 567899999999999999999999776   99999999999999999999999999999987


Q ss_pred             CccccCcceeecC
Q 022887          278 DELQGNTKRIVGT  290 (290)
Q Consensus       278 ~~~~~~~~~~~Gt  290 (290)
                      +..  .+.+++||
T Consensus       159 ~~~--~a~tvvGT  169 (426)
T KOG0589|consen  159 EDS--LASTVVGT  169 (426)
T ss_pred             chh--hhheecCC
Confidence            762  34456776

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.95  E-value=1.1e-27  Score=213.15  Aligned_cols=146  Identities=25%  Similarity=0.392  Sum_probs=129.0

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|+.++..++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999987 457889999986532   2234578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+++|+|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            9999999988743   345788888999999999999999987   999999999999999999999999998644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.95  E-value=1.1e-27  Score=212.20  Aligned_cols=151  Identities=25%  Similarity=0.299  Sum_probs=131.8

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ..++|+..+.||+|+||.||++... ++..||+|.+....   ......+..|+.++..++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3468999999999999999999874 57899999986421   2234557889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|+|..++..    ..+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999988742    34778888899999999999999887   9999999999999999999999999998775


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      .+
T Consensus       194 ~~  195 (370)
T cd05596         194 AN  195 (370)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.5e-28  Score=214.34  Aligned_cols=161  Identities=27%  Similarity=0.418  Sum_probs=135.2

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC-CcEEEEEEecccc---ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  195 (290)
                      ..++|..+++||+|.||+|+++...+ ++.+|||.+++..   ....+....|-.++... +||.++.++.+|.+.++.+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            45689999999999999999998854 7789999998753   33455667777776655 5999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||..+|++..+.    ....+++....-++..|+.||+|||+++   ||+||||.+|||||.+|.+||+||||++.-
T Consensus       446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999954333    3456889999999999999999999988   999999999999999999999999999865


Q ss_pred             CCCccccCcceeecC
Q 022887          276 GGDELQGNTKRIVGT  290 (290)
Q Consensus       276 ~~~~~~~~~~~~~Gt  290 (290)
                      -....  .|.++.||
T Consensus       519 m~~g~--~TsTfCGT  531 (694)
T KOG0694|consen  519 MGQGD--RTSTFCGT  531 (694)
T ss_pred             CCCCC--ccccccCC
Confidence            43222  36678887

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=2.4e-27  Score=206.67  Aligned_cols=141  Identities=28%  Similarity=0.321  Sum_probs=125.0

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK  204 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  204 (290)
                      +.||+|+||.||++... +++.||+|.+....   ......+.+|+.++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999874 58899999997532   233467888999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       205 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +|..++..   ...+++.+...++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            99887743   346899999999999999999999887   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.9e-28  Score=228.96  Aligned_cols=151  Identities=36%  Similarity=0.610  Sum_probs=133.4

Q ss_pred             hcCCCccceecccCCccEEEEEEcC--Cc----EEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      .++.+..+.||+|.||.||+|...+  +.    .||||.+.+. +.+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3455667899999999999998744  33    3899999765 345678999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          195 ILIYEYMPNKSLDVFLFYPK----KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                      ++++|||++|+|..||...+    ....++..+.+.++.|||+|+.||+++.   +|||||.++|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999996542    2457899999999999999999999887   9999999999999999999999999


Q ss_pred             Cceee
Q 022887          271 MARIF  275 (290)
Q Consensus       271 la~~~  275 (290)
                      |||.+
T Consensus       848 lArDi  852 (1025)
T KOG1095|consen  848 LARDI  852 (1025)
T ss_pred             hhHhh
Confidence            99944

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=1.8e-27  Score=207.02  Aligned_cols=141  Identities=26%  Similarity=0.318  Sum_probs=124.5

Q ss_pred             ceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCC
Q 022887          129 CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK  204 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  204 (290)
                      +.||+|+||.||++.. .++..||+|.+....   ......+..|+.++..++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999987 458899999987532   223456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       205 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            99887742   346889999999999999999999887   999999999999999999999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.95  E-value=1.9e-27  Score=210.59  Aligned_cols=154  Identities=24%  Similarity=0.286  Sum_probs=133.7

Q ss_pred             HHHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          118 VSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       118 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      .....++|+..+.||+|+||.||++... +++.+|+|.+....   ......+.+|+.++..++||||+++++.+...+.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3445689999999999999999999875 47889999986421   2234567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++||||+++|+|..++..    ..++......++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999988742    34788888899999999999999887   9999999999999999999999999998


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .+...
T Consensus       191 ~~~~~  195 (371)
T cd05622         191 KMNKE  195 (371)
T ss_pred             EcCcC
Confidence            87543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.95  E-value=2.2e-27  Score=207.12  Aligned_cols=151  Identities=22%  Similarity=0.321  Sum_probs=133.0

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++... +++.||+|.+....   ......+..|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47888999999999999999874 58899999997532   223456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|+|..++...  ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999988432  246899999999999999999999887   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=1.6e-27  Score=211.43  Aligned_cols=153  Identities=31%  Similarity=0.418  Sum_probs=131.0

Q ss_pred             hcCCCccceecccCCccEEEEEE------cCCcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  193 (290)
                      .++|+..+.||+|+||.||+|.+      .++..||||.++... ......+.+|+.++..+ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788899999999999999964      235689999986432 23345788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCC-----------------------------------------------------------
Q 022887          194 NILIYEYMPNKSLDVFLFYPK-----------------------------------------------------------  214 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  214 (290)
                      .++||||+++|+|..++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999988875321                                                           


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          215 -------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       215 -------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                                   ....++|.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+..
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                         0124788999999999999999999887   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.9e-27  Score=205.62  Aligned_cols=150  Identities=22%  Similarity=0.305  Sum_probs=131.7

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++... +++.||+|.+...   .......+.+|..++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999874 4789999998642   2223456888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++|+|..++..  ....+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999998843  2345888999999999999999999887   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.95  E-value=6.3e-27  Score=203.83  Aligned_cols=142  Identities=26%  Similarity=0.298  Sum_probs=124.1

Q ss_pred             ceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCC
Q 022887          129 CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK  204 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  204 (290)
                      +.||+|+||.||++.. .++..||+|.+....   ......+..|+.++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986 458899999987532   223456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       205 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +|..++..   ...+++.....++.|++.||.|||+ .+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            99887742   3468999999999999999999997 55   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.2e-27  Score=204.51  Aligned_cols=140  Identities=24%  Similarity=0.296  Sum_probs=124.1

Q ss_pred             ecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       131 ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      ||+|+||.||++... +++.||+|.+...   .......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999875 4788999998643   223446788899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~  144 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM  144 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence            988843   345889999999999999999999887   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.95  E-value=6e-28  Score=216.21  Aligned_cols=161  Identities=32%  Similarity=0.463  Sum_probs=137.8

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC------eeE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------ENI  195 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  195 (290)
                      .|...+.||+|+||.||+|+. .+|+.||||...+.. ....+.-..|++++++++|||||++.+.-.+..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            455678999999999999996 559999999997643 234566788999999999999999998765443      568


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc--CCC--CeEEeeccC
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDM--NPKISDFGM  271 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~--~~~--~~kl~DfGl  271 (290)
                      +|||||++|+|...+..+.+...|++.+.+.+..+++.||.|||+++   |+||||||.||++-  +++  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999988888888999999999999999999999887   99999999999983  334  369999999


Q ss_pred             ceeeCCCccccCcceeecC
Q 022887          272 ARIFGGDELQGNTKRIVGT  290 (290)
Q Consensus       272 a~~~~~~~~~~~~~~~~Gt  290 (290)
                      ||-++.++   ...+++||
T Consensus       171 Arel~d~s---~~~S~vGT  186 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGT  186 (732)
T ss_pred             cccCCCCC---eeeeecCc
Confidence            99998876   35577887

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.95  E-value=4.6e-27  Score=205.22  Aligned_cols=151  Identities=21%  Similarity=0.285  Sum_probs=131.7

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|...+.||+|+||.||+++.. +++.||+|.+....   ......+..|..++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999875 47889999986421   223455788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|+|..++...  ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999988532  345788999999999999999999887   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.95  E-value=5.9e-27  Score=204.59  Aligned_cols=148  Identities=26%  Similarity=0.360  Sum_probs=128.7

Q ss_pred             CCCccceecccCCccEEEEEE----cCCcEEEEEEecccc----ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCee
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  194 (290)
                      +|+..+.||+|+||.||+++.    .++..||+|.+....    ......+..|+.++..+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999875    357899999986421    22345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||+++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999888743   345889999999999999999999887   99999999999999999999999999987


Q ss_pred             eCC
Q 022887          275 FGG  277 (290)
Q Consensus       275 ~~~  277 (290)
                      +..
T Consensus       155 ~~~  157 (332)
T cd05614         155 FLS  157 (332)
T ss_pred             ccc
Confidence            643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.8e-27  Score=208.00  Aligned_cols=150  Identities=27%  Similarity=0.429  Sum_probs=133.6

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|...+.||+|+||.||++... +++.||||.+....   ......+..|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47888999999999999999875 58899999987432   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++++|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999988532   56889999999999999999999877   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.95  E-value=6.2e-27  Score=200.47  Aligned_cols=148  Identities=29%  Similarity=0.454  Sum_probs=128.7

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57888999999999999999874 57899999986432 23345778999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++ +|..++..  ....+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            985 78777642  2345788999999999999999999887   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.95  E-value=5.6e-27  Score=209.07  Aligned_cols=154  Identities=29%  Similarity=0.408  Sum_probs=130.9

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC------CcEEEEEEeccccc-cCHHHHHHHHHHHcccC-CCCcceeEEEEEeCC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQG  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  192 (290)
                      ..++|.+.+.||+|+||.||+|....      +..||||++..... .....+.+|+.++.++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            35688899999999999999997522      34699999975332 23467899999999996 999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCC----------------------------------------------------------
Q 022887          193 ENILIYEYMPNKSLDVFLFYPK----------------------------------------------------------  214 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  214 (290)
                      ..++||||+++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999988775321                                                          


Q ss_pred             -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc
Q 022887          215 -----------------------------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  259 (290)
Q Consensus       215 -----------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~  259 (290)
                                                         ....+++.+...++.|++.||.|||+.+   ++||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                               0124788889999999999999999887   99999999999999


Q ss_pred             CCCCeEEeeccCceeeCC
Q 022887          260 SDMNPKISDFGMARIFGG  277 (290)
Q Consensus       260 ~~~~~kl~DfGla~~~~~  277 (290)
                      +++.+||+|||+++.+..
T Consensus       272 ~~~~~kL~DfGla~~~~~  289 (400)
T cd05105         272 QGKIVKICDFGLARDIMH  289 (400)
T ss_pred             CCCEEEEEeCCcceeccc
Confidence            999999999999987644

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=4.8e-27  Score=203.76  Aligned_cols=150  Identities=34%  Similarity=0.580  Sum_probs=129.1

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCc----EEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.+.... .....++..|+.++..++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            57899999999999999999863 333    38999986533 23456889999999999999999999999864 5679


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ++||+++|+|.+++...  ...+++...+.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999888532  345889999999999999999999887   9999999999999999999999999999876


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      .+
T Consensus       161 ~~  162 (316)
T cd05108         161 AD  162 (316)
T ss_pred             CC
Confidence            44

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.95  E-value=5.3e-27  Score=198.53  Aligned_cols=149  Identities=28%  Similarity=0.434  Sum_probs=130.5

Q ss_pred             hcCCCccceecccCCccEEEEEEc----CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||+|.+.    .+..||+|.++.... .....+.+|+..+.+++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357888999999999999999763    356899999875432 234578999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ||||+++|+|+.++...  ...+++.+.+.++.|++.||+|||+.+   ++||||||+||++++++.+|++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999988532  346899999999999999999999887   999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.95  E-value=5.4e-27  Score=207.09  Aligned_cols=148  Identities=26%  Similarity=0.401  Sum_probs=131.1

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++... +++.||+|.+....   ......+..|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999874 58899999986432   233467888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||+++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            99999999998843   345889999999999999999999887   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.95  E-value=3e-27  Score=209.55  Aligned_cols=155  Identities=32%  Similarity=0.461  Sum_probs=131.2

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc------CCcEEEEEEeccccc-cCHHHHHHHHHHHccc-CCCCcceeEEEEEeC
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ  191 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  191 (290)
                      ...++|+..+.||+|+||.||++...      ++..||+|.+..... .....+..|+.++..+ +||||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34568999999999999999998742      235799999975332 2345688999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCC---------------------------------------------------------
Q 022887          192 GENILIYEYMPNKSLDVFLFYPK---------------------------------------------------------  214 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  214 (290)
                      +..++||||+++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999988874311                                                         


Q ss_pred             ----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          215 ----------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       215 ----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                                ....+++.+..+++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+..
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~  264 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN  264 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence                      1134788999999999999999999887   99999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.95  E-value=8.8e-27  Score=202.75  Aligned_cols=141  Identities=30%  Similarity=0.417  Sum_probs=123.5

Q ss_pred             ceecccCCccEEEEEE----cCCcEEEEEEecccc----ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          129 CKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +.||+|+||.||+++.    .+++.||+|.+....    ......+..|+.++..++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999975    347889999986431    22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +++++|..++..   ...+.+.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            999999888743   345788888899999999999999887   999999999999999999999999999754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.95  E-value=1e-26  Score=203.05  Aligned_cols=150  Identities=22%  Similarity=0.290  Sum_probs=130.5

Q ss_pred             cCCCccceecccCCccEEEEEEcC-CcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++.... ++.+|+|.+.+..   ......+..|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            478889999999999999998754 6789999986421   223345888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++|+|..++..  ....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999998853  2345889999999999999999999887   99999999999999999999999999976643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=1.1e-26  Score=207.01  Aligned_cols=141  Identities=23%  Similarity=0.295  Sum_probs=124.6

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|+..+.||+|+||.||++.. .+++.||+|....      ..+.+|+.++.+++||||+++++++...+..++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            35799999999999999999987 4578999996532      3568899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +. ++|..++..   ...+++.+.+.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            96 577766632   345889999999999999999999887   999999999999999999999999999764

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.94  E-value=9.2e-27  Score=199.10  Aligned_cols=149  Identities=23%  Similarity=0.389  Sum_probs=130.3

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+..+.||+|+||.||+++.. +++.||+|++....  ......+.+|+.++..++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999885 47889999986432  2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |++++++..+..   ....+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            999988776542   2345889999999999999999999887   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=1e-26  Score=201.85  Aligned_cols=144  Identities=29%  Similarity=0.356  Sum_probs=125.8

Q ss_pred             ceecccCCccEEEEEE----cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          129 CKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~----~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      +.||+|+||.||++..    .+++.+|+|.+....  ......+..|+.++.+++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999875    357899999987532  2234567789999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.....
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            9999888732   345899999999999999999999987   999999999999999999999999999866443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.94  E-value=1.4e-26  Score=199.62  Aligned_cols=149  Identities=30%  Similarity=0.433  Sum_probs=128.3

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++..++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999875 588999999864332 233467889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |++ ++|..++..  ....+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            996 566655532  2345788999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=1.6e-26  Score=194.33  Aligned_cols=148  Identities=32%  Similarity=0.485  Sum_probs=132.1

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      ++|+..+.||+|+||.||++.+.++..+|+|.+... .....++..|+.++.+++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            468888999999999999999888789999988643 3345688999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +|+|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++...
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            99999887532  235889999999999999999999887   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.9e-26  Score=194.49  Aligned_cols=151  Identities=31%  Similarity=0.475  Sum_probs=135.1

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|++|.||+|...+++.||+|.+.... ....++.+|+.++.+++||||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45788889999999999999998777889999987533 34578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++|.+++.... ...+++.+...++.|++.|+.|||+.+   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            9999999885432 346899999999999999999999887   99999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.94  E-value=1.3e-26  Score=201.87  Aligned_cols=144  Identities=28%  Similarity=0.436  Sum_probs=123.7

Q ss_pred             CCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHH---HcccCCCCcceeEEEEEeCCeeEEE
Q 022887          125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMML---IAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      |+..+.||+|+||.||++... +++.||||.+....   ......+..|+.+   +..++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999874 58899999997432   2233456666554   4677899999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |||+++++|..++.    ...+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++..
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            99999999988763    345899999999999999999999887   999999999999999999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.94  E-value=1.4e-26  Score=201.54  Aligned_cols=146  Identities=27%  Similarity=0.353  Sum_probs=126.1

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCC-CcceeEEEEEeCCeeEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHR-HLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  198 (290)
                      +|+..+.||+|+||.||+|... +++.||+|.+....   ......+..|..++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5788899999999999999875 46789999987532   23446778899999888765 5888999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ||+++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            99999999888742   345889999999999999999999887   999999999999999999999999999753

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=1.5e-26  Score=201.71  Aligned_cols=141  Identities=27%  Similarity=0.373  Sum_probs=122.7

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||++... +++.+|+|.+....   ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999874 47899999987532   22345677888888766 899999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            999887732   346899999999999999999999887   999999999999999999999999999754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.94  E-value=8.1e-27  Score=205.42  Aligned_cols=145  Identities=28%  Similarity=0.443  Sum_probs=126.6

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|+||.||++... +++.||||.+.... ......+.+|+.++..++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            46777889999999999999874 58899999986432 23346789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|...       ....+.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999998543       23456778899999999999999887   99999999999999999999999999987753

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=1.6e-26  Score=200.52  Aligned_cols=142  Identities=29%  Similarity=0.356  Sum_probs=120.4

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcc-cCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||+|... +++.||+|.+....   ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874 47889999987532   2233445566666654 4899999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            999888743   345888999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.94  E-value=1.8e-26  Score=196.96  Aligned_cols=152  Identities=34%  Similarity=0.513  Sum_probs=130.6

Q ss_pred             cCCCccceecccCCccEEEEEE-----cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++|+..+.||+|+||.||+|.+     .++..+++|.+.... .....++.+|+.++.+++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4678889999999999999975     245789999987433 2334678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC
Q 022887          197 IYEYMPNKSLDVFLFYPK--------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~  262 (290)
                      ||||+++++|.+++....              ....+++.+...++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999874321              1235788999999999999999999887   99999999999999999


Q ss_pred             CeEEeeccCceeeCC
Q 022887          263 NPKISDFGMARIFGG  277 (290)
Q Consensus       263 ~~kl~DfGla~~~~~  277 (290)
                      .+||+|||+++....
T Consensus       162 ~~kl~dfg~~~~~~~  176 (283)
T cd05090         162 HVKISDLGLSREIYS  176 (283)
T ss_pred             cEEeccccccccccC
Confidence            999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.94  E-value=1.2e-26  Score=195.73  Aligned_cols=146  Identities=43%  Similarity=0.653  Sum_probs=125.8

Q ss_pred             ccceecccCCccEEEEEEc-----CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          127 TQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       127 ~~~~ig~G~fg~V~~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ..+.||.|.||.||+|.+.     .+..|+||.++.... ....+|.+|+..+.+++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999886     256899999965332 3468899999999999999999999999988889999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++|+|.+++... ....+++.+++.|+.|+++||.|||+.+   ++|+||+++||++++++.+||+|||+++...
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            9999999998654 2456899999999999999999999987   9999999999999999999999999998873

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=1.7e-26  Score=200.81  Aligned_cols=141  Identities=27%  Similarity=0.377  Sum_probs=122.4

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||+|... +++.||+|.+....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999875 47899999987532   23345677888888765 799999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+|...+..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence            999887742   345889999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.94  E-value=2.4e-26  Score=193.46  Aligned_cols=149  Identities=31%  Similarity=0.489  Sum_probs=132.5

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      ++|...+.||+|+||.||++.+.++..+|+|.+... .....++.+|+.++.+++||||+++++++...+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            467888999999999999998877778999988743 3345679999999999999999999999999889999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++....
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            99999987432  236899999999999999999999887   99999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.94  E-value=2e-26  Score=201.20  Aligned_cols=151  Identities=26%  Similarity=0.342  Sum_probs=132.3

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++..++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999875 57889999886532 2334679999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |+++++|.+++..   ...+++.....++.|++.||.|||+.+  +|+||||||+|||+++++.+||+|||+++.+..
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            9999999998843   345889999999999999999999753  399999999999999999999999999986643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.94  E-value=2.1e-26  Score=196.57  Aligned_cols=150  Identities=31%  Similarity=0.540  Sum_probs=130.9

Q ss_pred             cCCCccceecccCCccEEEEEE-----cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENI  195 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  195 (290)
                      .+|+..+.||+|+||.||++..     .++..||+|.+..........+..|+.++.+++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4788889999999999999974     24778999998765555567899999999999999999999987643  4678


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +|+||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999988432  345899999999999999999999887   999999999999999999999999999977


Q ss_pred             CC
Q 022887          276 GG  277 (290)
Q Consensus       276 ~~  277 (290)
                      ..
T Consensus       159 ~~  160 (284)
T cd05081         159 PQ  160 (284)
T ss_pred             cC
Confidence            54

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.4e-26  Score=196.55  Aligned_cols=150  Identities=29%  Similarity=0.356  Sum_probs=130.5

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      +|+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++..++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999874 58899999986432   1223457789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |+++|+|..++... ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++.+..
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            99999998877532 2345899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.94  E-value=1.2e-26  Score=195.56  Aligned_cols=153  Identities=35%  Similarity=0.561  Sum_probs=137.9

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +.++|+..+.||+|+||.||+|...++..+++|.+..........+..|+.++..++||||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            45678999999999999999999988899999999765555567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|.+++... ....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+..
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            9999999998543 2356899999999999999999999887   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.94  E-value=2.3e-26  Score=200.67  Aligned_cols=140  Identities=24%  Similarity=0.364  Sum_probs=123.2

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||++... +++.||+|.++...   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999874 57899999997532   22345678899999888 799999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence            999887732   356899999999999999999999887   99999999999999999999999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.94  E-value=2.4e-26  Score=199.96  Aligned_cols=147  Identities=28%  Similarity=0.341  Sum_probs=125.6

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      +|...+.||+|+||.||++... +++.||+|.+....   ......+..|..++..+ +||+|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788899999999999999875 46799999987532   22234566777777766 5899999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||+++|+|..++..   ...+++.++..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            99999999887743   345889999999999999999999887   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.94  E-value=2.2e-26  Score=201.06  Aligned_cols=150  Identities=27%  Similarity=0.355  Sum_probs=131.1

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++..++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999885 47788999876532 2234678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |+++++|.+++..   ...+++.....++.|++.||.|||+..  +++|+||||+|||+++++.+||+|||++..+.
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            9999999998843   345788999999999999999999742  39999999999999999999999999997653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.94  E-value=2.5e-26  Score=193.64  Aligned_cols=151  Identities=34%  Similarity=0.508  Sum_probs=134.7

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|+||.||+|...++..||+|.+... ......+..|+.++.+++||||+++++.+...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            4678899999999999999999888889999988653 234578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++|.+++... ....+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence            999999988543 2345888999999999999999999877   99999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.94  E-value=1.9e-26  Score=201.68  Aligned_cols=146  Identities=26%  Similarity=0.421  Sum_probs=124.7

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-----eeE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----ENI  195 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  195 (290)
                      +|+..+.||+|+||.||+|... ++..||||++...  .......+.+|+.++..++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999874 5889999998643  2233457889999999999999999999886443     479


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||++ ++|..++.   ....+++.....++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 57877763   2345899999999999999999999987   999999999999999999999999999865


Q ss_pred             C
Q 022887          276 G  276 (290)
Q Consensus       276 ~  276 (290)
                      .
T Consensus       154 ~  154 (338)
T cd07859         154 F  154 (338)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.94  E-value=8.7e-27  Score=202.55  Aligned_cols=155  Identities=32%  Similarity=0.484  Sum_probs=132.4

Q ss_pred             cceecccCCccEEEEEE-cCCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCC
Q 022887          128 QCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK  204 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  204 (290)
                      .++||+|.||+||-|.. .+|+.||||.+.+.  ..+....+++|+.+|..++||.||.+.-.|...+..+.|||-+.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999976 56999999999754  3345578999999999999999999999999999999999999776


Q ss_pred             ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC---CCeEEeeccCceeeCCCccc
Q 022887          205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARIFGGDELQ  281 (290)
Q Consensus       205 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~---~~~kl~DfGla~~~~~~~~~  281 (290)
                      -|+..|..  ....+++.....++.||+.||.|||.++   |+|+||||+|||+.+.   -++||+|||.||+++...++
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            66666543  3456888888889999999999999988   9999999999999654   37999999999999887765


Q ss_pred             cCcceeecC
Q 022887          282 GNTKRIVGT  290 (290)
Q Consensus       282 ~~~~~~~Gt  290 (290)
                      .   +++||
T Consensus       724 r---sVVGT  729 (888)
T KOG4236|consen  724 R---SVVGT  729 (888)
T ss_pred             h---hhcCC
Confidence            3   45666

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.94  E-value=3.2e-26  Score=195.25  Aligned_cols=145  Identities=30%  Similarity=0.391  Sum_probs=125.6

Q ss_pred             ecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       131 ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      ||+|+||.||++... +++.+|+|.+.....   .....+..|+.++..++||||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            689999999999874 578999999864321   2335678899999999999999999999999999999999999999


Q ss_pred             hhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          207 DVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       207 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ..++... .....+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            8876432 23456899999999999999999999887   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.94  E-value=4e-26  Score=193.05  Aligned_cols=149  Identities=28%  Similarity=0.465  Sum_probs=133.5

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.++.+++||||+++++.+...+..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            45799999999999999999987 45788999998755444556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++++|.+++..   ...+++.+...++.|++.||.|||+.+   ++|||++|+||++++++.+||+|||+++.+.
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            999999988743   345789999999999999999999887   9999999999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.4e-26  Score=211.99  Aligned_cols=155  Identities=20%  Similarity=0.279  Sum_probs=131.6

Q ss_pred             HHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC----
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG----  192 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  192 (290)
                      ...++|...+.||+|+||.||++.. .+++.||||.+....  ......+..|+..+..++|+|++++...+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457999999999999999999976 468999999986432  233467889999999999999999988775433    


Q ss_pred             ----eeEEEEEecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEe
Q 022887          193 ----ENILIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       193 ----~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                          ..++||||+++|+|.+++... .....+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence                257999999999999888542 23456889999999999999999999887   9999999999999999999999


Q ss_pred             eccCceeeCC
Q 022887          268 DFGMARIFGG  277 (290)
Q Consensus       268 DfGla~~~~~  277 (290)
                      |||+++.+..
T Consensus       186 DFGls~~~~~  195 (496)
T PTZ00283        186 DFGFSKMYAA  195 (496)
T ss_pred             ecccCeeccc
Confidence            9999987754

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.94  E-value=2e-26  Score=205.46  Aligned_cols=155  Identities=29%  Similarity=0.431  Sum_probs=131.4

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc------CCcEEEEEEeccccc-cCHHHHHHHHHHHcccC-CCCcceeEEEEEeC
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQ  191 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  191 (290)
                      ...++|...+.||+|+||.||+|.+.      .+..||+|+++.... .....+..|+.++.++. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34567888899999999999999863      245799999975432 22457889999999997 99999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCC---------------------------------------------------------
Q 022887          192 GENILIYEYMPNKSLDVFLFYPK---------------------------------------------------------  214 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  214 (290)
                      +..++|+||+++|+|.+++....                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999998875321                                                         


Q ss_pred             --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCE
Q 022887          215 --------------------------------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNI  256 (290)
Q Consensus       215 --------------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Ni  256 (290)
                                                            ....+++.....++.|++.||.|||+.+   ++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence                                                  1134678889999999999999999877   99999999999


Q ss_pred             EEcCCCCeEEeeccCceeeCC
Q 022887          257 LLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       257 ll~~~~~~kl~DfGla~~~~~  277 (290)
                      |+++++.+||+|||+++.+..
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~  291 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMR  291 (401)
T ss_pred             EEeCCCEEEEEecCcceeccc
Confidence            999999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.94  E-value=4.1e-26  Score=216.29  Aligned_cols=150  Identities=25%  Similarity=0.329  Sum_probs=131.1

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||+|... +++.||+|++.....   ....++.+|+.++.+++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999875 488999999865322   23457899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          199 EYMPNKSLDVFLFYPK--------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                      ||+++++|.+++....        ....+++...+.++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999998875321        1234667888999999999999999887   9999999999999999999999999


Q ss_pred             Cceee
Q 022887          271 MARIF  275 (290)
Q Consensus       271 la~~~  275 (290)
                      +++..
T Consensus       159 LAk~i  163 (932)
T PRK13184        159 AAIFK  163 (932)
T ss_pred             cceec
Confidence            99877

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=3e-26  Score=199.52  Aligned_cols=141  Identities=28%  Similarity=0.372  Sum_probs=120.5

Q ss_pred             ceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHH-HHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMM-LIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||++.. .+++.+|+|.+....   ......+..|.. ++..++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999987 458899999986432   122345555554 56779999999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+|..++.   ....+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            99988773   3456889999999999999999999887   999999999999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=4.6e-27  Score=215.41  Aligned_cols=152  Identities=30%  Similarity=0.467  Sum_probs=131.5

Q ss_pred             hcCCCccceecccCCccEEEEEEcCC-cEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEE-EEeC------C
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGC-CIEQ------G  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~~------~  192 (290)
                      ..++++.+.|.+|||+.||.+....+ .++|+|++...+....+...+|+.+|+.|+ |||||.+++. ....      -
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34677889999999999999998765 999999997667777889999999999997 9999999993 2211      2


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      +.+|.||||++|.|-+++..+...+ |++.+.++|+.|+++|+.+||.. .+||||||||.+||||+.++..||+|||.|
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            5679999999999999886443334 99999999999999999999987 578999999999999999999999999999


Q ss_pred             eee
Q 022887          273 RIF  275 (290)
Q Consensus       273 ~~~  275 (290)
                      .-.
T Consensus       194 tt~  196 (738)
T KOG1989|consen  194 TTK  196 (738)
T ss_pred             ccc
Confidence            543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=5e-27  Score=208.78  Aligned_cols=152  Identities=30%  Similarity=0.461  Sum_probs=135.4

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      +-|...+.||.|+.|.|-.|++ .+|+.+|||.+.+..   ......+.+|+.+|+-+.|||++++++.+.+..+.|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4577889999999999999987 569999999997542   223467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|.|.+++.   ..+.+++.+..+++.||+.|+.|+|..+   |+|||+||+|+|||...++||+|||||.+-.++
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999998884   4566888999999999999999999877   999999999999999999999999999987666


Q ss_pred             cc
Q 022887          279 EL  280 (290)
Q Consensus       279 ~~  280 (290)
                      ..
T Consensus       166 kl  167 (786)
T KOG0588|consen  166 KL  167 (786)
T ss_pred             cc
Confidence            43

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=3.4e-28  Score=220.38  Aligned_cols=152  Identities=34%  Similarity=0.524  Sum_probs=132.6

Q ss_pred             CCccceecccCCccEEEEEE-cCC----cEEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          125 FSTQCKLGEGGFGPVYKGRL-LNG----QEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~-~~~----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ....++||+|+||+||+|.+ ..+    -+||||.+... ..+...++.+|+..|++++|||+++++|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34457899999999999976 333    36899988654 3445689999999999999999999999999876 77999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +||+.|+|.+++..  .+..+..+..+.|..|||+||.|||++.   ++||||.++|||+.+-..+||+|||+|+++..+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999855  3456888999999999999999999877   999999999999999999999999999999887


Q ss_pred             cccc
Q 022887          279 ELQG  282 (290)
Q Consensus       279 ~~~~  282 (290)
                      +.+-
T Consensus       852 ~~ey  855 (1177)
T KOG1025|consen  852 EKEY  855 (1177)
T ss_pred             cccc
Confidence            6553

>PHA02988 hypothetical protein; Provisional

Probab=99.94  E-value=4.1e-26  Score=194.91  Aligned_cols=142  Identities=20%  Similarity=0.358  Sum_probs=124.4

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEeccccccC---HHHHHHHHHHHcccCCCCcceeEEEEEe----CCeeEEEEEec
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGENILIYEYM  201 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  201 (290)
                      ..|++|+++.||+|.+ +++.||||.+.......   .+.|.+|+.++.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6899999999999998 67899999997543332   4678899999999999999999999877    34678999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++|+|..++..   ...++|.....++.|++.||.|||+. +   ++||||||+|||+++++.+||+|||+++.+..
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            99999999843   34688999999999999999999974 4   88999999999999999999999999987544

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=2.9e-26  Score=207.17  Aligned_cols=144  Identities=25%  Similarity=0.345  Sum_probs=125.5

Q ss_pred             cCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      ..|...+.||+|+||.||++.... ++.||||...      ...+.+|+.++.+++||||+++++++...+..++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            368888999999999999998754 7889999532      235678999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      . ++|..++..  ....++|.+++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       243 ~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        243 R-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             C-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            5 677776632  2346899999999999999999999887   999999999999999999999999999877543

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=2.9e-26  Score=199.26  Aligned_cols=141  Identities=28%  Similarity=0.414  Sum_probs=122.6

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||++... +++.||+|.+...   .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874 4789999998643   223345677888888766 699999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            999887743   345889999999999999999999887   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-26  Score=201.09  Aligned_cols=161  Identities=29%  Similarity=0.436  Sum_probs=138.8

Q ss_pred             HHhcCCCccceecccCCccEEEEEEcC-CcEEEEEEecccccc---CHHHHHHHHHHHcccC-CCCcceeEEEEEeCCee
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  194 (290)
                      .....|+..+.||+|.||.||++.... |+.+|+|.+.+....   ....+.+|+.+|.++. |||||.+.+.+.+.+..
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            345678888999999999999998755 899999999765443   3468999999999998 99999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC----CCeEEeecc
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKISDFG  270 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~----~~~kl~DfG  270 (290)
                      ++|||++.+|.|.+.+...    .+++.....++.|++.++.|||+.+   ++|||+||+|+|+...    +.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999998887543    2899999999999999999999987   9999999999999543    479999999


Q ss_pred             CceeeCCCccccCcceeecC
Q 022887          271 MARIFGGDELQGNTKRIVGT  290 (290)
Q Consensus       271 la~~~~~~~~~~~~~~~~Gt  290 (290)
                      +|.....+.   ....++||
T Consensus       185 la~~~~~~~---~~~~~~Gt  201 (382)
T KOG0032|consen  185 LAKFIKPGE---RLHTIVGT  201 (382)
T ss_pred             CceEccCCc---eEeeecCC
Confidence            999987732   23456665

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=4e-26  Score=198.63  Aligned_cols=141  Identities=29%  Similarity=0.364  Sum_probs=120.3

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHH-HHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMM-LIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||++... +++.||+|.+....   .....++..|.. ++..++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999874 58899999986432   122334455544 56789999999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            999888743   346888999999999999999999887   999999999999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.94  E-value=4.5e-26  Score=192.68  Aligned_cols=150  Identities=34%  Similarity=0.543  Sum_probs=131.9

Q ss_pred             hcCCCccceecccCCccEEEEEEcC----CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||+|.+..    ...||||.+.... .....+|..|+..+.+++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578899999999999999998742    3579999886533 2334678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +|||+++++|.+++...  ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+.
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999988542  236899999999999999999999877   9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.94  E-value=3.2e-26  Score=199.21  Aligned_cols=147  Identities=27%  Similarity=0.355  Sum_probs=125.9

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  198 (290)
                      +|+..+.||+|+||.||++... +++.||+|.+....   ......+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677789999999999999874 58899999987432   223456778888888775 577888999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||+++|+|..++..   ...+++.+...++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            99999999888732   345899999999999999999999887   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.3e-26  Score=191.84  Aligned_cols=149  Identities=32%  Similarity=0.489  Sum_probs=131.9

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      .+|+..+.||+|+||.||++.+.++..+|+|.+... .....++..|+.++..++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            467888999999999999998877778999988643 2344678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++|.+++...  ...+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence            99999988532  236899999999999999999999887   99999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.94  E-value=3.8e-26  Score=194.38  Aligned_cols=154  Identities=30%  Similarity=0.486  Sum_probs=131.1

Q ss_pred             HhcCCCccceecccCCccEEEEEEc------CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      ..++|+..+.||+|+||.||+|...      ++..||+|.+.... .....++.+|+.++..++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999753      24679999886432 2234578899999999999999999999999899


Q ss_pred             eEEEEEecCCCChhhhhhCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEE
Q 022887          194 NILIYEYMPNKSLDVFLFYPKK-------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  266 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl  266 (290)
                      .++||||+++++|.+++.....       ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999998753221       234688899999999999999999877   999999999999999999999


Q ss_pred             eeccCceeeCC
Q 022887          267 SDFGMARIFGG  277 (290)
Q Consensus       267 ~DfGla~~~~~  277 (290)
                      +|||+++.+..
T Consensus       161 ~dfg~~~~~~~  171 (277)
T cd05062         161 GDFGMTRDIYE  171 (277)
T ss_pred             CCCCCccccCC
Confidence            99999976543

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.94  E-value=5.3e-26  Score=197.23  Aligned_cols=141  Identities=28%  Similarity=0.387  Sum_probs=121.5

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcc-cCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||+|... +++.||||.+....   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999875 47889999987532   2234456667777765 5899999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+|..++..   ...+++.+...++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            999988742   345889999999999999999999887   999999999999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.94  E-value=4e-26  Score=193.33  Aligned_cols=144  Identities=30%  Similarity=0.447  Sum_probs=122.2

Q ss_pred             ceecccCCccEEEEEEcC---CcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCC
Q 022887          129 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK  204 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~---~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  204 (290)
                      +.||+|+||.||+|...+   ...+++|.+..... .....+.+|+..+..++||||+++++.+.+.+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997543   34688887754322 23457889999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          205 SLDVFLFYPKK--KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       205 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +|.+++.....  ....++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence            99998854332  234567888999999999999999887   999999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.94  E-value=5.7e-26  Score=193.61  Aligned_cols=150  Identities=34%  Similarity=0.505  Sum_probs=126.4

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCc----EEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++|+..+.||+|+||.||+|.+. +++    .+++|.+..... ....++..|+..+.+++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            57888899999999999999873 344    477887754322 234678888889999999999999998754 46789


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ++||+++|+|.+++...  ...+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999988532  346899999999999999999999887   9999999999999999999999999998775


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      .+
T Consensus       161 ~~  162 (279)
T cd05111         161 PD  162 (279)
T ss_pred             CC
Confidence            43

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.6e-27  Score=194.74  Aligned_cols=151  Identities=28%  Similarity=0.458  Sum_probs=129.3

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecc--ccccCHHHHHHHHHHHcccCCCCcceeEEEEEe-----CC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-----QG  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~  192 (290)
                      ....|...+.||+|+||.|..+.. .+++.||||++..  ......++..+|+.++..++|+||+.+.+.+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            345666678999999999999987 4589999999973  233456788999999999999999999999876     34


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..|+|+|+| ..+|...+.   .+..++......+..|+++||.|+|+.+   ++|||+||+|+|++.+...||+|||||
T Consensus       100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence            679999999 557777773   3455888999999999999999999888   999999999999999999999999999


Q ss_pred             eeeCCC
Q 022887          273 RIFGGD  278 (290)
Q Consensus       273 ~~~~~~  278 (290)
                      +..+..
T Consensus       173 R~~~~~  178 (359)
T KOG0660|consen  173 RYLDKF  178 (359)
T ss_pred             eecccc
Confidence            999654

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=4.4e-26  Score=198.19  Aligned_cols=141  Identities=28%  Similarity=0.355  Sum_probs=119.7

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHH-HHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMM-LIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||+++.. +++.||+|.+....   ......+..|.. ++..++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874 57899999986432   122344555554 57889999999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ++|...+..   ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            999877732   345788888899999999999999887   999999999999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.94  E-value=3.7e-26  Score=202.61  Aligned_cols=148  Identities=26%  Similarity=0.403  Sum_probs=127.2

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-----eeE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----ENI  195 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  195 (290)
                      +|+..+.||+|+||.||++.. .+++.||||++....  ......+.+|+.++..++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999987 468899999986432  223467889999999999999999999998776     789


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +|+||++ ++|...+.   ....+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 46666653   3356899999999999999999999887   999999999999999999999999999876


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      ..+
T Consensus       154 ~~~  156 (372)
T cd07853         154 EPD  156 (372)
T ss_pred             ccC
Confidence            543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=3.5e-26  Score=196.44  Aligned_cols=152  Identities=30%  Similarity=0.476  Sum_probs=129.6

Q ss_pred             hcCCCccceecccCCccEEEEEEcC---------------CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLF  185 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~  185 (290)
                      .++|+..+.||+|+||.||++...+               ...||+|.+.... ......|.+|++++.+++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578899999999999999987532               1248999887532 22345789999999999999999999


Q ss_pred             EEEEeCCeeEEEEEecCCCChhhhhhCCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCE
Q 022887          186 GCCIEQGENILIYEYMPNKSLDVFLFYPK---------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNI  256 (290)
Q Consensus       186 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Ni  256 (290)
                      +++...+..++||||+++++|..++....         ....+++..++.++.|++.||.|||+.+   ++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999875321         1134789999999999999999999887   99999999999


Q ss_pred             EEcCCCCeEEeeccCceeeC
Q 022887          257 LLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       257 ll~~~~~~kl~DfGla~~~~  276 (290)
                      ++++++.+||+|||+++.+.
T Consensus       161 ll~~~~~~kl~dfg~~~~~~  180 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLY  180 (295)
T ss_pred             EEcCCCcEEecccccccccc
Confidence            99999999999999998654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.94  E-value=4.7e-26  Score=194.95  Aligned_cols=152  Identities=34%  Similarity=0.581  Sum_probs=132.3

Q ss_pred             cCCCccceecccCCccEEEEEEc------CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .+|...+.||+|+||.||++...      ++..+|+|.+..........+..|+.++.+++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57888899999999999999742      245689998876554556789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEE
Q 022887          197 IYEYMPNKSLDVFLFYPK----------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  266 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl  266 (290)
                      ||||+++++|.+++....          ....+++.+.+.++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999998875321          2235899999999999999999999887   999999999999999999999


Q ss_pred             eeccCceeeCC
Q 022887          267 SDFGMARIFGG  277 (290)
Q Consensus       267 ~DfGla~~~~~  277 (290)
                      +|||+++.+..
T Consensus       162 ~dfg~~~~~~~  172 (288)
T cd05093         162 GDFGMSRDVYS  172 (288)
T ss_pred             ccCCccccccC
Confidence            99999986643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=210.25  Aligned_cols=160  Identities=28%  Similarity=0.459  Sum_probs=139.8

Q ss_pred             HhHHHHhcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          116 ASVSAATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       116 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      +.++....+.....+||-|.||.||.|.|.. .-.||||.++.. .....+|+.|..+|+.++|||+|+|+|+|+.....
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3444445566677899999999999999865 568999999763 44578999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      |+|+|||.+|+|.+||... ++..++.-..+.+|.||..||+||..++   +|||||.++|+|+.++..+||+||||+++
T Consensus       339 YIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence            9999999999999998543 3445677788999999999999999887   99999999999999999999999999999


Q ss_pred             eCCCcc
Q 022887          275 FGGDEL  280 (290)
Q Consensus       275 ~~~~~~  280 (290)
                      +..|.-
T Consensus       415 MtgDTY  420 (1157)
T KOG4278|consen  415 MTGDTY  420 (1157)
T ss_pred             hcCCce
Confidence            987754

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=5.6e-26  Score=198.03  Aligned_cols=141  Identities=28%  Similarity=0.370  Sum_probs=123.3

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||++... +++.+|+|.+....   ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999874 47889999997532   22345678899988888 699999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+|..++..   ...+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            999887732   346899999999999999999999987   999999999999999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.94  E-value=5.6e-26  Score=193.42  Aligned_cols=153  Identities=33%  Similarity=0.561  Sum_probs=133.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcC------CcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~------~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      .++|...+.||+|+||.||+|...+      +..||+|.+...... ....+.+|+.++..++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568888999999999999997633      468999998754433 457899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC
Q 022887          195 ILIYEYMPNKSLDVFLFYPK-----------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  263 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~  263 (290)
                      ++||||+++++|.+++....           ....+++.+...++.|++.|+.|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999885421           2345789999999999999999999887   999999999999999999


Q ss_pred             eEEeeccCceeeCC
Q 022887          264 PKISDFGMARIFGG  277 (290)
Q Consensus       264 ~kl~DfGla~~~~~  277 (290)
                      +||+|||+++.+..
T Consensus       161 ~kl~d~g~~~~~~~  174 (280)
T cd05049         161 VKIGDFGMSRDVYT  174 (280)
T ss_pred             EEECCcccceeccc
Confidence            99999999986543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.94  E-value=1.1e-25  Score=192.62  Aligned_cols=151  Identities=30%  Similarity=0.509  Sum_probs=122.6

Q ss_pred             cCCCccceecccCCccEEEEEEc--CCcEEEEEEecccc--ccCHHHHHHHHHHHccc---CCCCcceeEEEEEe-----
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKL---QHRHLVRLFGCCIE-----  190 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~--~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----  190 (290)
                      ++|+..+.||+|+||.||+|...  ++..||+|.+....  ......+.+|+.++..+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  46789999886432  22234566677666555   79999999999863     


Q ss_pred             CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          191 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       191 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                      ....++||||++ ++|..++... ....+++.++..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346789999997 5787777432 2345889999999999999999999987   9999999999999999999999999


Q ss_pred             CceeeCCC
Q 022887          271 MARIFGGD  278 (290)
Q Consensus       271 la~~~~~~  278 (290)
                      +++.....
T Consensus       156 ~~~~~~~~  163 (290)
T cd07862         156 LARIYSFQ  163 (290)
T ss_pred             ceEeccCC
Confidence            99877543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.94  E-value=7.5e-26  Score=193.96  Aligned_cols=152  Identities=34%  Similarity=0.570  Sum_probs=131.9

Q ss_pred             cCCCccceecccCCccEEEEEEc------CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++|...+.||+|+||.||++...      ++..+++|.+..........+.+|+..+.+++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46788899999999999999752      245688998876554455789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC
Q 022887          197 IYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  263 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~  263 (290)
                      ||||+++++|.+++....             ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999885422             1234899999999999999999999887   999999999999999999


Q ss_pred             eEEeeccCceeeCC
Q 022887          264 PKISDFGMARIFGG  277 (290)
Q Consensus       264 ~kl~DfGla~~~~~  277 (290)
                      ++|+|||+++....
T Consensus       162 ~~l~dfg~a~~~~~  175 (291)
T cd05094         162 VKIGDFGMSRDVYS  175 (291)
T ss_pred             EEECCCCcccccCC
Confidence            99999999986644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-27  Score=207.20  Aligned_cols=142  Identities=35%  Similarity=0.517  Sum_probs=126.3

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      +..+.++-||.|+-|.||+|++. ++.||||+++...       ..+|+-|.+|+||||+.+.|+|......++|||||+
T Consensus       124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             HHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            34455678999999999999994 5899999886432       347888999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      .|-|...|   +..+.++......|..+||.||.|||.+.   |||||||+-||||.-+..+||+|||.++.+..-
T Consensus       196 ~GqL~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  196 QGQLYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             cccHHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            99999998   44567888999999999999999999887   999999999999999999999999999988543

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=7.3e-26  Score=197.12  Aligned_cols=141  Identities=28%  Similarity=0.349  Sum_probs=118.7

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHH-HHHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEM-MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||++... +++.||+|.+....   ......+..|. .++..++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999875 46789999986432   12223444444 456788999999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+|..++..   ...+.+.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            999888743   345778888889999999999999987   999999999999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.94  E-value=8.6e-26  Score=195.28  Aligned_cols=149  Identities=28%  Similarity=0.445  Sum_probs=128.3

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57888999999999999999874 57889999987433 22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++ +|..++..  ....+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus        86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            985 67666532  2345788999999999999999999887   99999999999999999999999999986543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.94  E-value=7e-26  Score=196.51  Aligned_cols=141  Identities=28%  Similarity=0.375  Sum_probs=121.2

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcc-cCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||++... +++.||+|.++...   ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999875 57899999987532   2234556677777765 4899999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            999888743   345889999999999999999999887   999999999999999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.94  E-value=9e-26  Score=192.50  Aligned_cols=151  Identities=35%  Similarity=0.570  Sum_probs=130.4

Q ss_pred             cCCCccceecccCCccEEEEEEcC------CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      ++|+..+.||+|+||.||+|....      ...||+|.+.... .....+|.+|+..+..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            478889999999999999998643      2579999886433 223467899999999999999999999999989999


Q ss_pred             EEEEecCCCChhhhhhCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC
Q 022887          196 LIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~  262 (290)
                      ++|||+++++|.+++.....             ...+++.+...++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999988854211             145888999999999999999999887   99999999999999999


Q ss_pred             CeEEeeccCceeeC
Q 022887          263 NPKISDFGMARIFG  276 (290)
Q Consensus       263 ~~kl~DfGla~~~~  276 (290)
                      .+||+|||+++...
T Consensus       162 ~~~L~dfg~~~~~~  175 (283)
T cd05048         162 TVKISDFGLSRDIY  175 (283)
T ss_pred             cEEECCCcceeecc
Confidence            99999999998653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.94  E-value=7.4e-26  Score=191.53  Aligned_cols=151  Identities=32%  Similarity=0.536  Sum_probs=131.3

Q ss_pred             cCCCccceecccCCccEEEEEEc-C---CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-N---GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~---~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++|...+.||+|+||.||+|... +   +..+|+|.+.... ......+..|+.++.+++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57888899999999999999763 2   3379999886432 22346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|.+++...  ...+++.+...++.|++.||.|||+.+   ++||||||+||++++++.++++|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999988532  345899999999999999999999887   99999999999999999999999999987754


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       159 ~  159 (267)
T cd05066         159 D  159 (267)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.94  E-value=8.9e-26  Score=191.26  Aligned_cols=145  Identities=31%  Similarity=0.422  Sum_probs=123.6

Q ss_pred             ceecccCCccEEEEEEcC---CcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCC
Q 022887          129 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK  204 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~---~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  204 (290)
                      +.||+|+||.||+|...+   +..+|+|.+..... .....+.+|+..+.+++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998643   35799998865432 23457889999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          205 SLDVFLFYPK--KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       205 ~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +|.+++....  .....++.....++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999885432  2234677888899999999999999887   9999999999999999999999999997543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.94  E-value=5.2e-26  Score=194.67  Aligned_cols=153  Identities=30%  Similarity=0.498  Sum_probs=130.1

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC------CcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      ..++|+..+.||+|+||.||+|...+      +..||+|.+..... .....+.+|+..+..++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45789999999999999999996532      44799998864322 233567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEE
Q 022887          194 NILIYEYMPNKSLDVFLFYPK-------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  266 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl  266 (290)
                      .++||||+++|+|..++....       .....++.....++.|++.||.|||+.+   ++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999985321       1244677888999999999999999887   999999999999999999999


Q ss_pred             eeccCceeeC
Q 022887          267 SDFGMARIFG  276 (290)
Q Consensus       267 ~DfGla~~~~  276 (290)
                      +|||+++.+.
T Consensus       161 ~Dfg~~~~~~  170 (288)
T cd05061         161 GDFGMTRDIY  170 (288)
T ss_pred             CcCCcccccc
Confidence            9999998653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=2.6e-26  Score=194.38  Aligned_cols=151  Identities=26%  Similarity=0.330  Sum_probs=133.9

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+.++.||+|.-|+||++++.+ +...|+|++.+..   .+...+...|-++|+.++||.++.|++.+..++..+++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            4578888999999999999999865 5889999997643   33456778899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||++|+|...+.. +..+.+++....-++..++-||+|||-.+   ||+|||||+||||.++|.+-|+||.|+....
T Consensus       156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            999999999987743 45567888888899999999999999888   9999999999999999999999999997664

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.94  E-value=9.1e-26  Score=213.23  Aligned_cols=150  Identities=27%  Similarity=0.410  Sum_probs=132.4

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|.+.+.||+|+||.||+|... +++.||||.+.....   .....+..|+.++..++||||+++++.+...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999885 588999999865322   22367889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++++|..++..   ...+++...+.++.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~  157 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR  157 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence            99999999998843   345788999999999999999999887   999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=209.22  Aligned_cols=152  Identities=34%  Similarity=0.492  Sum_probs=131.2

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ...|+.++.||.|+||.||-++. .+.+.||||++.-.   ....+.++..|+..|.++.|||.+.+-|++......|||
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            35688889999999999999987 45778999999643   333467899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||||-+ +..+++.-  -.+++.+-++..|..+.+.||+|||+.+   .||||||+.|||+++.+.|||+|||.|.+..+
T Consensus       105 MEYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  105 MEYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             HHHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            999954 55555532  2456888899999999999999999988   99999999999999999999999999998866


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      ..
T Consensus       179 An  180 (948)
T KOG0577|consen  179 AN  180 (948)
T ss_pred             hh
Confidence            43

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.94  E-value=1.3e-25  Score=189.53  Aligned_cols=151  Identities=32%  Similarity=0.524  Sum_probs=131.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|+||.||+|...+...||+|.+.... .....+..|+.++..++||||+++++.+. .+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            45789999999999999999988777789999987532 34567899999999999999999999874 45679999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++|+|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+...
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            999999988532 2345789999999999999999999887   999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=3.9e-26  Score=201.88  Aligned_cols=154  Identities=29%  Similarity=0.437  Sum_probs=135.2

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ....|.+...||+|.|++|..++. .++.+||||.+.+...  .....+.+|++++..++|||||+++.+...+...|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            356789999999999999999987 4589999999976432  2335589999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||..+|.+.+++..   ...........++.|+.+|++|||+++   |+|||||++|+||+.+.++||+|||++.++..
T Consensus       134 ~eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999843   333445788889999999999999998   99999999999999999999999999999976


Q ss_pred             Ccc
Q 022887          278 DEL  280 (290)
Q Consensus       278 ~~~  280 (290)
                      +..
T Consensus       208 ~~~  210 (596)
T KOG0586|consen  208 GLM  210 (596)
T ss_pred             ccc
Confidence            554

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.94  E-value=1.2e-25  Score=192.61  Aligned_cols=150  Identities=34%  Similarity=0.552  Sum_probs=128.2

Q ss_pred             CCCccceecccCCccEEEEEEc------CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      +|+..+.||+|+||.||+|...      ....+++|.+..... .....+..|+..+..++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677889999999999999753      235688888864332 234678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCC
Q 022887          197 IYEYMPNKSLDVFLFYPK---------------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN  255 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~N  255 (290)
                      ++||+++++|.+++....                     ....+++.+.+.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999998874321                     1235889999999999999999999877   9999999999


Q ss_pred             EEEcCCCCeEEeeccCceeeC
Q 022887          256 ILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       256 ill~~~~~~kl~DfGla~~~~  276 (290)
                      |++++++.+||+|||+++.+.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~  178 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVY  178 (290)
T ss_pred             EEEcCCCcEEecccccccccc
Confidence            999999999999999998653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.94  E-value=5.9e-26  Score=199.18  Aligned_cols=152  Identities=29%  Similarity=0.451  Sum_probs=127.7

Q ss_pred             hcCCCccceecccCCccEEEEEE------cCCcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeC-C
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ-G  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  192 (290)
                      .++|+..+.||+|+||.||+|..      .+++.||||.++... ......+..|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46899999999999999999974      346789999997532 22345788999999999 689999999988765 4


Q ss_pred             eeEEEEEecCCCChhhhhhCCCC---------------------------------------------------------
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKK---------------------------------------------------------  215 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  215 (290)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            57899999999999988753210                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          216 -------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       216 -------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                             ...+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  230 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY  230 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence                   124688889999999999999999887   9999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.94  E-value=1.2e-25  Score=188.44  Aligned_cols=143  Identities=31%  Similarity=0.488  Sum_probs=125.9

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      +.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++..++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999874 68899999876432 23346789999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      .+++..  ....+++.+.+.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence            998843  2345889999999999999999999887   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.94  E-value=1e-25  Score=194.33  Aligned_cols=153  Identities=30%  Similarity=0.522  Sum_probs=131.5

Q ss_pred             hcCCCccceecccCCccEEEEEEc--------CCcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeC
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ  191 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  191 (290)
                      .++|...+.||+|+||.||++...        ++..||+|.+.... .....++.+|+.++..+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888899999999999999741        23479999886432 33456789999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE
Q 022887          192 GENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  258 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill  258 (290)
                      +..+++|||+++|+|..++.....             ...+++.++..++.|++.||.|||+.+   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999998864321             235788999999999999999999887   9999999999999


Q ss_pred             cCCCCeEEeeccCceeeCC
Q 022887          259 DSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       259 ~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++.+||+|||+++.+..
T Consensus       171 ~~~~~~kl~D~g~~~~~~~  189 (304)
T cd05101         171 TENNVMKIADFGLARDVNN  189 (304)
T ss_pred             cCCCcEEECCCccceeccc
Confidence            9999999999999987754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.94  E-value=1.1e-25  Score=193.53  Aligned_cols=153  Identities=30%  Similarity=0.492  Sum_probs=130.5

Q ss_pred             hcCCCccceecccCCccEEEEEEc-----------------CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcce
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVR  183 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~  183 (290)
                      .++|+..+.||+|+||.||++...                 +...+|+|.+.... ......+..|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357899999999999999998532                 23468999887542 233467899999999999999999


Q ss_pred             eEEEEEeCCeeEEEEEecCCCChhhhhhCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCC
Q 022887          184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPK--------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN  255 (290)
Q Consensus       184 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~N  255 (290)
                      +++++...+..+++|||+++++|..++....        ....+++.+...++.|++.||+|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            9999999999999999999999998875422        1234788899999999999999999887   9999999999


Q ss_pred             EEEcCCCCeEEeeccCceeeCC
Q 022887          256 ILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       256 ill~~~~~~kl~DfGla~~~~~  277 (290)
                      |++++++.++|+|||+++.+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             EEEcCCCCEEeccCcccccccC
Confidence            9999999999999999986643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=7.3e-26  Score=192.48  Aligned_cols=141  Identities=28%  Similarity=0.404  Sum_probs=119.8

Q ss_pred             eecccCCccEEEEEEcC-------------------------CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCccee
Q 022887          130 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL  184 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l  184 (290)
                      .||+|+||.||+|.+..                         ...|++|.+.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13488998875444445678899999999999999999


Q ss_pred             EEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC--
Q 022887          185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM--  262 (290)
Q Consensus       185 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~--  262 (290)
                      ++++...+..++||||+++|+|+.++..  ....+++..+..++.|+++||+|||+++   ++||||||+|||+++.+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999988743  2345789999999999999999999887   99999999999997643  


Q ss_pred             -----CeEEeeccCceee
Q 022887          263 -----NPKISDFGMARIF  275 (290)
Q Consensus       263 -----~~kl~DfGla~~~  275 (290)
                           .+|++|||++...
T Consensus       157 ~~~~~~~kl~d~g~~~~~  174 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTA  174 (274)
T ss_pred             cCccceeeecCCcccccc
Confidence                 3799999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.94  E-value=1.3e-25  Score=190.27  Aligned_cols=149  Identities=32%  Similarity=0.588  Sum_probs=124.4

Q ss_pred             CccceecccCCccEEEEEEcCC-c--EEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeC------Cee
Q 022887          126 STQCKLGEGGFGPVYKGRLLNG-Q--EVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------GEN  194 (290)
Q Consensus       126 ~~~~~ig~G~fg~V~~~~~~~~-~--~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  194 (290)
                      ...+.||+|+||.||+|.+.+. .  .+|+|.++..  .......+..|+..+..++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            4568899999999999987543 2  5899988643  223356788999999999999999999987542      246


Q ss_pred             EEEEEecCCCChhhhhhCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccC
Q 022887          195 ILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl  271 (290)
                      ++++||+++|+|..++....   ....+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            89999999999988774322   2345899999999999999999999877   99999999999999999999999999


Q ss_pred             ceeeCC
Q 022887          272 ARIFGG  277 (290)
Q Consensus       272 a~~~~~  277 (290)
                      ++.+..
T Consensus       159 ~~~~~~  164 (272)
T cd05075         159 SKKIYN  164 (272)
T ss_pred             ccccCc
Confidence            987654

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.94  E-value=1.5e-25  Score=192.37  Aligned_cols=153  Identities=31%  Similarity=0.475  Sum_probs=131.9

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-----------------CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcce
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVR  183 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~  183 (290)
                      .++|+..+.||+|+||.||++...+                 +..||+|.+.... .....++.+|+.++.+++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578999999999999999997643                 2458999887543 234567899999999999999999


Q ss_pred             eEEEEEeCCeeEEEEEecCCCChhhhhhCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCC
Q 022887          184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPK--------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN  255 (290)
Q Consensus       184 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~N  255 (290)
                      +++++...+..++++||+++++|..++....        ....+++...+.++.|++.||.|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999885432        1236899999999999999999999887   9999999999


Q ss_pred             EEEcCCCCeEEeeccCceeeCC
Q 022887          256 ILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       256 ill~~~~~~kl~DfGla~~~~~  277 (290)
                      |++++++.++|+|||+++.+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             eeecCCCceEEccccceeeccc
Confidence            9999999999999999986543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=8e-27  Score=177.41  Aligned_cols=148  Identities=28%  Similarity=0.463  Sum_probs=127.2

Q ss_pred             CCCccceecccCCccEEEEEEcC-CcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|...++||+|.||+||+|+..+ ++.||+|++.-.  .........+|+-+++.++|+|||++++..-.++..-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            46667899999999999998754 788999988633  333456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +.. .|..+...  -+..++.+....++.|+++||.|+|+..   +.|||+||.|.|++.+|..|++|||+|+.++-
T Consensus        83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            965 55555432  3456888999999999999999999988   99999999999999999999999999998864

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.93  E-value=1.1e-25  Score=190.71  Aligned_cols=150  Identities=32%  Similarity=0.536  Sum_probs=130.9

Q ss_pred             cCCCccceecccCCccEEEEEEcC-C---cEEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++|+..+.||+|+||.||+|.... +   ..||||.+... ......+|..|+..+..++||||+++.+++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357788999999999999998743 2   36999998754 233456899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|..++...  ...+++.++..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999988532  345899999999999999999999887   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.93  E-value=8.8e-26  Score=193.59  Aligned_cols=155  Identities=30%  Similarity=0.507  Sum_probs=132.8

Q ss_pred             HHhcCCCccceecccCCccEEEEEEcC------CcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeC
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ  191 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  191 (290)
                      ...++|+..+.||+|+||.||++...+      ...+|+|.+.... .....++.+|+.++.++ +||||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            344678889999999999999997632      3579999887532 23345788999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE
Q 022887          192 GENILIYEYMPNKSLDVFLFYP-------------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  258 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill  258 (290)
                      +..+++|||+++|+|..++...             .....+++..++.++.|++.||.|||+.+   ++||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence            9999999999999999987532             22456899999999999999999999887   9999999999999


Q ss_pred             cCCCCeEEeeccCceeeCC
Q 022887          259 DSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       259 ~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++.+||+|||+++.+..
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~  184 (293)
T cd05053         166 TEDHVMKIADFGLARDIHH  184 (293)
T ss_pred             cCCCeEEeCcccccccccc
Confidence            9999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.93  E-value=4.4e-26  Score=199.46  Aligned_cols=154  Identities=29%  Similarity=0.457  Sum_probs=128.5

Q ss_pred             HhcCCCccceecccCCccEEEEEEc------CCcEEEEEEeccccc-cCHHHHHHHHHHHccc-CCCCcceeEEEEEeC-
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ-  191 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-  191 (290)
                      +.++|++.+.||+|+||.||+|...      +++.||+|++..... .....+..|+.++.++ +||||++++++|... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3457999999999999999999642      246899999864322 2345678899999999 899999999988765 


Q ss_pred             CeeEEEEEecCCCChhhhhhCCCC--------------------------------------------------------
Q 022887          192 GENILIYEYMPNKSLDVFLFYPKK--------------------------------------------------------  215 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  215 (290)
                      ...++++||+++++|..++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            467899999999999988743211                                                        


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          216 --KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       216 --~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                        ...++|..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~  225 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK  225 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence              136899999999999999999999887   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.93  E-value=1.6e-25  Score=192.61  Aligned_cols=151  Identities=26%  Similarity=0.405  Sum_probs=134.7

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ..++|+..+.||+|+||.||++.. .+++.||+|.+..........+..|+.++..++|||++++++++...+..++|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            346899999999999999999986 4688999999876544455678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+++++|..++.    ...+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....+
T Consensus        97 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          97 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             ccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            999999999873    235788999999999999999999887   999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.93  E-value=1.4e-25  Score=194.87  Aligned_cols=141  Identities=30%  Similarity=0.389  Sum_probs=122.8

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||++... +++.||+|.+....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 47899999987532   23345677888888777 799999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            999887742   346899999999999999999999887   999999999999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.93  E-value=1.4e-25  Score=191.30  Aligned_cols=151  Identities=34%  Similarity=0.558  Sum_probs=131.5

Q ss_pred             cCCCccceecccCCccEEEEEEc------CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++|...++||+|+||.||++...      ++..+|+|.+..........+..|+.++..++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46777899999999999999642      345789998876555556789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCe
Q 022887          197 IYEYMPNKSLDVFLFYPKK------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  264 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~  264 (290)
                      +|||+++++|.+++.....            ...+++.+++.++.|++.|++|||+.+   ++|+||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999998754221            135889999999999999999999887   9999999999999999999


Q ss_pred             EEeeccCceeeC
Q 022887          265 KISDFGMARIFG  276 (290)
Q Consensus       265 kl~DfGla~~~~  276 (290)
                      ||+|||+++...
T Consensus       162 kL~dfg~~~~~~  173 (280)
T cd05092         162 KIGDFGMSRDIY  173 (280)
T ss_pred             EECCCCceeEcC
Confidence            999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.93  E-value=1.5e-25  Score=193.75  Aligned_cols=149  Identities=27%  Similarity=0.329  Sum_probs=129.7

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++.+++||||+++++.+..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999874 47788899886432 22345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++++|..++..   ...+++.....++.|++.||.|||+..  +++|+||||+||++++++.+||+|||++..+.
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            999999999843   355889999999999999999999731  39999999999999999999999999997653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.93  E-value=1.4e-25  Score=189.35  Aligned_cols=151  Identities=30%  Similarity=0.504  Sum_probs=133.0

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .+|+..+.||+|+||.||+|... .++.||+|.+... .....++..|+..+.+++||||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            46778899999999999999874 4788999988653 334568899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++++|.+++... ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.....
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            999999987432 2345899999999999999999999887   999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.93  E-value=8.2e-26  Score=192.83  Aligned_cols=152  Identities=34%  Similarity=0.512  Sum_probs=129.5

Q ss_pred             cCCCccceecccCCccEEEEEEcC------CcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~------~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      .+|...+.||+|+||.||+|...+      +..||+|.+...... ....+..|+.++..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            357778899999999999998632      468999999754322 2456889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC
Q 022887          196 LIYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~  262 (290)
                      +++||+++++|..++....             ....+++.....++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            9999999999998874221             1235788999999999999999999887   99999999999999999


Q ss_pred             CeEEeeccCceeeCC
Q 022887          263 NPKISDFGMARIFGG  277 (290)
Q Consensus       263 ~~kl~DfGla~~~~~  277 (290)
                      .+||+|||+++....
T Consensus       162 ~~kl~Dfg~~~~~~~  176 (283)
T cd05091         162 NVKISDLGLFREVYA  176 (283)
T ss_pred             ceEeccccccccccc
Confidence            999999999986643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.8e-25  Score=188.42  Aligned_cols=152  Identities=36%  Similarity=0.540  Sum_probs=135.6

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ..++|...+.||+|+||.||++...++..+|||.+... .....++.+|+..+.+++|||++++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            34688999999999999999999877889999998753 23457899999999999999999999999988899999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|.+++... ....+++.++..++.|++.|+.|||+.+   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence            9999999988542 2346899999999999999999999887   99999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.2e-25  Score=191.04  Aligned_cols=153  Identities=29%  Similarity=0.468  Sum_probs=131.7

Q ss_pred             hcCCCccceecccCCccEEEEEEcC------CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      .++|...+.||+|+||.||+|...+      +..||+|.+.... ......+.+|+.++..++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4688889999999999999997642      3689999986432 23345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEe
Q 022887          195 ILIYEYMPNKSLDVFLFYPKK-------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                      ++||||+++++|..++.....       ...++|.....++.|++.||.|||+.+   ++||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999998854321       234789999999999999999999877   9999999999999999999999


Q ss_pred             eccCceeeCC
Q 022887          268 DFGMARIFGG  277 (290)
Q Consensus       268 DfGla~~~~~  277 (290)
                      |||+++.+..
T Consensus       162 dfg~~~~~~~  171 (277)
T cd05032         162 DFGMTRDIYE  171 (277)
T ss_pred             Ccccchhhcc
Confidence            9999986644

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.93  E-value=1.7e-25  Score=190.63  Aligned_cols=154  Identities=29%  Similarity=0.468  Sum_probs=132.3

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC-----CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEe-CCe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGE  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  193 (290)
                      ..++|...+.||+|+||.||+|...+     +..|++|.+.... ......+.+|+.++.+++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35688889999999999999998755     6789999886432 2335678899999999999999999999876 467


Q ss_pred             eEEEEEecCCCChhhhhhCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEee
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKK-----RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  268 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  268 (290)
                      .++++||+++++|..++......     ..+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999988543322     56899999999999999999999877   99999999999999999999999


Q ss_pred             ccCceeeCC
Q 022887          269 FGMARIFGG  277 (290)
Q Consensus       269 fGla~~~~~  277 (290)
                      ||+++.+..
T Consensus       161 ~g~~~~~~~  169 (280)
T cd05043         161 NALSRDLFP  169 (280)
T ss_pred             CCCcccccC
Confidence            999987643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.93  E-value=2.7e-25  Score=189.73  Aligned_cols=149  Identities=34%  Similarity=0.542  Sum_probs=129.9

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|++|.||+|... ++..||+|.+....  ......+..|+.++..++|||++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999874 58899999886432  22346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ++ ++|..++........+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++...
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            97 578777654344466899999999999999999999887   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.93  E-value=2.1e-25  Score=190.66  Aligned_cols=148  Identities=28%  Similarity=0.345  Sum_probs=128.8

Q ss_pred             CCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      |+..+.||+|+||+||++... +++.+|+|.+....   ......+..|+.++..++|+|++++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            666789999999999999874 57899999986432   12234578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++++|..++... ....+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            9999998877532 2346899999999999999999999887   9999999999999999999999999997664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.8e-25  Score=187.90  Aligned_cols=150  Identities=30%  Similarity=0.524  Sum_probs=133.7

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|+||.||++... ++.||+|.+..... ..+.+.+|+.++..++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            457888999999999999999874 78999999976433 4678999999999999999999999999989999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++|.+++... ....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++....
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccc
Confidence            999999988532 2236899999999999999999999887   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.93  E-value=2.6e-25  Score=189.46  Aligned_cols=145  Identities=27%  Similarity=0.410  Sum_probs=127.6

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+... ......++..|+.++.+++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999986 46789999988643 223346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|..+.       .+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            9999987542       3678888999999999999999887   99999999999999999999999999987644

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.93  E-value=1.3e-25  Score=202.96  Aligned_cols=150  Identities=23%  Similarity=0.419  Sum_probs=121.9

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--------
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--------  191 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  191 (290)
                      ..++|+..+.||+|+||.||+|... +++.||||++....    ....+|+.++..++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999874 57899999885422    2345799999999999999999886532        


Q ss_pred             CeeEEEEEecCCCChhhhhh-CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-CeEEeec
Q 022887          192 GENILIYEYMPNKSLDVFLF-YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDF  269 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Df  269 (290)
                      ...++||||+++ ++..++. .......+++.....++.|++.||.|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            135689999986 5554443 2234456899999999999999999999987   99999999999999665 7999999


Q ss_pred             cCceeeCCC
Q 022887          270 GMARIFGGD  278 (290)
Q Consensus       270 Gla~~~~~~  278 (290)
                      |+|+.+...
T Consensus       216 Gla~~~~~~  224 (440)
T PTZ00036        216 GSAKNLLAG  224 (440)
T ss_pred             ccchhccCC
Confidence            999877543

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.93  E-value=2e-25  Score=191.90  Aligned_cols=149  Identities=26%  Similarity=0.407  Sum_probs=133.4

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ..+|+..+.||+|+||.||+|.. .+++.|++|.+..........+..|+.++..+.|||++++++.+...+..++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            35889999999999999999986 45789999998765555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|..++.    ...+++.+...++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            99999999873    234789999999999999999999887   99999999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.93  E-value=1.6e-25  Score=193.18  Aligned_cols=151  Identities=34%  Similarity=0.561  Sum_probs=128.7

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCc--EEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQ--EVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||+|.+. ++.  .+++|.+.... ......+.+|+.++.++ +||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888899999999999999874 343  46788776432 23346788999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC
Q 022887          197 IYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  263 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~  263 (290)
                      ||||+++++|..++....             ....+++.+.+.++.|++.||+|||+.+   ++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999885432             1235889999999999999999999887   999999999999999999


Q ss_pred             eEEeeccCceee
Q 022887          264 PKISDFGMARIF  275 (290)
Q Consensus       264 ~kl~DfGla~~~  275 (290)
                      +||+|||+++..
T Consensus       163 ~kl~dfg~~~~~  174 (303)
T cd05088         163 AKIADFGLSRGQ  174 (303)
T ss_pred             EEeCccccCccc
Confidence            999999999643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=1.7e-25  Score=188.15  Aligned_cols=142  Identities=31%  Similarity=0.501  Sum_probs=122.3

Q ss_pred             ceecccCCccEEEEEEcCCc-----------EEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          129 CKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.++..++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999885433           5788877644332 6789999999999999999999999988 778999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-------CeEEeecc
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-------NPKISDFG  270 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-------~~kl~DfG  270 (290)
                      |||+++|+|..++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999988542  226889999999999999999999877   99999999999999887       79999999


Q ss_pred             CceeeCC
Q 022887          271 MARIFGG  277 (290)
Q Consensus       271 la~~~~~  277 (290)
                      ++.....
T Consensus       154 ~a~~~~~  160 (259)
T cd05037         154 IPITVLS  160 (259)
T ss_pred             ccccccc
Confidence            9987543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.93  E-value=2.7e-25  Score=188.31  Aligned_cols=150  Identities=31%  Similarity=0.548  Sum_probs=127.2

Q ss_pred             CCccceecccCCccEEEEEEcC----CcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe-----
Q 022887          125 FSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-----  193 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  193 (290)
                      |...+.||+|+||.||+|....    +..||+|.++....  .....+..|+..+..++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998642    36799999875322  234678999999999999999999999876554     


Q ss_pred             -eEEEEEecCCCChhhhhhCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeec
Q 022887          194 -NILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  269 (290)
Q Consensus       194 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  269 (290)
                       .++++||+++|+|..++....   ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             689999999999998875432   2346899999999999999999999887   999999999999999999999999


Q ss_pred             cCceeeCC
Q 022887          270 GMARIFGG  277 (290)
Q Consensus       270 Gla~~~~~  277 (290)
                      |+++....
T Consensus       158 g~~~~~~~  165 (273)
T cd05035         158 GLSKKIYS  165 (273)
T ss_pred             cceeeccc
Confidence            99987643

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.93  E-value=1.2e-25  Score=190.05  Aligned_cols=149  Identities=27%  Similarity=0.488  Sum_probs=133.0

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|+..+.||+|+||.||+|... +++.||+|.++.........+.+|+.++..++||||+++++.+...+..++|+||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            357888899999999999999874 5789999998765444556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++++|.+++..   ...+++.+...++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+.
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            999999998742   346889999999999999999999887   9999999999999999999999999997664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=1.7e-25  Score=191.08  Aligned_cols=150  Identities=33%  Similarity=0.552  Sum_probs=129.7

Q ss_pred             cCCCccceecccCCccEEEEEE-----cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--Cee
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GEN  194 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  194 (290)
                      +.|...+.||+|+||.||.+.+     .++..||+|.+.... ......+.+|+.+++.++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4568889999999999999974     346789999987543 33346799999999999999999999998875  567


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||+++++|..++...  ...+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999987432  235899999999999999999999887   99999999999999999999999999987


Q ss_pred             eCC
Q 022887          275 FGG  277 (290)
Q Consensus       275 ~~~  277 (290)
                      +..
T Consensus       159 ~~~  161 (284)
T cd05079         159 IET  161 (284)
T ss_pred             ccc
Confidence            654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.93  E-value=2.3e-25  Score=189.72  Aligned_cols=150  Identities=32%  Similarity=0.520  Sum_probs=128.3

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCc----EEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      .++|+..+.||+|+||.||+|.+. ++.    .||+|.+.... .....++.+|+..+..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            357888899999999999999863 343    48999886533 2335678899999999999999999999875 4578


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +++||+++|+|.+++...  ...+++...+.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999887432  345899999999999999999999887   999999999999999999999999999887


Q ss_pred             CC
Q 022887          276 GG  277 (290)
Q Consensus       276 ~~  277 (290)
                      ..
T Consensus       160 ~~  161 (279)
T cd05109         160 DI  161 (279)
T ss_pred             cc
Confidence            54

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.93  E-value=3.3e-25  Score=189.17  Aligned_cols=150  Identities=30%  Similarity=0.434  Sum_probs=131.4

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+..+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++..++|||++++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999885 58899999886432  2234568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |++++++..+..   ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            999998887763   2345899999999999999999999877   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.93  E-value=3.1e-25  Score=187.55  Aligned_cols=152  Identities=24%  Similarity=0.456  Sum_probs=132.2

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||+|... +++.||||.+....   ......+..|+.++..++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999874 68899999875422   223457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++++|..++... .....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999998877432 22345788999999999999999999887   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.1e-25  Score=191.84  Aligned_cols=150  Identities=28%  Similarity=0.437  Sum_probs=134.1

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|++.+.||+|+||.||++... ++..+|+|.+..........+..|+.++.+++|||++++++.+..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467899999999999999999874 5789999998765555567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++++|..++..  ....+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            999999988743  2346899999999999999999999987   9999999999999999999999999987653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=1.9e-25  Score=188.63  Aligned_cols=143  Identities=27%  Similarity=0.423  Sum_probs=122.3

Q ss_pred             ceecccCCccEEEEEEcC-------------CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          129 CKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      +.||+|+||.||+|.+.+             ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2258899887654445567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC-------eEEee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-------PKISD  268 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~-------~kl~D  268 (290)
                      +||||+++++|+.++..  ....+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988743  2345899999999999999999999887   999999999999987664       89999


Q ss_pred             ccCceeeC
Q 022887          269 FGMARIFG  276 (290)
Q Consensus       269 fGla~~~~  276 (290)
                      ||++..+.
T Consensus       156 ~g~~~~~~  163 (262)
T cd05077         156 PGIPITVL  163 (262)
T ss_pred             CCCCcccc
Confidence            99997654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=1.3e-25  Score=200.34  Aligned_cols=145  Identities=23%  Similarity=0.350  Sum_probs=126.1

Q ss_pred             hcCCCccceecccCCccEEEEEEc---CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..+|...+.||+|+||.||++...   .+..||+|.+...     ..+.+|+.++..++||||+++++++...+..+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   3567999987642     24568999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |++. ++|..++   .....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 5676666   23456899999999999999999999887   999999999999999999999999999877554

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.93  E-value=2.3e-25  Score=188.55  Aligned_cols=155  Identities=28%  Similarity=0.429  Sum_probs=132.0

Q ss_pred             HHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      +.+++++.....||+|+||.||+|... ++..|++|.+..........+.+|+.++..++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345566666779999999999999864 5778999988765555567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-CCCeEEeeccCceeeC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFG  276 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~  276 (290)
                      +||+++++|..++.........++.....++.|++.||.|||+.+   |+||||||+||+++. ++.++|+|||++..+.
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999998854322212277888899999999999999887   999999999999976 6799999999998664

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.93  E-value=3.4e-25  Score=186.72  Aligned_cols=150  Identities=37%  Similarity=0.536  Sum_probs=132.1

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|+||.||+|...+++.||+|.+.... .....+.+|+.++.+++|||++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            46788899999999999999998888999999987533 34568999999999999999999998864 56789999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++|.+++... ....+++.+...++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++..+..
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            999999887543 2346899999999999999999999877   99999999999999999999999999987763

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.93  E-value=3.5e-25  Score=185.46  Aligned_cols=144  Identities=33%  Similarity=0.479  Sum_probs=126.8

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCChh
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD  207 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  207 (290)
                      +.||+|+||.||+|...++..+|+|.+..... .....+.+|+..+..++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988888999998875432 22356889999999999999999999999999999999999999999


Q ss_pred             hhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          208 VFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       208 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      .++...  ...+++.....++.|++.||.|+|+.+   ++|+||||+||++++++.+||+|||++.....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccc
Confidence            887432  345789999999999999999999887   99999999999999999999999999976543

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.93  E-value=2.2e-25  Score=191.63  Aligned_cols=150  Identities=31%  Similarity=0.539  Sum_probs=128.1

Q ss_pred             cCCCccceecccCCccEEEEEEcC-Cc--EEEEEEeccc-cccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++|+..+.||+|+||.||+|...+ +.  .+++|.++.. .......+..|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578888999999999999998744 32  4788887642 223456789999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhhCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCe
Q 022887          198 YEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  264 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~  264 (290)
                      +||+++++|.+++....             ....+++.....++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999885321             1235889999999999999999999877   9999999999999999999


Q ss_pred             EEeeccCceee
Q 022887          265 KISDFGMARIF  275 (290)
Q Consensus       265 kl~DfGla~~~  275 (290)
                      ||+|||++...
T Consensus       159 kl~dfg~~~~~  169 (297)
T cd05089         159 KIADFGLSRGE  169 (297)
T ss_pred             EECCcCCCccc
Confidence            99999998643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.93  E-value=4.2e-25  Score=188.07  Aligned_cols=143  Identities=27%  Similarity=0.389  Sum_probs=123.4

Q ss_pred             ecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       131 ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      ||+|+||.||++... +++.+|+|.+....   ......+..|++++.+++||||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999874 58899999986422   12234566799999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ..++... ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++..+..
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            8877432 2345889999999999999999999887   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=1.2e-25  Score=191.98  Aligned_cols=152  Identities=25%  Similarity=0.396  Sum_probs=131.8

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|+||.||++... ++..||+|.+... .......+.+|+.++.+++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999885 5889999988643 223346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++++|..++........+++.....++.|++.||.|||++.  +++|+||||+||++++++.+||+|||++..+.
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            999999888754323346899999999999999999999741  39999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.93  E-value=2.3e-25  Score=190.02  Aligned_cols=148  Identities=28%  Similarity=0.442  Sum_probs=130.7

Q ss_pred             CCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      -|+..+.||+|+||.||++.... +..+++|.+..........+..|+.++..++|||++++++++...+..++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            35777899999999999998754 67889998876554556788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++|..++..  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence            9999887643  2346899999999999999999999887   9999999999999999999999999997653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.93  E-value=3.7e-25  Score=186.50  Aligned_cols=150  Identities=33%  Similarity=0.515  Sum_probs=131.5

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|+||.||++...++..+|+|.+..... ....+.+|+.++.+++|||++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            357888999999999999999988888999999875332 3567999999999999999999999875 45689999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++|.+++... ....+++.++..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++..+..
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            999999988542 2345899999999999999999999887   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.93  E-value=3.3e-25  Score=189.11  Aligned_cols=146  Identities=38%  Similarity=0.563  Sum_probs=126.2

Q ss_pred             CCccceecccCCccEEEEEE-----cCCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEE
Q 022887          125 FSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENIL  196 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  196 (290)
                      |...+.||+|+||.||++..     .++..||+|.+..... .....+.+|+.++..++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37789999999999988653     3567899999875432 3456788999999999999999999988764  35789


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +|||+++++|.+++..    ..+++.++..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999998842    34899999999999999999999887   9999999999999999999999999998775


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       159 ~  159 (283)
T cd05080         159 E  159 (283)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.93  E-value=3e-25  Score=190.25  Aligned_cols=149  Identities=32%  Similarity=0.500  Sum_probs=133.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .+.|+..+.||+|+||.||+|.... +..+++|.+..........+..|+.++..++|||++++++.+..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            3678899999999999999998754 789999998765555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +++++|..++..  ....+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence            999999887643  2345899999999999999999999877   999999999999999999999999998764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.93  E-value=2.6e-25  Score=190.58  Aligned_cols=150  Identities=32%  Similarity=0.437  Sum_probs=132.6

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++... +++.+|+|.+....   ......+.+|++++.+++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888899999999999999875 57899999886432   233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999988743   356889999999999999999999877   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=2.2e-25  Score=188.87  Aligned_cols=142  Identities=27%  Similarity=0.432  Sum_probs=120.0

Q ss_pred             eecccCCccEEEEEEcCC---cEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCC
Q 022887          130 KLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKS  205 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~~~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  205 (290)
                      .||+|+||.||++...++   ..+++|.+.... ......+.+|+..+..++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999976443   345677665432 2345689999999999999999999999999999999999999999


Q ss_pred             hhhhhhCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          206 LDVFLFYPKK-KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       206 L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      |..++..... ....++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence            9998854322 234667778899999999999999877   99999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.93  E-value=2.1e-25  Score=192.70  Aligned_cols=152  Identities=31%  Similarity=0.518  Sum_probs=130.7

Q ss_pred             hcCCCccceecccCCccEEEEEEcC--------CcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeC
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ  191 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  191 (290)
                      .++|...+.||+|+||.||++...+        ...+|+|.+.... .....++..|+.++..+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4679999999999999999997522        2469999887532 23346788899999999 799999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE
Q 022887          192 GENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  258 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill  258 (290)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999854321             235899999999999999999999877   9999999999999


Q ss_pred             cCCCCeEEeeccCceeeC
Q 022887          259 DSDMNPKISDFGMARIFG  276 (290)
Q Consensus       259 ~~~~~~kl~DfGla~~~~  276 (290)
                      ++++.+||+|||+++.+.
T Consensus       174 ~~~~~~kL~dfg~a~~~~  191 (307)
T cd05098         174 TEDNVMKIADFGLARDIH  191 (307)
T ss_pred             cCCCcEEECCCccccccc
Confidence            999999999999998664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.93  E-value=2e-26  Score=185.68  Aligned_cols=156  Identities=30%  Similarity=0.426  Sum_probs=134.5

Q ss_pred             HHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc----ccC----HHHHHHHHHHHccc-CCCCcceeEEEE
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS----GQG----LTEFKNEMMLIAKL-QHRHLVRLFGCC  188 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~----~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~  188 (290)
                      ...-++|...+.+|+|..+.|-++.. .++.+.|+|++....    ...    .++-.+|+.+|.++ .||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            34456888889999999999998866 458899999885321    111    34457889999988 599999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEee
Q 022887          189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  268 (290)
Q Consensus       189 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  268 (290)
                      ..+.-.++|+|.|+.|.|.++|.   +...++++...+|+.|+..|++|||..+   |+||||||+|||+|++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            99999999999999999999983   4567899999999999999999999988   99999999999999999999999


Q ss_pred             ccCceeeCCCcc
Q 022887          269 FGMARIFGGDEL  280 (290)
Q Consensus       269 fGla~~~~~~~~  280 (290)
                      ||+|+.+.+++.
T Consensus       167 FGFa~~l~~Gek  178 (411)
T KOG0599|consen  167 FGFACQLEPGEK  178 (411)
T ss_pred             cceeeccCCchh
Confidence            999999987753

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=3.1e-25  Score=195.64  Aligned_cols=144  Identities=24%  Similarity=0.313  Sum_probs=124.5

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ...+|...+.||+|+||.||+|.... +..||+|.....      ....|+.++.+++||||+++++++...+..++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            34679999999999999999998754 678999975432      23568999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |+. ++|..++..  ....+++..+..|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            995 577766633  3456899999999999999999999887   9999999999999999999999999998543

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.93  E-value=1.5e-25  Score=188.52  Aligned_cols=145  Identities=34%  Similarity=0.543  Sum_probs=127.8

Q ss_pred             CCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCH--HHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          125 FSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      |+..+.||+|+||.||++.... ++.+|+|.+........  .....|+..+.+++||||+++++++...+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999998855 56899999976543322  23456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ++++|..++.   ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||.+...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            9999999885   3456899999999999999999999987   999999999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.93  E-value=5.1e-25  Score=185.67  Aligned_cols=150  Identities=33%  Similarity=0.517  Sum_probs=130.2

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      ++|...+.||+|+||.||++.+.++..+|+|.+.... .....+..|+.++.+++|||++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4688889999999999999998777789999886532 34567899999999999999999998875 456899999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.+...
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            99999988542 2345789999999999999999999877   999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.2e-25  Score=194.55  Aligned_cols=139  Identities=27%  Similarity=0.358  Sum_probs=117.6

Q ss_pred             ecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHHHccc---CCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKL---QHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       131 ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      ||+|+||.||+|+.. +++.||+|.+.....   .....+..|..++...   +||||+++++.+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999874 588999999864321   1223444565665544   699999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+|..++.   ....+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            99988774   2345889999999999999999999987   999999999999999999999999999764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.93  E-value=2.7e-25  Score=188.76  Aligned_cols=150  Identities=31%  Similarity=0.459  Sum_probs=131.1

Q ss_pred             cCCCccceecccCCccEEEEEEc------CCcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      ++|+..+.||+|+||.||+|+..      +...+++|.+...... ...++..|+.++.+++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999863      2457999988654433 3568999999999999999999999999989999


Q ss_pred             EEEEecCCCChhhhhhCCCCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeec
Q 022887          196 LIYEYMPNKSLDVFLFYPKKK------RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  269 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  269 (290)
                      +||||+++|+|.+++......      ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999988543321      25899999999999999999999887   999999999999999999999999


Q ss_pred             cCceee
Q 022887          270 GMARIF  275 (290)
Q Consensus       270 Gla~~~  275 (290)
                      |+++..
T Consensus       162 ~~~~~~  167 (275)
T cd05046         162 SLSKDV  167 (275)
T ss_pred             cccccc
Confidence            998754

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.93  E-value=3.2e-25  Score=187.61  Aligned_cols=151  Identities=32%  Similarity=0.565  Sum_probs=131.5

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-C---cEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||+|.... +   ..+|+|.+.... ......+..|+.++.+++|||++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3578888999999999999998743 3   368999886542 2335678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++++|..++..  ....+++.++..++.|++.|++|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999998843  2346899999999999999999999887   9999999999999999999999999998765


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       159 ~  159 (268)
T cd05063         159 D  159 (268)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.93  E-value=4.4e-25  Score=185.31  Aligned_cols=151  Identities=29%  Similarity=0.452  Sum_probs=133.0

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|++|.||++... +++.|++|.+...  ......++..|+.+++.++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777889999999999999874 5789999988643  233457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|.+++... ....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999988543 2456889999999999999999999877   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.93  E-value=4.5e-25  Score=185.35  Aligned_cols=149  Identities=32%  Similarity=0.469  Sum_probs=131.0

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-----ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     ....+.+..|+.++..++|||++++.+++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999886 68899999886432     12446789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999998843   345889999999999999999999887   99999999999999999999999999987654


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       155 ~  155 (258)
T cd06632         155 F  155 (258)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.93  E-value=2.9e-25  Score=188.23  Aligned_cols=152  Identities=30%  Similarity=0.481  Sum_probs=131.0

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeC------C
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ------G  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~  192 (290)
                      +++.|+..+.||+|+||.||+|... +++.||+|.+... ......+..|+.++.++ +|||++++++++...      +
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            5678888999999999999999874 4788999988653 34456788999999988 699999999998763      3


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..+++|||+++++|..++... ....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            578999999999999987542 2346889999999999999999999987   999999999999999999999999999


Q ss_pred             eeeCC
Q 022887          273 RIFGG  277 (290)
Q Consensus       273 ~~~~~  277 (290)
                      +.+..
T Consensus       159 ~~~~~  163 (272)
T cd06637         159 AQLDR  163 (272)
T ss_pred             eeccc
Confidence            87643

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.93  E-value=5.8e-25  Score=185.70  Aligned_cols=152  Identities=26%  Similarity=0.446  Sum_probs=133.9

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||+|... +++.||+|.++..   .......+.+|++++.+++|+|++++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999886 6889999988632   2233568899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++++|..++... .....+++.+...++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999887532 23456899999999999999999999887   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.93  E-value=4.7e-25  Score=188.57  Aligned_cols=150  Identities=29%  Similarity=0.351  Sum_probs=129.2

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .|+..+.||+|+||.||++... +++.+|+|.+.....   .....+..|+.++.+++|+|++++++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3667789999999999999874 578999998864322   223457789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |+++++|..++... ....+++.+...++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.....
T Consensus        81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            99999999887532 2245889999999999999999999877   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.93  E-value=3e-25  Score=189.84  Aligned_cols=152  Identities=31%  Similarity=0.518  Sum_probs=131.5

Q ss_pred             hcCCCccceecccCCccEEEEEEc------CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      .++|+..+.||+|+||.||++...      ++..||+|.+.... .....++..|+.++.+++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999863      35789999886532 23346789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCC
Q 022887          195 ILIYEYMPNKSLDVFLFYPK-------------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN  255 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~N  255 (290)
                      ++++||+++|+|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999885321                   1235788999999999999999999887   9999999999


Q ss_pred             EEEcCCCCeEEeeccCceeeC
Q 022887          256 ILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       256 ill~~~~~~kl~DfGla~~~~  276 (290)
                      |++++++.+||+|||+++.+.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~  181 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIY  181 (288)
T ss_pred             eEecCCCceEECccccceecc
Confidence            999999999999999998653

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=2.2e-26  Score=203.73  Aligned_cols=156  Identities=31%  Similarity=0.469  Sum_probs=129.0

Q ss_pred             ccceecccCCccEEEEEEc-CCcEEEEEEec----cccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe--eEEEEE
Q 022887          127 TQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE--NILIYE  199 (290)
Q Consensus       127 ~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  199 (290)
                      ..+.||+|+|-+||+|.+. +|-+||=-.++    ...+.....|..|+.+|+.|+||||++++..|.+..+  .-+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4478999999999999874 36667622221    1234456789999999999999999999999998766  678999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-CCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~~~  278 (290)
                      .|..|+|..|+.   ..+..+......|+.||++||.|||++. +||||||||.+||+|+. -|.|||+|+|||.+....
T Consensus       124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999984   4456788899999999999999999985 78999999999999985 579999999999988655


Q ss_pred             ccccCcceeecC
Q 022887          279 ELQGNTKRIVGT  290 (290)
Q Consensus       279 ~~~~~~~~~~Gt  290 (290)
                      ..    ..++||
T Consensus       200 ~a----ksvIGT  207 (632)
T KOG0584|consen  200 HA----KSVIGT  207 (632)
T ss_pred             cc----ceeccC
Confidence            42    346777

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.93  E-value=2.9e-25  Score=191.39  Aligned_cols=152  Identities=31%  Similarity=0.452  Sum_probs=131.1

Q ss_pred             hcCCCccceecccCCccEEEEEEc------CCcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  193 (290)
                      .++|...+.||+|+||.||++...      .+..||+|.++... ......+..|+.++.++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357888999999999999999742      24579999887543 23345789999999999 79999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .+++|||+++|+|..++.... ...+++.+...++.|++.||.|||+++   ++|+||||+||++++++.+|++|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999885322 234899999999999999999999887   9999999999999999999999999998


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      .+..
T Consensus       190 ~~~~  193 (302)
T cd05055         190 DIMN  193 (302)
T ss_pred             cccC
Confidence            6643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=5.5e-25  Score=185.53  Aligned_cols=149  Identities=32%  Similarity=0.499  Sum_probs=130.8

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc-----cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-----QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++|...+.||+|++|.||++.. .++.++|+|.+.....     .....+.+|+.++.+++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999986 4588999998864321     123578899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |+||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+.
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999988743   345788999999999999999999887   9999999999999999999999999998664


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       156 ~  156 (263)
T cd06625         156 T  156 (263)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.93  E-value=4.9e-25  Score=189.44  Aligned_cols=148  Identities=31%  Similarity=0.458  Sum_probs=129.9

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccccc-----CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      +|+..+.||+|+||.||+|... +++.||||.+......     ....+..|+.++.+++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999874 5889999999754322     234677899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+ +++|..++....  ..+++.....++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899998884322  36899999999999999999999887   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.93  E-value=6.5e-25  Score=184.49  Aligned_cols=147  Identities=39%  Similarity=0.599  Sum_probs=130.2

Q ss_pred             ceecccCCccEEEEEEcC----CcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||++....    +..+++|.+...... ....+..|+..+..++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998754    778999999764433 367899999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          204 KSLDVFLFYPKK------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       204 g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++|.+++.....      ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999854321      367899999999999999999999877   99999999999999999999999999988765


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       158 ~  158 (262)
T cd00192         158 D  158 (262)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.93  E-value=5.5e-25  Score=185.30  Aligned_cols=143  Identities=33%  Similarity=0.527  Sum_probs=122.5

Q ss_pred             eecccCCccEEEEEEc---CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCC
Q 022887          130 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKS  205 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  205 (290)
                      .||+|+||.||+|.+.   ++..||+|.+..... ....++.+|+.++.+++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999763   345699998875432 23467899999999999999999999875 457899999999999


Q ss_pred             hhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          206 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       206 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |.+++..  ....+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+..+
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  148 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence            9998743  2346899999999999999999999887   999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=4.7e-25  Score=187.84  Aligned_cols=149  Identities=34%  Similarity=0.567  Sum_probs=129.1

Q ss_pred             cCCCccceecccCCccEEEEEEcC-Cc----EEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .+|+..+.||+|+||.||+|.+.+ +.    .+|+|.+..... ....++.+|+..+.+++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            578888999999999999998643 32    589998865432 334678899999999999999999999987 78899


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |+||+++|+|.+++...  ...+++.....++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999988532  335899999999999999999999877   9999999999999999999999999998775


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       161 ~  161 (279)
T cd05057         161 V  161 (279)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.93  E-value=2.9e-25  Score=190.86  Aligned_cols=150  Identities=25%  Similarity=0.430  Sum_probs=134.1

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ..+|+..+.||.|+||.||+|.. .+++.|++|.+..........+.+|+..+..++|||++++++++...+..++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            35789999999999999999986 56889999998765545567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|..++.    ...+++.++..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++..+..+
T Consensus        98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            99999998873    235899999999999999999999887   999999999999999999999999999876443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.93  E-value=3.4e-25  Score=195.54  Aligned_cols=148  Identities=29%  Similarity=0.383  Sum_probs=124.8

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-----
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  192 (290)
                      ..++|+..+.||+|+||.||++... ++..||+|.+...  .......+.+|+.++..++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999874 5889999998643  2233567889999999999999999999987543     


Q ss_pred             -eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccC
Q 022887          193 -ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       193 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl  271 (290)
                       ..++||||++++ +...+.     ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             468999999765 444431     23788889999999999999999987   99999999999999999999999999


Q ss_pred             ceeeCC
Q 022887          272 ARIFGG  277 (290)
Q Consensus       272 a~~~~~  277 (290)
                      ++....
T Consensus       170 a~~~~~  175 (359)
T cd07876         170 ARTACT  175 (359)
T ss_pred             cccccc
Confidence            986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.93  E-value=8e-25  Score=183.90  Aligned_cols=151  Identities=24%  Similarity=0.386  Sum_probs=132.7

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|+||.||.++. .+++.+++|.+...  ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578889999999999999976 45788999987643  234456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|.+++.... ...+++.+...++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            99999999885432 346899999999999999999999887   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.93  E-value=5.2e-25  Score=189.68  Aligned_cols=148  Identities=29%  Similarity=0.450  Sum_probs=128.5

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+..+..++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57889999999999999999874 57899999886432 23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ++ ++|..++..  ....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++...
T Consensus        86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            97 578777643  2345789999999999999999999887   9999999999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.93  E-value=2.6e-25  Score=188.06  Aligned_cols=152  Identities=25%  Similarity=0.456  Sum_probs=132.7

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++.. .++..+|||.+....   .....++.+|+.++..++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999986 568899999876422   223467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++++|.+++... .....+++.+...++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999887532 23456899999999999999999999887   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.93  E-value=4.1e-25  Score=193.13  Aligned_cols=153  Identities=30%  Similarity=0.511  Sum_probs=130.6

Q ss_pred             hcCCCccceecccCCccEEEEEEcC--------CcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeC
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ  191 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  191 (290)
                      ..+|...+.||+|+||.||++...+        ...||+|.+.... .....++..|+.++.++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3468889999999999999997521        2368999886432 23456889999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE
Q 022887          192 GENILIYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  258 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill  258 (290)
                      +..++++||+++|+|.+++....             ....++|.++..++.|++.||.|||+.+   ++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            99999999999999999885421             1235889999999999999999999887   9999999999999


Q ss_pred             cCCCCeEEeeccCceeeCC
Q 022887          259 DSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       259 ~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++.+||+|||+++.+..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~  186 (334)
T cd05100         168 TEDNVMKIADFGLARDVHN  186 (334)
T ss_pred             cCCCcEEECCcccceeccc
Confidence            9999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=6.8e-25  Score=184.79  Aligned_cols=151  Identities=28%  Similarity=0.499  Sum_probs=134.8

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|+..+.||+|+||.||++... ++..+++|.+..........+..|+.++.+++||||+++++.+...+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367888999999999999999874 4778999998765555678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|..++...  ...+++.+...++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+..
T Consensus        82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            9999999887432  246889999999999999999999887   99999999999999999999999999987643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.93  E-value=1.1e-24  Score=214.99  Aligned_cols=144  Identities=27%  Similarity=0.493  Sum_probs=123.4

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ....+...+.||+|+||.||+|.. .++..||||++......    ...|+..+.+++||||++++|+|.+.+..++|||
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            345677888999999999999987 56889999998653322    2346888999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+++|+|.+++.      .++|.++.+++.|+++||+|||+....+++|||+||+||+++.++.+++. ||.+...
T Consensus       764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            999999999983      38999999999999999999997656679999999999999999988875 6666543

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.93  E-value=6.1e-25  Score=184.73  Aligned_cols=144  Identities=35%  Similarity=0.467  Sum_probs=126.7

Q ss_pred             ceecccCCccEEEEEEcC--C--cEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+..|+..+.+++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998743  2  2689999976554 456789999999999999999999999988 888999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++|..++..... ..++|...+.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||+++.+..
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence            999998854322 56899999999999999999999887   99999999999999999999999999988755

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.93  E-value=7.6e-25  Score=185.15  Aligned_cols=148  Identities=32%  Similarity=0.521  Sum_probs=129.3

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccccc---------CHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ---------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      +|.....||+|+||.||+|... +++.+|+|.+......         ....+..|+.++.+++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667789999999999999874 5789999988643221         12568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++++||+++++|..++..   ...+++.....++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999998843   355888999999999999999999887   9999999999999999999999999998


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      .+..
T Consensus       155 ~~~~  158 (267)
T cd06628         155 KLEA  158 (267)
T ss_pred             cccc
Confidence            7753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.93  E-value=6.1e-25  Score=186.96  Aligned_cols=153  Identities=32%  Similarity=0.491  Sum_probs=130.7

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC------CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      ..++|...+.||+|+||.||+|.+.+      +..|++|.+.... ......|..|+.++..++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34678999999999999999998743      5678999886433 2234578999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC---CeEE
Q 022887          194 NILIYEYMPNKSLDVFLFYPKK----KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKI  266 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~---~~kl  266 (290)
                      .++||||+++++|.+++.....    ...++|..+..++.|++.||.|||+.+   ++|+||||+||++++++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999998854321    235899999999999999999999887   99999999999998754   5999


Q ss_pred             eeccCceeeC
Q 022887          267 SDFGMARIFG  276 (290)
Q Consensus       267 ~DfGla~~~~  276 (290)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (277)
T cd05036         161 ADFGMARDIY  170 (277)
T ss_pred             ccCccccccC
Confidence            9999998764

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.93  E-value=6.1e-25  Score=189.62  Aligned_cols=146  Identities=26%  Similarity=0.400  Sum_probs=129.3

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++... .++.|++|.+....   ......+.+|+.++..++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999874 47899999886542   223457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ||+++++|..++..   ...+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            99999999999843   345889999999999999999999887   99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.93  E-value=5.4e-25  Score=190.75  Aligned_cols=152  Identities=32%  Similarity=0.528  Sum_probs=130.2

Q ss_pred             hcCCCccceecccCCccEEEEEEc--------CCcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeC
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ  191 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  191 (290)
                      .++|...+.||+|+||.||++...        ....+|+|.+.... .....++..|+.++.++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            467888999999999999999742        24568999887432 23356788999999999 699999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE
Q 022887          192 GENILIYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  258 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill  258 (290)
                      +..+++|||+++|+|..++....             ....+++.+...++.|++.||.|||+.+   ++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            99999999999999999885422             1245899999999999999999999887   9999999999999


Q ss_pred             cCCCCeEEeeccCceeeC
Q 022887          259 DSDMNPKISDFGMARIFG  276 (290)
Q Consensus       259 ~~~~~~kl~DfGla~~~~  276 (290)
                      ++++.+||+|||+++...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~  185 (314)
T cd05099         168 TEDNVMKIADFGLARGVH  185 (314)
T ss_pred             cCCCcEEEcccccccccc
Confidence            999999999999998664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=5.5e-25  Score=191.44  Aligned_cols=143  Identities=22%  Similarity=0.279  Sum_probs=114.7

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc--CCcEEEEEEecccc-----ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS-----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG  192 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~--~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  192 (290)
                      ...++|...+.||+|+||+||+|.+.  +++.||||++....     ......|.+|+.++.+++|+|+++.+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            34578999999999999999999874  56778999875321     1224568999999999999999853322   24


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCC-CCCCEEEcCCCCeEEeeccC
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dl-k~~Nill~~~~~~kl~DfGl  271 (290)
                      ..++||||+++++|....    ..   .   ...++.|+++||.|||+.+   |+|||| ||+|||++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            679999999999986321    10   1   1467889999999999887   999999 99999999999999999999


Q ss_pred             ceeeCCC
Q 022887          272 ARIFGGD  278 (290)
Q Consensus       272 a~~~~~~  278 (290)
                      |+.+...
T Consensus       159 A~~~~~~  165 (365)
T PRK09188        159 ASVFRRR  165 (365)
T ss_pred             ceecccC
Confidence            9987553

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.93  E-value=7.7e-25  Score=185.70  Aligned_cols=147  Identities=29%  Similarity=0.433  Sum_probs=127.6

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc---c-------CHHHHHHHHHHHcccCCCCcceeEEEEEeCC
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---Q-------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG  192 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  192 (290)
                      +|...+.||+|+||.||+|.. .+++.+|+|.+.....   .       ..+.+..|+.++..++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            466778999999999999976 4588999998753211   0       1246788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            99999999999999998743   246889999999999999999999887   999999999999999999999999999


Q ss_pred             eeeC
Q 022887          273 RIFG  276 (290)
Q Consensus       273 ~~~~  276 (290)
                      +...
T Consensus       156 ~~~~  159 (272)
T cd06629         156 KKSD  159 (272)
T ss_pred             cccc
Confidence            8654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.93  E-value=7.3e-25  Score=185.14  Aligned_cols=147  Identities=28%  Similarity=0.506  Sum_probs=129.5

Q ss_pred             CCCccceecccCCccEEEEEEcCCcEEEEEEeccccc------cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      +|...+.||+|+||.||+|...+++.+|+|.+.....      .....+.+|+..+..++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4677889999999999999888889999998864321      1235688899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +||+++++|.+++..   ...+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||+++...
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            999999999998843   245788999999999999999999887   9999999999999999999999999998653

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.93  E-value=7.1e-25  Score=184.82  Aligned_cols=151  Identities=31%  Similarity=0.466  Sum_probs=132.3

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ..++|+..+.||+|+||.||++...++..+|+|.+... ......+.+|+.++.+++|+||+++.+.+.. ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            34688899999999999999999877788999988653 2335678999999999999999999999887 778999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|.+++... ....+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..+..
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            9999999988542 2345789999999999999999999877   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.93  E-value=5.2e-25  Score=188.11  Aligned_cols=160  Identities=25%  Similarity=0.344  Sum_probs=133.8

Q ss_pred             cHHhHHHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEe-
Q 022887          114 SLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE-  190 (290)
Q Consensus       114 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  190 (290)
                      .+..+..+.++|+..+.||+|+||.||++... +++.+|+|.+... .....++..|+.++..+ +||||+++++++.. 
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34455567789999999999999999999874 4788999987642 22345788899999999 69999999998853 


Q ss_pred             ----CCeeEEEEEecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeE
Q 022887          191 ----QGENILIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  265 (290)
Q Consensus       191 ----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~k  265 (290)
                          .+..++||||+++++|..++... .....+++.....++.|++.||.|||+.+   ++||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence                34689999999999998876432 23346788999999999999999999887   99999999999999999999


Q ss_pred             EeeccCceeeCC
Q 022887          266 ISDFGMARIFGG  277 (290)
Q Consensus       266 l~DfGla~~~~~  277 (290)
                      |+|||+++.+..
T Consensus       165 l~dfg~~~~~~~  176 (286)
T cd06638         165 LVDFGVSAQLTS  176 (286)
T ss_pred             EccCCceeeccc
Confidence            999999987643

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2e-26  Score=196.33  Aligned_cols=161  Identities=27%  Similarity=0.408  Sum_probs=139.4

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ...|+..+.||+|+||.||+|.. ..++.||+|.+.-.. .....+..+|+.++++++++||.+.+|.+..+...+++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            34677779999999999999987 457889999997543 3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      |+.+|++.+.+.   ....+++....-+..++..|+.|||.+.   .+|||||+.|||+..++.+||+|||.+..+....
T Consensus        92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence            999999998883   3444577777788899999999999988   9999999999999999999999999999997766


Q ss_pred             cccCcceeecC
Q 022887          280 LQGNTKRIVGT  290 (290)
Q Consensus       280 ~~~~~~~~~Gt  290 (290)
                      ...  ..++||
T Consensus       166 ~rr--~tfvGT  174 (467)
T KOG0201|consen  166 KRR--KTFVGT  174 (467)
T ss_pred             hcc--cccccc
Confidence            544  346777

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.93  E-value=4.3e-25  Score=193.67  Aligned_cols=150  Identities=28%  Similarity=0.395  Sum_probs=126.8

Q ss_pred             HHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC-----
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-----  191 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  191 (290)
                      ...++|+..+.||+|+||.||++.. .++..||||.+....  ......+.+|+.++..++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999986 457899999986432  22345678899999999999999999887643     


Q ss_pred             -CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          192 -GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       192 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                       ...++++|++ +++|..++.    ...+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468999987 678877762    345899999999999999999999987   9999999999999999999999999


Q ss_pred             CceeeCC
Q 022887          271 MARIFGG  277 (290)
Q Consensus       271 la~~~~~  277 (290)
                      +++....
T Consensus       164 ~~~~~~~  170 (343)
T cd07878         164 LARQADD  170 (343)
T ss_pred             cceecCC
Confidence            9987654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.93  E-value=9.9e-25  Score=183.63  Aligned_cols=142  Identities=32%  Similarity=0.522  Sum_probs=122.6

Q ss_pred             eecccCCccEEEEEE---cCCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCC
Q 022887          130 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK  204 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~---~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  204 (290)
                      .||+|+||.||+|.+   .++..+|+|.+.....  ....++..|+.++..++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999965   3467899998864332  23567899999999999999999999875 45678999999999


Q ss_pred             ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       205 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +|.+++..   ...+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+..+
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            99998843   345889999999999999999999887   999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=8.6e-25  Score=186.34  Aligned_cols=150  Identities=33%  Similarity=0.526  Sum_probs=130.9

Q ss_pred             cCCCccceecccCCccEEEEEEc-----CCcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEe--CCee
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGEN  194 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  194 (290)
                      ++|+..+.||+|+||.||++.+.     ++..+|+|.+...... ....+..|+..+..++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46777899999999999999863     3578999999754332 46789999999999999999999999887  5578


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      +++|||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999998532  235899999999999999999999887   99999999999999999999999999988


Q ss_pred             eCC
Q 022887          275 FGG  277 (290)
Q Consensus       275 ~~~  277 (290)
                      +..
T Consensus       159 ~~~  161 (284)
T cd05038         159 LPE  161 (284)
T ss_pred             ccc
Confidence            763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.93  E-value=6.6e-25  Score=185.46  Aligned_cols=148  Identities=31%  Similarity=0.474  Sum_probs=127.2

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-----ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--Cee
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GEN  194 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  194 (290)
                      ++|+..+.||+|+||.||++... ++..||+|.+....     ......+.+|+.++.+++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999874 58899999885321     12245788899999999999999999988764  457


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      +++|||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999988743   234788889999999999999999887   99999999999999999999999999986


Q ss_pred             eC
Q 022887          275 FG  276 (290)
Q Consensus       275 ~~  276 (290)
                      +.
T Consensus       156 ~~  157 (265)
T cd06652         156 LQ  157 (265)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.92  E-value=1.4e-24  Score=182.48  Aligned_cols=149  Identities=30%  Similarity=0.536  Sum_probs=131.9

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      .+|+..+.||+|+||.||++.+.++..+|+|.+... .....+|..|+.++.+++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            477888999999999999998877889999988643 2335679999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++|.+++...  ...+++.....++.|++.|++|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            99999887432  245789999999999999999999887   99999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.92  E-value=3.8e-25  Score=188.88  Aligned_cols=149  Identities=28%  Similarity=0.429  Sum_probs=130.7

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+..+.||+|+||.||++... +++.||+|.+.....  ...+.+.+|+.++..++||||+++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888899999999999999885 478999998864322  234578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |++++++..+...   ...+++.+...++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+..
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999999877632   234899999999999999999999887   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.92  E-value=2.1e-24  Score=181.25  Aligned_cols=150  Identities=23%  Similarity=0.407  Sum_probs=131.0

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      +|+..+.||+|+||.||++... +++.+|+|.+... .......+..|+.++..++|||++++.+.+...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999874 5789999988542 2334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++|..++... ....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++++|||+++.+..
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            999998877432 2345788999999999999999999887   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.92  E-value=8.2e-25  Score=188.67  Aligned_cols=150  Identities=37%  Similarity=0.650  Sum_probs=126.6

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCc----EEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      .++|+..+.||+|+||.||+|.+. ++.    .||+|.+..... ....++..|+.++..++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            357788899999999999999863 343    478888865332 2234788999999999999999999998754 567


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +++||+++|+|.+++...  ...+++...+.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            899999999999887432  335789999999999999999999887   999999999999999999999999999877


Q ss_pred             CC
Q 022887          276 GG  277 (290)
Q Consensus       276 ~~  277 (290)
                      ..
T Consensus       160 ~~  161 (303)
T cd05110         160 EG  161 (303)
T ss_pred             cC
Confidence            54

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.92  E-value=1.4e-24  Score=184.02  Aligned_cols=143  Identities=35%  Similarity=0.592  Sum_probs=122.4

Q ss_pred             ceecccCCccEEEEEEcC-Cc--EEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||+|.+.+ +.  .+++|.+.... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998754 33  46888886432 33456788999999999 899999999999999999999999999


Q ss_pred             CChhhhhhCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          204 KSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       204 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                      |+|.+++....             ....+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999875322             1235789999999999999999999877   9999999999999999999999999


Q ss_pred             Ccee
Q 022887          271 MARI  274 (290)
Q Consensus       271 la~~  274 (290)
                      +++.
T Consensus       158 l~~~  161 (270)
T cd05047         158 LSRG  161 (270)
T ss_pred             Cccc
Confidence            9863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.92  E-value=9.5e-25  Score=185.00  Aligned_cols=150  Identities=29%  Similarity=0.461  Sum_probs=128.7

Q ss_pred             cCCCccceecccCCccEEEEEEcC----CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++|...+.||+|+||.||+|...+    ...|+||...... ....+.+.+|+.++.+++||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            468888999999999999998643    2468999886543 3345689999999999999999999998875 567899


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999998432  335899999999999999999999877   99999999999999999999999999987644


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       160 ~  160 (270)
T cd05056         160 E  160 (270)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.92  E-value=2e-24  Score=181.65  Aligned_cols=148  Identities=30%  Similarity=0.522  Sum_probs=128.3

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEe-CCeeEEEEEec
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGENILIYEYM  201 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  201 (290)
                      ++|...+.||+|+||.||++... +..+|+|.+...  .....+..|+.++.+++|+|++++++++.. .+..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            57888899999999999999774 678999988643  235678999999999999999999998654 45689999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++|.+++... ....+++.....++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++....
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence            999999987532 2345889999999999999999999887   99999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.92  E-value=1.9e-24  Score=181.41  Aligned_cols=150  Identities=37%  Similarity=0.594  Sum_probs=130.7

Q ss_pred             CCccceecccCCccEEEEEEcC-----CcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          125 FSTQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      |+..+.||+|+||.||++...+     +..||+|.+...... ....+..|+..+..++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3456899999999999998754     378999999754433 5678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++++|.+++..... ..+++.+...++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999998853221 12899999999999999999999887   999999999999999999999999999877544

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.92  E-value=8.1e-26  Score=179.67  Aligned_cols=154  Identities=28%  Similarity=0.320  Sum_probs=136.2

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-----ee
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----EN  194 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  194 (290)
                      ..++|.+.+.+|+|||+.||.++. .++..+|+|++.....+..+..++|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            457899999999999999999974 678899999998776677889999999999999999999998876443     48


Q ss_pred             EEEEEecCCCChhhhhhCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          195 ILIYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      |+++.|...|+|.+.+.... .+..+++.+.+.|+.++++||++||+.. +++.||||||.|||+.+.+.+++.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999988876543 3457999999999999999999999975 579999999999999999999999999997


Q ss_pred             ee
Q 022887          274 IF  275 (290)
Q Consensus       274 ~~  275 (290)
                      ..
T Consensus       178 ~a  179 (302)
T KOG2345|consen  178 QA  179 (302)
T ss_pred             cc
Confidence            65

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.92  E-value=1.6e-24  Score=182.66  Aligned_cols=148  Identities=31%  Similarity=0.506  Sum_probs=132.1

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccccc--CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|...+.||+|+||.||++... +++.+++|.+......  ....+..|+.++.+++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999874 5789999998754432  567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+..
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            999999998843   345788999999999999999999887   99999999999999999999999999987754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.92  E-value=1.1e-24  Score=186.56  Aligned_cols=149  Identities=31%  Similarity=0.427  Sum_probs=127.1

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++++|...+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+..+..++|+||+++.+++...+..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357899999999999999999986 4588999999865432 23346788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ||++ +++..++..  ....+.+.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++..
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence            9996 566555532  2245778888999999999999999887   999999999999999999999999999764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=2e-24  Score=184.39  Aligned_cols=149  Identities=30%  Similarity=0.474  Sum_probs=132.0

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|+||.||+|... +++.||+|.+....  ......+..|+.++.+++|||++++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999874 58899999987543  23356899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      + +++|.+++...  ...+++.++..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++......
T Consensus        81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 99999887532  256899999999999999999999887   999999999999999999999999999877554

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.92  E-value=7.2e-25  Score=193.16  Aligned_cols=148  Identities=28%  Similarity=0.384  Sum_probs=124.7

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-----
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  192 (290)
                      ..++|+..+.||+|+||.||++... .++.||||.+....  ......+.+|+.++..++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999864 57899999986532  223467788999999999999999999886543     


Q ss_pred             -eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccC
Q 022887          193 -ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       193 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl  271 (290)
                       ..++||||++++ +...+.     ..+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~~-l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhccc-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence             468999999764 544442     24788899999999999999999887   99999999999999999999999999


Q ss_pred             ceeeCC
Q 022887          272 ARIFGG  277 (290)
Q Consensus       272 a~~~~~  277 (290)
                      ++..+.
T Consensus       166 ~~~~~~  171 (355)
T cd07874         166 ARTAGT  171 (355)
T ss_pred             cccCCC
Confidence            987644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.92  E-value=1.7e-24  Score=187.73  Aligned_cols=144  Identities=28%  Similarity=0.493  Sum_probs=117.8

Q ss_pred             cceecccCCccEEEEEEc---CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEEEEEecC
Q 022887          128 QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILIYEYMP  202 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~  202 (290)
                      .+.||+|+||.||+|...   ++..+|+|.+....  ....+.+|+.++.+++||||+++++++...  ...+++|||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            368999999999999864   45789999986532  235678899999999999999999988653  46789999987


Q ss_pred             CCChhhhhhCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE----cCCCCeEEeeccCc
Q 022887          203 NKSLDVFLFYPK------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMA  272 (290)
Q Consensus       203 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DfGla  272 (290)
                      + +|..++....      ....+++.....++.|++.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 6666553211      1235888999999999999999999887   9999999999999    45678999999999


Q ss_pred             eeeCC
Q 022887          273 RIFGG  277 (290)
Q Consensus       273 ~~~~~  277 (290)
                      +.+..
T Consensus       160 ~~~~~  164 (317)
T cd07868         160 RLFNS  164 (317)
T ss_pred             eccCC
Confidence            88754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.92  E-value=1.4e-24  Score=185.90  Aligned_cols=147  Identities=31%  Similarity=0.456  Sum_probs=128.0

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|+.++.+++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999875 578999999864322 2234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +++ +|..++...  ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++..
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            985 888776432  236789999999999999999999887   999999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.92  E-value=1.8e-24  Score=187.31  Aligned_cols=150  Identities=27%  Similarity=0.471  Sum_probs=126.4

Q ss_pred             CCCccceecccCCccEEEEEEc---CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENI  195 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~---~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  195 (290)
                      +|+..+.||+|+||.||+|...   ++..||+|.+....   ......+.+|+.++..++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4777889999999999999874   47899999997632   33446778899999999999999999999988  7899


Q ss_pred             EEEEecCCCChhhhhhCC-C-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC----CCCeEEeec
Q 022887          196 LIYEYMPNKSLDVFLFYP-K-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS----DMNPKISDF  269 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~-~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~----~~~~kl~Df  269 (290)
                      +||||+++ ++..++... . ....+++.....++.|++.||.|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999986 454444322 1 2236888999999999999999999887   999999999999999    999999999


Q ss_pred             cCceeeCC
Q 022887          270 GMARIFGG  277 (290)
Q Consensus       270 Gla~~~~~  277 (290)
                      |+++.+..
T Consensus       157 g~~~~~~~  164 (316)
T cd07842         157 GLARLFNA  164 (316)
T ss_pred             ccccccCC
Confidence            99987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.1e-24  Score=180.78  Aligned_cols=143  Identities=35%  Similarity=0.506  Sum_probs=127.4

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCChh
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD  207 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  207 (290)
                      +.||+|+||.||++...+++.||+|.+...... ....+..|+.++.+++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877899999988754332 4568899999999999999999999999999999999999999999


Q ss_pred             hhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          208 VFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       208 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      .++...  ...+++.....++.+++.|+.|||+++   ++||||+|+||++++++.+||+|||+++...
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            887432  335789999999999999999999887   9999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.92  E-value=6e-25  Score=186.95  Aligned_cols=148  Identities=29%  Similarity=0.452  Sum_probs=129.7

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +.|+..+.||+|+||.||+|.+. ++..||+|.+.... ......+..|+.++.+++||||+++++.+...+..++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34666788999999999999864 47789999886432 23346789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|..++.    ...+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||+++.+..
T Consensus        84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence            99999998873    345889999999999999999999877   99999999999999999999999999987654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.92  E-value=1.1e-24  Score=192.52  Aligned_cols=148  Identities=28%  Similarity=0.378  Sum_probs=125.0

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC------
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------  191 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  191 (290)
                      ..++|...+.||+|+||.||++... .++.||||++....  ......+.+|+.++..++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999864 47889999986432  23346788999999999999999999987643      


Q ss_pred             CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccC
Q 022887          192 GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl  271 (290)
                      ...++||||+++ ++...+.     ..+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            356999999976 5555542     24788899999999999999999887   99999999999999999999999999


Q ss_pred             ceeeCC
Q 022887          272 ARIFGG  277 (290)
Q Consensus       272 a~~~~~  277 (290)
                      ++..+.
T Consensus       173 a~~~~~  178 (364)
T cd07875         173 ARTAGT  178 (364)
T ss_pred             ccccCC
Confidence            987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=2.1e-24  Score=187.09  Aligned_cols=151  Identities=26%  Similarity=0.339  Sum_probs=132.6

Q ss_pred             cCCCccceecccCCccEEEEEEcC-CcEEEEEEecccccc---CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++...+ +..+|+|.+......   ....+..|++.+..++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368888999999999999998754 889999998754322   4467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++++|.+++... ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999999987532 2356899999999999999999999887   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.92  E-value=2e-24  Score=184.19  Aligned_cols=149  Identities=31%  Similarity=0.531  Sum_probs=129.9

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      +|+..+.||+|++|.||+|... ++..||||.+..... .....+..|+.++.+++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788899999999999999985 588999999875432 23467788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ++ +|..++........+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+.
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            85 77777654333456899999999999999999999887   9999999999999999999999999997654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.92  E-value=1.7e-24  Score=181.78  Aligned_cols=149  Identities=30%  Similarity=0.484  Sum_probs=134.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|+..+.||+|+||.||++...+ +..+++|.+.....  ..++.+|+..+..++|||++++++++......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678999999999999999998855 78999999875432  67899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|.+++..  ....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+..
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999999998743  2456899999999999999999999887   99999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.92  E-value=5e-25  Score=196.42  Aligned_cols=149  Identities=29%  Similarity=0.400  Sum_probs=127.9

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccC-C-----CCcceeEEEEEeCCeeE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-H-----RHLVRLFGCCIEQGENI  195 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~  195 (290)
                      .+|++.+.||+|.||+|.+|.. .+++.||||++++.. ....+-..|+.+|..|+ |     -|+|++++++...++.+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            3788999999999999999976 558999999998743 34566788999999886 3     48999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC--CCeEEeeccCce
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMAR  273 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~--~~~kl~DfGla~  273 (290)
                      ||+|.++. +|.+++...+ -..++......++.||+.||.+||+.+   |||+||||+||||.+.  ..+||+|||.|.
T Consensus       265 iVfELL~~-NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  265 IVFELLST-NLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeehhhhh-hHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            99999965 7888886543 345889999999999999999999887   9999999999999754  479999999999


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      ..+.
T Consensus       340 ~~~q  343 (586)
T KOG0667|consen  340 FESQ  343 (586)
T ss_pred             ccCC
Confidence            7754

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.92  E-value=4.8e-25  Score=189.14  Aligned_cols=148  Identities=26%  Similarity=0.424  Sum_probs=129.4

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      +.|.....||+|+||.||++... ++..||||.+..........+.+|+..+..++|||++++++.+...+..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            34444567999999999999874 57899999987544445567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++|..++.    ...+++.+...++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++..+..
T Consensus       102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            9999998873    234789999999999999999999887   99999999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.92  E-value=2.1e-24  Score=184.81  Aligned_cols=149  Identities=29%  Similarity=0.360  Sum_probs=129.2

Q ss_pred             CCCccceecccCCccEEEEEE----cCCcEEEEEEecccc----ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCee
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  194 (290)
                      +|+..+.||+|+||.||++..    .++..||+|.+....    ....+.+..|+.++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477788999999999999976    367899999986432    22346788899999999 599999999999998899


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++|+||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++||||+|+|||+++++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999998843   345788999999999999999999887   99999999999999999999999999987


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      +..+
T Consensus       155 ~~~~  158 (290)
T cd05613         155 FHED  158 (290)
T ss_pred             cccc
Confidence            7543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.92  E-value=2.1e-24  Score=182.53  Aligned_cols=148  Identities=32%  Similarity=0.515  Sum_probs=127.4

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-----ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--Cee
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GEN  194 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  194 (290)
                      .+|+..+.||+|+||.||++... ++..|++|.+....     ......+.+|+.++..++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999874 58899999886432     12235688899999999999999999988753  567


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++++||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999988843   335789999999999999999999877   99999999999999999999999999986


Q ss_pred             eC
Q 022887          275 FG  276 (290)
Q Consensus       275 ~~  276 (290)
                      +.
T Consensus       156 ~~  157 (266)
T cd06651         156 LQ  157 (266)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.92  E-value=1.1e-24  Score=184.28  Aligned_cols=149  Identities=30%  Similarity=0.506  Sum_probs=129.8

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc------cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+.....      .....+..|+..+.+++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999986 5688999998864321      124678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-CeEEeeccCceee
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIF  275 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~  275 (290)
                      |+||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++..+
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999998843   346889999999999999999999987   99999999999998775 5999999999877


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      ...
T Consensus       155 ~~~  157 (268)
T cd06630         155 AAK  157 (268)
T ss_pred             ccc
Confidence            543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.92  E-value=8.6e-25  Score=188.05  Aligned_cols=146  Identities=29%  Similarity=0.443  Sum_probs=128.8

Q ss_pred             CCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      |+....||+|+||.||++... +++.||+|.+..........+.+|+..+..++|||++++++.+...+..++++||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            344457999999999999874 5889999998754445566788999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++|..++.    ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+..
T Consensus       103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~  169 (297)
T cd06659         103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  169 (297)
T ss_pred             CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence            99988763    245889999999999999999999887   99999999999999999999999999976643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.92  E-value=3.9e-24  Score=180.54  Aligned_cols=152  Identities=27%  Similarity=0.434  Sum_probs=134.0

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||.|+||.||+|... ++..+++|.+.... ......+.+|+..+..++|+|++++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47888999999999999999864 57889999986432 23557899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|..++........+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            999999998854333356899999999999999999999887   99999999999999999999999999977654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=1.9e-24  Score=188.31  Aligned_cols=145  Identities=21%  Similarity=0.289  Sum_probs=124.1

Q ss_pred             ccceeccc--CCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          127 TQCKLGEG--GFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       127 ~~~~ig~G--~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .+++||+|  +|++||++.. .+++.||+|++....  ......+..|+.++..++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  6889999977 458899999986532  223456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ++|+|.+++... ....+++.....++.|++.||.|||+.+   ++||||||+|||++.++.++++||+.+...
T Consensus        82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            999999987432 2234889999999999999999999887   999999999999999999999999875443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.92  E-value=2.3e-24  Score=181.01  Aligned_cols=146  Identities=34%  Similarity=0.544  Sum_probs=127.3

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      ++|+..+.||+|+||.||++.. +++.||+|.+...  .....+..|+.++.+++|||++++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5688889999999999999975 5678999988643  2346789999999999999999999998754 5799999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++|..++... ....+++.++..++.|++.|+.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            99999988543 2345789999999999999999999877   9999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.92  E-value=3.1e-24  Score=182.66  Aligned_cols=148  Identities=27%  Similarity=0.438  Sum_probs=131.0

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ..|+..+.||+|+||.||+|... ++..||+|.+.... ......+..|+.++..+.||||+++++.+...+..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            46777889999999999999874 57899999886432 23456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|.+++.    ...+++.+...++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+..
T Consensus        84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            99999998873    235788999999999999999999877   99999999999999999999999999987754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=1.3e-24  Score=185.57  Aligned_cols=148  Identities=26%  Similarity=0.390  Sum_probs=130.1

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++..++||||+++++.+...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57888899999999999999874 57889999876432 33457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +++++|..++..   ...+++.....++.+++.||.|||+..  +++|+||+|+||++++++.++|+|||++..+
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            999999888732   345899999999999999999999732  3999999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.92  E-value=4e-24  Score=181.94  Aligned_cols=148  Identities=28%  Similarity=0.448  Sum_probs=130.1

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +-|+..+.||+|+||.||+|.. .++..+|+|.+.... ......+.+|+..+.+++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            3467788999999999999986 457899999876432 23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|..++.    ...+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||+++.+..
T Consensus        84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            99999998873    245889999999999999999999877   99999999999999999999999999987644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.92  E-value=3.4e-24  Score=180.61  Aligned_cols=150  Identities=29%  Similarity=0.437  Sum_probs=134.6

Q ss_pred             cCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|++|.||++...+ ++.|++|.+..... .....+..|+..+.+++|||++++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            368888999999999999998864 88999999876433 3467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|.+++..   ...+++...+.++.|+++|+.|||+ .+   ++|+||+|+||++++++.++|+|||++..+...
T Consensus        81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            999999999843   2568999999999999999999998 77   999999999999999999999999999887554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.92  E-value=2e-24  Score=184.08  Aligned_cols=150  Identities=28%  Similarity=0.424  Sum_probs=125.1

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHH-HcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMML-IAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+..+.||+|+||.||++... ++..||+|.+.... ......+..|+.. ++.++|||++++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47888999999999999999875 58899999987532 2233455566664 566789999999999999999999999


Q ss_pred             ecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |++ |+|..++... .....+++...+.++.|++.||.|||++ +   ++||||||+||++++++.+||+|||+++.+.
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            997 6777666432 2335689999999999999999999986 5   9999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.92  E-value=9.9e-25  Score=183.60  Aligned_cols=149  Identities=28%  Similarity=0.360  Sum_probs=132.4

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      +|+..+.||.|+||.||++... ++..+|+|.+....   ....+.+.+|+..+.+++||||+++++.+...+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999875 48899999986432   2345789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+++++|..++..   ...+++.+...++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            9999999988843   246889999999999999999999887   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.92  E-value=1.1e-24  Score=207.44  Aligned_cols=160  Identities=23%  Similarity=0.363  Sum_probs=131.1

Q ss_pred             HHHhcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--Ce
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GE  193 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  193 (290)
                      +...++|.+.+.||+|+||.||++.... +..+|+|.+...  .......|..|+.++..++||||+++++++...  ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            4456789999999999999999998744 678899988643  223356789999999999999999999988654  46


Q ss_pred             eEEEEEecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCceecCCCCCCEEEcCC-------
Q 022887          194 NILIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSR----LRIIHRDLKASNILLDSD-------  261 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~iiH~dlk~~Nill~~~-------  261 (290)
                      .++||||+++|+|..++... .....+++...+.|+.||+.||.|||+.+.    .+|+||||||+||||+.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999887532 123468999999999999999999998532    349999999999999642       


Q ss_pred             ----------CCeEEeeccCceeeCCC
Q 022887          262 ----------MNPKISDFGMARIFGGD  278 (290)
Q Consensus       262 ----------~~~kl~DfGla~~~~~~  278 (290)
                                ..+||+|||+++.+...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~  195 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIE  195 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccc
Confidence                      34899999999877543

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=3.8e-24  Score=181.89  Aligned_cols=148  Identities=26%  Similarity=0.493  Sum_probs=130.3

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEeccc-cccCHHHHHHHHHHHcccC---CCCcceeEEEEEeCCeeEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .|+..+.||+|+||.||+|.. .+++.+|+|.+... ......++.+|+.++..++   |||++++++++...+..++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999987 46889999988643 2334567889999998886   999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++++|.+++..    ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999988732    36889999999999999999999887   999999999999999999999999999877543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=3e-24  Score=182.36  Aligned_cols=149  Identities=28%  Similarity=0.411  Sum_probs=132.5

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|||++++.+++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999874 57899999886543 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|.+++..    ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999998743    26899999999999999999999887   999999999999999999999999999887643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.92  E-value=3e-24  Score=181.02  Aligned_cols=143  Identities=29%  Similarity=0.517  Sum_probs=120.5

Q ss_pred             ceecccCCccEEEEEEcC----CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEe-CCeeEEEEEecC
Q 022887          129 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGENILIYEYMP  202 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  202 (290)
                      +.||+|+||.||+|.+.+    ...+|+|.+.... ......+..|+.+++.++|||++++++++.. ++..++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998632    3579999885432 2345678899999999999999999998764 456789999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++|..++...  ...+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999988432  234678888999999999999999877   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=3.5e-24  Score=180.21  Aligned_cols=143  Identities=38%  Similarity=0.564  Sum_probs=123.2

Q ss_pred             ceecccCCccEEEEEEcC----CcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||+|.+..    +..+|+|.+..... ....++..|+..+..++|||++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999997632    26899999875433 24567899999999999999999999876 4567999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+..+
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            999998853   236899999999999999999999887   999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.92  E-value=4.3e-24  Score=181.16  Aligned_cols=150  Identities=31%  Similarity=0.516  Sum_probs=125.0

Q ss_pred             CCccceecccCCccEEEEEEc----CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC------
Q 022887          125 FSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------  192 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~----~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  192 (290)
                      |...+.||+|+||.||+|.+.    ++..||||.+....  ....+++.+|+.++..++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556789999999999999753    36789999886532  233567889999999999999999999887543      


Q ss_pred             eeEEEEEecCCCChhhhhhCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeec
Q 022887          193 ENILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  269 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  269 (290)
                      ..++++||+++|+|..++....   ....+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2368899999999988764322   2235788999999999999999999887   999999999999999999999999


Q ss_pred             cCceeeCC
Q 022887          270 GMARIFGG  277 (290)
Q Consensus       270 Gla~~~~~  277 (290)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05074         158 GLSKKIYS  165 (273)
T ss_pred             cccccccC
Confidence            99987643

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.92  E-value=2.2e-24  Score=184.77  Aligned_cols=160  Identities=28%  Similarity=0.378  Sum_probs=134.4

Q ss_pred             cHHhHHHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeC
Q 022887          114 SLASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ  191 (290)
Q Consensus       114 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  191 (290)
                      ...++..+.++|+..+.||+|+||.||++.. .+++.+|+|.+.... .....+..|+.++.++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            3444555678999999999999999999987 457899999886432 2345678899999888 899999999998764


Q ss_pred             C-----eeEEEEEecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeE
Q 022887          192 G-----ENILIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  265 (290)
Q Consensus       192 ~-----~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~k  265 (290)
                      +     ..++|+||+++++|.+++... .....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence            3     579999999999999887432 22456899999999999999999999877   99999999999999999999


Q ss_pred             EeeccCceeeCC
Q 022887          266 ISDFGMARIFGG  277 (290)
Q Consensus       266 l~DfGla~~~~~  277 (290)
                      |+|||+++.+..
T Consensus       169 l~dfg~~~~~~~  180 (291)
T cd06639         169 LVDFGVSAQLTS  180 (291)
T ss_pred             Eeecccchhccc
Confidence            999999987643

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.92  E-value=2.5e-24  Score=184.82  Aligned_cols=149  Identities=27%  Similarity=0.417  Sum_probs=132.7

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|...+.||+|+||.||++.. .++..|++|.+..........+..|+.++..++|||++++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            46899999999999999999976 45788999998654444557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|..++.    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+..
T Consensus        98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             CCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            99999999873    234789999999999999999999887   99999999999999999999999999876644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.92  E-value=2.3e-26  Score=187.75  Aligned_cols=148  Identities=30%  Similarity=0.506  Sum_probs=133.0

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      +-|.++++||+|+||.||++.+. .|+.+|||++.-  .....+...|+.++.+.+.|++|+.+|.+.....+|+|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            45778899999999999999764 589999998864  345689999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      .-|+..+.+..  .++++++.+...+....++||+|||...   -||||||+.|||++.+|.+||+|||.|..+..
T Consensus       111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            99999998743  4577999999999999999999999766   89999999999999999999999999987743

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.92  E-value=5.4e-25  Score=194.69  Aligned_cols=148  Identities=32%  Similarity=0.536  Sum_probs=128.7

Q ss_pred             CCccceecccCCccEEEEEEcC---Cc--EEEEEEecc-ccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          125 FSTQCKLGEGGFGPVYKGRLLN---GQ--EVAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~~---~~--~vavK~l~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ....+.||.|-||.||+|.+.+   |+  .||||.-+. ......+.|..|..+++.++||||++++|+|.+. ..|+||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            3445789999999999998643   22  488998775 3445578899999999999999999999999875 789999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |.++.|.|..||..  +...++..+...++.|+..||.|||+..   +|||||..+|||+.+..-+||+||||+|.+..+
T Consensus       470 EL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  470 ELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             ecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999954  3456888999999999999999999887   999999999999999999999999999988654

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.92  E-value=6e-24  Score=184.21  Aligned_cols=143  Identities=29%  Similarity=0.502  Sum_probs=117.1

Q ss_pred             ceecccCCccEEEEEEcC---CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEe--CCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~---~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  203 (290)
                      ..||+|+||.||+|...+   +..||+|.+....  ....+.+|+.++..++||||+++++++..  ....++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            579999999999998643   4689999886532  23567889999999999999999999864  4567899999876


Q ss_pred             CChhhhhhCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE----cCCCCeEEeeccCce
Q 022887          204 KSLDVFLFYP------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR  273 (290)
Q Consensus       204 g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DfGla~  273 (290)
                       +|..++...      .....+++.....++.|++.||.|||+.+   ++||||||+|||+    ++++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             555544221      12235888999999999999999999887   9999999999999    566789999999999


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      .+..
T Consensus       161 ~~~~  164 (317)
T cd07867         161 LFNS  164 (317)
T ss_pred             ccCC
Confidence            7754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=9.4e-25  Score=183.92  Aligned_cols=144  Identities=28%  Similarity=0.433  Sum_probs=122.5

Q ss_pred             ceecccCCccEEEEEEcC--------CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          129 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +.||+|+||.||+|....        ..++++|.+.........++.+|+.++..++|||++++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997632        234888887654444456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC--------eEEeeccCc
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--------PKISDFGMA  272 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~--------~kl~DfGla  272 (290)
                      +++|+|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998532  236889999999999999999999887   999999999999987765        699999998


Q ss_pred             eeeCC
Q 022887          273 RIFGG  277 (290)
Q Consensus       273 ~~~~~  277 (290)
                      .....
T Consensus       156 ~~~~~  160 (258)
T cd05078         156 ITVLP  160 (258)
T ss_pred             cccCC
Confidence            76543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.92  E-value=4e-24  Score=182.79  Aligned_cols=149  Identities=31%  Similarity=0.500  Sum_probs=121.5

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHccc---CCCCcceeEEEEEeC-----C
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKL---QHRHLVRLFGCCIEQ-----G  192 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~  192 (290)
                      +|+..+.||+|+||.||+|... +++.||+|.+.....  .....+..|+.++..+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999875 588999998864321  2234556677766655   799999999988653     3


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..+++|||+++ +|..++... ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999985 777776432 2345899999999999999999999987   999999999999999999999999999


Q ss_pred             eeeCC
Q 022887          273 RIFGG  277 (290)
Q Consensus       273 ~~~~~  277 (290)
                      +.+..
T Consensus       156 ~~~~~  160 (288)
T cd07863         156 RIYSC  160 (288)
T ss_pred             ccccC
Confidence            87754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.92  E-value=5.4e-24  Score=178.86  Aligned_cols=150  Identities=24%  Similarity=0.399  Sum_probs=131.2

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|+||.+|++... +++.+|+|.+...  ......++.+|+..+++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999874 5789999988643  223456889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|.+++... ....+++.+...++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            9999998887432 2235789999999999999999999887   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=4.2e-24  Score=180.50  Aligned_cols=148  Identities=33%  Similarity=0.503  Sum_probs=127.6

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc-----cccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--Cee
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-----SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GEN  194 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  194 (290)
                      .+|+..+.||+|+||.||++.. .++..||+|.+...     .......+.+|+.++.+++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5788999999999999999987 45889999987432     122345788999999999999999999998764  457


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++++||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999988742   234788999999999999999999887   99999999999999999999999999986


Q ss_pred             eC
Q 022887          275 FG  276 (290)
Q Consensus       275 ~~  276 (290)
                      +.
T Consensus       156 ~~  157 (264)
T cd06653         156 IQ  157 (264)
T ss_pred             cc
Confidence            64

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.92  E-value=5.8e-24  Score=182.40  Aligned_cols=150  Identities=28%  Similarity=0.417  Sum_probs=126.4

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCe-----
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGE-----  193 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  193 (290)
                      ++|+..+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.++..+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999874 58899999876432  223467888999999995 6999999999887665     


Q ss_pred             eEEEEEecCCCChhhhhhCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-CCCeEEeecc
Q 022887          194 NILIYEYMPNKSLDVFLFYPKK--KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFG  270 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfG  270 (290)
                      .++||||+++ +|..++.....  ...+++.....++.|++.||.|||+.+   ++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 77777643322  346899999999999999999999887   999999999999998 8899999999


Q ss_pred             CceeeC
Q 022887          271 MARIFG  276 (290)
Q Consensus       271 la~~~~  276 (290)
                      +++.+.
T Consensus       157 ~~~~~~  162 (295)
T cd07837         157 LGRAFS  162 (295)
T ss_pred             cceecC
Confidence            998654

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.92  E-value=4.5e-24  Score=183.02  Aligned_cols=150  Identities=28%  Similarity=0.425  Sum_probs=128.9

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILI  197 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  197 (290)
                      ++|+..+.||+|+||.||+|... +++.+++|.++....  .....+.+|+..+.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888899999999999999885 478999999864322  2234567899999999999999999999877  789999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +||+++ +|..++...  ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 887776432  236899999999999999999999887   99999999999999999999999999987754


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       159 ~  159 (293)
T cd07843         159 P  159 (293)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.91  E-value=3.5e-24  Score=183.03  Aligned_cols=150  Identities=28%  Similarity=0.414  Sum_probs=131.0

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+..+.||+|+||.||+|... +++.||+|.+....  ......+..|+.++++++||||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888899999999999999875 47899999886432  2345688999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |++++.+..+..   ....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            999887776552   2345889999999999999999999887   999999999999999999999999999877654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=2.7e-24  Score=197.26  Aligned_cols=154  Identities=21%  Similarity=0.357  Sum_probs=118.9

Q ss_pred             HHhcCCCccceecccCCccEEEEEEcC--CcEEEEE------------------EeccccccCHHHHHHHHHHHcccCCC
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLLN--GQEVAVK------------------RLSNQSGQGLTEFKNEMMLIAKLQHR  179 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~e~~~l~~l~h~  179 (290)
                      ...++|+..+.||+|+||+||++....  +...+.|                  .+.. .......+.+|+.++.+++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence            445789999999999999999986532  2222222                  1111 112345688999999999999


Q ss_pred             CcceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEE
Q 022887          180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKK--KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  257 (290)
Q Consensus       180 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nil  257 (290)
                      ||+++++++...+..++|+|++.. ++..++.....  ...........++.|++.||.|||+.+   |+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            999999999999999999999865 55555432211  122345667789999999999999887   999999999999


Q ss_pred             EcCCCCeEEeeccCceeeCCC
Q 022887          258 LDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       258 l~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++.++.+||+|||+++.+...
T Consensus       300 l~~~~~vkL~DFGla~~~~~~  320 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKE  320 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcc
Confidence            999999999999999887543

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-25  Score=209.33  Aligned_cols=167  Identities=25%  Similarity=0.280  Sum_probs=139.3

Q ss_pred             hHHHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC
Q 022887          117 SVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG  192 (290)
Q Consensus       117 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  192 (290)
                      ++....++|.++++||+|+||.|..++.. +++.+|+|++.+.   ......-|..|-.+|..-+.+=|+.+.-.|.+.+
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            34445679999999999999999999874 4778999999762   2334567888999998888999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ++|+|||||+||+|-.++...   ..+++.-...++..|+.||.-||+.+   +|||||||+|||||..|.+||+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence            999999999999998887332   25677666777778999999999887   999999999999999999999999999


Q ss_pred             eeeCCCccccCcceeecC
Q 022887          273 RIFGGDELQGNTKRIVGT  290 (290)
Q Consensus       273 ~~~~~~~~~~~~~~~~Gt  290 (290)
                      -.++.|..... ...+||
T Consensus       223 lkm~~dG~V~s-~~aVGT  239 (1317)
T KOG0612|consen  223 LKMDADGTVRS-SVAVGT  239 (1317)
T ss_pred             HhcCCCCcEEe-ccccCC
Confidence            88887665432 235777

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.91  E-value=3.5e-24  Score=182.77  Aligned_cols=149  Identities=30%  Similarity=0.501  Sum_probs=128.9

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|+||.||+|... +++.||||.+....  ......+..|+.++.+++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999874 58899999886432  22345788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++ ++|..++... ....+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            96 5787776443 2356899999999999999999999887   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.9e-26  Score=201.16  Aligned_cols=149  Identities=27%  Similarity=0.420  Sum_probs=132.8

Q ss_pred             cCCCccceecccCCccEEEEEEcCC-cEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      +.|.++..||.|+||+||++...+. -..|.|.+.........+|.-|+++|+..+||+||+|++.+...+.+|++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            4567778899999999999987653 345678887777778899999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      .+|-.+..+..  -.+.+++.+...++.|++.||.|||++.   |||||||+.|||++-+|.++|+|||.+....
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch
Confidence            99999887642  3577999999999999999999999988   9999999999999999999999999986553

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=3e-24  Score=172.10  Aligned_cols=142  Identities=18%  Similarity=0.157  Sum_probs=108.8

Q ss_pred             cceecccCCccEEEEEEcCCcEEEEEEecccccc--C-------HHH-----------------HHHHHHHHcccCCCCc
Q 022887          128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--G-------LTE-----------------FKNEMMLIAKLQHRHL  181 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~--~-------~~~-----------------~~~e~~~l~~l~h~ni  181 (290)
                      ...||+|+||.||+|...+|++||||.++.....  .       ...                 ...|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3679999999999999888999999999753211  1       112                 2348899999988776


Q ss_pred             ceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCceecCCCCCCEEEcC
Q 022887          182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL-HQYSRLRIIHRDLKASNILLDS  260 (290)
Q Consensus       182 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~iiH~dlk~~Nill~~  260 (290)
                      .....+..  ...++||||++++++.....   ....+++.+...++.|++.+|.|+ |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            44333222  23489999999887654421   234588899999999999999999 6766   99999999999998 


Q ss_pred             CCCeEEeeccCceeeCCC
Q 022887          261 DMNPKISDFGMARIFGGD  278 (290)
Q Consensus       261 ~~~~kl~DfGla~~~~~~  278 (290)
                      ++.++|+|||+|...+..
T Consensus       153 ~~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         153 DGKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             CCcEEEEEccccccCCCc
Confidence            478999999999866443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.91  E-value=6.7e-24  Score=183.29  Aligned_cols=150  Identities=31%  Similarity=0.483  Sum_probs=128.3

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .+.|+..+.||+|+||.||+|... +++.||+|.+.....   ....++.+|+.++..++|||++++.+++...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888899999999999999874 588999998864322   2335788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +||++ |++.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 466555532  2345899999999999999999999887   99999999999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.91  E-value=1.9e-25  Score=182.96  Aligned_cols=152  Identities=28%  Similarity=0.460  Sum_probs=125.6

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-----CcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEe-CCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-----~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  193 (290)
                      ...|+....||+|.||.||+|...+     ...+|||+++.+..  ......-+|+.+++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4578888999999999999995432     23789999975432  223567889999999999999999998887 778


Q ss_pred             eEEEEEecCCCChhhhhhC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC----CCeEEe
Q 022887          194 NILIYEYMPNKSLDVFLFY--PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKIS  267 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~----~~~kl~  267 (290)
                      .+|++||.+.. |...++.  ....+.++......|..||+.|+.|||++-   |+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            89999999885 4444432  223467888999999999999999999988   9999999999999877    899999


Q ss_pred             eccCceeeCC
Q 022887          268 DFGMARIFGG  277 (290)
Q Consensus       268 DfGla~~~~~  277 (290)
                      |||+||++.+
T Consensus       179 DlGlaR~~~~  188 (438)
T KOG0666|consen  179 DLGLARLFNN  188 (438)
T ss_pred             cccHHHHhhc
Confidence            9999999865

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.3e-23  Score=175.90  Aligned_cols=149  Identities=33%  Similarity=0.470  Sum_probs=132.7

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|++|.||++... +++.+++|.+.....  .....+..|++++.+++|||++++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777899999999999999875 578999999976443  3456899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            999999988743   256899999999999999999999887   999999999999999999999999999887653

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.91  E-value=1e-23  Score=177.11  Aligned_cols=150  Identities=26%  Similarity=0.375  Sum_probs=128.8

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC-CeeEEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-GENILIYE  199 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  199 (290)
                      +|+..+.||+|++|.||++... +++.+|+|.+....  ....+.+..|+.++.+++|||++++.+.+... +..+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999874 47889999986432  23456788999999999999999999887644 45789999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |+++++|.+++... ....+++.+...++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||+++.+..
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            99999999887532 2345899999999999999999999887   99999999999999999999999999987743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.91  E-value=1.8e-23  Score=174.52  Aligned_cols=150  Identities=34%  Similarity=0.551  Sum_probs=134.5

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      +|+..+.||+|++|.||++... ++..+++|++..........+.+|+..+..++|||++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4777889999999999999885 578999999976554466789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++|.+++...  ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            99999987432  256899999999999999999999877   999999999999999999999999999887654

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.91  E-value=2.6e-24  Score=183.55  Aligned_cols=148  Identities=27%  Similarity=0.475  Sum_probs=127.1

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|+||.||++... +++.+|+|.+....  ......+..|+.++.+++||||+++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999874 58899999886432  22335678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++ +|..++..  ....+++.....++.|+++||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            975 66666532  2345899999999999999999999887   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.91  E-value=9.5e-24  Score=178.72  Aligned_cols=152  Identities=27%  Similarity=0.451  Sum_probs=127.6

Q ss_pred             CCCccceecccCCccEEEEEEcC--CcEEEEEEecccc----------ccCHHHHHHHHHHHcc-cCCCCcceeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS----------GQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIE  190 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~--~~~vavK~l~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  190 (290)
                      +|+..+.||+|+||.||++.+..  ++.+|+|.+....          .....++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999998854  6789999875321          1223457778887764 799999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCceecCCCCCCEEEcCCCCeEEee
Q 022887          191 QGENILIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISD  268 (290)
Q Consensus       191 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlk~~Nill~~~~~~kl~D  268 (290)
                      .+..+++|||+++++|.+++... .....+++...+.++.|++.||.|||+ .+   ++|+||+|+||++++++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999998876431 234568899999999999999999996 44   99999999999999999999999


Q ss_pred             ccCceeeCCC
Q 022887          269 FGMARIFGGD  278 (290)
Q Consensus       269 fGla~~~~~~  278 (290)
                      ||++......
T Consensus       158 fg~~~~~~~~  167 (269)
T cd08528         158 FGLAKQKQPE  167 (269)
T ss_pred             ccceeecccc
Confidence            9999876554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=9.7e-25  Score=179.46  Aligned_cols=142  Identities=29%  Similarity=0.415  Sum_probs=126.7

Q ss_pred             ceecccCCccEEEEE-EcCCcEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          129 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      +.||+|+|+.|.-+. ..++.++|||++.+..........+|++++...+ |+||++|+++|.++...|||||-|.+|+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            689999999999886 4789999999999887778889999999998885 99999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC---CeEEeeccCceeeC
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARIFG  276 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DfGla~~~~  276 (290)
                      ...+.   .+.-+++.+..++..+|+.||.|||.++   |.|||+||+|||-.+-.   -+||+||.|+.-+.
T Consensus       164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence            88774   3456889999999999999999999988   99999999999986443   47999999986553

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.91  E-value=3.1e-26  Score=181.90  Aligned_cols=153  Identities=28%  Similarity=0.432  Sum_probs=128.8

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecc--ccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ..+.|+..+.||+|.|+.|++... .+|+.+|+|.+..  -.....+++.+|+.+-..|+||||+++.....+.+..++|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            456888889999999999999865 5688888887752  2334678899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---CCCeEEeeccCcee
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARI  274 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGla~~  274 (290)
                      +|+|.+++|-.-+..   +..+++...-.+..||+.||.|+|.++   |||||+||.|+|+.+   ..-+||+|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999998554421   234677788899999999999999988   999999999999953   34589999999999


Q ss_pred             eCCCc
Q 022887          275 FGGDE  279 (290)
Q Consensus       275 ~~~~~  279 (290)
                      ++.++
T Consensus       163 l~~g~  167 (355)
T KOG0033|consen  163 VNDGE  167 (355)
T ss_pred             eCCcc
Confidence            98433

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=1e-23  Score=180.45  Aligned_cols=151  Identities=30%  Similarity=0.429  Sum_probs=129.0

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  198 (290)
                      ++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999884 578899998875332 3456789999999999999999999998754  3679999


Q ss_pred             EecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          199 EYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       199 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||+++++|.+++... .....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999998876432 23455788999999999999999999887   9999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.91  E-value=4.3e-24  Score=180.73  Aligned_cols=145  Identities=35%  Similarity=0.525  Sum_probs=124.1

Q ss_pred             ceecccCCccEEEEEEcC-------CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          129 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +.||+|+||.||+|...+       +..+|+|.+.... .....++.+|+..++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998643       2578999876432 23456889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-----CeEEeeccC
Q 022887          201 MPNKSLDVFLFYPK----KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-----NPKISDFGM  271 (290)
Q Consensus       201 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-----~~kl~DfGl  271 (290)
                      +++++|.+++....    ....+++.+++.++.|++.||.|||+.+   ++|+||||+||+++++.     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999885422    2345789999999999999999999877   99999999999999877     899999999


Q ss_pred             ceeeC
Q 022887          272 ARIFG  276 (290)
Q Consensus       272 a~~~~  276 (290)
                      ++.+.
T Consensus       158 ~~~~~  162 (269)
T cd05044         158 ARDIY  162 (269)
T ss_pred             ccccc
Confidence            97654

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.91  E-value=8e-24  Score=182.15  Aligned_cols=152  Identities=29%  Similarity=0.474  Sum_probs=128.9

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC----
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG----  192 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  192 (290)
                      ...++|+..+.||+|+||.||+|... +++.||+|.+....  ......+..|+.++.+++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999885 47899999986432  223456788999999999999999999987655    


Q ss_pred             ------eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEE
Q 022887          193 ------ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  266 (290)
Q Consensus       193 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl  266 (290)
                            ..++|+||+++ ++...+..  ....+++.....++.|++.||.|||+.+   |+|+||+|+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 55555532  2346899999999999999999999887   999999999999999999999


Q ss_pred             eeccCceeeCC
Q 022887          267 SDFGMARIFGG  277 (290)
Q Consensus       267 ~DfGla~~~~~  277 (290)
                      +|||++..+..
T Consensus       158 ~dfg~~~~~~~  168 (302)
T cd07864         158 ADFGLARLYNS  168 (302)
T ss_pred             CcccccccccC
Confidence            99999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.91  E-value=1.3e-23  Score=179.52  Aligned_cols=152  Identities=30%  Similarity=0.450  Sum_probs=135.0

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..++.|+..+.||+|+||.||++... ++..+++|.+..... ....+..|++.+..++|+|++++++.+...+..++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            35567888899999999999999886 578999999975433 4678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            9999999999985422  37899999999999999999999877   99999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.91  E-value=1.9e-23  Score=175.09  Aligned_cols=150  Identities=33%  Similarity=0.495  Sum_probs=133.5

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILIY  198 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  198 (290)
                      +|+..+.||+|++|.||+|... ++..|++|.+.....  .....+.+|+..+.+++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999886 588999999865432  3467899999999999999999999999988  8899999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999988432   37899999999999999999999877   999999999999999999999999999988665


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       155 ~  155 (260)
T cd06606         155 E  155 (260)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.4e-23  Score=177.87  Aligned_cols=153  Identities=30%  Similarity=0.454  Sum_probs=132.0

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCC------
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG------  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------  192 (290)
                      ++++|+..+.||+|+||.||+|... +++.+++|.+.... .....+..|+.++.++ +||||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4679999999999999999999884 47789999886533 2346789999999998 7999999999997654      


Q ss_pred             eeEEEEEecCCCChhhhhhCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccC
Q 022887          193 ENILIYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl  271 (290)
                      ..++||||+++++|.+++.... ....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4799999999999998875322 2456899999999999999999999887   99999999999999999999999999


Q ss_pred             ceeeCC
Q 022887          272 ARIFGG  277 (290)
Q Consensus       272 a~~~~~  277 (290)
                      +.....
T Consensus       160 ~~~~~~  165 (275)
T cd06608         160 SAQLDS  165 (275)
T ss_pred             ceeccc
Confidence            986643

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.91  E-value=1.5e-23  Score=175.97  Aligned_cols=151  Identities=26%  Similarity=0.429  Sum_probs=130.4

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+...  .......+..|+.++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            578889999999999999987 45789999988643  223456889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC-CCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGla~~~~~~  278 (290)
                      +++++|.+++... ....+++.....++.|++.||.|||+++   ++|+||+|+||+++++ ..+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999988532 2345889999999999999999999887   9999999999999855 46899999999877543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=1.7e-23  Score=168.21  Aligned_cols=143  Identities=21%  Similarity=0.234  Sum_probs=112.2

Q ss_pred             cceecccCCccEEEEEEcCCcEEEEEEecccccc--C------------------------HHHHHHHHHHHcccCCCCc
Q 022887          128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--G------------------------LTEFKNEMMLIAKLQHRHL  181 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  181 (290)
                      ...||+|+||.||+|...+|+.||||.+......  .                        ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998754211  0                        1123578889999999987


Q ss_pred             ceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCceecCCCCCCEEEcC
Q 022887          182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDS  260 (290)
Q Consensus       182 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlk~~Nill~~  260 (290)
                      .....+...  ..++||||++++++.....   ....++......++.|++.++.++|+ .+   |+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            554444333  3489999999886543321   12346778889999999999999998 77   99999999999998 


Q ss_pred             CCCeEEeeccCceeeCCCc
Q 022887          261 DMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       261 ~~~~kl~DfGla~~~~~~~  279 (290)
                      ++.++|+|||+|+.++.+.
T Consensus       153 ~~~~~liDFG~a~~~~~~~  171 (190)
T cd05145         153 DGKPYIIDVSQAVELDHPN  171 (190)
T ss_pred             CCCEEEEEcccceecCCCC
Confidence            8899999999999886653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.91  E-value=1.2e-23  Score=179.11  Aligned_cols=142  Identities=30%  Similarity=0.389  Sum_probs=123.7

Q ss_pred             ecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       131 ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      ||+|+||.||++... +++.+|+|.+....   ......+..|+.++..++|||++++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999764 58899999886432   22345667899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ..++.... ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+.
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            98885432 246899999999999999999999887   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.91  E-value=6e-24  Score=179.40  Aligned_cols=149  Identities=29%  Similarity=0.386  Sum_probs=131.4

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|+||.||++... +++.+|+|.+.... .....++.+|+..+.+++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36778889999999999999885 57899999887543 23456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++++|.+++....  ..+++.....++.|++.||.|||+ .+   ++|+||+|+||++++++.++|+|||++..+.
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            99999999885422  568889999999999999999998 66   9999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.91  E-value=7.3e-24  Score=185.44  Aligned_cols=149  Identities=30%  Similarity=0.502  Sum_probs=127.0

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCC--ee
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG--EN  194 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~--~~  194 (290)
                      ..++|+..+.||+|+||.||+|... +++.+|+|++...  .......+..|+.++.++ +||||+++++++...+  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3568899999999999999999875 5789999988542  223345677899999999 9999999999987543  57


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||++ ++|..++..    ..++|..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 588777632    26889999999999999999999887   99999999999999999999999999987


Q ss_pred             eCC
Q 022887          275 FGG  277 (290)
Q Consensus       275 ~~~  277 (290)
                      +..
T Consensus       157 ~~~  159 (337)
T cd07852         157 LSE  159 (337)
T ss_pred             ccc
Confidence            654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.91  E-value=9.7e-24  Score=181.07  Aligned_cols=143  Identities=26%  Similarity=0.403  Sum_probs=127.1

Q ss_pred             cceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          128 QCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      ...||+|+||.||++.. .+++.||||++..........+.+|+.++..++|||++++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            36799999999999987 46889999988654444556789999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      .+++.    ...+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+..
T Consensus       105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657         105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            98763    235789999999999999999999887   99999999999999999999999999876644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.91  E-value=6.6e-24  Score=192.23  Aligned_cols=154  Identities=24%  Similarity=0.363  Sum_probs=120.6

Q ss_pred             HhcCCCccceecccCCccEEEEEE-----------------cCCcEEEEEEeccccccCHHH--------------HHHH
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSNQSGQGLTE--------------FKNE  169 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~e  169 (290)
                      ..++|+..++||+|+||.||+|..                 ..++.||||++.........+              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 234679999986533222223              3346


Q ss_pred             HHHHcccCCCCc-----ceeEEEEEe--------CCeeEEEEEecCCCChhhhhhCCCC---------------------
Q 022887          170 MMLIAKLQHRHL-----VRLFGCCIE--------QGENILIYEYMPNKSLDVFLFYPKK---------------------  215 (290)
Q Consensus       170 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  215 (290)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777776654     677887754        3568999999999999988864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          216 KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       216 ~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ...++|.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  361 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT  361 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence            123567888999999999999999887   99999999999999999999999999976543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.91  E-value=1.5e-23  Score=178.71  Aligned_cols=141  Identities=29%  Similarity=0.353  Sum_probs=117.2

Q ss_pred             eecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHH---HcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          130 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMML---IAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      .||+|+||.||++... +++.+|+|.+.....   .....+.+|..+   +...+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999874 578999998864321   112234444433   334579999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++|..++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++....
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            9999988742   345899999999999999999999987   9999999999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.91  E-value=5.2e-24  Score=179.42  Aligned_cols=141  Identities=28%  Similarity=0.411  Sum_probs=125.0

Q ss_pred             ecccCCccEEEEEEcC-CcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       131 ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      ||+|+||.||++...+ ++.+++|.+.....   .....+..|+.++.+++||||+++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999998864 88999999865432   3456788999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      .+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            998843   236899999999999999999999887   99999999999999999999999999976543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.91  E-value=1.1e-23  Score=179.57  Aligned_cols=158  Identities=28%  Similarity=0.444  Sum_probs=132.5

Q ss_pred             cHHhHHHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEe-
Q 022887          114 SLASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE-  190 (290)
Q Consensus       114 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  190 (290)
                      +..+...+.+.|+..+.||+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +|||++++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            3444555678999999999999999999987 457889999886432 3346788899999888 69999999999863 


Q ss_pred             -----CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeE
Q 022887          191 -----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  265 (290)
Q Consensus       191 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~k  265 (290)
                           .+..+++|||+++|+|..++.... ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 356799999999999998875422 345788888999999999999999887   99999999999999999999


Q ss_pred             EeeccCceeeC
Q 022887          266 ISDFGMARIFG  276 (290)
Q Consensus       266 l~DfGla~~~~  276 (290)
                      |+|||++....
T Consensus       162 l~dfg~~~~~~  172 (282)
T cd06636         162 LVDFGVSAQLD  172 (282)
T ss_pred             EeeCcchhhhh
Confidence            99999987653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.91  E-value=2e-23  Score=178.51  Aligned_cols=147  Identities=26%  Similarity=0.408  Sum_probs=129.6

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      .|...+.||+|++|.||++.. .+++.+++|++..........+.+|+.++..++|||++++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            455567999999999999986 4578999998865444445678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++|.+++..    ..+++.....++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++.....
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            9999998743    45889999999999999999999887   99999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=9.1e-25  Score=195.41  Aligned_cols=153  Identities=37%  Similarity=0.516  Sum_probs=133.3

Q ss_pred             cCCCccceecccCCccEEEEEEcC--Cc--EEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~--~~--~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++....++||+|.||.|++|.|..  |.  .||||.+...... ...+|.+|+..|.+|+|||+++|+|...+ ....||
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            445566899999999999998843  33  5899999865443 67899999999999999999999999988 677899


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +|.++.|+|.+-|.. .....+-......++.|||.||.||.++.   +|||||.++|+||-..-.+||+||||.|-++.
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999998865 34455777888999999999999999887   99999999999999999999999999999987


Q ss_pred             Ccc
Q 022887          278 DEL  280 (290)
Q Consensus       278 ~~~  280 (290)
                      ++.
T Consensus       265 ned  267 (1039)
T KOG0199|consen  265 NED  267 (1039)
T ss_pred             CCc
Confidence            653

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.91  E-value=1.4e-23  Score=176.82  Aligned_cols=156  Identities=27%  Similarity=0.464  Sum_probs=129.9

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILIY  198 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  198 (290)
                      +|+..+.||.|+||.||++.. .++..+|+|.+....  ......+..|+..++.++|||++++++++...  ...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999986 457889999886432  23345788899999999999999999987643  4578999


Q ss_pred             EecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          199 EYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       199 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ||+++++|..++... .....+++...+.++.|++.||.|||..+  ..+++|+||+|+||++++++.+||+|||++..+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999887542 22456899999999999999999999332  334999999999999999999999999999987


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      ....
T Consensus       161 ~~~~  164 (265)
T cd08217         161 GHDS  164 (265)
T ss_pred             cCCc
Confidence            6543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.91  E-value=1.9e-23  Score=178.16  Aligned_cols=148  Identities=32%  Similarity=0.527  Sum_probs=128.6

Q ss_pred             CCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEEEEE
Q 022887          125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILIYE  199 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  199 (290)
                      |+..+.||+|+||.||+|... +++.+|+|.+....  ......+..|+.++..++|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999875 47899999997642  33446788999999999999999999999988  78999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+++ +|..++...  ...+++...+.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9985 777776432  246899999999999999999999887   999999999999999999999999999877554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.91  E-value=1.9e-23  Score=180.61  Aligned_cols=150  Identities=31%  Similarity=0.466  Sum_probs=127.6

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  196 (290)
                      .++|+..+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.++.+++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            468999999999999999999874 588999998864322  2234567899999999999999999998765  46799


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++ +|..++...  ...+++.+...++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 677766432  356899999999999999999999987   9999999999999999999999999998775


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       160 ~  160 (309)
T cd07845         160 L  160 (309)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.91  E-value=1.5e-23  Score=183.98  Aligned_cols=150  Identities=25%  Similarity=0.399  Sum_probs=127.5

Q ss_pred             HHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC----
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG----  192 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  192 (290)
                      ...++|+..+.||+|+||.||++.. .++..||||.+....  ......+..|+.++..++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3467899999999999999999986 458899999985422  223456889999999999999999999987654    


Q ss_pred             --eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          193 --ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       193 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                        ..++||||+ +++|..++.    ...+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence              348999998 668877763    245889999999999999999999887   9999999999999999999999999


Q ss_pred             CceeeCC
Q 022887          271 MARIFGG  277 (290)
Q Consensus       271 la~~~~~  277 (290)
                      +++....
T Consensus       164 ~~~~~~~  170 (343)
T cd07880         164 LARQTDS  170 (343)
T ss_pred             ccccccc
Confidence            9987654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.91  E-value=2.2e-23  Score=175.83  Aligned_cols=142  Identities=27%  Similarity=0.361  Sum_probs=125.5

Q ss_pred             ecccCCccEEEEEEcC-CcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       131 ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      ||.|+||.||++.... ++.+|+|.+.....   .....+..|+.++..++||||+++++.+.+.+..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999998854 78999999864322   2346789999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      .+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            998843   345889999999999999999999877   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.90  E-value=1.4e-23  Score=183.62  Aligned_cols=148  Identities=26%  Similarity=0.435  Sum_probs=126.0

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-----ee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----EN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  194 (290)
                      +++|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+..|+.++.+++||||+++++++...+     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999986 458899999986432 234467888999999999999999998876543     47


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++++||+++ ++...+.    ...+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            899999975 6665552    345899999999999999999999887   99999999999999999999999999987


Q ss_pred             eCC
Q 022887          275 FGG  277 (290)
Q Consensus       275 ~~~  277 (290)
                      ...
T Consensus       156 ~~~  158 (336)
T cd07849         156 ADP  158 (336)
T ss_pred             ccc
Confidence            644

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.90  E-value=6.3e-24  Score=180.51  Aligned_cols=150  Identities=31%  Similarity=0.462  Sum_probs=132.5

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++|...+.||+|+||.||++... +++.||+|.+....   ......+..|..++.+++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47888899999999999999875 68899999886522   233467888999999998 99999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++..+..
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999988843   346999999999999999999999887   99999999999999999999999999987754


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       155 ~  155 (280)
T cd05581         155 N  155 (280)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.90  E-value=3.8e-23  Score=179.46  Aligned_cols=149  Identities=32%  Similarity=0.502  Sum_probs=127.3

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      +.|+..+.||+|+||.||++... ++..+|+|.+.....   .....+..|+..+..++|||++++++++...+..++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34777889999999999999874 578999998864322   23457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++ ++.+.+..  ....+++.++..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus       105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            99975 66665532  2345899999999999999999999887   99999999999999999999999999876643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.90  E-value=2.6e-23  Score=177.36  Aligned_cols=147  Identities=30%  Similarity=0.502  Sum_probs=127.4

Q ss_pred             CCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      |+..+.||.|++|.||+|... ++..||+|++....  ......+.+|+..+..++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999874 68999999886432  223467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      + ++|..++.... ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+.
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            5 68888774322 236899999999999999999999877   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.90  E-value=1.9e-23  Score=178.68  Aligned_cols=148  Identities=28%  Similarity=0.364  Sum_probs=127.7

Q ss_pred             CCCccceecccCCccEEEEEE----cCCcEEEEEEecccc----ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCee
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  194 (290)
                      +|+..+.||+|+||.||++..    .++..||||.+....    ......+..|+.++.++ +||||+++++.+...+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            467788999999999999975    346789999886432    22345688999999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||+++++|..++..   ...+++.....++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999888742   345889999999999999999999877   99999999999999999999999999987


Q ss_pred             eCC
Q 022887          275 FGG  277 (290)
Q Consensus       275 ~~~  277 (290)
                      +..
T Consensus       155 ~~~  157 (288)
T cd05583         155 FLA  157 (288)
T ss_pred             ccc
Confidence            644

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.90  E-value=3.4e-24  Score=201.70  Aligned_cols=150  Identities=34%  Similarity=0.511  Sum_probs=116.6

Q ss_pred             HHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe----
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE----  193 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  193 (290)
                      +-.++|+.++.||+||||.||+++. -||+.+|||++... .........+|+.++++|+|||||+++..|.+...    
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4457899999999999999999987 47999999999743 33445678899999999999999998765522110    


Q ss_pred             --------------------------------------------------------------------------------
Q 022887          194 --------------------------------------------------------------------------------  193 (290)
Q Consensus       194 --------------------------------------------------------------------------------  193 (290)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 022887          194 -----------------------------------NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL  238 (290)
Q Consensus       194 -----------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL  238 (290)
                                                         .|+-||||+..++..++....-.  -.....++++.+|+.||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence                                               13445555555555444221110  02456788999999999999


Q ss_pred             hhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       239 H~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      |+++   ||||||||.||++|++..|||+|||+|..
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence            9988   99999999999999999999999999987

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.90  E-value=4.2e-23  Score=177.11  Aligned_cols=149  Identities=28%  Similarity=0.464  Sum_probs=125.3

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+..+.||+|++|.||+|... +++.||+|.+....  ......+..|+.++.+++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57888999999999999999875 58899999886432  2234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-CCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~  276 (290)
                      |+++ ++..++... ....+++.....++.|++.||+|||+.+   ++|+||+|+||++++ +..+||+|||++....
T Consensus        82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            9964 666665322 2234678888899999999999999887   999999999999985 5679999999998664

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.90  E-value=1.3e-23  Score=183.69  Aligned_cols=149  Identities=23%  Similarity=0.399  Sum_probs=127.3

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEe----CCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  194 (290)
                      .++|+..+.||+|+||.||++... ++..||+|++....  ......+..|+.++.+++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999874 58899999986532  2345677889999999999999999988763    3467


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||++ ++|..++.   ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 57877763   2345899999999999999999999887   99999999999999999999999999987


Q ss_pred             eCC
Q 022887          275 FGG  277 (290)
Q Consensus       275 ~~~  277 (290)
                      ...
T Consensus       157 ~~~  159 (334)
T cd07855         157 LSS  159 (334)
T ss_pred             ecc
Confidence            654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5.4e-24  Score=190.51  Aligned_cols=156  Identities=29%  Similarity=0.477  Sum_probs=130.3

Q ss_pred             eecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCChhh
Q 022887          130 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDV  208 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  208 (290)
                      +||+|.||+||-|++.+ ...+|||-+.........-+.+|+.+-++++|.|||+.+|.+.+.+..-+.||-+++|+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999998855 55799999987777777889999999999999999999999999999999999999999999


Q ss_pred             hhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc-CCCCeEEeeccCceeeCCCccccCccee
Q 022887          209 FLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARIFGGDELQGNTKRI  287 (290)
Q Consensus       209 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~  287 (290)
                      +|...=..-.-.+.+.-.+..||++||.|||++.   |||||||-+|+|++ -.|.+||+|||.++.+-.  ....|.++
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence            8854211111266777888999999999999987   99999999999997 468899999999987733  22234445


Q ss_pred             ecC
Q 022887          288 VGT  290 (290)
Q Consensus       288 ~Gt  290 (290)
                      -||
T Consensus       737 TGT  739 (1226)
T KOG4279|consen  737 TGT  739 (1226)
T ss_pred             ccc
Confidence            555

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.90  E-value=5.7e-23  Score=172.29  Aligned_cols=152  Identities=24%  Similarity=0.431  Sum_probs=133.9

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|+||.||++... ++..+++|.+.....  ....++..|++.+..++|||++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999875 578999999875432  4556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|..++.... ....+++.....++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999998875432 2366899999999999999999999887   999999999999999999999999999877554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.90  E-value=2.4e-23  Score=174.86  Aligned_cols=151  Identities=26%  Similarity=0.459  Sum_probs=130.1

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|+||.||++... ++..+|+|.+....  ......+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999875 47889999886431  23446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-CeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~~~  278 (290)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++ .+||+|||.+..+..+
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999887532 2335799999999999999999999887   99999999999999875 5699999999877543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PTZ00284 protein kinase; Provisional

Probab=99.90  E-value=2.2e-23  Score=190.11  Aligned_cols=149  Identities=23%  Similarity=0.297  Sum_probs=117.7

Q ss_pred             HHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccC------CCCcceeEEEEEeC
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ------HRHLVRLFGCCIEQ  191 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~  191 (290)
                      ....++|+..+.||+|+||.||+|... +++.||||+++... ....++..|+.++..++      |++++++++++...
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            345678999999999999999999874 47889999986432 23345566777666664      45588898888765


Q ss_pred             -CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEcCCC-------
Q 022887          192 -GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDM-------  262 (290)
Q Consensus       192 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~~~~-------  262 (290)
                       +..++|||++ +++|..++..   ...+++.....|+.|++.||.|||++ +   |+||||||+|||++.++       
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence             4678999988 5567666632   34689999999999999999999974 5   99999999999998765       


Q ss_pred             ---------CeEEeeccCceee
Q 022887          263 ---------NPKISDFGMARIF  275 (290)
Q Consensus       263 ---------~~kl~DfGla~~~  275 (290)
                               .+||+|||++...
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~  298 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDE  298 (467)
T ss_pred             ccccCCCCceEEECCCCccccC
Confidence                     4999999988643

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.90  E-value=4.4e-23  Score=175.75  Aligned_cols=141  Identities=30%  Similarity=0.356  Sum_probs=117.3

Q ss_pred             eecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHH---HHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          130 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMM---LIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      .||+|+||.||++... +++.||+|.+.....   .....+..|..   .+....||||+++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999874 578999998865321   11222334433   3445689999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++|..++.   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            999988874   2346899999999999999999999887   9999999999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.90  E-value=3.1e-23  Score=182.60  Aligned_cols=149  Identities=30%  Similarity=0.411  Sum_probs=125.8

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-----
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  192 (290)
                      ..++|+..+.||+|+||.||++... +++.||+|.+...  .......+..|+.++.+++||||+++++++....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999874 6889999998642  2233456788999999999999999999886443     


Q ss_pred             -eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccC
Q 022887          193 -ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       193 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl  271 (290)
                       ..++||||+++ +|...+..     .+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence             46899999965 66666521     2788899999999999999999887   99999999999999999999999999


Q ss_pred             ceeeCCC
Q 022887          272 ARIFGGD  278 (290)
Q Consensus       272 a~~~~~~  278 (290)
                      ++..+..
T Consensus       165 ~~~~~~~  171 (353)
T cd07850         165 ARTAGTS  171 (353)
T ss_pred             ceeCCCC
Confidence            9877543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.90  E-value=3.9e-23  Score=178.40  Aligned_cols=151  Identities=29%  Similarity=0.491  Sum_probs=126.1

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe----
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE----  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  193 (290)
                      ..++|+..+.||+|+||.||++... +++.||||.+....  ......+.+|+.++.+++||||+++++++...+.    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999874 58899999886432  2223456789999999999999999999876543    


Q ss_pred             ----eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeec
Q 022887          194 ----NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  269 (290)
Q Consensus       194 ----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  269 (290)
                          .++||||+++ ++...+..  ....+++.+...++.|++.||.|||+.+   ++|+||||+||++++++.+||+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence                4999999975 66666532  2335899999999999999999999887   999999999999999999999999


Q ss_pred             cCceeeCC
Q 022887          270 GMARIFGG  277 (290)
Q Consensus       270 Gla~~~~~  277 (290)
                      |++..+..
T Consensus       164 g~~~~~~~  171 (310)
T cd07865         164 GLARAFSL  171 (310)
T ss_pred             CCcccccC
Confidence            99987644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.1e-24  Score=183.44  Aligned_cols=153  Identities=31%  Similarity=0.429  Sum_probs=126.8

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEec--ccc-----ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC-Ce
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLS--NQS-----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-GE  193 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~--~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~  193 (290)
                      ++|-.+.+||+|+|+.||++.+ ...+.||+|+-.  +..     ....+...+|..+-+.|+||.||++++++.-+ +.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            3566678999999999999975 456788988543  111     11234466888899999999999999998755 56


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---CCCeEEeecc
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFG  270 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfG  270 (290)
                      .+-|+||+++.+|+-||   +..+.+++.+...|++||+.||.||.+. .+||||-||||.||||-+   .|.+||+|||
T Consensus       543 FCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            78899999999999998   4567799999999999999999999986 578999999999999954   4789999999


Q ss_pred             CceeeCCCc
Q 022887          271 MARIFGGDE  279 (290)
Q Consensus       271 la~~~~~~~  279 (290)
                      |+++++.+.
T Consensus       619 LSKIMdddS  627 (775)
T KOG1151|consen  619 LSKIMDDDS  627 (775)
T ss_pred             hhhhccCCc
Confidence            999997753

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.90  E-value=4.1e-23  Score=180.56  Aligned_cols=147  Identities=29%  Similarity=0.412  Sum_probs=125.7

Q ss_pred             cCCCc-cceecccCCccEEEEEEc-CCcEEEEEEeccccccC--------------HHHHHHHHHHHcccCCCCcceeEE
Q 022887          123 ENFST-QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG--------------LTEFKNEMMLIAKLQHRHLVRLFG  186 (290)
Q Consensus       123 ~~~~~-~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~  186 (290)
                      ++|.. .+.||+|+||.||+|... +++.||+|.+.......              ...+.+|+.++..++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            46654 467999999999999874 58899999886432211              125778999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEE
Q 022887          187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  266 (290)
Q Consensus       187 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl  266 (290)
                      ++...+..++||||++ |+|.+++.   ....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 58887773   2345889999999999999999999887   999999999999999999999


Q ss_pred             eeccCceeeC
Q 022887          267 SDFGMARIFG  276 (290)
Q Consensus       267 ~DfGla~~~~  276 (290)
                      +|||+++...
T Consensus       161 ~dfg~~~~~~  170 (335)
T PTZ00024        161 ADFGLARRYG  170 (335)
T ss_pred             CCccceeecc
Confidence            9999998776

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.90  E-value=5e-23  Score=180.79  Aligned_cols=155  Identities=28%  Similarity=0.383  Sum_probs=129.0

Q ss_pred             HHhHHHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC
Q 022887          115 LASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ  191 (290)
Q Consensus       115 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  191 (290)
                      ..++...+++|+..+.||+|+||.||++.. .+++.||+|++....  ......+.+|+.++.+++||||+++.+++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            344556778999999999999999999976 468899999986432  22345678899999999999999999988643


Q ss_pred             ------CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeE
Q 022887          192 ------GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  265 (290)
Q Consensus       192 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~k  265 (290)
                            ...+++++++ +++|..++.    ...+++..+..++.|+++||.|||+.+   ++||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  2357777776 678877763    235899999999999999999999887   99999999999999999999


Q ss_pred             EeeccCceeeCC
Q 022887          266 ISDFGMARIFGG  277 (290)
Q Consensus       266 l~DfGla~~~~~  277 (290)
                      |+|||+++....
T Consensus       161 l~dfg~~~~~~~  172 (345)
T cd07877         161 ILDFGLARHTDD  172 (345)
T ss_pred             Eecccccccccc
Confidence            999999986543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.90  E-value=6.7e-23  Score=174.56  Aligned_cols=146  Identities=26%  Similarity=0.373  Sum_probs=121.9

Q ss_pred             CCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccC-CCCcceeEEEEEeC--CeeEEEEE
Q 022887          125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQ--GENILIYE  199 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  199 (290)
                      |+..+.||+|+||.||++... +++.+|+|.+.... .........|+..+.++. |||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566789999999999999874 57899999886532 222234457888888885 99999999999987  88999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |+++ ++.+++..  ....++|.+...++.|++.||.|||+.+   ++||||+|+||++++ +.+||+|||+++.+..
T Consensus        81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            9974 66666532  2346899999999999999999999887   999999999999999 9999999999987643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.90  E-value=1.2e-22  Score=172.16  Aligned_cols=151  Identities=23%  Similarity=0.301  Sum_probs=122.6

Q ss_pred             hHHHHhcCCCcccee--cccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcc-cCCCCcceeEEEEEeCC
Q 022887          117 SVSAATENFSTQCKL--GEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQG  192 (290)
Q Consensus       117 ~~~~~~~~~~~~~~i--g~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~  192 (290)
                      +.....++|+..+.+  |+|+||.||++.. .++..+|+|.+.......   .  |+..... .+|||++++++.+...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            344455677777776  9999999999987 457889999886532211   1  2221111 27999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-CeEEeeccC
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGM  271 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGl  271 (290)
                      ..++||||+++++|..++..   ...+++.+...++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            99999999999999998843   237899999999999999999999887   99999999999999988 999999999


Q ss_pred             ceeeCCC
Q 022887          272 ARIFGGD  278 (290)
Q Consensus       272 a~~~~~~  278 (290)
                      ++..+..
T Consensus       157 ~~~~~~~  163 (267)
T PHA03390        157 CKIIGTP  163 (267)
T ss_pred             ceecCCC
Confidence            9876543

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.90  E-value=3.5e-23  Score=181.16  Aligned_cols=149  Identities=25%  Similarity=0.438  Sum_probs=126.6

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-----e
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----E  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~  193 (290)
                      .++|...+.||+|+||.||++.. .++..||||.+...  .......+..|+.++..++||||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35789999999999999999987 45889999998643  2233456788999999999999999999876542     4


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++|+||+. ++|..++.   ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 57777663   2356899999999999999999999887   9999999999999999999999999998


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      ....
T Consensus       157 ~~~~  160 (337)
T cd07858         157 TTSE  160 (337)
T ss_pred             ccCC
Confidence            7644

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.90  E-value=7.9e-24  Score=181.19  Aligned_cols=154  Identities=28%  Similarity=0.345  Sum_probs=135.5

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      +.|+.-++||+|+||.|+-+.. .+|.-+|.|++.+.   ..+......+|-.++.+++.+.||.+--.+.+.+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5677778999999999999965 45888999988643   2345567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ..|++|+|.-++++.. .+.+++....-++.+|+.||++||...   ||.||+||+|||||+.|+++|+|+|||.-+..+
T Consensus       265 tlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            9999999988876543 367899999999999999999999887   999999999999999999999999999998776


Q ss_pred             cc
Q 022887          279 EL  280 (290)
Q Consensus       279 ~~  280 (290)
                      +.
T Consensus       341 ~~  342 (591)
T KOG0986|consen  341 KP  342 (591)
T ss_pred             Cc
Confidence            54

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-23  Score=184.83  Aligned_cols=158  Identities=26%  Similarity=0.362  Sum_probs=131.4

Q ss_pred             cCCCccceecccCCccEEEEEEcC-CcEEEEEEecccccc--------CHHHHHHHHHHHcccC---CCCcceeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ--------GLTEFKNEMMLIAKLQ---HRHLVRLFGCCIE  190 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  190 (290)
                      .+|+..+.+|+|+||+|+.+.++. .-+|+||.+.++..-        ..-..-.|+.+|..++   |+||++++++|.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            358889999999999999998854 568999988754211        1223567999999997   9999999999999


Q ss_pred             CCeeEEEEEecCCC-ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeec
Q 022887          191 QGENILIYEYMPNK-SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  269 (290)
Q Consensus       191 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  269 (290)
                      ++..||+||-...| +|.+++   ...+.+++.+...|+.||+.|+++||+++   |||||||-+|+.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999987544 344444   34566899999999999999999999998   999999999999999999999999


Q ss_pred             cCceeeCCCccccCcceeecC
Q 022887          270 GMARIFGGDELQGNTKRIVGT  290 (290)
Q Consensus       270 Gla~~~~~~~~~~~~~~~~Gt  290 (290)
                      |.|.....++++    .++||
T Consensus       715 gsaa~~ksgpfd----~f~gt  731 (772)
T KOG1152|consen  715 GSAAYTKSGPFD----VFVGT  731 (772)
T ss_pred             cchhhhcCCCcc----eeeee
Confidence            999988777654    35555

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=7.5e-23  Score=172.34  Aligned_cols=142  Identities=25%  Similarity=0.338  Sum_probs=119.0

Q ss_pred             ceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHH-HcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMML-IAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||+|... +++.||+|.+.....   .....+..|... ....+|||++++++.+...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999874 578999999864321   122334445443 4556899999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ++|..++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++...
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            999998843   345788999999999999999999887   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.90  E-value=9.9e-23  Score=177.95  Aligned_cols=147  Identities=29%  Similarity=0.413  Sum_probs=122.3

Q ss_pred             CCCccceecccCCccEEEEEEcC---CcEEEEEEecccc--ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeC----Ce
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ----GE  193 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~---~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  193 (290)
                      +|+..+.||+|+||.||++....   +..||+|.+....  ......+..|+.++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            47778899999999999998743   6789999886432  22346788899999999 599999999876543    34


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++++||++ ++|..++.   ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888886 57877763   3456899999999999999999999887   9999999999999999999999999998


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      .+..
T Consensus       154 ~~~~  157 (332)
T cd07857         154 GFSE  157 (332)
T ss_pred             eccc
Confidence            7653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.90  E-value=4.3e-23  Score=173.13  Aligned_cols=152  Identities=30%  Similarity=0.471  Sum_probs=131.9

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +|+..+.||+|+||.||++... +++.+++|.+....  .....++..|+.+++.++||||+++.+++...+..++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999764 57899999986432  23356788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|..++.... ....+++...+.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            99999998874421 2356899999999999999999999887   999999999999999999999999999877554

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.89  E-value=3.9e-23  Score=180.23  Aligned_cols=148  Identities=30%  Similarity=0.432  Sum_probs=129.0

Q ss_pred             CCCccceecccCCccEEEEEEcC-CcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-----eeE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----ENI  195 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  195 (290)
                      +|...+.||+|+||.||++...+ +..+|+|++....  ....+.+..|+..+..++||||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            47788999999999999998754 8899999987543  334568899999999999999999999988775     789


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ++|||+++ +|..++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999984 77777632   337899999999999999999999887   999999999999999999999999999987


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      ...
T Consensus       154 ~~~  156 (330)
T cd07834         154 DPD  156 (330)
T ss_pred             ccc
Confidence            654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.89  E-value=8.9e-23  Score=177.94  Aligned_cols=150  Identities=31%  Similarity=0.453  Sum_probs=127.5

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEe-CCeeE
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGENI  195 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~  195 (290)
                      ..+++|+..+.||+|+||.||++... ++..||+|++...  .......+..|+.++..++||||+++.+++.. .+..+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45688999999999999999999864 6889999988542  22335678899999999999999999999876 45788


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +++||+ +++|..++.    ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 457877763    235788888899999999999999887   999999999999999999999999999865


Q ss_pred             CC
Q 022887          276 GG  277 (290)
Q Consensus       276 ~~  277 (290)
                      +.
T Consensus       159 ~~  160 (328)
T cd07856         159 DP  160 (328)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.89  E-value=6.6e-23  Score=174.75  Aligned_cols=148  Identities=31%  Similarity=0.427  Sum_probs=126.5

Q ss_pred             CCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEEEec
Q 022887          125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      |+..+.||+|+||.||+|... +++.|+||++..... .......+|+..+.+++ |||++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999985 478899999865322 22234567889999999 999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                       +|+|..++.... ...+++.....++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence             788887764322 346899999999999999999999887   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=5.7e-24  Score=175.44  Aligned_cols=161  Identities=29%  Similarity=0.319  Sum_probs=133.4

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccC---HHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|..+++||+|.||+|.+++- .+++.+|||++++...-.   ...-..|-.+|...+||.+..+--.+...+..++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46899999999999999999976 458899999998653322   33456788899999999999998889999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||..+|.|.-+|.   ..+.+++....-+-..|..||.|||+++   ||.||+|.+|.|+|.+|.+||+||||++.=-.
T Consensus       247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999977763   3456777777778889999999999988   99999999999999999999999999985333


Q ss_pred             CccccCcceeecC
Q 022887          278 DELQGNTKRIVGT  290 (290)
Q Consensus       278 ~~~~~~~~~~~Gt  290 (290)
                      +..  .+..+.||
T Consensus       321 ~g~--t~kTFCGT  331 (516)
T KOG0690|consen  321 YGD--TTKTFCGT  331 (516)
T ss_pred             ccc--eeccccCC
Confidence            222  24456666

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.89  E-value=1e-22  Score=174.97  Aligned_cols=150  Identities=27%  Similarity=0.419  Sum_probs=124.8

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccc-cCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .++|+..+.||+|+||.||++...+ ++.||||.+..... ....++..|+..+.+.. ||||+++++++......+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3678889999999999999999865 88999999875322 23456677777666664 999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++ ++..+...  ....+++..+..++.|++.||.|||+. +   ++||||+|+||++++++.+||+|||++..+..
T Consensus        94 e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            99864 56555432  234689999999999999999999973 5   99999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.89  E-value=1.1e-22  Score=178.36  Aligned_cols=146  Identities=28%  Similarity=0.442  Sum_probs=123.6

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  192 (290)
                      .++|...+.||+|+||.||+|... +++.||+|++....  ......+.+|+.++..++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468999999999999999999874 58899999986432  223456889999999999999999999987543      


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..++|+||+.. ++..+.     ...+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999964 565543     235889999999999999999999887   999999999999999999999999999


Q ss_pred             eeeC
Q 022887          273 RIFG  276 (290)
Q Consensus       273 ~~~~  276 (290)
                      +...
T Consensus       165 ~~~~  168 (342)
T cd07879         165 RHAD  168 (342)
T ss_pred             cCCC
Confidence            8654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.6e-23  Score=180.65  Aligned_cols=153  Identities=25%  Similarity=0.350  Sum_probs=132.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..-|...+.||+|-|..|-++++ -+|+.||||++.+..-  .....+.+|+.-|+.++|||||+|+.+...+...|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            34677789999999999999976 5799999999976432  23457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE-cCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill-~~~~~~kl~DfGla~~~~~  277 (290)
                      |.=.+|+|.+|+...  ...+.+....+++.||+.|+.|+|+..   +|||||||+|+.+ ..-|-+||+|||++..+.+
T Consensus        97 ELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999998543  345888889999999999999999877   9999999999876 5678899999999988876


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      ++
T Consensus       172 G~  173 (864)
T KOG4717|consen  172 GK  173 (864)
T ss_pred             cc
Confidence            64

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.89  E-value=2.6e-22  Score=173.92  Aligned_cols=145  Identities=32%  Similarity=0.485  Sum_probs=123.9

Q ss_pred             CCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      |...+.||+|+||.||+|... ++..|++|.+.....   .....+..|+.++..++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666678999999999999874 578999999864322   2235688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +. +++..++..  ....+++.++..++.|++.|+.|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            96 466655532  2345899999999999999999999887   999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.89  E-value=3.2e-24  Score=202.89  Aligned_cols=149  Identities=30%  Similarity=0.437  Sum_probs=129.6

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++.....||.|.||.||-+.. ++|+..|+|-+...  .........+|+.++..++|||+|+.+|+-.+.+..++.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            456667899999999999976 55888999977543  334556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |++|+|.+.+..   ++..++.....+..|++.|+.|||+.+   ||||||||.||+|+.+|.+|++|||.|..+.++
T Consensus      1316 C~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             hccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            999999998833   344566666778889999999999988   999999999999999999999999999988765

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.89  E-value=6.7e-23  Score=177.00  Aligned_cols=150  Identities=33%  Similarity=0.502  Sum_probs=125.5

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCC------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  192 (290)
                      .++|+..+.||+|+||.||+|... +++.+|+|.+.....  .....+.+|++++..++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999874 578999998864322  22346788999999999999999999876543      


Q ss_pred             --eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          193 --ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       193 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                        ..++|+||++. ++...+..  ....+++.....++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              35899999976 45554432  2346899999999999999999999887   9999999999999999999999999


Q ss_pred             CceeeCC
Q 022887          271 MARIFGG  277 (290)
Q Consensus       271 la~~~~~  277 (290)
                      +++....
T Consensus       161 ~~~~~~~  167 (311)
T cd07866         161 LARPYDG  167 (311)
T ss_pred             cchhccC
Confidence            9987654

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-22  Score=185.11  Aligned_cols=160  Identities=28%  Similarity=0.441  Sum_probs=137.3

Q ss_pred             cHHhHHHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEe-
Q 022887          114 SLASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE-  190 (290)
Q Consensus       114 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  190 (290)
                      .++.+..+++.|++.+.||.|.+|.||+++. .+++.+|+|++... .....+...|..++... +|||++.++|++.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3444556678899999999999999999976 56888999988753 33446778888888777 69999999999874 


Q ss_pred             ----CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEE
Q 022887          191 ----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  266 (290)
Q Consensus       191 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl  266 (290)
                          ++.+|||||||.+||.-++..... +..+.|.....|+..++.|+.+||...   ++|||+|-.|||++.++.+|+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence                367899999999999999886655 677999999999999999999999877   999999999999999999999


Q ss_pred             eeccCceeeCCC
Q 022887          267 SDFGMARIFGGD  278 (290)
Q Consensus       267 ~DfGla~~~~~~  278 (290)
                      .|||.+..++..
T Consensus       165 vDFGvSaQldsT  176 (953)
T KOG0587|consen  165 VDFGVSAQLDST  176 (953)
T ss_pred             eeeeeeeeeecc
Confidence            999999988654

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.89  E-value=1.5e-22  Score=174.90  Aligned_cols=149  Identities=34%  Similarity=0.515  Sum_probs=126.7

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      +.|+..+.||+|+||.||+|... ++..+|+|.+...   ......++..|+.++..++|||++++.+++...+..++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45777789999999999999874 5788999988642   1223457888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+. |++...+...  ...+++.++..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.....
T Consensus        95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9997 5776655322  345789999999999999999999887   99999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.89  E-value=1.2e-22  Score=173.11  Aligned_cols=148  Identities=30%  Similarity=0.501  Sum_probs=128.1

Q ss_pred             CCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      |+..+.||+|++|.||++... +++.+++|.+.....  .....+..|+..+.+++||||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            556789999999999999874 588899998865432  23567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++ ++..++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||.+..+...
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            76 777666432  246899999999999999999999887   999999999999999999999999999877654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.89  E-value=3.4e-22  Score=170.56  Aligned_cols=149  Identities=34%  Similarity=0.530  Sum_probs=123.3

Q ss_pred             CCccceecccCCccEEEEEEcC-CcEEEEEEeccccc--cCHHHHHHHHHHHccc---CCCCcceeEEEEEeCCe-----
Q 022887          125 FSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLTEFKNEMMLIAKL---QHRHLVRLFGCCIEQGE-----  193 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  193 (290)
                      |+..+.||+|+||.||+|.... +..+|+|.+.....  .....+..|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5677899999999999999864 88999999864322  2234566777766555   69999999999998776     


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .+++|||+++ +|..++.... ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 7877764322 235899999999999999999999887   9999999999999999999999999998


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .+...
T Consensus       156 ~~~~~  160 (287)
T cd07838         156 IYSFE  160 (287)
T ss_pred             eccCC
Confidence            87543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.89  E-value=3.5e-22  Score=171.57  Aligned_cols=149  Identities=19%  Similarity=0.289  Sum_probs=109.8

Q ss_pred             hcCCCccceecccCCccEEEEEEcCC----cEEEEEEeccccccCH-----------HHHHHHHHHHcccCCCCcceeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQSGQGL-----------TEFKNEMMLIAKLQHRHLVRLFG  186 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~----~~vavK~l~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~  186 (290)
                      .++|.+.+.||+|+||.||+|...++    ..+|+|..........           .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46899999999999999999987543    4556664332211111           11223344566779999999999


Q ss_pred             EEEeCC----eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC
Q 022887          187 CCIEQG----ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       187 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~  262 (290)
                      ++....    ..++++|++.. ++...+..   ....++.....++.|++.||.|||+.+   ++||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            876554    34677777644 44444421   223567888999999999999999887   99999999999999999


Q ss_pred             CeEEeeccCceeeCC
Q 022887          263 NPKISDFGMARIFGG  277 (290)
Q Consensus       263 ~~kl~DfGla~~~~~  277 (290)
                      .+||+|||+|+.+..
T Consensus       164 ~~~l~DFGla~~~~~  178 (294)
T PHA02882        164 RGYIIDYGIASHFII  178 (294)
T ss_pred             cEEEEEcCCceeecc
Confidence            999999999987743

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.89  E-value=1.1e-22  Score=173.09  Aligned_cols=147  Identities=33%  Similarity=0.498  Sum_probs=128.6

Q ss_pred             CCccceecccCCccEEEEEEcC-CcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          125 FSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      |+..+.||+|+||.||+|.... ++.+|+|.+....  ......+..|+.++..++|||++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            4566889999999999998854 8899999987643  334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      + ++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++....
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            8 58888874321  46899999999999999999999987   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.89  E-value=1.4e-22  Score=176.72  Aligned_cols=141  Identities=25%  Similarity=0.307  Sum_probs=121.1

Q ss_pred             ceeccc--CCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEG--GFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G--~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      ..||+|  +||+||++.. .+++.||+|.+....  ....+.+.+|+.++..++||||+++++++...+..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            457766  8999999987 468999999986432  22346788999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      +++.+++.... ...+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+|++||+.+.
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            99998875432 234888999999999999999999877   9999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.89  E-value=8.7e-23  Score=174.57  Aligned_cols=150  Identities=29%  Similarity=0.439  Sum_probs=123.5

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|...+.||+|+||.||++... +++.+|+|.+.... ......+..|+..+.++. ||||+++++++...+..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35666789999999999999874 47899999986432 234567889999999996 9999999999999999999999


Q ss_pred             ecCCCChhhhhh--CCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLF--YPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~--~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |++. ++..+..  .......+++.....++.|++.||+|||+. +   ++||||||+||++++++.+||+|||+++.+.
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9875 4443321  112235689999999999999999999974 5   9999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.89  E-value=1.6e-22  Score=175.12  Aligned_cols=142  Identities=23%  Similarity=0.224  Sum_probs=118.7

Q ss_pred             eecccCCccEEEEEEcCCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCChh
Q 022887          130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD  207 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  207 (290)
                      .+|.|+++.|+++.. +++.||+|++...  .......+..|+..+..++||||+++++++...+..+++|||+++++|.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            334444444444444 5889999998653  3345578999999999999999999999999999999999999999999


Q ss_pred             hhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          208 VFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       208 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      .++... ....+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||.+..+.
T Consensus        88 ~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          88 DLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             HHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence            988543 2235788899999999999999999887   9999999999999999999999999997653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.89  E-value=1.3e-22  Score=177.93  Aligned_cols=147  Identities=27%  Similarity=0.436  Sum_probs=125.5

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeC---------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ---------  191 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------  191 (290)
                      ..+|...+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++..++||||+++++.+...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368899999999999999999874 5889999998765556667889999999999999999998765543         


Q ss_pred             -----CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc-CCCCeE
Q 022887          192 -----GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPK  265 (290)
Q Consensus       192 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~-~~~~~k  265 (290)
                           ...++|+||++ ++|..++.    ...+++.....++.|++.||.|||+.+   ++||||||+||+++ ++..+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 35789999997 57877663    235889999999999999999999887   99999999999997 456789


Q ss_pred             EeeccCceeeC
Q 022887          266 ISDFGMARIFG  276 (290)
Q Consensus       266 l~DfGla~~~~  276 (290)
                      ++|||+++.+.
T Consensus       156 l~dfg~~~~~~  166 (342)
T cd07854         156 IGDFGLARIVD  166 (342)
T ss_pred             ECCcccceecC
Confidence            99999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.89  E-value=2.3e-22  Score=168.15  Aligned_cols=141  Identities=30%  Similarity=0.409  Sum_probs=124.9

Q ss_pred             ecccCCccEEEEEEc-CCcEEEEEEecccccc---CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       131 ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      ||+|+||.||++... +++.+++|.+......   ....+..|+.++.+++|||++++++.+...+..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999875 4889999988654322   345789999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      .+++..   ...+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            988843   235899999999999999999999877   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=7e-23  Score=179.16  Aligned_cols=162  Identities=26%  Similarity=0.352  Sum_probs=136.2

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEecc--ccccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ...|+++++||+||.+.||++...+.+.+|+|++..  .+.+....|..|+..|.+|+ |.+|++|++|-..++..||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            346889999999999999999998889999998753  34566788999999999995 999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||= ..+|..+|... ......| .+..+..||+.|+.++|+.+   |||.||||.|+|+- .|.+||+|||+|..+..+
T Consensus       440 E~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            984 44787777432 2233445 66788999999999999988   99999999999984 567999999999999988


Q ss_pred             ccccCcceeecC
Q 022887          279 ELQGNTKRIVGT  290 (290)
Q Consensus       279 ~~~~~~~~~~Gt  290 (290)
                      .+...-..++||
T Consensus       513 TTsI~kdsQvGT  524 (677)
T KOG0596|consen  513 TTSIVKDSQVGT  524 (677)
T ss_pred             ccceeeccccCc
Confidence            776655667777

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-22  Score=189.19  Aligned_cols=157  Identities=32%  Similarity=0.465  Sum_probs=133.5

Q ss_pred             HHHHhcCCCccceecccCCccEEEEEEcC--------CcEEEEEEeccccc-cCHHHHHHHHHHHccc-CCCCcceeEEE
Q 022887          118 VSAATENFSTQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGC  187 (290)
Q Consensus       118 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~  187 (290)
                      ++...++....+.+|+|.||.|++|....        ...||||.++.... ...+.+..|+.++..+ +||||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            34445566666799999999999997531        34699999975433 4567899999999988 59999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhCCC-------C----C--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCC
Q 022887          188 CIEQGENILIYEYMPNKSLDVFLFYPK-------K----K--RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKAS  254 (290)
Q Consensus       188 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~----~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~  254 (290)
                      |...+..++|+||++.|+|..++...+       .    .  ..++..+.+.++.|||.||+||++..   ++||||.++
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence            999999999999999999999986544       0    0  23888999999999999999999877   999999999


Q ss_pred             CEEEcCCCCeEEeeccCceeeCC
Q 022887          255 NILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       255 Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+.++..+||+|||+||....
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~  470 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYN  470 (609)
T ss_pred             hEEecCCCEEEEccccceeccCC
Confidence            99999999999999999996544

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=8.4e-25  Score=174.52  Aligned_cols=151  Identities=29%  Similarity=0.554  Sum_probs=123.3

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEecc--ccccCHHHHHHHHHHHcccCCCCcceeEEEEEeC-------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-------  191 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  191 (290)
                      .+.|....+||+|.||.||+|+..+ ++.||+|++..  +.........+|+.++..++|+|++.++..|...       
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            3567777899999999999998744 77889887643  2333345678899999999999999998887543       


Q ss_pred             -CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          192 -GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       192 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                       ...++|+.+++. +|.-+|..  ....++..+..++..+++.||.|+|...   |+|||+||.|+|++.++.+||+|||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence             246899999987 45545522  2346888999999999999999999877   9999999999999999999999999


Q ss_pred             CceeeCCC
Q 022887          271 MARIFGGD  278 (290)
Q Consensus       271 la~~~~~~  278 (290)
                      +|+.+...
T Consensus       170 lar~fs~~  177 (376)
T KOG0669|consen  170 LARAFSTS  177 (376)
T ss_pred             cccceecc
Confidence            99888643

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.88  E-value=2.2e-22  Score=169.49  Aligned_cols=150  Identities=31%  Similarity=0.444  Sum_probs=123.6

Q ss_pred             CCCccceecccCCccEEEEEEcC-CcEEEEEEeccc-----cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-----SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      +|...+.||+|+||.||++.... +..+++|.++..     .......+..|+.++..++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47778999999999999998744 344555555431     122334577889999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          198 YEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +||+++++|..++... .....+++.....++.|++.||.|||+.+   ++|+||+|+||++++ +.+||+|||+++.+.
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999998877532 23456899999999999999999999887   999999999999975 569999999998764


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       157 ~  157 (260)
T cd08222         157 G  157 (260)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.88  E-value=2e-22  Score=176.88  Aligned_cols=149  Identities=28%  Similarity=0.434  Sum_probs=127.2

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe----
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE----  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  193 (290)
                      ..++|+..+.||+|+||.||+|... +++.||+|.+...  .......+..|+.++..++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999885 4789999988642  12234567789999999999999999988766554    


Q ss_pred             --eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccC
Q 022887          194 --NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       194 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl  271 (290)
                        .++|+||+ +++|.+++..    ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              79999998 5688887732    45899999999999999999999887   99999999999999999999999999


Q ss_pred             ceeeCC
Q 022887          272 ARIFGG  277 (290)
Q Consensus       272 a~~~~~  277 (290)
                      +.....
T Consensus       165 ~~~~~~  170 (343)
T cd07851         165 ARHTDD  170 (343)
T ss_pred             cccccc
Confidence            987644

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=1e-22  Score=180.73  Aligned_cols=146  Identities=25%  Similarity=0.377  Sum_probs=124.4

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      -|..++.||-|+||+|.+++- ++...+|+|.|.+.+.   .....+..|-.+|+..+++=||+|+-.|.+++++|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            466778999999999999965 4466789999976432   234567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      |+++|++-.+|..   -..+.+.....++..+..|+++.|..+   +|||||||+|||||.+|.+||+||||+.-+
T Consensus       710 YIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             ccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence            9999999887743   244667666667778999999999887   999999999999999999999999998654

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.3e-21  Score=158.52  Aligned_cols=140  Identities=22%  Similarity=0.326  Sum_probs=107.5

Q ss_pred             CCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHccc-----CCCCcceeEEEEEeCC---eeE-
Q 022887          125 FSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-----QHRHLVRLFGCCIEQG---ENI-  195 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-  195 (290)
                      ++..+.||+|+||.||.  +.+....+||++........+.+.+|+..+..+     +||||++++|++.++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567999999999996  433233479988765444567899999999999     6799999999998874   333 


Q ss_pred             EEEEe--cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCceecCCCCCCEEEcC----CCCeEEee
Q 022887          196 LIYEY--MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL-LYLHQYSRLRIIHRDLKASNILLDS----DMNPKISD  268 (290)
Q Consensus       196 lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~iiH~dlk~~Nill~~----~~~~kl~D  268 (290)
                      +|+||  ++.++|.+++..    ..+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  558999999843    224444  35577777777 9999988   999999999999974    34799999


Q ss_pred             -ccCceee
Q 022887          269 -FGMARIF  275 (290)
Q Consensus       269 -fGla~~~  275 (290)
                       ||...++
T Consensus       153 g~G~~~~i  160 (210)
T PRK10345        153 NIGESTFI  160 (210)
T ss_pred             CCCCccee
Confidence             5655554

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.87  E-value=3.7e-23  Score=163.03  Aligned_cols=147  Identities=22%  Similarity=0.412  Sum_probs=126.6

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCC--eeEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQG--ENIL  196 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~l  196 (290)
                      ..++|++.+.+|+|.|+.||.|.. .+++.++||.+++..   .+...+|+.++..|. ||||+++++...++.  -..|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            457899999999999999999975 567899999997643   367899999999997 999999999988765  4579


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-CCCeEEeeccCceee
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIF  275 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~  275 (290)
                      ++||.++.+...+.      ..++......+..++++||.|+|+.+   |.|||+||.|+++|. .-..+|+|||||.++
T Consensus       113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999998876653      44777888899999999999999998   999999999999985 457999999999998


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      .++.
T Consensus       184 Hp~~  187 (338)
T KOG0668|consen  184 HPGK  187 (338)
T ss_pred             CCCc
Confidence            7653

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.87  E-value=9.1e-22  Score=163.73  Aligned_cols=133  Identities=20%  Similarity=0.154  Sum_probs=113.8

Q ss_pred             cCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCChhhhhhC
Q 022887          134 GGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFY  212 (290)
Q Consensus       134 G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  212 (290)
                      |.||.||++.. .+++.+|+|.+....     .+..|...+....|||++++++++...+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            88999999987 457899999986532     234455555566799999999999999999999999999999888743


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          213 PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       213 ~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                         ...+++.....++.|++.||.|||+.+   ++||||||+||++++++.++++|||++..+..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~  137 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED  137 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence               235899999999999999999999887   99999999999999999999999998866543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.87  E-value=1.9e-21  Score=179.97  Aligned_cols=149  Identities=25%  Similarity=0.308  Sum_probs=105.0

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC-----CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEE------EE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC------CI  189 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~-----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~  189 (290)
                      ..++|+..+.||+|+||.||+|.+.+     +..||+|++......  .....+  .+....+.+++.+...      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999998743     689999988643211  111111  1112222222222111      24


Q ss_pred             eCCeeEEEEEecCCCChhhhhhCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCC
Q 022887          190 EQGENILIYEYMPNKSLDVFLFYPKKK-----------------RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK  252 (290)
Q Consensus       190 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk  252 (290)
                      ..+..++||||+++++|.+++......                 ..........++.|++.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            556789999999999998887532110                 01122345678999999999999887   9999999


Q ss_pred             CCCEEEcC-CCCeEEeeccCceeeC
Q 022887          253 ASNILLDS-DMNPKISDFGMARIFG  276 (290)
Q Consensus       253 ~~Nill~~-~~~~kl~DfGla~~~~  276 (290)
                      |+|||+++ ++.+||+|||+|+.+.
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~  307 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLR  307 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccc
Confidence            99999985 5799999999998664

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.87  E-value=2e-22  Score=156.49  Aligned_cols=157  Identities=29%  Similarity=0.429  Sum_probs=128.2

Q ss_pred             HHHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc-cccCHHHHHHHHHHHcc-cCCCCcceeEEEEEeCCee
Q 022887          118 VSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       118 ~~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~  194 (290)
                      .+...++......||+|++|.|-+-++ .+|...|+|++... ..+..+....|+.+..+ ...|.+|.++|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            344556677778999999999988876 67899999999743 34556777888886554 5799999999999999999


Q ss_pred             EEEEEecCCCChhhhhhC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          195 ILIYEYMPNKSLDVFLFY-PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      |+.||.|.- ||+.+... -..+...++...-+||..+.+||.|||++  ..+||||+||+|||++.+|++|++|||++-
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999954 66665321 12355678888899999999999999985  469999999999999999999999999998


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      .+.+
T Consensus       198 ~L~d  201 (282)
T KOG0984|consen  198 YLVD  201 (282)
T ss_pred             eehh
Confidence            7754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.87  E-value=5.4e-21  Score=156.94  Aligned_cols=149  Identities=36%  Similarity=0.522  Sum_probs=131.7

Q ss_pred             CCccceecccCCccEEEEEEcC-CcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          125 FSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      |+..+.||+|++|.||++...+ +..+++|.+...... ....+..|+..+.+++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4566889999999999998865 789999999765444 56789999999999999999999999999899999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++|.+++.....  .+++.....++.+++.++.|||+.+   ++|+|++|+||+++.++.++|+|||++..+...
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999998743221  1789999999999999999999886   999999999999999999999999999988654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.2e-23  Score=169.91  Aligned_cols=155  Identities=26%  Similarity=0.405  Sum_probs=127.4

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-----eeE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----ENI  195 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  195 (290)
                      +.+..+.||-|+||.||..++ .+|+.||.|++.+.-  -...+.+.+|+.++...+|.|++..++...-.+     +.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            456668999999999999987 568999999886532  234578899999999999999999988766543     456


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      .++|.|. .+|...+.   +...++.....-+..||++||.|||+.+   |.||||||.|.|+++|...||+|||+|+..
T Consensus       134 V~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            7788774 36666653   3445777888889999999999999887   999999999999999999999999999999


Q ss_pred             CCCccccCcc
Q 022887          276 GGDELQGNTK  285 (290)
Q Consensus       276 ~~~~~~~~~~  285 (290)
                      +.++...+|+
T Consensus       207 e~d~~~hMTq  216 (449)
T KOG0664|consen  207 DQRDRLNMTH  216 (449)
T ss_pred             chhhhhhhHH
Confidence            8887766654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.1e-22  Score=170.90  Aligned_cols=163  Identities=29%  Similarity=0.358  Sum_probs=128.2

Q ss_pred             HHhcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccc---cCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCee
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  194 (290)
                      ....+|..+.+||+|+||+|.++...+ .+.+|||++++...   ...+--..|-.+|+.. +-|.++++..++...+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            344678889999999999999997754 56799999876421   1222234455566555 468899999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      |+||||+.+|+|--.+   ..-..+.+....-+|..||-||-|||+++   ||.||||.+||+||.+|.+||+||||++.
T Consensus       426 yFVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence            9999999999986555   23345667778889999999999999998   99999999999999999999999999985


Q ss_pred             eCCCccccCcceeecC
Q 022887          275 FGGDELQGNTKRIVGT  290 (290)
Q Consensus       275 ~~~~~~~~~~~~~~Gt  290 (290)
                      ---+..  .|.++.||
T Consensus       500 ni~~~~--TTkTFCGT  513 (683)
T KOG0696|consen  500 NIFDGV--TTKTFCGT  513 (683)
T ss_pred             cccCCc--ceeeecCC
Confidence            433332  24456676

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-22  Score=179.87  Aligned_cols=151  Identities=27%  Similarity=0.459  Sum_probs=137.3

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      +.++|+....+|.|.||.|||++. ..++..|+|.++-.......-..+|+-++...+||||+.++|.+...+..|+.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            456899999999999999999987 4578899999988777777888999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |+.+|+|.+..+   ...++++.+....+...++|++|||+++   -+|||||-.|||+++.+.+|++|||.+..++.
T Consensus        93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh
Confidence            999999998764   3456888899999999999999999988   89999999999999999999999999988765

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.9e-21  Score=161.29  Aligned_cols=160  Identities=26%  Similarity=0.375  Sum_probs=132.2

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++|..+++||+|+|.+|..+++. +.+.+|+|.++++   ..+.....+.|-.+..+. +||.+|-+..++......++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57899999999999999999874 4678999988754   233455677777777655 799999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      .||+++|+|--.+   ...+.++++...-+...|..||.|||+.+   ||.||||.+|+|+|.++.+|++|||+++.--.
T Consensus       330 ieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence            9999999985544   45667888888889999999999999988   99999999999999999999999999985322


Q ss_pred             CccccCcceeecC
Q 022887          278 DELQGNTKRIVGT  290 (290)
Q Consensus       278 ~~~~~~~~~~~Gt  290 (290)
                      +.-  .|+++.||
T Consensus       404 ~gd--~tstfcgt  414 (593)
T KOG0695|consen  404 PGD--TTSTFCGT  414 (593)
T ss_pred             CCc--ccccccCC
Confidence            221  24456666

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.85  E-value=4e-20  Score=149.56  Aligned_cols=143  Identities=39%  Similarity=0.634  Sum_probs=126.5

Q ss_pred             ecccCCccEEEEEEcC-CcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCChhh
Q 022887          131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDV  208 (290)
Q Consensus       131 ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  208 (290)
                      ||+|++|.||++...+ ++++++|.+...... ....+.+|+..+..++|++++++++++......++++||+++++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998854 889999998764332 35689999999999999999999999999999999999999999999


Q ss_pred             hhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-CCCeEEeeccCceeeCCC
Q 022887          209 FLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGD  278 (290)
Q Consensus       209 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~~~  278 (290)
                      ++....  ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            874321  45889999999999999999999887   999999999999999 899999999999877554

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.85  E-value=1e-22  Score=163.76  Aligned_cols=151  Identities=29%  Similarity=0.409  Sum_probs=122.2

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc-ccCHHHHHHHHHHHcc-cCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++.+.+..||.|+||+|++-.+ ..|+..|||++.... ....++++.|.+...+ -+.||||+++|.+..++.-|+-||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            3455667899999999999876 458999999997543 3556788888876544 478999999999999999999999


Q ss_pred             ecCCCChhhhhhC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFY--PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      .|.- |++.+...  ......+++.-.-.|..-...||.||-+.  ..|||||+||+|||++..|.+||+|||++..+.
T Consensus       144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            9954 66654321  22345677887888888889999999874  469999999999999999999999999987664

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=2.6e-20  Score=152.19  Aligned_cols=136  Identities=19%  Similarity=0.271  Sum_probs=113.9

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEecccccc--------CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      +.||+|++|.||+|.. ++..+++|........        ....+..|+..+..+.|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6678999976542211        124577899999999999998877777777888999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      +++++|.+++...      .+ .+..++.+++.+|.++|+.+   ++|+|++|.||+++ ++.++|+|||+++...
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            9999999887321      22 78899999999999999887   99999999999999 7889999999998643

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.84  E-value=3.6e-20  Score=171.34  Aligned_cols=140  Identities=19%  Similarity=0.281  Sum_probs=113.7

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEE-ecccc-c------cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQS-G------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~-l~~~~-~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      ...|...+.||+|+||.||+|.+.+.. +++|+ +.... .      .....+..|+.++..++|++++....++...+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345566789999999999999885544 44443 22111 1      113568899999999999999988888888778


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++||||+++++|.+++.           ....++.+++++|.|||+.+   ++|||+||+|||+ +++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999988772           45778999999999999887   9999999999999 67889999999998


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      ..+.
T Consensus       476 ~~~~  479 (535)
T PRK09605        476 YSDL  479 (535)
T ss_pred             cCCc
Confidence            7644

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=1.6e-20  Score=152.77  Aligned_cols=141  Identities=14%  Similarity=0.111  Sum_probs=115.0

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHH---------HHHHHHHHcccCCCCcceeEEEEEeC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE---------FKNEMMLIAKLQHRHLVRLFGCCIEQ  191 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~~~~~~~  191 (290)
                      ..++|...+.+|.|+||.||.... ++..+|||.+.+........         +.+|+..+.++.||+|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            467899999999999999999755 56789999997543332222         68899999999999999998886643


Q ss_pred             --------CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC
Q 022887          192 --------GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  263 (290)
Q Consensus       192 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~  263 (290)
                              +..+++|||+++.+|.++..       ++.    ....+++.++..+|+.+   ++|||++|+||++++++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999977631       222    24558999999999888   99999999999999988 


Q ss_pred             eEEeeccCceeeCC
Q 022887          264 PKISDFGMARIFGG  277 (290)
Q Consensus       264 ~kl~DfGla~~~~~  277 (290)
                      ++|+|||..+....
T Consensus       173 i~liDfg~~~~~~e  186 (232)
T PRK10359        173 LRIIDLSGKRCTAQ  186 (232)
T ss_pred             EEEEECCCcccccc
Confidence            99999999987643

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.84  E-value=1.5e-21  Score=159.42  Aligned_cols=148  Identities=25%  Similarity=0.324  Sum_probs=120.5

Q ss_pred             HhcCCCcc-ceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeC----Ce
Q 022887          121 ATENFSTQ-CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ----GE  193 (290)
Q Consensus       121 ~~~~~~~~-~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  193 (290)
                      .+++|++. ++||-|-.|+|..+.. .+++.+|+|.+...     ...++|+++--.. .|||||.+++++...    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45677654 5789999999999976 56889999988653     3456777765444 699999999987643    45


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---CCCeEEeecc
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFG  270 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfG  270 (290)
                      +++|||.|++|.|...+.. +....+++.+...|..||+.|+.|||+.+   |.||||||+|+|...   |..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            6899999999999877643 34556999999999999999999999888   999999999999964   5679999999


Q ss_pred             CceeeCC
Q 022887          271 MARIFGG  277 (290)
Q Consensus       271 la~~~~~  277 (290)
                      +|+.-..
T Consensus       210 FAK~t~~  216 (400)
T KOG0604|consen  210 FAKETQE  216 (400)
T ss_pred             cccccCC
Confidence            9997653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.84  E-value=3.6e-20  Score=153.50  Aligned_cols=138  Identities=33%  Similarity=0.462  Sum_probs=123.4

Q ss_pred             CCccEEEEEEcC-CcEEEEEEeccccccC-HHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCChhhhhhC
Q 022887          135 GFGPVYKGRLLN-GQEVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFY  212 (290)
Q Consensus       135 ~fg~V~~~~~~~-~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  212 (290)
                      +||.||++...+ ++.+++|.+....... ...+.+|+..+.+++|+|++++++++......++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999998864 8899999997654444 68999999999999999999999999999999999999999999998743


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          213 PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       213 ~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      .   ..+++.....++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  140 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG  140 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence            2   22889999999999999999999887   999999999999999999999999999987654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=3.1e-20  Score=153.82  Aligned_cols=146  Identities=18%  Similarity=0.145  Sum_probs=112.1

Q ss_pred             cCCCccceecccCCccEEEEE--EcCCcEEEEEEecccccc------------------------CHHHHHHHHHHHccc
Q 022887          123 ENFSTQCKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQ------------------------GLTEFKNEMMLIAKL  176 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~e~~~l~~l  176 (290)
                      ..|++.+.||+|+||.||+|.  ..+|+.||+|.+......                        ....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999998  467999999988643210                        012356799999999


Q ss_pred             CCCC--cceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCC
Q 022887          177 QHRH--LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKAS  254 (290)
Q Consensus       177 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~  254 (290)
                      .+..  +.+++++    ...++||||++++++.....   ....+...+...++.|++.++.+||+.+  .++||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            7633  3444443    23589999999988866542   1233555667889999999999999765  3999999999


Q ss_pred             CEEEcCCCCeEEeeccCceeeCCC
Q 022887          255 NILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       255 Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++ ++.++|+|||+|...+..
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccCCc
Confidence            99999 889999999999976554

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.84  E-value=4.1e-21  Score=155.17  Aligned_cols=150  Identities=27%  Similarity=0.401  Sum_probs=120.3

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++.+.+..||.|..|.|++.+.. +|..+|||.+..... +..++....+.++..- +.|.||+.+|+|..+...++-||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            45566778999999999999874 578999999975433 3446667777766554 48999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      .|.-. ++.++.  +...++++...-++...+.+||.||.++.  +|+|||+||+|||+|+.|++|++|||++..+-.
T Consensus       172 lMs~C-~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  172 LMSTC-AEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHH-HHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence            88542 344442  23455778878889999999999998854  699999999999999999999999999976644

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=3.4e-22  Score=173.33  Aligned_cols=160  Identities=24%  Similarity=0.331  Sum_probs=135.2

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCc-EEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQ-EVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~-~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ..++..+..||-|+||.|-+....... .+|+|.+++.   .....+....|-.+|...+.|.||+++-.+.+....|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            346667778999999999999875433 4788877643   233456678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||-|-+|.+...+   +.+..++..+..-++..+++|++|||.++   ||.|||||+|.+||.+|-+||.|||+|+.+..
T Consensus       499 mEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  499 MEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            9999999999988   34566788888888889999999999888   99999999999999999999999999999977


Q ss_pred             CccccCcceeecC
Q 022887          278 DELQGNTKRIVGT  290 (290)
Q Consensus       278 ~~~~~~~~~~~Gt  290 (290)
                      ++.   |-++.||
T Consensus       573 g~K---TwTFcGT  582 (732)
T KOG0614|consen  573 GRK---TWTFCGT  582 (732)
T ss_pred             CCc---eeeecCC
Confidence            653   4456776

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.83  E-value=5.1e-20  Score=149.05  Aligned_cols=141  Identities=19%  Similarity=0.179  Sum_probs=110.3

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEecccccc----------------------CHHHHHHHHHHHcccCCCC
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ----------------------GLTEFKNEMMLIAKLQHRH  180 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~e~~~l~~l~h~n  180 (290)
                      ..|...+.||+|+||.||++...+++.||||.+......                      ....+..|...+..+.|++
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            347778999999999999999888999999987542210                      0123567888888888774


Q ss_pred             --cceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE
Q 022887          181 --LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  258 (290)
Q Consensus       181 --iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill  258 (290)
                        +.+.++    ....++||||+++++|......         .....++.+++.++.++|+.+   ++|+||+|+||++
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill  158 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV  158 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence              444443    2456899999999998765310         234578889999999999877   9999999999999


Q ss_pred             cCCCCeEEeeccCceeeCCCc
Q 022887          259 DSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       259 ~~~~~~kl~DfGla~~~~~~~  279 (290)
                      ++++.++|+|||++...+.+.
T Consensus       159 ~~~~~~~liDfg~~~~~~~~~  179 (198)
T cd05144         159 DDDEKIYIIDWPQMVSTDHPN  179 (198)
T ss_pred             cCCCcEEEEECCccccCCCcc
Confidence            999999999999997776543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.2e-20  Score=152.40  Aligned_cols=147  Identities=22%  Similarity=0.443  Sum_probs=121.2

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEE-EEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGC-CIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~  198 (290)
                      .+.|.+.+.+|+|.||.+-++++.. .+.+++|-+.. .....++|.+|..---.| .|.||+.-++. |...+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4578888999999999999998854 67899998764 334568999998765555 58999987654 66677788999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE-c-CCCCeEEeeccCceeeC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-D-SDMNPKISDFGMARIFG  276 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill-~-~~~~~kl~DfGla~~~~  276 (290)
                      ||+|.|+|.+-+    ....+.+.-..+++.|++.|+.|+|++.   +||||||.+|||+ + +...+||+|||+.+..+
T Consensus       102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999998765    2345777888999999999999999998   9999999999998 3 34579999999998764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=2.6e-20  Score=148.06  Aligned_cols=150  Identities=23%  Similarity=0.378  Sum_probs=123.7

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCC-CCcceeEEEEEeCCeeEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH-RHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..++|..++.||.|+||.+|.|.. .+|++||||.-....  ....+..|..+...|++ ..|..+..+..+.+...+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            457899999999999999999975 679999999765432  23467778888888875 77888888889999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC---CCeEEeeccCceee
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARIF  275 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~---~~~kl~DfGla~~~  275 (290)
                      |.+ +.||+++..-  -.+.++..+.+-++-|++.-++|+|..+   ++||||||+|+|+.-+   ..+.++|||||+.+
T Consensus        91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            998 5577776532  2355888999999999999999999988   9999999999998643   46899999999887


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      -..
T Consensus       165 ~d~  167 (341)
T KOG1163|consen  165 RDI  167 (341)
T ss_pred             ccc
Confidence            543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.3e-19  Score=144.58  Aligned_cols=133  Identities=20%  Similarity=0.188  Sum_probs=105.8

Q ss_pred             ccceecccCCccEEEEEEcCCcEEEEEEeccccccC----HHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEEEec
Q 022887          127 TQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG----LTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       127 ~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      ....|++|+||+||.+.. .+.+++.+.+.......    ...+.+|+.++.+++ |+++.+++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999997765 66788888776533211    225889999999995 5889999886    4569999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCC-CCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dl-k~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++.+|.....    .      ....++.|++.+|.++|+.+   |+|||| ||.|||+++++.++|+|||+|.....
T Consensus        81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            9988864321    0      11357788999999999988   999999 79999999999999999999996654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=1e-19  Score=147.33  Aligned_cols=133  Identities=20%  Similarity=0.304  Sum_probs=107.8

Q ss_pred             eecccCCccEEEEEEcCCcEEEEEEecccccc--------CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .||+|+||.||+|.+ ++..+++|........        ....+.+|+.++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 5678999986532111        1255778999999999988766666666777789999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++|.+.+...   .       ..++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||+++....
T Consensus        80 ~g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~  141 (199)
T TIGR03724        80 EGKPLKDVIEEG---N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE  141 (199)
T ss_pred             CCccHHHHHhhc---H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence            999998876321   0       078999999999999887   99999999999999 88999999999987643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.80  E-value=7.5e-20  Score=167.01  Aligned_cols=148  Identities=31%  Similarity=0.475  Sum_probs=116.6

Q ss_pred             CCccceecccCCcc-EEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          125 FSTQCKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       125 ~~~~~~ig~G~fg~-V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      |...+.+|.|+-|+ ||+|.. ++++||||++...   ...-..+|+..+..- .|||||++++.-.++...|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            44557788998865 699988 6789999998643   334668899988776 69999999988888889999999995


Q ss_pred             CCChhhhhhCCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---C--CCeEEeeccCceeeC
Q 022887          203 NKSLDVFLFYPKKK-RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---D--MNPKISDFGMARIFG  276 (290)
Q Consensus       203 ~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~--~~~kl~DfGla~~~~  276 (290)
                       .+|++++...... ....-...+.+..|++.||++||+.+   ||||||||.||||+.   +  ..++|+|||+++.++
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             4888888653111 11111344677889999999999876   999999999999976   2  468999999999998


Q ss_pred             CCcc
Q 022887          277 GDEL  280 (290)
Q Consensus       277 ~~~~  280 (290)
                      .+..
T Consensus       663 ~~~s  666 (903)
T KOG1027|consen  663 GGKS  666 (903)
T ss_pred             CCcc
Confidence            8754

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=6e-19  Score=146.26  Aligned_cols=150  Identities=23%  Similarity=0.368  Sum_probs=123.3

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .-+|.+.++||+|+||.++.|+. -++++||||.-...  .....++.|....+.|. .++|..++-+..++.+..||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            45899999999999999999964 67899999965332  23356777777777764 6899999988888888999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-----CCCeEEeeccCcee
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARI  274 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~DfGla~~  274 (290)
                      .+ +.||+++...  -++.++.++...+|.|+..-++|+|++.   +|.|||||+|+||..     ...+.|+|||||+.
T Consensus       105 LL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            98 5577776533  2566999999999999999999999988   999999999999964     34589999999998


Q ss_pred             eCCCc
Q 022887          275 FGGDE  279 (290)
Q Consensus       275 ~~~~~  279 (290)
                      +....
T Consensus       179 YrDp~  183 (449)
T KOG1165|consen  179 YRDPK  183 (449)
T ss_pred             hcCcc
Confidence            86543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.79  E-value=2.8e-19  Score=151.04  Aligned_cols=154  Identities=26%  Similarity=0.398  Sum_probs=129.6

Q ss_pred             HhcCCCccceecccCCccEEEEEEc------CCcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeC-C
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-G  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~  192 (290)
                      ...+++...++.+|.||.||+|.|.      +.+.|-+|.++....+ ....+..|..++..+.|||+..+.+.+.+. .
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            3456777778999999999999653      3456778888754433 456788999999999999999999999876 4


Q ss_pred             eeEEEEEecCCCChhhhhh-----CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEe
Q 022887          193 ENILIYEYMPNKSLDVFLF-----YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                      ..+..|.++.-|+|..||.     .......++-.+...++.|++.||+|||..+   +||.||.++|+++|+..++||+
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEec
Confidence            6788899999999999997     3444566788889999999999999999887   9999999999999999999999


Q ss_pred             eccCceeeCC
Q 022887          268 DFGMARIFGG  277 (290)
Q Consensus       268 DfGla~~~~~  277 (290)
                      |=.++|.+-+
T Consensus       439 DsaLSRDLFP  448 (563)
T KOG1024|consen  439 DSALSRDLFP  448 (563)
T ss_pred             cchhccccCc
Confidence            9999987643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.3e-19  Score=161.52  Aligned_cols=146  Identities=25%  Similarity=0.327  Sum_probs=120.4

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcc-cCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK-LQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++.|.....+|.|+|+.|-.+.. .+++..++|.+.+..    .+..+|+.++.. -+||||+++.+.+.+..+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            56777888899999999999876 457889999997652    234556654444 479999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE-cCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill-~~~~~~kl~DfGla~~~~~~  278 (290)
                      .+.++-+.+.+..   .+... ..+..|+.+|+.|+.|||+++   ++||||||+|||+ ++.++++|+|||.++...++
T Consensus       397 ~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            9999887665532   22233 677789999999999999988   9999999999999 68999999999999988665

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=1.1e-18  Score=151.77  Aligned_cols=145  Identities=26%  Similarity=0.363  Sum_probs=118.7

Q ss_pred             CCCccceecccCCccEEEEEEcCC--cEEEEEEeccccccCHHHHHHHHHHHcccCC----CCcceeEEEE-EeCCeeEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLNG--QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH----RHLVRLFGCC-IEQGENIL  196 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~~--~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l  196 (290)
                      +|.+.+.||+|+||.||.+.....  ..+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999987553  4788887765433332367888888888863    6888888888 47778899


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC-----CCeEEeeccC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-----MNPKISDFGM  271 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~-----~~~kl~DfGl  271 (290)
                      ||+.+ +.+|.++..... .+.++..+.++|+.|++.+|++||+.+   ++||||||.|+++...     ..++|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99987 557777653333 567999999999999999999999988   9999999999999754     4699999999


Q ss_pred             ce
Q 022887          272 AR  273 (290)
Q Consensus       272 a~  273 (290)
                      |+
T Consensus       174 ar  175 (322)
T KOG1164|consen  174 AR  175 (322)
T ss_pred             Cc
Confidence            98

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.78  E-value=4.8e-18  Score=130.74  Aligned_cols=138  Identities=22%  Similarity=0.224  Sum_probs=116.3

Q ss_pred             ccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCC--CCcceeEEEEEeCCeeEEEEEecCCC
Q 022887          127 TQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQGENILIYEYMPNK  204 (290)
Q Consensus       127 ~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  204 (290)
                      ..+.||+|.++.||++...+ ..+++|.......  ...+..|+..+..++|  +++.+++++...++..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35689999999999999855 7899998865432  4678999999999976  58899999888888899999999988


Q ss_pred             ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       205 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      .+..+          +......++.++++++.++|.....+++|+|++|+||++++.+.+++.|||+++..+.
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~~  141 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP  141 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCCh
Confidence            76543          5567778899999999999986555699999999999999989999999999986543

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.77  E-value=6.3e-19  Score=150.08  Aligned_cols=148  Identities=25%  Similarity=0.462  Sum_probs=126.7

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc----CCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCee
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~----~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  194 (290)
                      ...+.|...++||+|.|+.||++.+.    ..+.||+|.+....  ......+|+++|..+ .+.||+++.+++...++.
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            34567888999999999999999763    35789999987543  335789999999998 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC-CCeEEeeccCce
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR  273 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGla~  273 (290)
                      .+|+||+++....+++      ..++......+...+..||.++|.++   ||||||||+|+|.+.. +.-.|.|||||-
T Consensus       111 ~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             EEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence            9999999999988887      33668888999999999999999988   9999999999999865 456899999998


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      ..+.+
T Consensus       182 ~~d~~  186 (418)
T KOG1167|consen  182 RYDGY  186 (418)
T ss_pred             HHHhh
Confidence            55443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=3e-18  Score=137.31  Aligned_cols=139  Identities=19%  Similarity=0.193  Sum_probs=98.4

Q ss_pred             cceecccCCccEEEEEEcCCcEEEEEEecccccc--CHHH----------------------HHHHHHHHcccCCCC--c
Q 022887          128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLTE----------------------FKNEMMLIAKLQHRH--L  181 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i  181 (290)
                      .+.||+|+||.||+|...++++||||.+......  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999988653211  1111                      134555555554433  3


Q ss_pred             ceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCceecCCCCCCEEEcC
Q 022887          182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDS  260 (290)
Q Consensus       182 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlk~~Nill~~  260 (290)
                      .+.++.    ...++||||++++.+........   ... .....++.+++.++.++|. .+   ++|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            344432    34689999999965422111000   011 5567899999999999998 66   99999999999999 


Q ss_pred             CCCeEEeeccCceeeCCC
Q 022887          261 DMNPKISDFGMARIFGGD  278 (290)
Q Consensus       261 ~~~~kl~DfGla~~~~~~  278 (290)
                      ++.++++|||++......
T Consensus       150 ~~~~~liDfg~a~~~~~~  167 (187)
T cd05119         150 DGKVYIIDVPQAVEIDHP  167 (187)
T ss_pred             CCcEEEEECcccccccCc
Confidence            899999999999877553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.77  E-value=1.4e-18  Score=146.24  Aligned_cols=156  Identities=22%  Similarity=0.237  Sum_probs=127.5

Q ss_pred             HHHHhcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCC--CC----cceeEEEEEe
Q 022887          118 VSAATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH--RH----LVRLFGCCIE  190 (290)
Q Consensus       118 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~n----iv~l~~~~~~  190 (290)
                      ....+++|.+...+|+|.||.|..+.... +..||||+++.. ....+..+-|++++.++.+  |+    +|.+.+|+.-
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            34457899999999999999999997644 688999998763 3445677889999999942  33    6788899999


Q ss_pred             CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC----------
Q 022887          191 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS----------  260 (290)
Q Consensus       191 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~----------  260 (290)
                      .++.++|+|.+ +-|+.+++.. ++..+++..+...|+.|++++++|||+..   ++|-||||+|||+.+          
T Consensus       163 rghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccC
Confidence            99999999998 4467777743 34556888999999999999999999887   999999999999832          


Q ss_pred             ----------CCCeEEeeccCceeeCCCc
Q 022887          261 ----------DMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       261 ----------~~~~kl~DfGla~~~~~~~  279 (290)
                                +..+||+|||.|..-....
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h  266 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH  266 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccCc
Confidence                      3458999999999877665

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.74  E-value=2.9e-18  Score=149.56  Aligned_cols=158  Identities=25%  Similarity=0.317  Sum_probs=130.6

Q ss_pred             HHHhcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccC------CCCcceeEEEEEeC
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ------HRHLVRLFGCCIEQ  191 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~  191 (290)
                      +..-.+|.+....|+|-|++|.+|.... ++.||||++.+.. ...+.=+.|+++|.+|+      --++++++-.|...
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            3444677777889999999999998754 7899999997632 33455678999999985      34789999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-CeEEeecc
Q 022887          192 GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFG  270 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfG  270 (290)
                      ++++||+|-+.- +|.+.|..-.....|.......++.|+.-||..|-..+   |+|.||||+|||+++.. .+||+|||
T Consensus       507 nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence            999999998754 67777765555566888899999999999999999776   99999999999999765 57999999


Q ss_pred             CceeeCCCccc
Q 022887          271 MARIFGGDELQ  281 (290)
Q Consensus       271 la~~~~~~~~~  281 (290)
                      .|...+.++.+
T Consensus       583 SA~~~~eneit  593 (752)
T KOG0670|consen  583 SASFASENEIT  593 (752)
T ss_pred             ccccccccccc
Confidence            99998887653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.73  E-value=3e-18  Score=141.34  Aligned_cols=147  Identities=30%  Similarity=0.400  Sum_probs=118.0

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  192 (290)
                      ..+|..+..+|.|.- .|..+.+ -.+++||+|++...  .....+...+|...+..++|+|+++++.+++-..      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777778888876 4555543 34789999988532  2344678889999999999999999999987553      


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      +.|+|||+|.. +|...+.     -.++-.+...|..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+|
T Consensus        95 e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence            56899999954 5655553     22556788899999999999999887   999999999999999999999999999


Q ss_pred             eeeCCC
Q 022887          273 RIFGGD  278 (290)
Q Consensus       273 ~~~~~~  278 (290)
                      +.-+.+
T Consensus       166 r~e~~~  171 (369)
T KOG0665|consen  166 RTEDTD  171 (369)
T ss_pred             cccCcc
Confidence            976655

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=1.1e-16  Score=132.84  Aligned_cols=136  Identities=23%  Similarity=0.246  Sum_probs=104.6

Q ss_pred             ceec-ccCCccEEEEEEcCCcEEEEEEecccc-------------ccCHHHHHHHHHHHcccCCCCc--ceeEEEEEeCC
Q 022887          129 CKLG-EGGFGPVYKGRLLNGQEVAVKRLSNQS-------------GQGLTEFKNEMMLIAKLQHRHL--VRLFGCCIEQG  192 (290)
Q Consensus       129 ~~ig-~G~fg~V~~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~  192 (290)
                      ..|| .|+.|+||..... +..+++|......             ......+.+|+.++..+.|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 7899999999874 6788998775311             1123567889999999998885  66777654432


Q ss_pred             ----eeEEEEEecCC-CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEe
Q 022887          193 ----ENILIYEYMPN-KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       193 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                          ..++|+||+++ .+|..++..    ..++..    .+.+++.++.+||+.+   |+|+||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence                23599999997 688877632    234433    3568999999999988   9999999999999998999999


Q ss_pred             eccCceeeC
Q 022887          268 DFGMARIFG  276 (290)
Q Consensus       268 DfGla~~~~  276 (290)
                      |||.++...
T Consensus       185 Dfg~~~~~~  193 (239)
T PRK01723        185 DFDRGELRT  193 (239)
T ss_pred             ECCCcccCC
Confidence            999998764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=2e-17  Score=143.29  Aligned_cols=134  Identities=27%  Similarity=0.381  Sum_probs=108.2

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccC-----C---CCcceeEEEEEeCC-
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-----H---RHLVRLFGCCIEQG-  192 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~~-  192 (290)
                      .+|...++||-|-|++||++.+ .+.+-||+|+.+.. ....+....||++|++++     |   ..||+|+++|...+ 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            5788899999999999999987 45778999988752 334466789999999873     3   34899999998654 


Q ss_pred             ---eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC
Q 022887          193 ---ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD  261 (290)
Q Consensus       193 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~  261 (290)
                         +.+||+|++....|..+..  ...+-++......|+.||+.||.|||.++  +|||-||||+|||+..+
T Consensus       157 NG~HVCMVfEvLGdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  157 NGQHVCMVFEVLGDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCcEEEEEehhhhhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence               6799999996655544432  23455888999999999999999999876  69999999999999654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.71  E-value=3.6e-16  Score=134.64  Aligned_cols=150  Identities=35%  Similarity=0.534  Sum_probs=126.9

Q ss_pred             CCccceecccCCccEEEEEEcCCcEEEEEEecccccc---CHHHHHHHHHHHcccCCC-CcceeEEEEEeCCeeEEEEEe
Q 022887          125 FSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHR-HLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  200 (290)
                      |...+.||.|+|+.||++...  ..+++|.+......   ....+.+|+..+..+.|+ +++++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999886  78899988754332   367899999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-CeEEeeccCceeeCCCc
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFGGDE  279 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~~~~  279 (290)
                      +.++++..++........+.......+..|++.++.|+|+.+   ++|||+||+||+++... .++++|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999866532211136888999999999999999999988   99999999999999988 79999999999765543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=7.7e-17  Score=152.99  Aligned_cols=146  Identities=24%  Similarity=0.338  Sum_probs=116.1

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccC---CCCcceeEEEEEeCCeeEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  197 (290)
                      ..+.|.+.+.||+|+||+||+|...+++.||+|.=++....   +|.-=.+++.+|+   -+-|..+.....-.+.-++|
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            34678888999999999999999988999999987654332   3444444555555   23444455555666778999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc-------CCCCeEEeecc
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-------SDMNPKISDFG  270 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~-------~~~~~kl~DfG  270 (290)
                      +||.+.|+|.+++.   ..+.++|.....++.|+++-++.||..+   |||+||||+|+||.       ++..++|+|||
T Consensus       773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence            99999999999884   5677999999999999999999999888   99999999999993       24568999999


Q ss_pred             Cceee
Q 022887          271 MARIF  275 (290)
Q Consensus       271 la~~~  275 (290)
                      -+-.+
T Consensus       847 ~siDm  851 (974)
T KOG1166|consen  847 RSIDM  851 (974)
T ss_pred             cceee
Confidence            98543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.67  E-value=3.6e-16  Score=140.57  Aligned_cols=142  Identities=23%  Similarity=0.258  Sum_probs=100.0

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEeccccccC----------------------------------------HHHHHH
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG----------------------------------------LTEFKN  168 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~~~  168 (290)
                      +.||.|++|+||+|++.+|+.||||+..+.....                                        .-+|..
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            6899999999999999999999999986532110                                        012444


Q ss_pred             HHHHHccc----CCCCcceeEEEE-EeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHH-HHHHHhhCC
Q 022887          169 EMMLIAKL----QHRHLVRLFGCC-IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ-GLLYLHQYS  242 (290)
Q Consensus       169 e~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~yLH~~~  242 (290)
                      |...+.++    +|.+-+.+-..+ ...+..++||||++++++.++......  ..   .+..++.+++. .+..+|..+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence            55544444    232223322222 223457999999999999877532111  11   23456666666 467888777


Q ss_pred             CCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       243 ~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                         ++|+|++|.||++++++.+++.|||++..++++
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence               999999999999999999999999999988654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.55  E-value=5.1e-14  Score=110.87  Aligned_cols=133  Identities=23%  Similarity=0.169  Sum_probs=98.3

Q ss_pred             cceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcc-eeEEEEEeCCeeEEEEEecCCCCh
Q 022887          128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      .+.++.|.++.||++... +..+++|....... ....+..|+..+..+.+.+++ +++.+.  .+..++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            367889999999999874 67899998754322 234567888888888765654 444433  3346899999999877


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ....           .....++.+++++|..||+..  ...++|+|++|.||+++ ++.+++.|||.+..-+
T Consensus        79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~  138 (170)
T cd05151          79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND  138 (170)
T ss_pred             cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence            5420           111245678999999999876  23369999999999999 6689999999998543

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.51  E-value=6.8e-14  Score=127.56  Aligned_cols=147  Identities=17%  Similarity=0.197  Sum_probs=94.6

Q ss_pred             cCCCccceecccCCccEEEEEEcC-CcEEEEEEecccccc--------------------------C--------H----
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ--------------------------G--------L----  163 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~--------------------------~--------~----  163 (290)
                      ..|+. +.||+|++|+||+|++.+ |++||||++.+....                          .        .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 789999999999999977 999999999753110                          0        0    


Q ss_pred             --HHHHHHHHHHcccC----CCCcceeEEEEEe-CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHH-H
Q 022887          164 --TEFKNEMMLIAKLQ----HRHLVRLFGCCIE-QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG-L  235 (290)
Q Consensus       164 --~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l  235 (290)
                        -+|..|...+.++.    +.+.+.+-..+.+ ....+|||||++++.+.++......+  .+   +..++...+.. +
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d---~~~la~~~v~~~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TD---MKLLAERGVEVFF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CC---HHHHHHHHHHHHH
Confidence              12444554444442    4443443333332 34678999999999997643211111  11   11222222211 2


Q ss_pred             HHHhhCCCCCceecCCCCCCEEEcCCC----CeEEeeccCceeeCCC
Q 022887          236 LYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFGMARIFGGD  278 (290)
Q Consensus       236 ~yLH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DfGla~~~~~~  278 (290)
                      ..+...+   ++|+|++|.||+++.++    .+++.|||++..++++
T Consensus       274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            2233344   99999999999999888    9999999999988664

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.45  E-value=5.6e-14  Score=136.14  Aligned_cols=87  Identities=16%  Similarity=0.177  Sum_probs=67.1

Q ss_pred             ccCC-CCcceeEEEE-------EeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 022887          175 KLQH-RHLVRLFGCC-------IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI  246 (290)
Q Consensus       175 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i  246 (290)
                      .++| +||.++++++       .+....+.++||+ .++|.+++..  ....+++.+.+.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            3455 5788888877       2334567788887 5589988853  2355899999999999999999999887   9


Q ss_pred             eecCCCCCCEEEcCCCCeEEe
Q 022887          247 IHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       247 iH~dlk~~Nill~~~~~~kl~  267 (290)
                      +||||||+||||+..+.+|++
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~  122 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFI  122 (793)
T ss_pred             eeccCCchhEEEcccCcEEEe
Confidence            999999999999654333333

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=7.3e-14  Score=129.67  Aligned_cols=156  Identities=24%  Similarity=0.309  Sum_probs=113.8

Q ss_pred             ccceecccCCccEEEEEEc-CCcEEEEEEec----cc-c-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          127 TQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----NQ-S-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       127 ~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~----~~-~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ..+.+|.|++|.|+..... .....+.|...    .. . ......+..|+.+-..++|||++..+....+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4578999999977776542 22223333221    11 1 1112236667778888999999887777777666666699


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      |++. +|..++..   ...++..+.-.++.|+..|+.|+|+.+   |.|||+|++|++++.++.+||+|||.+..+.-+-
T Consensus       402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 88777632   235778888999999999999999988   9999999999999999999999999998886543


Q ss_pred             cc--cCcceeec
Q 022887          280 LQ--GNTKRIVG  289 (290)
Q Consensus       280 ~~--~~~~~~~G  289 (290)
                      ..  ....+++|
T Consensus       475 e~~~~~~~g~~g  486 (601)
T KOG0590|consen  475 EKNIHESSGIVG  486 (601)
T ss_pred             chhhhhhcCccc
Confidence            32  33344444

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.40  E-value=5.4e-12  Score=103.58  Aligned_cols=143  Identities=17%  Similarity=0.233  Sum_probs=110.1

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEeccccc-cCHHHHHHHHHHHcccCC--CCcceeEEEEEeCC---eeEEEEEecC
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQG---ENILIYEYMP  202 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~  202 (290)
                      +.|+.|.++.+|++...+|..+++|....... .....+..|..++..+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999887668899998764332 235678999999999875  44567777766542   5689999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS----------------------------------------  242 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~----------------------------------------  242 (290)
                      +.++...+..    ..++..++..++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888665421    34677777888888888888888521                                        


Q ss_pred             -------------CCCceecCCCCCCEEEcC--CCCeEEeeccCceee
Q 022887          243 -------------RLRIIHRDLKASNILLDS--DMNPKISDFGMARIF  275 (290)
Q Consensus       243 -------------~~~iiH~dlk~~Nill~~--~~~~kl~DfGla~~~  275 (290)
                                   ...++|+|+.|.||+++.  +..+.|+||+.+..-
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                         244799999999999998  667899999998854

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.36  E-value=2e-11  Score=97.46  Aligned_cols=138  Identities=14%  Similarity=0.102  Sum_probs=97.0

Q ss_pred             ceecccCCccEEEEEEcC-------CcEEEEEEecccc------------c----------cCHHHH----HHHHHHHcc
Q 022887          129 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS------------G----------QGLTEF----KNEMMLIAK  175 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~-------~~~vavK~l~~~~------------~----------~~~~~~----~~e~~~l~~  175 (290)
                      ..||.|.-+.||.|...+       +..+|||..+...            .          .....+    ..|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997643       4789999664210            0          001223    378888888


Q ss_pred             cCC--CCcceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCceecCCC
Q 022887          176 LQH--RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL-HQYSRLRIIHRDLK  252 (290)
Q Consensus       176 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~iiH~dlk  252 (290)
                      +..  -++.+.+++    ...++||||+.+..+.....   ....++..+...+..+++.+|..+ |..+   ++|+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            854  455566654    56789999998754422110   112244455667788999999999 7666   9999999


Q ss_pred             CCCEEEcCCCCeEEeeccCceeeCC
Q 022887          253 ASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       253 ~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +.||+++ ++.++|+|||-|...+.
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999997 46799999999987753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.34  E-value=2.5e-13  Score=110.45  Aligned_cols=139  Identities=24%  Similarity=0.417  Sum_probs=112.5

Q ss_pred             CccceecccCCccEEEEEEcCCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          126 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       126 ~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      ....+|.+...|+.|+|+++.+ .+++|.+.-.  .....++|..|.-.+.-..||||..++|.|....+..++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            3445678888999999999664 4555665422  233447899999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEe
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                      |+|...++.. ..-..+-.+..+++.++|+|++|||+.. +-|..--|.+..+++|++.+++|+
T Consensus       272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee
Confidence            9999988653 3344667888999999999999999975 235555689999999999998875

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.31  E-value=2.5e-13  Score=128.35  Aligned_cols=142  Identities=21%  Similarity=0.237  Sum_probs=114.9

Q ss_pred             CCCccceecccCCccEEEEEEcCCcEEEEEEeccccc-cCHHHHHHHHHH--HcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLTEFKNEMML--IAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~-~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++...+.+|++.|=+|.+++.++|. |+||++.+..+ -..+.|.++++-  ...++|||.+++.-+-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5677789999999999999998876 89998876543 345566555543  4456899999887776666677888888


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      ..+ +|.+.+   ..++.+...+...|+.|++.|+..+|..+   |.|||||.+|||+++..-+.|+||.--|
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence            866 444444   34566788889999999999999999888   9999999999999999999999998764

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=8e-11  Score=91.30  Aligned_cols=134  Identities=19%  Similarity=0.267  Sum_probs=99.4

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEe-ccccc--c-----CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRL-SNQSG--Q-----GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l-~~~~~--~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ..+++|+-+.+|.+.+.+ .++.+|.= .+.-.  .     ....-.+|..++.+++--.|..-.-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            357889999999997744 34555532 22111  1     123467888888888766665555567778888999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      .++-.|.+.+...          +..++..+-.-+.-||..+   |+|+||.++||++..+. +.++||||+.+-+.
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~  143 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE  143 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccccc
Confidence            9999998887322          2456667777888899888   99999999999997666 99999999996544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.25  E-value=3.6e-11  Score=101.15  Aligned_cols=151  Identities=22%  Similarity=0.311  Sum_probs=96.1

Q ss_pred             cCCCccceecccCCccEEEEEEcC-CcEEEEEEeccc---cccCHHHHHHHHHHHcccCC----------CCcceeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH----------RHLVRLFGCC  188 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~  188 (290)
                      ..+...+.||.|+++.||.+++.+ ++++|+|.....   .....+++.+|......+.+          -.++--++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            345566899999999999999855 899999987532   22345677777765555332          1121111111


Q ss_pred             E---------eCC--------eeEEEEEecCCCChhhhhh---CC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCce
Q 022887          189 I---------EQG--------ENILIYEYMPNKSLDVFLF---YP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII  247 (290)
Q Consensus       189 ~---------~~~--------~~~lv~e~~~~g~L~~~l~---~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ii  247 (290)
                      .         ...        +.+++|.-+ .++|..++.   .. .....+....++.+..|+.+.+++||+.+   ++
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence            1         110        224566665 556766542   11 11233445667788899999999999998   99


Q ss_pred             ecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          248 HRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       248 H~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |+||+|+|++++.+|.++|+||+.....+.
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~  197 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGT  197 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCc
Confidence            999999999999999999999988876654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.25  E-value=9.9e-13  Score=118.00  Aligned_cols=144  Identities=26%  Similarity=0.329  Sum_probs=114.8

Q ss_pred             eecccCCccEEEEE----EcCCcEEEEEEecccccc--CHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEEEecC
Q 022887          130 KLGEGGFGPVYKGR----LLNGQEVAVKRLSNQSGQ--GLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       130 ~ig~G~fg~V~~~~----~~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      .+|+|.||.|+..+    .+.+..+|+|.+.+....  .......|..++...+ ||.+|++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            36899999999764    234667888877653221  1225566778888887 9999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      +|.+...+.   ....++......+...++-+++++|..+   ++|||+|++||+++.+|.+|+.|||+.+.+-..+
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            998876653   2344555556666677899999999887   9999999999999999999999999999875543

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.23  E-value=5.9e-12  Score=82.44  Aligned_cols=40  Identities=60%  Similarity=1.419  Sum_probs=35.1

Q ss_pred             CChhhHHHHHhhccCeeeEeeccccCCCcceeEeecccccc
Q 022887            1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDL   41 (290)
Q Consensus         1 ~~~~~C~~~c~~~c~C~a~~~~~~~~g~~~c~~~~~~l~~~   41 (290)
                      +++++|+..|++||+|+||+|.+.. ++.+|.+|.++|+|+
T Consensus        27 ~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~   66 (66)
T PF08276_consen   27 VSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL   66 (66)
T ss_pred             CCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence            4789999999999999999998655 567899999999874

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.21  E-value=3.1e-10  Score=87.78  Aligned_cols=147  Identities=22%  Similarity=0.266  Sum_probs=104.0

Q ss_pred             ccceecccCCccEEEEEEcCCcEEEEEE-ecccc-------ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          127 TQCKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQS-------GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       127 ~~~~ig~G~fg~V~~~~~~~~~~vavK~-l~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ....+-+|+-+.|+++.++ |+...||. ..+..       .-......+|+..+.++.--.|..-.-++.+.....++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578999999999999884 45555663 22211       112356778999998887656655555677777788999


Q ss_pred             EecCC-CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC---CeEEeeccCcee
Q 022887          199 EYMPN-KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARI  274 (290)
Q Consensus       199 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DfGla~~  274 (290)
                      ||+++ .++.+++...-.... ........+.++-+.+.-||...   |+|+||..+||++.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 356666643322222 22333678888899999999888   99999999999997554   358999999976


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      -...
T Consensus       166 s~~~  169 (229)
T KOG3087|consen  166 SRLP  169 (229)
T ss_pred             ccCc
Confidence            5433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.20  E-value=3e-11  Score=107.97  Aligned_cols=100  Identities=32%  Similarity=0.489  Sum_probs=89.9

Q ss_pred             HcccCCCCcceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCC
Q 022887          173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK  252 (290)
Q Consensus       173 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk  252 (290)
                      |..+.|.|+.+++|.+.+++..+.|.+|++.|+|.+.+..  ..-.++|.-...+..+++.||.|||+..  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3568899999999999999999999999999999999854  3456899999999999999999999754  23999999


Q ss_pred             CCCEEEcCCCCeEEeeccCceeeC
Q 022887          253 ASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       253 ~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ++|+++|..+.+||+|||+..+..
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             cccceeeeeEEEEechhhhccccc
Confidence            999999999999999999998874

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=4.6e-10  Score=89.27  Aligned_cols=127  Identities=26%  Similarity=0.313  Sum_probs=81.8

Q ss_pred             cEEEEEEcCCcEEEEEEecccc--------------c-------c-----CHHHHHHHHHHHcccCCC--CcceeEEEEE
Q 022887          138 PVYKGRLLNGQEVAVKRLSNQS--------------G-------Q-----GLTEFKNEMMLIAKLQHR--HLVRLFGCCI  189 (290)
Q Consensus       138 ~V~~~~~~~~~~vavK~l~~~~--------------~-------~-----~~~~~~~e~~~l~~l~h~--niv~l~~~~~  189 (290)
                      .||.|...++.++|+|......              .       .     ......+|...|.++..-  ++.+.+.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            3899998889999999664310              0       0     022467899999999765  45556544  


Q ss_pred             eCCeeEEEEEecC--CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCceecCCCCCCEEEcCCCCeEE
Q 022887          190 EQGENILIYEYMP--NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-LHQYSRLRIIHRDLKASNILLDSDMNPKI  266 (290)
Q Consensus       190 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~y-LH~~~~~~iiH~dlk~~Nill~~~~~~kl  266 (290)
                        +...+||||++  +..+..+....     ++......++.+++..+.. +|..+   |+|+|+.+.||+++++ .+.+
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              24579999998  54454432111     1123445677777776655 46666   9999999999999988 8999


Q ss_pred             eeccCceeeCC
Q 022887          267 SDFGMARIFGG  277 (290)
Q Consensus       267 ~DfGla~~~~~  277 (290)
                      +|||.+.....
T Consensus       148 IDf~qav~~~~  158 (188)
T PF01163_consen  148 IDFGQAVDSSH  158 (188)
T ss_dssp             --GTTEEETTS
T ss_pred             EecCcceecCC
Confidence            99999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=2.2e-09  Score=90.35  Aligned_cols=140  Identities=17%  Similarity=0.105  Sum_probs=98.2

Q ss_pred             eecccCCccEEEEEEcCCcEEEEEEeccccc-----------cCHHHHHHHHHHHcccCCCCc--ceeEEEEEe-----C
Q 022887          130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-----------QGLTEFKNEMMLIAKLQHRHL--VRLFGCCIE-----Q  191 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~-----~  191 (290)
                      .+-+.....|++..+ +|+.+.||+......           .....+.+|...+.++...+|  .+.+++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            444334444677766 567899997643221           011247788888888754443  344555543     2


Q ss_pred             CeeEEEEEecCCC-ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-------CCC
Q 022887          192 GENILIYEYMPNK-SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------DMN  263 (290)
Q Consensus       192 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-------~~~  263 (290)
                      ...++|+|++++. +|.+++.... ....+...+..++.+++..+.-||..+   |+|+|+++.|||++.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            3468999999986 7888763211 233455677789999999999999988   999999999999975       468


Q ss_pred             eEEeeccCcee
Q 022887          264 PKISDFGMARI  274 (290)
Q Consensus       264 ~kl~DfGla~~  274 (290)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999999965

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.11  E-value=9.2e-11  Score=100.37  Aligned_cols=89  Identities=28%  Similarity=0.473  Sum_probs=68.2

Q ss_pred             CCCCcceeEEEEEeC---------------------------CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHH
Q 022887          177 QHRHLVRLFGCCIEQ---------------------------GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE  229 (290)
Q Consensus       177 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  229 (290)
                      +|||||++.+.|.+.                           ...|+||...+. +|..++..    ...+.....-|..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence            599999999887542                           124677776644 67777732    2345566677888


Q ss_pred             HHHHHHHHHhhCCCCCceecCCCCCCEEE--cCCC--CeEEeeccCce
Q 022887          230 GIAQGLLYLHQYSRLRIIHRDLKASNILL--DSDM--NPKISDFGMAR  273 (290)
Q Consensus       230 ~i~~~l~yLH~~~~~~iiH~dlk~~Nill--~~~~--~~kl~DfGla~  273 (290)
                      |+++|+.|||.++   +.|||+|++|||+  |+|.  ...|+|||.+-
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence            9999999999888   9999999999998  4444  57899999874

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.10  E-value=1.1e-10  Score=78.93  Aligned_cols=51  Identities=27%  Similarity=0.513  Sum_probs=42.4

Q ss_pred             CChhhHHHHHhh---ccCeeeEeeccccCCCcceeEeeccc-ccccccccCCCCceEEEE
Q 022887            1 MNLNQCQAKCLK---NCSCRAYANSKLTGGGSGCLMWFGDL-IDLRKPISNFTGQSVYIR   56 (290)
Q Consensus         1 ~~~~~C~~~c~~---~c~C~a~~~~~~~~g~~~c~~~~~~l-~~~~~~~~~~~~~~~~i~   56 (290)
                      ++++||++.|++   ||+|+||+|.+.   +.+|.+|.+++ .+.+...+  .+.++|+|
T Consensus        25 ~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~--~g~~Ly~r   79 (80)
T cd00129          25 NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFS--HGFDLYEN   79 (80)
T ss_pred             cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccC--CCceeEeE
Confidence            478999999999   999999999752   34799999999 88876644  47788886

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.03  E-value=4.2e-10  Score=77.74  Aligned_cols=53  Identities=45%  Similarity=1.014  Sum_probs=43.0

Q ss_pred             CChhhHHHHHhhccCeeeEeeccccCCCcceeEeecccccccccccCCCCceEEEEec
Q 022887            1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFGDLIDLRKPISNFTGQSVYIRVP   58 (290)
Q Consensus         1 ~~~~~C~~~c~~~c~C~a~~~~~~~~g~~~c~~~~~~l~~~~~~~~~~~~~~~~i~~~   58 (290)
                      +++++|++.|+.||+|.||+|.+   ++.+|.+|.+++.+.+.+..  .+...|+|+|
T Consensus        32 ~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~--~~~~~yiKv~   84 (84)
T cd01098          32 ISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSS--GGGTLYLRLA   84 (84)
T ss_pred             CCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecC--CCcEEEEEeC
Confidence            47899999999999999999975   35679999999888766432  3567899875

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.96  E-value=1e-10  Score=108.92  Aligned_cols=152  Identities=24%  Similarity=0.311  Sum_probs=116.2

Q ss_pred             hcCCCccceecccCCccEEEEEEcC--CcEEEEEEecccc--ccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~--~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  196 (290)
                      ...|...+.||+|+|+.|-......  ...+|+|.+....  .........|..+=..+. |+|++.+++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3467777889999999999887643  3456666554332  122233344555555565 9999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCceecCCCCCCEEEcCCC-CeEEeeccCcee
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH-QYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARI  274 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~  274 (290)
                      +.+|..++++...+.. ......+....-.+..|+..++.|+| +.+   +.|+|+||+|.+++..+ ..|++|||+|..
T Consensus        99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999988776521 11113445566778899999999999 766   99999999999999999 999999999988


Q ss_pred             eCC
Q 022887          275 FGG  277 (290)
Q Consensus       275 ~~~  277 (290)
                      +..
T Consensus       175 ~~~  177 (601)
T KOG0590|consen  175 YRN  177 (601)
T ss_pred             ccc
Confidence            866

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.93  E-value=9.3e-09  Score=93.62  Aligned_cols=145  Identities=18%  Similarity=0.238  Sum_probs=94.8

Q ss_pred             CCCccceecccCCccEEEEEEcCCcEEEEEEeccccccC--------------------------H----H---------
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG--------------------------L----T---------  164 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~--------------------------~----~---------  164 (290)
                      .|+. +.|+.++-|+||+|++.+|++||||+..+.-...                          .    +         
T Consensus       127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E  205 (517)
T COG0661         127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE  205 (517)
T ss_pred             HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence            4543 6899999999999999999999999886531110                          0    0         


Q ss_pred             -HHHHHHHHHccc-----CCCCcceeEEEE-EeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHH-H
Q 022887          165 -EFKNEMMLIAKL-----QHRHLVRLFGCC-IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL-L  236 (290)
Q Consensus       165 -~~~~e~~~l~~l-----~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~  236 (290)
                       +|..|...+.++     +.|++ ++=..+ .-.+...|+|||++|-.+.+....+.  ...+   +..++..++++. .
T Consensus       206 lDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f~~  279 (517)
T COG0661         206 LDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAFLR  279 (517)
T ss_pred             hCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHHHH
Confidence             133444444333     23443 222222 33457799999999998888753322  2233   233444443332 2


Q ss_pred             HHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       237 yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      .+-..+   ++|.|..|.||+++.++.+-+.|||+...+++.
T Consensus       280 q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         280 QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            222234   999999999999999999999999999988654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.89  E-value=2e-08  Score=89.17  Aligned_cols=140  Identities=20%  Similarity=0.295  Sum_probs=109.6

Q ss_pred             ccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEe----CCeeEEEEEecCCC-Chhhhh
Q 022887          137 GPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGENILIYEYMPNK-SLDVFL  210 (290)
Q Consensus       137 g~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~g-~L~~~l  210 (290)
                      .+.|++.. .||..+++|++.....+.......-++.++++.|+|+|++..++..    +...++||+|.|.. +|.++.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            56788865 5788999999954333333233455778999999999999888763    34678999999864 454433


Q ss_pred             hCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          211 FYP------------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       211 ~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +..            ..+...++...|.++.|+..||.++|+.+   +.-+-|.+++||++.+..++|+..|+..++..|
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            221            12345678999999999999999999988   888999999999999999999999999999887


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       447 ~  447 (655)
T KOG3741|consen  447 P  447 (655)
T ss_pred             C
Confidence            6

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.83  E-value=1.7e-08  Score=92.01  Aligned_cols=124  Identities=17%  Similarity=0.230  Sum_probs=98.5

Q ss_pred             EcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHH
Q 022887          144 LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQA  223 (290)
Q Consensus       144 ~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~  223 (290)
                      ..++.+|.|...+...........+.++.++.++||||++++......+..|+|+|-+..  |..++..      ++...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH------hHHHH
Confidence            356788988888765553345567788899999999999999999999999999998744  3334421      22344


Q ss_pred             HHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          224 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       224 ~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ...-+.||+.||.|||+.+  .++|++|.-+.|++++.|..||++|-++...+.
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~  157 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASG  157 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence            5556789999999999755  599999999999999999999999998865543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=6.3e-08  Score=78.69  Aligned_cols=108  Identities=24%  Similarity=0.235  Sum_probs=83.4

Q ss_pred             HHHHHHHHHHHcccCCCC--cceeEEEEEeCC----eeEEEEEecCCC-ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHH
Q 022887          163 LTEFKNEMMLIAKLQHRH--LVRLFGCCIEQG----ENILIYEYMPNK-SLDVFLFYPKKKRLLGWQARVRIIEGIAQGL  235 (290)
Q Consensus       163 ~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l  235 (290)
                      .....+|...+..+....  ..+.+++.....    ..++|+|++++. +|.+++...   ...+......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence            346778888777775433  445666665532    348999999875 788877431   1155567788999999999


Q ss_pred             HHHhhCCCCCceecCCCCCCEEEcCCC---CeEEeeccCceeeC
Q 022887          236 LYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARIFG  276 (290)
Q Consensus       236 ~yLH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DfGla~~~~  276 (290)
                      .-||+.+   ++|+|+++.|||++.+.   .+.++||+-++...
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9999988   99999999999999887   89999999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.80  E-value=4.3e-08  Score=80.78  Aligned_cols=136  Identities=21%  Similarity=0.221  Sum_probs=92.1

Q ss_pred             CccceecccCCccEEEEEEcCCcEEEEEEeccc-----------------cc-----cCHHHHHHHHHHHcccCCC--Cc
Q 022887          126 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-----------------SG-----QGLTEFKNEMMLIAKLQHR--HL  181 (290)
Q Consensus       126 ~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~-----------------~~-----~~~~~~~~e~~~l~~l~h~--ni  181 (290)
                      .+.+.||-|.-+.||.|..+.|.++|||.=+..                 ..     .......+|.+.|.+|.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            455789999999999999999999999932110                 00     0123467888889888655  55


Q ss_pred             ceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC
Q 022887          182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD  261 (290)
Q Consensus       182 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~  261 (290)
                      .+.+++    +...+||||.++-.|...-        ++....-.++..|+.-+.-+-..+   +||+|+++-||+++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence            555544    4557999999886654321        111222233333344333333445   9999999999999999


Q ss_pred             CCeEEeeccCceeeC
Q 022887          262 MNPKISDFGMARIFG  276 (290)
Q Consensus       262 ~~~kl~DfGla~~~~  276 (290)
                      +.+.++||-=+...+
T Consensus       239 g~~~vIDwPQ~v~~~  253 (304)
T COG0478         239 GDIVVIDWPQAVPIS  253 (304)
T ss_pred             CCEEEEeCcccccCC
Confidence            999999997665543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.76  E-value=6.9e-09  Score=98.64  Aligned_cols=112  Identities=28%  Similarity=0.418  Sum_probs=76.5

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|..++.|..|+||.||..++.. .+.+|+ ++.+...    -+++   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l----ilRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL----ILRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccccch----hhhc---cccccCCccee------------------
Confidence            4689999999999999999998754 677888 4433211    0000   22222333333                  


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                         |+-...+..   .+.++.        +++.+++|||+.+   |+|||+||+|.+++.-|.+|++|||+.+...
T Consensus       136 ---gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ---GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ---chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhh
Confidence               333333321   122221        2378999999888   9999999999999999999999999998653

>PRK09902 hypothetical protein; Provisional

Probab=98.72  E-value=5.8e-07  Score=72.23  Aligned_cols=139  Identities=14%  Similarity=0.126  Sum_probs=100.1

Q ss_pred             cccCCccEEEEEEcCCcEEEEEEecccc------ccCHHHHHHHHHHHcccCCCC--cceeEEEEEeCC----eeEEEEE
Q 022887          132 GEGGFGPVYKGRLLNGQEVAVKRLSNQS------GQGLTEFKNEMMLIAKLQHRH--LVRLFGCCIEQG----ENILIYE  199 (290)
Q Consensus       132 g~G~fg~V~~~~~~~~~~vavK~l~~~~------~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e  199 (290)
                      |+||-+-|++-.+.+ ..+-+|+-.+..      +.....|.+|+..+.++..-+  +.+.........    .-+||+|
T Consensus        27 ~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            468888899987744 478899775221      345678999999998885333  444442222221    3579999


Q ss_pred             ecCC-CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC--eEEeeccCceee
Q 022887          200 YMPN-KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMARIF  275 (290)
Q Consensus       200 ~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~--~kl~DfGla~~~  275 (290)
                      -+++ -+|.+++... .....+...+..+..++++.+.-||..+   +.|+|+.+.||+++.++.  ++++||--++..
T Consensus       106 ~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        106 DMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             eCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            7763 4677776322 2234567778899999999999999988   999999999999986666  999999877643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.69  E-value=1.2e-07  Score=75.64  Aligned_cols=107  Identities=21%  Similarity=0.189  Sum_probs=84.5

Q ss_pred             HHHHHHHcccCC-CCcceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 022887          167 KNEMMLIAKLQH-RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR  245 (290)
Q Consensus       167 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~  245 (290)
                      ..|..++..+++ +++.+++|+|-+    +++.||.+.+++......-..-...+|..|.+||.++++.+.++++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457778888876 699999999943    789999998765421000011124689999999999999999999866556


Q ss_pred             ceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          246 IIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       246 iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +.-.|++++|+.+++++.+|++|...+...+.
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~~  114 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVEDK  114 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhHH
Confidence            88899999999999999999999998876644

Proteins in this uncharacterised family are described as transmembrane proteins.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.67  E-value=5.2e-08  Score=76.90  Aligned_cols=62  Identities=26%  Similarity=0.144  Sum_probs=53.2

Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+|.+++..  ....++|.+++.++.|++.||.|||+.+         ||+|||++.++.+|+  ||+++.....
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~   62 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE   62 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence            678888743  2446999999999999999999999865         999999999999999  9999987543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=2.4e-07  Score=84.29  Aligned_cols=140  Identities=19%  Similarity=0.262  Sum_probs=89.1

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEeccccccC-------------------------------------HHHHHHHHH
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-------------------------------------LTEFKNEMM  171 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~e~~  171 (290)
                      +.|+..+.|+|++|++.+|+.||||+-++.-...                                     .-+|..|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6899999999999999999999999776532111                                     011344444


Q ss_pred             HHcc----cCCCC------cceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 022887          172 LIAK----LQHRH------LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY  241 (290)
Q Consensus       172 ~l~~----l~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~  241 (290)
                      -..+    +.|-+      |.+++..+  ...+.|+||||+|..+.+.....+  ..++...   ++..+.++.  ++.-
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i~~~l~~~~--~~qI  317 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK--RGISPHD---ILNKLVEAY--LEQI  317 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH--cCCCHHH---HHHHHHHHH--HHHH
Confidence            3322    33444      33333222  246799999999998877643322  2233333   333333322  1111


Q ss_pred             CCCCceecCCCCCCEEEcC----CCCeEEeeccCceeeCC
Q 022887          242 SRLRIIHRDLKASNILLDS----DMNPKISDFGMARIFGG  277 (290)
Q Consensus       242 ~~~~iiH~dlk~~Nill~~----~~~~kl~DfGla~~~~~  277 (290)
                      -..+++|+|-.|-||+++.    ++.+.+-|||+...+..
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            1223999999999999984    67899999999988754

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.66  E-value=8.3e-07  Score=73.14  Aligned_cols=140  Identities=18%  Similarity=0.192  Sum_probs=85.1

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCc--ceeEEEEEeCCeeEEEEEecCCCC-
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL--VRLFGCCIEQGENILIYEYMPNKS-  205 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~g~-  205 (290)
                      ..||+|..+.||+.   .+..+++|......  ......+|.+.+..+..-.+  .+.+++....+...+|||++++.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57999999999983   24567778765422  34567889999888864443  566777777777789999999863 


Q ss_pred             hhhhh---------------------hCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHhh-CCCCCceecCC
Q 022887          206 LDVFL---------------------FYPKKKRLLGWQARV-RIIE----------GIAQ-GLLYLHQ-YSRLRIIHRDL  251 (290)
Q Consensus       206 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~i~~-~l~yLH~-~~~~~iiH~dl  251 (290)
                      +...+                     +.-. .......... .+..          .+.. ...+|.. .....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            21111                     1100 0011111100 0000          0111 1122221 12334789999


Q ss_pred             CCCCEEEcCCCCeEEeeccCceee
Q 022887          252 KASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       252 k~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      .|.||++++++ +.|.||+.+..=
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~G  183 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGYG  183 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCcC
Confidence            99999999888 999999998743

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.65  E-value=1.4e-08  Score=91.28  Aligned_cols=147  Identities=24%  Similarity=0.288  Sum_probs=113.4

Q ss_pred             HhcCCCccceecccCCccEEEEEE--cCCcEEEEEEeccccccCHHH--HHHHHHHHccc-CCCCcceeEEEEEeCCeeE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLTE--FKNEMMLIAKL-QHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~--~~~~~vavK~l~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  195 (290)
                      ...+|..+..||.|.|+.|+....  .++..+++|.+.+.......+  -..|+.+...+ .|.+++.....+....+.+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            455788899999999999998754  457788999876543322222  23444444444 5888888777777777888


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC-CCeEEeeccCce
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR  273 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGla~  273 (290)
                      +=-||++++++....   .....++...++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||.+.
T Consensus       343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            999999999987655   22334677788999999999999999877   9999999999999876 788999999986

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.63  E-value=3.3e-08  Score=88.98  Aligned_cols=152  Identities=24%  Similarity=0.288  Sum_probs=115.8

Q ss_pred             cCCCccceecc--cCCccEEEEEE---cCCcEEEEEEecc--ccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCee
Q 022887          123 ENFSTQCKLGE--GGFGPVYKGRL---LNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       123 ~~~~~~~~ig~--G~fg~V~~~~~---~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  194 (290)
                      ..|.....+|.  |.+|.+|.+..   .++..+|+|+-+.  ..+.....=.+|+.....+ .|+|.++....+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34556678999  99999999976   3467889987432  2223333345566666666 499999988899999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCceecCCCCCCEEEcCC-CCeEEeec
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDF  269 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Df  269 (290)
                      ++-+|++. .++..+-+.  ....++....+....+...    |+..+|+..   ++|-|+||.||++.++ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            99999886 566665532  2333555666667777777    999999887   9999999999999999 88999999


Q ss_pred             cCceeeCCCcc
Q 022887          270 GMARIFGGDEL  280 (290)
Q Consensus       270 Gla~~~~~~~~  280 (290)
                      |+...++...+
T Consensus       268 ~~v~~i~~~~~  278 (524)
T KOG0601|consen  268 GLVSKISDGNF  278 (524)
T ss_pred             ceeEEccCCcc
Confidence            99999987654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.57  E-value=3.6e-08  Score=82.80  Aligned_cols=96  Identities=29%  Similarity=0.365  Sum_probs=80.0

Q ss_pred             HHHcccCCCCcceeEEEEEeCC-----eeEEEEEecCCCChhhhhhCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 022887          171 MLIAKLQHRHLVRLFGCCIEQG-----ENILIYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRL  244 (290)
Q Consensus       171 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~  244 (290)
                      .-+-.+-|.|||++..|+.+..     ...++.|||+-|++..+|...+ ....+......+|+.||..||.|||+. .+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            3455667999999999987654     3578999999999999986543 345567777889999999999999996 57


Q ss_pred             CceecCCCCCCEEEcCCCCeEEe
Q 022887          245 RIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       245 ~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                      +|+|+++..+.|++..++-+|+.
T Consensus       198 piihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             ccccCCcchhheeecCCceEEec
Confidence            89999999999999999988874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.53  E-value=1.8e-06  Score=72.09  Aligned_cols=143  Identities=15%  Similarity=0.129  Sum_probs=86.4

Q ss_pred             eecccCC-ccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEEEecCCCChh
Q 022887          130 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSLD  207 (290)
Q Consensus       130 ~ig~G~f-g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  207 (290)
                      .|..|.. ..||+.... +..+.+|......   ...+..|+.++..+. +--+.+++++....+..++|||++++.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            4555655 778998764 4678888775432   345677888877774 334556777777666789999999988775


Q ss_pred             hhh-------------------hCCCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHhh----C
Q 022887          208 VFL-------------------FYPKK-KRLLG--WQARVRIIE--------------------GIAQGLLYLHQ----Y  241 (290)
Q Consensus       208 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~i~~~l~yLH~----~  241 (290)
                      ...                   +.... ...+.  ...+.....                    .....+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            331                   11000 00111  001110000                    01111222211    1


Q ss_pred             CCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       242 ~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ....++|+|+.|.|||++++..+.|+||+.|..-+
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gd  195 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVAD  195 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccccc
Confidence            23458999999999999998888999999987543

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.52  E-value=1.5e-06  Score=70.20  Aligned_cols=139  Identities=14%  Similarity=0.159  Sum_probs=88.9

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHH---------HHHHHHHHcccCCC---CcceeEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE---------FKNEMMLIAKLQHR---HLVRLFGCC  188 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~---------~~~e~~~l~~l~h~---niv~l~~~~  188 (290)
                      ..++|...+.+-......|.+-.. ++..+.+|...+......+.         +.+++..+.++...   ..+.++...
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346777777777666666666665 45788888776543222222         22333333344322   222222222


Q ss_pred             E-----eCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC
Q 022887          189 I-----EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN  263 (290)
Q Consensus       189 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~  263 (290)
                      .     -....+++|||+++-.|.+...       ++.    .++..+++++.-+|..+   +.|+|..|.|+++++++ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence            2     1234568999999988765431       221    35566788899999888   99999999999998655 


Q ss_pred             eEEeeccCceee
Q 022887          264 PKISDFGMARIF  275 (290)
Q Consensus       264 ~kl~DfGla~~~  275 (290)
                      +++.||+..+..
T Consensus       173 i~iID~~~k~~~  184 (229)
T PF06176_consen  173 IRIIDTQGKRMS  184 (229)
T ss_pred             EEEEECcccccc
Confidence            999999888754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.51  E-value=2.2e-08  Score=88.81  Aligned_cols=81  Identities=28%  Similarity=0.379  Sum_probs=73.2

Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..++.|+++...+|.+++.........+|...+.++.|++.|++|   ++   .+|+|+||.||+...+.++||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999776667778899999999999999999   55   999999999999999999999999999


Q ss_pred             eeeCCCc
Q 022887          273 RIFGGDE  279 (290)
Q Consensus       273 ~~~~~~~  279 (290)
                      .-...++
T Consensus       404 ts~~~~~  410 (516)
T KOG1033|consen  404 TSQDKDE  410 (516)
T ss_pred             eecccCC
Confidence            8777665

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.50  E-value=2.6e-06  Score=69.67  Aligned_cols=156  Identities=19%  Similarity=0.194  Sum_probs=98.5

Q ss_pred             cccHHhHHHHhcCCCccce---ecccCCccEEEEEEcCCcEEEEEEeccccccC------------------------HH
Q 022887          112 LFSLASVSAATENFSTQCK---LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG------------------------LT  164 (290)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~~---ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~------------------------~~  164 (290)
                      ..+...+....+...+.+.   |.+|.-+.||+|...++..+|+|+........                        ..
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            3455555555566555554   44677778999988889999999886432111                        01


Q ss_pred             HHHHHHHHHcccC--CCCcceeEEEEEeCCeeEEEEEecCCCCh-hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 022887          165 EFKNEMMLIAKLQ--HRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY  241 (290)
Q Consensus       165 ~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~  241 (290)
                      ....|..-|.++.  +-.+.+-+++    .+..|||||+..... .-.|    ....+...+...+..++++.+.-|-..
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence            1345555565553  2223333332    234799999976521 1111    112223335666777788888777652


Q ss_pred             CCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       242 ~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                        .++||+||+.=|||+. ++.+.|+|||=|......
T Consensus       186 --a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         186 --AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             --cCcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence              2499999999999999 889999999999877643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.49  E-value=1.9e-06  Score=70.94  Aligned_cols=146  Identities=23%  Similarity=0.202  Sum_probs=85.9

Q ss_pred             cceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCC--cceeEEEEEeC---CeeEEEEEecC
Q 022887          128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFGCCIEQ---GENILIYEYMP  202 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~---~~~~lv~e~~~  202 (290)
                      ++.++.|..+.||+....+ ..+++|.....  .....+..|..++..+....  +.+++.+....   ...+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3678899999999999877 69999987653  34467778888887775433  45666654333   34689999999


Q ss_pred             CCChhh----------------hh---hCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 022887          203 NKSLDV----------------FL---FYP-KKKRLLGWQA---------RVRI------------IEGIAQ-GLLYLHQ  240 (290)
Q Consensus       203 ~g~L~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~i~~-~l~yLH~  240 (290)
                      +..+..                .+   +.. .......+..         ....            ...+.. .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987766                11   111 0111111111         0000            011222 2333332


Q ss_pred             ----CCCCCceecCCCCCCEEEc-CCCCeEEeeccCceeeC
Q 022887          241 ----YSRLRIIHRDLKASNILLD-SDMNPKISDFGMARIFG  276 (290)
Q Consensus       241 ----~~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~~~  276 (290)
                          ..+..++|+|+.|.||+++ +++.+.|.||+.+..-+
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~~  199 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWGD  199 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEEE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceECC
Confidence                2345699999999999999 66666899999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.41  E-value=7.2e-06  Score=80.11  Aligned_cols=79  Identities=18%  Similarity=0.393  Sum_probs=57.3

Q ss_pred             cceecccCCccEEEEEEcCC---cEEEEEEecccc-ccCHHHHHHHHHHHcccC-CCCc--ceeEEEEEeC---CeeEEE
Q 022887          128 QCKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQ-HRHL--VRLFGCCIEQ---GENILI  197 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  197 (290)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|..++..+. |+++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46788999999999877554   367777654322 123457889999999885 6665  7788887764   467899


Q ss_pred             EEecCCCCh
Q 022887          198 YEYMPNKSL  206 (290)
Q Consensus       198 ~e~~~~g~L  206 (290)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.19  E-value=1.7e-05  Score=65.84  Aligned_cols=141  Identities=17%  Similarity=0.186  Sum_probs=76.3

Q ss_pred             ceecccCCc-cEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCC---CcceeEEEEEeC---CeeEEEEEec
Q 022887          129 CKLGEGGFG-PVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR---HLVRLFGCCIEQ---GENILIYEYM  201 (290)
Q Consensus       129 ~~ig~G~fg-~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~  201 (290)
                      +.|+.|+.. .||+.    +..+++|....  ......+..|.+.+..+...   -+.+.++.....   ...+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            567777665 58875    23566775443  22345788899888776531   233344433322   2348899999


Q ss_pred             CCCChhhh------------------hhCCCC-C-CC-----------C-CHHHHH--HHH-------HHHHHHH-H-HH
Q 022887          202 PNKSLDVF------------------LFYPKK-K-RL-----------L-GWQARV--RII-------EGIAQGL-L-YL  238 (290)
Q Consensus       202 ~~g~L~~~------------------l~~~~~-~-~~-----------l-~~~~~~--~i~-------~~i~~~l-~-yL  238 (290)
                      ++.++...                  ++.-.. . ..           + .|....  .+.       .+....+ + ++
T Consensus        77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  156 (235)
T cd05155          77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL  156 (235)
T ss_pred             cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence            98776322                  111000 0 00           0 111110  000       0111111 1 11


Q ss_pred             hh--CCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          239 HQ--YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       239 H~--~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +.  ..+..++|+|+.+.||+++++....|.||+.|..-
T Consensus       157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            11  12344899999999999987766789999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.18  E-value=4.5e-05  Score=61.29  Aligned_cols=136  Identities=18%  Similarity=0.250  Sum_probs=89.0

Q ss_pred             ccceecccCCccEEEEEEcCCcEEEEEEecccc----------------ccCHHHHHHHHHHHcccC------CCCccee
Q 022887          127 TQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------GQGLTEFKNEMMLIAKLQ------HRHLVRL  184 (290)
Q Consensus       127 ~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l  184 (290)
                      ....||+|+.=.||.  +++.....||+.....                ....++..+|+.-...+.      +..|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            446899999888885  3455667888886544                123466777776555554      8889999


Q ss_pred             EEEEEeCCeeEEEEEecCC--C----ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE
Q 022887          185 FGCCIEQGENILIYEYMPN--K----SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  258 (290)
Q Consensus       185 ~~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill  258 (290)
                      +|+..+....-+|+|...+  |    +|.+++.    ...++. ....   .+-+-..||-+..   |+.+|++|.||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHH---HHHHHHHHHHHcC---CeecCCCcccEEE
Confidence            9999999889999998743  3    3555552    223444 2222   2333445665555   9999999999999


Q ss_pred             cCCC----CeEEee-ccCceee
Q 022887          259 DSDM----NPKISD-FGMARIF  275 (290)
Q Consensus       259 ~~~~----~~kl~D-fGla~~~  275 (290)
                      ..+.    .+.|.| ||-..++
T Consensus       152 ~~~~~~~~~lvlIDG~G~~~~i  173 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEKELI  173 (199)
T ss_pred             EecCCCceEEEEEeCCCCcccc
Confidence            5332    455555 4554443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=98.17  E-value=5.9e-05  Score=64.87  Aligned_cols=80  Identities=13%  Similarity=0.135  Sum_probs=57.6

Q ss_pred             CCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCC---CCcceeEEEEEe---CCeeEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH---RHLVRLFGCCIE---QGENILI  197 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv  197 (290)
                      .....+.||.|..+.||+....++ .+.+|..+.  ......+..|...+..+.-   ..+.++++.+..   .+..++|
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            344557899999999999876555 466666432  1123588899998888753   357788888754   3568999


Q ss_pred             EEecCCCCh
Q 022887          198 YEYMPNKSL  206 (290)
Q Consensus       198 ~e~~~~g~L  206 (290)
                      ||++++.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.11  E-value=5.2e-05  Score=62.80  Aligned_cols=143  Identities=21%  Similarity=0.272  Sum_probs=81.6

Q ss_pred             ceecccCCccEEEEEEcC--CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcc-eeEEEEEeCCeeEEEEEecCCCC
Q 022887          129 CKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCCIEQGENILIYEYMPNKS  205 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~--~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~  205 (290)
                      +.|..|-...+|+....+  +..+++|....... ...+...|+.++..+...+++ ++++...    ..++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            467777788999987754  56888887654322 222345788888777544443 4443322    248999999877


Q ss_pred             hhhh-----------------hhCCCCC--------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 022887          206 LDVF-----------------LFYPKKK--------RLL-GWQARVRIIE----------------------GIAQGLLY  237 (290)
Q Consensus       206 L~~~-----------------l~~~~~~--------~~l-~~~~~~~i~~----------------------~i~~~l~y  237 (290)
                      +...                 ++.....        ... -|.....+..                      .+...+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            5321                 1111100        111 1222111111                      11111111


Q ss_pred             H----hhC-CCCCceecCCCCCCEEEcC-CCCeEEeeccCceeeC
Q 022887          238 L----HQY-SRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFG  276 (290)
Q Consensus       238 L----H~~-~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~  276 (290)
                      |    -.. .+..++|+|+.+.|||+++ +..+.++||-.|..-.
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~  203 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNY  203 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCc
Confidence            1    111 2345999999999999998 5789999999887543

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.09  E-value=4.7e-05  Score=60.84  Aligned_cols=125  Identities=24%  Similarity=0.385  Sum_probs=89.2

Q ss_pred             cCCCccceecccCC-ccEEEEEEcCCcEEEEEEecc---cc--------c----------cCHHHHHHHHHHHcccC---
Q 022887          123 ENFSTQCKLGEGGF-GPVYKGRLLNGQEVAVKRLSN---QS--------G----------QGLTEFKNEMMLIAKLQ---  177 (290)
Q Consensus       123 ~~~~~~~~ig~G~f-g~V~~~~~~~~~~vavK~l~~---~~--------~----------~~~~~~~~e~~~l~~l~---  177 (290)
                      .+++.++.||.|.- |.||+++. +|+.+|+|....   ..        .          .....|..|....++|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78889999999999 99999999 567999998321   00        0          11245889999888885   


Q ss_pred             CCCc--ceeEEEEEeCC------------------eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 022887          178 HRHL--VRLFGCCIEQG------------------ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY  237 (290)
Q Consensus       178 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~y  237 (290)
                      +.++  |+.+||..-..                  ...+|.||.+...            .++    .+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            4455  89999874321                  1246777765543            111    2234567778888


Q ss_pred             HhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       238 LH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      +|..+   |+-+|+++.|..     .-||.|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99777   999999999985     3588899875

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.09  E-value=6.1e-05  Score=58.56  Aligned_cols=131  Identities=20%  Similarity=0.238  Sum_probs=88.4

Q ss_pred             CccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcce-eEEEEEeCCeeEEEEEecCCC
Q 022887          126 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR-LFGCCIEQGENILIYEYMPNK  204 (290)
Q Consensus       126 ~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g  204 (290)
                      ...+.|++|.+|.||++.+.+ .++|+|.-...  .....+..|.+++..+.-.++.+ ++.+.    ..++.|||..+-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRG-GEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeeccC-ceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            445789999999999999954 58888876543  34578999999998888777654 44333    334569999888


Q ss_pred             ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCC-CCCCEEEcCCCCeEEeeccCceeeC
Q 022887          205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       205 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dl-k~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      .|.+.-..      .+..+..++    +..---|-..+   |-|+.| .|...++-.+..+.|+||--|++-.
T Consensus        98 ~L~~~~~~------~~rk~l~~v----lE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~  157 (201)
T COG2112          98 PLGKLEIG------GDRKHLLRV----LEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFKK  157 (201)
T ss_pred             chhhhhhc------ccHHHHHHH----HHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence            87665311      122333333    33322233224   888888 4666666666699999999998543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.08  E-value=4e-05  Score=64.46  Aligned_cols=140  Identities=16%  Similarity=0.086  Sum_probs=78.8

Q ss_pred             ecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcc-eeEEEEEeCCeeEEEEEecCCCChhhh
Q 022887          131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCCIEQGENILIYEYMPNKSLDVF  209 (290)
Q Consensus       131 ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~~~  209 (290)
                      +..|-...+|+... ++..+++|...........+...|..++..+....++ +++...    ..++||||+++..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence            45577788998874 5667888875443222112457788888877644443 344332    24789999998765421


Q ss_pred             -----------------hhCCC-CCCCCCHHHH-HHHHHH---------HHHHHHHHhhC-----CCCCceecCCCCCCE
Q 022887          210 -----------------LFYPK-KKRLLGWQAR-VRIIEG---------IAQGLLYLHQY-----SRLRIIHRDLKASNI  256 (290)
Q Consensus       210 -----------------l~~~~-~~~~l~~~~~-~~i~~~---------i~~~l~yLH~~-----~~~~iiH~dlk~~Ni  256 (290)
                                       ++... ....++...+ ..+..+         +...+..+-..     .+..++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             11111 1112222211 111111         11112222111     123589999999999


Q ss_pred             EEcCCCCeEEeeccCceeeC
Q 022887          257 LLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       257 ll~~~~~~kl~DfGla~~~~  276 (290)
                      ++++++ ++++||..|..=+
T Consensus       159 l~~~~~-~~lIDwE~a~~gd  177 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASDGD  177 (256)
T ss_pred             EEeCCC-CEEEeccccCcCC
Confidence            999877 7899999887543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=97.95  E-value=1.8e-05  Score=53.29  Aligned_cols=39  Identities=46%  Similarity=1.110  Sum_probs=31.8

Q ss_pred             CChhhHHHHHhh-ccCeeeEeeccccCCCcceeEee-ccccccc
Q 022887            1 MNLNQCQAKCLK-NCSCRAYANSKLTGGGSGCLMWF-GDLIDLR   42 (290)
Q Consensus         1 ~~~~~C~~~c~~-~c~C~a~~~~~~~~g~~~c~~~~-~~l~~~~   42 (290)
                      .++++|++.|+. +|+|.++.|.+   ++.+|.+|. +.+.+..
T Consensus        25 ~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~   65 (78)
T smart00473       25 ASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDAR   65 (78)
T ss_pred             CCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccce
Confidence            378999999999 99999999964   455799999 6655554

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.93  E-value=0.00016  Score=62.08  Aligned_cols=143  Identities=19%  Similarity=0.162  Sum_probs=85.1

Q ss_pred             cceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCC--cceeEEE------EEeCCeeEEEEE
Q 022887          128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFGC------CIEQGENILIYE  199 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e  199 (290)
                      .+.+..|....+|+....+ ..+++|....   ........|+.++..+.+.+  +.+.+..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567777778999987644 4688887754   23345666777776664332  3444331      223456689999


Q ss_pred             ecCCCChhhh--------------hhCC--C------CCCCCCHHHHH----------HHHHHHHHHHHHHhh----CCC
Q 022887          200 YMPNKSLDVF--------------LFYP--K------KKRLLGWQARV----------RIIEGIAQGLLYLHQ----YSR  243 (290)
Q Consensus       200 ~~~~g~L~~~--------------l~~~--~------~~~~l~~~~~~----------~i~~~i~~~l~yLH~----~~~  243 (290)
                      |+++..+...              ++..  .      ......|....          .....+..++.++..    ..+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9998775320              0100  0      01122332221          011123344455543    123


Q ss_pred             CCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          244 LRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       244 ~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ..++|+|+.|.|++++++..+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4599999999999999988789999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.91  E-value=0.00025  Score=63.06  Aligned_cols=75  Identities=13%  Similarity=0.212  Sum_probs=52.7

Q ss_pred             ceecccCCccEEEEEEcCC-cEEEEEEeccc-----c--ccCHHHHHHHHHHHcccC---CCCcceeEEEEEeCCeeEEE
Q 022887          129 CKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ-----S--GQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~-~~vavK~l~~~-----~--~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  197 (290)
                      +.||.|.+..||+....+| +.+.||.-.+.     .  +.....+..|.+.|..+.   -..+.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999998776 48999975421     1  123456677777776652   2456667766  44567899


Q ss_pred             EEecCCCC
Q 022887          198 YEYMPNKS  205 (290)
Q Consensus       198 ~e~~~~g~  205 (290)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>PRK05231 homoserine kinase; Provisional

Probab=97.85  E-value=0.0011  Score=57.70  Aligned_cols=141  Identities=18%  Similarity=0.195  Sum_probs=75.2

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCC--cceeEE------EEEeCCeeEEEEEe
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFG------CCIEQGENILIYEY  200 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e~  200 (290)
                      +.++.|....+|+....++ .+++|.....   .......|+..+..|...+  +.+.+.      +....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4566677778999876555 6888877521   1233334444444442111  223332      12234567899999


Q ss_pred             cCCCChhh-----------h---hhCCC--------CCCCCCH-HHHHHH------------H-HHHHHHHHHHhhC---
Q 022887          201 MPNKSLDV-----------F---LFYPK--------KKRLLGW-QARVRI------------I-EGIAQGLLYLHQY---  241 (290)
Q Consensus       201 ~~~g~L~~-----------~---l~~~~--------~~~~l~~-~~~~~i------------~-~~i~~~l~yLH~~---  241 (290)
                      +++..+..           .   ++...        ....+.| .....-            . ..+...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99875421           0   11100        0111222 111111            1 1111122233211   


Q ss_pred             -CCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          242 -SRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       242 -~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                       -+.+++|+|+.|.||+++++...-|.||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             24469999999999999977667899999985

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.60  E-value=0.00052  Score=59.14  Aligned_cols=143  Identities=26%  Similarity=0.310  Sum_probs=82.6

Q ss_pred             ceecccCCccEEEEEEcC-------CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcc-eeEEEEEeCCeeEEEEEe
Q 022887          129 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCCIEQGENILIYEY  200 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~-------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~  200 (290)
                      +.+..|-...+|+....+       ++.+++|...... ....+...|..++..+....+. ++++.+.    ..+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            345556667889887654       4788888865432 2234567777777776543333 4555443    2368999


Q ss_pred             cCCCChhhh-----------------hhCCCCC-------C-CCCHHHHHH--------------------------HHH
Q 022887          201 MPNKSLDVF-----------------LFYPKKK-------R-LLGWQARVR--------------------------IIE  229 (290)
Q Consensus       201 ~~~g~L~~~-----------------l~~~~~~-------~-~l~~~~~~~--------------------------i~~  229 (290)
                      +++..+...                 ++.....       . ..-|.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988776431                 1111110       0 011111111                          111


Q ss_pred             HHHHHHHHHhh------CCCCCceecCCCCCCEEEcCC----CCeEEeeccCceeeC
Q 022887          230 GIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSD----MNPKISDFGMARIFG  276 (290)
Q Consensus       230 ~i~~~l~yLH~------~~~~~iiH~dlk~~Nill~~~----~~~kl~DfGla~~~~  276 (290)
                      .+...+.++-.      ..+..++|+|+.+.||+++++    +.++++||..|..-.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~  215 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNY  215 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCC
Confidence            22223334432      234568999999999999985    889999999997544

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.50  E-value=0.0064  Score=52.54  Aligned_cols=143  Identities=20%  Similarity=0.213  Sum_probs=80.5

Q ss_pred             cceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCC--cceeEEE------EEeCCeeEEEEE
Q 022887          128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFGC------CIEQGENILIYE  199 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e  199 (290)
                      .+.++.|....+|+....++ .+++|......  ...+...|..++..|....  +.+.+..      ....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45566776788999876544 57778765421  2234555666665553222  3333331      112356789999


Q ss_pred             ecCCCChhhh--------------hhCC-C----C----CCCCCHHHHHH------------HHHHHHHHHHHHhh----
Q 022887          200 YMPNKSLDVF--------------LFYP-K----K----KRLLGWQARVR------------IIEGIAQGLLYLHQ----  240 (290)
Q Consensus       200 ~~~~g~L~~~--------------l~~~-~----~----~~~l~~~~~~~------------i~~~i~~~l~yLH~----  240 (290)
                      |+++..+...              ++.. .    .    .....|.....            ....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9988654210              1110 0    0    01112221110            11123344555532    


Q ss_pred             CCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       241 ~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      ..+..++|+|+.+.|+++++++...|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            224569999999999999998877999999985

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.50  E-value=0.00098  Score=56.66  Aligned_cols=33  Identities=27%  Similarity=0.477  Sum_probs=27.3

Q ss_pred             CCceecCCCCCCEEEcCCCC-eEEeeccCceeeC
Q 022887          244 LRIIHRDLKASNILLDSDMN-PKISDFGMARIFG  276 (290)
Q Consensus       244 ~~iiH~dlk~~Nill~~~~~-~kl~DfGla~~~~  276 (290)
                      ..++|+|+.|.||++++++. .-|.||+.+.+-+
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD  218 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD  218 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence            34899999999999997554 5799999998653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.49  E-value=0.00088  Score=58.23  Aligned_cols=140  Identities=19%  Similarity=0.159  Sum_probs=95.0

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEecccc----------------------ccC----HHHHHHHHHHHcccCCCCcc
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------------GQG----LTEFKNEMMLIAKLQHRHLV  182 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~----------------------~~~----~~~~~~e~~~l~~l~h~niv  182 (290)
                      ..|..|.-..||.+.-.+|..+|||+.+...                      ...    ......|+.-|.+++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            4677888899999999999999999775310                      000    12345678888888766554


Q ss_pred             eeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC
Q 022887          183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       183 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~  262 (290)
                      .---+..  ....|||+|+....-   -...-..-.++......+-.|++.-|.-|-+.+  .+||.||.--|+|+. +|
T Consensus       230 ~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG  301 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DG  301 (520)
T ss_pred             CCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CC
Confidence            2222212  245799999963321   111112334666677788888888888888766  599999999999995 56


Q ss_pred             CeEEeeccCceeeC
Q 022887          263 NPKISDFGMARIFG  276 (290)
Q Consensus       263 ~~kl~DfGla~~~~  276 (290)
                      .+.|+|.+=+.-.+
T Consensus       302 ~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  302 KLYIIDVSQSVEHD  315 (520)
T ss_pred             EEEEEEccccccCC
Confidence            68999988776553

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.45  E-value=0.002  Score=54.95  Aligned_cols=76  Identities=16%  Similarity=0.215  Sum_probs=48.0

Q ss_pred             CCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccC---CCCcceeEEEEEeCCeeEEEEEec
Q 022887          125 FSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .+..+.++.|....+|+.. .+++.+.||.-..   .....|..|..-|..|.   --.+.+++++....+..+|++||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            3445678888889999887 5678899997763   22356888888777773   445778899888888889999999


Q ss_pred             CCC
Q 022887          202 PNK  204 (290)
Q Consensus       202 ~~g  204 (290)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.37  E-value=0.0024  Score=56.09  Aligned_cols=143  Identities=17%  Similarity=0.230  Sum_probs=81.7

Q ss_pred             ceecccCCccEEEEEEcC-----CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcc-eeEEEEEeCCeeEEEEEecC
Q 022887          129 CKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~-----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~  202 (290)
                      +.+-.|-.-.+|+....+     +..+.+|........ .-+-..|..++..+...++. ++++.+.. +   .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence            345456677888886532     357888877554322 22336788888877655554 45555432 2   5899998


Q ss_pred             CCChhhh-----------------hhCCC--CCC-CCCHHHHHHHHHHH-----------------HHHHHHH----hh-
Q 022887          203 NKSLDVF-----------------LFYPK--KKR-LLGWQARVRIIEGI-----------------AQGLLYL----HQ-  240 (290)
Q Consensus       203 ~g~L~~~-----------------l~~~~--~~~-~l~~~~~~~i~~~i-----------------~~~l~yL----H~-  240 (290)
                      +.++...                 ++...  ... ...|.+...+..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7766421                 11111  011 12233322332111                 1111122    21 


Q ss_pred             CCCCCceecCCCCCCEEEcC-CCCeEEeeccCceeeC
Q 022887          241 YSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFG  276 (290)
Q Consensus       241 ~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~  276 (290)
                      ..+..++|+|+++.||++++ +..+.++||..|..-.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~  233 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP  233 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence            22345899999999999986 4789999999988554

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.33  E-value=0.0038  Score=53.82  Aligned_cols=34  Identities=18%  Similarity=0.375  Sum_probs=29.9

Q ss_pred             CCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       244 ~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ..++|+|+.+.|++++.+.-+-|.||+++.+=++
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            4699999999999999988899999999986543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.91  E-value=0.0015  Score=55.90  Aligned_cols=132  Identities=14%  Similarity=0.156  Sum_probs=85.4

Q ss_pred             CCCccceecccCCccEEEEEEcCCcEEEEEEecc-----------------ccccC-----HHHHHHHHHHHcccCC-CC
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN-----------------QSGQG-----LTEFKNEMMLIAKLQH-RH  180 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~-----------------~~~~~-----~~~~~~e~~~l~~l~h-~n  180 (290)
                      -++..+.||-|.-+.||.+...+|++.++|.=.-                 .....     .-....|...|+.|.- -.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            3567889999999999999998899988882110                 00001     1234567777776642 21


Q ss_pred             -cceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc
Q 022887          181 -LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  259 (290)
Q Consensus       181 -iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~  259 (290)
                       +.+.++    .+..++|||++.+-.|...-      ...+..+..   ..+..-+--|...+   +||+|..--||+++
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeee------ecCChHHHH---HHHHHHHHHHHHcC---ceecccchheeEEe
Confidence             223333    23457899998876664332      122333333   33334445566556   99999999999999


Q ss_pred             CCCCeEEeeccC
Q 022887          260 SDMNPKISDFGM  271 (290)
Q Consensus       260 ~~~~~kl~DfGl  271 (290)
                      ++..++++||-=
T Consensus       237 dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  237 DDDKIVVIDFPQ  248 (465)
T ss_pred             cCCCEEEeechH
Confidence            999999999953

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=96.90  E-value=0.00012  Score=70.68  Aligned_cols=148  Identities=18%  Similarity=0.177  Sum_probs=96.6

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEecc---ccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .+.+.+.+-+.+|.++.++.+.-.. +...++|....   ......+....+-.+.-..+||-+++..--+....+.+|+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            4566677788889999998775422 32222222211   1111122233333333334556666555555566788999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ++|+.+++|...++...   ..+..-.......+.++.+|||...   +.|+|++|.|.+...++..+++|||+....
T Consensus       883 ~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            99999999988875432   2333333344455788999999865   899999999999999999999999966544

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.79  E-value=0.036  Score=49.55  Aligned_cols=73  Identities=11%  Similarity=0.062  Sum_probs=47.7

Q ss_pred             cceecccCCccEEEEEEcCCcEEEEEEeccccc-------cCHHHHHHHHHHHcccC---CCCcceeEEEEEeCCeeEEE
Q 022887          128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-------QGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  197 (290)
                      .+.||.|....||+.... +..++||+-.....       .....-..|...|..+.   ...+.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            468899999999998764 45788997652111       12233334455554442   346777888777  456789


Q ss_pred             EEecCC
Q 022887          198 YEYMPN  203 (290)
Q Consensus       198 ~e~~~~  203 (290)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.75  E-value=0.022  Score=50.02  Aligned_cols=73  Identities=16%  Similarity=0.238  Sum_probs=45.7

Q ss_pred             eecccCCccEEEEEEcCC-cEEEEEEeccc-------cccCHHHHHHHHHHHcccC--CCC-cceeEEEEEeCCeeEEEE
Q 022887          130 KLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ-------SGQGLTEFKNEMMLIAKLQ--HRH-LVRLFGCCIEQGENILIY  198 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~~~-~~vavK~l~~~-------~~~~~~~~~~e~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~  198 (290)
                      .||.|....||++...++ +.|+||.-.+.       .+-...+...|...|....  -|. +.+++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            578899999999998654 58999965421       1223345556666665442  343 334443  3444567999


Q ss_pred             EecCCC
Q 022887          199 EYMPNK  204 (290)
Q Consensus       199 e~~~~g  204 (290)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999654

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.75  E-value=0.00026  Score=65.24  Aligned_cols=139  Identities=16%  Similarity=0.078  Sum_probs=93.1

Q ss_pred             CCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCC-cceeEEEEEeCCeeEEEEEecCC
Q 022887          125 FSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH-LVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +....-++++++++++|.+....+....+.+...     .+..-++++|.+++||| .+..++-+..++..+++++++..
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3444567899999999987644444445544322     45567889999999999 66666667777788999999987


Q ss_pred             C-ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          204 K-SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       204 g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      + +.....  ....-.+...+...+...-+++++|+|+..   -+|+|    ||+..+ ...|..||+.+.-+++.
T Consensus       319 ~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  319 GRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             CccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            7 221111  011111223333445555668899999754   58888    777655 67899999999877654

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=96.66  E-value=0.0016  Score=43.28  Aligned_cols=32  Identities=25%  Similarity=0.568  Sum_probs=26.7

Q ss_pred             ChhhHHHHHhhccCeeeEeeccccCCCcceeEeec
Q 022887            2 NLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFG   36 (290)
Q Consensus         2 ~~~~C~~~c~~~c~C~a~~~~~~~~g~~~c~~~~~   36 (290)
                      +.++|++.|+.+|.|.||.|..   +...|+++..
T Consensus        26 s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~   57 (73)
T cd01100          26 SAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS   57 (73)
T ss_pred             CHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence            6789999999999999999964   3456998665

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>PRK06148 hypothetical protein; Provisional

Probab=96.66  E-value=0.038  Score=55.58  Aligned_cols=142  Identities=20%  Similarity=0.258  Sum_probs=77.0

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHccc-------CCCCcceeE-----EEEEe-CC--e
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-------QHRHLVRLF-----GCCIE-QG--E  193 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-------~h~niv~l~-----~~~~~-~~--~  193 (290)
                      +.|+ |..-.+|+....++..+++|........  .....|...+..|       .-|.+++-.     ..... .+  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            3453 4567789988878888999998764322  2333344444333       233333321     11111 22  4


Q ss_pred             eEEEEEecCCCChhhhh-----------------h-------CCCCCCCCCHHH-----------------HHHHHHHHH
Q 022887          194 NILIYEYMPNKSLDVFL-----------------F-------YPKKKRLLGWQA-----------------RVRIIEGIA  232 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l-----------------~-------~~~~~~~l~~~~-----------------~~~i~~~i~  232 (290)
                      .+.+++|+++..+....                 +       .....+.+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            56789999987765410                 0       001112233321                 112222222


Q ss_pred             HHHH-----HHhhCCCCCceecCCCCCCEEEcCCC--Ce-EEeeccCcee
Q 022887          233 QGLL-----YLHQYSRLRIIHRDLKASNILLDSDM--NP-KISDFGMARI  274 (290)
Q Consensus       233 ~~l~-----yLH~~~~~~iiH~dlk~~Nill~~~~--~~-kl~DfGla~~  274 (290)
                      ....     .+. .-+..+||+|+.+.|||++.+.  .+ -|+|||.+..
T Consensus       188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            2221     121 2245699999999999999875  44 5999998853

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.59  E-value=0.055  Score=44.28  Aligned_cols=74  Identities=19%  Similarity=0.293  Sum_probs=49.8

Q ss_pred             eecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHccc---CCCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL---QHRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      .+.-|.--.-|.... +..++-+|.-..   .....|..|+.-|..+   +-.++.+++.+....+..|+|+||++-|.+
T Consensus        23 ~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          23 EVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            343333333343332 456788886532   3346788887765555   456678888888999999999999998777


Q ss_pred             h
Q 022887          207 D  207 (290)
Q Consensus       207 ~  207 (290)
                      +
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            5

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.52  E-value=0.051  Score=47.35  Aligned_cols=136  Identities=24%  Similarity=0.308  Sum_probs=78.6

Q ss_pred             CCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCC------cceeEEEE--EeC--CeeEEEEEecCCC
Q 022887          135 GFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH------LVRLFGCC--IEQ--GENILIYEYMPNK  204 (290)
Q Consensus       135 ~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~--~~~--~~~~lv~e~~~~g  204 (290)
                      .-..+|+....+++. ++|.....  ....+...|+..+..+.-.+      +..+-|-.  .-.  ...+-+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            456688888877666 77777654  34456666777666653211      22222211  112  3678899999998


Q ss_pred             Chhh-h--------------hh---------CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHhhC----CC
Q 022887          205 SLDV-F--------------LF---------YPKKKRLLGWQA-------------RVRIIEGIAQGLLYLHQY----SR  243 (290)
Q Consensus       205 ~L~~-~--------------l~---------~~~~~~~l~~~~-------------~~~i~~~i~~~l~yLH~~----~~  243 (290)
                      .+.. .              ++         .+...+...|..             ......++...+..+.+.    -+
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            8772 1              00         001111334431             011223344444444432    11


Q ss_pred             ---CCceecCCCCCCEEEcCCCC-eEEeeccCce
Q 022887          244 ---LRIIHRDLKASNILLDSDMN-PKISDFGMAR  273 (290)
Q Consensus       244 ---~~iiH~dlk~~Nill~~~~~-~kl~DfGla~  273 (290)
                         ..+||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               22899999999999998885 8999999876

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.40  E-value=0.037  Score=48.38  Aligned_cols=143  Identities=15%  Similarity=0.211  Sum_probs=79.3

Q ss_pred             ceecccCCccEEEEEEcC----CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcc-eeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.+..|=.-.+|+....+    +..|.+|....... ..-+-.+|..++..+..-++. ++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            345446667788886543    23788887754332 223346788888877665654 4555542 22   58999977


Q ss_pred             CChhhh-----------------hhCCC--CCC-CCCHHHHHHHHHHH----------------------HHHHH----H
Q 022887          204 KSLDVF-----------------LFYPK--KKR-LLGWQARVRIIEGI----------------------AQGLL----Y  237 (290)
Q Consensus       204 g~L~~~-----------------l~~~~--~~~-~l~~~~~~~i~~~i----------------------~~~l~----y  237 (290)
                      ..+..-                 ++...  ... +.-|.....+..++                      .+-+.    +
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            665321                 11111  011 11233322222211                      11111    1


Q ss_pred             Hhh-CCCCCceecCCCCCCEEEcC-CCCeEEeeccCceeeC
Q 022887          238 LHQ-YSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFG  276 (290)
Q Consensus       238 LH~-~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~  276 (290)
                      +.. ..+.-+.|.|+.+.|||+++ ++.++++||..|..-+
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd  215 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY  215 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence            111 12234789999999999975 5789999999987544

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.37  E-value=0.011  Score=48.15  Aligned_cols=31  Identities=35%  Similarity=0.475  Sum_probs=22.1

Q ss_pred             CceecCCCCCCEEE-cCCCCeEEeeccCceee
Q 022887          245 RIIHRDLKASNILL-DSDMNPKISDFGMARIF  275 (290)
Q Consensus       245 ~iiH~dlk~~Nill-~~~~~~kl~DfGla~~~  275 (290)
                      .+.|+|+.|.|||+ +.++.++++||-.|..-
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~n  175 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGYN  175 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EEE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhhc
Confidence            47899999999999 88999999999998754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.32  E-value=0.064  Score=46.39  Aligned_cols=32  Identities=25%  Similarity=0.349  Sum_probs=28.7

Q ss_pred             CCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          243 RLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       243 ~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      +..++|+|+.+.|+|+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            44699999999999999999999999998874

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.12  E-value=0.032  Score=49.60  Aligned_cols=75  Identities=12%  Similarity=0.140  Sum_probs=48.0

Q ss_pred             cceecccCCccEEEEEEcC-CcEEEEEEeccc------cccCHHHHHHHHHHHcccC--CCC-cceeEEEEEeCCeeEEE
Q 022887          128 QCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ------SGQGLTEFKNEMMLIAKLQ--HRH-LVRLFGCCIEQGENILI  197 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~------~~~~~~~~~~e~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv  197 (290)
                      .+.||-|.-..||++.+.+ +..|+||.-.+.      -+-...+...|...|....  -|. +.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4688999999999999843 568999965321      1233456666666666542  344 4445543  34456788


Q ss_pred             EEecCCC
Q 022887          198 YEYMPNK  204 (290)
Q Consensus       198 ~e~~~~g  204 (290)
                      ||+++..
T Consensus       112 MEdL~~~  118 (409)
T PRK12396        112 MEDLSDH  118 (409)
T ss_pred             HHhCccc
Confidence            9998643

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.81  E-value=0.035  Score=49.21  Aligned_cols=61  Identities=18%  Similarity=0.183  Sum_probs=40.6

Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS  260 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~  260 (290)
                      ..++-+|+++-++..++...    ..++..+.+++.-.++|+.-+-.-.  .++|.|+.|.||++.-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~----~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK----SQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhcc----cChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence            45677788888887777432    2334456667766666665433222  2999999999999953

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.69  E-value=0.44  Score=41.54  Aligned_cols=72  Identities=15%  Similarity=0.108  Sum_probs=43.5

Q ss_pred             cCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCC--cce---eEE--EEEeCCeeEEEEEecCCCCh
Q 022887          134 GGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH--LVR---LFG--CCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       134 G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~---l~~--~~~~~~~~~lv~e~~~~g~L  206 (290)
                      +.-..||+....++..+++|..... .....+...|+..+..|....  ++.   .-|  ....++..+.+++++++...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            3446799998877888998877532 234456667777766553211  222   112  12234567889999987653

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.36  E-value=0.087  Score=46.15  Aligned_cols=56  Identities=23%  Similarity=0.318  Sum_probs=46.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          217 RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       217 ~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ..-.|++...++.+-+.-++-+..  ..+.=|||+.-.|||++ +|++-|+||-++|+-
T Consensus       316 k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         316 KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            345688888888877776666654  34689999999999999 999999999999954

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.19  E-value=0.13  Score=42.01  Aligned_cols=102  Identities=17%  Similarity=0.123  Sum_probs=65.3

Q ss_pred             EEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHH
Q 022887          149 EVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI  227 (290)
Q Consensus       149 ~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i  227 (290)
                      +..+|++...+-. ...-|..+..++++++  .|+++..-  .....-++.|++-....            ..    ..+
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~  146 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNF  146 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHH
Confidence            4566777654444 4456778888888764  45555521  12234477887733211            00    122


Q ss_pred             HHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccC
Q 022887          228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       228 ~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl  271 (290)
                      +..-.++|.-.|+.. ...+|+|-.|+||+-|..|.+||.|=+.
T Consensus       147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence            222246788889653 4699999999999999999999999764

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=95.04  E-value=0.33  Score=43.33  Aligned_cols=74  Identities=18%  Similarity=0.284  Sum_probs=44.4

Q ss_pred             ceecccCCccEEEEEEcCC--cE-----EEEEEeccccccCHHHHHHHHHHHcccCCCCcce-eEEEEEeCCeeEEEEEe
Q 022887          129 CKLGEGGFGPVYKGRLLNG--QE-----VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR-LFGCCIEQGENILIYEY  200 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~--~~-----vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~  200 (290)
                      +.|..|-...+|++...++  ..     |.++.... .....-+-..|..++..+...++.+ +++.+.    .++++||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            4555577788999876443  22     33333211 1111223366888888887666654 555543    2699999


Q ss_pred             cCCCChh
Q 022887          201 MPNKSLD  207 (290)
Q Consensus       201 ~~~g~L~  207 (290)
                      +++.++.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9988764

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=94.71  E-value=0.013  Score=43.04  Aligned_cols=48  Identities=23%  Similarity=0.374  Sum_probs=35.6

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHc
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIA  174 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~  174 (290)
                      ..|+ .+.|+.|+.|+||+|++.+|++||||...+..   ...+...+.++.
T Consensus        12 ~~fd-~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i---~~~i~~Dl~~l~   59 (119)
T PF03109_consen   12 DEFD-PEPLASASIAQVHRARLKDGEEVAVKVQRPGI---EEQIEADLRILR   59 (119)
T ss_pred             HHCC-cchhhheehhhheeeeecccchhhhhhcchHH---HHHHHHHHHHHH
Confidence            4455 36899999999999999999999999887543   234444555443

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	290
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-33
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-32
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-28
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-28
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-23
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
3soa_A	444	Full-Length Human Camkii Length = 444		2e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		7e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		7e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		7e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		9e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 75/165 (45%), Positives = 104/165 (63%), Gaps = 2/165 (1%)
Query: 113 FSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-LTEFKNEMM 171
           FSL  +  A++NFS +  LG GGFG VYKGRL +G  VAVKRL  +  QG   +F+ E+ 
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFY-PKKKRLLGWQARVRIIEG 230
           +I+   HR+L+RL G C+   E +L+Y YM N S+   L   P+ +  L W  R RI  G
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 147
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
            A+GL YLH +   +IIHRD+KA+NILLD +    + DFG+A++ 
Sbjct: 148 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 192

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 74/165 (44%), Positives = 103/165 (62%), Gaps = 2/165 (1%)
Query: 113 FSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-LTEFKNEMM 171
           FSL  +  A++NF  +  LG GGFG VYKGRL +G  VAVKRL  +  QG   +F+ E+ 
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFY-PKKKRLLGWQARVRIIEG 230
           +I+   HR+L+RL G C+   E +L+Y YM N S+   L   P+ +  L W  R RI  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
            A+GL YLH +   +IIHRD+KA+NILLD +    + DFG+A++ 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  121 bits (303), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 9/187 (4%)
Query: 93  KHKEKDGEGNDKSKDSWLPLFS-----LASVSAATENFSTQCKLGEGGFGPVYKGRLLNG 147
           K+ +     ND    S+L  F      L  +  AT NF  +  +G G FG VYKG L +G
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 148 QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD 207
            +VA+KR + +S QG+ EF+ E+  ++  +H HLV L G C E+ E ILIY+YM N +L 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 208 VFLFYPKKKRL-LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 266
             L+      + + W+ R+ I  G A+GL YLH  +   IIHRD+K+ NILLD +  PKI
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 267 SDFGMAR 273
           +DFG+++
Sbjct: 181 TDFGISK 187

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  121 bits (303), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 110/187 (58%), Gaps = 9/187 (4%)
Query: 93  KHKEKDGEGNDKSKDSWLPLFS-----LASVSAATENFSTQCKLGEGGFGPVYKGRLLNG 147
           K+ +     ND    S+L  F      L  +  AT NF  +  +G G FG VYKG L +G
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 148 QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD 207
            +VA+KR + +S QG+ EF+ E+  ++  +H HLV L G C E+ E ILIY+YM N +L 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 208 VFLFYPKKKRL-LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 266
             L+      + + W+ R+ I  G A+GL YLH  +   IIHRD+K+ NILLD +  PKI
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 267 SDFGMAR 273
           +DFG+++
Sbjct: 181 TDFGISK 187

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/194 (38%), Positives = 98/194 (50%), Gaps = 14/194 (7%)
Query: 107 DSWLPLFSLASVSAATENFSTQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG 160
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L+    
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 67
Query: 161 QGLTE----FKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKK 216
               E    F  E+ ++AK QH +LV L G   +  +  L+Y YMPN SL   L      
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 217 RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
             L W  R +I +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 277 GDELQGNTKRIVGT 290
                    RIVGT
Sbjct: 185 KFAQTVMXSRIVGT 198

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/194 (38%), Positives = 98/194 (50%), Gaps = 14/194 (7%)
Query: 107 DSWLPLFSLASVSAATENFSTQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG 160
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L+    
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 61
Query: 161 QGLTE----FKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKK 216
               E    F  E+ ++AK QH +LV L G   +  +  L+Y YMPN SL   L      
Sbjct: 62  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 121
Query: 217 RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
             L W  R +I +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR   
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 277 GDELQGNTKRIVGT 290
                    RIVGT
Sbjct: 179 KFAQXVMXXRIVGT 192

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/194 (38%), Positives = 98/194 (50%), Gaps = 14/194 (7%)
Query: 107 DSWLPLFSLASVSAATENFSTQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG 160
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L+    
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 67
Query: 161 QGLTE----FKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKK 216
               E    F  E+ ++AK QH +LV L G   +  +  L+Y YMPN SL   L      
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 217 RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
             L W  R +I +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 277 GDELQGNTKRIVGT 290
                    RIVGT
Sbjct: 185 KFAQTVMXXRIVGT 198

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/188 (38%), Positives = 93/188 (49%), Gaps = 14/188 (7%)
Query: 113 FSLASVSAATENFSTQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE- 165
           FS   +   T NF  +       K GEGGFG VYKG  +N   VAVK+L+        E 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 166 ---FKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ 222
              F  E+ + AK QH +LV L G   +  +  L+Y Y PN SL   L        L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
            R +I +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR         
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 283 NTKRIVGT 290
              RIVGT
Sbjct: 182 XXSRIVGT 189

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 91/160 (56%), Gaps = 12/160 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L+  +G +   EF +E +++A + H HLVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      L+ + MP+  L  ++   + K  +G Q  +     IA+G++YL +    
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVH--EHKDNIGSQLLLNWCVQIAKGMMYLEER--- 159
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           R++HRDL A N+L+ S  + KI+DFG+AR+  GDE + N 
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 199

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 90/160 (56%), Gaps = 12/160 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L+  +G +   EF +E +++A + H HLVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      L+ + MP+  L    +  + K  +G Q  +     IA+G++YL +    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCL--LEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           R++HRDL A N+L+ S  + KI+DFG+AR+  GDE + N 
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 176

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG V+ G  LN  +VA+K +  +      +F  E  ++ KL H  LV+L+G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           EQ    L++E+M +  L  +L    ++ L   +  + +   + +G+ YL + S   +IHR
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIHR 127
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L+  +   K+SDFGM R    D+   +T
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/168 (35%), Positives = 85/168 (50%), Gaps = 22/168 (13%)
Query: 130 KLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           +LGEG FG V+      LL  Q+   VAVK L   S     +F+ E  L+  LQH+H+VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRL----------LGWQARVRIIEGI 231
            FG C E    ++++EYM +  L+ FL    P  K L          LG    + +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R I+  D
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/168 (35%), Positives = 85/168 (50%), Gaps = 22/168 (13%)
Query: 130 KLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           +LGEG FG V+      LL  Q+   VAVK L   S     +F+ E  L+  LQH+H+VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRL----------LGWQARVRIIEGI 231
            FG C E    ++++EYM +  L+ FL    P  K L          LG    + +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R I+  D
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 183

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG V+ G  LN  +VA+K +  +      +F  E  ++ KL H  LV+L+G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           EQ    L++E+M +  L  +L    ++ L   +  + +   + +G+ YL +     +IHR
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L+  +   K+SDFGM R    D+   +T
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG V+ G  LN  +VA+K +  +      +F  E  ++ KL H  LV+L+G C+
Sbjct: 17  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           EQ    L++E+M +  L  +L    ++ L   +  + +   + +G+ YL +     +IHR
Sbjct: 76  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L+  +   K+SDFGM R    D+   +T
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/168 (35%), Positives = 85/168 (50%), Gaps = 22/168 (13%)
Query: 130 KLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           +LGEG FG V+      LL  Q+   VAVK L   S     +F+ E  L+  LQH+H+VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRL----------LGWQARVRIIEGI 231
            FG C E    ++++EYM +  L+ FL    P  K L          LG    + +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R I+  D
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 189

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG V+ G  LN  +VA+K +  +      +F  E  ++ KL H  LV+L+G C+
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           EQ    L++E+M +  L  +L    ++ L   +  + +   + +G+ YL +     +IHR
Sbjct: 71  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L+  +   K+SDFGM R    D+   +T
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG V+ G  LN  +VA+K +   S     +F  E  ++ KL H  LV+L+G C+
Sbjct: 34  EIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           EQ    L++E+M +  L  +L    ++ L   +  + +   + +G+ YL +     +IHR
Sbjct: 93  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 147
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L+  +   K+SDFGM R    D+   +T
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 182

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN---GQE---VAVKRLSNQSGQGLTEFKNEMMLIAKL 176
            N   + +LGEG FG V+     N    Q+   VAVK L + S     +F  E  L+  L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR----------VR 226
           QH H+V+ +G C+E    I+++EYM +  L+ FL       +L  +            + 
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           I + IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 81/155 (52%), Gaps = 6/155 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG V+ G  LN  +VA+K +  +      +F  E  ++ KL H  LV+L+G C+
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           EQ    L+ E+M +  L  +L    ++ L   +  + +   + +G+ YL +     +IHR
Sbjct: 74  EQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L+  +   K+SDFGM R    D+   +T
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/172 (35%), Positives = 87/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 101
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ EYM N SLD FL   K          V ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASG 159
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG+AR+   D     T R
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR 208

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE 163

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 87/165 (52%), Gaps = 17/165 (10%)
Query: 131 LGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 184
           LGEG FG V   R        G++VAVK L  +SG   + + K E+ ++  L H ++V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 185 FGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL--HQ 240
            G C E G N   LI E++P+ SL  +L  PK K  +  + +++    I +G+ YL   Q
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTK 285
           Y     +HRDL A N+L++S+   KI DFG+ +    D+     K
Sbjct: 147 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 186

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 83
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNE 169

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 78
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 134
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNE 164

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 85
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 141
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNE 171

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 82
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 138
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNE 168

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 87/165 (52%), Gaps = 17/165 (10%)
Query: 131 LGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 184
           LGEG FG V   R        G++VAVK L  +SG   + + K E+ ++  L H ++V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 185 FGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL--HQ 240
            G C E G N   LI E++P+ SL  +L  PK K  +  + +++    I +G+ YL   Q
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTK 285
           Y     +HRDL A N+L++S+   KI DFG+ +    D+     K
Sbjct: 135 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 174

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 79
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 135
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNE 165

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE 163

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE 163

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 83
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNE 169

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 86
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 142
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNE 172

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 87
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 143
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNE 173

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 72
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 128
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNE 158

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 79/150 (52%), Gaps = 5/150 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           KLG G FG V+ G   N  +VAVK L   +   +  F  E  L+  LQH  LVRL+    
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           ++    +I E+M   SL  FL   +  ++L     +     IA+G+ Y+    R   IHR
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 133
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+N+L+   +  KI+DFG+AR+   +E
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNE 163

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 78/150 (52%), Gaps = 5/150 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G   N  +VAVK L   +   +  F  E  L+  LQH  LVRL+    
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            +    +I EYM   SL  FL   +  ++L     +     IA+G+ Y+    R   IHR
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 134
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+N+L+   +  KI+DFG+AR+   +E
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNE 164

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 87/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 101
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ EYM N SLD FL   K          V ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASG 159
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 160 MKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 87/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 72
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ EYM N SLD FL   K          V ++ GIA G
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASG 130
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 131 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 87/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 101
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ EYM N SLD FL   K          V ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASG 159
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 87/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 89
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ EYM N SLD FL   K          V ++ GIA G
Sbjct: 90  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASG 147
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 148 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 87/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 101
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ EYM N SLD FL   K          V ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASG 159
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 87/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 101
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ EYM N SLD FL   K          V ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASG 159
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 81/163 (49%), Gaps = 22/163 (13%)
Query: 130 KLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           +LGEG FG V+     N         VAVK L + +     +F+ E  L+  LQH H+V+
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFY------------PKK-KRLLGWQARVRIIEG 230
            +G C +    I+++EYM +  L+ FL              P++ K  LG    + I   
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 87/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 101
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ EYM N SLD FL   K          V ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASG 159
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLS-NQSGQGLTEFKNEMMLIAKLQH 178
           N S    +G G FG V  GRL L  ++   VA+K L    + +   +F  E  ++ +  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            +++RL G   +    +++ EYM N SLD FL   K          V ++ GIA G+ YL
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYL 161
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
              S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 162 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 84/157 (53%), Gaps = 11/157 (7%)
Query: 128 QCKLGEGGFGPVYKGRLLNGQ-----EVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHL 181
           Q  +G G FG VYKG L          VA+K L +  + +   +F  E  ++ +  H ++
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL G   +    ++I EYM N +LD FL   +K         V ++ GIA G+ YL   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           + +  +HRDL A NIL++S++  K+SDFG++R+   D
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/154 (36%), Positives = 80/154 (51%), Gaps = 21/154 (13%)
Query: 131 LGEGGFG--------PVYKGRLLNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHL 181
           LGEG FG        P   G    G+ VAVK L    G Q  + +K E+ ++  L H H+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDG---TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 182 VRLFGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++  GCC +QGE  L  + EY+P  SL  +L     +  +G    +   + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                  IHR+L A N+LLD+D   KI DFG+A+
Sbjct: 135 SQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 101
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ EYM N SLD FL   K          V ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASG 159
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG+ R+   D     T R
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/154 (36%), Positives = 80/154 (51%), Gaps = 21/154 (13%)
Query: 131 LGEGGFG--------PVYKGRLLNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHL 181
           LGEG FG        P   G    G+ VAVK L    G Q  + +K E+ ++  L H H+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDG---TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 182 VRLFGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++  GCC +QGE  L  + EY+P  SL  +L     +  +G    +   + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                  IHR+L A N+LLD+D   KI DFG+A+
Sbjct: 135 AQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 83/153 (54%), Gaps = 4/153 (2%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHL 181
           + + + K+G G FG V++    +G +VAVK L  Q    + + EF  E+ ++ +L+H ++
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V   G   +     ++ EY+   SL   L     +  L  + R+ +   +A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
           +   I+HRDLK+ N+L+D     K+ DFG++R+
Sbjct: 157 NP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 82/150 (54%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 73
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 129
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           +L+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNE 159

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/151 (37%), Positives = 80/151 (52%), Gaps = 15/151 (9%)
Query: 131 LGEGGFGPV--YKGRLLN---GQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRHLVRL 184
           LGEG FG V  Y     N   G+ VAVK L    G  L + ++ E+ ++  L H H+V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 185 FGCCIEQGENI--LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            GCC +QGE    L+ EY+P  SL  +L     +  +G    +   + I +G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               IHR L A N+LLD+D   KI DFG+A+
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/151 (37%), Positives = 80/151 (52%), Gaps = 15/151 (9%)
Query: 131 LGEGGFGPV--YKGRLLN---GQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRHLVRL 184
           LGEG FG V  Y     N   G+ VAVK L    G  L + ++ E+ ++  L H H+V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 185 FGCCIEQGENI--LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            GCC +QGE    L+ EY+P  SL  +L     +  +G    +   + I +G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               IHR L A N+LLD+D   KI DFG+A+
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I+I EYM   SL  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQL- 116
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I+I EYM   SL  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQL- 116
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 86/161 (53%), Gaps = 10/161 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG V  GRL + G+    VA+K L +  + +   +F +E  ++ +  H +++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G   +    ++I EYM N SLD FL      R    Q  V ++ GI  G+ YL   S + 
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQL-VGMLRGIGSGMKYL---SDMS 151
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
            +HRDL A NIL++S++  K+SDFGM+R+   D     T R
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 192

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 10/161 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG V  GRL + G+    VA+K L +  + +   +F +E  ++ +  H +++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G   +    ++I EYM N SLD FL   K          V ++ GI  G+ YL   S + 
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYL---SDMS 130
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
            +HRDL A NIL++S++  K+SDFGM+R+   D     T R
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 10/161 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG V  GRL + G+    VA+K L +  + +   +F +E  ++ +  H +++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G   +    ++I EYM N SLD FL   K          V ++ GI  G+ YL   S + 
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYL---SDMS 136
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
            +HRDL A NIL++S++  K+SDFGM+R+   D     T R
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 79/154 (51%), Gaps = 21/154 (13%)
Query: 131 LGEGGFG--------PVYKGRLLNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHL 181
           LGEG FG        P   G    G+ VAVK L   +G Q  + +K E+ ++  L H H+
Sbjct: 39  LGEGHFGKVSLYCYDPTNDG---TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 182 VRLFGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++  GCC + G   L  + EY+P  SL  +L     +  +G    +   + I +G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                  IHRDL A N+LLD+D   KI DFG+A+
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/172 (34%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 72
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ E M N SLD FL   K          V ++ GIA G
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASG 130
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 131 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/172 (34%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 101
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ E M N SLD FL   K          V ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASG 159
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 160 MKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 175 AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 224
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q  
Sbjct: 225 AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL- 282
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 283 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/172 (34%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLTE-----FKNEMMLIA 174
           N S    +G G FG V  GRL L  ++   VA+K L      G TE     F  E  ++ 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----VGYTEKQRRDFLGEASIMG 101
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +  H +++RL G   +    +++ E M N SLD FL   K          V ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASG 159
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           + YL   S +  +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 83/153 (54%), Gaps = 4/153 (2%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHL 181
           + + + K+G G FG V++    +G +VAVK L  Q    + + EF  E+ ++ +L+H ++
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V   G   +     ++ EY+   SL   L     +  L  + R+ +   +A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
           +   I+HR+LK+ N+L+D     K+ DFG++R+
Sbjct: 157 NP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 258 AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 307
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q  
Sbjct: 308 AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL- 365
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 366 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 175 AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 224
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q  
Sbjct: 225 AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL- 282
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 283 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 87/171 (50%), Gaps = 16/171 (9%)
Query: 111 PLFSLASVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVK-----RLSNQSGQGLT 164
           P  SLA   A   N+     LGEG FG V        GQ+VA+K      L+    QG  
Sbjct: 2   PKSSLAD-GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI 60
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
           E   E+  +  L+H H+++L+     + E I++ EY  N+  D  +   ++ ++   +AR
Sbjct: 61  E--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR 115
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
            R  + I   + Y H   R +I+HRDLK  N+LLD  +N KI+DFG++ I 
Sbjct: 116 -RFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 88/168 (52%), Gaps = 15/168 (8%)
Query: 117 SVSAATE------NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFK 167
           S+++AT+      N+  Q  +G+G F  V   R +L G+EVAVK +  +  +   L +  
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 168 NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI 227
            E+ ++  L H ++V+LF     +    L+ EY      +VF +     R+   +AR + 
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKF 120
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
            + I   + Y HQ     I+HRDLKA N+LLD DMN KI+DFG +  F
Sbjct: 121 RQ-IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEF 164

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 87/171 (50%), Gaps = 16/171 (9%)
Query: 111 PLFSLASVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVK-----RLSNQSGQGLT 164
           P  SLA   A   N+     LGEG FG V        GQ+VA+K      L+    QG  
Sbjct: 3   PKSSLAD-GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI 61
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
           E   E+  +  L+H H+++L+     + E I++ EY  N+  D  +   ++ ++   +AR
Sbjct: 62  E--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR 116
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
            R  + I   + Y H   R +I+HRDLK  N+LLD  +N KI+DFG++ I 
Sbjct: 117 -RFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 163

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 84/161 (52%), Gaps = 10/161 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQ---EVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG V  GRL L G+    VA+K L    + +   +F  E  ++ +  H +++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G   +    +++ EYM N SLD FL   K          V ++ GI+ G+ YL   S + 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFL--KKNDGQFTVIQLVGMLRGISAGMKYL---SDMG 144
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
            +HRDL A NIL++S++  K+SDFG++R+   D     T R
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 185

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G  G V+ G      +VAVK L  Q       F  E  L+ +LQH+ LVRL+   +
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            Q    +I EYM N SL  FL  P   +L      + +   IA+G+ ++ + +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+   ++ KI+DFG+AR+    E
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAE 163

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 2   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 51
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q  
Sbjct: 52  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL- 109
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 110 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 161

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM---DASALTGIPLPLIKSYLFQLLQGL 119
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 83/162 (51%), Gaps = 15/162 (9%)
Query: 120 AATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVK-----RLSNQSGQGLTEFKNEMMLI 173
           A   N+     LGEG FG V        GQ+VA+K      L+    QG  E   E+  +
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 58
Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
             L+H H+++L+     + E I++ EY  N+  D  +   ++ ++   +AR R  + I  
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIIS 114
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
            + Y H   R +I+HRDLK  N+LLD  +N KI+DFG++ I 
Sbjct: 115 AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 153

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E+   + KLG+G FG V+ G       VA+K L   +      F  E  ++ KL+H  LV
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 66
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L+    E+   I + EYM   SL  FL     K L   Q  V +   IA G+ Y+    
Sbjct: 67  QLYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 121
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 122 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 158

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL- 116
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 83/162 (51%), Gaps = 15/162 (9%)
Query: 120 AATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVK-----RLSNQSGQGLTEFKNEMMLI 173
           A   N+     LGEG FG V        GQ+VA+K      L+    QG  E   E+  +
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 62
Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
             L+H H+++L+     + E I++ EY  N+  D  +   ++ ++   +AR R  + I  
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIIS 118
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
            + Y H   R +I+HRDLK  N+LLD  +N KI+DFG++ I 
Sbjct: 119 AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 157

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 90/167 (53%), Gaps = 24/167 (14%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI--------IE 229
           H ++V+L      + +  L++E++   S+D+       K+ +   A   I        + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDL-------KKFMDASALTGIPLPLIKSYLF 113
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + QGL + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 157

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 90/167 (53%), Gaps = 24/167 (14%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI--------IE 229
           H ++V+L      + +  L++E++   S+D+       K+ +   A   I        + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDL-------KKFMDASALTGIPLPLIKSYLF 111
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + QGL + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 112 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 155

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 175 AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 224
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q  
Sbjct: 225 AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VGEYMSKGSLLDFLKGETGKYLRLPQL- 282
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 283 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLT---EFKNEMMLIAKLQHRHLVRLFG 186
           LG G FG V  G+  L G +VAVK L+ Q  + L    + + E+  +   +H H+++L+ 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
                 +  ++ EY+    L  F +  K  RL   ++R R+ + I  G+ Y H   R  +
Sbjct: 84  VISTPSDIFMVMEYVSGGEL--FDYICKNGRLDEKESR-RLFQQILSGVDYCH---RHMV 137
Query: 247 IHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
           +HRDLK  N+LLD+ MN KI+DFG++ +    E 
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 125 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQHRH 180
           FS   ++G G FG VY  R + N + VA+K++S    QS +   +   E+  + KL+H +
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
            ++  GC + +    L+ EY    + D+   + K  + +   A   +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHS 133
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           ++   +IHRD+KA NILL      K+ DFG A I  
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VCEYMSKGSLLDFLKGEMGKYLRLPQL- 116
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 83/156 (53%), Gaps = 12/156 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 138
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
             R IHRDL   NIL++++   KI DFG+ ++   D
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 174

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 125 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQHRH 180
           FS   ++G G FG VY  R + N + VA+K++S    QS +   +   E+  + KL+H +
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
            ++  GC + +    L+ EY    + D+   + K  + +   A   +  G  QGL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHS 172
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           ++   +IHRD+KA NILL      K+ DFG A I  
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 83/156 (53%), Gaps = 12/156 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 136
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
             R IHRDL   NIL++++   KI DFG+ ++   D
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 172

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 83/156 (53%), Gaps = 12/156 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 162
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
             R IHRDL   NIL++++   KI DFG+ ++   D
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 83/156 (53%), Gaps = 12/156 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 129
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
             R IHRDL   NIL++++   KI DFG+ ++   D
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 165

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 83/156 (53%), Gaps = 12/156 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
             R IHRDL   NIL++++   KI DFG+ ++   D
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 170

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 88/177 (49%), Gaps = 19/177 (10%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQSGQG 162
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   N S + 
Sbjct: 176 AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA 226
Query: 163 LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ 222
              F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q
Sbjct: 227 ---FLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQ 282
Query: 223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+ R+   +E
Sbjct: 283 L-VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNE 335

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 130
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             R IHRDL   NIL++++   KI DFG+ ++   D+
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 167

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             R IHRDL   NIL++++   KI DFG+ ++   D+
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 83/156 (53%), Gaps = 12/156 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 137
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
             R IHRDL   NIL++++   KI DFG+ ++   D
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 173

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             R IHRDL   NIL++++   KI DFG+ ++   D+
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             R IHRDL   NIL++++   KI DFG+ ++   D+
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 6   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 55
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q  
Sbjct: 56  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQL- 113
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 114 VDMSAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 165

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 117
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 155

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             R IHRDL   NIL++++   KI DFG+ ++   D+
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 186

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 118
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 119 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 156

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             R IHRDL   NIL++++   KI DFG+ ++   D+
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 186

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 86/174 (49%), Gaps = 15/174 (8%)
Query: 106 KDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE 165
           KD+W             E+   + KLG+G FG V+ G       VA+K L   +      
Sbjct: 1   KDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEA 50
Query: 166 FKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV 225
           F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q  V
Sbjct: 51  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-V 108
Query: 226 RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 109 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 159

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 6   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 55
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q  
Sbjct: 56  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQL- 113
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 114 VDMSAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 165

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++   S+D+  F      L G    +    +  + QGL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGL 119
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 83/156 (53%), Gaps = 12/156 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 135
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
             R IHRDL   NIL++++   KI DFG+ ++   D
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 171

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 118
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 117 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 154

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E+   + KLG+G FG V+ G       VA+K L   +      F  E  ++ KL+H  LV
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 65
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L+    E+   I + EYM   SL  FL     K L   Q  V +   IA G+ Y+    
Sbjct: 66  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 120
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 121 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 157

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ K++H  LV+L+    E+   I + EYM   SL  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKIRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL- 116
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 119
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++   S+D+  F      L G    +    +  + QGL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGL 118
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 161

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 18/163 (11%)
Query: 131 LGEGGFGPVYKGRLL----NGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LGEG FG V +G L        +VAVK  +L N S + + EF +E   +    H +++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 185 FGCCIEQGEN-----ILIYEYMPNKSLDVFLFYPKKK---RLLGWQARVRIIEGIAQGLL 236
            G CIE         ++I  +M    L  +L Y + +   + +  Q  ++ +  IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RIFGGD 278
           YL   S    +HRDL A N +L  DM   ++DFG++ +I+ GD
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 117
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 119
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 118
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 117
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 158

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 120
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 121 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 158

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 161

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 86/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I + EYM   SL  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL- 116
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNE 168

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 82/155 (52%), Gaps = 9/155 (5%)
Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHRH 180
           N+     +G+G F  V   R +L G+EVA+K +  +  +   L +   E+ ++  L H +
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V+LF     +    LI EY      +VF +     R+   +AR +  + I   + Y HQ
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGG--EVFDYLVAHGRMKEKEARSKFRQ-IVSAVQYCHQ 132
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
               RI+HRDLKA N+LLD+DMN KI+DFG +  F
Sbjct: 133 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 82/155 (52%), Gaps = 9/155 (5%)
Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHRH 180
           N+     +G+G F  V   R +L G+EVA+K +  +  +   L +   E+ ++  L H +
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V+LF     +    LI EY      +VF +     R+   +AR +  + I   + Y HQ
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGG--EVFDYLVAHGRMKEKEARSKFRQ-IVSAVQYCHQ 129
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
               RI+HRDLKA N+LLD+DMN KI+DFG +  F
Sbjct: 130 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 161

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQ 177
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGL 235
           H ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM---DASALTGIPLPLIKSYLFQLLQGL 119
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            + H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I++ EYM    L  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVM-EYMSKGCLLDFLKGEMGKYLRLPQL- 116
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLSF 118
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 86/159 (54%), Gaps = 16/159 (10%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG V+KG  +   E     V +K + ++SG Q      + M+ I  L H H+VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 185 FGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKR-LLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G ++ L+ +Y+P  SL   L + ++ R  LG Q  +     IA+G+ YL ++ 
Sbjct: 99  LGLC--PGSSLQLVTQYLPLGSL---LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
              ++HR+L A N+LL S    +++DFG+A +   D+ Q
Sbjct: 154 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 87/178 (48%), Gaps = 26/178 (14%)
Query: 130 KLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLV 182
           +LGE  FG VYKG L         Q VA+K L +++ G    EF++E ML A+LQH ++V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFY--PKK-----------KRLLGWQARVRIIE 229
            L G   +     +I+ Y  +  L  FL    P             K  L     V ++ 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD--ELQGNT 284
            IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R ++  D  +L GN+
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G  G V  GRL + GQ    VA+K L +  + +   +F +E  ++ +  H +++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G        +++ EYM N SLD FL     +  +     V ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
            +HRDL A N+L+DS++  K+SDFG++R+   D     T
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 87/178 (48%), Gaps = 26/178 (14%)
Query: 130 KLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLV 182
           +LGE  FG VYKG L         Q VA+K L +++ G    EF++E ML A+LQH ++V
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFY--PKK-----------KRLLGWQARVRIIE 229
            L G   +     +I+ Y  +  L  FL    P             K  L     V ++ 
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD--ELQGNT 284
            IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R ++  D  +L GN+
Sbjct: 153 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 207

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 83/153 (54%), Gaps = 10/153 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G  G V  GRL + GQ    VA+K L +  + +   +F +E  ++ +  H +++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G        +++ EYM N SLD FL     +  +     V ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
            +HRDL A N+L+DS++  K+SDFG++R+   D
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 83/156 (53%), Gaps = 12/156 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI E++P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
             R IHRDL   NIL++++   KI DFG+ ++   D
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 170

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 86/159 (54%), Gaps = 16/159 (10%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG V+KG  +   E     V +K + ++SG Q      + M+ I  L H H+VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 185 FGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKR-LLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G ++ L+ +Y+P  SL   L + ++ R  LG Q  +     IA+G+ YL ++ 
Sbjct: 81  LGLC--PGSSLQLVTQYLPLGSL---LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
              ++HR+L A N+LL S    +++DFG+A +   D+ Q
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 86/175 (49%), Gaps = 15/175 (8%)
Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT 164
           +KD+W             E+   + KLG+G FG V+ G       VA+K L   +     
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
            F  E  ++ KL+H  LV+L+    E+   I + EYM    L  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGCLLDFLKGEMGKYLRLPQL- 116
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           V +   IA G+ Y+    R+  +HRDL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR--- 133
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 168

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 138
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 173

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGXL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 137
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 172

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 140
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 175

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 139
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 137
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 172

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 108 LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 161
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 162 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 196

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 130
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 138
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 173

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 139
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LITQLMPFGXL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 89  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 142
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 177

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 143
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 139
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 90/168 (53%), Gaps = 18/168 (10%)
Query: 119 SAATENFSTQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLT-------EFKNEM 170
           + A      + ++G+GGFG V+KGRL+  +  VA+K L     +G T       EF+ E+
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG 230
            +++ L H ++V+L+G         ++ E++P   L   L    K   + W  ++R++  
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLD 130
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMN----PKISDFGMAR 273
           IA G+ Y+ Q     I+HRDL++ NI L S D N     K++DFG+++
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 139
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 146
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 147 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 181

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G  N+ LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 132
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             R IHR+L   NIL++++   KI DFG+ ++   D+
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDK 169

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 86/167 (51%), Gaps = 14/167 (8%)
Query: 117 SVSAATE-----NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKN 168
           S ++A E     N+     +G+G F  V   R +L G+EVAVK +  +  +   L +   
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ ++  L H ++V+LF     +    L+ EY      +VF +     R+   +AR +  
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFR 120
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           + I   + Y HQ     I+HRDLKA N+LLD+DMN KI+DFG +  F
Sbjct: 121 Q-IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLT---EFKNEMMLIAKLQHRHLVRLFG 186
           LG G FG V  G   L G +VAVK L+ Q  + L    + K E+  +   +H H+++L+ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
                 +  ++ EY+    L  F +  K  R+   +AR R+ + I   + Y H   R  +
Sbjct: 79  VISTPTDFFMVMEYVSGGEL--FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMV 132
Query: 247 IHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
           +HRDLK  N+LLD+ MN KI+DFG++ +    E 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 86/167 (51%), Gaps = 14/167 (8%)
Query: 117 SVSAATE-----NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKN 168
           S ++A E     N+     +G+G F  V   R +L G+EVAVK +  +  +   L +   
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ ++  L H ++V+LF     +    L+ EY      +VF +     R+   +AR +  
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFR 120
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           + I   + Y HQ     I+HRDLKA N+LLD+DMN KI+DFG +  F
Sbjct: 121 Q-IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 86/167 (51%), Gaps = 14/167 (8%)
Query: 117 SVSAATE-----NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKN 168
           S ++A E     N+     +G+G F  V   R +L G+EVAVK +  +  +   L +   
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ ++  L H ++V+LF     +    L+ EY      +VF +     R+   +AR +  
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFR 120
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           + I   + Y HQ     I+HRDLKA N+LLD+DMN KI+DFG +  F
Sbjct: 121 Q-IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLT---EFKNEMMLIAKLQHRHLVRLFG 186
           LG G FG V  G   L G +VAVK L+ Q  + L    + K E+  +   +H H+++L+ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
                 +  ++ EY+    L  F +  K  R+   +AR R+ + I   + Y H   R  +
Sbjct: 79  VISTPTDFFMVMEYVSGGEL--FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMV 132
Query: 247 IHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
           +HRDLK  N+LLD+ MN KI+DFG++ +    E 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 86/160 (53%), Gaps = 27/160 (16%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE----FKNEMMLIAKLQHRHLVRLFG 186
           +G GGFG VY+   + G EVAVK   +   + +++     + E  L A L+H +++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKR-----LLGWQARVRIIEGIAQGLLYLHQY 241
            C+++    L+ E+     L+  L     KR     L+ W  +      IA+G+ YLH  
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQ------IARGMNYLHDE 124
Query: 242 SRLRIIHRDLKASNILL-----DSDMNP---KISDFGMAR 273
           + + IIHRDLK+SNIL+     + D++    KI+DFG+AR
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 85/154 (55%), Gaps = 18/154 (11%)
Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG V +GRL   G++   VA+K L    + +   EF +E  ++ + +H +++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR----IIEGIAQGLLYLHQY 241
           G        +++ E+M N +LD FL      RL   Q  V     ++ GIA G+ YL + 
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFL------RLNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           S    +HRDL A NIL++S++  K+SDFG++R  
Sbjct: 138 S---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 168

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 90/170 (52%), Gaps = 19/170 (11%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG--LTEFKNEMMLIAKLQHR 179
           E ++  C LG+G FG V K +  +  QE AVK ++  S +    +    E+ L+ KL H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 180 HLVRLFGCCIEQGENILIYE-YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
           ++++LF    +     ++ E Y   +  D  +   K+KR     A  RII+ +  G+ Y+
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDA-ARIIKQVFSGITYM 137
Query: 239 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTK 285
           H+++   I+HRDLK  NILL+S   D + KI DFG++  F     Q NTK
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTK 179

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 90/170 (52%), Gaps = 19/170 (11%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG--LTEFKNEMMLIAKLQHR 179
           E ++  C LG+G FG V K +  +  QE AVK ++  S +    +    E+ L+ KL H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 180 HLVRLFGCCIEQGENILIYE-YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
           ++++LF    +     ++ E Y   +  D  +   K+KR     A  RII+ +  G+ Y+
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDA-ARIIKQVFSGITYM 137
Query: 239 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTK 285
           H+++   I+HRDLK  NILL+S   D + KI DFG++  F     Q NTK
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTK 179

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 90/170 (52%), Gaps = 19/170 (11%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG--LTEFKNEMMLIAKLQHR 179
           E ++  C LG+G FG V K +  +  QE AVK ++  S +    +    E+ L+ KL H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 180 HLVRLFGCCIEQGENILIYE-YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
           ++++LF    +     ++ E Y   +  D  +   K+KR     A  RII+ +  G+ Y+
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDA-ARIIKQVFSGITYM 137
Query: 239 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTK 285
           H+++   I+HRDLK  NILL+S   D + KI DFG++  F     Q NTK
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTK 179

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 85/154 (55%), Gaps = 18/154 (11%)
Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG V +GRL   G++   VA+K L    + +   EF +E  ++ + +H +++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR----IIEGIAQGLLYLHQY 241
           G        +++ E+M N +LD FL      RL   Q  V     ++ GIA G+ YL + 
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFL------RLNDGQFTVIQLVGMLRGIASGMRYLAEM 135
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           S    +HRDL A NIL++S++  K+SDFG++R  
Sbjct: 136 S---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 166

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 87/159 (54%), Gaps = 14/159 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLTEFK-NEMMLIAKLQHRH 180
           E +    K+GEG +G VYK +   G+ VA+KR+  +   +G+      E+ L+ +L H +
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 181 LVRLFGCCIEQGENILIYEYMPN---KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           +V L      +    L++E+M     K LD       K  L   Q ++ + + + +G+ +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLD-----ENKTGLQDSQIKIYLYQ-LLRGVAH 134
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            HQ+   RI+HRDLK  N+L++SD   K++DFG+AR FG
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 87/159 (54%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+   RL  ++    +    E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 87/159 (54%), Gaps = 12/159 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+   RL  ++    +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+L      + +  L++E++ ++ L  F+       L G    +    +  + QGL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H +   R++HRDLK  N+L++++   K++DFG+AR FG
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 87/159 (54%), Gaps = 14/159 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLTEFK-NEMMLIAKLQHRH 180
           E +    K+GEG +G VYK +   G+ VA+KR+  +   +G+      E+ L+ +L H +
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 181 LVRLFGCCIEQGENILIYEYMPN---KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           +V L      +    L++E+M     K LD       K  L   Q ++ + + + +G+ +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLD-----ENKTGLQDSQIKIYLYQ-LLRGVAH 134
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            HQ+   RI+HRDLK  N+L++SD   K++DFG+AR FG
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 82/152 (53%), Gaps = 10/152 (6%)
Query: 123 ENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           E F    KLGEG +G VYK      GQ VA+K++  +S   L E   E+ ++ +    H+
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHV 86
Query: 182 VRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           V+ +G   +  +  ++ EY    S+ D+      + + L       I++   +GL YLH 
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLH- 142
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
              +R IHRD+KA NILL+++ + K++DFG+A
Sbjct: 143 --FMRKIHRDIKAGNILLNTEGHAKLADFGVA 172

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 86/160 (53%), Gaps = 20/160 (12%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 185 FGCCIEQG-ENI-LIYEYMPNKSLDVFLFYPKKK----RLLGWQARVRIIEGIAQGLLYL 238
            G C   G  N+ LI EY+P  SL  +L    ++    +LL + ++      I +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
                 R IHRDL   NIL++++   KI DFG+ ++   D
Sbjct: 134 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 170

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 89/168 (52%), Gaps = 18/168 (10%)
Query: 119 SAATENFSTQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLT-------EFKNEM 170
           + A      + ++G+GGFG V+KGRL+  +  VA+K L     +G T       EF+ E+
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG 230
            +++ L H ++V+L+G         ++ E++P   L   L    K   + W  ++R++  
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLD 130
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMN----PKISDFGMAR 273
           IA G+ Y+ Q     I+HRDL++ NI L S D N     K++DFG ++
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 86/167 (51%), Gaps = 14/167 (8%)
Query: 117 SVSAATE-----NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKN 168
           S ++A E     N+     +G+G F  V   R +L G+EVAV+ +  +  +   L +   
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR 62
Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ ++  L H ++V+LF     +    L+ EY      +VF +     R+   +AR +  
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFR 120
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           + I   + Y HQ     I+HRDLKA N+LLD+DMN KI+DFG +  F
Sbjct: 121 Q-IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 86/167 (51%), Gaps = 14/167 (8%)
Query: 117 SVSAATE-----NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKN 168
           S ++A E     N+     +G+G F  V   R +L G+EVAV+ +  +  +   L +   
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR 62
Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ ++  L H ++V+LF     +    L+ EY      +VF +     R+   +AR +  
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFR 120
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           + I   + Y HQ     I+HRDLKA N+LLD+DMN KI+DFG +  F
Sbjct: 121 Q-IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 138
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG A++ G +E
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 138
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG A++ G +E
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L  N S +   E  +E  ++A +   ++ RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKR-LLGWQARVRIIEGIAQGLLYLHQYSR 243
            G C+      L+ + MP   L   L + ++ R  LG Q  +     IA+G+ YL     
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCL---LDHVRENRGRLGSQDLLNWCMQIAKGMSYLED--- 137
Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
           +R++HRDL A N+L+ S  + KI+DFG+AR+   DE +
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 175

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 138
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG A++ G +E
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 143
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG A++ G +E
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 178

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 140
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG A++ G +E
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 175

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 92/168 (54%), Gaps = 17/168 (10%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQ---GLTEFKNEMML--I 173
           A + +    ++GEG +G V+K R L   G+ VA+KR+  Q+G+    L+  +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 174 AKLQHRHLVRLFGCCI-----EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
              +H ++VRLF  C       + +  L++E++ ++ L  +L    +  +     +  + 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           + + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+ARI+ 
Sbjct: 128 Q-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG A++ G +E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 171

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 92/168 (54%), Gaps = 17/168 (10%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQ---GLTEFKNEMML--I 173
           A + +    ++GEG +G V+K R L   G+ VA+KR+  Q+G+    L+  +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 174 AKLQHRHLVRLFGCCI-----EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
              +H ++VRLF  C       + +  L++E++ ++ L  +L    +  +     +  + 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           + + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+ARI+ 
Sbjct: 128 Q-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 92/168 (54%), Gaps = 17/168 (10%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQ---GLTEFKNEMML--I 173
           A + +    ++GEG +G V+K R L   G+ VA+KR+  Q+G+    L+  +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 174 AKLQHRHLVRLFGCCI-----EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
              +H ++VRLF  C       + +  L++E++ ++ L  +L    +  +     +  + 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           + + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+ARI+ 
Sbjct: 128 Q-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           L  G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           L  G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 90  LGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 143
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           L  G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 143
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 82/153 (53%), Gaps = 10/153 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG V  G L L G+    VA+K L S  + +   +F +E  ++ +  H +++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G   +    ++I E+M N SLD FL   +          V ++ GIA G+ YL   + + 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 155
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
            +HRDL A NIL++S++  K+SDFG++R    D
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 89/168 (52%), Gaps = 18/168 (10%)
Query: 119 SAATENFSTQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLT-------EFKNEM 170
           + A      + ++G+GGFG V+KGRL+  +  VA+K L     +G T       EF+ E+
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG 230
            +++ L H ++V+L+G         ++ E++P   L   L    K   + W  ++R++  
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLD 130
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMN----PKISDFGMAR 273
           IA G+ Y+ Q     I+HRDL++ NI L S D N     K++DF +++
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +  +  ++ ++    SL   L   + K        + I    AQG+ YLH  S   IIHR
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIHR 156
Query: 250 DLKASNILLDSDMNPKISDFGMARI 274
           DLK++NI L  D+  KI DFG+A +
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATV 181

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 42  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 101
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +  +  ++ ++    SL   L   + K        + I    AQG+ YLH  S   IIHR
Sbjct: 102 KP-QLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIHR 155
Query: 250 DLKASNILLDSDMNPKISDFGMARI 274
           DLK++NI L  D+  KI DFG+A +
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATV 180

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +  +  ++ ++    SL   L   + K        + I    AQG+ YLH  S   IIHR
Sbjct: 80  KP-QLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIHR 133
Query: 250 DLKASNILLDSDMNPKISDFGMARI 274
           DLK++NI L  D+  KI DFG+A +
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 78
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            + +  ++ ++    SL   L   + K        + I    AQG+ YLH  S   IIHR
Sbjct: 79  TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIHR 133
Query: 250 DLKASNILLDSDMNPKISDFGMARI 274
           DLK++NI L  D+  KI DFG+A +
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG G FG VYKG  +   E     VA+  L    S +   E  +E  ++A + + H+ RL
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ YL      
Sbjct: 117 LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 170
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 171 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 205

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 17  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 75
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            + +  ++ ++    SL   L   + K        + I    AQG+ YLH  S   IIHR
Sbjct: 76  TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIHR 130
Query: 250 DLKASNILLDSDMNPKISDFGMARI 274
           DLK++NI L  D+  KI DFG+A +
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATV 155

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 80/153 (52%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPV-----YKGRLLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLV 182
           LGEG FG V     YK +    Q+VA+K +S Q           + E+  +  L+H H++
Sbjct: 17  LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L+       + +++ EY   +  D  +   +KKR+   + R R  + I   + Y H   
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIV---EKKRMTEDEGR-RFFQQIICAIEYCH--- 125
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           R +I+HRDLK  N+LLD ++N KI+DFG++ I 
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 82/171 (47%), Gaps = 31/171 (18%)
Query: 131 LGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           LGEG FG V K     L G+     VAVK L  N S   L +  +E  ++ ++ H H+++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKK---------------------KRLLGWQ 222
           L+G C + G  +LI EY    SL  FL   +K                     +R L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             +     I+QG+ YL   + ++++HRDL A NIL+      KISDFG++R
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 82/171 (47%), Gaps = 31/171 (18%)
Query: 131 LGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           LGEG FG V K     L G+     VAVK L  N S   L +  +E  ++ ++ H H+++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKK---------------------KRLLGWQ 222
           L+G C + G  +LI EY    SL  FL   +K                     +R L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             +     I+QG+ YL   + ++++HRDL A NIL+      KISDFG++R
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 73
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            + +  ++ ++    SL   L   + K        + I    AQG+ YLH  S   IIHR
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 250 DLKASNILLDSDMNPKISDFGMARI 274
           DLK++NI L  D+  KI DFG+A +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V+ G      +VA+K L   +      F  E  ++ KL+H  LV+L+    
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           E+   I + EYM   SL  FL    + R L     V +   +A G+ Y+    R+  IHR
Sbjct: 75  EEPIYI-VTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+++NIL+ + +  KI+DFG+AR+   +E
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNE 159

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 74/143 (51%), Gaps = 6/143 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 35  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 94
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            + +  ++ ++    SL   L   + K        + I    AQG+ YLH  S   IIHR
Sbjct: 95  -KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIHR 148
Query: 250 DLKASNILLDSDMNPKISDFGMA 272
           DLK++NI L  D+  KI DFG+A
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 81/171 (47%), Gaps = 31/171 (18%)
Query: 131 LGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           LGEG FG V K     L G+     VAVK L  N S   L +  +E  ++ ++ H H+++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKK---------------------KRLLGWQ 222
           L+G C + G  +LI EY    SL  FL   +K                     +R L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             +     I+QG+ YL + S   ++HRDL A NIL+      KISDFG++R
Sbjct: 151 DLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 74/143 (51%), Gaps = 6/143 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +  +  ++ ++    SL   L   + K        + I    AQG+ YLH  S   IIHR
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIHR 156
Query: 250 DLKASNILLDSDMNPKISDFGMA 272
           DLK++NI L  D+  KI DFG+A
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
              +  ++ ++    SL   L   + K        + I    AQG+ YLH  S   IIHR
Sbjct: 75  AP-QLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 250 DLKASNILLDSDMNPKISDFGMARI 274
           DLK++NI L  D+  KI DFG+A +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 19  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            + +  ++ ++    SL   L   + K     +  + I    A+G+ YLH  S   IIHR
Sbjct: 79  -KPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHR 132
Query: 250 DLKASNILLDSDMNPKISDFGMARI 274
           DLK++NI L  D   KI DFG+A +
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATV 157

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 24/166 (14%)
Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +F     LG+G FG V K R  L+ +  A+K++   + + L+   +E+ML+A L H+++V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 183 RLFGCCIEQGENI-------------LIYEYMPNKSLDVFLFYPK--KKRLLGWQARVRI 227
           R +   +E+   +             +  EY  N++L   +      ++R   W    R+
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW----RL 121
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              I + L Y+H      IIHRDLK  NI +D   N KI DFG+A+
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 74/143 (51%), Gaps = 6/143 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 73
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            + +  ++ ++    SL   L   + K        + I    AQG+ YLH  S   IIHR
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 250 DLKASNILLDSDMNPKISDFGMA 272
           DLK++NI L  D+  KI DFG+A
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ YL  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 146
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 167
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 168
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ YL  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 141
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 147
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ YL  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 144
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 80/155 (51%), Gaps = 9/155 (5%)
Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHRH 180
           N+     +G+G F  V   R +L G+EVAVK +  +  +   L +   E+ ++  L H +
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V+LF     +    L+ EY      +VF +      +   +AR +  + I   + Y HQ
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGWMKEKEARAKFRQ-IVSAVQYCHQ 124
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
                I+HRDLKA N+LLD+DMN KI+DFG +  F
Sbjct: 125 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 156

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 10/153 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG V  GRL L G+    VA+K L    + +   +F  E  ++ +  H ++V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G        +++ E+M N +LD FL   K          V ++ GIA G+ YL   + + 
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL--RKHDGQFTVIQLVGMLRGIAAGMRYL---ADMG 165
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
            +HRDL A NIL++S++  K+SDFG++R+   D
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E  +   +LG G FG V  G+     +VAVK +  +      EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           + +G C ++    ++ EY+ N  L  +L      + L     + +   + +G+ +L  + 
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH- 123
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             + IHRDL A N L+D D+  K+SDFGM R    D+
Sbjct: 124 --QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 74/143 (51%), Gaps = 6/143 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
            + +  ++ ++    SL   L   + K     +  + I    A+G+ YLH  S   IIHR
Sbjct: 91  -KPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 250 DLKASNILLDSDMNPKISDFGMA 272
           DLK++NI L  D   KI DFG+A
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 208
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 6/155 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V  G+     +VA+K +  +      EF  E  ++  L H  LV+L+G C 
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +Q    +I EYM N  L  +L   + +     Q  + + + + + + YL      + +HR
Sbjct: 74  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 128
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L++     K+SDFG++R    DE   + 
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 163

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 6/155 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V  G+     +VA+K +   S     EF  E  ++  L H  LV+L+G C 
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +Q    +I EYM N  L  +L   + +     Q  + + + + + + YL      + +HR
Sbjct: 81  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 135
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L++     K+SDFG++R    DE   + 
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 170

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 6/155 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V  G+     +VA+K +  +      EF  E  ++  L H  LV+L+G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +Q    +I EYM N  L  +L   + +     Q  + + + + + + YL      + +HR
Sbjct: 70  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L++     K+SDFG++R    DE   + 
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V  G+     +VA+K +   S     EF  E  ++  L H  LV+L+G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +Q    +I EYM N  L  +L   + +     Q  + + + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL A N L++     K+SDFG++R    DE
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 83/167 (49%), Gaps = 14/167 (8%)
Query: 117 SVSAATE-----NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKN 168
           S ++A E     N+     +G+G F  V   R +L G+EVAVK +  +  +   L +   
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ +   L H ++V+LF     +    L+ EY      +VF +     R    +AR +  
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGG--EVFDYLVAHGRXKEKEARAKFR 120
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           + I   + Y HQ     I+HRDLKA N+LLD+D N KI+DFG +  F
Sbjct: 121 Q-IVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF 163

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 6/155 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V  G+     +VA+K +   S     EF  E  ++  L H  LV+L+G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +Q    +I EYM N  L  +L   + +     Q  + + + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L++     K+SDFG++R    DE   + 
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 84/173 (48%), Gaps = 38/173 (21%)
Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +F     LG+G FG V K R  L+ +  A+K++   + + L+   +E+ML+A L H+++V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 183 RLFGCCIEQG----------------------ENILIYEYMPNKSLDVFLFYPKKKRLLG 220
           R +   +E+                       EN  +Y+ + +++L+       ++R   
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-------QQRDEY 118
Query: 221 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           W    R+   I + L Y+H      IIHRDLK  NI +D   N KI DFG+A+
Sbjct: 119 W----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 73/143 (51%), Gaps = 6/143 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++   G   
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
              +  ++ ++    SL   L   + K     +  + I    A+G+ YLH  S   IIHR
Sbjct: 91  AP-QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 250 DLKASNILLDSDMNPKISDFGMA 272
           DLK++NI L  D   KI DFG+A
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 83/160 (51%), Gaps = 12/160 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E+   + KLG G FG V+        +VAVK +   S   +  F  E  ++  LQH  LV
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 73
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE---GIAQGLLYLH 239
           +L     ++   I I E+M   SL  FL   +  +    Q   ++I+    IA+G+ ++ 
Sbjct: 74  KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSK----QPLPKLIDFSAQIAEGMAFIE 128
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+   +E
Sbjct: 129 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 165

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 6/155 (3%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V  G+     +VA+K +  +      EF  E  ++  L H  LV+L+G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +Q    +I EYM N  L  +L   + +     Q  + + + + + + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           DL A N L++     K+SDFG++R    DE   + 
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 164

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +LG G FG V  G+     +VA+K +  +      EF  E  ++  L H  LV+L+G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           +Q    +I EYM N  L  +L   + +     Q  + + + + + + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL A N L++     K+SDFG++R    DE
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 147
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 83/160 (51%), Gaps = 12/160 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E+   + KLG G FG V+        +VAVK +   S   +  F  E  ++  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 246
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE---GIAQGLLYLH 239
           +L     ++   I I E+M   SL  FL   +  +    Q   ++I+    IA+G+ ++ 
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSK----QPLPKLIDFSAQIAEGMAFIE 301
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+   +E
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLN--GQEV--AVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG VY G LL+  G+++  AVK L+  +  G +++F  E +++    H +++ L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 186 GCCI-EQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           G C+  +G  +++  YM +  L  F+      P  K L+G+  +V      A+G+ +L  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 154
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 79/144 (54%), Gaps = 6/144 (4%)
Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           +LG+G FG VYK +    G   A K +  +S + L ++  E+ ++A   H ++V+L G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
              G+  ++ E+ P  ++D  +     + L   Q +V +   + + L +LH     RIIH
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-VCRQMLEALNFLHSK---RIIH 140
Query: 249 RDLKASNILLDSDMNPKISDFGMA 272
           RDLKA N+L+  + + +++DFG++
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 16/167 (9%)
Query: 114 SLAS-VSAATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLTE-FKN 168
           SLA+ +    E+F     LG+G F  VY+   ++ G EVA+K +  ++    G+ +  +N
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW---QARV 225
           E+ +  +L+H  ++ L+    +     L+ E   N  ++ +L    K R+  +   +AR 
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL----KNRVKPFSENEAR- 115
Query: 226 RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             +  I  G+LYLH +    I+HRDL  SN+LL  +MN KI+DFG+A
Sbjct: 116 HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA 159

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 79/144 (54%), Gaps = 6/144 (4%)
Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           +LG+G FG VYK +    G   A K +  +S + L ++  E+ ++A   H ++V+L G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
              G+  ++ E+ P  ++D  +     + L   Q +V +   + + L +LH     RIIH
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-VCRQMLEALNFLHSK---RIIH 132
Query: 249 RDLKASNILLDSDMNPKISDFGMA 272
           RDLKA N+L+  + + +++DFG++
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 82/153 (53%), Gaps = 10/153 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G FG V  G L L G+    VA+K L S  + +   +F +E  ++ +  H +++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G   +    ++I E+M N SLD FL     +  +     V ++ GIA G+ YL   + + 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 129
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
            +HR L A NIL++S++  K+SDFG++R    D
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDD 162

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    ++ EYMP  +L  +L    ++ +      + +   I+  + YL    
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTA-VVLLYMATQISSAMEYL---E 147
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGD 183

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 88/170 (51%), Gaps = 25/170 (14%)
Query: 120 AATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKL 176
           +++  F    KLG G +  VYKG     G  VA+K  +L ++ G   T  + E+ L+ +L
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKEL 60
Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPN---KSLDVFLFYPKKKRLLGWQAR------VRI 227
           +H ++VRL+     + +  L++E+M N   K +D         R +G   R      V+ 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMD--------SRTVGNTPRGLELNLVKY 112
Query: 228 IEG-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            +  + QGL + H+    +I+HRDLK  N+L++     K+ DFG+AR FG
Sbjct: 113 FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 19/169 (11%)
Query: 134 GGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 193
           G FG V+K +LLN + VAVK    Q  Q     + E+  +  ++H ++++  G   ++G 
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGA-EKRGT 91
Query: 194 NI-----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY------- 241
           ++     LI  +    SL  FL    K  ++ W     I E +A+GL YLH+        
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            +  I HRD+K+ N+LL +++   I+DFG+A  F   +  G+T   VGT
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 27/167 (16%)
Query: 128 QCKLGEGGFGPVYKGRLLNG---QEVAVKRLSN-QSGQGLTEFKNEMMLIAKL-QHRHLV 182
           Q  +GEG FG V K R+       + A+KR+    S     +F  E+ ++ KL  H +++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL----------------GWQARVR 226
            L G C  +G   L  EY P+ +L  FL   +K R+L                  Q  + 
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               +A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R
Sbjct: 137 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 27/167 (16%)
Query: 128 QCKLGEGGFGPVYKGRLLNG---QEVAVKRLSN-QSGQGLTEFKNEMMLIAKL-QHRHLV 182
           Q  +GEG FG V K R+       + A+KR+    S     +F  E+ ++ KL  H +++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL----------------GWQARVR 226
            L G C  +G   L  EY P+ +L  FL   +K R+L                  Q  + 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               +A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 86/182 (47%), Gaps = 32/182 (17%)
Query: 131 LGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRHLVR 183
           +GEG FG V++ R   LL  +    VAVK L  ++   +  +F+ E  L+A+  + ++V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------LGWQARVR---------- 226
           L G C       L++EYM    L+ FL       +       L  +ARV           
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 227 ----IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDELQ 281
               I   +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R I+  D  +
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 282 GN 283
            +
Sbjct: 232 AD 233

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 81/155 (52%), Gaps = 12/155 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E+   + KLG G FG V+        +VAVK +   S   +  F  E  ++  LQH  LV
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 240
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE---GIAQGLLYLH 239
           +L     ++   I I E+M   SL  FL   +  +    Q   ++I+    IA+G+ ++ 
Sbjct: 241 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSK----QPLPKLIDFSAQIAEGMAFIE 295
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
           Q +    IHRDL+A+NIL+ + +  KI+DFG+AR+
Sbjct: 296 QRN---YIHRDLRAANILVSASLVCKIADFGLARV 327

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 84/154 (54%), Gaps = 14/154 (9%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLS----NQSGQGLTEFK-NEMMLIAKLQHRHLVRL 184
           LGEG F  VYK R  N  Q VA+K++     +++  G+      E+ L+ +L H +++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA-QGLLYLHQYSR 243
                 +    L++++M    L+V +   K   L+   + ++    +  QGL YLHQ+  
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 131
Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 277
             I+HRDLK +N+LLD +   K++DFG+A+ FG 
Sbjct: 132 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 97/187 (51%), Gaps = 18/187 (9%)
Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN-- 168
           +F   S +  ++ +  Q  LG+G FG V   +  + GQE AVK +S +  +  T+ ++  
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 80
Query: 169 -EMMLIAKLQHRHLVRLFGCCIEQGENILIYE-YMPNKSLDVFLFYPKKKRLLGWQARVR 226
            E+ L+ +L H ++++L+    ++G   L+ E Y   +  D  +    +KR     A  R
Sbjct: 81  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDA-AR 136
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGN 283
           II  +  G+ Y+H   + +I+HRDLK  N+LL+S   D N +I DFG++  F   E    
Sbjct: 137 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 190
Query: 284 TKRIVGT 290
            K  +GT
Sbjct: 191 MKDKIGT 197

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 16/186 (8%)
Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN-- 168
           +F   S +  ++ +  Q  LG+G FG V   +  + GQE AVK +S +  +  T+ ++  
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 97
Query: 169 -EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI 227
            E+ L+ +L H ++++L+    ++G   L+ E      L  F     +KR     A  RI
Sbjct: 98  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDA-ARI 154
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNT 284
           I  +  G+ Y+H   + +I+HRDLK  N+LL+S   D N +I DFG++  F   E     
Sbjct: 155 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKM 208
Query: 285 KRIVGT 290
           K  +GT
Sbjct: 209 KDKIGT 214

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 16/186 (8%)
Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN-- 168
           +F   S +  ++ +  Q  LG+G FG V   +  + GQE AVK +S +  +  T+ ++  
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 98
Query: 169 -EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI 227
            E+ L+ +L H ++++L+    ++G   L+ E      L  F     +KR     A  RI
Sbjct: 99  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDA-ARI 155
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNT 284
           I  +  G+ Y+H   + +I+HRDLK  N+LL+S   D N +I DFG++  F   E     
Sbjct: 156 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKM 209
Query: 285 KRIVGT 290
           K  +GT
Sbjct: 210 KDKIGT 215

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 79/146 (54%), Gaps = 6/146 (4%)
Query: 129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
            ++G G FG VYKG+      V + ++ + + +    F+NE+ ++ K +H +++ LF   
Sbjct: 42  TRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFMGY 100
Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
           + +    ++ ++    SL   L + ++ +   +Q  + I    AQG+ YLH  +   IIH
Sbjct: 101 MTKDNLAIVTQWCEGSSLYKHL-HVQETKFQMFQL-IDIARQTAQGMDYLHAKN---IIH 155
Query: 249 RDLKASNILLDSDMNPKISDFGMARI 274
           RD+K++NI L   +  KI DFG+A +
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATV 181

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 16/186 (8%)
Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN-- 168
           +F   S +  ++ +  Q  LG+G FG V   +  + GQE AVK +S +  +  T+ ++  
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 169 -EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI 227
            E+ L+ +L H ++++L+    ++G   L+ E      L  F     +KR     A  RI
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDA-ARI 131
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNT 284
           I  +  G+ Y+H+    +I+HRDLK  N+LL+S   D N +I DFG++  F   E     
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKM 185
Query: 285 KRIVGT 290
           K  +GT
Sbjct: 186 KDKIGT 191

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG---- 186
           +G G +G VYKG L + + VAVK  S  + Q     KN +  +  ++H ++ R       
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIARFIVGDER 78
Query: 187 -CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH------ 239
                + E +L+ EY PN SL  +L          W +  R+   + +GL YLH      
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSLHTSD----WVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
            + +  I HRDL + N+L+ +D    ISDFG++    G+ L
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 24/166 (14%)
Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +F     LG+G FG V K R  L+ +  A+K++   + + L+   +E+ L+A L H+++V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVV 65
Query: 183 RLFGCCIEQGENI-------------LIYEYMPNKSLDVFLFYPK--KKRLLGWQARVRI 227
           R +   +E+   +             +  EY  N++L   +      ++R   W    R+
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW----RL 121
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              I + L Y+H      IIHR+LK  NI +D   N KI DFG+A+
Sbjct: 122 FRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G FG VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLE--- 126
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 84  FYIFRRRRRKHKEKDGEGNDKSKDSWLPLFSLASV------SAATENFSTQCKLGEGGFG 137
            Y+F R+R   +  +G         +   FS A V        A E  +   +LG+G FG
Sbjct: 5   LYVFHRKRNNSRLGNGVLYASVNPEY---FSAADVYVPDEWEVAREKITMSRELGQGSFG 61
Query: 138 PVY----KGRLLNGQE--VAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 190
            VY    KG + +  E  VA+K ++   S +   EF NE  ++ +    H+VRL G   +
Sbjct: 62  MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 121
Query: 191 QGENILIYEYMPNKSLDVFL--FYPKKKR--LLGWQARVRIIE---GIAQGLLYLHQYSR 243
               ++I E M    L  +L    P+ +   +L   +  ++I+    IA G+ YL+    
Sbjct: 122 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN-- 179
Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            + +HRDL A N ++  D   KI DFGM R
Sbjct: 180 -KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 27/167 (16%)
Query: 128 QCKLGEGGFGPVYKGRLLNG---QEVAVKRLSN-QSGQGLTEFKNEMMLIAKL-QHRHLV 182
           Q  +GEG FG V K R+       + A+KR+    S     +F  E+ ++ KL  H +++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL----------------GWQARVR 226
            L G C  +G   L  EY P+ +L  FL   +K R+L                  Q  + 
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLH 143
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               +A+G+ YL   S+ + IHR+L A NIL+  +   KI+DFG++R
Sbjct: 144 FAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 130 KLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLV 182
           +LG+G FG VY+G    ++ G+    VAVK ++  +  +   EF NE  ++      H+V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLG-----WQARVRIIEGIAQGL 235
           RL G   +    +++ E M +  L  +L    P+ +   G      Q  +++   IA G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 141 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 130 KLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLV 182
           +LG+G FG VY+G    ++ G+    VAVK ++  +  +   EF NE  ++      H+V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLG-----WQARVRIIEGIAQGL 235
           RL G   +    +++ E M +  L  +L    P+ +   G      Q  +++   IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 130 KLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLV 182
           +LG+G FG VY+G    ++ G+    VAVK ++  +  +   EF NE  ++      H+V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLG-----WQARVRIIEGIAQGL 235
           RL G   +    +++ E M +  L  +L    P+ +   G      Q  +++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 130 KLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLV 182
           +LG+G FG VY+G    ++ G+    VAVK ++  +  +   EF NE  ++      H+V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLG-----WQARVRIIEGIAQGL 235
           RL G   +    +++ E M +  L  +L    P+ +   G      Q  +++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 85/167 (50%), Gaps = 17/167 (10%)
Query: 131 LGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           LG+G +G VY GR L+ Q  +A+K +  +  +       E+ L   L+H+++V+  G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 190 EQGENILIYEYMPNKSLDVFL---FYPKK--KRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
           E G   +  E +P  SL   L   + P K  ++ +G+  +      I +GL YLH     
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLHDN--- 141
Query: 245 RIIHRDLKASNILLDSDMNP-KISDFGMARIFGGDELQGNTKRIVGT 290
           +I+HRD+K  N+L+++     KISDFG ++   G  +   T+   GT
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGT 186

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 23/166 (13%)
Query: 125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQHRH 180
           +    K+G+G FG V+K R    GQ+VA+K++   + + G  +T  + E+ ++  L+H +
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHEN 78
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV----------RIIEG 230
           +V L   C  +        Y   K+    +F   +  L G  + V          R+++ 
Sbjct: 79  VVNLIEICRTKAS-----PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           +  GL Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F 
Sbjct: 134 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 130 KLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLV 182
           +LG+G FG VY+G    ++ G+    VAVK ++  +  +   EF NE  ++      H+V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLG-----WQARVRIIEGIAQGL 235
           RL G   +    +++ E M +  L  +L    P+ +   G      Q  +++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 87/159 (54%), Gaps = 14/159 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLTEFK-NEMMLIAKLQHRH 180
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 181 LVRLFGCCIEQGENILIYEYMPN---KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           +V+L+     +   +L++E++     K LDV      +  L    A+  +++ +  G+ Y
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQ-LLNGIAY 115
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H     R++HRDLK  N+L++ +   KI+DFG+AR FG
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 130 KLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLV 182
           +LG+G FG VY+G    ++ G+    VAVK ++  +  +   EF NE  ++      H+V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLG-----WQARVRIIEGIAQGL 235
           RL G   +    +++ E M +  L  +L    P+ +   G      Q  +++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 87/159 (54%), Gaps = 14/159 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLTEFK-NEMMLIAKLQHRH 180
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 181 LVRLFGCCIEQGENILIYEYMPN---KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           +V+L+     +   +L++E++     K LDV      +  L    A+  +++ +  G+ Y
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQ-LLNGIAY 115
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H     R++HRDLK  N+L++ +   KI+DFG+AR FG
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 87/159 (54%), Gaps = 14/159 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLTEFK-NEMMLIAKLQHRH 180
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 181 LVRLFGCCIEQGENILIYEYMPN---KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           +V+L+     +   +L++E++     K LDV      +  L    A+  +++ +  G+ Y
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQ-LLNGIAY 115
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            H     R++HRDLK  N+L++ +   KI+DFG+AR FG
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 6/162 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLE--- 126
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           +   IHRDL A N L+  +   K++DFG++R+  GD    + 
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHA 168

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLE--- 128
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLE--- 133
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLE--- 128
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLE--- 126
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 87/176 (49%), Gaps = 25/176 (14%)
Query: 114 SLASVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRL---SNQSGQGLTEFKNE 169
           S A  + + + +    KLGEG +G VYK    +  + VA+KR+     + G   T  + E
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-E 83
Query: 170 MMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE 229
           + L+ +LQHR+++ L           LI+EY  N   D+  +  K          +R+I+
Sbjct: 84  VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN---DLKKYMDKNP-----DVSMRVIK 135
Query: 230 G----IAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNP--KISDFGMARIFG 276
                +  G+ + H  SR R +HRDLK  N+LL   D+   P  KI DFG+AR FG
Sbjct: 136 SFLYQLINGVNFCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 74/158 (46%), Gaps = 19/158 (12%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+KL H+++VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 240 QYSRLRIIHRDLKASNILLDSDMNP----KISDFGMAR 273
           +      IHRD+ A N LL     P    KI DFGMAR
Sbjct: 159 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 192

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLE--- 128
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 17/173 (9%)
Query: 116 ASVSAATENFSTQCK--------LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTE- 165
           + V   TEN   Q          +GEG +G V K R  + G+ VA+K+        + + 
Sbjct: 10  SGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK 69
Query: 166 -FKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
               E+ L+ +L+H +LV L   C ++    L++E++ +  LD    +P     L +Q  
Sbjct: 70  IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVV 126
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 277
            + +  I  G+ + H ++   IIHRD+K  NIL+      K+ DFG AR    
Sbjct: 127 QKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLE--- 128
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 23/162 (14%)
Query: 129 CKLGEGGFGPVYKGRLL-NGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
            K+G+G FG V+K R    GQ+VA+K++   + + G  +T  + E+ ++  L+H ++V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV----------RIIEGIAQG 234
              C  +        Y   K     +F   +  L G  + V          R+++ +  G
Sbjct: 83  IEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           L Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 20/170 (11%)
Query: 134 GGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE 193
           G FG V+K +L+N   VAVK    Q  Q   + + E+     ++H +L++ F    ++G 
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSW-QSEREIFSTPGMKHENLLQ-FIAAEKRGS 82
Query: 194 NI-----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY------- 241
           N+     LI  +    SL  +L    K  ++ W     + E +++GL YLH+        
Sbjct: 83  NLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 242 -SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
             +  I HRD K+ N+LL SD+   ++DFG+A  F   +  G+T   VGT
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGT 188

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 73/157 (46%), Gaps = 17/157 (10%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+KL H+++VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 240 QYSRLRIIHRDLKASNILLDSDMN---PKISDFGMAR 273
           +      IHRD+ A N LL         KI DFGMAR
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 13/173 (7%)
Query: 123 ENFSTQCKLGEGGFGPVY--KGRLLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQ 177
           E +    KLG GG   VY  +  +LN + VA+K +     +  + L  F+ E+   ++L 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H+++V +     E     L+ EY+   +L  ++   +    L     +     I  G+ +
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKH 126
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            H    +RI+HRD+K  NIL+DS+   KI DFG+A+      L   T  ++GT
Sbjct: 127 AHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGT 175

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 85/167 (50%), Gaps = 17/167 (10%)
Query: 131 LGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           LG+G +G VY GR L+ Q  +A+K +  +  +       E+ L   L+H+++V+  G   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 190 EQGENILIYEYMPNKSLDVFL---FYPKK--KRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
           E G   +  E +P  SL   L   + P K  ++ +G+  +      I +GL YLH     
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLHDN--- 127
Query: 245 RIIHRDLKASNILLDSDMNP-KISDFGMARIFGGDELQGNTKRIVGT 290
           +I+HRD+K  N+L+++     KISDFG ++   G  +   T+   GT
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGT 172

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 74/172 (43%), Gaps = 10/172 (5%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
              V+L+ C  +  +      Y  N  L   L Y +K               I   L YL
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVSALEYL 153
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           H      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT
Sbjct: 154 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLE--- 129
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 23/166 (13%)
Query: 125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQHRH 180
           +    K+G+G FG V+K R    GQ+VA+K++   + + G  +T  + E+ ++  L+H +
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHEN 78
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV----------RIIEG 230
           +V L   C  +        Y   K     +F   +  L G  + V          R+++ 
Sbjct: 79  VVNLIEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           +  GL Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F 
Sbjct: 134 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLE--- 133
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 130
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLE--- 129
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 133
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLE--- 133
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 133
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 130
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 23/166 (13%)
Query: 125 FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQHRH 180
           +    K+G+G FG V+K R    GQ+VA+K++   + + G  +T  + E+ ++  L+H +
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHEN 77
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV----------RIIEG 230
           +V L   C  +        Y   K     +F   +  L G  + V          R+++ 
Sbjct: 78  VVNLIEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           +  GL Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F 
Sbjct: 133 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLE--- 130
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 92/185 (49%), Gaps = 16/185 (8%)
Query: 113 FSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN--- 168
           F   S +  ++ +  Q  LG+G FG V   +  + GQE AVK +S +  +  T+ ++   
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ L+ +L H ++ +L+    ++G   L+ E      L  F     +KR     A  RII
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDA-ARII 132
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTK 285
             +  G+ Y H   + +I+HRDLK  N+LL+S   D N +I DFG++  F   E     K
Sbjct: 133 RQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXK 186
Query: 286 RIVGT 290
             +GT
Sbjct: 187 DKIGT 191

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 85
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLE--- 141
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 142 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 177

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 86/181 (47%), Gaps = 23/181 (12%)
Query: 113 FSLASV------SAATENFSTQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-S 159
           FS A V        A E  +   +LG+G FG VY    KG + +  E  VA+K ++   S
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 62
Query: 160 GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKR 217
            +   EF NE  ++ +    H+VRL G   +    ++I E M    L  +L    P+ + 
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 218 --LLGWQARVRIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             +L   +  ++I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 123 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 273 R 273
           R
Sbjct: 180 R 180

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 128
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 132
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 128
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHRDL A N L+  +   K++DFG++R+  GD
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 8/144 (5%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 190
           +G+G FG V  G    G +VAVK + N +      F  E  ++ +L+H +LV+L G  +E
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 191 Q-GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           + G   ++ EYM   SL  +L   + + +LG    ++    + + + YL   +    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 250 DLKASNILLDSDMNPKISDFGMAR 273
           DL A N+L+  D   K+SDFG+ +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 8/144 (5%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 190
           +G+G FG V  G    G +VAVK + N +      F  E  ++ +L+H +LV+L G  +E
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 191 Q-GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           + G   ++ EYM   SL  +L   + + +LG    ++    + + + YL   +    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 250 DLKASNILLDSDMNPKISDFGMAR 273
           DL A N+L+  D   K+SDFG+ +
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 86/181 (47%), Gaps = 23/181 (12%)
Query: 113 FSLASV------SAATENFSTQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-S 159
           FS A V        A E  +   +LG+G FG VY    KG + +  E  VA+K ++   S
Sbjct: 3   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 62
Query: 160 GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKR 217
            +   EF NE  ++ +    H+VRL G   +    ++I E M    L  +L    P+ + 
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 218 --LLGWQARVRIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             +L   +  ++I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 123 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 273 R 273
           R
Sbjct: 180 R 180

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 120 AATENFSTQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-SGQGLTEFKNEMML 172
            A E  +   +LG+G FG VY    KG + +  E  VA+K ++   S +   EF NE  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKR--LLGWQARVRII 228
           + +    H+VRL G   +    ++I E M    L  +L    P+ +   +L   +  ++I
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 229 E---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 86/181 (47%), Gaps = 23/181 (12%)
Query: 113 FSLASV------SAATENFSTQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-S 159
           FS A V        A E  +   +LG+G FG VY    KG + +  E  VA+K ++   S
Sbjct: 9   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 160 GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKR 217
            +   EF NE  ++ +    H+VRL G   +    ++I E M    L  +L    P+ + 
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 128
Query: 218 --LLGWQARVRIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             +L   +  ++I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 273 R 273
           R
Sbjct: 186 R 186

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 8/144 (5%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 190
           +G+G FG V  G    G +VAVK + N +      F  E  ++ +L+H +LV+L G  +E
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 191 Q-GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           + G   ++ EYM   SL  +L   + + +LG    ++    + + + YL   +    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 250 DLKASNILLDSDMNPKISDFGMAR 273
           DL A N+L+  D   K+SDFG+ +
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 8/144 (5%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 190
           +G+G FG V  G    G +VAVK + N +      F  E  ++ +L+H +LV+L G  +E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 191 Q-GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           + G   ++ EYM   SL  +L   + + +LG    ++    + + + YL   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 250 DLKASNILLDSDMNPKISDFGMAR 273
           DL A N+L+  D   K+SDFG+ +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 91/171 (53%), Gaps = 13/171 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRH 180
           E F+   ++G+G FG VYKG   + +EV   ++ +  ++   + + + E+ ++++    +
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 181 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           + R FG  ++  +  +I EY+   S LD+    P ++  +       I+  I +GL YLH
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLH 133
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                R IHRD+KA+N+LL    + K++DFG+A      +++ N    VGT
Sbjct: 134 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGT 179

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 120 AATENFSTQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-SGQGLTEFKNEMML 172
            A E  +   +LG+G FG VY    KG + +  E  VA+K ++   S +   EF NE  +
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKR--LLGWQARVRII 228
           + +    H+VRL G   +    ++I E M    L  +L    P+ +   +L   +  ++I
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 229 E---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 120 AATENFSTQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-SGQGLTEFKNEMML 172
            A E  +   +LG+G FG VY    KG + +  E  VA+K ++   S +   EF NE  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKR--LLGWQARVRII 228
           + +    H+VRL G   +    ++I E M    L  +L    P+ +   +L   +  ++I
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 229 E---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 120 AATENFSTQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-SGQGLTEFKNEMML 172
            A E  +   +LG+G FG VY    KG + +  E  VA+K ++   S +   EF NE  +
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKR--LLGWQARVRII 228
           + +    H+VRL G   +    ++I E M    L  +L    P+ +   +L   +  ++I
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 229 E---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 240 QYSRLRIIHRDLKASNILLDSDMNP----KISDFGMAR 273
           +      IHRD+ A N LL     P    KI DFGMAR
Sbjct: 158 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 191

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 240 QYSRLRIIHRDLKASNILLDSDMN---PKISDFGMAR 273
           +      IHRD+ A N LL         KI DFGMAR
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 240 QYSRLRIIHRDLKASNILLDSDMN---PKISDFGMAR 273
           +      IHRD+ A N LL         KI DFGMAR
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 120 AATENFSTQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-SGQGLTEFKNEMML 172
            A E  +   +LG+G FG VY    KG + +  E  VA+K ++   S +   EF NE  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKR--LLGWQARVRII 228
           + +    H+VRL G   +    ++I E M    L  +L    P+ +   +L   +  ++I
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 229 E---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 240 QYSRLRIIHRDLKASNILLDSDMNP----KISDFGMAR 273
           +      IHRD+ A N LL     P    KI DFGMAR
Sbjct: 199 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 232

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 240 QYSRLRIIHRDLKASNILLDSDMN---PKISDFGMAR 273
           +      IHRD+ A N LL         KI DFGMAR
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 240 QYSRLRIIHRDLKASNILLDSDMN---PKISDFGMAR 273
           +      IHRD+ A N LL         KI DFGMAR
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 240 QYSRLRIIHRDLKASNILLDSDMNP----KISDFGMAR 273
           +      IHRD+ A N LL     P    KI DFGMAR
Sbjct: 165 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 198

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 115 LASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ--SGQGLTEFKN 168
           L  V    + F+    LG+G FG V + +L        +VAVK L     +   + EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGEN------ILIYEYMPNKSLDVFLFYPK---KKRLL 219
           E   + +  H H+ +L G  +           ++I  +M +  L  FL   +       L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 220 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
             Q  VR +  IA G+ YL   S    IHRDL A N +L  DM   ++DFG++R I+ GD
Sbjct: 135 PLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQHR 179
           NF  + K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFL-FYPKKKRLLG----WQARVRIIEGIAQG 234
           ++++ +   IE  E  ++ E      L   +  + K+KRL+     W+  V++   +   
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE-- 150
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
               H +SR R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT
Sbjct: 151 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 20/161 (12%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G  VAVK+L +       +F+ E+ ++  L    +V+ 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 185 FGCCIEQG--ENILIYEYMPNKSLDVFLFYPKKK----RLLGWQARVRIIEGIAQGLLYL 238
            G     G  E  L+ EY+P+  L  FL   + +    RLL + ++      I +G+ YL
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEYL 127
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
              SR R +HRDL A NIL++S+ + KI+DFG+A++   D+
Sbjct: 128 G--SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 165

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 240 QYSRLRIIHRDLKASNILLDSDMN---PKISDFGMAR 273
           +      IHRD+ A N LL         KI DFGMAR
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSN-QSGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 240 QYSRLRIIHRDLKASNILLDSDMN---PKISDFGMAR 273
           +      IHRD+ A N LL         KI DFGMAR
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 240 QYSRLRIIHRDLKASNILLDSDMNP----KISDFGMAR 273
           +      IHRD+ A N LL     P    KI DFGMAR
Sbjct: 175 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 208

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 130 KLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLV 182
           +LG+G FG VY+G    ++ G+    VAVK ++  +  +   EF NE  ++      H+V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLG-----WQARVRIIEGIAQGL 235
           RL G   +    +++ E M +  L  +L    P+ +   G      Q  +++   IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            YL+     + +HR+L A N ++  D   KI DFGM R
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 130 KLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLV 182
           +LG+G FG VY+G    ++ G+    VAVK ++  +  +   EF NE  ++      H+V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLG-----WQARVRIIEGIAQGL 235
           RL G   +    +++ E M +  L  +L    P+ +   G      Q  +++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            YL+     + +HR+L A N ++  D   KI DFGM R
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 240 QYSRLRIIHRDLKASNILLDSDMNP----KISDFGMAR 273
           +      IHRD+ A N LL     P    KI DFGMAR
Sbjct: 185 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 218

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           E +    KLGEG +  VYKG+  L    VA+K  RL ++ G   T  + E+ L+  L+H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 60
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++V L      +    L++EY+ +K L  +L       ++        +  + +GL Y H
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              R +++HRDLK  N+L++     K++DFG+AR
Sbjct: 118 ---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 20/161 (12%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G  VAVK+L +       +F+ E+ ++  L    +V+ 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 185 FGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKK----RLLGWQARVRIIEGIAQGLLYL 238
            G     G   L  + EY+P+  L  FL   + +    RLL + ++      I +G+ YL
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEYL 130
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
                 R +HRDL A NIL++S+ + KI+DFG+A++   D+
Sbjct: 131 ---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 168

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 20/161 (12%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G  VAVK+L +       +F+ E+ ++  L    +V+ 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 185 FGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKK----RLLGWQARVRIIEGIAQGLLYL 238
            G     G   L  + EY+P+  L  FL   + +    RLL + ++      I +G+ YL
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEYL 131
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
                 R +HRDL A NIL++S+ + KI+DFG+A++   D+
Sbjct: 132 ---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 169

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 279
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLE--- 335
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHR+L A N L+  +   K++DFG++R+  GD
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 20/161 (12%)
Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G  VAVK+L +       +F+ E+ ++  L    +V+ 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 185 FGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKK----RLLGWQARVRIIEGIAQGLLYL 238
            G     G   L  + EY+P+  L  FL   + +    RLL + ++      I +G+ YL
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEYL 143
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
                 R +HRDL A NIL++S+ + KI+DFG+A++   D+
Sbjct: 144 ---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 84/181 (46%), Gaps = 23/181 (12%)
Query: 113 FSLASV------SAATENFSTQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-S 159
           FS A V        A E  +   +LG+G FG VY    KG + +  E  VA+K ++   S
Sbjct: 9   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 160 GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPK--K 215
            +   EF NE  ++ +    H+VRL G   +    ++I E M    L  +L    P    
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 216 KRLLGWQARVRIIE---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             +L   +  ++I+    IA G+ YL+     + +HRDL A N ++  D   KI DFGM 
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 273 R 273
           R
Sbjct: 186 R 186

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 110
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 170
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 171 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 199

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 17/168 (10%)
Query: 120 AATENFSTQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-SGQGLTEFKNEMML 172
            A E  +   +LG+G FG VY    KG + +  E  VA+K ++   S +   EF NE  +
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPK--KKRLLGWQARVRII 228
           + +    H+VRL G   +    ++I E M    L  +L    P      +L   +  ++I
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 229 E---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFGM R
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 177 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 118
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 178
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 179 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 207

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 177 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +     +VAVK L S+ + + L++  +EM ++  + +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPK--KKRLLGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L           F P    +  L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 120
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 180
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 181 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 209

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 90  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 290 T 290
           T
Sbjct: 195 T 195

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 92  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 290 T 290
           T
Sbjct: 197 T 197

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 124 NFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +LV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 318
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL    
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYL---E 374
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +   IHR+L A N L+  +   K++DFG++R+  GD
Sbjct: 375 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 410

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 92  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 290 T 290
           T
Sbjct: 197 T 197

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 93  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 140
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 141 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 290 T 290
           T
Sbjct: 198 T 198

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 67  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 114
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 115 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 290 T 290
           T
Sbjct: 172 T 172

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 92  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 290 T 290
           T
Sbjct: 197 T 197

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 93  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 140
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 141 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 290 T 290
           T
Sbjct: 198 T 198

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 92  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 290 T 290
           T
Sbjct: 197 T 197

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 74  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 121
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 122 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 290 T 290
           T
Sbjct: 179 T 179

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 68  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 115
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 116 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 290 T 290
           T
Sbjct: 173 T 173

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 17/168 (10%)
Query: 120 AATENFSTQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQ-SGQGLTEFKNEMML 172
            A E  +   +LG+G FG VY    KG + +  E  VA+K ++   S +   EF NE  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKR--LLGWQARVRII 228
           + +    H+VRL G   +    ++I E M    L  +L    P+ +   +L   +  ++I
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 229 E---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +    IA G+ YL+     + +HRDL A N  +  D   KI DFGM R
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 69  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 116
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 117 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 290 T 290
           T
Sbjct: 174 T 174

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 70  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 117
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 118 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 290 T 290
           T
Sbjct: 175 T 175

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 90  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 290 T 290
           T
Sbjct: 195 T 195

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 90  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 290 T 290
           T
Sbjct: 195 T 195

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 161
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 221
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 222 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 250

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 95  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 142
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 143 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 290 T 290
           T
Sbjct: 200 T 200

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 20/169 (11%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSN-QSGQGLTEFKNEMML--IA 174
           AT  +    ++G G +G VYK R   +G  VA+K  R+ N + G  ++  +   +L  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 175 KLQHRHLVRLFGCCIEQGEN-----ILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RI 227
             +H ++VRL   C     +      L++E++ ++ L  +L    K    G  A     +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAETIKDL 117
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           +    +GL +LH      I+HRDLK  NIL+ S    K++DFG+ARI+ 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 13/167 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCI 189
           +G G +G VYKGR +   ++A  ++ + +G    E K E+ ++ K   HR++   +G  I
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 190 EQGEN------ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
           ++          L+ E+    S+   L    K   L  +    I   I +GL +LHQ+  
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 148
Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            ++IHRD+K  N+LL  +   K+ DFG++     D   G     +GT
Sbjct: 149 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 192

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 20/169 (11%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSN-QSGQGLTEFKNEMML--IA 174
           AT  +    ++G G +G VYK R   +G  VA+K  R+ N + G  ++  +   +L  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 175 KLQHRHLVRLFGCCIEQGEN-----ILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RI 227
             +H ++VRL   C     +      L++E++ ++ L  +L    K    G  A     +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAETIKDL 117
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           +    +GL +LH      I+HRDLK  NIL+ S    K++DFG+ARI+ 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 92  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 139
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 290 T 290
           T
Sbjct: 197 T 197

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 20/169 (11%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSN-QSGQGLTEFKNEMML--IA 174
           AT  +    ++G G +G VYK R   +G  VA+K  R+ N + G  ++  +   +L  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 175 KLQHRHLVRLFGCCIEQGEN-----ILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RI 227
             +H ++VRL   C     +      L++E++ ++ L  +L    K    G  A     +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAETIKDL 117
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           +    +GL +LH      I+HRDLK  NIL+ S    K++DFG+ARI+ 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 87
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 147
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 148 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 176

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 18/158 (11%)
Query: 130 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR----HLV 182
           +LG G FG V +G  R+   Q +VA+K L   + +  TE   EMM  A++ H+    ++V
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE---EMMREAQIMHQLDNPYIV 73
Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           RL G C  Q E + L+ E      L  FL    K+  +       ++  ++ G+ YL + 
Sbjct: 74  RLIGVC--QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           +    +HRDL A N+LL +    KISDFG+++  G D+
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 150
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 151 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 179

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 155 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 131 LGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVR 183
           LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K  H+++VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
             G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 240 QYSRLRIIHRDLKASNILLDSDMNP----KISDFGMAR 273
           +      IHRD+ A N LL     P    KI DFGMA+
Sbjct: 159 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAQ 192

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 89  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 136
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 290 T 290
           T
Sbjct: 194 T 194

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 88/184 (47%), Gaps = 16/184 (8%)
Query: 118 VSAATENFSTQCKLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLTEFKNEMM 171
           + +  E++     +G G +G   K      G++L  +E+    ++    Q L    +E+ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 172 LIAKLQHRHLVRLFGCCIEQGENIL--IYEYMPNKSL-DVFLFYPKKKRLLGWQARVRII 228
           L+ +L+H ++VR +   I++    L  + EY     L  V     K+++ L  +  +R++
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 229 EGIAQGLLYLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
             +   L   H+ S     ++HRDLK +N+ LD   N K+ DFG+ARI   DE     K 
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE--DFAKE 175
Query: 287 IVGT 290
            VGT
Sbjct: 176 FVGT 179

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 161
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 162 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 190

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 155
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 156 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 184

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 155 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 80/147 (54%), Gaps = 12/147 (8%)
Query: 130 KLGEGGFGPVYKGRLLNGQE---VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           +LG+G FG VYK +  N +     A K +  +S + L ++  E+ ++A   H ++V+L  
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII-EGIAQGLLYLHQYSRLR 245
               +    ++ E+    ++D  +   + +R L  +++++++ +     L YLH     +
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVML--ELERPLT-ESQIQVVCKQTLDALNYLHDN---K 155
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMA 272
           IIHRDLKA NIL   D + K++DFG++
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 89  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 136
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 290 T 290
           T
Sbjct: 194 T 194

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 80/147 (54%), Gaps = 12/147 (8%)
Query: 130 KLGEGGFGPVYKGRLLNGQE---VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           +LG+G FG VYK +  N +     A K +  +S + L ++  E+ ++A   H ++V+L  
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII-EGIAQGLLYLHQYSRLR 245
               +    ++ E+    ++D  +   + +R L  +++++++ +     L YLH     +
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVML--ELERPLT-ESQIQVVCKQTLDALNYLHDN---K 155
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMA 272
           IIHRDLKA NIL   D + K++DFG++
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 80/147 (54%), Gaps = 12/147 (8%)
Query: 130 KLGEGGFGPVYKGRLLNGQE---VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           +LG+G FG VYK +  N +     A K +  +S + L ++  E+ ++A   H ++V+L  
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII-EGIAQGLLYLHQYSRLR 245
               +    ++ E+    ++D  +   + +R L  +++++++ +     L YLH     +
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVML--ELERPLT-ESQIQVVCKQTLDALNYLHDN---K 155
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMA 272
           IIHRDLKA NIL   D + K++DFG++
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 165 EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL---DVFLFYPKKKR--LL 219
           +FKNE+ +I  +++ + +   G      E  +IYEYM N S+   D + F   K     +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 220 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             Q    II+ +     Y+H  +   I HRD+K SNIL+D +   K+SDFG +      +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 280 LQG 282
           ++G
Sbjct: 207 IKG 209

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 143
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 144 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 172

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 146
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 147 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 175

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +     +VAVK L S+ + + L++  +EM ++  + +H++
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPK--KKRLLGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L           + P    +  L  +  V  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 187

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +     +VAVK L S+ + + L++  +EM ++  + +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPK--KKRLLGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L           + P    +  L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +     +VAVK L S+ + + L++  +EM ++  + +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPK--KKRLLGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L           + P    +  L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +     +VAVK L S+ + + L++  +EM ++  + +H++
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPK--KKRLLGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L           + P    +  L  +  V  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 190

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +     +VAVK L S+ + + L++  +EM ++  + +H++
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPK--KKRLLGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L           + P    +  L  +  V  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 191

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++     QG   FKN E+ ++ KL H ++VRL   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +     +VAVK L S+ + + L++  +EM ++  + +H++
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPK--KKRLLGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L           + P    +  L  +  V  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++     QG   FKN E+ ++ KL H ++VRL   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 79/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ + A L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +     +VAVK L S+ + + L++  +EM ++  + +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPK--KKRLLGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L           + P    +  L  +  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRLFGCC 188
           +G G FG VY+ +L + G+ VA+K++          FKN E+ ++ KL H ++VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 189 IEQGENI------LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
              GE        L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL---F 185
           +G G FG VY+ +L + G+ VA+K++     QG   FKN E+ ++ KL H ++VRL   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 186 GCCIEQGENI---LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
               E+ + +   L+ +Y+P     V   Y + K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 243 RLRIIHRDLKASNILLDSDMNP-KISDFGMAR 273
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +     +VAVK L S+ + + L++  +EM ++  + +H++
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPK--KKRLLGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L           + P    +  L  +  V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 92  PFFVKLY------------FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA 139
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 290 T 290
           T
Sbjct: 197 T 197

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 77/181 (42%), Gaps = 28/181 (15%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F      R L   +E A+K L  +       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-------- 230
              V+L+            + +  ++ L   L Y K   LL +  ++   +         
Sbjct: 90  PFFVKLY------------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
            I   L YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 290 T 290
           T
Sbjct: 195 T 195

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 82/158 (51%), Gaps = 18/158 (11%)
Query: 130 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR----HLV 182
           +LG G FG V +G  R+   Q +VA+K L   + +  TE   EMM  A++ H+    ++V
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE---EMMREAQIMHQLDNPYIV 399
Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           RL G C  Q E + L+ E      L  FL    K+  +       ++  ++ G+ YL + 
Sbjct: 400 RLIGVC--QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           +    +HR+L A N+LL +    KISDFG+++  G D+
Sbjct: 456 N---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 20/162 (12%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 154

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 20/162 (12%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 130 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRHLVRLFGC 187
           ++G G FG V+ GRL  +   VAVK         L  +F  E  ++ +  H ++VRL G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 188 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR----IIEGIAQGLLYLHQYSR 243
           C ++    ++ E +       FL      R  G + RV+    ++   A G+ YL     
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL------RTEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              IHRDL A N L+      KISDFGM+R
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 20/159 (12%)
Query: 131 LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           LG+G FG   K      G+ + +K L     +    F  E+ ++  L+H ++++  G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 190 EQGENILIYEYMPN-------KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +      I EY+         KS+D    YP       W  RV   + IA G+ YLH   
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQ--YP-------WSQRVSFAKDIASGMAYLHS-- 126
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
            + IIHRDL + N L+  + N  ++DFG+AR+   ++ Q
Sbjct: 127 -MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 16/184 (8%)
Query: 118 VSAATENFSTQCKLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLTEFKNEMM 171
           + +  E++     +G G +G   K      G++L  +E+    ++    Q L    +E+ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 172 LIAKLQHRHLVRLFGCCIEQGENIL--IYEYMPNKSL-DVFLFYPKKKRLLGWQARVRII 228
           L+ +L+H ++VR +   I++    L  + EY     L  V     K+++ L  +  +R++
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 229 EGIAQGLLYLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
             +   L   H+ S     ++HRDLK +N+ LD   N K+ DFG+ARI   D      K 
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKT 175
Query: 287 IVGT 290
            VGT
Sbjct: 176 FVGT 179

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 130 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRHLVRLFGC 187
           ++G G FG V+ GRL  +   VAVK         L  +F  E  ++ +  H ++VRL G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 188 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR----IIEGIAQGLLYLHQYSR 243
           C ++    ++ E +       FL      R  G + RV+    ++   A G+ YL     
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL------RTEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              IHRDL A N L+      KISDFGM+R
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 20/162 (12%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 154

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQGLTE-FKNEMMLIAK 175
           A E+      LGEG FG VY+G   N +     VAVK           E F +E +++  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L H H+V+L G  IE+    +I E  P   L  +L   + K  L     V     I + +
Sbjct: 66  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 122
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDELQGNTKRI 287
            YL     +  +HRD+   NIL+ S    K+ DFG++R I   D  + +  R+
Sbjct: 123 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 172

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 16/184 (8%)
Query: 118 VSAATENFSTQCKLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLTEFKNEMM 171
           + +  E++     +G G +G   K      G++L  +E+    ++    Q L    +E+ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 172 LIAKLQHRHLVRLFGCCIEQGENIL--IYEYMPNKSL-DVFLFYPKKKRLLGWQARVRII 228
           L+ +L+H ++VR +   I++    L  + EY     L  V     K+++ L  +  +R++
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 229 EGIAQGLLYLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
             +   L   H+ S     ++HRDLK +N+ LD   N K+ DFG+ARI   D      K 
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKA 175
Query: 287 IVGT 290
            VGT
Sbjct: 176 FVGT 179

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQGLTE-FKNEMMLIAK 175
           A E+      LGEG FG VY+G   N +     VAVK           E F +E +++  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L H H+V+L G  IE+    +I E  P   L  +L   + K  L     V     I + +
Sbjct: 82  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 138
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDELQGNTKRI 287
            YL     +  +HRD+   NIL+ S    K+ DFG++R I   D  + +  R+
Sbjct: 139 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 188

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQGLTE-FKNEMMLIAK 175
           A E+      LGEG FG VY+G   N +     VAVK           E F +E +++  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L H H+V+L G  IE+    +I E  P   L  +L   + K  L     V     I + +
Sbjct: 70  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 126
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDELQGNTKRI 287
            YL     +  +HRD+   NIL+ S    K+ DFG++R I   D  + +  R+
Sbjct: 127 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 20/162 (12%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 20/162 (12%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 20/162 (12%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 114
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 115 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 23/174 (13%)
Query: 119 SAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGL---TEFKNEMML 172
           S AT  +    ++G G +G VYK R   +G  VA+K  R+ N  G G         E+ L
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 173 IAKLQ---HRHLVRLFGCCIEQGEN-----ILIYEYMPNKSLDVFLFYPKKKRLLGWQAR 224
           + +L+   H ++VRL   C     +      L++E++ ++ L  +L    K    G  A 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAE 120
Query: 225 V--RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
               ++    +GL +LH      I+HRDLK  NIL+ S    K++DFG+ARI+ 
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 130 KLGEGGFGPVYKGRL--LNGQ--EVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLV 182
           KLG+G FG V +G     +G+   VAVK L        + + +F  E+  +  L HR+L+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+G  +      ++ E  P  SL   L   +   LLG  +R  +   +A+G+ YL    
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             R IHRDL A N+LL +    KI DFG+ R
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMR 163

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 89/171 (52%), Gaps = 13/171 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRH 180
           E F+   K+G+G FG V+KG     Q+V   ++ +  ++   + + + E+ ++++    +
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 181 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           + + +G  ++  +  +I EY+   S LD+    P  +  +       I+  I +GL YLH
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 121
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              +   IHRD+KA+N+LL      K++DFG+A      +++ NT   VGT
Sbjct: 122 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 167

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 81/150 (54%), Gaps = 9/150 (6%)
Query: 130 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-NQSGQGL-TEFKNEMMLIAKLQHRHLVRLFG 186
           K+GEG +G V+K +     E VA+KR+  +   +G+ +    E+ L+ +L+H+++VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
                 +  L++E+      D+  ++      L  +     +  + +GL + H  +   +
Sbjct: 69  VLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 247 IHRDLKASNILLDSDMNPKISDFGMARIFG 276
           +HRDLK  N+L++ +   K++DFG+AR FG
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFG 152

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 130 KLGEGGFGPVYKGRL--LNGQ--EVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLV 182
           KLG+G FG V +G     +G+   VAVK L        + + +F  E+  +  L HR+L+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+G  +      ++ E  P  SL   L   +   LLG  +R  +   +A+G+ YL    
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 140
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             R IHRDL A N+LL +    KI DFG+ R
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMR 169

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 130 KLGEGGFGPVYKGRL--LNGQ--EVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLV 182
           KLG+G FG V +G     +G+   VAVK L        + + +F  E+  +  L HR+L+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+G  +      ++ E  P  SL   L   +   LLG  +R  +   +A+G+ YL    
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 140
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             R IHRDL A N+LL +    KI DFG+ R
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMR 169

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 26/177 (14%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L   +   +             + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR     +   NT
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 190
           +G G FG V K +    ++VA+K++ ++S +    F  E+  ++++ H ++V+L+G C+ 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 191 QGENILIYEYMPNKSLDVFLF------YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
                L+ EY    SL   L       Y      + W  +       +QG+ YLH     
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 125
Query: 245 RIIHRDLKASNILLDSDMNP-KISDFGMA 272
            +IHRDLK  N+LL +     KI DFG A
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 94/177 (53%), Gaps = 13/177 (7%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIA 174
           +++   E F+   ++G+G FG V+KG     Q+V   ++ +  ++   + + + E+ +++
Sbjct: 17  NIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS 76
Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           +    ++ + +G  ++  +  +I EY+   S LD+    P  +  +       +++ I +
Sbjct: 77  QCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILK 131
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           GL YLH   +   IHRD+KA+N+LL    + K++DFG+A      +++ NT   VGT
Sbjct: 132 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 183

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 130 KLGEGGFGPVYKGRL--LNGQ--EVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLV 182
           KLG+G FG V +G     +G+   VAVK L        + + +F  E+  +  L HR+L+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+G  +      ++ E  P  SL   L   +   LLG  +R  +   +A+G+ YL    
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             R IHRDL A N+LL +    KI DFG+ R
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 130 KLGEGGFGPVYKGRL--LNGQ--EVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLV 182
           KLG+G FG V +G     +G+   VAVK L        + + +F  E+  +  L HR+L+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+G  +      ++ E  P  SL   L   +   LLG  +R  +   +A+G+ YL    
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             R IHRDL A N+LL +    KI DFG+ R
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMR 163

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 130 KLGEGGFGPVYKGRL--LNGQ--EVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLV 182
           KLG+G FG V +G     +G+   VAVK L        + + +F  E+  +  L HR+L+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+G  +      ++ E  P  SL   L   +   LLG  +R  +   +A+G+ YL    
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             R IHRDL A N+LL +    KI DFG+ R
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 130 KLGEGGFGPVYKGRL--LNGQ--EVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLV 182
           KLG+G FG V +G     +G+   VAVK L        + + +F  E+  +  L HR+L+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+G  +      ++ E  P  SL   L   +   LLG  +R  +   +A+G+ YL    
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             R IHRDL A N+LL +    KI DFG+ R
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 88/171 (51%), Gaps = 13/171 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRH 180
           E F+   K+G+G FG V+KG     Q+V   ++ +  ++   + + + E+ ++++    +
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 181 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           + + +G  ++  +  +I EY+   S LD+    P     L       I+  I +GL YLH
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLH 141
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              +   IHRD+KA+N+LL      K++DFG+A      +++ NT   VGT
Sbjct: 142 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 187

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 80/179 (44%), Gaps = 23/179 (12%)
Query: 131 LGEGGFGPVYKGRLLN-GQE-----VAVKRLSNQSGQGLTE-FKNEMMLIAKL-QHRHLV 182
           LG G FG V +      G+E     VAVK L + +     E   +E+ +++ L QH ++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            L G C   G  ++I EY      D+  F  +K R+L       I    A     LH  S
Sbjct: 114 NLLGACTHGGPVLVITEYCCYG--DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 243 RL----------RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQGNTKRIV 288
           ++            IHRD+ A N+LL +    KI DFG+AR    D    ++GN +  V
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 190
           +G G FG V K +    ++VA+K++ ++S +    F  E+  ++++ H ++V+L+G C+ 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 191 QGENILIYEYMPNKSLDVFLF------YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
                L+ EY    SL   L       Y      + W  +       +QG+ YLH     
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 124
Query: 245 RIIHRDLKASNILLDSDMNP-KISDFGMA 272
            +IHRDLK  N+LL +     KI DFG A
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 32/169 (18%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV---RIIEG------- 230
           ++ L G C + G   +I EY    +L  +L   + +R  G +      R+ E        
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 231 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                 +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L   +   +             + ++  V  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 12/163 (7%)
Query: 115 LASVSAATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNE 169
           L S   A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E
Sbjct: 3   LGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRRE 61
Query: 170 MMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE 229
           + + + L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYIT 118
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 82/182 (45%), Gaps = 29/182 (15%)
Query: 131 LGEGGFGPVYKGRLLN-GQE-----VAVKRLSNQSGQGLTE-FKNEMMLIAKL-QHRHLV 182
           LG G FG V +      G+E     VAVK L + +     E   +E+ +++ L QH ++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG------------ 230
            L G C   G  ++I EY      D+  F  +K R+L       I               
Sbjct: 114 NLLGACTHGGPVLVITEYCCYG--DLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 231 -IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQGNTKR 286
            +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++GN + 
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 287 IV 288
            V
Sbjct: 229 PV 230

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L   +   +             + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L   +   +             + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L   +   +             + ++  V  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLL----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G+G FG VY G  +    N  + A+K LS  +  Q +  F  E +L+  L H +++ L 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 186 GCCIE-QGENILIYEYMPNKSLDVFLFYPKK----KRLLGWQARVRIIEGIAQGLLYLHQ 240
           G  +  +G   ++  YM +  L  F+  P++    K L+ +  +V      A+G+ YL  
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV------ARGMEYL-- 140
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +  + +HRDL A N +LD     K++DFG+AR
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 121 ATENFSTQCK---LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL 176
           A  +F T  K   LG G FG V+K      G ++A K +  +  +   E KNE+ ++ +L
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
            H +L++L+     + + +L+ EY+    L  F     +   L     +  ++ I +G+ 
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGEL--FDRIIDESYNLTELDTILFMKQICEGIR 201
Query: 237 YLHQYSRLRIIHRDLKASNIL-LDSDMNP-KISDFGMAR 273
           ++HQ   + I+H DLK  NIL ++ D    KI DFG+AR
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 127 TQCK-LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRHLVRL 184
           T CK +G G FG V++ +L+   EVA+K++          FKN E+ ++  ++H ++V L
Sbjct: 43  TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDL 97
Query: 185 FGCCIEQGENI------LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                  G+        L+ EY+P         Y K K+ +        +  + + L Y+
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFGGDE 279
           H    + I HRD+K  N+LLD      K+ DFG A+I    E
Sbjct: 158 HS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW--QARVRIIEGIAQ 233
           L+H +++RL+G   +     LI EY P   +     Y + ++L  +  Q     I  +A 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEV-----YKELQKLSKFDEQRTATYITELAN 124
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            L Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 12/164 (7%)
Query: 114 SLASVSAATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKN 168
           ++ S   A E+F     LG+G FG VY  R      +   +V  K    ++G    + + 
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRR 60
Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ + + L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYI 117
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 118 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SNQSGQGLT-EFKNEMMLIAKL 176
           A E+F     LG+G FG VY  R  N + + A+K L  +     G+  + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
           +H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
           Y H     ++IHRD+K  N+LL S    KI+DFG +
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW--QARVRIIEGIAQ 233
           L+H +++RL+G   +     LI EY P   +     Y + ++L  +  Q     I  +A 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEV-----YKELQKLSKFDEQRTATYITELAN 124
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            L Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 22/168 (13%)
Query: 131 LGEGGFGPVYKGR--------LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           LG+G F  ++KG          L+  EV +K L          F     +++KL H+HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
             +G C+   ENIL+ E++   SLD +L   K K  +    ++ + + +A  + +L + +
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLEENT 133
Query: 243 RLRIIHRDLKASNILLDSDM-----NP---KISDFGMA-RIFGGDELQ 281
              +IH ++ A NILL  +      NP   K+SD G++  +   D LQ
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 10/157 (6%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK---NEMMLIAKL 176
           + ++F     LG G FG V+  R   NG+  A+K L  +    L + +   +E ++++ +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
            H  ++R++G   +  +  +I +Y+    L  F    K +R     A+    E +   L 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALE 120
Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           YLH      II+RDLK  NILLD + + KI+DFG A+
Sbjct: 121 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK 154

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 21/176 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQE-----VAVKRLSNQSGQGLTE-FKNEMMLIAKL-QHRHLV 182
           LG G FG V +      G+E     VAVK L + +     E   +E+ +++ L QH ++V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL-------FYPKKKRLLGWQARVRIIEGIAQGL 235
            L G C   G  ++I EY     L  FL          +  R L  +  +     +AQG+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQGNTKRIV 288
            +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++GN +  V
Sbjct: 166 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 21/176 (11%)
Query: 131 LGEGGFGPVYKGRLLN-GQE-----VAVKRLSNQSGQGLTE-FKNEMMLIAKL-QHRHLV 182
           LG G FG V +      G+E     VAVK L + +     E   +E+ +++ L QH ++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL-------FYPKKKRLLGWQARVRIIEGIAQGL 235
            L G C   G  ++I EY     L  FL          +  R L  +  +     +AQG+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQGNTKRIV 288
            +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++GN +  V
Sbjct: 174 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ 177
           E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + L+
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLR 70
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L Y
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSY 127
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            H     R+IHRD+K  N+LL S+   KI+DFG +
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 126
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 82/155 (52%), Gaps = 20/155 (12%)
Query: 130 KLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQ-HRHLVRLF 185
           KLG+G +G V+K      G+ VAVK++ +  Q+         E+M++ +L  H ++V L 
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 186 GCCIEQGEN--ILIYEYMPNKSLDVF---LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
                  +    L+++YM      V    +  P  K+ + +Q  +++I+       YLH 
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL-IKVIK-------YLHS 127
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
                ++HRD+K SNILL+++ + K++DFG++R F
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ 177
           E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + L+
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLR 70
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L Y
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSY 127
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            H     R+IHRD+K  N+LL S+   KI+DFG +
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 122
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 122
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 68
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 125
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 159

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 121
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +GEG FG V++G  ++ +     VA+K   N +   + E F  E + + +  H H+V+L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G  I +    +I E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
            +HRD+ A N+L+ S+   K+ DFG++R
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR 164

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +GEG FG V++G  ++ +     VA+K   N +   + E F  E + + +  H H+V+L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G  I +    +I E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
            +HRD+ A N+L+ S+   K+ DFG++R
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSR 162

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   Y+   ++ +EV   ++  +S         +   E+ +   L + H+V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
              +     ++ E    +SL     + ++K +   +AR  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 247 IHRDLKASNILLDSDMNPKISDFGMA 272
           IHRDLK  N+ L+ DM+ KI DFG+A
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 121
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 121
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 126
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +GEG FG V++G  ++ +     VA+K   N +   + E F  E + + +  H H+V+L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G  I +    +I E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
            +HRD+ A N+L+ S+   K+ DFG++R
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSR 187

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 65
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 122
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L   +   +             + ++  V  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 10/167 (5%)
Query: 125 FSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
             +  K+GEG  G V   R  + G++VAVK +  +  Q      NE++++   QH ++V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
           ++   +   E  ++ E++   +L   +     +  L  +    + E + Q L YLH    
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQG- 161
Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
             +IHRD+K+ +ILL  D   K+SDFG       D      K +VGT
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGT 204

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 124
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   Y+   ++ +EV   ++  +S         +   E+ +   L + H+V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
              +     ++ E    +SL     + ++K +   +AR  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 247 IHRDLKASNILLDSDMNPKISDFGMA 272
           IHRDLK  N+ L+ DM+ KI DFG+A
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 66
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 123
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 157

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   Y+   ++ +EV   ++  +S         +   E+ +   L + H+V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
              +     ++ E    +SL     + ++K +   +AR  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 247 IHRDLKASNILLDSDMNPKISDFGMA 272
           IHRDLK  N+ L+ DM+ KI DFG+A
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L   +   +             + ++  V  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 121
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 77/166 (46%), Gaps = 18/166 (10%)
Query: 128 QCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           QC LG GGFG V++ +  ++    A+KR+   + +   E    E+  +AKL+H  +VR F
Sbjct: 11  QC-LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW-------QARVR-----IIEGIAQ 233
              +E+     +    P   L + +   +K+ L  W       + R R     I   IA+
Sbjct: 70  NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            + +LH      ++HRDLK SNI    D   K+ DFG+      DE
Sbjct: 130 AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 69
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 126
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 121
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 63
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 120
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 121 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 154

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 121
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 20/162 (12%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            E++     LGEG  G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V+ +G   E     L  EY     L      D+ +  P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 154

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 64
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 121
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +GEG FG V++G  ++ +     VA+K   N +   + E F  E + + +  H H+V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G  I +    +I E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
            +HRD+ A N+L+ S+   K+ DFG++R
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +GEG FG V++G  ++ +     VA+K   N +   + E F  E + + +  H H+V+L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G  I +    +I E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
            +HRD+ A N+L+ S+   K+ DFG++R
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSR 161

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L   +   +             + ++  V  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L   +   +             + ++  V  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 16/159 (10%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW--QARVRIIEGIAQ 233
           L+H +++RL+G   +     LI EY P  ++     Y + ++L  +  Q     I  +A 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTV-----YRELQKLSKFDEQRTATYITELAN 122
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            L Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 16/159 (10%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW--QARVRIIEGIAQ 233
           L+H +++RL+G   +     LI EY P  ++     Y + ++L  +  Q     I  +A 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTV-----YRELQKLSKFDEQRTATYITELAN 122
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            L Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I EY    +L  +L   +   +             + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  +   +I+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +GEG FG V++G  ++ +     VA+K   N +   + E F  E + + +  H H+V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G  I +    +I E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
            +HRD+ A N+L+ S+   K+ DFG++R
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 81
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P   L       +K      Q     I  +A  L
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 138
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 139 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 172

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   Y+   ++ +EV   ++  +S         +   E+ +   L + H+V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
              +     ++ E    +SL     + ++K +   +AR  + + I QG+ YLH     R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 247 IHRDLKASNILLDSDMNPKISDFGMA 272
           IHRDLK  N+ L+ DM+ KI DFG+A
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 90
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 147
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 148 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 90
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 147
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 148 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 16/159 (10%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 61
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW--QARVRIIEGIAQ 233
           L+H +++RL+G   +     LI EY P  ++     Y + ++L  +  Q     I  +A 
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTV-----YRELQKLSKFDEQRTATYITELAN 116
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            L Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 117 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 152

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 87/177 (49%), Gaps = 20/177 (11%)
Query: 116 ASVSAATENFSTQC------KLGEGGFGPVYKG-RLLNGQEVAVKRLSNQ--SGQGLTEF 166
           + V   TEN   Q       +LG+G F  V +  ++L GQE A K ++ +  S +   + 
Sbjct: 9   SGVDLGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL 68
Query: 167 KNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV- 225
           + E  +   L+H ++VRL     E+G + LI++ +    L    F     R    +A   
Sbjct: 69  EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS 124
Query: 226 RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARIFGGDE 279
             I+ I + +L+ HQ   + ++HRDLK  N+LL S +     K++DFG+A    G++
Sbjct: 125 HCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 178

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +GEG FG V++G  ++ +     VA+K   N +   + E F  E + + +  H H+V+L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G  I +    +I E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 75  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
            +HRD+ A N+L+ S+   K+ DFG++R
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR 156

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 88/171 (51%), Gaps = 13/171 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRH 180
           E F+   K+G+G FG V+KG     Q+V   ++ +  ++   + + + E+ ++++    +
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 181 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           + + +G  ++  +  +I EY+   S LD+    P  +  +       I+  I +GL YLH
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 136
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              +   IHRD+KA+N+LL      K++DFG+A      +++ N    VGT
Sbjct: 137 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGT 182

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E + T   +G G +G V     + +G ++AVK+LS   QS         E+ L+
Sbjct: 45  TIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLL 104
Query: 174 AKLQHRHLVRLF-----GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 105 KHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 160
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 161 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 210

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 81/150 (54%), Gaps = 9/150 (6%)
Query: 130 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-NQSGQGL-TEFKNEMMLIAKLQHRHLVRLFG 186
           K+GEG +G V+K +     E VA+KR+  +   +G+ +    E+ L+ +L+H+++VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
                 +  L++E+      D+  ++      L  +     +  + +GL + H  +   +
Sbjct: 69  VLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 247 IHRDLKASNILLDSDMNPKISDFGMARIFG 276
           +HRDLK  N+L++ +   K+++FG+AR FG
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFG 152

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 23/166 (13%)
Query: 130 KLGEGGFGPVYKGRLLNGQ-EVAVKRLS-NQSGQG------------LTEFKNEMMLIAK 175
           KLG G +G V   +  NG  E A+K +  +Q  +G              E  NE+ L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L H ++++LF    ++    L+ E+     L  F     + +     A   I++ I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--FEQIINRHKFDECDA-ANIMKQILSGI 159
Query: 236 LYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARIFGGD 278
            YLH+++   I+HRD+K  NILL+   S +N KI DFG++  F  D
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 88/171 (51%), Gaps = 13/171 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRH 180
           E F+   K+G+G FG V+KG     Q+V   ++ +  ++   + + + E+ ++++    +
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 181 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           + + +G  ++  +  +I EY+   S LD+    P  +  +       I+  I +GL YLH
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 121
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              +   IHRD+KA+N+LL      K++DFG+A      +++ N    VGT
Sbjct: 122 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGT 167

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +GEG FG V++G  ++ +     VA+K   N +   + E F  E + + +  H H+V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G  I +    +I E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
            +HRD+ A N+L+ S+   K+ DFG++R
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEM 170
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q         NE+
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 229
           +++ + ++ ++V      +   E  ++ EY+   SL DV       +  +       +  
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 123
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
              Q L +LH     ++IHRD+K+ NILL  D + K++DFG       +  Q     +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSEMVG 178
Query: 290 T 290
           T
Sbjct: 179 T 179

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 89/181 (49%), Gaps = 12/181 (6%)
Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEM 170
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q         NE+
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 229
           +++ + ++ ++V      +   E  ++ EY+   SL DV       +  +       +  
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 123
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
              Q L +LH     ++IHRD+K+ NILL  D + K++DFG       ++ + +T  +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 178
Query: 290 T 290
           T
Sbjct: 179 T 179

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 131 LGEGGFGPVYKGR--------LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           LG+G F  ++KG          L+  EV +K L          F     +++KL H+HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
             +G C    ENIL+ E++   SLD +L   K K  +    ++ + + +A  + +L + +
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAWAMHFLEENT 133
Query: 243 RLRIIHRDLKASNILLDSDM-----NP---KISDFGMA-RIFGGDELQ 281
              +IH ++ A NILL  +      NP   K+SD G++  +   D LQ
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 10/161 (6%)
Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEM 170
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q         NE+
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 229
           +++ + ++ ++V      +   E  ++ EY+   SL DV       +  +       +  
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 123
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
              Q L +LH     ++IHRD+K+ NILL  D + K++DFG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG 161

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +GEG FG V++G  ++ +     VA+K   N +   + E F  E + + +  H H+V+L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G  I +    +I E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
            +HRD+ A N+L+ S+   K+ DFG++R
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR 539

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 10/161 (6%)
Query: 112 LFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEM 170
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q         NE+
Sbjct: 10  LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 229
           +++ + ++ ++V      +   E  ++ EY+   SL DV       +  +       +  
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 124
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
              Q L +LH     ++IHRD+K+ NILL  D + K++DFG
Sbjct: 125 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG 162

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 21/174 (12%)
Query: 116 ASVSAATENFSTQC--------KLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQ 161
           + V   TEN   Q         K+GEG FG          GR    +E+ + R+S++  +
Sbjct: 9   SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 162 GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW 221
              E + E+ ++A ++H ++V+      E G   ++ +Y   +  D+F     +K +L  
Sbjct: 69  ---ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC--EGGDLFKRINAQKGVLFQ 123
Query: 222 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
           + +  I++   Q  L L      +I+HRD+K+ NI L  D   ++ DFG+AR+ 
Sbjct: 124 EDQ--ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 83/185 (44%), Gaps = 33/185 (17%)
Query: 131 LGEGGFGPVYKGRLLN-GQE-----VAVKRLSNQSGQGLTE-FKNEMMLIAKL-QHRHLV 182
           LG G FG V +      G+E     VAVK L + +     E   +E+ +++ L QH ++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR----------------VR 226
            L G C   G  ++I EY     L  FL   ++KR  G +                  + 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFL---RRKRPPGLEYSYNPSHNPEEQLSSRDLLH 170
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQGN 283
               +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    ++GN
Sbjct: 171 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 227
Query: 284 TKRIV 288
            +  V
Sbjct: 228 ARLPV 232

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I  Y    +L  +L   +   +             + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 86/178 (48%), Gaps = 13/178 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRH 180
           +++  Q  +G G    V        +E VA+KR++ +  Q  + E   E+  +++  H +
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 181 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKR----LLGWQARVRIIEGIAQGL 235
           +V  +   + + E  L+ + +   S LD+      K      +L       I+  + +GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF--GGDELQGNTKR-IVGT 290
            YLH+  +   IHRD+KA NILL  D + +I+DFG++     GGD  +   ++  VGT
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE 190
           +G+G FG VY GR      + +  +   +   L  FK E+M   + +H ++V   G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 191 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRD 250
                +I      ++L  +      K +L      +I + I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTL--YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 251 LKASNILLDSDMNPKISDFGMARIFG 276
           LK+ N+  D+     I+DFG+  I G
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISG 180

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 86/178 (48%), Gaps = 13/178 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRH 180
           +++  Q  +G G    V        +E VA+KR++ +  Q  + E   E+  +++  H +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 181 LVRLFGCCIEQGENILIYEYMPNKS-LDVFLFYPKKKR----LLGWQARVRIIEGIAQGL 235
           +V  +   + + E  L+ + +   S LD+      K      +L       I+  + +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF--GGDELQGNTKR-IVGT 290
            YLH+  +   IHRD+KA NILL  D + +I+DFG++     GGD  +   ++  VGT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 144
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 182

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 17/168 (10%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLTEFKN---EMMLIAKL 176
             +N+  +  +G G +G VY     N  + VA+K++ N+  + L + K    E+ ++ +L
Sbjct: 26  VPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKV-NRMFEDLIDCKRILREITILNRL 84
Query: 177 QHRHLVRLFGCCIEQG-----ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           +  +++RL    I +      E  ++ E   +    +F    K    L  Q    I+  +
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLF----KTPIFLTEQHVKTILYNL 140
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             G  ++H+     IIHRDLK +N LL+ D + KI DFG+AR    D+
Sbjct: 141 LLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 144
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 182

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLTEFKNEMMLIA 174
           ENF     LG G +G V+  R ++G +     A+K L      Q  +     + E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 175 KL-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
            + Q   LV L      + +  LI +Y+    L  F    +++R    + ++ + E I  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IVL 170
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
            L +LH   +L II+RD+K  NILLDS+ +  ++DFG+++ F  DE +
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 70/131 (53%), Gaps = 13/131 (9%)
Query: 163 LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLG 220
           + +   E+ ++ KL H ++V+L     +  E+ L  ++E +    +   +  P  K L  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSE 136
Query: 221 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF-GGDE 279
            QAR    + + +G+ YLH     +IIHRD+K SN+L+  D + KI+DFG++  F G D 
Sbjct: 137 DQARFYF-QDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 280 LQGNTKRIVGT 290
           L  NT   VGT
Sbjct: 193 LLSNT---VGT 200

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 95  KEKDGEGNDKSKDSWL---PLFSLASVSAAT----------------ENFSTQCKLGEGG 135
           KE+DGE         +   P  + ASV+A                  + +     +G G 
Sbjct: 8   KEEDGEDGSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGA 67
Query: 136 FGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRL---FGCC 188
           +G V   R  L GQ+VA+K++ N +   +T  K    E+ ++   +H +++ +       
Sbjct: 68  YGVVSSARRRLTGQQVAIKKIPN-AFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPT 126
Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
           +  GE   +Y  +     D+       + L     R  + + + +GL Y+H     ++IH
Sbjct: 127 VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQ-LLRGLKYMHS---AQVIH 182
Query: 249 RDLKASNILLDSDMNPKISDFGMAR 273
           RDLK SN+L++ +   KI DFGMAR
Sbjct: 183 RDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 95  KEKDGEGNDKSKDSWL---PLFSLASVSAAT----------------ENFSTQCKLGEGG 135
           KE+DGE         +   P  + ASV+A                  + +     +G G 
Sbjct: 7   KEEDGEDGSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGA 66
Query: 136 FGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRL---FGCC 188
           +G V   R  L GQ+VA+K++ N +   +T  K    E+ ++   +H +++ +       
Sbjct: 67  YGVVSSARRRLTGQQVAIKKIPN-AFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPT 125
Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
           +  GE   +Y  +     D+       + L     R  + + + +GL Y+H     ++IH
Sbjct: 126 VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQ-LLRGLKYMHS---AQVIH 181
Query: 249 RDLKASNILLDSDMNPKISDFGMAR 273
           RDLK SN+L++ +   KI DFGMAR
Sbjct: 182 RDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 67
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 124
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI++FG +
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS 158

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 11/148 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +GEG FG V++G  ++ +     VA+K   N +   + E F  E + + +  H H+V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G  I +    +I E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
            +HRD+ A N+L+ +    K+ DFG++R
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR 159

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           A E+F     LG+G FG VY  R      +   +V  K    ++G    + + E+ + + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSH 66
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L+H +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 123
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            Y H     R+IHRD+K  N+LL S    KI++FG +
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS 157

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 145
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 183

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 146
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 147 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 184

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 137
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 138 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 175

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 144
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KXQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG 181

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 131 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKL-QHRH 180
           LGEG FG V         K +      VAVK L + + +  L++  +EM ++  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------LGWQARVRI 227
           ++ L G C + G   +I  Y    +L  +L   +   +             + ++  V  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 138
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 139 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 176

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 39/189 (20%)
Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +G GGFG V+K +  ++G+   ++R+   + +     + E+  +AKL H ++V   GC  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIVHYNGCWD 75
Query: 190 -------EQGENILIYEYMPNKS----------LDVFLFYPKKKRLLGWQARVR------ 226
                     +++   +Y P  S          L + + +  K  L  W  + R      
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 227 -----IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
                + E I +G+ Y+H     ++IHRDLK SNI L      KI DFG+      D   
Sbjct: 136 VLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--- 189
Query: 282 GNTKRIVGT 290
           G   R  GT
Sbjct: 190 GKRTRSKGT 198

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 138
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 139 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 176

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 26  TIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 86  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 141
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 142 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 191

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++    Y+    ++  L+   K + L        +  I +GL Y+
Sbjct: 89  GINDIIRAPTIEQMKDV----YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++    Y+    ++  L+   K + L        +  I +GL Y+
Sbjct: 90  GINDIIRAPTIEQMKDV----YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 183

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 127
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 128 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 177

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLTEFKNEMM- 171
           S  A   +F     LG+G FG V+  R +    +G   A+K L   + +     + +M  
Sbjct: 22  SEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMER 81
Query: 172 -LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG 230
            ++A + H  +V+L      +G+  LI +++  +  D+F    K+        +  + E 
Sbjct: 82  DILADVNHPFVVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE- 138
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +A GL +LH    L II+RDLK  NILLD + + K++DFG+++
Sbjct: 139 LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 178

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 127
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 128 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG 177

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 150
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 151 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 200

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 137
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 187

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  I 
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIY 152
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
           + I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 153 Q-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 201

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 151
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 152 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMXG 201

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 181

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KXQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 181

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVA-----VKRLSNQSGQGLTEFKNEMMLIAK 175
           TE +    +LG+G F  V +  ++L GQE A      K+LS +  Q L   + E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL---EREARICRL 66
Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEGIAQG 234
           L+H ++VRL     E+G + LI++ +        LF     R    +A     I+ I + 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEA 122
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARIFGGDE 279
           +L+ HQ   + ++HR+LK  N+LL S +     K++DFG+A    G++
Sbjct: 123 VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG 181

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG 181

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN----QSGQGLTEFKNEMMLIAKLQ 177
           +NF     LG+G FG V   R+   G   AVK L      Q          + +L     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 178 HRHLVRLFGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQGL 235
           H  L +LF CC +  + +  + E++    L   +F+ +K R    +AR R     I   L
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEIISAL 137
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           ++LH      II+RDLK  N+LLD + + K++DFGM +
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 22/184 (11%)
Query: 119 SAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLTEFKNEMM 171
           S   +++    +LG G F  V K R    G+E A K +      S++ G    E + E+ 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++ +++H +++ L      + + +LI E +    L  F F  +K+ L   +A  + ++ I
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL--FDFLAEKESLTEDEA-TQFLKQI 117
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNI-LLDSDM-NPKIS--DFGMA-RIFGGDELQGNTKR 286
             G+ YLH     RI H DLK  NI LLD ++ NP+I   DFG+A +I  G+E     K 
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KN 170
Query: 287 IVGT 290
           I GT
Sbjct: 171 IFGT 174

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 140
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 178

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 11/148 (7%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +GEG FG V++G  ++ +     VA+K   N +   + E F  E + + +  H H+V+L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G  I +    +I E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 246 IIHRDLKASNILLDSDMNPKISDFGMAR 273
            +HRD+ A N+L+ +    K+ DFG++R
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSR 539

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 22/184 (11%)
Query: 119 SAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLTEFKNEMM 171
           S   +++    +LG G F  V K R    G+E A K +      S++ G    E + E+ 
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++ +++H +++ L      + + +LI E +    L  F F  +K+ L   +A  + ++ I
Sbjct: 82  ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL--FDFLAEKESLTEDEA-TQFLKQI 138
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNI-LLDSDM-NPKIS--DFGMA-RIFGGDELQGNTKR 286
             G+ YLH     RI H DLK  NI LLD ++ NP+I   DFG+A +I  G+E     K 
Sbjct: 139 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KN 191
Query: 287 IVGT 290
           I GT
Sbjct: 192 IFGT 195

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   ++    + +EV   ++  +S         +   E+ +   L H+H+V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
              +     ++ E    +SL     + ++K L   +AR   +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 247 IHRDLKASNILLDSDMNPKISDFGMA 272
           IHRDLK  N+ L+ D+  KI DFG+A
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 140
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDH 178

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 40/183 (21%)
Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           +G GGFG V+K +  ++G+   +KR+   + +     + E+  +AKL H ++V   GC  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVHYNGCW- 73
Query: 190 EQGENILIYEYMPNKS-----------LDVFLFYPKKKRLLGWQARVR-----------I 227
             G     ++Y P  S           L + + +  K  L  W  + R           +
Sbjct: 74  -DG-----FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRI 287
            E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      D   G   R 
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRXRS 181
Query: 288 VGT 290
            GT
Sbjct: 182 KGT 184

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   ++    + +EV   ++  +S         +   E+ +   L H+H+V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
              +     ++ E    +SL     + ++K L   +AR   +  I  G  YLH   R R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 160
Query: 247 IHRDLKASNILLDSDMNPKISDFGMA 272
           IHRDLK  N+ L+ D+  KI DFG+A
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA 186

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 21  TIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 136
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG 186

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   ++    + +EV   ++  +S         +   E+ +   L H+H+V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
              +     ++ E    +SL     + ++K L   +AR   +  I  G  YLH   R R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 142
Query: 247 IHRDLKASNILLDSDMNPKISDFGMA 272
           IHRDLK  N+ L+ D+  KI DFG+A
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLA 168

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K  +L     +  +I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCAKLTDDHVQF-LI 127
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 128 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 177

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   ++    + +EV   ++  +S         +   E+ +   L H+H+V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
              +     ++ E    +SL     + ++K L   +AR   +  I  G  YLH   R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 162
Query: 247 IHRDLKASNILLDSDMNPKISDFGMA 272
           IHRDLK  N+ L+ D+  KI DFG+A
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA 188

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 140
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 178

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   ++    + +EV   ++  +S         +   E+ +   L H+H+V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
              +     ++ E    +SL     + ++K L   +AR   +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 247 IHRDLKASNILLDSDMNPKISDFGMA 272
           IHRDLK  N+ L+ D+  KI DFG+A
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 8/149 (5%)
Query: 123 ENFSTQCKLGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           E  +   K+GEG  G V        G++VAVK++  +  Q      NE++++    H ++
Sbjct: 45  EYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNV 104
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V ++   +   E  ++ E++   +L   + + +    +  +    +   + + L YLH  
Sbjct: 105 VDMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQ 160
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFG 270
               +IHRD+K+ +ILL SD   K+SDFG
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFG 186

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 130 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L N++       E   E  ++ +L + ++VR+
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C E    +L+ E      L+ +L   ++ R +  +  + ++  ++ G+ YL + +  
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 489
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +HRDL A N+LL +    KISDFG+++    DE
Sbjct: 490 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   ++    + +EV   ++  +S         +   E+ +   L H+H+V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
              +     ++ E    +SL     + ++K L   +AR   +  I  G  YLH   R R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 136
Query: 247 IHRDLKASNILLDSDMNPKISDFGMA 272
           IHRDLK  N+ L+ D+  KI DFG+A
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA 162

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KCQHLSNDHICYFLYQILRGLKYI 144
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      LN   VA++++S    Q   +    E+ ++ + +H +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 144
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 24/177 (13%)
Query: 112 LFSLASVSAATENFSTQC-------KLGEGGFGPVYKGR-LLNGQEVAVKRL-----SNQ 158
           L S A +S   +NF  +        +LG G +G V K R + +GQ +AVKR+     S +
Sbjct: 33  LDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE 92
Query: 159 SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPK---K 215
             + L +    M  +        V  +G    +G+  +  E M + SLD F  Y +   K
Sbjct: 93  QKRLLMDLDISMRTV---DCPFTVTFYGALFREGDVWICMELM-DTSLDKF--YKQVIDK 146
Query: 216 KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            + +      +I   I + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++
Sbjct: 147 GQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 201

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 140
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 178

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 138
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG 188

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 130 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L N++       E   E  ++ +L + ++VR+
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C E    +L+ E      L+ +L   ++ R +  +  + ++  ++ G+ YL + +  
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 490
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +HRDL A N+LL +    KISDFG+++    DE
Sbjct: 491 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 524

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 142
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 180

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 130 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L N++       E   E  ++ +L + ++VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C E    +L+ E      L+ +L   ++ R +  +  + ++  ++ G+ YL + +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +HRDL A N+LL +    KISDFG+++    DE
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 165

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++    Y+    ++  L+   K + L        +  I +GL Y+
Sbjct: 93  GINDIIRAPTIEQMKDV----YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 148
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 149 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 186

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 136
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG 186

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++    Y+    ++  L+   K + L        +  I +GL Y+
Sbjct: 85  GINDIIRAPTIEQMKDV----YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 178

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 138
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG 188

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 138
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG 188

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 130 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L N++       E   E  ++ +L + ++VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C E    +L+ E      L+ +L   ++ R +  +  + ++  ++ G+ YL + +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +HRDL A N+LL +    KISDFG+++    DE
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 181

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 130 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L N++       E   E  ++ +L + ++VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C E    +L+ E      L+ +L   ++ R +  +  + ++  ++ G+ YL + +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +HRDL A N+LL +    KISDFG+++    DE
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 181

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 142
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 143 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG 192

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 160
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 161 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 198

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 130 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L N++       E   E  ++ +L + ++VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C E    +L+ E      L+ +L   ++ R +  +  + ++  ++ G+ YL + +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +HRDL A N+LL +    KISDFG+++    DE
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 165

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 127
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 128 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 177

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQ-EVAVKRL--SNQSGQGLT-EFKNEMMLIAKLQH 178
           ++F     LG+G FG VY  R       VA+K L  S    +G+  + + E+ + A L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            +++RL+    ++    LI EY P   L   L   +K      Q    I+E +A  L+Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYC 139
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
           H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFG 168

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 130 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L N++       E   E  ++ +L + ++VR+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C E    +L+ E      L+ +L   ++ R +  +  + ++  ++ G+ YL + +  
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 145
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +HRDL A N+LL +    KISDFG+++    DE
Sbjct: 146 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 179

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 128
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 179

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 130 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L N++       E   E  ++ +L + ++VR+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C E    +L+ E      L+ +L   ++ R +  +  + ++  ++ G+ YL + +  
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 125
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +HRDL A N+LL +    KISDFG+++    DE
Sbjct: 126 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 159

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 128
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 129 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 178

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 130 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L N++       E   E  ++ +L + ++VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C E    +L+ E      L+ +L   ++ R +  +  + ++  ++ G+ YL + +  
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +HRDL A N+LL +    KISDFG+++    DE
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 181

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 24/161 (14%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLF---- 185
           LG GG G V+     +  + VA+K++     Q +     E+ +I +L H ++V++F    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 186 ----------GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
                     G   E     ++ EYM     +V     ++  LL   AR+ + + + +GL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL----EQGPLLEEHARLFMYQ-LLRGL 133
Query: 236 LYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIF 275
            Y+H  +   ++HRDLK +N+ +++ D+  KI DFG+ARI 
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H +++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ +  ++    L   L    K + L        +  I +GL Y+
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLL----KTQHLSNDHICYFLYQILRGLKYI 160
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 161 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 198

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 14  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 74  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 129
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 130 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 179

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 128
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 179

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 133
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 183

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 181

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 128
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 129 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 178

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 130 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQSGQGL--TEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L N++       E   E  ++ +L + ++VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C E    +L+ E      L+ +L   ++ R +  +  + ++  ++ G+ YL + +  
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 127
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +HRDL A N+LL +    KISDFG+++    DE
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 133
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 183

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 133
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-HTDDEMTG 183

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 142
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 143 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 192

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 143
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 144 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 193

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  I 
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIY 151
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
           + I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 152 Q-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 200

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 181

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 88/173 (50%), Gaps = 22/173 (12%)
Query: 130 KLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +LG G F  V K R    G+E A K +      S++ G    E + E+ ++ +++H +++
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            L      + + +LI E +    L  F F  +K+ L   +A  + ++ I  G+ YLH   
Sbjct: 79  TLHDIFENKTDVVLILELVSGGEL--FDFLAEKESLTEDEA-TQFLKQILDGVHYLHSK- 134
Query: 243 RLRIIHRDLKASNI-LLDSDM-NPKIS--DFGMA-RIFGGDELQGNTKRIVGT 290
             RI H DLK  NI LLD ++ NP+I   DFG+A +I  G+E     K I GT
Sbjct: 135 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KNIFGT 181

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 136
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 186

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 15  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 75  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 130
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 131 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 180

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 138
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 188

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 181

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 181

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 181

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  I 
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIY 152
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
           + I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 153 Q-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 201

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 137
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-HTDDEMTG 187

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 181

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 133
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 183

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 143
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 144 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 193

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 143
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 144 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 193

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 181

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 137
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 187

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 181

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 137
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 187

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 154
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 155 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 204

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 136
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 186

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQH 178
           T+ +     +G+G F  V +  +L  G E A K ++ +  S +   + + E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEGIAQGLLY 237
            ++VRL     E+G + L+++ +    L    F     R    +A     I+ I + +L+
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARIFGGDE 279
            HQ   + ++HRDLK  N+LL S       K++DFG+A    GD+
Sbjct: 119 CHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ 160

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  I 
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIY 155
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
           + I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    DE+ G
Sbjct: 156 Q-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMXG 204

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++   +H +++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 142
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 180

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KSQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+ R    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-HTDDEMTG 181

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
           ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++   +H +++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 183 ----RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                +    IEQ +++ I + +    L   L    K + L        +  I +GL Y+
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 142
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDH 180

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 82/189 (43%), Gaps = 34/189 (17%)
Query: 131 LGEGGFGPVYKGRLLN-GQE-----VAVKRLSNQSGQGLTE-FKNEMMLIAKL-QHRHLV 182
           LG G FG V +      G+E     VAVK L + +     E   +E+ +++ L QH ++V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPKKK---------RLLGWQ 222
            L G C   G  ++I EY     L  FL             P +          R L  +
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE--- 279
             +     +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D    
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 280 LQGNTKRIV 288
           ++GN +  V
Sbjct: 216 VKGNARLPV 224

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKR-LSNQSGQGLTEFK-NEMMLIAKLQHR 179
           E +    K+GEG +G V+K R  + GQ VA+K+ L ++    + +    E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           +LV L      +    L++EY  +  L     Y   +R +       I     Q + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCH 119
Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 277
           +++    IHRD+K  NIL+      K+ DFG AR+  G
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 18/169 (10%)
Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE---FKNEMMLIAKLQHRHLVRLF 185
           KLG G +G V   +  L G E A+K +   S    +      +E+ ++ +L H ++++L+
Sbjct: 11  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 186 GCCIEQGENILIYE-YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
               ++    L+ E Y   +  D  +   K   +    A V I++ +  G  YLH+++  
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV---DAAV-IMKQVLSGTTYLHKHN-- 124
Query: 245 RIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            I+HRDLK  N+LL+S   D   KI DFG++  F   E+ G  K  +GT
Sbjct: 125 -IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGT 169

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSNQSGQGLT--EFKNEMMLIAKLQ 177
           + T  +LG G F  V K R     L    +   KR +  S +G++  + + E+ ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGEL--FDFLAEKESLTEEEA-TEFLKQILNGVYY 129
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMA-RIFGGDELQGNTKRIVGT 290
           LH    L+I H DLK  NI+L     P    KI DFG+A +I  G+E     K I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGT 180

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRH 180
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +    +
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V  +G     GE  +  E+M   SLD  L   KK   +  Q   ++   + +GL YL +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDELQGNTKRIVGT 290
             + +I+HRD+K SNIL++S    K+ DFG        MA  F G     + +R+ GT
Sbjct: 185 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 240

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQH 178
           +E +    KLG G +G V   R  +   E A+K  R ++ S    ++   E+ ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 179 RHLVRLFGCCIEQGENILIYE-YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
            ++++L+    ++    L+ E Y   +  D  +   K   +    A V II+ +  G+ Y
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV---DAAV-IIKQVLSGVTY 151
Query: 238 LHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           LH+++   I+HRDLK  N+LL+S   D   KI DFG++ +F   E Q   K  +GT
Sbjct: 152 LHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGT 201

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q      NE++++   QH ++
Sbjct: 34  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V ++   +   E  ++ E++   +L   + + +    +  +    +   + Q L  LH  
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 146
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFG 270
               +IHRD+K+ +ILL  D   K+SDFG
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFG 172

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRH 180
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +    +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V  +G     GE  +  E+M   SLD  L   KK   +  Q   ++   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDELQGNTKRIVGT 290
             + +I+HRD+K SNIL++S    K+ DFG        MA  F G     + +R+ GT
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q      NE++++   QH ++
Sbjct: 23  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V ++   +   E  ++ E++   +L   + + +    +  +    +   + Q L  LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 135
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFG 270
               +IHRD+K+ +ILL  D   K+SDFG
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFG 161

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q      NE++++   QH ++
Sbjct: 154 DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V ++   +   E  ++ E++   +L   + + +    +  +    +   + Q L  LH  
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 266
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFG 270
               +IHRD+K+ +ILL  D   K+SDFG
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFG 292

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRH 180
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +    +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V  +G     GE  +  E+M   SLD  L   KK   +  Q   ++   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDELQGNTKRIVGT 290
             + +I+HRD+K SNIL++S    K+ DFG        MA  F G     + +R+ GT
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           +NF    K+GEG  G V    +  +G+ VAVK++  +  Q      NE++++   QH ++
Sbjct: 27  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V ++   +   E  ++ E++   +L   + + +    +  +    +   + Q L  LH  
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 139
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFG 270
               +IHRD+K+ +ILL  D   K+SDFG
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFG 165

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 85/169 (50%), Gaps = 18/169 (10%)
Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE---FKNEMMLIAKLQHRHLVRLF 185
           KLG G +G V   +  L G E A+K +   S    +      +E+ ++ +L H ++++L+
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 186 GCCIEQGENILIYE-YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
               ++    L+ E Y   +  D  +    +++     A V I++ +  G  YLH+++  
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIIL---RQKFSEVDAAV-IMKQVLSGTTYLHKHN-- 141
Query: 245 RIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            I+HRDLK  N+LL+S   D   KI DFG++  F   E+ G  K  +GT
Sbjct: 142 -IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGT 186

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRH 180
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +    +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V  +G     GE  +  E+M   SLD  L   KK   +  Q   ++   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDELQGNTKRIVGT 290
             + +I+HRD+K SNIL++S    K+ DFG        MA  F G     + +R+ GT
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 17/165 (10%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL-----SNQSGQGLTEFKNEM 170
           S+    ++     +LG G +G V K R + +GQ +AVKR+     S +  + L +    M
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 171 MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRI 227
             +        V  +G    +G+  +  E M + SLD F  Y +   K + +      +I
Sbjct: 61  RTV---DCPFTVTFYGALFREGDVWICMELM-DTSLDKF--YKQVIDKGQTIPEDILGKI 114
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
              I + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q      NE++++   QH ++
Sbjct: 32  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V ++   +   E  ++ E++   +L   + + +    +  +    +   + Q L  LH  
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 144
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFG 270
               +IHRD+K+ +ILL  D   K+SDFG
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFG 170

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           +NF    K+GEG  G V    + + G+ VAVK++  +  Q      NE++++   QH ++
Sbjct: 77  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V ++   +   E  ++ E++   +L   + + +    +  +    +   + Q L  LH  
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ 189
Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFG 270
               +IHRD+K+ +ILL  D   K+SDFG
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFG 215

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI D+G+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-HTDDEMTG 181

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 75/170 (44%), Gaps = 27/170 (15%)
Query: 130 KLGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGC 187
           KLG G FG V+      +G E  +K ++    Q  + + + E+ ++  L H +++++F  
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 188 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR---------VRIIEGIAQGLLYL 238
             +     ++ E      L         +R++  QAR           +++ +   L Y 
Sbjct: 89  FEDYHNMYIVMETCEGGEL--------LERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNT 284
           H      ++H+DLK  NIL   D +P    KI DFG+A +F  DE   N 
Sbjct: 141 HSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA 186

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G +G V   Y  RL   Q+VAVK+LS   QS         E+ L+  L+H +++ L 
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 186 -----GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
                   IE    + +   +    L+  +    K + L  +    ++  + +GL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                IIHRDLK SN+ ++ D   +I DFG+AR
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 19/173 (10%)
Query: 114 SLASVSAATENFSTQC-----KLGEGGFGPVYKGRLLNG--------QEVAVKRLSNQSG 160
           S  SV+   E    +C      LG+GG+G V++ R + G         +V  K +  ++ 
Sbjct: 3   SETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA 62
Query: 161 QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG 220
           +     K E  ++ +++H  +V L       G+  LI EY+    L  F+   ++   + 
Sbjct: 63  KDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFME 120
Query: 221 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             A   + E I+  L +LHQ     II+RDLK  NI+L+   + K++DFG+ +
Sbjct: 121 DTACFYLAE-ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 87/178 (48%), Gaps = 12/178 (6%)
Query: 115 LASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLI 173
           + SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q         NE++++
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIA 232
            + ++ ++V      +   E  ++ EY+   SL DV       +  +       +     
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECL 127
Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           Q L +LH     ++IHR++K+ NILL  D + K++DFG       ++ + +T  +VGT
Sbjct: 128 QALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 180

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRH 180
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +    +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V  +G     GE  +  E+M   SLD  L   KK   +  Q   ++   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDELQGNTKRIVGT 290
             + +I+HRD+K SNIL++S    K+ DFG        MA  F G     + +R+ GT
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 83/170 (48%), Gaps = 20/170 (11%)
Query: 121 ATENFS-----TQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQS-GQGL-TEFKNEMML 172
           + ENF+     T  +LG G F  V +      GQE A K L  +  GQ    E  +E+ +
Sbjct: 22  SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAV 81
Query: 173 I--AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVF-LFYPKKKRLLGWQARVRIIE 229
           +  AK   R ++ L        E ILI EY      ++F L  P+   ++     +R+I+
Sbjct: 82  LELAKSCPR-VINLHEVYENTSEIILILEYAAGG--EIFSLCLPELAEMVSENDVIRLIK 138
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARIFG 276
            I +G+ YLHQ +   I+H DLK  NILL S     + KI DFGM+R  G
Sbjct: 139 QILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRH 180
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +    +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V  +G     GE  +  E+M   SLD  L   KK   +  Q   ++   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDELQGNTKRIVGT 290
             + +I+HRD+K SNIL++S    K+ DFG        MA  F G     + +R+ GT
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 19/173 (10%)
Query: 114 SLASVSAATENFSTQC-----KLGEGGFGPVYKGRLLNG--------QEVAVKRLSNQSG 160
           S  SV+   E    +C      LG+GG+G V++ R + G         +V  K +  ++ 
Sbjct: 3   SETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA 62
Query: 161 QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG 220
           +     K E  ++ +++H  +V L       G+  LI EY+    L  F+   ++   + 
Sbjct: 63  KDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFME 120
Query: 221 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             A   + E I+  L +LHQ     II+RDLK  NI+L+   + K++DFG+ +
Sbjct: 121 DTACFYLAE-ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 24/172 (13%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL---TEFKNEMMLIAKLQHRHLVRLFGC 187
           +G+G +G V++G L +G+ VAVK  S++  Q     TE  N ++L    +H +++     
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNILGFIAS 70
Query: 188 CI----EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH---- 239
            +       +  LI  Y  + SL  FL    +++ L     +R+    A GL +LH    
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 240 -QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF--GGDELQ-GNTKRI 287
               +  I HRD K+ N+L+ S++   I+D G+A +   G D L  GN  R+
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV 178

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQ--------SGQGLTEFKNEMML 172
           ++ +ST   LG G FG V+        +EV VK +  +            L +   E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 232
           +++++H +++++      QG   L+ E      LD+F F  +  RL        +   I 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFIDRHPRL-----DEPLASYIF 136
Query: 233 QGLLYLHQYSRLR-IIHRDLKASNILLDSDMNPKISDFGMA 272
           + L+    Y RL+ IIHRD+K  NI++  D   K+ DFG A
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 87  FRRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLN 146
           F R+     +   + +DK+  S     +   +S     +S   ++G GG   V++     
Sbjct: 25  FERQHMDSPDLGTDDDDKASSS-----ANECISVKGRIYSILKQIGSGGSSKVFQVLNEK 79
Query: 147 GQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFGCCIEQGENILIYEYMP 202
            Q  A+K   L     Q L  ++NE+  + KLQ     ++RL+   I    +  IY  M 
Sbjct: 80  KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT---DQYIYMVME 136
Query: 203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 262
             ++D+  +  KKK +  W+ R    + + + +  +HQ+    I+H DLK +N L+   M
Sbjct: 137 CGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM 192
Query: 263 NPKISDFGMARIFGGDELQGNTKRIV 288
             K+ DFG+A     +++Q +T  +V
Sbjct: 193 -LKLIDFGIA-----NQMQPDTTSVV 212

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 87  FRRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLN 146
           F R+     +   + +DK+  S     +   +S     +S   ++G GG   V++     
Sbjct: 25  FERQHMDSPDLGTDDDDKASSS-----ANECISVKGRIYSILKQIGSGGSSKVFQVLNEK 79
Query: 147 GQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFGCCIEQGENILIYEYMP 202
            Q  A+K   L     Q L  ++NE+  + KLQ     ++RL+   I    +  IY  M 
Sbjct: 80  KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT---DQYIYMVME 136
Query: 203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 262
             ++D+  +  KKK +  W+ R    + + + +  +HQ+    I+H DLK +N L+   M
Sbjct: 137 CGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM 192
Query: 263 NPKISDFGMARIFGGDELQGNTKRIV 288
             K+ DFG+A     +++Q +T  +V
Sbjct: 193 -LKLIDFGIA-----NQMQPDTTSVV 212

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 87  FRRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLN 146
           F R+     +   + +DK+  S     +   +S     +S   ++G GG   V++     
Sbjct: 25  FERQHMDSPDLGTDDDDKASSS-----ANECISVKGRIYSILKQIGSGGSSKVFQVLNEK 79
Query: 147 GQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFGCCIEQGENILIYEYMP 202
            Q  A+K   L     Q L  ++NE+  + KLQ     ++RL+   I    +  IY  M 
Sbjct: 80  KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT---DQYIYMVME 136
Query: 203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 262
             ++D+  +  KKK +  W+ R    + + + +  +HQ+    I+H DLK +N L+   M
Sbjct: 137 CGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM 192
Query: 263 NPKISDFGMARIFGGDELQGNTKRIV 288
             K+ DFG+A     +++Q +T  +V
Sbjct: 193 -LKLIDFGIA-----NQMQPDTTSVV 212

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRH 180
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +    +
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V  +G     GE  +  E+M   SLD  L   KK   +  Q   ++   + +GL YL +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDELQGNTKRIVGT 290
             + +I+HRD+K SNIL++S    K+ DFG        MA  F G     + +R+ GT
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 205

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 120 AATENFSTQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQSGQGLTEFKNEMM--LI 173
           A    F     LG+G FG V+  + ++G +     A+K L   + +     + +M   ++
Sbjct: 21  ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
            ++ H  +V+L      +G+  LI +++  +  D+F    K+        +  + E +A 
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LAL 137
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            L +LH    L II+RDLK  NILLD + + K++DFG+++
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRH 180
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +    +
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V  +G     GE  +  E+M   SLD  L   KK   +  Q   ++   + +GL YL +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDELQGNTKRIVGT 290
             + +I+HRD+K SNIL++S    K+ DFG        MA  F G     + +R+ GT
Sbjct: 142 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 197

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQHRH 180
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +    +
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V  +G     GE  +  E+M   SLD  L   KK   +  Q   ++   + +GL YL +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDELQGNTKRIVGT 290
             + +I+HRD+K SNIL++S    K+ DFG        MA  F G     + +R+ GT
Sbjct: 126 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGT 181

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 125 FSTQCKLGEGGFGPVYKGRLLNGQEV--AVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           ++ +  +G G +G V K  +  G  +  A K++     + +  FK E+ ++  L H +++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+    +  +  L+ E      L   + +   KR+       RI++ +   + Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 243 RLRIIHRDLKASNILL--DSDMNP-KISDFGMARIF 275
           +L + HRDLK  N L   DS  +P K+ DFG+A  F
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 125 FSTQCKLGEGGFGPVYKGRLLNGQEV--AVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           ++ +  +G G +G V K  +  G  +  A K++     + +  FK E+ ++  L H +++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+    +  +  L+ E      L   + +   KR+       RI++ +   + Y H   
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCH--- 140
Query: 243 RLRIIHRDLKASNILL--DSDMNP-KISDFGMARIF 275
           +L + HRDLK  N L   DS  +P K+ DFG+A  F
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 176

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 121 ATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR 179
             E+     ++G G +G V K     +GQ +AVKR+ +   +   E K  +M +  +   
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRS 77
Query: 180 ----HLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQ 233
               ++V+ +G    +G+  +  E M + S D F    Y     ++  +   +I     +
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            L +L +   L+IIHRD+K SNILLD   N K+ DFG++
Sbjct: 137 ALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 34/177 (19%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL---TEFKNEMML---------IAKLQH 178
           +G+G +G V++G    G+ VAVK  S++  +     TE  N +ML          + +  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 103
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
           RH            E   +Y+Y+   +LD               + +RI+  IA GL +L
Sbjct: 104 RHSSTQLWLITHYHEMGSLYDYLQLTTLDTV-------------SCLRIVLSIASGLAHL 150
Query: 239 H-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ---GNTKRI 287
           H        +  I HRDLK+ NIL+  +    I+D G+A +      Q   GN  R+
Sbjct: 151 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 207

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 75/163 (46%), Gaps = 25/163 (15%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK---KRLLGWQARVRIIEG 230
           +V L G C + G  ++ I E+    +L  +L      F P K   K  L  +  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 17/176 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIA 174
           S+S     +S   ++G GG   V++      Q  A+K   L     Q L  ++NE+  + 
Sbjct: 22  SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 175 KLQHRH--LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 232
           KLQ     ++RL+   I       IY  M   ++D+  +  KKK +  W+ R    + + 
Sbjct: 82  KLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNML 137
Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
           + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     +++Q +T  +V
Sbjct: 138 EAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVV 184

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI DF +AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-HTDDEMTG 181

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 120 AATENFSTQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQSGQGLTEFKNEMM--LI 173
           A    F     LG+G FG V+  + ++G +     A+K L   + +     + +M   ++
Sbjct: 21  ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
            ++ H  +V+L      +G+  LI +++  +  D+F    K+        +  + E +A 
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LAL 137
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            L +LH    L II+RDLK  NILLD + + K++DFG+++
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 120 AATENFSTQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQSGQGLTEFKNEMM--LI 173
           A    F     LG+G FG V+  + ++G +     A+K L   + +     + +M   ++
Sbjct: 22  ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 81
Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
            ++ H  +V+L      +G+  LI +++  +  D+F    K+        +  + E +A 
Sbjct: 82  VEVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LAL 138
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            L +LH    L II+RDLK  NILLD + + K++DFG+++
Sbjct: 139 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 175

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 34/177 (19%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL---TEFKNEMML---------IAKLQH 178
           +G+G +G V++G    G+ VAVK  S++  +     TE  N +ML          + +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
           RH            E   +Y+Y+   +LD               + +RI+  IA GL +L
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYLQLTTLDTV-------------SCLRIVLSIASGLAHL 121
Query: 239 H-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ---GNTKRI 287
           H        +  I HRDLK+ NIL+  +    I+D G+A +      Q   GN  R+
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 34/177 (19%)
Query: 131 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL---TEFKNEMML---------IAKLQH 178
           +G+G +G V++G    G+ VAVK  S++  +     TE  N +ML          + +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
           RH            E   +Y+Y+   +LD               + +RI+  IA GL +L
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYLQLTTLDTV-------------SCLRIVLSIASGLAHL 121
Query: 239 H-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ---GNTKRI 287
           H        +  I HRDLK+ NIL+  +    I+D G+A +      Q   GN  R+
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLVRLFGCC 188
           LG+G    V++GR    G   A+K  +N S     + +  E  ++ KL H+++V+LF   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 189 IEQG--ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
            E      +LI E+ P  SL   L  P     L     + ++  +  G+ +L +     I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 247 IHRDLKASNILL----DSDMNPKISDFGMARIFGGDE 279
           +HR++K  NI+     D     K++DFG AR    DE
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLTEFKN---EMMLIAKL 176
             +N+  +  +G G +G VY     N ++ VA+K++ N+  + L + K    E+ ++ +L
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLIDCKRILREITILNRL 82
Query: 177 QHRHLVRLFGCCIEQG-----ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           +  +++RL+   I        E  ++ E   +    +F    K    L  +    I+  +
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF----KTPIFLTEEHIKTILYNL 138
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             G  ++H+     IIHRDLK +N LL+ D + K+ DFG+AR    ++
Sbjct: 139 LLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 11/146 (7%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCC 188
           LGEG +  V     L NG+E AVK +  Q+G   +    E+  + + Q +++++ L    
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
            +     L++E +   S+   L + +K++    +   R++  +A  L +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 249 RDLKASNILLDSD--MNP-KISDFGM 271
           RDLK  NIL +S   ++P KI DF +
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDL 160

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 123 ENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHR 179
           + + +   +G G +G V       +G++VA+K+LS   QS         E++L+  +QH 
Sbjct: 42  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 101
Query: 180 HLVRLFGCCIEQGENILIYEY---MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA---- 232
           +++ L             Y++   MP    D+       ++++G +     I+ +     
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL-------QKIMGMEFSEEKIQYLVYQML 154
Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +GL Y+H      ++HRDLK  N+ ++ D   KI DFG+AR
Sbjct: 155 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEM 170
           AS S   ++F     +G G +  V   RL     +   +V  K L N   + +   + E 
Sbjct: 13  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTEK 71
Query: 171 MLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE 229
            +  +   H  LV L  C   +     + EY+    L   +F+ +++R L  +       
Sbjct: 72  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA 128
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            I+  L YLH+     II+RDLK  N+LLDS+ + K++D+GM +
Sbjct: 129 EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 169

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 17/168 (10%)
Query: 125 FSTQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRH-- 180
           +S   ++G GG   V++      Q  A+K   L     Q L  ++NE+  + KLQ     
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           ++RL+   I       IY  M   ++D+  +  KKK +  W+ R    + + + +  +HQ
Sbjct: 71  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 126
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
           +    I+H DLK +N L+   M  K+ DFG+A     +++Q +T  +V
Sbjct: 127 HG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVV 165

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 113 FSLASVSAATENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQ--SGQGLTEFKNE 169
           F + + +  ++N+  + +LG+G F  V +      G E A K ++ +  S +   + + E
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 170 MMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--DVFL--FYPKKKRLLGWQARV 225
             +  KLQH ++VRL     E+  + L+++ +    L  D+    FY +           
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-------AS 131
Query: 226 RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMA 272
             I+ I + + Y H      I+HR+LK  N+LL S       K++DFG+A
Sbjct: 132 HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SNQSGQGLT-EFKNEMMLIAKL 176
             ++F     LG+G FG VY  R    + + A+K L  S    +G+  + + E+ + + L
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
           +H +++R++    ++    L+ E+ P   L   L   +K      Q     +E +A  L 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALH 128
Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
           Y H+    ++IHRD+K  N+L+      KI+DFG
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFG 159

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/61 (40%), Positives = 37/61 (60%), Gaps = 3/61 (4%)
Query: 212 YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
           Y  +K  L  +   +I+  + + +  LH   +L I+HRDLK  NILLD DMN K++DFG 
Sbjct: 101 YLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 157
Query: 272 A 272
           +
Sbjct: 158 S 158

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/61 (40%), Positives = 37/61 (60%), Gaps = 3/61 (4%)
Query: 212 YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
           Y  +K  L  +   +I+  + + +  LH   +L I+HRDLK  NILLD DMN K++DFG 
Sbjct: 114 YLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 272 A 272
           +
Sbjct: 171 S 171

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 76/170 (44%), Gaps = 27/170 (15%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 94
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK-----KRLLGWQARVRII 228
           +V L G C + G  ++ I E+    +L  +L      F P K     K  L  +  +   
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
             +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SNQSGQGLT-EFKNEMMLIAKL 176
             ++F     LG+G FG VY  R    + + A+K L  S    +G+  + + E+ + + L
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 72
Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
           +H +++R++    ++    L+ E+ P   L   L   +K      Q     +E +A  L 
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALH 129
Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
           Y H+    ++IHRD+K  N+L+      KI+DFG
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/61 (40%), Positives = 37/61 (60%), Gaps = 3/61 (4%)
Query: 212 YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 271
           Y  +K  L  +   +I+  + + +  LH   +L I+HRDLK  NILLD DMN K++DFG 
Sbjct: 114 YLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 272 A 272
           +
Sbjct: 171 S 171

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 17/175 (9%)
Query: 118 VSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAK 175
           +S     +S   ++G GG   V++      Q  A+K   L     Q L  ++NE+  + K
Sbjct: 7   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 66
Query: 176 LQHRH--LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           LQ     ++RL+   I       IY  M   ++D+  +  KKK +  W+ R    + + +
Sbjct: 67  LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLE 122
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     +++Q +T  +V
Sbjct: 123 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVV 168

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 20/178 (11%)
Query: 113 FSLASVSAATENFSTQCK-LGEGGFGPVYKGRLLN---GQEVAVK-----RLSNQSGQGL 163
             +A      E+    C+ +G+G F  V   R +N   GQ+ AVK     + ++  G   
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGAFSVVR--RCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 164 TEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQA 223
            + K E  +   L+H H+V L       G   +++E+M    L  F    +      +  
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL-CFEIVKRADAGFVYSE 129
Query: 224 RV--RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP---KISDFGMARIFG 276
            V    +  I + L Y H  +   IIHRD+K  N+LL S  N    K+ DFG+A   G
Sbjct: 130 AVASHYMRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG 184

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLVRLFGCC 188
           LG+G    V++GR    G   A+K  +N S     + +  E  ++ KL H+++V+LF   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 189 IEQG--ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
            E      +LI E+ P  SL   L  P     L     + ++  +  G+ +L +     I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 247 IHRDLKASNILL----DSDMNPKISDFGMARIFGGDE 279
           +HR++K  NI+     D     K++DFG AR    DE
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 130 KLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           +LG G FG V++      G+    K ++          KNE+ ++ +L H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
            ++ E +LI E++    L  F     +   +     +  +    +GL ++H++S   I+H
Sbjct: 118 EDKYEMVLILEFLSGGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVH 172
Query: 249 RDLKASNILLDSD--MNPKISDFGMARIFGGDEL 280
            D+K  NI+ ++    + KI DFG+A     DE+
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     +G G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EYMP    D+F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     K++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGT 201

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 17/175 (9%)
Query: 118 VSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAK 175
           +S     +S   ++G GG   V++      Q  A+K   L     Q L  ++NE+  + K
Sbjct: 3   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 62
Query: 176 LQHRH--LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           LQ     ++RL+   I       IY  M   ++D+  +  KKK +  W+ R    + + +
Sbjct: 63  LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLE 118
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     +++Q +T  +V
Sbjct: 119 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVV 164

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G +G V   Y  RL   Q+VAVK+LS   QS         E+ L+  L+H +++ L 
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 186 -----GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
                   IE    + +   +    L+  +    K + L  +    ++  + +GL Y+H 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                IIHRDLK SN+ ++ D   +I DFG+AR
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           +G G +G V   Y  RL   Q+VAVK+LS   QS         E+ L+  L+H +++ L 
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 186 -----GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
                   IE    + +   +    L+  +    K + L  +    ++  + +GL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                IIHRDLK SN+ ++ D   +I DFG+AR
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     +G G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EYMP    D+F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     K++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGT 201

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEM 170
           AS S   ++F     +G G +  V   RL     +    V  K L N   + +   + E 
Sbjct: 45  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEK 103
Query: 171 MLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE 229
            +  +   H  LV L  C   +     + EY+     D+     ++++L    AR    E
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYV--NGGDLMFHMQRQRKLPEEHARFYSAE 161
Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            I+  L YLH+     II+RDLK  N+LLDS+ + K++D+GM +
Sbjct: 162 -ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 13/162 (8%)
Query: 118 VSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMM----L 172
           +    E+F     LG+G FG V+        Q  A+K L         + +  M+    L
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 173 IAKLQHRHLVRLFGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
               +H  L  +F C  +  EN+  + EY+    L   +++ +                I
Sbjct: 73  SLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 128
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             GL +LH      I++RDLK  NILLD D + KI+DFGM +
Sbjct: 129 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 167

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 123 ENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHR 179
           + + +   +G G +G V       +G++VA+K+LS   QS         E++L+  +QH 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 180 HLVRLFGCCIEQGENILIYEY---MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA---- 232
           +++ L             Y++   MP    D+       ++++G +     I+ +     
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL-------QKIMGLKFSEEKIQYLVYQML 136
Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +GL Y+H      ++HRDLK  N+ ++ D   KI DFG+AR
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 12/178 (6%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIA 174
           S+S     +S   ++G GG   V++      Q  A+K   L     Q L  ++NE+  + 
Sbjct: 22  SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 175 KLQHRH--LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 232
           KLQ     ++RL+   I       IY  M   ++D+  +  KKK +  W+ R    + + 
Sbjct: 82  KLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNML 137
Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     D         VGT
Sbjct: 138 EAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGT 191

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 75/163 (46%), Gaps = 25/163 (15%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK---KRLLGWQARVRIIEG 230
           +V L G C + G  ++ I E+    +L  +L      F P K   K  L  +  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 10/148 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMM---LIAKLQHRHLVRLFG 186
           LG GGFG V+  ++   G+  A K+L+ +  +    ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII--EGIAQGLLYLHQYSRL 244
              E   ++ +   + N     +  Y   +   G+Q    I     I  GL +LHQ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMA 272
            II+RDLK  N+LLD D N +ISD G+A
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 81/194 (41%), Gaps = 34/194 (17%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLTE-FKNEMMLIAK 175
           EN      LG G FG V               +VAVK L  ++     E   +E+ ++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 176 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL------------FYPKKKRL---- 218
           L  H ++V L G C   G   LI+EY     L  +L             Y  +KRL    
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 219 ----LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
               L ++  +     +A+G+ +L   S    +HRDL A N+L+      KI DFG+AR 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 275 FGGDE---LQGNTK 285
              D    ++GN +
Sbjct: 222 IMSDSNYVVRGNAR 235

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 66/126 (52%), Gaps = 8/126 (6%)
Query: 149 EVAVKRLSNQSGQGLTE-FKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSL 206
           EV  +RLS +  + + E  + E  ++ ++  H H++ L           L+++ M  +  
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM--RKG 185
Query: 207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 266
           ++F +  +K  L   + R  I+  + + + +LH  +   I+HRDLK  NILLD +M  ++
Sbjct: 186 ELFDYLTEKVALSEKETR-SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241
Query: 267 SDFGMA 272
           SDFG +
Sbjct: 242 SDFGFS 247

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 10/148 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMM---LIAKLQHRHLVRLFG 186
           LG GGFG V+  ++   G+  A K+L+ +  +    ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII--EGIAQGLLYLHQYSRL 244
              E   ++ +   + N     +  Y   +   G+Q    I     I  GL +LHQ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMA 272
            II+RDLK  N+LLD D N +ISD G+A
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI D G+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-HTDDEMTG 181

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI  FG+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-HTDDEMTG 181

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 10/148 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMM---LIAKLQHRHLVRLFG 186
           LG GGFG V+  ++   G+  A K+L+ +  +    ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII--EGIAQGLLYLHQYSRL 244
              E   ++ +   + N     +  Y   +   G+Q    I     I  GL +LHQ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMA 272
            II+RDLK  N+LLD D N +ISD G+A
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 10/148 (6%)
Query: 131 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMM---LIAKLQHRHLVRLFG 186
           LG GGFG V+  ++   G+  A K+L+ +  +    ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII--EGIAQGLLYLHQYSRL 244
              E   ++ +   + N     +  Y   +   G+Q    I     I  GL +LHQ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMA 272
            II+RDLK  N+LLD D N +ISD G+A
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLA 336

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 14/158 (8%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQH 178
           ++N+  + +LG+G F  V +      G E A K ++ +  S +   + + E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEGIAQGLLY 237
            ++VRL     E+  + L+++ +        LF     R    +A     I+ I + + Y
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMA 272
            H      I+HR+LK  N+LL S       K++DFG+A
Sbjct: 120 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 154

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 13/162 (8%)
Query: 118 VSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMM----L 172
           +    E+F     LG+G FG V+        Q  A+K L         + +  M+    L
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 173 IAKLQHRHLVRLFGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
               +H  L  +F C  +  EN+  + EY+    L   +++ +                I
Sbjct: 72  SLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 127
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             GL +LH      I++RDLK  NILLD D + KI+DFGM +
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 14/158 (8%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQH 178
           ++N+  + +LG+G F  V +      G E A K ++ +  S +   + + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEGIAQGLLY 237
            ++VRL     E+  + L+++ +        LF     R    +A     I+ I + + Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMA 272
            H      I+HR+LK  N+LL S       K++DFG+A
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 76/171 (44%), Gaps = 28/171 (16%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 93
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK------KRLLGWQARVRI 227
           +V L G C + G  ++ I E+    +L  +L      F P K      K  L  +  +  
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
              +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI D G+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-HTDDEMTG 181

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 14/158 (8%)
Query: 122 TENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQH 178
           ++N+  + +LG+G F  V +      G E A K ++ +  S +   + + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEGIAQGLLY 237
            ++VRL     E+  + L+++ +        LF     R    +A     I+ I + + Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMA 272
            H      I+HR+LK  N+LL S       K++DFG+A
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 67/153 (43%), Gaps = 8/153 (5%)
Query: 123 ENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           +++    +LG G FG V++      G   A K +           + E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V L     +  E ++IYE+M    L  F     +   +     V  +  + +GL ++H+ 
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 242 SRLRIIHRDLKASNILLDSDMNP--KISDFGMA 272
           +    +H DLK  NI+  +  +   K+ DFG+ 
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLT 198

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 29/172 (16%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK-------KRLLGWQARVR 226
           +V L G C + G  ++ I E+    +L  +L      F P K       K  L  +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 117 SVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLTEFKNEMMLI 173
           ++    E +     +G G +G V        G  VAVK+LS   QS         E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 174 AKLQHRHLVRLFGC-----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
             ++H +++ L         +E+  ++ +  ++    L+  +   K ++L     +  +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 131
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG 282
             I +GL Y+H      IIHRDLK SN+ ++ D   KI D G+AR    DE+ G
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-HTDDEMTG 181

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 67/153 (43%), Gaps = 8/153 (5%)
Query: 123 ENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           +++    +LG G FG V++      G   A K +           + E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V L     +  E ++IYE+M    L  F     +   +     V  +  + +GL ++H+ 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 242 SRLRIIHRDLKASNILLDSDMNP--KISDFGMA 272
           +    +H DLK  NI+  +  +   K+ DFG+ 
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLT 304

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 121 ATENFSTQC-------KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMML 172
           A ENF  +        +LG G +G V K R + +GQ  AVKR+        ++ +  ++ 
Sbjct: 25  AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVN---SQEQKRLLX 81
Query: 173 IAKLQHRHL-----VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPK---KKRLLGWQAR 224
              +  R +     V  +G    +G ++ I   + + SLD   FY +   K + +     
Sbjct: 82  DLDISXRTVDCPFTVTFYGALFREG-DVWICXELXDTSLD--KFYKQVIDKGQTIPEDIL 138
Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            +I   I + L +LH  S+L +IHRD+K SN+L+++    K  DFG++
Sbjct: 139 GKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS 184

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 29/172 (16%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK-------KRLLGWQARVR 226
           +V L G C + G  ++ I E+    +L  +L      F P K       K  L  +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLVRLFGC 187
           CK+G G +G VYK +  +G++     L    G G++     E+ L+ +L+H +++ L   
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 188 CIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQ 240
            +   +    L+++Y  +    +  F+   K     +  V++  G+ + LLY     +H 
Sbjct: 87  FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 241 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARIFGG 277
                ++HRDLK +NIL+  +  P     KI+D G AR+F  
Sbjct: 144 LHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNS 184

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 29/172 (16%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK-------KRLLGWQARVR 226
           +V L G C + G  ++ I E+    +L  +L      F P K       K  L  +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR    D
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 115 LASVSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQ--SGQGLTEFKNEMM 171
           +A+ +  T+++    +LG+G F  V +  +    QE A K ++ +  S +   + + E  
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREAR 82
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEG 230
           +   L+H ++VRL     E+G + L+++ +    L    F     R    +A     I  
Sbjct: 83  ICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIHQ 138
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARIFGGDE 279
           I + + ++HQ+    I+HRDLK  N+LL S       K++DFG+A    G++
Sbjct: 139 ILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ 187

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 29/167 (17%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK-------KRLLGWQARVR 226
           +V L G C + G  ++ I E+    +L  +L      F P K       K  L  +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 16/150 (10%)
Query: 130 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH----LVRL 184
           ++G G  G V+K R    G  +AVK++     +   E K  +M +  +   H    +V+ 
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRILMDLDVVLKSHDCPYIVQC 89
Query: 185 FGCCIEQGENILIYEYMPN--KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           FG  I   +  +  E M    + L   +  P  +R+LG     ++   I + L YL +  
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKE-- 142
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMA 272
           +  +IHRD+K SNILLD     K+ DFG++
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 29/167 (17%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK-------KRLLGWQARVR 226
           +V L G C + G  ++ I E+    +L  +L      F P K       K  L  +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 15/161 (9%)
Query: 120 AATENFSTQCKLGEGGFGPVYKGRLLNGQEV--AVKRLSNQSGQGLTEFKNEM----MLI 173
           A   +F     +G+G FG V   R    +EV  AVK L  ++     E K+ M    +L+
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IA 232
             ++H  LV L        +   + +Y+    L    FY  ++     + R R     IA
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIA 149
Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             L YLH    L I++RDLK  NILLDS  +  ++DFG+ +
Sbjct: 150 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 187

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGC-----CIEQGENI-LIYEY 200
           VA+K+LS +  Q  T  K    E++L+  + H++++ L         +E+ +++ L+ E 
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 260
           M      V       +R+        ++  +  G+ +LH      IIHRDLK SNI++ S
Sbjct: 111 MDANLXQVIQMELDHERM------SYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DXTLKILDFGLARTAG 177

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 29/167 (17%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK-------KRLLGWQARVR 226
           +V L G C + G  ++ I E+    +L  +L      F P K       K  L  +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 29/167 (17%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 129
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK-------KRLLGWQARVR 226
           +V L G C + G  ++ I E+    +L  +L      F P K       K  L  +  + 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR
Sbjct: 190 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 233

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 29/167 (17%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 94
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK-------KRLLGWQARVR 226
           +V L G C + G  ++ I E+    +L  +L      F P K       K  L  +  + 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 29/167 (17%)
Query: 131 LGEGGFGPVYKG------RLLNGQEVAVKRLSNQSGQGLTEFKNEM----MLIAKLQHRH 180
           LG G FG V +       +    + VAVK L  + G   +E +  M    +LI    H +
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 181 LVRLFGCCIEQGENIL-IYEYMPNKSLDVFL------FYPKK-------KRLLGWQARVR 226
           +V L G C + G  ++ I E+    +L  +L      F P K       K  L  +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
               +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L E +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+++D     K++DFG+A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGT 201

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLT-EFKNEMMLIAKLQHRHLVRLFGCC 188
           LG G F  V        Q+ VA+K ++ ++ +G     +NE+ ++ K++H ++V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 189 IEQGENILIYEYMPNKSL-DVFL---FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
              G   LI + +    L D  +   FY ++          R+I  +   + YLH    L
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-------SRLIFQVLDAVKYLHD---L 135
Query: 245 RIIHRDLKASNIL---LDSDMNPKISDFGMARI 274
            I+HRDLK  N+L   LD D    ISDFG++++
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV----RL 184
           +GEG +G V      +    VA+K++S    Q   +    E+ ++ + +H +++     L
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
               +E   ++ I + +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 111 RASTLEAMRDVYIVQDL----METDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARI 274
            ++HRDLK SN+L+++  + KI DFG+ARI
Sbjct: 165 -VLHRDLKPSNLLINTTCDLKICDFGLARI 193

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLT-EFKNEMMLIAKLQHRHLVRLFGCC 188
           LG G F  V        Q+ VA+K ++ ++ +G     +NE+ ++ K++H ++V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 189 IEQGENILIYEYMPNKSL-DVFL---FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
              G   LI + +    L D  +   FY ++          R+I  +   + YLH    L
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-------SRLIFQVLDAVKYLHD---L 135
Query: 245 RIIHRDLKASNIL---LDSDMNPKISDFGMARI 274
            I+HRDLK  N+L   LD D    ISDFG++++
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLT-EFKNEMMLIAKLQHRHLVRLFGCC 188
           LG G F  V        Q+ VA+K ++ ++ +G     +NE+ ++ K++H ++V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 189 IEQGENILIYEYMPNKSL-DVFL---FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
              G   LI + +    L D  +   FY ++          R+I  +   + YLH    L
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-------SRLIFQVLDAVKYLHD---L 135
Query: 245 RIIHRDLKASNIL---LDSDMNPKISDFGMARI 274
            I+HRDLK  N+L   LD D    ISDFG++++
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 13/161 (8%)
Query: 119 SAATENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLI 173
           S   ++F     +G G +  V   RL     +   +V  K L N   + +   + E  + 
Sbjct: 1   SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTEKHVF 59
Query: 174 AKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 232
            +   H  LV L  C   +     + EY+    L   +F+ +++R L  +        I+
Sbjct: 60  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEIS 116
Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
             L YLH+     II+RDLK  N+LLDS+ + K++D+GM +
Sbjct: 117 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 154

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCC 188
           LGEG    V     L+  QE AVK +  Q G   +    E+ ++ + Q HR+++ L    
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
            E+    L++E M   S+   L +  K+R         +++ +A  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 249 RDLKASNILLD--SDMNP-KISDFGMARIFGGDELQGNTKRI 287
           RDLK  NIL +  + ++P KI DFG+     G +L G+   I
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLG---SGIKLNGDCSPI 173

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 19/153 (12%)
Query: 131 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLT-EFKNEMMLIAKLQHRHLVRLFGCC 188
           LG G F  V        Q+ VA+K ++ ++ +G     +NE+ ++ K++H ++V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 189 IEQGENILIYEYMPNKSL-DVFL---FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
              G   LI + +    L D  +   FY ++          R+I  +   + YLH    L
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-------SRLIFQVLDAVKYLHD---L 135
Query: 245 RIIHRDLKASNIL---LDSDMNPKISDFGMARI 274
            I+HRDLK  N+L   LD D    ISDFG++++
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 29/176 (16%)
Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLT---EFKNEMMLIAKLQHRHLVRLFG 186
           LG GG   V+  R L + ++VAVK L     +  +    F+ E    A L H  +V ++ 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 187 CCIEQGE----NILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIA---QGLLYL 238
               +        ++ EY+   +L D+           G     R IE IA   Q L + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV-------HTEGPMTPKRAIEVIADACQALNFS 132
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN----TKRIVGT 290
           HQ     IIHRD+K +NIL+ +    K+ DFG+AR        GN    T  ++GT
Sbjct: 133 HQNG---IIHRDVKPANILISATNAVKVVDFGIARAIAD---SGNSVXQTAAVIGT 182

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 79/187 (42%), Gaps = 35/187 (18%)
Query: 131 LGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLTE---FKNEMMLIAKL-QHRH 180
           LG G FG V +              VAVK L  +    LTE     +E+ +++ L  H +
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG---------- 230
           +V L G C   G  ++I EY     L  FL   K+   +  +    I+E           
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 231 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQ 281
                 +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 282 GNTKRIV 288
           GN +  V
Sbjct: 205 GNARLPV 211

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ ++ +    ++V  +G     GE  +  E+M   SLD  L   K+ + +  +   ++ 
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVS 120
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARIFGGDEL 280
             + +GL YL +  + +I+HRD+K SNIL++S    K+ DFG        MA  F G   
Sbjct: 121 IAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 178
Query: 281 QGNTKRIVGT 290
               +R+ GT
Sbjct: 179 YMAPERLQGT 188

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 73/159 (45%), Gaps = 31/159 (19%)
Query: 131 LGEGGFGPV---YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           +G G +G V     GR   G +VA+K+L          F++E  L AK  +R L RL   
Sbjct: 33  VGSGAYGAVCSAVDGR--TGAKVAIKKLYRP-------FQSE--LFAKRAYREL-RLLKH 80
Query: 188 CIEQGENILIYEYMPNKSLDVF----LFYP---------KKKRLLGWQARVRIIEGIAQG 234
              +    L+  + P+++LD F    L  P          K   LG      ++  + +G
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           L Y+H      IIHRDLK  N+ ++ D   KI DFG+AR
Sbjct: 141 LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGC-----CIEQGENI-LIYEY 200
           VA+K+LS +  Q  T  K    E++L+  + H++++ L         +E+ +++ L+ E 
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 260
           M      V       +R+        ++  +  G+ +LH      IIHRDLK SNI++ S
Sbjct: 111 MDANLXQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DXTLKILDFGLARTAG 177

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGC-----CIEQGENI-LIYEY 200
           VA+K+LS +  Q  T  K    E++L+  + H++++ L         +E+ +++ L+ E 
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 260
           M      V       +R+        ++  +  G+ +LH      IIHRDLK SNI++ S
Sbjct: 111 MDANLXQVIQMELDHERM------SYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DXTLKILDFGLARTAG 177

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 79/187 (42%), Gaps = 35/187 (18%)
Query: 131 LGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLTE---FKNEMMLIAKL-QHRH 180
           LG G FG V +              VAVK L  +    LTE     +E+ +++ L  H +
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLGNHMN 104
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG---------- 230
           +V L G C   G  ++I EY     L  FL   K+   +  +    I+E           
Sbjct: 105 IVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 231 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQ 281
                 +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++
Sbjct: 164 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 282 GNTKRIV 288
           GN +  V
Sbjct: 221 GNARLPV 227

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 24/158 (15%)
Query: 131 LGEGGFGPV---YKGRLLNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRL 184
           +G G  G V   Y   L   + VA+K+LS +  Q  T  K    E++L+  + H++++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 185 FGC-----CIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
                    +E+ +++ L+ E M      V       +R+        ++  +  G+ +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM------SYLLYQMLCGIKHL 142
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           H      IIHRDLK SNI++ SD   KI DFG+AR  G
Sbjct: 143 HSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGC-----CIEQGENI-LIYEY 200
           VA+K+LS +  Q  T  K    E++L+  + H++++ L         +E+ +++ L+ E 
Sbjct: 45  VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 260
           M      V       +R+        ++  +  G+ +LH      IIHRDLK SNI++ S
Sbjct: 104 MDANLXQVIQMELDHERM------SYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKS 154
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 155 DXTLKILDFGLARTAG 170

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 77/176 (43%), Gaps = 29/176 (16%)
Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLT---EFKNEMMLIAKLQHRHLVRLFG 186
           LG GG   V+  R L + ++VAVK L     +  +    F+ E    A L H  +V ++ 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 187 CCIEQGE----NILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIA---QGLLYL 238
               +        ++ EY+   +L D+           G     R IE IA   Q L + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV-------HTEGPMTPKRAIEVIADACQALNFS 132
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN----TKRIVGT 290
           HQ     IIHRD+K +NI++ +    K+ DFG+AR        GN    T  ++GT
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD---SGNSVTQTAAVIGT 182

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ 177
           ++F     +G G +  V   RL     +   +V  K L N   + +   + E  +  +  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQAS 67
Query: 178 -HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
            H  LV L  C   +     + EY+    L   +F+ +++R L  +        I+  L 
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           YLH+     II+RDLK  N+LLDS+ + K++D+GM +
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 158

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 79/187 (42%), Gaps = 35/187 (18%)
Query: 131 LGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLTE---FKNEMMLIAKL-QHRH 180
           LG G FG V +              VAVK L  +    LTE     +E+ +++ L  H +
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLGNHMN 106
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG---------- 230
           +V L G C   G  ++I EY     L  FL   K+   +  +    I+E           
Sbjct: 107 IVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 231 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQ 281
                 +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++
Sbjct: 166 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 282 GNTKRIV 288
           GN +  V
Sbjct: 223 GNARLPV 229

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L E +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+++D     +++DFG+A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGT 201

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 126 STQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLVR 183
           + Q +LG G FG V++      G + AVK++       L  F+  E+M  A L    +V 
Sbjct: 77  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVP 130
Query: 184 LFGCCIEQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           L+G  + +G  + I+ E +   SL   +   K++  L     +  +    +GL YLH  S
Sbjct: 131 LYGA-VREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--S 184
Query: 243 RLRIIHRDLKASNILLDSD-MNPKISDFGMARIFGGDEL 280
           R RI+H D+KA N+LL SD  +  + DFG A     D L
Sbjct: 185 R-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGL 222

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 126 STQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLVR 183
           + Q +LG G FG V++      G + AVK++       L  F+  E+M  A L    +V 
Sbjct: 96  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVP 149
Query: 184 LFGCCIEQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           L+G  + +G  + I+ E +   SL   +   K++  L     +  +    +GL YLH  S
Sbjct: 150 LYGA-VREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--S 203
Query: 243 RLRIIHRDLKASNILLDSD-MNPKISDFGMARIFGGDEL 280
           R RI+H D+KA N+LL SD  +  + DFG A     D L
Sbjct: 204 R-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGL 241

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 79/187 (42%), Gaps = 35/187 (18%)
Query: 131 LGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLTE---FKNEMMLIAKL-QHRH 180
           LG G FG V +              VAVK L  +    LTE     +E+ +++ L  H +
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG---------- 230
           +V L G C   G  ++I EY     L  FL   K+   +  +    I+E           
Sbjct: 112 IVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 231 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQ 281
                 +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++
Sbjct: 171 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 282 GNTKRIV 288
           GN +  V
Sbjct: 228 GNARLPV 234

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 77/176 (43%), Gaps = 29/176 (16%)
Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLT---EFKNEMMLIAKLQHRHLVRLFG 186
           LG GG   V+  R L + ++VAVK L     +  +    F+ E    A L H  +V ++ 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 187 CCIEQGE----NILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIA---QGLLYL 238
               +        ++ EY+   +L D+           G     R IE IA   Q L + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV-------HTEGPMTPKRAIEVIADACQALNFS 132
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN----TKRIVGT 290
           HQ     IIHRD+K +NI++ +    K+ DFG+AR        GN    T  ++GT
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD---SGNSVTQTAAVIGT 182

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 122 TENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQH 178
           T+ +    +LG+G F  V +  ++  GQE A K ++ +  S +   + + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEGIAQGLLY 237
            ++VRL     E+G + L+++ +    L    F     R    +A     I+ I + + +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILESVNH 118
Query: 238 LHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARIFGGDE 279
            H      I+HRDLK  N+LL S       K++DFG+A    GD+
Sbjct: 119 CHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ 160

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 131 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCC 188
           L EGGF  VY+ + + +G+E A+KRL +   +       E+  + KL  H ++V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 189 --------IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
                     Q E +L+ E    + ++ FL   + +  L     ++I     + + ++H+
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVE-FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             +  IIHRDLK  N+LL +    K+ DFG A
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 79/187 (42%), Gaps = 35/187 (18%)
Query: 131 LGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLTE---FKNEMMLIAKL-QHRH 180
           LG G FG V +              VAVK L  +    LTE     +E+ +++ L  H +
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG---------- 230
           +V L G C   G  ++I EY     L  FL   K+   +  +    I+E           
Sbjct: 112 IVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 231 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE---LQ 281
                 +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D    ++
Sbjct: 171 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 282 GNTKRIV 288
           GN +  V
Sbjct: 228 GNARLPV 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 70/158 (44%), Gaps = 24/158 (15%)
Query: 131 LGEGGFGPV---YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           +G G  G V   Y   L   + VA+K+LS         F+N+    AK  +R LV L  C
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSR-------PFQNQTH--AKRAYRELV-LMKC 117
Query: 188 CIEQGENILIYEYMPNKSL----DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----L 238
              +    L+  + P K+L    DV+L        L    ++ +       LLY     +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
                  IIHRDLK SNI++ SD   KI DFG+AR  G
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     +G G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     K++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGT 201

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEPHARFYAAQ-I 151
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 152 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFXEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 71/160 (44%), Gaps = 26/160 (16%)
Query: 130 KLGEGGFGPVYKG-RLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           ++G G F  VYKG       EVA   L ++  +      FK E   +  LQH ++VR + 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 187 C---------CIEQGENILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGL 235
                     CI     +L+ E   + +L  +L  F   K ++L    R      I +GL
Sbjct: 93  SWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCR-----QILKGL 142
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARI 274
            +LH  +   IIHRDLK  NI +     + KI D G+A +
Sbjct: 143 QFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 17/135 (12%)
Query: 150 VAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGC-----CIEQGENILIYEYM 201
           VA+K+LS +  Q  T  K    E++L+  + H++++ L         +E+ +++ I   +
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 261
            + +L   +     +  L  +    ++  +  G+ +LH      IIHRDLK SNI++ SD
Sbjct: 111 MDANLSQVI-----QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSD 162
Query: 262 MNPKISDFGMARIFG 276
              KI DFG+AR  G
Sbjct: 163 ATLKILDFGLARTAG 177

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL   
Sbjct: 52  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 101
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV++        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DATLKILDFGLARTAG 177

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 122 TENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQH 178
           T+ +    +LG+G F  V +  ++  GQE A K ++ +  S +   + + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEGIAQGLLY 237
            ++VRL     E+G + L+++ +    L    F     R    +A     I+ I + + +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILESVNH 118
Query: 238 LHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARIFGGDE 279
            H      I+HRDLK  N+LL S       K++DFG+A    GD+
Sbjct: 119 CHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ 160

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 17/135 (12%)
Query: 150 VAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGC-----CIEQGENILIYEYM 201
           VA+K+LS +  Q  T  K    E++L+  + H++++ L         +E+ +++ I   +
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 261
            + +L   +     +  L  +    ++  +  G+ +LH      IIHRDLK SNI++ SD
Sbjct: 111 MDANLSQVI-----QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSD 162
Query: 262 MNPKISDFGMARIFG 276
              KI DFG+AR  G
Sbjct: 163 ATLKILDFGLARTAG 177

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 81/173 (46%), Gaps = 26/173 (15%)
Query: 117 SVSAATENFST-----QCK-LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN- 168
           SV  A   F+      Q K +G G  G V      + G  VAVK+LS +  Q  T  K  
Sbjct: 12  SVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRA 70
Query: 169 --EMMLIAKLQHRHLVRLFGC-----CIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLG 220
             E++L+  + H++++ L         +E+ +++ L+ E M      V       +R+  
Sbjct: 71  YRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERM-- 128
Query: 221 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                 ++  +  G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR
Sbjct: 129 ----SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 20  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 79
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 80  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 136
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 137 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 187

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 151
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 152 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 202

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 17/135 (12%)
Query: 150 VAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGC-----CIEQGENILIYEYM 201
           VA+K+LS +  Q  T  K    E++L+  + H++++ L         +E+ +++ I   +
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 261
            + +L   +     +  L  +    ++  +  G+ +LH      IIHRDLK SNI++ SD
Sbjct: 111 MDANLSQVI-----QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSD 162
Query: 262 MNPKISDFGMARIFG 276
              KI DFG+AR  G
Sbjct: 163 ATLKILDFGLARTAG 177

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 118 VSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLTEFKNEMMLIA 174
           V   + +F  +  LGEG +G V        G+ VA+K++   ++    L   + E+ ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 175 KLQHRHLVRLFGC----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ--ARVRII 228
             +H +++ +F        E    + I + +    L          R++  Q  +   I 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDL---------HRVISTQMLSDDHIQ 115
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
             I Q L  +       +IHRDLK SN+L++S+ + K+ DFG+ARI   DE   +     
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPT 173
Query: 289 G 289
           G
Sbjct: 174 G 174

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 151
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 152 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 25/174 (14%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLT---EFKNEMMLIAKLQHRHLVRLFG 186
           LG GG   V+  R L   ++VAVK L     +  +    F+ E    A L H  +V ++ 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 187 CCIEQGE----NILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIA---QGLLYL 238
               +        ++ EY+   +L D+           G     R IE IA   Q L + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV-------HTEGPMTPKRAIEVIADACQALNFS 132
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG--GDELQGNTKRIVGT 290
           HQ     IIHRD+K +NI++ +    K+ DFG+AR     G+ +   T  ++GT
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QTAAVIGT 182

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P K+L   
Sbjct: 90  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEF 139
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV+L        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 200 DCTLKILDFGLARTAG 215

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 118 VSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLTEFKNEMMLIA 174
           V   + +F  +  LGEG +G V        G+ VA+K++   ++    L   + E+ ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 175 KLQHRHLVRLFGC----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ--ARVRII 228
             +H +++ +F        E    + I + +    L          R++  Q  +   I 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDL---------HRVISTQMLSDDHIQ 115
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
             I Q L  +       +IHRDLK SN+L++S+ + K+ DFG+ARI   DE   +     
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPT 173
Query: 289 G 289
           G
Sbjct: 174 G 174

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 118 VSAATENFSTQCKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLTEFKNEMMLIA 174
           V   + +F  +  LGEG +G V        G+ VA+K++   ++    L   + E+ ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 175 KLQHRHLVRLFGC----CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ--ARVRII 228
             +H +++ +F        E    + I + +    L          R++  Q  +   I 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDL---------HRVISTQMLSDDHIQ 115
Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
             I Q L  +       +IHRDLK SN+L++S+ + K+ DFG+ARI   DE   +     
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPT 173
Query: 289 G 289
           G
Sbjct: 174 G 174

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 22/174 (12%)
Query: 110 LPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE 169
           LPL    +++        Q  +G+G FG V++G+   G+EVAVK  S++  +     + E
Sbjct: 19  LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAE 73
Query: 170 MMLIAKLQHRHLVRLFGCCIEQGEN------ILIYEYMPNKSLDVFLFYPKKKRLLGWQA 223
           +     L+H +++       +  +N       L+ +Y  + SL  +L     +  +  + 
Sbjct: 74  IYQTVMLRHENILGFIAA--DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEG 127
Query: 224 RVRIIEGIAQGLLYLH-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            +++    A GL +LH        +  I HRDLK+ NIL+  +    I+D G+A
Sbjct: 128 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL   
Sbjct: 52  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 101
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV++        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DCTLKILDFGLARTAG 177

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 22/174 (12%)
Query: 110 LPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE 169
           LPL    +++        Q  +G+G FG V++G+   G+EVAVK  S++  +     + E
Sbjct: 32  LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAE 86
Query: 170 MMLIAKLQHRHLVRLFGCCIEQGEN------ILIYEYMPNKSLDVFLFYPKKKRLLGWQA 223
           +     L+H +++       +  +N       L+ +Y  + SL  +L     +  +  + 
Sbjct: 87  IYQTVMLRHENILGFIAA--DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEG 140
Query: 224 RVRIIEGIAQGLLYLHQ-----YSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            +++    A GL +LH        +  I HRDLK+ NIL+  +    I+D G+A
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 63/139 (45%), Gaps = 25/139 (17%)
Query: 150 VAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL 206
           VA+K+LS +  Q  T  K    E++L+  + H++++ L               + P KSL
Sbjct: 52  VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSL 98
Query: 207 ----DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNIL 257
               DV++        L    ++ +       LLY     +       IIHRDLK SNI+
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 258 LDSDMNPKISDFGMARIFG 276
           + SD   KI DFG+AR  G
Sbjct: 159 VKSDATLKILDFGLARTAG 177

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 20/164 (12%)
Query: 125 FSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLV 182
           F  +  LG G F  V        G+  AVK +  ++ +G  +  +NE+ ++ K++H ++V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 183 RLFGCCIEQGENILIYEYMPNKSL-DVFL---FYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            L           L+ + +    L D  +   FY +K           +I  +   + YL
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDA-------STLIRQVLDAVYYL 136
Query: 239 HQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFG-GD 278
           H   R+ I+HRDLK  N+L    D +    ISDFG++++ G GD
Sbjct: 137 H---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 122 TENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKL- 176
           T  F    K+G G FG V+K  + L+G   A+KR S +   G  + +N   E+   A L 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 68
Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW--QARVR-IIEGIAQ 233
           QH H+VR F    E    ++  EY    SL   +   +  R++ +  +A ++ ++  + +
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 126
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNP 264
           GL Y+H  S   ++H D+K SNI +     P
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIP 154

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 74/173 (42%), Gaps = 26/173 (15%)
Query: 117 SVSAATENFST-----QCK-LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNE 169
           SV  A   F+      Q K +G G  G V      + G  VAVK+LS         F+N+
Sbjct: 10  SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-------PFQNQ 62
Query: 170 MMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL----DVFLFYPKKKRLLGWQARV 225
               AK  +R LV L  C   +    L+  + P K+L    DV+L        L     +
Sbjct: 63  TH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHM 119
Query: 226 RIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +       LLY     +       IIHRDLK SNI++ SD   KI DFG+AR
Sbjct: 120 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 172

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 122 TENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKL- 176
           T  F    K+G G FG V+K  + L+G   A+KR S +   G  + +N   E+   A L 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW--QARVR-IIEGIAQ 233
           QH H+VR F    E    ++  EY    SL   +   +  R++ +  +A ++ ++  + +
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 124
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNP 264
           GL Y+H  S   ++H D+K SNI +     P
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFISRTSIP 152

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 16/192 (8%)
Query: 104 KSKDSWLPLF-SLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ 161
           K+K+ +L  + S A  +A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 14  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 73
Query: 162 GLTEFK---NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 218
            L + +   NE  ++  +    LV+L     +     ++ EY+P    ++F    +  R 
Sbjct: 74  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRF 131
Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               AR    + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     
Sbjct: 132 XEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 182
Query: 279 ELQGNTKRIVGT 290
            ++G T  + GT
Sbjct: 183 RVKGRTWXLCGT 194

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P K+L   
Sbjct: 51  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEF 100
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV+L        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 101 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 160
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 161 DCTLKILDFGLARTAG 176

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 119 SAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH 178
           S        Q  +G+G FG V++G+   G+EVAVK  S++  +     + E+     L+H
Sbjct: 5   STIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRH 62
Query: 179 RHLVRLFGCCIEQGEN------ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 232
            +++       +  +N       L+ +Y  + SL  +L     +  +  +  +++    A
Sbjct: 63  ENILGFIAA--DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTA 116
Query: 233 QGLLYLH-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            GL +LH        +  I HRDLK+ NIL+  +    I+D G+A
Sbjct: 117 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P K+L   
Sbjct: 53  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEF 102
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV+L        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 103 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 163 DCTLKILDFGLARTAG 178

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 122 TENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKL- 176
           T  F    K+G G FG V+K  + L+G   A+KR S +   G  + +N   E+   A L 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW--QARVR-IIEGIAQ 233
           QH H+VR F    E    ++  EY    SL   +   +  R++ +  +A ++ ++  + +
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 124
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNP 264
           GL Y+H  S   ++H D+K SNI +     P
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFISRTSIP 152

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P K+L   
Sbjct: 52  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEF 101
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV+L        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 102 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DCTLKILDFGLARTAG 177

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P K+L   
Sbjct: 52  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEF 101
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV+L        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 102 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DCTLKILDFGLARTAG 177

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 122 TENFSTQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKL- 176
           T  F    K+G G FG V+K  + L+G   A+KR S +   G  + +N   E+   A L 
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 64
Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW--QARVR-IIEGIAQ 233
           QH H+VR F    E    ++  EY    SL   +   +  R++ +  +A ++ ++  + +
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 122
Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNP 264
           GL Y+H  S   ++H D+K SNI +     P
Sbjct: 123 GLRYIHSMS---LVHMDIKPSNIFISRTSIP 150

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P K+L   
Sbjct: 53  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEF 102
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV+L        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 103 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 163 DCTLKILDFGLARTAG 178

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P K+L   
Sbjct: 45  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEF 94
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV+L        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 95  QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 155 DCTLKILDFGLARTAG 170

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 19/156 (12%)
Query: 128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           Q  +G+G FG V++G+   G+EVAVK  S++  +     + E+     L+H +++     
Sbjct: 9   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 66
Query: 188 CIEQGEN------ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH-- 239
             +  +N       L+ +Y  + SL  +L     +  +  +  +++    A GL +LH  
Sbjct: 67  --DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 120
Query: 240 ---QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
                 +  I HRDLK+ NIL+  +    I+D G+A
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P K+L   
Sbjct: 46  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEF 95
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV+L        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 96  QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 156 DCTLKILDFGLARTAG 171

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P K+L   
Sbjct: 46  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEF 95
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV+L        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 96  QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 156 DCTLKILDFGLARTAG 171

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 19/156 (12%)
Query: 128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           Q  +G+G FG V++G+   G+EVAVK  S++  +     + E+     L+H +++     
Sbjct: 11  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 68
Query: 188 CIEQGEN------ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ- 240
             +  +N       L+ +Y  + SL  +L     +  +  +  +++    A GL +LH  
Sbjct: 69  --DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 122
Query: 241 ----YSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
                 +  I HRDLK+ NIL+  +    I+D G+A
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 76/176 (43%), Gaps = 29/176 (16%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLT---EFKNEMMLIAKLQHRHLVRLFG 186
           LG GG   V+  R L   ++VAVK L     +  +    F+ E    A L H  +V ++ 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 187 CCIEQGE----NILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIA---QGLLYL 238
               +        ++ EY+   +L D+           G     R IE IA   Q L + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV-------HTEGPMTPKRAIEVIADACQALNFS 132
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN----TKRIVGT 290
           HQ     IIHRD+K +NI++ +    K+ DFG+AR        GN    T  ++GT
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD---SGNSVTQTAAVIGT 182

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 19/156 (12%)
Query: 128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           Q  +G+G FG V++G+   G+EVAVK  S++  +     + E+     L+H +++     
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 65
Query: 188 CIEQGEN------ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH-- 239
             +  +N       L+ +Y  + SL  +L     +  +  +  +++    A GL +LH  
Sbjct: 66  --DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 240 ---QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
                 +  I HRDLK+ NIL+  +    I+D G+A
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 14/162 (8%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCC 188
           LGEG    V     L+  QE AVK +  Q G   +    E+ ++ + Q HR+++ L    
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
            E+    L++E M   S+   L +  K+R         +++ +A  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 249 RDLKASNILLD--SDMNP-KISDFGMARIFGGDELQGNTKRI 287
           RDLK  NIL +  + ++P KI DF +     G +L G+   I
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLG---SGIKLNGDCSPI 173

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL   
Sbjct: 54  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 103
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV++        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 104 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 163
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 164 DCTLKILDFGLARTAG 179

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 16/192 (8%)
Query: 104 KSKDSWLPLF-SLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ 161
           K+K+ +L  + S A  +A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 42  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 101
Query: 162 GLTEFK---NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 218
            L + +   NE  ++  +    LV+L     +     ++ EY+P    ++F    +  R 
Sbjct: 102 KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRF 159
Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               AR    + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     
Sbjct: 160 SEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 210
Query: 279 ELQGNTKRIVGT 290
            ++G T  + GT
Sbjct: 211 RVKGRTWXLCGT 222

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 16/192 (8%)
Query: 104 KSKDSWLPLF-SLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ 161
           K+K+ +L  + S A  +A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 14  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 73
Query: 162 GLTEFK---NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 218
            L + +   NE  ++  +    LV+L     +     ++ EY+P    ++F    +  R 
Sbjct: 74  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRF 131
Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               AR    + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     
Sbjct: 132 SEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 182
Query: 279 ELQGNTKRIVGT 290
            ++G T  + GT
Sbjct: 183 RVKGRTWXLCGT 194

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 16/192 (8%)
Query: 104 KSKDSWLPLF-SLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ 161
           K+K+ +L  + S A  +A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 22  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 81
Query: 162 GLTEFK---NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 218
            L + +   NE  ++  +    LV+L     +     ++ EY+P    ++F    +  R 
Sbjct: 82  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRF 139
Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               AR    + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     
Sbjct: 140 SEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 190
Query: 279 ELQGNTKRIVGT 290
            ++G T  + GT
Sbjct: 191 RVKGRTWXLCGT 202

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 84/192 (43%), Gaps = 16/192 (8%)
Query: 104 KSKDSWLPLF-SLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ 161
           K+K+ +L  + S A  +A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 22  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 81
Query: 162 GLTEFK---NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 218
            L + +   NE  ++  +    LV+L     +     ++ EY P    ++F    +  R 
Sbjct: 82  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRF 139
Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               AR    + I     YLH    L +I+RDLK  N+++D     K++DFG A+     
Sbjct: 140 SEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----- 190
Query: 279 ELQGNTKRIVGT 290
            ++G T  + GT
Sbjct: 191 RVKGRTWXLCGT 202

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL   
Sbjct: 52  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 101
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV++        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DCTLKILDFGLARTAG 177

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL   
Sbjct: 53  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 102
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV++        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 163 DCTLKILDFGLARTAG 178

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    L +L     +     ++ EY P    ++F    +  R     AR    + I
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFXEPHARFYAAQ-I 151
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT
Sbjct: 152 VLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGT 202

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 16/192 (8%)
Query: 104 KSKDSWLPLF-SLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ 161
           K+K+ +L  + S A  +A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 22  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 81
Query: 162 GLTEFK---NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 218
            L + +   NE  ++  +    LV+L     +     ++ EY+P    ++F    +  R 
Sbjct: 82  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRF 139
Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               AR    + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     
Sbjct: 140 SEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 190
Query: 279 ELQGNTKRIVGT 290
            ++G T  + GT
Sbjct: 191 RVKGRTWXLCGT 202

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 23/175 (13%)
Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           ++G+G +G V+ G+   G++VAVK   + +      E   E+     ++H +++      
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAAD 100
Query: 189 IE----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ---- 240
           I+      +  LI +Y  N SL  +L    K   L  ++ +++      GL +LH     
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 241 -YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD----ELQGNTKRIVGT 290
              +  I HRDLK+ NIL+  +    I+D G+A  F  D    ++  NT+  VGT
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR--VGT 209

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL   
Sbjct: 52  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 101
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV++        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DCTLKILDFGLARTAG 177

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 16/192 (8%)
Query: 104 KSKDSWLPLF-SLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ 161
           K+K+ +L  + S A  +A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 22  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 81
Query: 162 GLTEFK---NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 218
            L + +   NE  ++  +    LV+L     +     ++ EY+P    ++F    +  R 
Sbjct: 82  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRF 139
Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               AR    + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     
Sbjct: 140 SEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 190
Query: 279 ELQGNTKRIVGT 290
            ++G T  + GT
Sbjct: 191 RVKGRTWXLCGT 202

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL   
Sbjct: 57  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 106
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV++        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 107 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 166
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 167 DCTLKILDFGLARTAG 182

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 20/177 (11%)
Query: 110 LPLFSLASVSAATENFSTQCK-LGEGGFGPVYKGRLLN---GQEVAVK-----RLSNQSG 160
           +P  S+A      E+    C+ +G+G F  V   R +N   GQ+ AVK     + ++  G
Sbjct: 12  VPRGSMADDDVLFEDVYELCEVIGKGPFSVVR--RCINRETGQQFAVKIVDVAKFTSSPG 69
Query: 161 QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLG 220
               + K E  +   L+H H+V L       G   +++E+M    L  F    +      
Sbjct: 70  LSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL-CFEIVKRADAGFV 128
Query: 221 WQARV--RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP---KISDFGMA 272
           +   V    +  I + L Y H  +   IIHRD+K   +LL S  N    K+  FG+A
Sbjct: 129 YSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 182

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL   
Sbjct: 52  VAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 101
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV++        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DCTLKILDFGLARTAG 177

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL   
Sbjct: 52  VAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 101
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV++        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DCTLKILDFGLARTAG 177

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+++D     +++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL   
Sbjct: 52  VAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 101
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV++        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 162 DCTLKILDFGLARTAG 177

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 33/178 (18%)
Query: 131 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLT---EFKNEMMLIAKLQHRHLVRLFG 186
           LG GG   V+  R L   ++VAVK L     +  +    F+ E    A L H  +V ++ 
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY- 95
Query: 187 CCIEQGE--------NILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIA---QG 234
              + GE          ++ EY+   +L D+           G     R IE IA   Q 
Sbjct: 96  ---DTGEAETPAGPLPYIVMEYVDGVTLRDIV-------HTEGPMTPKRAIEVIADACQA 145
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG--GDELQGNTKRIVGT 290
           L + HQ     IIHRD+K +NI++ +    K+ DFG+AR     G+ +   T  ++GT
Sbjct: 146 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QTAAVIGT 199

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 150 VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--- 206
           VA+K+LS         F+N+    AK  +R LV L  C   +    L+  + P KSL   
Sbjct: 46  VAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEF 95
Query: 207 -DVFLFYPKKKRLLGWQARVRIIEGIAQGLLY-----LHQYSRLRIIHRDLKASNILLDS 260
            DV++        L    ++ +       LLY     +       IIHRDLK SNI++ S
Sbjct: 96  QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 261 DMNPKISDFGMARIFG 276
           D   KI DFG+AR  G
Sbjct: 156 DCTLKILDFGLARTAG 171

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 85/179 (47%), Gaps = 23/179 (12%)
Query: 120 AATENFSTQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLTEFKNEMMLIAKLQH 178
           A ++ F  + +LG G    VY+ +    Q+  A+K L     + +   + E+ ++ +L H
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSH 107
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSL-DVFL---FYPKKKRLLGWQARVRIIEGIAQG 234
            ++++L        E  L+ E +    L D  +   +Y ++       A  +I+E +A  
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD---AADAVKQILEAVA-- 162
Query: 235 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
             YLH+     I+HRDLK  N+L  +   D   KI+DFG+++I    E Q   K + GT
Sbjct: 163 --YLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGT 213

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/206 (21%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 88  RRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKG-RLLN 146
           ++R++ H  K      +    W             + +  +  +G G +G V +    L 
Sbjct: 28  QQRKQHHSSKPTASMPRPHSDW----------QIPDRYEIRHLIGTGSYGHVCEAYDKLE 77
Query: 147 GQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFGCCI----EQGENILIYE 199
            + VA+K++  +  + L + K    E+ ++ +L H H+V++    I    E+ + + +  
Sbjct: 78  KRVVAIKKIL-RVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136
Query: 200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 259
            + +         P     L  +    ++  +  G+ Y+H      I+HRDLK +N L++
Sbjct: 137 EIADSDFKKLFRTPVYLTELHIKT---LLYNLLVGVKYVHSAG---ILHRDLKPANCLVN 190
Query: 260 SDMNPKISDFGMARIFGGDELQGNTK 285
            D + K+ DFG+AR     E  GN++
Sbjct: 191 QDCSVKVCDFGLARTVDYPE-NGNSQ 215

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   +    G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    L +L     +     ++ EY P    ++F    +  R     AR    + I
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 151
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT
Sbjct: 152 VLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGT 202

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    L +L     +     ++ EY P    ++F    +  R     AR    + I
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 151
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+++D     K++DFG A+      ++G T  + GT
Sbjct: 152 VLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGT 202

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   +    G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   +    G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+P    ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 15/159 (9%)
Query: 125 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
            + Q +LG G FG V++ +    G + AVK++       L  F+  E++  A L    +V
Sbjct: 74  MTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 127
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            L+G   E     +  E +   SL   +   K+   L     +  +    +GL YLH   
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR- 183
Query: 243 RLRIIHRDLKASNILLDSDMN-PKISDFGMARIFGGDEL 280
             RI+H D+KA N+LL SD +   + DFG A     D L
Sbjct: 184 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 220

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 20/153 (13%)
Query: 131 LGEGGFGPVY--KGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           LG G F  V+  K RL  G+  A+K +        +  +NE+ ++ K++H ++V L    
Sbjct: 17  LGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 189 IEQGENILIYEYMPNKSL-DVFL---FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
                  L+ + +    L D  L    Y +K   L       +I+ +   + YLH+    
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQQVLSAVKYLHENG-- 126
Query: 245 RIIHRDLKASNIL-LDSDMNPK--ISDFGMARI 274
            I+HRDLK  N+L L  + N K  I+DFG++++
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 83/192 (43%), Gaps = 16/192 (8%)
Query: 104 KSKDSWLPLF-SLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ 161
           K+K+ +L  + S A  +A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 22  KAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 81
Query: 162 GLTEFK---NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 218
            L + +   NE  +   +    LV+L     +     ++ EY P    ++F    +  R 
Sbjct: 82  KLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGG--EMFSHLRRIGRF 139
Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               AR    + I     YLH    L +I+RDLK  N+L+D     K++DFG A+     
Sbjct: 140 SEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----- 190
Query: 279 ELQGNTKRIVGT 290
            ++G T  + GT
Sbjct: 191 RVKGRTWXLCGT 202

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/43 (48%), Positives = 31/43 (72%), Gaps = 3/43 (6%)
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           I+ GL +LH+     II+RDLK  N++LDS+ + KI+DFGM +
Sbjct: 129 ISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 168

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +G G FG     RL+  ++    VAVK +  + G+ + E  K E++    L+H ++VR  
Sbjct: 27  IGAGNFG---VARLMRDKQANELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFK 81
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
              +      ++ EY     L  F       R    +AR    + +  G+ Y H    ++
Sbjct: 82  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-FFQQLISGVSYAHA---MQ 135
Query: 246 IIHRDLKASNILLDSDMNP--KISDFGMARIFGGDELQGNTKRIVGT 290
           + HRDLK  N LLD    P  KI+DFG ++      L    K  VGT
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGT 179

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 71/172 (41%), Gaps = 16/172 (9%)
Query: 115 LASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT---------- 164
           +A + A    ++ Q  +  G +G V  G    G  VA+KR+ N    G T          
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 165 -EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--DVFLFYPKKKRLLGW 221
                E+ L+    H +++ L    +   E  +   Y+  + +  D+      ++ ++  
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 222 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           Q     +  I  GL  LH+     ++HRDL   NILL  + +  I DF +AR
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 131 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+GGFG V        G++   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
                 +    L+   M    L   +++  +      +A     E I  GL  LH   R 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMA 272
           RI++RDLK  NILLD   + +ISD G+A
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 71/172 (41%), Gaps = 16/172 (9%)
Query: 115 LASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT---------- 164
           +A + A    ++ Q  +  G +G V  G    G  VA+KR+ N    G T          
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 165 -EFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSL--DVFLFYPKKKRLLGW 221
                E+ L+    H +++ L    +   E  +   Y+  + +  D+      ++ ++  
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 222 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           Q     +  I  GL  LH+     ++HRDL   NILL  + +  I DF +AR
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 131 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+GGFG V        G++   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
                 +    L+   M    L   +++  +      +A     E I  GL  LH   R 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMA 272
           RI++RDLK  NILLD   + +ISD G+A
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 68/153 (44%), Gaps = 7/153 (4%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E +     LG G FG V++    + ++  + +     G      K E+ ++   +HR+++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            L        E ++I+E++    LD+F         L  +  V  +  + + L +LH ++
Sbjct: 65  HLHESFESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 243 RLRIIHRDLKASNILLDS--DMNPKISDFGMAR 273
              I H D++  NI+  +      KI +FG AR
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 125 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
            + Q ++G G FG V++ +    G + AVK++       L  F+  E++  A L    +V
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 113
Query: 183 RLFGCCIEQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
            L+G  + +G  + I+ E +   SL   +   K+   L     +  +    +GL YLH  
Sbjct: 114 PLYGA-VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 242 SRLRIIHRDLKASNILLDSDMN-PKISDFGMARIFGGDEL 280
              RI+H D+KA N+LL SD +   + DFG A     D L
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 10/157 (6%)
Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTEFKN---EMMLIAKLQH 178
           ++F     +G+G FG V   +  + +++ A+K ++ Q      E +N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
             LV L+    ++ +  ++ + +    L   L Y  ++ +   +  V++   I + ++ L
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLL----LGGDLRYHLQQNVHFKEETVKLF--ICELVMAL 128
Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
                 RIIHRD+K  NILLD   +  I+DF +A + 
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 20/178 (11%)
Query: 113 FSLASVSAATENFSTQCK-LGEGGFGPVYKGRLLN---GQEVAVK-----RLSNQSGQGL 163
             +A      E+    C+ +G+G F  V   R +N   GQ+ AVK     + ++  G   
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGPFSVVR--RCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 164 TEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQA 223
            + K E  +   L+H H+V L       G   +++E+M    L  F    +      +  
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL-CFEIVKRADAGFVYSE 129
Query: 224 RV--RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP---KISDFGMARIFG 276
            V    +  I + L Y H  +   IIHRD+K   +LL S  N    K+  FG+A   G
Sbjct: 130 AVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 11/148 (7%)
Query: 130 KLGEGGFGPV--YKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           KLGEGGF  V   +G L +G   A+KR+     Q   E + E  +     H +++RL   
Sbjct: 36  KLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 188 CI-EQG---ENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           C+ E+G   E  L+  +    +L +       K   L     + ++ GI +GL  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFG 270
                HRDLK +NILL  +  P + D G
Sbjct: 155 ---YAHRDLKPTNILLGDEGQPVLMDLG 179

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 125 FSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFK-NEMMLIAKLQHRHLV 182
            + Q ++G G FG V++ +    G + AVK++       L  F+  E++  A L    +V
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 129
Query: 183 RLFGCCIEQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
            L+G  + +G  + I+ E +   SL   +   K+   L     +  +    +GL YLH  
Sbjct: 130 PLYGA-VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR 185
Query: 242 SRLRIIHRDLKASNILLDSDMN-PKISDFGMARIFGGDEL 280
              RI+H D+KA N+LL SD +   + DFG A     D L
Sbjct: 186 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 222

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFK---NEMM 171
           A  +A  + F     LG G FG V   + +  G   A+K L  Q    L + +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++  +    LV+L     +     ++ EY+     ++F    +  R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                YLH    L +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 149
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 21/167 (12%)
Query: 131 LGEGGFGPVYKGRLLNGQE----VAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLF 185
           +G G FG     RL+  ++    VAVK +  + G+ + E  K E++    L+H ++VR  
Sbjct: 26  IGSGNFG---VARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFK 80
Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
              +      ++ EY     L  F       R    +AR    + +  G+ Y H    ++
Sbjct: 81  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-FFQQLISGVSYCHA---MQ 134
Query: 246 IIHRDLKASNILLDSDMNP--KISDFGMARIFGGDELQGNTKRIVGT 290
           + HRDLK  N LLD    P  KI DFG ++      L    K  VGT
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGT 178

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 17/152 (11%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQ----HR 179
           LG+GGFG V+ G RL +  +VA+K +      G +   +      E+ L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
            ++RL     E  E  ++    P  + D+F +  +K  L    +R    + +A      H
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA---IQH 154
Query: 240 QYSRLRIIHRDLKASNILLDSDMN-PKISDFG 270
            +SR  ++HRD+K  NIL+D      K+ DFG
Sbjct: 155 CHSR-GVVHRDIKDENILIDLRRGCAKLIDFG 185

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 148
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 149 G---VLHRDIKDENILIDLNRGELKLIDFG 175

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR      + + + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNX 129
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 149
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 162
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 16/192 (8%)
Query: 104 KSKDSWLPLFSLASVSAAT-ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ 161
           K+K+ +L  +   S + A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 162 GLTEFK---NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 218
            L + +   NE  ++  +    LV+L     +     ++ EY+    +   L      R 
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL------RR 134
Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           +G  A        AQ +L       L +I+RDLK  N+L+D     +++DFG A+     
Sbjct: 135 IGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 279 ELQGNTKRIVGT 290
            ++G T  + GT
Sbjct: 190 RVKGRTWXLCGT 201

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 149
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 162
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 134
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 111 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 168
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 169 G---VLHRDIKDENILIDLNRGELKLIDFG 195

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 176
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFG 203

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 148
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 149 G---VLHRDIKDENILIDLNRGELKLIDFG 175

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR      + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 161
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 16/192 (8%)
Query: 104 KSKDSWLPLFSLASVSAAT-ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ 161
           K+K+ +L  +   S + A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 162 GLTEFK---NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 218
            L + +   NE  ++  +    LV+L     +     ++ EY+     ++F    +  R 
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRF 138
Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               AR    + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     
Sbjct: 139 XEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 279 ELQGNTKRIVGT 290
            ++G T  + GT
Sbjct: 190 RVKGRTWXLCGT 201

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR      + + + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 134
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 161
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 162
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 124 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 181
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 182 G---VLHRDIKDENILIDLNRGELKLIDFG 208

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 162
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 161
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR      + + + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 134
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR      + + + + H  
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 133
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFG 160

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 122 TENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTE---FKNEMMLIAKLQ 177
            E++     +G G FG V   R    Q+V A+K LS       ++   F  E  ++A   
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 178 HRHLVRLFGCCIEQGENI-LIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
              +V+LF C  +  + + ++ EYMP   L ++   Y   ++   +          A+ +
Sbjct: 134 SPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYT--------AEVV 184
Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
           L L     + +IHRD+K  N+LLD   + K++DFG
Sbjct: 185 LALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 219

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR      + + + + H  
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 176
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFG 203

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 131 LGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLTEFKN------EMMLIAKLQH--RHL 181
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +RL          +LI E  P    D+F F  ++  L    AR    + + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNC 161
Query: 242 SRLRIIHRDLKASNILLDSDMNP-KISDFG 270
               ++HRD+K  NIL+D +    K+ DFG
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           IA GL +L       II+RDLK  N++LDS+ + KI+DFGM +
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	290
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-94
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-89
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-83
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-66
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-57
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-49
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-46
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-45
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-44
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-44
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-43
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-41
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-40
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-39
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-38
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-31
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-27
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-23
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-20
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-09
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  279 bits (717), Expect = 3e-94
 Identities = 74/191 (38%), Positives = 99/191 (51%), Gaps = 14/191 (7%)

Query: 110 LPLFSLASVSAATENFSTQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSN----QS 159
              FS   +   T NF  +       K+GEGGFG VYKG + N   VAVK+L+      +
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70

Query: 160 GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLL 219
            +   +F  E+ ++AK QH +LV L G   +  +  L+Y YMPN SL   L        L
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130

Query: 220 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            W  R +I +G A G+ +LH+      IHRD+K++NILLD     KISDFG+AR      
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 280 LQGNTKRIVGT 290
               T RIVGT
Sbjct: 188 QTVMTSRIVGT 198

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  268 bits (688), Expect = 1e-89
 Identities = 79/184 (42%), Positives = 110/184 (59%), Gaps = 3/184 (1%)

Query: 109 WLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLT-EFK 167
            L  FSL  +  A++NFS +  LG GGFG VYKGRL +G  VAVKRL  +  QG   +F+
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75

Query: 168 NEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLF-YPKKKRLLGWQARVR 226
            E+ +I+   HR+L+RL G C+   E +L+Y YM N S+   L   P+ +  L W  R R
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           I  G A+GL YLH +   +IIHRD+KA+NILLD +    + DFG+A++    +    T  
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-A 194

Query: 287 IVGT 290
           + GT
Sbjct: 195 VRGT 198

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  252 bits (646), Expect = 3e-83
 Identities = 73/204 (35%), Positives = 111/204 (54%), Gaps = 4/204 (1%)

Query: 88  RRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNG 147
           +  +  +   D   +            L  +  AT NF  +  +G G FG VYKG L +G
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63

Query: 148 QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD 207
            +VA+KR + +S QG+ EF+ E+  ++  +H HLV L G C E+ E ILIY+YM N +L 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123

Query: 208 VFLFYPKKKRL-LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 266
             L+      + + W+ R+ I  G A+GL YLH  +   IIHRD+K+ NILLD +  PKI
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180

Query: 267 SDFGMARIFGGDELQGNTKRIVGT 290
           +DFG+++     +    +  + GT
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGT 204

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  207 bits (529), Expect = 8e-66
 Identities = 50/189 (26%), Positives = 84/189 (44%), Gaps = 17/189 (8%)

Query: 113 FSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMML 172
               ++   +           G FG V+K +L   + VAVK    Q  Q   + + E+  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71

Query: 173 IAKLQHRHLVRLFGCCIE----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           +  ++H ++++  G          +  LI  +    SL  FL    K  ++ W     I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 229 EGIAQGLLYLHQ-------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
           E +A+GL YLH+         +  I HRD+K+ N+LL +++   I+DFG+A  F   +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 282 GNTKRIVGT 290
           G+T   VGT
Sbjct: 188 GDTHGQVGT 196

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  186 bits (474), Expect = 2e-57
 Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 27/197 (13%)

Query: 113 FSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE--M 170
            + +  S   +N      +G G +G VYKG L + + VAVK  S  + Q    F NE  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 171 MLIAKLQHRHLVRLFGCCIEQGENI-----LIYEYMPNKSLDVFLFYPKKKRLLGWQARV 225
             +  ++H ++ R          +      L+ EY PN SL  +L          W +  
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114

Query: 226 RIIEGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG-- 277
           R+   + +GL YLH       + +  I HRDL + N+L+ +D    ISDFG++    G  
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 278 ----DELQGNTKRIVGT 290
                E        VGT
Sbjct: 175 LVRPGEEDNAAISEVGT 191

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  163 bits (415), Expect = 6e-49
 Identities = 49/163 (30%), Positives = 84/163 (51%), Gaps = 6/163 (3%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           K+G G FG V++    +G +VAVK L  Q    + + EF  E+ ++ +L+H ++V   G 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 188 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 247
             +     ++ EY+   SL   L     +  L  + R+ +   +A+G+ YLH      I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161

Query: 248 HRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           HR+LK+ N+L+D     K+ DFG++R+     L   +K   GT
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGT 202

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  156 bits (397), Expect = 3e-46
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 11/162 (6%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
            +G G FG V K +    ++VA+K++ ++S +    F  E+  ++++ H ++V+L+G C+
Sbjct: 15  VVGRGAFGVVCKAKW-RAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACL 71

Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
                 L+ EY    SL   L   +          +      +QG+ YLH      +IHR
Sbjct: 72  N--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129

Query: 250 DLKASNILLDSDMN-PKISDFGMARIFGGDELQGNTKRIVGT 290
           DLK  N+LL +     KI DFG A      ++Q +     G+
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGS 166

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  154 bits (392), Expect = 2e-45
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 6/158 (3%)

Query: 130 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
            LG+G FG   K      G+ + +K L     +    F  E+ ++  L+H ++++  G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
            +      I EY+   +L   +          W  RV   + IA G+ YLH    + IIH
Sbjct: 77  YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131

Query: 249 RDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           RDL + N L+  + N  ++DFG+AR+   ++ Q    R
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  152 bits (385), Expect = 1e-44
 Identities = 48/174 (27%), Positives = 89/174 (51%), Gaps = 23/174 (13%)

Query: 130 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG-------LTEFKNEMMLIAKLQHRHL 181
           ++G+GGFG V+KGRL+ +   VA+K L     +G         EF+ E+ +++ L H ++
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V+L+G         ++ E++P   L   L    K   + W  ++R++  IA G+ Y+   
Sbjct: 86  VKLYGLMHNP--PRMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQN- 140

Query: 242 SRLRIIHRDLKASNILLDS-----DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
               I+HRDL++ NI L S      +  K++DFG+++     +   +   ++G 
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGN 189

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  151 bits (383), Expect = 2e-44
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 17/167 (10%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRL----SNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
            +G GGFG VY+     G EVAVK           Q +   + E  L A L+H +++ L 
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           G C+++    L+ E+     L+  L      + +     V     IA+G+ YLH  + + 
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128

Query: 246 IIHRDLKASNILLDSDMNP--------KISDFGMARIFGGDELQGNT 284
           IIHRDLK+SNIL+   +          KI+DFG+AR +         
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  150 bits (381), Expect = 3e-44
 Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 7/150 (4%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           KL E   G ++KGR   G ++ VK L  +  S +   +F  E   +    H +++ + G 
Sbjct: 17  KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 188 CIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
           C          I  +MP  SL   L +     ++     V+    +A+G+ +LH    L 
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL- 133

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIF 275
           I    L + ++++D DM  +IS   +   F
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSF 163

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  147 bits (373), Expect = 7e-43
 Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 12/164 (7%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           ++G G FG VYKG+  +G +VAVK L+    + Q L  FKNE+ ++ K +H +++   G 
Sbjct: 31  RIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 188 CIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
                  + ++ ++    SL   L   + K     +  + I    A+G+ YLH      I
Sbjct: 89  STA--PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KSI 141

Query: 247 IHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           IHRDLK++NI L  D   KI DFG+A            +++ G+
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  142 bits (361), Expect = 6e-41
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 21/174 (12%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE--MMLIAKLQHRHLVRLFGC 187
            +G+G +G V++G    G+ VAVK  S++       +  E  +     L+H +++     
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIAS 70

Query: 188 CIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH---- 239
            +    +     LI  Y    SL  +L    +   L   + +RI+  IA GL +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 240 -QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF--GGDELQGNTKRIVGT 290
               +  I HRDLK+ NIL+  +    I+D G+A +     ++L       VGT
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  143 bits (363), Expect = 6e-41
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 21/174 (12%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE--MMLIAKLQHRHLVRLFGC 187
           ++G+G +G V+ G+   G++VAVK            +  E  +     ++H +++     
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAA 99

Query: 188 CIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH---- 239
            I+   +     LI +Y  N SL  +L    K   L  ++ +++      GL +LH    
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 240 -QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF--GGDELQGNTKRIVGT 290
               +  I HRDLK+ NIL+  +    I+D G+A  F    +E+       VGT
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  139 bits (353), Expect = 1e-39
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 10/159 (6%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
            +G+G FG VY GR  +G EVA++ +  +  +   L  FK E+M   + +H ++V   G 
Sbjct: 40  LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 188 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 247
           C+      +I      ++L   +     K +L      +I + I +G+ YLH      I+
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152

Query: 248 HRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
           H+DLK+ N+  D +    I+DFG+  I G  +      +
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  138 bits (349), Expect = 7e-39
 Identities = 43/174 (24%), Positives = 76/174 (43%), Gaps = 21/174 (12%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNE--MMLIAKLQHRHLVRLFGC 187
            +G+G FG V++G+   G+EVAVK  S++       +  E  +     L+H +++     
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 188 CIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ--- 240
             +         L+ +Y  + SL  +L     +  +  +  +++    A GL +LH    
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 241 --YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF--GGDELQGNTKRIVGT 290
               +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  136 bits (345), Expect = 1e-38
 Identities = 53/158 (33%), Positives = 83/158 (52%), Gaps = 13/158 (8%)

Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
            LGEG FG V   R        G++VAVK L     G  + + K E+ ++  L H ++V+
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 184 LFGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
             G C E G N   LI E++P+ SL  +L  PK K  +  + +++    I +G+ YL   
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--- 142

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
              + +HRDL A N+L++S+   KI DFG+ +    D+
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  136 bits (344), Expect = 2e-38
 Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 12/157 (7%)

Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 185 FGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G     LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             R IHRDL   NIL++++   KI DFG+ ++   D+
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  136 bits (345), Expect = 2e-38
 Identities = 53/158 (33%), Positives = 78/158 (49%), Gaps = 15/158 (9%)

Query: 130 KLGEGGFGPVYKGRLLN-----GQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
            LGEG FG V            G+ VAVK L ++   Q  + +K E+ ++  L H H+++
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 184 LFGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
             GCC + G     L+ EY+P  SL  +L     +  +G    +   + I +G+ YLH  
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA- 152

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
                IHRDL A N+LLD+D   KI DFG+A+      
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  136 bits (345), Expect = 2e-38
 Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 12/157 (7%)

Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G+ VAVK+L + + + L +F+ E+ ++  LQH ++V+ 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 185 FGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G C   G     LI EY+P  SL  +L   K K  +     ++    I +G+ YL    
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 162

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             R IHRDL   NIL++++   KI DFG+ ++   D+
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  136 bits (344), Expect = 3e-38
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 12/157 (7%)

Query: 130 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG+G FG V   R        G  VAVK+L +       +F+ E+ ++  L    +V+ 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 185 FGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            G     G     L+ EY+P+  L  FL   + +  L     +     I +G+ YL    
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 145

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             R +HRDL A NIL++S+ + KI+DFG+A++   D+
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  136 bits (344), Expect = 8e-38
 Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 7/159 (4%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRH 180
           E+     ++G G FG V+ GRL  +   VAVK            +F  E  ++ +  H +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +VRL G C ++    ++ E +       FL    +   L  +  ++++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
                 IHRDL A N L+      KISDFGM+R      
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  134 bits (340), Expect = 1e-37
 Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 12/156 (7%)

Query: 130 KLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
            LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
           L G C+      LI + MP   L  ++   + K  +G Q  +     IA+G+ YL     
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---ED 135

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  131 bits (333), Expect = 4e-37
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 6/157 (3%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
              +   ++G G FG V+ G  LN  +VA+K +  +      +F  E  ++ KL H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L+G C+EQ    L+ E+M +  L  +L    ++ L   +  + +   + +G+ YL    
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
              +IHRDL A N L+  +   K+SDFGM R    D+
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  130 bits (330), Expect = 1e-36
 Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 8/152 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +       +G+G FG V  G    G +VAVK +  ++      F  E  ++ +L+H +LV
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77

Query: 183 RLFGCCIEQGENILI-YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +L G  +E+   + I  EYM   SL  +L   + + +LG    ++    + + + YL   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 133

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                +HRDL A N+L+  D   K+SDFG+ +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  130 bits (329), Expect = 1e-36
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 6/157 (3%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E  +   +LG G FG V  G+     +VAVK +  +      EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           + +G C ++    ++ EY+ N  L  +L      + L     + +   + +G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             + IHRDL A N L+D D+  K+SDFGM R    D+
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  130 bits (329), Expect = 3e-36
 Identities = 52/163 (31%), Positives = 79/163 (48%), Gaps = 22/163 (13%)

Query: 130 KLGEGGFGPVYKGRLLNG------QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           +LGEG FG V+     N         VAVK L + +     +F+ E  L+  LQH H+V+
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL-------------FYPKKKRLLGWQARVRIIEG 230
            +G C +    I+++EYM +  L+ FL                + K  LG    + I   
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  130 bits (330), Expect = 3e-36
 Identities = 53/162 (32%), Positives = 76/162 (46%), Gaps = 21/162 (12%)

Query: 130 KLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
           +LGEG FG V+     N         VAVK L   S     +F+ E  L+  LQH+H+VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFL------------FYPKKKRLLGWQARVRIIEGI 231
            FG C E    ++++EYM +  L+ FL                    LG    + +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  130 bits (330), Expect = 3e-36
 Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 12/156 (7%)

Query: 130 KLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVR 183
            LG G FG V+KG  +   E     V +K + ++SG Q      + M+ I  L H H+VR
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
           L G C       L+ +Y+P  SL   +   + +  LG Q  +     IA+G+ YL     
Sbjct: 80  LLGLCPGS-SLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYL---EE 133

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             ++HR+L A N+LL S    +++DFG+A +   D+
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  129 bits (327), Expect = 4e-36
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 12/157 (7%)

Query: 128 QCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
             +LG G FG V +G     ++   VA+K L          E   E  ++ +L + ++VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 184 LFGCCIEQGENILI-YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           L G C  Q E +++  E      L  FL    K+  +       ++  ++ G+ YL    
Sbjct: 75  LIGVC--QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
               +HRDL A N+LL +    KISDFG+++  G D+
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  129 bits (327), Expect = 4e-36
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 6/157 (3%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           ++ +   +LG G FG V  G+     +VA+K +  +      EF  E  ++  L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L+G C +Q    +I EYM N  L  +L   + +     Q  + + + + + + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             + +HRDL A N L++     K+SDFG++R    DE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  133 bits (336), Expect = 5e-36
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 8/152 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +       +G+G FG V  G    G +VAVK +  ++      F  E  ++ +L+H +LV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +L G  +E+   + ++ EYM   SL  +L    +  L G    ++    + + + YL   
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL--- 305

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                +HRDL A N+L+  D   K+SDFG+ +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (329), Expect = 6e-36
 Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 12/156 (7%)

Query: 130 KLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
            LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A + + H+ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
           L G C+      LI + MP   L  ++   + K  +G Q  +     IA+G+ YL     
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYL---ED 135

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            R++HRDL A N+L+ +  + KI+DFG+A++ G +E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  130 bits (328), Expect = 6e-36
 Identities = 49/155 (31%), Positives = 78/155 (50%), Gaps = 10/155 (6%)

Query: 130 KLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
            +G G  G V  GRL         VA+K L +  + +   +F +E  ++ +  H +++RL
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G        +++ EYM N SLD FL              V ++ G+  G+ YL   S L
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDL 170

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +HRDL A N+L+DS++  K+SDFG++R+   D 
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  129 bits (326), Expect = 7e-36
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 14/156 (8%)

Query: 130 KLGEGGFGPVYKGRLLNG---QEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L           E   E  ++ +L + ++VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 185 FGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
            G C  + E+  L+ E      L+ +L   ++ R +  +  + ++  ++ G+ YL     
Sbjct: 84  IGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
              +HRDL A N+LL +    KISDFG+++    DE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  128 bits (325), Expect = 8e-36
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 6/158 (3%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
            + + + KLG G +G VY+G        VAVK L  +    + EF  E  ++ +++H +L
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V+L G C  +    +I E+M   +L  +L    ++ +      + +   I+  + YL   
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL--- 127

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            +   IHRDL A N L+  +   K++DFG++R+  GD 
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (324), Expect = 1e-35
 Identities = 54/164 (32%), Positives = 75/164 (45%), Gaps = 23/164 (14%)

Query: 130 KLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +LGE  FG VYKG L         Q VA+K L     G    EF++E ML A+LQH ++V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL-------------FYPKKKRLLGWQARVRIIE 229
            L G   +     +I+ Y  +  L  FL                  K  L     V ++ 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  131 bits (332), Expect = 2e-35
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 6/157 (3%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E+   + KLG G FG V+        +VAVK +       +  F  E  ++  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L     ++   I I E+M   SL  FL   +  +    +  +     IA+G+ ++    
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFI---E 301

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           +   IHRDL+A+NIL+ + +  KI+DFG+AR+   +E
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  127 bits (322), Expect = 2e-35
 Identities = 56/157 (35%), Positives = 82/157 (52%), Gaps = 6/157 (3%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E      +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+    ++   I I EYM N SL  FL  P   +L   +  + +   IA+G+ ++    
Sbjct: 72  RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIAEGMAFI---E 126

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  128 bits (324), Expect = 3e-35
 Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 11/163 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLTEFKNEMMLIAKL 176
              + Q  +G G FG VYKG L          VA+K L +  + +   +F  E  ++ + 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
            H +++RL G   +    ++I EYM N +LD FL   +K         V ++ GIA G+ 
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           YL   + +  +HRDL A NIL++S++  K+SDFG++R+   D 
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  128 bits (323), Expect = 3e-35
 Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 21/162 (12%)

Query: 130 KLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRHLVRL 184
            +GEG FG V K R+         A+KR+    S     +F  E+ ++ KL  H +++ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFL-------------FYPKKKRLLGWQARVRIIEGI 231
            G C  +G   L  EY P+ +L  FL                     L  Q  +     +
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           A+G+ YL   S+ + IHRDL A NIL+  +   KI+DFG++R
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  129 bits (325), Expect = 4e-35
 Identities = 54/162 (33%), Positives = 82/162 (50%), Gaps = 10/162 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQ 177
            N S    +G G FG V  GRL    +    VA+K L    + +   +F  E  ++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H +++RL G   +    +++ EYM N SLD FL   K          V ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           L   S +  +HRDL A NIL++S++  K+SDFG+ R+   D 
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (320), Expect = 4e-35
 Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 21/173 (12%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRL--------LNGQEVAVKRLSNQSGQGLTEFKNEMMLIA 174
           E+      LG+G F  ++KG          L+  EV +K L          F     +++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           KL H+HLV  +G C+   ENIL+ E++   SLD +L   K K  +    ++ + + +A  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNP--------KISDFGMARIFGGDE 279
           + +L       +IH ++ A NILL  + +         K+SD G++      +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  130 bits (329), Expect = 6e-35
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 6/151 (3%)

Query: 130 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           KLG G +G VY+G        VAVK L  +    + EF  E  ++ +++H +LV+L G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
             +    +I E+M   +L  +L    ++ +      + +   I+  + YL    +   IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL---EKKNFIH 341

Query: 249 RDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R+L A N L+  +   K++DFG++R+  GD 
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDT 372

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  126 bits (319), Expect = 8e-35
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 11/150 (7%)

Query: 130 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
            +G G FG VY G LL+        AVK L        +++F  E +++    H +++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 185 FGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
            G C+    + L +  YM +  L  F+    +      +  +     +A+G+ YL   + 
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---AS 146

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            + +HRDL A N +LD     K++DFG+AR
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  127 bits (320), Expect = 8e-35
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 18/164 (10%)

Query: 130 KLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +LG+G FG VY+G      +      VA+K +    S +   EF NE  ++ +    H+V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL-------FYPKKKRLLGWQARVRIIEGIAQGL 235
           RL G   +    ++I E M    L  +L                     +++   IA G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
            YL   +  + +HRDL A N ++  D   KI DFGM R I+  D
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  126 bits (318), Expect = 8e-35
 Identities = 49/157 (31%), Positives = 71/157 (45%), Gaps = 13/157 (8%)

Query: 130 KLGEGGFGPVYKGRLL----NGQEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQHRHLV 182
           KLG+G FG V +G           VAVK L        + + +F  E+  +  L HR+L+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+G  +     + + E  P  SL   L   K +         R    +A+G+ YL    
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYL---E 138

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             R IHRDL A N+LL +    KI DFG+ R    ++
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  125 bits (316), Expect = 2e-34
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 11/150 (7%)

Query: 130 KLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
            +G+G FG VY G  ++  +     A+K L      Q +  F  E +L+  L H +++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 185 FGCCIEQGENILI-YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
            G  +       +   YM +  L  F+  P++      +  +     +A+G+ YL   + 
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL---AE 142

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            + +HRDL A N +LD     K++DFG+AR
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  127 bits (320), Expect = 2e-34
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 11/150 (7%)

Query: 130 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
            +G G FG VY G LL+        AVK L        +++F  E +++    H +++ L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 185 FGCCIEQGENIL-IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
            G C+    + L +  YM +  L  F+    +      +  +     +A+G+ +L   + 
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL---AS 210

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMAR 273
            + +HRDL A N +LD     K++DFG+AR
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (327), Expect = 3e-34
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 10/157 (6%)

Query: 127 TQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 182
              +LG G FG V +G     ++   VA+K L          E   E  ++ +L + ++V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL G C  +   +L+ E      L  FL    K+  +       ++  ++ G+ YL    
Sbjct: 400 RLIGVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
               +HR+L A N+LL +    KISDFG+++  G D+
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  125 bits (315), Expect = 4e-34
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 18/171 (10%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQE----VAVKRL--SNQSGQGLTEFKNEMMLIAKL 176
                   LGEG FG V +G L         VAVK +   N S + + EF +E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 177 QHRHLVRLFGCCIEQG-----ENILIYEYMPNKSLDVFLFY---PKKKRLLGWQARVRII 228
            H +++RL G CIE       + ++I  +M    L  +L Y       + +  Q  ++ +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
             IA G+ YL   S    +HRDL A N +L  DM   ++DFG+++ I+ GD
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  123 bits (312), Expect = 6e-34
 Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 11/162 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQ 177
           E       +GEG FG V++G  ++ +     VA+K   +  S     +F  E + + +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H H+V+L G   E     +I E      L  FL    +K  L   + +     ++  L Y
Sbjct: 75  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           L      R +HRD+ A N+L+ S+   K+ DFG++R      
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  124 bits (314), Expect = 7e-34
 Identities = 52/172 (30%), Positives = 77/172 (44%), Gaps = 19/172 (11%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNG----QEVAVKRL--SNQSGQGLTEFKNEMMLIAKL 176
           + F+    LG+G FG V + +L        +VAVK L     +   + EF  E   + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 177 QHRHLVRLFGCCIEQGENI------LIYEYMPNKSLDVFL---FYPKKKRLLGWQARVRI 227
            H H+ +L G  +            +I  +M +  L  FL      +    L  Q  VR 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
           +  IA G+ YL   S    IHRDL A N +L  DM   ++DFG++R I+ GD
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  126 bits (319), Expect = 9e-34
 Identities = 51/150 (34%), Positives = 78/150 (52%), Gaps = 6/150 (4%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           KLG+G FG V+ G       VA+K L          F  E  ++ KL+H  LV+L+    
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249

Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           E+   I + EYM   SL  FL   +  + L     V +   IA G+ Y+    R+  +HR
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 304

Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE 334

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  123 bits (310), Expect = 1e-33
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 11/162 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQ 177
           E+      LGEG FG VY+G   N +     VAVK    + +     +F +E +++  L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H H+V+L G   E+    +I E  P   L  +L   + K  L     V     I + + Y
Sbjct: 72  HPHIVKLIGIIEEE-PTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           L     +  +HRD+   NIL+ S    K+ DFG++R    ++
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  127 bits (321), Expect = 1e-33
 Identities = 51/150 (34%), Positives = 78/150 (52%), Gaps = 6/150 (4%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           KLG+G FG V+ G       VA+K L          F  E  ++ KL+H  LV+L+    
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332

Query: 190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHR 249
           E+   I + EYM   SL  FL   +  + L     V +   IA G+ Y+    R+  +HR
Sbjct: 333 EEPIYI-VTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 387

Query: 250 DLKASNILLDSDMNPKISDFGMARIFGGDE 279
           DL+A+NIL+  ++  K++DFG+AR+   +E
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNE 417

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  123 bits (311), Expect = 2e-33
 Identities = 51/158 (32%), Positives = 70/158 (44%), Gaps = 17/158 (10%)

Query: 130 KLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 182
            LG G FG VY+G++          +VAVK L    S Q   +F  E ++I+K  H+++V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYL 238
           R  G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 239 HQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR 273
                   IHRD+ A N LL         KI DFGMAR
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  123 bits (312), Expect = 2e-33
 Identities = 50/178 (28%), Positives = 76/178 (42%), Gaps = 32/178 (17%)

Query: 130 KLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 182
            +GEG FG V++ R            VAVK L    S     +F+ E  L+A+  + ++V
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL---------------------FYPKKKRLLGW 221
           +L G C       L++EYM    L+ FL                             L  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 222 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
             ++ I   +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R I+  D
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  123 bits (311), Expect = 4e-33
 Identities = 51/158 (32%), Positives = 70/158 (44%), Gaps = 17/158 (10%)

Query: 130 KLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 182
            LG G FG VY+G++          +VAVK L    S Q   +F  E ++I+K  H+++V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYL 238
           R  G  ++     ++ E M    L  FL      P +   L     + +   IA G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 239 HQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR 273
                   IHRD+ A N LL         KI DFGMAR
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  121 bits (305), Expect = 2e-32
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 27/181 (14%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLTEFKNEMMLI 173
           +  +    LGEG FG V     +            VAVK L  + + + L++  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 174 AKL-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL-------------FYPKKKRLL 219
             + +H++++ L G C + G   +I EY    +L  +L                  +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 220 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGD 278
            ++  V     +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I   D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 279 E 279
            
Sbjct: 212 Y 212

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  120 bits (303), Expect = 2e-32
 Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 25/166 (15%)

Query: 130 KLGEGGFGPVYKGRLLN------GQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRHL 181
            LG G FG V +            + VAVK L    +        +E+ ++  +  H ++
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 182 VRLFGCCIEQGENI-LIYEYMPNKSLDVFL-------------FYPKKKRLLGWQARVRI 227
           V L G C + G  + +I E+    +L  +L                  K  L  +  +  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  124 bits (314), Expect = 2e-32
 Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 11/155 (7%)

Query: 130 KLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLVRL 184
            +GEG FG V++G  ++ +     VA+K   +  S     +F  E + + +  H H+V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G   E     +I E      L  FL    +K  L   + +     ++  L YL      
Sbjct: 457 IGVITEN-PVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           R +HRD+ A N+L+ S+   K+ DFG++R      
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  120 bits (303), Expect = 2e-32
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 32/186 (17%)

Query: 130 KLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLTEFKNEMMLIAKLQHRHLV 182
            LGEG FG V K    +         VAVK L  N S   L +  +E  ++ ++ H H++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG------------ 230
           +L+G C + G  +LI EY    SL  FL   +K       +                   
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 231 ---------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDEL 280
                    I+QG+ YL   + ++++HRDL A NIL+      KISDFG++R ++  D  
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206

Query: 281 QGNTKR 286
              ++ 
Sbjct: 207 VKRSQG 212

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  120 bits (303), Expect = 3e-32
 Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 12/172 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQH-- 178
             +S   ++G GG   V++      Q  A+K   L     Q L  ++NE+  + KLQ   
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
             ++RL+   I      ++ E   N  L+ +L   KKK +  W+ +    + + + +  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTI 143

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           HQ+    I+H DLK +N L+  D   K+ DFG+A     D         VGT
Sbjct: 144 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  121 bits (305), Expect = 4e-32
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 14/206 (6%)

Query: 89  RRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQ 148
           +  R+H +    G D    +        SV      +S   ++G GG   V++      Q
Sbjct: 24  KFERQHMDSPDLGTDDDDKASSSANECISVKG--RIYSILKQIGSGGSSKVFQVLNEKKQ 81

Query: 149 EVAVKR--LSNQSGQGLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQGENILIYEYMPNK 204
             A+K   L     Q L  ++NE+  + KLQ     ++RL+   I      ++ E   N 
Sbjct: 82  IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 140

Query: 205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 264
            L+ +L   KKK +  W+ +    + + + +  +HQ+    I+H DLK +N L+  D   
Sbjct: 141 DLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML 193

Query: 265 KISDFGMARIFGGDELQGNTKRIVGT 290
           K+ DFG+A     D         VG 
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGA 219

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  120 bits (304), Expect = 4e-32
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 27/174 (15%)

Query: 130 KLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHR 179
            LGEG FG V     +            VAVK L  + + + L++  +EM ++  + +H+
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFL-------------FYPKKKRLLGWQARVR 226
           +++ L G C + G   +I EY    +L  +L                  +  + ++  V 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDE 279
               +A+G+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR I   D 
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  119 bits (301), Expect = 7e-32
 Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 12/172 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLTEFKNEMMLIAKLQH-- 178
             +S   ++G GG   V++      Q  A+K   L     Q L  ++NE+  + KLQ   
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
             ++RL+   I      ++ E   N  L+ +L   KKK +  W+ +    + + + +  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTI 124

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           HQ+    I+H DLK +N L+  D   K+ DFG+A     D         VGT
Sbjct: 125 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  118 bits (299), Expect = 7e-32
 Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLTE-FKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   ++       +  A K +           E    E+ +   L H+H+V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 187 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
              E  + + ++ E    +SL     + ++K L   +AR   +  I  G  YLH   R R
Sbjct: 83  F-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNR 135

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMA 272
           +IHRDLK  N+ L+ D+  KI DFG+A
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  119 bits (300), Expect = 1e-31
 Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 12/154 (7%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLTE-FKNEMMLIAKLQHRHLVRLFG 186
           LG+GGF   ++       +  A K +           E    E+ +   L H+H+V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 187 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
              E  + + ++ E    +SL     + ++K L   +AR   +  I  G  YLH+    R
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---NR 161

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
           +IHRDLK  N+ L+ D+  KI DFG+A     D 
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  118 bits (298), Expect = 1e-31
 Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 11/164 (6%)

Query: 118 VSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL 176
           V    +++    KLGEGGF  V     L +G   A+KR+     Q   E + E  +    
Sbjct: 24  VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83

Query: 177 QHRHLVRLFGCCIEQGEN----ILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEG 230
            H +++RL   C+ +        L+  +    +L   +     K   L   Q    ++ G
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLG 142

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
           I +GL  +H        HRDLK +NILL  +  P + D G    
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  117 bits (296), Expect = 2e-31
 Identities = 46/181 (25%), Positives = 69/181 (38%), Gaps = 27/181 (14%)

Query: 130 KLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRHL 181
            LG G FG V +       +      VAVK L  +          +E+ +++ L  H ++
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG----------- 230
           V L G C   G  ++I EY     L  FL   +   +    +   + +            
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 231 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDELQGNTK 285
               +A+G+ +L   +    IHRDL A NILL      KI DFG+AR I           
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 286 R 286
            
Sbjct: 207 A 207

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  118 bits (297), Expect = 2e-31
 Identities = 47/170 (27%), Positives = 69/170 (40%), Gaps = 23/170 (13%)

Query: 130 KLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRHL 181
            LG G FG V +       +      VAVK L S           +E+ +++ L QH ++
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFL-----------FYPKKKRLLGWQARVRIIEG 230
           V L G C   G  ++I EY     L  FL            +         +  +     
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IFGGDE 279
           +AQG+ +L   +    IHRD+ A N+LL +    KI DFG+AR I     
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (294), Expect = 3e-31
 Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 11/164 (6%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
           LG+G +G VY GR L N   +A+K +  +  +       E+ L   L+H+++V+  G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 190 EQGENILIY-EYMPNKSLDVFLFYPKKKRLLGWQARVRII-EGIAQGLLYLHQYSRLRII 247
           E    I I+ E +P  SL   L   K   L   +  +    + I +GL YLH     +I+
Sbjct: 90  E-NGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 144

Query: 248 HRDLKASNILLDSDM-NPKISDFGMARIFGGDELQGNTKRIVGT 290
           HRD+K  N+L+++     KISDFG ++   G  +   T+   GT
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGT 186

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  118 bits (298), Expect = 4e-31
 Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 32/170 (18%)

Query: 130 KLGEGGFGPVYKGRLLN--------GQEVAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHR 179
            LGEG FG V     +           +VAVK L S+ + + L++  +EM ++  + +H+
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG--------- 230
           +++ L G C + G   +I EY    +L  +L   + +R  G +                 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYL---QARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 231 -------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                  +A+G+ YL   +  + IHRDL A N+L+  D   KI+DFG+AR
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  117 bits (296), Expect = 4e-31
 Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 9/171 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           E +    K+GEG FG     +   +G++  +K   +S  S +   E + E+ ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++V+      E G   ++ +Y     L   +   +K  L      +     I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                +I+HRD+K+ NI L  D   ++ DFG+AR+             +GT
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  115 bits (291), Expect = 6e-31
 Identities = 47/187 (25%), Positives = 82/187 (43%), Gaps = 32/187 (17%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
            +F     +G GGFG V+K +  ++G+   +K  + +N+      + + E+  +AKL H 
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDHV 64

Query: 180 HLVRLFGCCIEQGENI----------------LIYEYMPNKSLDVFLFYPKKKRLLGWQA 223
           ++V   GC      +                 +  E+    +L+ ++   + ++L    A
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 224 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGN 283
              + E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      D   G 
Sbjct: 125 L-ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GK 177

Query: 284 TKRIVGT 290
             R  GT
Sbjct: 178 RTRSKGT 184

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  115 bits (291), Expect = 7e-31
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 16/169 (9%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           ++G G F  VYKG       EVA    +    +      FK E  ++  LQH ++VR + 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 187 CCIEQGEN----ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
                 +     +L+ E M + +L  +L   K+ +++  +        I +GL +LH   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148

Query: 243 RLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              IIHRDLK  NI +     + KI D G+A +          K ++GT
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 193

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  115 bits (291), Expect = 1e-30
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 20/168 (11%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 180
             +F     LG+G FG V K R  L+ +  A+K++ +   + L+   +E+ML+A L H++
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 181 LVRLFGCCIEQGENIL----------IY---EYMPNKSLDVFLFYPKKKRLLGWQARVRI 227
           +VR +   +E+   +           ++   EY  N +L  +     +          R+
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL--YDLIHSENLNQQRDEYWRL 121

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
              I + L Y+H      IIHRDLK  NI +D   N KI DFG+A+  
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  114 bits (288), Expect = 2e-30
 Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 17/176 (9%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRH 180
            +F     LG GGFG V++ +  ++    A+KR+          +   E+  +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 181 LVRLFGCCIE---------QGENILIY---EYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           +VR F   +E             + +Y   +    ++L  ++              + I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
             IA+ + +LH      ++HRDLK SNI    D   K+ DFG+      DE +   
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  114 bits (288), Expect = 3e-30
 Identities = 43/173 (24%), Positives = 83/173 (47%), Gaps = 10/173 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQH 178
            NF  + K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEGIAQGLLY 237
            ++++ +   IE  E  ++ E      L   + + KK++ L  +  V +    +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           +H     R++HRD+K +N+ + +    K+ D G+ R F       ++  +VGT
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  115 bits (289), Expect = 5e-30
 Identities = 43/172 (25%), Positives = 63/172 (36%), Gaps = 31/172 (18%)

Query: 130 KLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLTEFKNEMMLIAKL-QHRHL 181
            LG G FG V         +      VAVK L             +E+ ++ +L  H ++
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG----------- 230
           V L G C   G   LI+EY     L  +L   ++K                         
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 231 ---------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                    +A+G+ +L        +HRDL A N+L+      KI DFG+AR
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  111 bits (280), Expect = 2e-29
 Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 10/176 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           E++     +G G +G   K R   +G+ +  K     + +        +E+ L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 180 HLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARV-RIIEGIAQGLL 236
           ++VR +   I++    L  + EY     L   +    K+R    +  V R++  +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 237 YLHQ--YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
             H+       ++HRDLK +N+ LD   N K+ DFG+ARI   D     T   VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  112 bits (283), Expect = 2e-29
 Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 21/211 (9%)

Query: 87  FRRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LL 145
              + ++   +  +         L               + Q ++G G FG V++ +   
Sbjct: 23  GSAKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQ 81

Query: 146 NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY-EYMPNK 204
            G + AVK++  +  +       E++  A L    +V L+G   E G  + I+ E +   
Sbjct: 82  TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMELLEGG 135

Query: 205 SLDVFLFYPKKKRLLGWQARVRIIEG-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 263
           SL   +   K+   L  + R     G   +GL YLH     RI+H D+KA N+LL SD +
Sbjct: 136 SLGQLI---KQMGCLP-EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGS 188

Query: 264 P-KISDFGMARIFGGDELQGNTKR---IVGT 290
              + DFG A     D L  +      I GT
Sbjct: 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  110 bits (278), Expect = 6e-29
 Identities = 48/147 (32%), Positives = 80/147 (54%), Gaps = 11/147 (7%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLTE-FKNEMMLIAKLQHRHLVRLFG 186
           LG+G F  VY+   +  G EVA+K +  ++    G+ +  +NE+ +  +L+H  ++ L+ 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 187 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
              E    + L+ E   N  ++ +L   + K     +AR   +  I  G+LYLH +    
Sbjct: 79  Y-FEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEAR-HFMHQIITGMLYLHSH---G 132

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMA 272
           I+HRDL  SN+LL  +MN KI+DFG+A
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLA 159

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  111 bits (278), Expect = 8e-29
 Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 13/171 (7%)

Query: 119 SAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKL 176
           S +   +     LG+G    V++GR    G   A+K  +N S     +    E  ++ KL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 177 QHRHLVRLFGCCIEQGENILIY---EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
            H+++V+LF    E+          E+ P  SL   L  P     L     + ++  +  
Sbjct: 65  NHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 234 GLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMARIFGGDEL 280
           G+ +L +     I+HR++K  NI+     D     K++DFG AR    DE 
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (279), Expect = 2e-28
 Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 13/171 (7%)

Query: 119 SAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKL 176
           S +   +     LG+G    V++GR    G   A+K  +N S     +    E  ++ KL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 177 QHRHLVRLFGCCIEQGENILIY---EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
            H+++V+LF    E+          E+ P  SL   L  P     L     + ++  +  
Sbjct: 65  NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 234 GLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMARIFGGDEL 280
           G+ +L +     I+HR++K  NI+     D     K++DFG AR    DE 
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  109 bits (275), Expect = 2e-28
 Identities = 46/170 (27%), Positives = 87/170 (51%), Gaps = 8/170 (4%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 180
            E +    +LG+G FG VYK +    G   A K +  +S + L ++  E+ ++A   H +
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V+L G     G+  ++ E+ P  ++D  +     + L   Q +V +   + + L +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
               RIIHRDLKA N+L+  + + +++DFG++        + ++   +GT
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (271), Expect = 7e-28
 Identities = 45/171 (26%), Positives = 85/171 (49%), Gaps = 12/171 (7%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 180
            + ++   K+G+G  G VY    +  GQEVA+++++ Q         NE++++ + ++ +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           +V      +   E  ++ EY+   SL DV      +  +   Q    +     Q L +LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAA-VCRECLQALEFLH 133

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                ++IHRD+K+ NILL  D + K++DFG       ++ + +T  +VGT
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  107 bits (269), Expect = 2e-27
 Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 12/156 (7%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGC 187
            L EGGF  VY+ + + +G+E A+KRL +   +       E+  + KL  H ++V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 188 CI--------EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
                      Q E +L+ E    + ++       +  L       +I     + + ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTCRAVQHMH 153

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
              +  IIHRDLK  N+LL +    K+ DFG A   
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  106 bits (267), Expect = 3e-27
 Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 12/171 (7%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 180
                +  K+GEG  G V   R   +G++VAVK +  +  Q      NE++++   QH +
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           +V ++   +   E  ++ E++   +L D+       +  +       + E + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA-----TVCEAVLQALAYLH 158

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                 +IHRD+K+ +ILL  D   K+SDFG       D  +  +  +VGT
Sbjct: 159 A---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  106 bits (266), Expect = 4e-27
 Identities = 44/210 (20%), Positives = 73/210 (34%), Gaps = 16/210 (7%)

Query: 87  FRRRRRKHKEKDGEGNDKSKDSWLPLFSLASV-SAATENFSTQCKLGEGGFGPVYKGR-L 144
           F+   +    +     + S+    P +  +   S   ++F    +LG G +G V+K R  
Sbjct: 20  FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK 79

Query: 145 LNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYM 201
            +G+  AVK      +  +       E+    K+ QH   VRL     E G   L  E  
Sbjct: 80  EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139

Query: 202 PNKSLDVFLFYPKKKRLLG-WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 260
                 +          L   Q    + +     L +LH      ++H D+K +NI L  
Sbjct: 140 GP---SLQQHCEAWGASLPEAQVWGYLRD-TLLALAHLHS---QGLVHLDVKPANIFLGP 192

Query: 261 DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
               K+ DFG+    G        +   G 
Sbjct: 193 RGRCKLGDFGLLVELGTAGA---GEVQEGD 219

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (266), Expect = 8e-27
 Identities = 44/183 (24%), Positives = 81/183 (44%), Gaps = 7/183 (3%)

Query: 92  RKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEV 150
           +K +E + +   + +                ++F    +LG G  G V+K     +G  +
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61

Query: 151 AVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVF 209
           A K +          +   E+ ++ +    ++V  +G     GE  +  E+M   SLD  
Sbjct: 62  ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121

Query: 210 LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 269
           L   KK   +  Q   ++   + +GL YL    + +I+HRD+K SNIL++S    K+ DF
Sbjct: 122 L---KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDF 176

Query: 270 GMA 272
           G++
Sbjct: 177 GVS 179

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  104 bits (262), Expect = 1e-26
 Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 20/183 (10%)

Query: 117 SVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLTEFKNEM-MLI 173
           S+    ++     +LG G +G V K R + +GQ +AVKR+ +  + Q       ++ + +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL--FYPKKKRL----LGWQARVRI 227
             +     V  +G    +G+  +  E M + SLD F      K + +    LG     +I
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KI 114

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRI 287
              I + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++     D++  +    
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID-- 169

Query: 288 VGT 290
            G 
Sbjct: 170 AGC 172

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (264), Expect = 1e-26
 Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 10/155 (6%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQ 177
            + FS   ++G G FG VY  R + N + VA+K++S    QS +   +   E+  + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H + ++  GC + +    L+ EY    + D+   + K   L   +    +  G  QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAA-VTHGALQGLAY 169

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
           LH      +IHRD+KA NILL      K+ DFG A
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  105 bits (264), Expect = 2e-26
 Identities = 39/176 (22%), Positives = 71/176 (40%), Gaps = 29/176 (16%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------NQSGQGLTEFKNEMML 172
            L +G F  +      + +  A+K+                           +FKNE+ +
Sbjct: 38  TLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 173 IAKLQHRHLVRLFGCCIEQGENI-LIYEYMPNKSL------DVFLFYPKKKRLLGWQARV 225
           I  +++ + +   G  I   + + +IYEYM N S+         L       +     + 
Sbjct: 97  ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK- 154

Query: 226 RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
            II+ +     Y+H  +   I HRD+K SNIL+D +   K+SDFG +      +++
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  104 bits (261), Expect = 2e-26
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 33/181 (18%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN--------EMMLI 173
           ENF    K+GEG +G VYK R  L G+ VA+K++       L             E+ L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56

Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLGWQARVRI 227
            +L H ++V+L      + +  L++E++         +  +        +   +Q     
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRI 287
              + QGL + H +   R++HRDLK  N+L++++   K++DFG+AR F G  ++  T  +
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164

Query: 288 V 288
           V
Sbjct: 165 V 165

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  104 bits (261), Expect = 2e-26
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 21/182 (11%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRH 180
           +++  Q  +G G    V         ++VA+KR++ +  Q  + E   E+  +++  H +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEG-IA------ 232
           +V  +   + + E  L+ + +   S+ D+     K     G      + E  IA      
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDII----KHIVAKGEHKSGVLDESTIATILREV 130

Query: 233 -QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARIFGGDELQGNTKR--IV 288
            +GL YLH   +   IHRD+KA NILL  D + +I+DFG+ A +  G ++  N  R   V
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 289 GT 290
           GT
Sbjct: 188 GT 189

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  104 bits (261), Expect = 2e-26
 Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 18/155 (11%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           LGEG +G V +          AVK L      +   G    K E+ L+ +L+H+++++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 186 GCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQAR---VRIIEGIAQGLLYLHQ 240
                + +    ++ EY      ++      +KR    QA     ++I+G+     YLH 
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEML-DSVPEKRFPVCQAHGYFCQLIDGLE----YLH- 126

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
                I+H+D+K  N+LL +    KIS  G+A   
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  107 bits (267), Expect = 4e-26
 Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 16/169 (9%)

Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHL 181
            +  + +LG GGFG V +      G++VA+K+   +      E +  E+ ++ KL H ++
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 182 VRLFGCCIEQGENI-------LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           V       +  + +       L  EY     L  +L   +    L       ++  I+  
Sbjct: 75  VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDEL 280
           L YLH+    RIIHRDLK  NI+L      +  KI D G A+     EL
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  103 bits (259), Expect = 5e-26
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 12/175 (6%)

Query: 120 AATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKL 176
           +++  F    KLG G +  VYKG     G  VA+K  +L ++ G   T  + E+ L+ +L
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKEL 60

Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPN---KSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           +H ++VRL+     + +  L++E+M N   K +D        + L     +    + + Q
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ-LLQ 119

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
           GL + H+    +I+HRDLK  N+L++     K+ DFG+AR F G  +   +  +V
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  102 bits (256), Expect = 6e-26
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 20/159 (12%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLTEFKNEMMLIA 174
           E+F     LG+G FG VY  R   +   +A+K L       +    Q     + E+ + +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ----LRREVEIQS 64

Query: 175 KLQHRHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
            L+H +++RL+G        + LI EY P  ++  +    K  +    +     I  +A 
Sbjct: 65  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTV--YRELQKLSKFDEQRTA-TYITELAN 120

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
            L Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  102 bits (256), Expect = 1e-25
 Identities = 52/179 (29%), Positives = 87/179 (48%), Gaps = 31/179 (17%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKN--------EMMLIA 174
           E +    K+GEG +G VYK +   G+ VA+KR+       L             E+ L+ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74

Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPN---KSLDVF--LFYPKKKRLLGWQARVRIIE 229
           +L H ++V L      +    L++E+M     K LD         + ++  +Q       
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
            + +G+ + HQ+   RI+HRDLK  N+L++SD   K++DFG+AR F G  ++  T  +V
Sbjct: 128 -LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  102 bits (257), Expect = 2e-25
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 34/176 (19%)

Query: 118 VSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKN------ 168
           V +  + +     LGEG F  VYK R     Q VA+K  +L ++S     E K+      
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTA 59

Query: 169 --EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLG 220
             E+ L+ +L H +++ L      +    L++++M        K   + L     K  + 
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM- 118

Query: 221 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
                       QGL YLHQ+    I+HRDLK +N+LLD +   K++DFG+A+ FG
Sbjct: 119 LM--------TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (255), Expect = 2e-25
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 8/153 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLTEFKNEM-MLIAKLQHR 179
           E+     ++G G +G V K     +GQ +AVKR+ S    +   +   ++ +++      
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARV--RIIEGIAQGLLY 237
           ++V+ +G    +G+  +  E M + S D F  Y            +  +I     + L +
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 270
           L     L+IIHRD+K SNILLD   N K+ DFG
Sbjct: 141 LK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  101 bits (254), Expect = 2e-25
 Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 12/171 (7%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 180
            E F    KLGEG +G VYK      GQ VA+K++  +    L E   E+ ++ +    H
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           +V+ +G   +  +  ++ EY    S+ D+      + + L       I++   +GL YLH
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
               +R IHRD+KA NILL+++ + K++DFG+A        + NT  ++GT
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  101 bits (253), Expect = 3e-25
 Identities = 43/180 (23%), Positives = 84/180 (46%), Gaps = 32/180 (17%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN--------EMMLI 173
           + +    K+GEG +G V+K +     + VA+KR+       L +           E+ L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPN---KSLDV--FLFYPKKKRLLGWQARVRII 228
            +L+H+++VRL        +  L++E+      K  D       P+  +   +Q      
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
             + +GL + H      ++HRDLK  N+L++ +   K+++FG+AR F G  ++  +  +V
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  102 bits (257), Expect = 4e-25
 Identities = 41/175 (23%), Positives = 72/175 (41%), Gaps = 18/175 (10%)

Query: 124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEM-MLIAKLQHRHLV 182
           +F  +  LG G  G +    + + ++VAVKR+  +     +    E+ +L    +H +++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           R F C  +  +   +  E       +      K    LG +    +++    GL +LH  
Sbjct: 82  RYF-CTEKDRQFQYIAIELCAATLQEYVE--QKDFAHLGLEPI-TLLQQTTSGLAHLHS- 136

Query: 242 SRLRIIHRDLKASNILL-----DSDMNPKISDFGMARIFGGDEL-QGNTKRIVGT 290
             L I+HRDLK  NIL+        +   ISDFG+ +              + GT
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  102 bits (255), Expect = 5e-25
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 37/171 (21%)

Query: 129 CKLGEGGFGPVYKGR---LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
           CK+G G +G VYK +     + ++ A+K++   +G  ++  + E+ L+ +L+H +++ L 
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQ 84

Query: 186 GCCIEQGENI--LIYEYM--------------PNKSLDVFLFYPKKKRLLGWQARVRIIE 229
              +   +    L+++Y                     V L     K LL +Q       
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQ------- 136

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFG 276
            I  G+ YLH      ++HRDLK +NIL+  +       KI+D G AR+F 
Sbjct: 137 -ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  100 bits (251), Expect = 6e-25
 Identities = 43/164 (26%), Positives = 69/164 (42%), Gaps = 23/164 (14%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ-SGQGLTEFKNEMMLIAKLQH 178
           E +    K+GEG +G V+K R    GQ VA+K    S           + E+ ++ +L+H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKH 61

Query: 179 RHLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLGWQARVRIIEGIA 232
            +LV L      +    L++EY  +            +     K +  WQ          
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT-WQ--------TL 112

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           Q + + H++     IHRD+K  NIL+      K+ DFG AR+  
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  100 bits (251), Expect = 8e-25
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 22/163 (13%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           E +    KLGEG +  VYKG+  L    VA+K  RL ++ G   T  + E+ L+  L+H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 60

Query: 180 HLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++V L      +    L++EY+              +     K  L +Q        + +
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL-FQ--------LLR 111

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           GL Y H+    +++HRDLK  N+L++     K++DFG+AR   
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  100 bits (250), Expect = 8e-25
 Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 11/171 (6%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHR 179
            E F+   K+G+G FG V+KG      + VA+K +  +  +  + + + E+ ++++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++ + +G  ++  +  +I EY+   S    L    +   L       I+  I +GL YLH
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH 136

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                + IHRD+KA+N+LL      K++DFG+A      +++ NT   VGT
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  100 bits (250), Expect = 8e-25
 Identities = 38/177 (21%), Positives = 73/177 (41%), Gaps = 8/177 (4%)

Query: 99  GEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-S 156
           G      K +           A   +     ++G G  G V+K R    G  +AVK++  
Sbjct: 1   GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60

Query: 157 NQSGQGLTEFKNEM-MLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKK 215
           + + +       ++ +++      ++V+ FG  I   +  +  E M     +      + 
Sbjct: 61  SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRM 117

Query: 216 KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
           +  +  +   ++   I + L YL    +  +IHRD+K SNILLD     K+ DFG++
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 99.5 bits (249), Expect = 8e-25
 Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 33/180 (18%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKN--------EMMLIA 174
           E +    K+GEG +G VYK +   G+  A+K++       L +           E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLGWQARVRII 228
           +L+H ++V+L+     +   +L++E++           +  L     K  L  Q      
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-LQ------ 108

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
             +  G+ Y H     R++HRDLK  N+L++ +   KI+DFG+AR F G  ++  T  IV
Sbjct: 109 --LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 99.7 bits (249), Expect = 9e-25
 Identities = 46/201 (22%), Positives = 69/201 (34%), Gaps = 33/201 (16%)

Query: 114 SLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLTEFKNEM 170
           ++   S  T  F    K+G G FG V+K    L+G   A+KR                E+
Sbjct: 2   AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV 61

Query: 171 MLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRII 228
              A L QH H+VR F    E    ++  EY    SL D      +            ++
Sbjct: 62  YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-------------------KISDF 269
             + +GL Y+H    + ++H D+K SNI +     P                   KI D 
Sbjct: 122 LQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 270 GMARIFGGDELQGNTKRIVGT 290
           G            + +   G 
Sbjct: 179 GHVTRI------SSPQVEEGD 193

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =   99 bits (250), Expect = 1e-24
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 23/164 (14%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ-SGQGLTEFKNEMMLIAKLQH 178
           E +     +GEG +G V K R    G+ VA+K    S+          + E+ L+ +L+H
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRH 83

Query: 179 RHLVRLFGCCIEQGENILIYEYMPN------KSLDVFLFYPKKKRLLGWQARVRIIEGIA 232
            +LV L   C ++    L++E++ +      +     L Y   ++ L +Q        I 
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL-FQ--------II 134

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            G+ + H +    IIHRD+K  NIL+      K+ DFG AR   
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  100 bits (251), Expect = 2e-24
 Identities = 44/182 (24%), Positives = 72/182 (39%), Gaps = 29/182 (15%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEM-MLIAKLQHRHLVRLFGCC 188
            LG G  G V       G+ VAVKR+             E+ +L     H +++R + C 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY-CS 77

Query: 189 IEQGENI-LIYEYMPNKSLDVFL----FYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
                 + +  E   N +L   +       +  +L      + ++  IA G+ +LH    
Sbjct: 78  ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133

Query: 244 LRIIHRDLKASNILLDS-------------DMNPKISDFGMARIFGGDE--LQGNTKRIV 288
           L+IIHRDLK  NIL+ +             ++   ISDFG+ +     +   + N     
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 289 GT 290
           GT
Sbjct: 194 GT 195

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.0 bits (247), Expect = 3e-24
 Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 15/177 (8%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHR 179
              F     +G G +G VYKGR +  GQ  A+K + + +G    E K E+ ++ K   HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHR 81

Query: 180 HLVRLFGCCIEQGENI------LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           ++   +G  I++          L+ E+    S+   +   K   L        I   I +
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILR 140

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           GL +LHQ    ++IHRD+K  N+LL  +   K+ DFG++        + NT   +GT
Sbjct: 141 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGT 192

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 99.0 bits (247), Expect = 3e-24
 Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 16/167 (9%)

Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RLSNQSGQGLTEFKNEMMLIA 174
            +ST   LG G FG V+        +EV VK                 L +   E+ +++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 175 KLQHRHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           +++H +++++     E      L+ E   +  LD+F F  +  RL    A   I   +  
Sbjct: 85  RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVS 141

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
            + YL       IIHRD+K  NI++  D   K+ DFG A      +L
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 98.9 bits (247), Expect = 3e-24
 Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 28/180 (15%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQS-GQGLTEFKNEMMLIAKLQH 178
           + +    KLGEG +G VYK    +  + VA+K  RL ++  G   T  + E+ L+ +LQH
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQH 92

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFL-----FYPKKKRLLGWQARVRIIEGIAQ 233
           R+++ L           LI+EY     L  ++        +  +   +Q        +  
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ--------LIN 143

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARIFGGDELQGNTKRIV 288
           G+ + H     R +HRDLK  N+LL           KI DFG+AR F G  ++  T  I+
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII 199

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 98.5 bits (246), Expect = 4e-24
 Identities = 52/154 (33%), Positives = 79/154 (51%), Gaps = 11/154 (7%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           +G+G F  V   R +L G+EVA+K +     +   L +   E+ ++  L H ++V+LF  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 188 CIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI 246
            IE  + + LI EY     +  F +     R+   +AR      I   + Y H   + RI
Sbjct: 83  -IETEKTLYLIMEYASGGEV--FDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QKRI 135

Query: 247 IHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
           +HRDLKA N+LLD+DMN KI+DFG +  F     
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 97.7 bits (244), Expect = 5e-24
 Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 20/149 (13%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           LG+G FG VY  R   N   +A+K L            Q     + E+ + + L+H +++
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----LRREIEIQSHLRHPNIL 77

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           R++       + I L+ E+ P   L  +    K  R    ++    +E +A  L Y H  
Sbjct: 78  RMYNY-FHDRKRIYLMLEFAPRGEL--YKELQKHGRFDEQRSA-TFMEELADALHYCH-- 131

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFG 270
              ++IHRD+K  N+L+      KI+DFG
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFG 159

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 99.3 bits (248), Expect = 5e-24
 Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 32/174 (18%)

Query: 122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHRH 180
              ++    +G G FG V++ +L+   EVA+K++          FKN E+ ++  ++H +
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPN 93

Query: 181 LVRLFGCCIEQGENI------LIYEYMPNKSLDVFLFYPKKK--------RLLGWQARVR 226
           +V L       G+        L+ EY+P         Y K K        +L  +Q    
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ---- 149

Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFGGDE 279
               + + L Y+H    + I HRD+K  N+LLD      K+ DFG A+I    E
Sbjct: 150 ----LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 97.3 bits (243), Expect = 6e-24
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 16/166 (9%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLFGCC 188
           LGEG +G V      +  + VAVK +  +      E  K E+ +   L H ++V+ +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73

Query: 189 IEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARV---RIIEGIAQGLLYLHQYSRL 244
             +G    L  EY     L  F        +    A+    +++ G+     YLH    +
Sbjct: 74  RREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GI 124

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 97.4 bits (243), Expect = 1e-23
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 16/166 (9%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLFGCC 188
           LGEG +G V      +  + VAVK +  +      E  K E+ +   L H ++V+ +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73

Query: 189 IEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARV---RIIEGIAQGLLYLHQYSRL 244
             +G    L  EY     L  F        +    A+    +++ G+     YLH    +
Sbjct: 74  RREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GI 124

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 96.5 bits (241), Expect = 1e-23
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 11/165 (6%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQHRHLVRLF 185
           KLG GG   VY     +   +VA+K +     +    L  F+ E+   ++L H+++V + 
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
               E     L+ EY+   +L  ++   +    L     +     I  G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           I+HRD+K  NIL+DS+   KI DFG+A+      L   T  ++GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGT 175

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 98.1 bits (244), Expect = 1e-23
 Identities = 33/164 (20%), Positives = 63/164 (38%), Gaps = 9/164 (5%)

Query: 114 SLASVSAATENFSTQCKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLTEFKN 168
            ++S       +     +G+G      V   R    G+ V V+R  L   S + +T  + 
Sbjct: 16  GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75

Query: 169 EMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           E+ +     H ++V      I   E  ++  +M   S    +       +        I+
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-IL 134

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
           +G+ + L Y+H    +  +HR +KAS+IL+  D    +S     
Sbjct: 135 QGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSN 175

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 97.8 bits (243), Expect = 2e-23
 Identities = 25/225 (11%), Positives = 47/225 (20%), Gaps = 39/225 (17%)

Query: 88  RRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATE---NFSTQCKLGEGGFGPVYKGR- 143
             R    KE        +   W         S  ++          L  G    V+  R 
Sbjct: 24  YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83

Query: 144 LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC----------IE 190
           +   ++ A+K     +  S   L          A+L                      ++
Sbjct: 84  VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143

Query: 191 QGENI----------------LIYEYMP---NKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
                                L+                F    +   G  A   +   +
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            +    L       ++H      N+ +  D    + D       G
Sbjct: 204 IRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 33/175 (18%)

Query: 122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHR 179
             +++    +G G FG VY+ +L  +G+ VA+K++          FKN E+ ++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHC 107

Query: 180 HLVRLFGCCIEQGENI------LIYEYMPNKSLDVFLFYPKKK--------RLLGWQARV 225
           ++VRL       GE        L+ +Y+P     V   Y + K        +L  +Q   
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--- 164

Query: 226 RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFGGDE 279
                + + L Y+H      I HRD+K  N+LLD D    K+ DFG A+     E
Sbjct: 165 -----LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 97.4 bits (242), Expect = 3e-23
 Identities = 26/194 (13%), Positives = 56/194 (28%), Gaps = 38/194 (19%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQ--------- 177
           LG+       +      G+   V             + + K E++ +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 178 -HRHLVRLFGCCIEQGENILI--------------YEYMPNKSLDVFLF------YPKKK 216
            H   +  F    +  +  +I              +   P    ++  F      +    
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 217 RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           + L   AR+++   + + L  LH      ++H  L+  +I+LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261

Query: 277 GDELQGNTKRIVGT 290
           G        R    
Sbjct: 262 GASAVSPIGRGFAP 275

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 98.4 bits (245), Expect = 3e-23
 Identities = 36/169 (21%), Positives = 65/169 (38%), Gaps = 23/169 (13%)

Query: 130 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRL-- 184
            +  GG G +Y      +NG+ V +K L +            E   +A++ H  +V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 185 FGCCIEQGENILIY---EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           F    ++  + + Y   EY+  +SL          + L     +  +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
             + +++ DLK  NI+L  +   K+ D G                + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.0 bits (237), Expect = 4e-23
 Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 12/155 (7%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG G FG V  G   L G +VAVK L+ Q   S   + + K E+  +   +H H+++L+ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 187 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
             I    +  ++ EY+    L  F +  K  R+   +AR R+ + I   + Y H   R  
Sbjct: 79  V-ISTPTDFFMVMEYVSGGEL--FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHM 131

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
           ++HRDLK  N+LLD+ MN KI+DFG++ +    E 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 95.3 bits (238), Expect = 4e-23
 Identities = 51/179 (28%), Positives = 79/179 (44%), Gaps = 33/179 (18%)

Query: 119 SAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKN----EMM 171
           S AT  +    ++G G +G VYK R   +G  VA+K  R+ N  G G          E+ 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVA 63

Query: 172 LIAKLQ---HRHLVRLFGCCIEQGENI-----LIYEYMPN------KSLDVFLFYPKKKR 217
           L+ +L+   H ++VRL   C     +      L++E++                  +  +
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123

Query: 218 LLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
            L  Q          +GL +LH      I+HRDLK  NIL+ S    K++DFG+ARI+ 
Sbjct: 124 DLMRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 97.2 bits (242), Expect = 5e-23
 Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 12/155 (7%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG G FG V  G+  L G +VAVK L+ Q   S   + + + E+  +   +H H+++L+ 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 187 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
             I    +I ++ EY+    L  F +  K  RL   ++R R+ + I  G+ Y H   R  
Sbjct: 84  V-ISTPSDIFMVMEYVSGGEL--FDYICKNGRLDEKESR-RLFQQILSGVDYCH---RHM 136

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
           ++HRDLK  N+LLD+ MN KI+DFG++ +    E 
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.8 bits (241), Expect = 9e-23
 Identities = 42/210 (20%), Positives = 77/210 (36%), Gaps = 15/210 (7%)

Query: 88  RRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQ----CKLGEGGFGPVYKGR 143
           + +  + K       D         +    V    ++         +LG G FG V++  
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 177

Query: 144 -LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 202
               G   A K +           + E+  ++ L+H  LV L     +  E ++IYE+M 
Sbjct: 178 ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237

Query: 203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 262
              L  F     +   +     V  +  + +GL ++H+      +H DLK  NI+  +  
Sbjct: 238 GGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKR 292

Query: 263 NP--KISDFGMARIFGGDELQGNTKRIVGT 290
           +   K+ DFG+       +   + K   GT
Sbjct: 293 SNELKLIDFGLTAHLDPKQ---SVKVTTGT 319

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 95.0 bits (237), Expect = 1e-22
 Identities = 45/172 (26%), Positives = 86/172 (50%), Gaps = 31/172 (18%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLTEFKNEMMLIAKLQH 178
             +    K+G+G FG V+K R    GQ+VA+K++   + + G  +T  + E+ ++  L+H
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKH 75

Query: 179 RHLVRLFGCCIEQGENI--------LIYEYMPN------KSLDVFLFYPKKKRLLGWQAR 224
            ++V L   C  +            L++++  +       ++ V     + KR++     
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM-QM-- 132

Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
                 +  GL Y+H+    +I+HRD+KA+N+L+  D   K++DFG+AR F 
Sbjct: 133 ------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 93.9 bits (234), Expect = 1e-22
 Identities = 46/181 (25%), Positives = 74/181 (40%), Gaps = 39/181 (21%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLS-----------------NQSGQGLTEFKNEMML 172
           +G+G +G V       +    A+K LS                           +    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 173 ------IA---KLQHRHLVRLFGCCIEQGENILIY---EYMPNKSLDVFLFYPKKKRLLG 220
                 IA   KL H ++V+L    ++      +Y   E +    +   +  P  K L  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSE 136

Query: 221 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF-GGDE 279
            QAR    + + +G+ YLH     +IIHRD+K SN+L+  D + KI+DFG++  F G D 
Sbjct: 137 DQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 280 L 280
           L
Sbjct: 193 L 193

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 45/210 (21%), Positives = 80/210 (38%), Gaps = 15/210 (7%)

Query: 88  RRRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFS----TQCKLGEGGFGPVYKGR 143
            + R K+        DK  +     +    V     +         +LG G FG V++  
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 144 -LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP 202
               G+    K ++          KNE+ ++ +L H  L+ L     ++ E +LI E++ 
Sbjct: 72  EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131

Query: 203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 262
              L  F     +   +     +  +    +GL ++H+     I+H D+K  NI+ ++  
Sbjct: 132 GGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKK 186

Query: 263 NP--KISDFGMARIFGGDELQGNTKRIVGT 290
               KI DFG+A     DE     K    T
Sbjct: 187 ASSVKIIDFGLATKLNPDE---IVKVTTAT 213

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 93.5 bits (233), Expect = 3e-22
 Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 13/155 (8%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLTE-FKNEMMLIAKLQHRHLVRLFG 186
           LGEG FG V         Q+VA+K +S Q      +    + E+  +  L+H H+++L+ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 187 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
             I    +I ++ EY      ++F +  +KKR+   + R R  + I   + Y H   R +
Sbjct: 77  V-ITTPTDIVMVIEYA---GGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RHK 128

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
           I+HRDLK  N+LLD ++N KI+DFG++ I      
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 92.7 bits (231), Expect = 4e-22
 Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 15/170 (8%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQHRHLVRLF 185
            LG GG   V+  R L + ++VAVK L     +       F+ E    A L H  +V ++
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 186 GCCIEQGENILIY----EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
                +     +     EY+   +L   +     +  +  +  + +I    Q L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQG-NTKRIVGT 290
            +  IIHRD+K +NI++ +    K+ DFG+AR           T  ++GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 93.0 bits (232), Expect = 5e-22
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 33/174 (18%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR--LLNGQEVAVKRL---SNQSGQGLT---EFKNEMMLIA 174
           + +    ++GEG +G V+K R     G+ VA+KR+   + + G  L+   E    +  + 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69

Query: 175 KLQHRHLVRLFGCCIEQGENI-----LIYEYMPN--KSL-----DVFLFYPKKKRLLGWQ 222
             +H ++VRLF  C     +      L++E++     +      +  +     K ++ +Q
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM-FQ 128

Query: 223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
                   + +GL +LH +   R++HRDLK  NIL+ S    K++DFG+ARI+ 
Sbjct: 129 --------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 91.6 bits (228), Expect = 1e-21
 Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 17/162 (10%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRL------SNQSGQGLTEFKNEMMLIAKLQHR--HL 181
           LG GGFG VY G  + +   VA+K +              T    E++L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 182 VRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +RL     E+ ++  LI E  P    D+F F  ++  L    AR      + + + + H 
Sbjct: 111 IRLLDW-FERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 166

Query: 241 YSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIFGGDELQ 281
                ++HRD+K  NIL+D +    K+ DFG   +       
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 206

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 91.2 bits (227), Expect = 1e-21
 Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 13/166 (7%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQHRHLVRLF 185
            +G GG G VY+    +  + VA+K +S          T  + E     +LQ  H+V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
                 G+  +    +    L   L   +++  L     V I+  I   L   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL-QGNTKRIVGT 290
             HRD+K  NIL+ +D    + DFG+A     ++L Q      VGT
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGT 198

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 92.1 bits (229), Expect = 1e-21
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 19/212 (8%)

Query: 89  RRRRKHKEKDGEGNDKSKDSWLPLFSLASVSAATENFS------TQCKLGEGGFGPVYKG 142
             R   K K          +    F    V+A     +          LG G FG V+K 
Sbjct: 49  TERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC 108

Query: 143 R-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM 201
                G ++A K +  +  +   E KNE+ ++ +L H +L++L+     + + +L+ EY+
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168

Query: 202 PNKSL-DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 260
               L D  +    +   L     +  ++ I +G+ ++HQ   + I+H DLK  NIL  +
Sbjct: 169 DGGELFDRII---DESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVN 222

Query: 261 DMNP--KISDFGMARIFGGDELQGNTKRIVGT 290
                 KI DFG+AR +   E     K   GT
Sbjct: 223 RDAKQIKIIDFGLARRYKPRE---KLKVNFGT 251

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 91.2 bits (227), Expect = 1e-21
 Identities = 40/163 (24%), Positives = 67/163 (41%), Gaps = 19/163 (11%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNE----------MMLIAKLQHR 179
           LG+GGFG V+ G  L +  +VA+K +      G +   +             + A   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 180 HLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            ++RL     E  E   L+ E  P  + D+F +  +K  L    +R      +   + + 
Sbjct: 99  GVIRLLDW-FETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHC 155

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARIFGGDEL 280
           H      ++HRD+K  NIL+D      K+ DFG   +   +  
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY 195

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 91.2 bits (226), Expect = 3e-21
 Identities = 25/180 (13%), Positives = 55/180 (30%), Gaps = 37/180 (20%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQ--------- 177
           LG+       +      G+   V             + + K E++ +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 178 ----------------HRHLVRLFGCC-IEQGENILIYEYMPNKSL----DVFLFYPKKK 216
                            + ++R+          +          +L    +V L +    
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 217 RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           + L   AR+++   + + L  LH Y    ++H  L+  +I+LD      ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 20/209 (9%)

Query: 93  KHKEKDGEGNDKSKDSWLPLFSLAS-VSAATENFSTQ----CKLGEGGFGPVYKGR-LLN 146
            H      G +          +    +++   + S       KLG G +G V   R  + 
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 147 GQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 204
             E A+K +  ++ S    ++   E+ ++  L H ++++L+    ++    L+ E     
Sbjct: 62  HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121

Query: 205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---D 261
            L  F     + +     A   II+ +  G+ YLH+     I+HRDLK  N+LL+S   D
Sbjct: 122 EL--FDEIIHRMKFNEVDAA-VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKD 175

Query: 262 MNPKISDFGMARIFGGDELQGNTKRIVGT 290
              KI DFG++ +F   +     K  +GT
Sbjct: 176 ALIKIVDFGLSAVFENQK---KMKERLGT 201

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.4 bits (225), Expect = 5e-21
 Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 21/172 (12%)

Query: 122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKR-LSNQSGQGLTEFKN----EMMLIAK 175
            + F  +   G+G FG V  G+    G  VA+K+ + +        F+N     M  +A 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAV 75

Query: 176 LQHRHLVRLFGCCIEQGEN-------ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRII 228
           L H ++V+L       GE         ++ EY+P+        Y +++           +
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARIFGGDE 279
             + + +  LH  S + + HRD+K  N+L++ +D   K+ DFG A+     E
Sbjct: 136 FQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 89.2 bits (222), Expect = 6e-21
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 22/197 (11%)

Query: 105 SKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL 163
           ++D+ LP     S     EN+  +  LG G    V +       +E AVK +    G   
Sbjct: 1   TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58

Query: 164 TE---------FKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYP 213
           +             E+ ++ K+  H ++++L           L+++ M    L  F +  
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLT 116

Query: 214 KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +K  L   + R +I+  + + +  LH+   L I+HRDLK  NILLD DMN K++DFG + 
Sbjct: 117 EKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 172

Query: 274 IFGGDELQGNTKRIVGT 290
                E     + + GT
Sbjct: 173 QLDPGEK---LREVCGT 186

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 88.8 bits (221), Expect = 7e-21
 Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 15/166 (9%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
            +G G +G V            A K++     + +  FK E+ ++  L H +++RL+   
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET- 74

Query: 189 IEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 247
            E   +I L+ E      L  F     K+      A  RI++ +   + Y H+   L + 
Sbjct: 75  FEDNTDIYLVMELCTGGEL--FERVVHKRVFRESDAA-RIMKDVLSAVAYCHK---LNVA 128

Query: 248 HRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           HRDLK  N L  +   D   K+ DFG+A  F   ++    +  VGT
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGT 171

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 89.7 bits (223), Expect = 8e-21
 Identities = 43/179 (24%), Positives = 67/179 (37%), Gaps = 31/179 (17%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
            +G+G F  V +      GQ+ AVK     + ++  G    + K E  +   L+H H+V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 184 LFGCCIEQGENILIYEYMP---------NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           L       G   +++E+M           ++   F++          Q        I + 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ--------ILEA 142

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           L Y H      IIHRD+K   +LL S       K+  FG+A   G           VGT
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGT 196

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 88.4 bits (220), Expect = 9e-21
 Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 16/169 (9%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRHLVRLFGC 187
           KLG G FG V+      +G E  +K ++ ++S   + + + E+ ++  L H +++++F  
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 188 CIEQGENI-LIYEYMPNKSL--DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
             E   N+ ++ E      L   +     + K L        +++ +   L Y H     
Sbjct: 89  -FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQMMNALAYFHS---Q 143

Query: 245 RIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            ++H+DLK  NIL          KI DFG+A +F  DE         GT
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 90.1 bits (224), Expect = 9e-21
 Identities = 44/181 (24%), Positives = 74/181 (40%), Gaps = 22/181 (12%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------NQSGQGLTEFKNEMML 172
            + +     LG G  G V         ++VA++ +S         +        + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 232
           + KL H  ++++     +  +  ++ E M    L  F      KRL     +      + 
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCK-LYFYQML 249

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVG 289
             + YLH+     IIHRDLK  N+LL S   D   KI+DFG ++I G   L    + + G
Sbjct: 250 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 303

Query: 290 T 290
           T
Sbjct: 304 T 304

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 89.3 bits (221), Expect = 1e-20
 Identities = 27/172 (15%), Positives = 52/172 (30%), Gaps = 24/172 (13%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK 175
           ++       LGEG F  VY+          N Q+  +K     +          M  +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLD---VFLFYPKKKRLLGWQARVRIIEGIA 232
                 ++ +   + Q  ++L+ E     +L           +K +         +  + 
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR-ML 182

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILL-----------DSDMNPKISDFGMAR 273
             +  +H      IIH D+K  N +L           D      + D G + 
Sbjct: 183 YMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 22/181 (12%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTE---FKNEMML 172
            + +     LG G  G V         ++VA+K     + +  S +        + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 232
           + KL H  ++++     +  +  ++ E M    L  F      KRL     +      + 
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL--FDKVVGNKRLKEATCK-LYFYQML 124

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVG 289
             + YLH      IIHRDLK  N+LL S   D   KI+DFG ++I G   L    + + G
Sbjct: 125 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 178

Query: 290 T 290
           T
Sbjct: 179 T 179

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 87.6 bits (218), Expect = 2e-20
 Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 20/180 (11%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTE-FKNEMMLIA 174
            +++    +LG G F  V K R    G+E A K     RLS+       E  + E+ ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           +++H +++ L      + + +LI E +    L  F F  +K+ L   +A  + ++ I  G
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGEL--FDFLAEKESLTEDEAT-QFLKQILDG 120

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 290
           + YLH     RI H DLK  NI+L     P    K+ DFG+A            K I GT
Sbjct: 121 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGT 174

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 87.7 bits (218), Expect = 2e-20
 Identities = 55/175 (31%), Positives = 87/175 (49%), Gaps = 15/175 (8%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQH 178
            E ++  C LG+G FG V K +  +  QE AVK +  ++   +  +    E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            ++++LF    +     ++ E      L  F    K+KR     A  RII+ +  G+ Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAA-RIIKQVFSGITYM 137

Query: 239 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           H+     I+HRDLK  NILL+S   D + KI DFG++  F  +      K  +GT
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 55/175 (31%), Positives = 87/175 (49%), Gaps = 15/175 (8%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQH 178
            E ++  C LG+G FG V K +  +  QE AVK +  ++   +  +    E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            ++++LF    +     ++ E      L  F    K+KR     A  RII+ +  G+ Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAA-RIIKQVFSGITYM 137

Query: 239 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           H+     I+HRDLK  NILL+S   D + KI DFG++  F  +      K  +GT
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGT 186

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 87.8 bits (218), Expect = 4e-20
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 21/180 (11%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-------RLSNQSGQGLTE-FKNEMML 172
            + +  +  +G G    V +      G E AVK       RLS +  + + E  + E  +
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 173 IAKL-QHRHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG 230
           + ++  H H++ L     E    + L+++ M    L  F +  +K  L   + R  I+  
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGEL--FDYLTEKVALSEKETR-SIMRS 208

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           + + + +LH      I+HRDLK  NILLD +M  ++SDFG +      E     + + GT
Sbjct: 209 LLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGT 262

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 87.8 bits (218), Expect = 5e-20
 Identities = 48/180 (26%), Positives = 74/180 (41%), Gaps = 20/180 (11%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTE-FKNEMMLIA 174
            + +    +LG G F  V K R    G E A K     +          E  + E+ ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           ++ H +++ L      + + +LI E +    L  F F  +K+ L   +A    I+ I  G
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGEL--FDFLAQKESLSEEEAT-SFIKQILDG 127

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 290
           + YLH     +I H DLK  NI+L     P    K+ DFG+A            K I GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGT 181

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 86.9 bits (216), Expect = 5e-20
 Identities = 48/180 (26%), Positives = 74/180 (41%), Gaps = 20/180 (11%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTE-FKNEMMLIA 174
            + +    +LG G F  V K R    G E A K     +          E  + E+ ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           ++ H +++ L      + + +LI E +    L  F F  +K+ L   +A    I+ I  G
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGEL--FDFLAQKESLSEEEAT-SFIKQILDG 127

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 290
           + YLH     +I H DLK  NI+L     P    K+ DFG+A            K I GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGT 181

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 86.9 bits (216), Expect = 7e-20
 Identities = 34/172 (19%), Positives = 67/172 (38%), Gaps = 12/172 (6%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 180
            E +     LG G FG V++     + +    K +    G      K E+ ++   +HR+
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           ++ L        E ++I+E++    +  F         L  +  V  +  + + L +LH 
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDI--FERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 241 YSRLRIIHRDLKASNILLDSDMNP--KISDFGMARIFGGDELQGNTKRIVGT 290
                I H D++  NI+  +  +   KI +FG AR     +     + +   
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTA 166

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 85.3 bits (212), Expect = 1e-19
 Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 21/178 (11%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTEFKNEMMLIAK 175
           ++N+  + +LG+G F  V +      G E A K     +LS +  Q L   + E  +  K
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL---EREARICRK 61

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           LQH ++VRL     E+  + L+++ +    L  F     ++      A    I+ I + +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADAS-HCIQQILESI 118

Query: 236 LYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            Y H      I+HR+LK  N+LL S       K++DFG+A      E         GT
Sbjct: 119 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 16/168 (9%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQHRHLVRLF 185
            LG+G FG V   +  + GQE AVK +S    +          E+ L+ +L H ++++L+
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92

Query: 186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
               ++G   L+ E      L  F     +KR     A  RII  +  G+ Y+H+    +
Sbjct: 93  EFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAA-RIIRQVLSGITYMHK---NK 146

Query: 246 IIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           I+HRDLK  N+LL+S   D N +I DFG++  F   +     K  +GT
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGT 191

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 85.2 bits (211), Expect = 1e-19
 Identities = 18/149 (12%), Positives = 48/149 (32%), Gaps = 14/149 (9%)

Query: 130 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRL 184
             G       ++     L  ++VA+  +  Q       L E  +  + ++++    + R+
Sbjct: 38  FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
                 +   +++ E++   SL                A +R ++ +A      H   R 
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMAR 273
            +       S + +  D +  ++      
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMP 177

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 54/174 (31%), Positives = 74/174 (42%), Gaps = 14/174 (8%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEF---KNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +      +      E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 179 RHLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
              V+L+     Q +  L     Y  N  L    +  K         R    E I   L 
Sbjct: 90  PFFVKLYFTF--QDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAE-IVSALE 144

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           YLH      IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VGT
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 84.9 bits (210), Expect = 4e-19
 Identities = 39/211 (18%), Positives = 65/211 (30%), Gaps = 56/211 (26%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
            +G+G +G V            A+K     ++   + + +   K E+ L+ KL H ++ R
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 184 LFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARV----------------- 225
           L+    E  + I L+ E      L               +  +                 
Sbjct: 93  LYEV-YEDEQYICLVMELCHGGHL--LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 226 ----------------------RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-- 261
                                  I+  I   L YLH      I HRD+K  N L  ++  
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKS 206

Query: 262 MNPKISDFGMARIFGGDELQGNT--KRIVGT 290
              K+ DFG+++ F               GT
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 84.6 bits (210), Expect = 5e-19
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 20/180 (11%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTE-FKNEMMLIA 174
            + + T  +LG G F  V K R    G + A K     R  +       E  + E+ ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           ++QH +++ L      + + ILI E +    L  F F  +K+ L   +A    ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEAT-EFLKQILNG 126

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 290
           + YLH    L+I H DLK  NI+L     P    KI DFG+A            K I GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 180

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 84.3 bits (209), Expect = 7e-19
 Identities = 42/154 (27%), Positives = 63/154 (40%), Gaps = 12/154 (7%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRHLVRLFGCC 188
           +G G FG     R  L  + VAVK +    G  + E  + E++    L+H ++VR     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
           +      +I EY     L  +       R    +AR    + +  G+ Y H    ++I H
Sbjct: 86  LTPTHLAIIMEYASGGEL--YERICNAGRFSEDEAR-FFFQQLLSGVSYCH---SMQICH 139

Query: 249 RDLKASNILLDSD--MNPKISDFGMARIFGGDEL 280
           RDLK  N LLD       KI DFG ++       
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 84.3 bits (209), Expect = 7e-19
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 15/175 (8%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQH 178
           ++N+  + +LG+G F  V +      G E A K +     S +   + + E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            ++VRL     E+  + L+++ +    L  F     ++      A    I+ I + + Y 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADAS-HCIQQILESIAYC 144

Query: 239 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           H      I+HR+LK  N+LL S       K++DFG+A      E         GT
Sbjct: 145 HS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 83.5 bits (207), Expect = 1e-18
 Identities = 47/174 (27%), Positives = 71/174 (40%), Gaps = 26/174 (14%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR-HLVRLF 185
           +LG G F  V +      GQE A K  +   +      E  +E+ ++   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 186 GCCIEQGENILIYEYMPNKSL------DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
                  E ILI EY     +      ++     +           R+I+ I +G+ YLH
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND------VI-RLIKQILEGVYYLH 148

Query: 240 QYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           Q     I+H DLK  NILL       + KI DFGM+R  G        + I+GT
Sbjct: 149 Q---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGT 196

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 28/179 (15%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------NQSGQGLTEFKNEMMLIAK 175
           KLG G +G V   +      E A+K +                  +   E  NE+ L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 176 LQHRHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
           L H ++++LF    E  +   L+ E+     L  F     + +     A   I++ I  G
Sbjct: 103 LDHPNIIKLFDVF-EDKKYFYLVTEFYEGGEL--FEQIINRHKFDECDAA-NIMKQILSG 158

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           + YLH+     I+HRD+K  NILL++    +N KI DFG++  F  D      +  +GT
Sbjct: 159 ICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLGT 211

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 81.1 bits (201), Expect = 6e-18
 Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 14/173 (8%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 180
            + F     LG G F  V+  +  L G+  A+K +        +  +NE+ ++ K++H +
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V L           L+ + +    L  F    ++       A   +I+ +   + YLH+
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGEL--FDRILERGVYTEKDAS-LVIQQVLSAVKYLHE 124

Query: 241 YSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                I+HRDLK  N+L  +   +    I+DFG++++     +        GT
Sbjct: 125 ---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGT 170

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 81.1 bits (200), Expect = 9e-18
 Identities = 43/218 (19%), Positives = 67/218 (30%), Gaps = 56/218 (25%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLTEFKNEMMLIAKLQHRH 180
            +F     +G GGFG V++ +  ++    A+KR+          +   E+  +AKL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI------------- 227
           +VR F   +E        E       D    +P           V+I             
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 228 --IEGIAQGLLY----------LHQYSRLR-----------------------------I 246
                  +  LY          L  +   R                             +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 247 IHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           +HRDLK SNI    D   K+ DFG+      DE +   
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 22/187 (11%)

Query: 115 LASVSAA--TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLTEF 166
           +A+++    TE +    +LG+G F  V +   +L GQE A       +LS +  Q L   
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL--- 57

Query: 167 KNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVR 226
           + E  +   L+H ++VRL     E+G + LI++ +    L  F     ++      A   
Sbjct: 58  EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL--FEDIVAREYYSEADAS-H 114

Query: 227 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGN 283
            I+ I + +L+ HQ   + ++HR+LK  N+LL S       K++DFG+A    G+  Q  
Sbjct: 115 CIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQA 169

Query: 284 TKRIVGT 290
                GT
Sbjct: 170 WFGFAGT 176

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 39/182 (21%), Positives = 73/182 (40%), Gaps = 47/182 (25%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 171
            + +  +  +G G +G V +    L  + VA+K++          F++         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 172 LIAKLQHRHLVRLFGCCI-EQGENI----LIYEYMP---------NKSLDVFLFYPKKKR 217
           ++ +L H H+V++    I +  E      ++ E               L          +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT-----ELHIK 159

Query: 218 LLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 277
            L +         +  G+ Y+H  S   I+HRDLK +N L++ D + K+ DFG+AR    
Sbjct: 160 TLLYN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208

Query: 278 DE 279
            E
Sbjct: 209 PE 210

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.4 bits (196), Expect = 4e-17
 Identities = 40/207 (19%), Positives = 77/207 (37%), Gaps = 65/207 (31%)

Query: 122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKN-EMMLIAKLQHR 179
           ++ +S    LG G FG V +   + +G+  A+K++          +KN E+ ++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60

Query: 180 HLVRLFGCCIEQGENI--------------------------------------LIYEYM 201
           ++++L       G+                                        +I EY+
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 202 PNKSLDVFLFYPKKK--------RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKA 253
           P+    V   + +           +  +Q        + + + ++H    L I HRD+K 
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQ--------LFRAVGFIHS---LGICHRDIKP 169

Query: 254 SNILLDSDMNP-KISDFGMARIFGGDE 279
            N+L++S  N  K+ DFG A+     E
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSE 196

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 78.5 bits (194), Expect = 6e-17
 Identities = 43/170 (25%), Positives = 68/170 (40%), Gaps = 16/170 (9%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCC 188
           LGEG    V     L+  QE AVK +  Q G   +    E+ ++ + Q HR+++ L    
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
            E+    L++E M   S+       K++     +A   +++ +A  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSI--LSHIHKRRHFNELEAS-VVVQDVASALDFLHN---KGIAH 134

Query: 249 RDLKASNILL---DSDMNPKISDFGMARIF-----GGDELQGNTKRIVGT 290
           RDLK  NIL    +     KI DF +                      G+
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 76.2 bits (188), Expect = 5e-16
 Identities = 37/174 (21%), Positives = 65/174 (37%), Gaps = 16/174 (9%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 180
           T+ +  +  +G G +    +        E AVK +         E     +L+   QH +
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           ++ L     +     ++ E M    L       ++K     +A   ++  I + + YLH 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGEL--LDKILRQKFFSEREAS-AVLFTITKTVEYLHA 134

Query: 241 YSRLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 290
                ++HRDLK SNIL   +       +I DFG A+    +   G       T
Sbjct: 135 ---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYT 183

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 21/169 (12%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +G GGFG VY  R  +  ++ A+K L              L E +  + L++      +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 255

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
            +        + +  I + M     D+     +         R    E I  GL ++H  
Sbjct: 256 CMS-YAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFYAAE-IILGLEHMHN- 310

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
               +++RDLK +NILLD   + +ISD G+A  F   +        VGT
Sbjct: 311 --RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 13/165 (7%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG+GGFG V   ++    ++ A K+L  +     +G     NE  ++ K+  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250

Query: 187 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLR 245
              E  + + L+   M    L   +++  +      +A     E I  GL  LH   R R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RER 306

Query: 246 IIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           I++RDLK  NILLD   + +ISD G+A      +     K  VGT
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 12/166 (7%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           LG GGFG V+  ++    ++ A K+L+ +     +G      E  ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 187 CCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRI-IEGIAQGLLYLHQYSRL 244
              E   ++ L+   M    +   ++   +      + R       I  GL +LHQ    
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            II+RDLK  N+LLD D N +ISD G+A      +    TK   GT
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGT 352

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 73.8 bits (180), Expect = 3e-15
 Identities = 34/199 (17%), Positives = 57/199 (28%), Gaps = 46/199 (23%)

Query: 121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRL--------SNQSGQGLTEFKNEMML 172
            TE      K+GEG FG V++    +   VA+K +        +    +   E   E+++
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 173 IAKLQ---------HRHLVRLFGCCIEQG-------------------ENILIYEYMPNK 204
             +L              + L      QG                    N     +  ++
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 205 SLDVFLF-------YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 257
              V  F          + +L        I+  +   L        LR  HRDL   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 258 LDSDMNPKISDFGMARIFG 276
           L      K+      +   
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 73.5 bits (181), Expect = 4e-15
 Identities = 37/186 (19%), Positives = 65/186 (34%), Gaps = 54/186 (29%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGC 187
            LG G  G V +      GQ+ A+K L +       + + E+    +     H+V +   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILD- 89

Query: 188 CIEQGENILIYEYMPNKSLDVFL--------------------FYPKKKRLLGWQARVRI 227
                    +YE M +    + +                     + ++      +A   I
Sbjct: 90  ---------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER------EAA-EI 133

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFGGDELQGNT 284
           +  I   + +LH      I HRD+K  N+L    + D   K++DFG A+    + LQ   
Sbjct: 134 MRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT-- 188

Query: 285 KRIVGT 290
                T
Sbjct: 189 --PCYT 192

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 73.1 bits (180), Expect = 5e-15
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 16/166 (9%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGC 187
            LGEG F    K     + Q  AVK +S +        + E+  +   + H ++V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74

Query: 188 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRII 247
             +Q    L+ E +    L  F    KKK     +A   I+  +   + ++H    + ++
Sbjct: 75  FHDQLHTFLVMELLNGGEL--FERIKKKKHFSETEAS-YIMRKLVSAVSHMHD---VGVV 128

Query: 248 HRDLKASNILL---DSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           HRDLK  N+L    + ++  KI DFG AR+   D      K    T
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFT 172

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 73.1 bits (180), Expect = 5e-15
 Identities = 41/180 (22%), Positives = 66/180 (36%), Gaps = 34/180 (18%)

Query: 122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTE--FKN---------EM 170
              ++ Q  +  G +G V  G    G  VA+KR+ N    G T     +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 171 MLIAKLQHRHLVRLFGCCIEQGENI-----LIYEYMPN------KSLDVFLFYPKKKRLL 219
            L+    H +++ L    +   E       L+ E M            + +  P+  +  
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI-SPQHIQYF 139

Query: 220 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            +         I  GL  LH+     ++HRDL   NILL  + +  I DF +AR    D 
Sbjct: 140 MYH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 72.4 bits (178), Expect = 9e-15
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 15/173 (8%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 180
           ++ F  + +LG G    VY+ +     +  A+K L     + +   + E+ ++ +L H +
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPN 109

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +++L        E  L+ E +    L  F    +K       A    ++ I + + YLH+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL--FDRIVEKGYYSERDAA-DAVKQILEAVAYLHE 166

Query: 241 YSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                I+HRDLK  N+L      D   KI+DFG+++I     L    K + GT
Sbjct: 167 ---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 16/206 (7%)

Query: 90  RRRKHKEKDGEGNDKSKDSWLPLFSLASVSAAT-ENFSTQCKLGEGGFGPVYKGRL-LNG 147
           ++   +E   E   K+K+ +L  +   S + A  + F     LG G FG V   +   +G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 148 QEVAVKRLSNQSGQGLTEF---KNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 204
              A+K L  Q    L +     NE  ++  +    LV+L     +     ++ EY+   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 264
            +  F    +  R     AR    + I     YLH      +I+RDLK  N+L+D     
Sbjct: 127 EM--FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYI 180

Query: 265 KISDFGMARIFGGDELQGNTKRIVGT 290
           +++DFG A+      ++G T  + GT
Sbjct: 181 QVTDFGFAK-----RVKGRTWTLCGT 201

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 36/182 (19%), Positives = 76/182 (41%), Gaps = 47/182 (25%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 171
            +N+  +  +G G +G VY        + VA+K+++         F++         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77

Query: 172 LIAKLQHRHLVRLFGCCI----EQGENI-LIYEYMP---------NKSLDVFLFYPKKKR 217
           ++ +L+  +++RL+   I     + + + ++ E               L       +  +
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT-----EEHIK 132

Query: 218 LLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG 277
            + +         +  G  ++H      IIHRDLK +N LL+ D + K+ DFG+AR    
Sbjct: 133 TILYN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181

Query: 278 DE 279
           ++
Sbjct: 182 EK 183

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.2 bits (175), Expect = 3e-14
 Identities = 41/176 (23%), Positives = 78/176 (44%), Gaps = 38/176 (21%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 171
            + + +   +G G +G V       +G++VA+K+LS         F++         E++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 172 LIAKLQHRHLVRLF-----GCCIEQGENI-LIYEYMPNKSLDVFL---FYPKKKRLLGWQ 222
           L+  +QH +++ L         +    +  L+  +M    L   +   F  +K + L +Q
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQ 134

Query: 223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
                   + +GL Y+H      ++HRDLK  N+ ++ D   KI DFG+AR    +
Sbjct: 135 --------MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.4 bits (173), Expect = 5e-14
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 37/176 (21%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 171
              ++    +GEG +G V      LN   VA+K++S         F++         E+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 172 LIAKLQHRHLVRLFGC----CIEQGENI-LIYEYMP---NKSLDVFLFYPKKKRLLGWQA 223
           ++ + +H +++ +        IEQ +++ ++ + M     K L              +Q 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136

Query: 224 RVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
                  I +GL Y+H  S   ++HRDLK SN+LL++  + KI DFG+AR+   D 
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 70.3 bits (172), Expect = 7e-14
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 32/174 (18%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 171
            + +     +G G  G V      +  + VA+K+LS         F+N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113

Query: 172 LIAKLQHRHLVRLF-----GCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARV 225
           L+  + H++++ L         +E+ +++ L+ E M     D  L    +  L   +   
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSY 168

Query: 226 RIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            + + +  G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR  G   
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 70.2 bits (172), Expect = 8e-14
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 12/173 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTE---FKNEMMLIAKLQH 178
           E+F     +G G FG V   +L N  +V A+K L+        E   F+ E  ++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 179 RHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           + +  L     +   N+ L+ +Y     L + L    + RL    AR  + E +   +  
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           +HQ   L  +HRD+K  NIL+D + + +++DFG       D     +   VGT
Sbjct: 191 VHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGT 239

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 40/177 (22%), Positives = 72/177 (40%), Gaps = 20/177 (11%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIA 174
           ++F     +G G F  V   ++    +V A+K ++        +       F+ E  ++ 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC----FREERDVLV 116

Query: 175 KLQHRHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
               R + +L     +    + L+ EY     L + L     +R+    AR  + E I  
Sbjct: 117 NGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVM 173

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            +  +H+   L  +HRD+K  NILLD   + +++DFG       D     +   VGT
Sbjct: 174 AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGT 226

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 16/174 (9%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTE---FKNEMMLIAKLQH 178
           E++     +G G FG V   R  + ++V A+K LS       ++   F  E  ++A    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 179 RHLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
             +V+LF     Q +  L  + EYMP   L   +       +    AR    E +   L 
Sbjct: 129 PWVVQLFYAF--QDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAE-VVLALD 182

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            +H    +  IHRD+K  N+LLD   + K++DFG       + +       VGT
Sbjct: 183 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGT 232

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 33/161 (20%), Positives = 70/161 (43%), Gaps = 21/161 (13%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HR 179
            +++    KLG G +  V++   + N ++V VK L     +   + K E+ ++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91

Query: 180 HLVRLFGCCIEQGEN--ILIYEYMPNKSLDVFL--FYPKKKRLLGWQARVRIIEGIAQGL 235
           +++ L     +       L++E++ N               R   ++        I + L
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKAL 143

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIF 275
            Y H  S   I+HRD+K  N+++D +    ++ D+G+A  +
Sbjct: 144 DYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 22/173 (12%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---EMMLIAKLQ 177
              +     LG GG G V+        + VA+K++           K+   E+ +I +L 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLD 66

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYP----------KKKRLLGWQARVRI 227
           H ++V++F      G  +        +   V++             ++  LL   AR+  
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-F 125

Query: 228 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGDE 279
           +  + +GL Y+H  +   ++HRDLK +N+ +++ D+  KI DFG+ARI     
Sbjct: 126 MYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 40/176 (22%), Positives = 70/176 (39%), Gaps = 37/176 (21%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 171
              +     +G G +G V        G +VA+K+L          F++         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76

Query: 172 LIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPK---------KKRLLGWQ 222
           L+  ++H +++ L         ++   +   +   D +L  P          K   LG  
Sbjct: 77  LLKHMRHENVIGLL--------DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128

Query: 223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
               ++  + +GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR    +
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 68.6 bits (168), Expect = 2e-13
 Identities = 36/176 (20%), Positives = 63/176 (35%), Gaps = 33/176 (18%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGC 187
            LG G  G V +       ++ A+K L +       + + E+ L  +     H+VR+   
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV 123

Query: 188 CIEQGENILIYEYMPNKSLDVF-------LF---YPKKKRLLGWQARVRIIEGIAQGLLY 237
             E          +      V        LF     +  +    +    I++ I + + Y
Sbjct: 124 Y-ENLYAGRKCLLI------VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 238 LHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           LH    + I HRD+K  N+L  S   +   K++DFG A+         +      T
Sbjct: 177 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYT 226

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 46/182 (25%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 171
            + +     +G G  G V      +  + VA+K+LS         F+N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76

Query: 172 LIAKLQHRHLVRLF-----GCCIEQGENI-LIYEYMP-------NKSLDVFLFYPKKKRL 218
           L+  + H++++ L         +E+ +++ ++ E M           LD      ++   
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-----HERMSY 131

Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           L +Q        +  G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR  G  
Sbjct: 132 LLYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180

Query: 279 EL 280
            +
Sbjct: 181 FM 182

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 66.9 bits (164), Expect = 7e-13
 Identities = 40/177 (22%), Positives = 72/177 (40%), Gaps = 47/177 (26%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 171
           + +F  +  LGEG +G V        G+ VA+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 172 LIAKLQHRHLVRLFGC----CIEQGENI-LIYEYMP--------NKSLDVFLFYPKKKRL 218
           ++   +H +++ +F        E    + +I E M          + L          + 
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS-----DDHIQY 116

Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF 275
             +Q          + +  LH  +   +IHRDLK SN+L++S+ + K+ DFG+ARI 
Sbjct: 117 FIYQ--------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.8 bits (161), Expect = 1e-12
 Identities = 36/161 (22%), Positives = 63/161 (39%), Gaps = 36/161 (22%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGC 187
            LG G  G V +       ++ A+K L +       + + E+ L  +  Q  H+VR+   
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVD- 78

Query: 188 CIEQGENILIYEYMPNKSLDVF----------LF---YPKKKRLLGWQARVRIIEGIAQG 234
                    +YE +      +           LF     +  +    +    I++ I + 
Sbjct: 79  ---------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMA 272
           + YLH    + I HRD+K  N+L  S   +   K++DFG A
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 171
              +    KLG+G +G V+K      G+ VAVK++ +        F+N         E+M
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60

Query: 172 LIAKLQ-HRHLVRLFGCCI-EQGENI-LIYEYMP--------NKSLDVFLFYPKKKRLLG 220
           ++ +L  H ++V L      +   ++ L+++YM            L+     P  K+ + 
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE-----PVHKQYVV 115

Query: 221 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
           +Q        + + + YLH  S   ++HRD+K SNILL+++ + K++DFG++R F     
Sbjct: 116 YQ--------LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164

Query: 281 QGNTKR 286
             N   
Sbjct: 165 VTNNIP 170

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 65.2 bits (160), Expect = 2e-12
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 15/172 (8%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTEF---KNEMMLIAKLQH 178
           ++F     LG G FG V+  R  +     A+K L  +    L +     +E ++++ + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
             ++R++G   +  +  +I +Y+    L  F    K +R     A+    E +   L YL
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALEYL 122

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           H      II+RDLK  NILLD + + KI+DFG A+      +   T  + GT
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 37/171 (21%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKN---------EMM 171
            E +     +G G +G V        G  VAVK+LS         F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 172 LIAKLQHRHLVRLF-----GCCIEQGENI-LIYEYMP---NKSLDVFLFYPKKKRLLGWQ 222
           L+  ++H +++ L         +E+  ++ L+   M    N  +          + L +Q
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140

Query: 223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
                   I +GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR
Sbjct: 141 --------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 64.7 bits (158), Expect = 5e-12
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 16/157 (10%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLTEFKN---EMMLIAKLQHRHLVRLFG 186
           +G+G FG V   +  + +++ A+K ++ Q      E +N   E+ ++  L+H  LV L+ 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81

Query: 187 CCIEQGENI-LIYEYMPNKSLDVFLFY--PKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
              +  E++ ++ + +    L     Y   +         ++ I E +   L YL     
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFKEETVKLFICE-LVMALDYLQN--- 133

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
            RIIHRD+K  NILLD   +  I+DF +A +   +  
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.9 bits (156), Expect = 7e-12
 Identities = 37/165 (22%), Positives = 66/165 (40%), Gaps = 27/165 (16%)

Query: 124 NFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH-RHL 181
           NF    K+G G FG +  G+ L   + VA+K    +S     +   E     +L     +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67

Query: 182 VRLFGCCIEQGENILIYEYMPNKSL-DVFLFYPKKKRL-----LGWQARVRIIEGIAQGL 235
            +++        N ++ E +   SL D+F    +   L     +  Q  +  +E      
Sbjct: 68  PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQL-ISRME------ 119

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARIF 275
            Y+H  +   +I+RD+K  N L+    N       I DF +A+ +
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.8 bits (153), Expect = 1e-11
 Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 29/160 (18%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFG 186
           ++GEG FG +++G  LLN Q+VA+K    +S   Q   E++   +L        +  ++ 
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TGIPNVYY 73

Query: 187 CCIEQGENILIYEYMPNKSL-DVFLFYPKKKRL-----LGWQARVRIIEGIAQGLLYLHQ 240
              E   N+L+ + +   SL D+     +K  +        Q  +  ++        +H+
Sbjct: 74  FGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQM-LARVQ-------SIHE 124

Query: 241 YSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARIF 275
            S   +++RD+K  N L+    +       + DFGM + +
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 25/176 (14%), Positives = 56/176 (31%), Gaps = 43/176 (24%)

Query: 130 KLGEGGFGPVYKGR---------LLNGQEVAVKRLSNQSGQGLTEFK-----------NE 169
                  G +Y+               Q+ ++K L  + G+   E             N+
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 170 MMLIAKLQHRHLVRLFGCCIEQGE-NILIYEYMPNKSL-DVFLFYPKKK------RLLGW 221
              +       +    G  + Q +   L+   +  +SL       PK          +  
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVAC 166

Query: 222 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARIF 275
           +  +  +E       +LH+      +H ++ A NI +D +   ++  + +G A  +
Sbjct: 167 RL-LDALE-------FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 35/175 (20%), Positives = 67/175 (38%), Gaps = 41/175 (23%)

Query: 130 KLGEGGFGPVYKGRLLNGQ------EVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR 183
            +G+GGFG +Y   + + +         VK   + +G   TE K         Q +  +R
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 184 L-------------FGCCIEQGE--NILIYEYMPNKSL-DVFLFYPKKKRL-----LGWQ 222
                          G   + G+    +I +      L  ++    K+        L  +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLR 160

Query: 223 ARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARIF 275
             + I+E       Y+H++     +H D+KASN+LL+     ++   D+G+A  +
Sbjct: 161 I-LDILE-------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 62.6 bits (152), Expect = 2e-11
 Identities = 33/160 (20%), Positives = 55/160 (34%), Gaps = 19/160 (11%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LTEFKNEM-MLIA 174
           +       LG G FG V +            + VAVK L   +         +E+ +LI 
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 175 KLQHRHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
              H ++V L G C + G  + +I E+    +L  +L             R   +    +
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           G  +      +  I  DLK     + S  +   S F   +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 2e-09
 Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +A+G+ +L   +  + IHRDL A NILL      KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 25/157 (15%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGC 187
           K+G G FG +Y G  +   +EVA+K  + ++     +   E  +   LQ    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71

Query: 188 CIEQGENILIYEYMPNKSL-DVFLFYPKKKRL-----LGWQARVRIIEGIAQGLLYLHQY 241
            +E   N+L+ + +   SL D+F F  +K  L     L  Q  +  +E       ++H  
Sbjct: 72  GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM-INRVE-------FVHSK 122

Query: 242 SRLRIIHRDLKASNILLDSDMNPK---ISDFGMARIF 275
           S    +HRD+K  N L+          I DFG+A+ +
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 19/151 (12%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           LG+G FG V   +        A+K L        ++    LTE +    ++   +H  L 
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR----VLQNSRHPFLT 211

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
            L     +  + +  + EY      ++F    +++     +AR    E I   L YLH  
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAE-IVSALDYLH-- 265

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
           S   +++RDLK  N++LD D + KI+DFG+ 
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 61.6 bits (150), Expect = 3e-11
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 25/157 (15%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH-RHLVRLFGC 187
           K+G G FG +Y G  +  G+EVA+K    ++         E  +   +Q    +  +  C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73

Query: 188 CIEQGENILIYEYMPNKSL-DVFLFYPKKKRL-----LGWQARVRIIEGIAQGLLYLHQY 241
             E   N+++ E +   SL D+F F  +K  L     L  Q  +  IE       Y+H  
Sbjct: 74  GAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQM-ISRIE-------YIHSK 124

Query: 242 SRLRIIHRDLKASNILLDSDMNPK---ISDFGMARIF 275
           +    IHRD+K  N L+          I DFG+A+ +
Sbjct: 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 60.7 bits (148), Expect = 8e-11
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 21/159 (13%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +G G +  V   RL     + A+K +               TE K+     +   H  LV
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE-KHVFEQASN--HPFLV 73

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
            L   C +    +  + EY+     D+     ++++L    AR    E I+  L YLH+ 
Sbjct: 74  GLH-SCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHE- 128

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 278
               II+RDLK  N+LLDS+ + K++D+GM +  +  GD
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 60.7 bits (148), Expect = 8e-11
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 19/151 (12%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +G+G FG V   R    +   AVK L         +    ++E +N  +L+  ++H  LV
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE-RN--VLLKNVKHPFLV 102

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
            L     +  + +  + +Y+     ++F    +++  L  +AR    E IA  L YLH  
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAE-IASALGYLHS- 157

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             L I++RDLK  NILLDS  +  ++DFG+ 
Sbjct: 158 --LNIVYRDLKPENILLDSQGHIVLTDFGLC 186

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 37/164 (22%), Positives = 70/164 (42%), Gaps = 25/164 (15%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLTEFK-------NEMMLIAKLQH 178
           KLG G F  V+  + ++N   VA+K +            E K        +      +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 179 RHLVRLFGCCIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG 234
            H+++L      +G N     +++E +  ++L   +   + + +     + +I + +  G
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLLLG 143

Query: 235 LLYLHQYSRLRIIHRDLKASNILLDSDMNP------KISDFGMA 272
           L Y+H   R  IIH D+K  N+L++   +P      KI+D G A
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 21/159 (13%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +G G +  V   RL     + A++ +               TE K+     +   H  LV
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE-KHVFEQASN--HPFLV 116

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
            L   C +    +  + EY+     D+     ++++L    AR    E I+  L YLH+ 
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHE- 171

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 278
               II+RDLK  N+LLDS+ + K++D+GM +  +  GD
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 59.9 bits (146), Expect = 1e-10
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 21/159 (13%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           LG+G FG V+        +  A+K L        +     + E K   +L    +H  L 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE-KR--VLSLAWEHPFLT 81

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
            +F C  +  EN+  + EY+     D+        +    +A     E I  GL +LH  
Sbjct: 82  HMF-CTFQTKENLFFVMEYLNGG--DLMYHIQSCHKFDLSRATFYAAE-IILGLQFLHS- 136

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 278
               I++RDLK  NILLD D + KI+DFGM +  + G  
Sbjct: 137 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 59.5 bits (145), Expect = 2e-10
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 21/159 (13%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           LG+G FG V         E+ AVK L        +     + E K   +L    +   L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE-KR--VLALPGKPPFLT 84

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +L   C +  + +  + EY+     D+     +  R     A     E IA GL +L   
Sbjct: 85  QLH-SCFQTMDRLYFVMEYVNGG--DLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQS- 139

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 278
               II+RDLK  N++LDS+ + KI+DFGM +  I+ G 
Sbjct: 140 --KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 44/167 (26%), Positives = 70/167 (41%), Gaps = 21/167 (12%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIA 174
            +F+    LG+G FG V         E+ AVK L        +     + E K   +L  
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE-KR--VLAL 397

Query: 175 KLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEG-IAQ 233
             +   L +L  C         + EY+    L   +++ ++      +         IA 
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFK-EPHAVFYAAEIAI 453

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 278
           GL +L       II+RDLK  N++LDS+ + KI+DFGM +  I+ G 
Sbjct: 454 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 19/158 (12%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           LG+G FG V   R+    ++ AVK L        +     +TE K   +L     H  L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE-KR--ILSLARNHPFLT 87

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +LF C         + E++     D+     K +R    +AR    E I   L++LH   
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAE-IISALMFLHD-- 142

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMA--RIFGGD 278
              II+RDLK  N+LLD + + K++DFGM    I  G 
Sbjct: 143 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 58.4 bits (142), Expect = 4e-10
 Identities = 40/159 (25%), Positives = 68/159 (42%), Gaps = 22/159 (13%)

Query: 131 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLTEFKNEMMLIAKLQHRHLV 182
           LG+G FG V   R        A+K L        ++    +TE      ++   +H  L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE-SR---VLQNTRHPFLT 68

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
            L     +  + +  + EY      ++F    +++     +AR    E I   L YLH  
Sbjct: 69  ALK-YAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE-IVSALEYLHS- 123

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR--IFGGD 278
               +++RD+K  N++LD D + KI+DFG+ +  I  G 
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.2 bits (141), Expect = 7e-10
 Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 23/157 (14%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHR------ 179
            +G+G FG V K    +  + VA+K + N+     Q   E +    L+  +         
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHDTEMKY 116

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRII-EGIAQGLLY 237
           ++V L    + +    L++E +   S +++    +     G      R   + +   LL+
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML---SYNLYDLL-RNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMA 272
           L     L IIH DLK  NILL +      KI DFG +
Sbjct: 173 LAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 57.2 bits (139), Expect = 1e-09
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 18/151 (11%)

Query: 131 LGEGGFGPVYKGRLLNGQEV----AVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRL 184
           LG+G FG V+  + ++G +     A+K L   +   +     K E  ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 185 FGCCIEQGENI-LIYEYMPNKSLDVFLFY--PKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
                +    + LI +++    L    F    K+        +  + E +A  L +LH  
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE-LALALDHLHS- 144

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
             L II+RDLK  NILLD + + K++DFG++
Sbjct: 145 --LGIIYRDLKPENILLDEEGHIKLTDFGLS 173

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 34/168 (20%), Positives = 66/168 (39%), Gaps = 30/168 (17%)

Query: 130 KLGEGGFGPVYKG-RLLNGQEVA---VKRLSNQSGQGLTEFKNEMML-----IAKLQHRH 180
           K+G GGFG +Y        ++ A   VK    ++G   +E K    +     I K   R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 181 L--------VRLFGCCIEQGE--NILIYEYMPNKSL-DVFLFYPKKKRLLGWQARVRIIE 229
                        G    +G     ++ E +    L  +       K+    Q  +R+++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLD 162

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARIF 275
            +     Y+H+      +H D+KA+N+LL      ++  +D+G++  +
Sbjct: 163 VLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 56.1 bits (136), Expect = 3e-09
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 24/173 (13%)

Query: 131 LGEGGFGPVYKGRLLNGQEV----AVKRLS--------NQSGQGLTEFKNEMMLIAKLQH 178
           LG G +G V+  R ++G +     A+K L           +    TE +   +L    Q 
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE-RQ--VLEHIRQS 118

Query: 179 RHLVRLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
             LV L     +    + LI +Y+    L  F    +++R    + ++ + E I   L +
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IVLALEH 174

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           LH+   L II+RD+K  NILLDS+ +  ++DFG+++ F  DE +       GT
Sbjct: 175 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 55.6 bits (135), Expect = 4e-09
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 16/151 (10%)

Query: 131 LGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLTEFKNEMMLIAKLQHRHLV 182
           LG+GG+G V++ R + G       A+K L      ++ +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
            L     + G  + LI EY+    L  F+   ++   +   A   + E I+  L +LHQ 
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISMALGHLHQ- 139

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMA 272
               II+RDLK  NI+L+   + K++DFG+ 
Sbjct: 140 --KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 55.9 bits (135), Expect = 5e-09
 Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 25/156 (16%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHR------H 180
           +G+G FG V K       Q VA+K + N+     Q   E +    ++  L+ +      +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRII-EGIAQGLLYL 238
           ++ +      +    + +E +   S++++    KK +  G+    VR     I Q L  L
Sbjct: 161 VIHMLENFTFRNHICMTFELL---SMNLYELI-KKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMA 272
           H   + RIIH DLK  NILL        K+ DFG +
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.5 bits (118), Expect = 4e-07
 Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 18/172 (10%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ--------HRH 180
           KLG G F  V+    +   + VA+K + +      T   +E+ L+  ++           
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102

Query: 181 LVRLFGCCIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
           +V+L       G N     +++E +    L  ++     + L     + +II+ + QGL 
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLD 160

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
           YLH  ++ RIIH D+K  NILL  +          A  +        +   V
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 46.9 bits (112), Expect = 3e-06
 Identities = 37/168 (22%), Positives = 63/168 (37%), Gaps = 22/168 (13%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHR-----H 180
           K+G+G FG V   + + N +  AVK + N          E      ++ K+Q+      +
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDDINNNN 97

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVR-IIEGIAQGLLYL 238
           +V+  G  +      LI+E +      ++     +    G+    ++     I + L YL
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPL---GPSLYEII-TRNNYNGFHIEDIKLYCIEILKALNYL 153

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
               ++ + H DLK  NILLD     K          G       TK 
Sbjct: 154 R---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 32/157 (20%), Positives = 57/157 (36%), Gaps = 24/157 (15%)

Query: 130 KLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHR----- 179
            LGEG FG V +         +VA+K + N          E      ++ K++ +     
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEKDKENK 81

Query: 180 -HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRII-EGIAQGLL 236
              V +       G   + +E +  K+   FL   K+     +    VR +   +   L 
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFL---KENNFQPYPLPHVRHMAYQLCHALR 137

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +LH     ++ H DLK  NIL  +     + +   + 
Sbjct: 138 FLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 34/157 (21%), Positives = 61/157 (38%), Gaps = 24/157 (15%)

Query: 130 KLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHR----- 179
            LGEG FG V +       G+ VAVK + N         +E +    ++  L        
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ----VLEHLNTTDPNST 76

Query: 180 -HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQ-ARVRII-EGIAQGLL 236
              V++       G   +++E +    L  + F  K+   L ++   +R +   I + + 
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELL---GLSTYDFI-KENGFLPFRLDHIRKMAYQICKSVN 132

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
           +LH     ++ H DLK  NIL       +  +  + R
Sbjct: 133 FLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 7e-05
 Identities = 42/277 (15%), Positives = 83/277 (29%), Gaps = 88/277 (31%)

Query: 35  FGDLIDLRKPISNFTGQSV--YIRVPAPEQGNKKLLWIIVVLVLPVVLLPSFYIFRRRRR 92
             D+ D+ K I   + + +   I       G  +L W                    ++ 
Sbjct: 35  CKDVQDMPKSI--LSKEEIDHIIMSKDAVSGTLRLFWT----------------LLSKQE 76

Query: 93  KHKEKDGEGNDKSKDSWLPLFSLASVSAATENFSTQCKLGEGGFGPV--------YKGRL 144
           +  +K  E   +    +L                T+ +       P          + RL
Sbjct: 77  EMVQKFVEEVLRINYKFL-----------MSPIKTEQR------QPSMMTRMYIEQRDRL 119

Query: 145 LNGQEV----AVKRLS--NQSGQGLTEFKNE-------MM------LIA------KLQHR 179
            N  +V     V RL    +  Q L E +         ++      +        K+Q +
Sbjct: 120 YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK 179

Query: 180 HLVRLF----GCC------IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIE 229
              ++F      C      +E  +  L+Y+  PN +         K R+   QA +R   
Sbjct: 180 MDFKIFWLNLKNCNSPETVLEMLQK-LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR-- 236

Query: 230 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 266
                LL    Y    ++  +++ +      +++ KI
Sbjct: 237 -----LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI 268

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	290
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.98
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.97
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.97
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.97
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.97
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.97
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.97
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.97
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.97
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.97
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.97
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.97
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.97
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.96
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.96
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.96
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.96
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.96
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.96
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.96
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.96
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.96
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.96
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.96
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.96
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.96
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.96
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.96
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.96
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.96
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.96
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.96
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.96
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.96
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.96
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.96
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.96
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.96
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.96
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.96
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.96
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.96
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.96
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.96
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.96
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.96
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.96
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.96
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.96
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.96
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.96
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.96
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.96
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.96
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.96
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.96
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.96
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.96
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.96
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.96
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.96
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.96
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.96
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.96
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.96
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.96
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.96
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.96
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.96
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.95
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.95
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.95
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.95
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.95
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.95
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.95
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.95
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.95
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.95
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.95
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.95
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.95
3bhy_A	283	Death-associated protein kinase 3; death associate	99.95
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.95
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.95
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.95
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.95
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.95
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.95
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.95
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.95
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.95
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.95
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.95
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.95
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.95
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.95
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.95
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.95
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.95
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.95
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.95
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.95
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.95
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.95
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.95
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.95
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.95
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.95
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.95
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.95
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.95
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.95
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.95
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.95
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.95
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.95
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.95
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.95
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.95
3uqc_A	286	Probable conserved transmembrane protein; structur	99.95
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.95
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.95
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.95
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.95
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.95
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.95
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.95
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.95
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.95
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.95
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.95
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.95
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.95
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.94
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.94
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.94
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.94
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.94
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.94
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.94
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.94
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.94
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.94
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.94
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.94
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.94
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.94
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.94
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.94
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.94
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.94
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.94
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.93
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.93
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.93
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.93
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.93
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.93
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.93
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.93
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.93
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.93
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.92
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.55
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.31
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.86
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.83
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.77
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.67
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.64
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.64
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.33
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.32
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.18
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.18
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.01
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.86
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.8
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.66
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.6
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.52
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.48
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.37
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.28
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.08
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.52
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.02
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.74
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	93.73
2ll3_A	82	Micronemal protein 4; cell adhesion; NMR {Toxoplas	93.36
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.12
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.03
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.93
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	84.09
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	82.87
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	80.91

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1e-40  Score=284.84  Aligned_cols=165  Identities=32%  Similarity=0.519  Sum_probs=140.3

Q ss_pred             cCCCccceecccCCccEEEEEEc------CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++|...+.||+|+||+||+|++.      ++..||||+++.......++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888899999999999999863      367899999987666667889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEE
Q 022887          197 IYEYMPNKSLDVFLFYP----------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  266 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl  266 (290)
                      ||||+++|+|.+++...          .....++|.+++.|+.|+++||+|||+++   |+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            99999999999998642          22456999999999999999999999987   999999999999999999999


Q ss_pred             eeccCceeeCCCccccCcceeecC
Q 022887          267 SDFGMARIFGGDELQGNTKRIVGT  290 (290)
Q Consensus       267 ~DfGla~~~~~~~~~~~~~~~~Gt  290 (290)
                      +|||+|+..........+....||
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt  193 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLP  193 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEEC
T ss_pred             CCcccceecCCCCceeecCceecC
Confidence            999999987654433333334454

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=285.15  Aligned_cols=165  Identities=32%  Similarity=0.516  Sum_probs=132.9

Q ss_pred             cCCCccceecccCCccEEEEEEc------CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++|...++||+|+||.||+|++.      ++..||||+++.......++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56777889999999999999864      467899999987666667889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCe
Q 022887          197 IYEYMPNKSLDVFLFYPK------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  264 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~  264 (290)
                      ||||+++|+|.+++....            ....++|.+++.|+.|+|+||+|||+++   |+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999986532            1346999999999999999999999987   9999999999999999999


Q ss_pred             EEeeccCceeeCCCccccCcceeecC
Q 022887          265 KISDFGMARIFGGDELQGNTKRIVGT  290 (290)
Q Consensus       265 kl~DfGla~~~~~~~~~~~~~~~~Gt  290 (290)
                      ||+|||+|+.+........+....||
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt  223 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLP  223 (329)
T ss_dssp             EECCCC----------------CCCC
T ss_pred             EEcccccceeccCCCcceecCccccc
Confidence            99999999987654433333334454

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.9e-40  Score=280.46  Aligned_cols=165  Identities=32%  Similarity=0.474  Sum_probs=138.8

Q ss_pred             cCCCccceecccCCccEEEEEEc------CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      ++++..+.||+|+||+||+|.+.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45667789999999999999862      46789999997543 345678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC
Q 022887          196 LIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~  262 (290)
                      +||||+++|+|.++|.....             ...++|.++++|+.|||+||+|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999864321             246899999999999999999999987   99999999999999999


Q ss_pred             CeEEeeccCceeeCCCccccCcceeecC
Q 022887          263 NPKISDFGMARIFGGDELQGNTKRIVGT  290 (290)
Q Consensus       263 ~~kl~DfGla~~~~~~~~~~~~~~~~Gt  290 (290)
                      .+||+|||+|+.+........+....||
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt  210 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLP  210 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred             CEEECCcccceeccCCCceeEecccccC
Confidence            9999999999987654433333344554

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.3e-39  Score=275.37  Aligned_cols=162  Identities=30%  Similarity=0.416  Sum_probs=144.6

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||+||+|+. .+++.||||.+.+.   .......+.+|+.++++++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999987 45899999999643   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|+|.+++..   ...+++.+...++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999998843   356999999999999999999999988   999999999999999999999999999998766


Q ss_pred             ccccCcceeecC
Q 022887          279 ELQGNTKRIVGT  290 (290)
Q Consensus       279 ~~~~~~~~~~Gt  290 (290)
                      .....+...+||
T Consensus       186 ~~~~~~~~~~GT  197 (311)
T 4aw0_A          186 SKQARANSFVGT  197 (311)
T ss_dssp             TTCCCBCCCCSC
T ss_pred             CCcccccCcccC
Confidence            555555567787

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=275.02  Aligned_cols=161  Identities=28%  Similarity=0.462  Sum_probs=131.4

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .+++...+.||+|+||+||+|++.+  .||||.++...  ....++|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            4678888999999999999998753  69999986432  3345789999999999999999999998864 57899999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      |+++|+|.+++...  ...++|.+++.|+.|+|.||+|||+++   ||||||||+||||++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999998543  346999999999999999999999987   9999999999999999999999999999876544


Q ss_pred             cccCcceeecC
Q 022887          280 LQGNTKRIVGT  290 (290)
Q Consensus       280 ~~~~~~~~~Gt  290 (290)
                      ....+...+||
T Consensus       187 ~~~~~~~~~GT  197 (307)
T 3omv_A          187 GSQQVEQPTGS  197 (307)
T ss_dssp             -------CCCC
T ss_pred             cceeecccccC
Confidence            33334455666

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-38  Score=276.29  Aligned_cols=159  Identities=26%  Similarity=0.401  Sum_probs=141.7

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      +.|+..+.||+|+||.||+|... +++.||||++........+.+.+|+.++..++|||||++++++.+.+..|+||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999884 58999999997665566678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCccc
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ  281 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  281 (290)
                      ++|+|.+++..    ..+++.+...++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+..+...
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999998843    45899999999999999999999988   999999999999999999999999999988654322


Q ss_pred             cCcceeecC
Q 022887          282 GNTKRIVGT  290 (290)
Q Consensus       282 ~~~~~~~Gt  290 (290)
                        +...+||
T Consensus       227 --~~~~~GT  233 (346)
T 4fih_A          227 --RKSLVGT  233 (346)
T ss_dssp             --BCCCCSC
T ss_pred             --ccccccC
Confidence              2345676

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.2e-38  Score=277.34  Aligned_cols=160  Identities=26%  Similarity=0.398  Sum_probs=142.4

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .+.|+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++..++|||||++++++.+.+..|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            356999999999999999999874 5899999999866666667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCcc
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL  280 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~  280 (290)
                      |++|+|.+++..    ..+++.+...|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+..+..
T Consensus       230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            999999998843    35899999999999999999999988   99999999999999999999999999998865432


Q ss_pred             ccCcceeecC
Q 022887          281 QGNTKRIVGT  290 (290)
Q Consensus       281 ~~~~~~~~Gt  290 (290)
                      .  ....+||
T Consensus       303 ~--~~~~~GT  310 (423)
T 4fie_A          303 R--RKSLVGT  310 (423)
T ss_dssp             C--BCCCEEC
T ss_pred             c--ccccccC
Confidence            2  3345676

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-38  Score=275.15  Aligned_cols=152  Identities=24%  Similarity=0.395  Sum_probs=130.3

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+.++.||+|+||+||+|+. .+++.||||.+....  ......+.+|+.++++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999987 458999999997532  2345689999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+++|+|.+++... ....+++.+.+.|+.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999988542 3445789999999999999999999988   999999999999999999999999999987543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.5e-37  Score=265.57  Aligned_cols=155  Identities=26%  Similarity=0.409  Sum_probs=127.5

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE------  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------  193 (290)
                      .++|+..+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++|||||++++++.+.+.      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            35789999999999999999987 4589999999965332 334678999999999999999999999876543      


Q ss_pred             ------eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEe
Q 022887          194 ------NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       194 ------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                            .|+||||+++|+|.+++.........++...+.|+.|++.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                  6899999999999999865544445677888999999999999999988   9999999999999999999999


Q ss_pred             eccCceeeCCCc
Q 022887          268 DFGMARIFGGDE  279 (290)
Q Consensus       268 DfGla~~~~~~~  279 (290)
                      |||+|+.++.+.
T Consensus       161 DFGla~~~~~~~  172 (299)
T 4g31_A          161 DFGLVTAMDQDE  172 (299)
T ss_dssp             CCCCC-------
T ss_pred             cCccceecCCCc
Confidence            999999887654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.6e-37  Score=266.19  Aligned_cols=162  Identities=27%  Similarity=0.350  Sum_probs=129.8

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC----eeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG----ENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  198 (290)
                      ++|...+.||+|+||.||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++|++.+.+    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577789999999999999998 578999999965322 1223345666677899999999999998764    579999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      ||+++|+|.+++..    ..++|..+.+++.|+++||+|||++     ..++|+||||||+|||+++++++||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999853    4589999999999999999999986     23459999999999999999999999999999


Q ss_pred             eeCCCccc--cCcceeecC
Q 022887          274 IFGGDELQ--GNTKRIVGT  290 (290)
Q Consensus       274 ~~~~~~~~--~~~~~~~Gt  290 (290)
                      ........  ..+...+||
T Consensus       157 ~~~~~~~~~~~~~~~~~GT  175 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGT  175 (303)
T ss_dssp             EEETTTTEESCC-----CC
T ss_pred             cccCCCCceeeeccccccc
Confidence            88654322  223344565

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.3e-37  Score=257.33  Aligned_cols=151  Identities=30%  Similarity=0.508  Sum_probs=125.1

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||+||+|.. .+++.||||.+.+..   ......+.+|+.++++++|||||++++++.+.+..++|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            36899999999999999999987 458999999996532   23456799999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+ +|+|.+++..   ...+++.+...++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+....
T Consensus        92 mEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 5788887743   356999999999999999999999988   99999999999999999999999999998755


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      ..
T Consensus       165 ~~  166 (275)
T 3hyh_A          165 GN  166 (275)
T ss_dssp             --
T ss_pred             CC
Confidence            43

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.4e-37  Score=265.94  Aligned_cols=146  Identities=28%  Similarity=0.354  Sum_probs=128.5

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      +.|...+.||+|+||.||+|+. .+++.||||+++....     ..+|+.++..++|||||++++++.+.+..|+||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4677888999999999999987 4589999999975322     246999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-CeEEeeccCceeeCCCc
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFGGDE  279 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~~~~  279 (290)
                      ++|+|.+++..   ...+++.+...++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+|+.+..+.
T Consensus       133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999843   356999999999999999999999887   99999999999999987 69999999999887654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-37  Score=260.19  Aligned_cols=157  Identities=29%  Similarity=0.439  Sum_probs=131.3

Q ss_pred             CccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEe----CCeeEEEE
Q 022887          126 STQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGENILIY  198 (290)
Q Consensus       126 ~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  198 (290)
                      ...+.||+|+||.||+|.+. ++..||+|.+....  ......|.+|+.++++++|||||++++++..    .+..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999874 58899999996432  2335679999999999999999999999875    24579999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc-CCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++|+|.+++..   ...+++.....|+.|++.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999843   456899999999999999999999864 4599999999999998 478999999999986543


Q ss_pred             CccccCcceeecC
Q 022887          278 DELQGNTKRIVGT  290 (290)
Q Consensus       278 ~~~~~~~~~~~Gt  290 (290)
                      ..    +...+||
T Consensus       185 ~~----~~~~~GT  193 (290)
T 3fpq_A          185 SF----AKAVIGT  193 (290)
T ss_dssp             TS----BEESCSS
T ss_pred             Cc----cCCcccC
Confidence            32    2345666

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.5e-37  Score=269.42  Aligned_cols=174  Identities=26%  Similarity=0.355  Sum_probs=143.2

Q ss_pred             cHHhHHHHhcCCCccceecccCCccEEEEEEcC------CcEEEEEEeccccc-cCHHHHHHHHHHHcccCC-CCcceeE
Q 022887          114 SLASVSAATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQH-RHLVRLF  185 (290)
Q Consensus       114 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h-~niv~l~  185 (290)
                      ....++...++|+..+.||+|+||+||+|.+.+      ++.||||.+..... ...++|.+|+.++.+++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            334455667899999999999999999998643      35799999975433 335679999999999965 9999999


Q ss_pred             EEEEeC-CeeEEEEEecCCCChhhhhhCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCC
Q 022887          186 GCCIEQ-GENILIYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDL  251 (290)
Q Consensus       186 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dl  251 (290)
                      |+|.+. +..++|||||++|+|.+++....             ....++|.+++.++.|||+||+|||+++   ||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence            999875 46899999999999999986432             1345899999999999999999999988   999999


Q ss_pred             CCCCEEEcCCCCeEEeeccCceeeCCCccccCcceeecC
Q 022887          252 KASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT  290 (290)
Q Consensus       252 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~Gt  290 (290)
                      ||+|||+++++.+||+|||+|+.+..+.....+....||
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt  250 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  250 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence            999999999999999999999988665433333344554

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-37  Score=264.81  Aligned_cols=160  Identities=27%  Similarity=0.345  Sum_probs=130.0

Q ss_pred             cCCCccceecccCCccEEEEEEc----CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~----~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++|+..+.||+|+||+||+|+..    +++.||||.+....  ......+.+|+.++.+++|||||++++++.+.+..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999762    36789999996532  2233468899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|+|.+++..   ...+++.+...++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999998843   356899999999999999999999988   9999999999999999999999999999765


Q ss_pred             CCccccCcceeecC
Q 022887          277 GDELQGNTKRIVGT  290 (290)
Q Consensus       277 ~~~~~~~~~~~~Gt  290 (290)
                      .....  ....+||
T Consensus       178 ~~~~~--~~~~~GT  189 (304)
T 3ubd_A          178 DHEKK--AYSFCGT  189 (304)
T ss_dssp             ---CC--CCSCCCC
T ss_pred             CCCcc--ccccccC
Confidence            43322  2335666

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-34  Score=253.67  Aligned_cols=161  Identities=25%  Similarity=0.414  Sum_probs=133.2

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC------Ce
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------GE  193 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  193 (290)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+.+|..++|||||++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999987 468999999997532  22346788999999999999999999997643      56


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .|+||||++ |+|..++.   ....+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 67888773   3457999999999999999999999988   9999999999999999999999999999


Q ss_pred             eeCCCcc--ccCcceeecC
Q 022887          274 IFGGDEL--QGNTKRIVGT  290 (290)
Q Consensus       274 ~~~~~~~--~~~~~~~~Gt  290 (290)
                      .+.....  .......+||
T Consensus       207 ~~~~~~~~~~~~~~~~~GT  225 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVAT  225 (398)
T ss_dssp             CC-------CCCCCSSCCC
T ss_pred             ecccCccccccccccceeC
Confidence            8754321  2223345666

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.9e-33  Score=246.18  Aligned_cols=148  Identities=22%  Similarity=0.361  Sum_probs=131.3

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc----CCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCee
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~----~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  194 (290)
                      ...++|+..+.||+|+||.||+|+..    +++.||||++...  .....+.+|+.++..+ +||||+++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999753    3678999998653  3446788999999988 699999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC-CCeEEeeccCce
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR  273 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGla~  273 (290)
                      ++||||+++|+|.+++      ..+++.+...++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            9999999999999987      24889999999999999999999988   9999999999999876 799999999999


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .....
T Consensus       167 ~~~~~  171 (361)
T 4f9c_A          167 GTHDT  171 (361)
T ss_dssp             ECTTC
T ss_pred             ccCCc
Confidence            77543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-33  Score=260.47  Aligned_cols=158  Identities=28%  Similarity=0.341  Sum_probs=134.5

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHH---HHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFK---NEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+.+..   ......+.   .++.++..++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999874 58999999996431   22223333   3466778889999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||+++|+|..++..   ...+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999998843   356899999999999999999999988   999999999999999999999999999988


Q ss_pred             CCCccccCcceeecC
Q 022887          276 GGDELQGNTKRIVGT  290 (290)
Q Consensus       276 ~~~~~~~~~~~~~Gt  290 (290)
                      ..+.    +.+.+||
T Consensus       343 ~~~~----~~t~~GT  353 (689)
T 3v5w_A          343 SKKK----PHASVGT  353 (689)
T ss_dssp             SSCC----CCSCCSC
T ss_pred             CCCC----CCCccCC
Confidence            6543    2345676

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.2e-33  Score=256.69  Aligned_cols=153  Identities=23%  Similarity=0.391  Sum_probs=136.9

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.+..........+.+|+.+|..++|||||++++++.+.+..++||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            36899999999999999999987 45899999999765555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC--CCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~--~~~kl~DfGla~~~~~~  278 (290)
                      +++|+|.+++..  ....+++.+...++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+|+.+..+
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999988743  2346899999999999999999999988   9999999999999854  89999999999998665


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       311 ~  311 (573)
T 3uto_A          311 Q  311 (573)
T ss_dssp             S
T ss_pred             C
Confidence            4

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.98  E-value=5.4e-32  Score=233.88  Aligned_cols=158  Identities=44%  Similarity=0.730  Sum_probs=142.2

Q ss_pred             hHHHHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          117 SVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       117 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++...+++|+..+.||+|+||.||+|.+.+++.||||++..........+.+|+.++..++||||+++++++...+..++
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            34456789999999999999999999988899999999887665667889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          197 IYEYMPNKSLDVFLFYPKK-KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ||||+++|+|.+++..... ...++|..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++..
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999998854332 335899999999999999999999987   999999999999999999999999999876


Q ss_pred             CC
Q 022887          276 GG  277 (290)
Q Consensus       276 ~~  277 (290)
                      ..
T Consensus       190 ~~  191 (321)
T 2qkw_B          190 TE  191 (321)
T ss_dssp             SS
T ss_pred             cc
Confidence            54

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=2.3e-31  Score=230.23  Aligned_cols=169  Identities=44%  Similarity=0.729  Sum_probs=148.5

Q ss_pred             CCcccHHhHHHHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEE
Q 022887          110 LPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCC  188 (290)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~  188 (290)
                      ...+++.++....++|+..+.||+|+||.||+|...+++.||||++..... .....+.+|+.++..++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            556889999999999999999999999999999988899999999975432 2334789999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEe
Q 022887          189 IEQGENILIYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       189 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                      ...+..++||||+++|+|.+++.... ....++|..+..++.|++.||.|||+....+|+||||||+|||+++++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999986543 34469999999999999999999999833349999999999999999999999


Q ss_pred             eccCceeeCCC
Q 022887          268 DFGMARIFGGD  278 (290)
Q Consensus       268 DfGla~~~~~~  278 (290)
                      |||+++.+...
T Consensus       177 Dfg~~~~~~~~  187 (326)
T 3uim_A          177 DFGLAKLMDYK  187 (326)
T ss_dssp             CCSSCEECCSS
T ss_pred             cCccccccCcc
Confidence            99999987644

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=2e-32  Score=245.74  Aligned_cols=158  Identities=22%  Similarity=0.282  Sum_probs=138.0

Q ss_pred             hHHHHhcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC
Q 022887          117 SVSAATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG  192 (290)
Q Consensus       117 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  192 (290)
                      +.....++|+..+.||+|+||.||+++..+ ++.||+|++.+.   .......+.+|..++..++||||+++++++.+.+
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            333456789999999999999999999854 788999999642   1223345899999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..++||||+++|+|..++..  ....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence            99999999999999999854  2356899999999999999999999988   999999999999999999999999999


Q ss_pred             eeeCCCc
Q 022887          273 RIFGGDE  279 (290)
Q Consensus       273 ~~~~~~~  279 (290)
                      +.+..+.
T Consensus       223 ~~~~~~~  229 (437)
T 4aw2_A          223 LKLMEDG  229 (437)
T ss_dssp             EECCTTS
T ss_pred             hhcccCC
Confidence            8876544

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.97  E-value=1.3e-30  Score=225.39  Aligned_cols=161  Identities=28%  Similarity=0.407  Sum_probs=143.3

Q ss_pred             CcccHHhHHHHhcC----------CCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCC
Q 022887          111 PLFSLASVSAATEN----------FSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR  179 (290)
Q Consensus       111 ~~~~~~~~~~~~~~----------~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~  179 (290)
                      +.++++++..+++.          |+..+.||+|+||.||+|... +++.||||.+..........+.+|+.++.+++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45677777777654          666779999999999999985 6899999999876666678899999999999999


Q ss_pred             CcceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc
Q 022887          180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  259 (290)
Q Consensus       180 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~  259 (290)
                      ||+++++++...+..++||||+++++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            99999999999999999999999999999873    345899999999999999999999987   99999999999999


Q ss_pred             CCCCeEEeeccCceeeCCC
Q 022887          260 SDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       260 ~~~~~kl~DfGla~~~~~~  278 (290)
                      .++.+||+|||+++.+..+
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~  194 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKD  194 (321)
T ss_dssp             TTCCEEECCCTTCEECCSS
T ss_pred             CCCcEEEeeeeeeeecccC
Confidence            9999999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.97  E-value=1.1e-30  Score=223.48  Aligned_cols=152  Identities=25%  Similarity=0.401  Sum_probs=138.3

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ..++|+..+.||+|+||.||+|.. .+++.||||.+..........+.+|+.++..++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            346899999999999999999986 5688999999976666667789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      |+++|+|.+++..    ..+++.+...++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+.
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999998843    35899999999999999999999987   9999999999999999999999999999876543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=1.2e-30  Score=223.90  Aligned_cols=166  Identities=41%  Similarity=0.636  Sum_probs=147.9

Q ss_pred             CCCcccHHhHHHHhcCCCcc------ceecccCCccEEEEEEcCCcEEEEEEecccc----ccCHHHHHHHHHHHcccCC
Q 022887          109 WLPLFSLASVSAATENFSTQ------CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQH  178 (290)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~------~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h  178 (290)
                      ..+.|++.++..++++|...      +.||+|+||.||+|.. +++.||+|++....    ......+.+|+.++..++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            35678999999999999877      8999999999999987 67899999986432    2235678999999999999


Q ss_pred             CCcceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE
Q 022887          179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  258 (290)
Q Consensus       179 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill  258 (290)
                      |||+++++++...+..++||||+++++|.+++........+++..++.++.|++.||.|||+.+   ++||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999865444567999999999999999999999987   9999999999999


Q ss_pred             cCCCCeEEeeccCceeeCCC
Q 022887          259 DSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       259 ~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++++.+||+|||+++.....
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSC
T ss_pred             cCCCcEEEeecccccccccc
Confidence            99999999999999987653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=8.6e-31  Score=225.20  Aligned_cols=152  Identities=27%  Similarity=0.460  Sum_probs=137.3

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|...+.||+|+||.||++... +++.||+|.+..........+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            367889999999999999999884 5889999998765556678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|.+++...  ...+++.++..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            9999999998542  356899999999999999999999988   999999999999999999999999999987554

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.97  E-value=1.8e-30  Score=224.77  Aligned_cols=155  Identities=25%  Similarity=0.379  Sum_probs=135.8

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe-----
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-----  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  193 (290)
                      ..++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+.     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3468999999999999999999985 68999999997433 2345789999999999999999999999876542     


Q ss_pred             ----------------------------------------------------eEEEEEecCCCChhhhhhCCCCCCCCCH
Q 022887          194 ----------------------------------------------------NILIYEYMPNKSLDVFLFYPKKKRLLGW  221 (290)
Q Consensus       194 ----------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~  221 (290)
                                                                          .++||||+++++|.+++.........++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                                7899999999999999976655566788


Q ss_pred             HHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          222 QARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       222 ~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            889999999999999999988   999999999999999999999999999988665

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.97  E-value=1.4e-30  Score=225.43  Aligned_cols=151  Identities=30%  Similarity=0.421  Sum_probs=132.6

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||.||+|... +++.||||.+..... .....+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999875 688999999864332 234678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+++|+|.+++.   ....+++.+...++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999998873   3446899999999999999999999988   999999999999999999999999999877543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.97  E-value=1.3e-30  Score=225.99  Aligned_cols=151  Identities=32%  Similarity=0.471  Sum_probs=135.5

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||||++....  ......+.+|+.++..++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46899999999999999999987 568999999996532  234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus        94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999998843   345899999999999999999999988   999999999999999999999999999877554

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.97  E-value=6e-31  Score=234.35  Aligned_cols=154  Identities=24%  Similarity=0.280  Sum_probs=135.9

Q ss_pred             HHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      ....++|+..+.||+|+||.||+++.. +++.||+|.+...   .......+.+|+.++..++||||+++++++.+.+..
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            344678999999999999999999885 4789999998642   122345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||+++|+|..++..    ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus       145 ~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            999999999999998843    35889999999999999999999988   99999999999999999999999999998


Q ss_pred             eCCCc
Q 022887          275 FGGDE  279 (290)
Q Consensus       275 ~~~~~  279 (290)
                      +....
T Consensus       218 ~~~~~  222 (410)
T 3v8s_A          218 MNKEG  222 (410)
T ss_dssp             CCTTS
T ss_pred             eccCC
Confidence            76543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.97  E-value=2.2e-30  Score=225.24  Aligned_cols=150  Identities=25%  Similarity=0.307  Sum_probs=134.3

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||.||+++.. +++.||+|.+...   .......+..|+.++..++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            368899999999999999999875 5889999999753   234567789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++|+|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999888743   346899999999999999999999988   99999999999999999999999999986533

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=1e-30  Score=226.03  Aligned_cols=153  Identities=29%  Similarity=0.451  Sum_probs=131.2

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC----eeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG----ENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv  197 (290)
                      .++|+..+.||+|+||.||+|++. ++.||||++.... .....+..|+.++.+++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468999999999999999999875 6899999996532 23345667889999999999999999998854    36999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-------CCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-------SRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-------~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                      |||+++|+|.+++..    ..+++..++.++.|++.||.|||+.       ...+|+||||||+|||++.++.+||+|||
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            999999999999843    3489999999999999999999987       01139999999999999999999999999


Q ss_pred             CceeeCCCcc
Q 022887          271 MARIFGGDEL  280 (290)
Q Consensus       271 la~~~~~~~~  280 (290)
                      +++.+.....
T Consensus       177 ~a~~~~~~~~  186 (322)
T 3soc_A          177 LALKFEAGKS  186 (322)
T ss_dssp             TCEEECTTSC
T ss_pred             cccccccccC
Confidence            9998866543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=1.7e-30  Score=228.91  Aligned_cols=154  Identities=29%  Similarity=0.509  Sum_probs=134.5

Q ss_pred             hcCCCccceecccCCccEEEEEEc--------CCcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeC
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ  191 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  191 (290)
                      .++|...+.||+|+||.||+|.+.        ++..||||.+.... ......+.+|+.++.++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            468889999999999999999863        34579999997543 23456799999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE
Q 022887          192 GENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  258 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill  258 (290)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999864321             235899999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEeeccCceeeCCC
Q 022887          259 DSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       259 ~~~~~~kl~DfGla~~~~~~  278 (290)
                      +.++.+||+|||+++.+...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~  256 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNI  256 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCC
T ss_pred             CCCCCEEEccccCCcccCcc
Confidence            99999999999999977553

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.97  E-value=8.7e-31  Score=233.47  Aligned_cols=158  Identities=22%  Similarity=0.284  Sum_probs=138.1

Q ss_pred             hHHHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC
Q 022887          117 SVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG  192 (290)
Q Consensus       117 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  192 (290)
                      +.....++|+..+.||+|+||.||+++.. +++.||||++.+..   ......+.+|..++..++||||+++++++.+.+
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            33345678999999999999999999884 68999999996421   223456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..++||||+++|+|..++...  ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhh
Confidence            999999999999999998532  246899999999999999999999988   999999999999999999999999999


Q ss_pred             eeeCCCc
Q 022887          273 RIFGGDE  279 (290)
Q Consensus       273 ~~~~~~~  279 (290)
                      +.+..+.
T Consensus       210 ~~~~~~~  216 (412)
T 2vd5_A          210 LKLRADG  216 (412)
T ss_dssp             EECCTTS
T ss_pred             eeccCCC
Confidence            9886543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.97  E-value=1.3e-29  Score=222.47  Aligned_cols=151  Identities=28%  Similarity=0.394  Sum_probs=135.0

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccccc------CHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      .++|...+.||+|+||.||++... +++.||+|.+......      ....+.+|+.++..++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            468999999999999999999875 5889999999754321      357899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC----CeEEeecc
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG  270 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DfG  270 (290)
                      ++||||+++|+|.+++.   ....+++.....++.|++.||.|||+.+   |+||||||+|||+++++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999884   3456899999999999999999999988   99999999999998877    79999999


Q ss_pred             CceeeCCC
Q 022887          271 MARIFGGD  278 (290)
Q Consensus       271 la~~~~~~  278 (290)
                      +++.+..+
T Consensus       165 ~a~~~~~~  172 (361)
T 2yab_A          165 LAHEIEDG  172 (361)
T ss_dssp             SCEECCTT
T ss_pred             CceEcCCC
Confidence            99987654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.97  E-value=2.7e-30  Score=226.07  Aligned_cols=151  Identities=28%  Similarity=0.387  Sum_probs=133.0

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  195 (290)
                      ..++|+..+.||+|+||.||+++.. +++.||||.+...   .......+..|..++..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999874 5889999999753   233456788899999887 7999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||+++|+|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus       101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999988843   356899999999999999999999988   999999999999999999999999999865


Q ss_pred             CC
Q 022887          276 GG  277 (290)
Q Consensus       276 ~~  277 (290)
                      ..
T Consensus       175 ~~  176 (353)
T 3txo_A          175 IC  176 (353)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.97  E-value=4.5e-30  Score=226.84  Aligned_cols=151  Identities=24%  Similarity=0.358  Sum_probs=135.8

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||.||++... +++.||+|.+...   .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            368999999999999999999874 4789999998643   234567889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999998843   456899999999999999999999988   99999999999999999999999999998765


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      +
T Consensus       168 ~  168 (384)
T 4fr4_A          168 E  168 (384)
T ss_dssp             T
T ss_pred             C
Confidence            4

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.97  E-value=4e-30  Score=219.61  Aligned_cols=151  Identities=28%  Similarity=0.439  Sum_probs=133.2

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||.||++... ++..||+|.+.....   .....+.+|+..+.+++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            468999999999999999999874 588999999854322   2346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999998843   346899999999999999999999988   99999999999999999999999999987754


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       164 ~  164 (294)
T 4eqm_A          164 T  164 (294)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.97  E-value=4.9e-30  Score=222.12  Aligned_cols=152  Identities=31%  Similarity=0.522  Sum_probs=133.4

Q ss_pred             hcCCCccceecccCCccEEEEEEc----CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|...+.||+|+||.||+|.+.    .+..||||.+.... ......+.+|+.++.+++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356888899999999999999874    34569999997542 3345679999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++++|.+++...  ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999998532  346899999999999999999999988   9999999999999999999999999999876


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      .+
T Consensus       203 ~~  204 (325)
T 3kul_A          203 DD  204 (325)
T ss_dssp             --
T ss_pred             cC
Confidence            54

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=3.3e-30  Score=227.34  Aligned_cols=152  Identities=34%  Similarity=0.558  Sum_probs=127.6

Q ss_pred             hcCCCccceecccCCccEEEEEEc----CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||+|++.    ++..||||.+.... .....+|.+|+.++.+++||||+++++++...+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            358999999999999999999874    46789999997542 3345689999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|+|.+++..  ....+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999853  2346899999999999999999999987   9999999999999999999999999999876


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      .+
T Consensus       199 ~~  200 (373)
T 2qol_A          199 DD  200 (373)
T ss_dssp             --
T ss_pred             cC
Confidence            54

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.97  E-value=7.3e-30  Score=220.35  Aligned_cols=150  Identities=28%  Similarity=0.414  Sum_probs=134.6

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||.||+++.. +++.||+|.+...   .......+.+|..++..++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367899999999999999999884 5889999999753   223556788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999998853   345899999999999999999999887   99999999999999999999999999997654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.97  E-value=4.5e-30  Score=227.61  Aligned_cols=148  Identities=26%  Similarity=0.372  Sum_probs=130.4

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||+++.. +++.||+|.+.+..   ......+..|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999885 47889999997542   22335678899988877 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ||||+++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            9999999999888743   356899999999999999999999988   999999999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.97  E-value=7e-30  Score=222.75  Aligned_cols=151  Identities=27%  Similarity=0.366  Sum_probs=133.1

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCee
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  194 (290)
                      ...++|...+.||+|+||.||+|+.. +++.||||.+....   ......+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            44678999999999999999999985 58899999997532   33456788899888876 899999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||+++|+|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            999999999999998843   345899999999999999999999988   99999999999999999999999999986


Q ss_pred             eC
Q 022887          275 FG  276 (290)
Q Consensus       275 ~~  276 (290)
                      ..
T Consensus       168 ~~  169 (345)
T 1xjd_A          168 NM  169 (345)
T ss_dssp             CC
T ss_pred             cc
Confidence            54

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=8.8e-30  Score=214.47  Aligned_cols=151  Identities=32%  Similarity=0.553  Sum_probs=136.6

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|+||.||++...+++.||+|++... .....++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            3678899999999999999999988899999999753 334578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++++|.+++..  ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....+
T Consensus        88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999854  2346899999999999999999999988   999999999999999999999999999877543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=3.7e-30  Score=221.36  Aligned_cols=156  Identities=29%  Similarity=0.522  Sum_probs=130.6

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..++|+..+.||+|+||.||+|.. +++.||||.+....  .....++.+|+.++.+++||||+++++++...+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            456889999999999999999987 67899999987543  223467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|+|.+++........+++..++.++.|++.||+|||+.+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999865433345899999999999999999999864 34999999999999999999999999999866543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=1.4e-29  Score=216.45  Aligned_cols=150  Identities=25%  Similarity=0.401  Sum_probs=128.3

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc--------------------------cCHHHHHHHHHHHc
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--------------------------QGLTEFKNEMMLIA  174 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~--------------------------~~~~~~~~e~~~l~  174 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+.....                          .....+.+|+.++.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46899999999999999999987 4578999999864321                          12356899999999


Q ss_pred             ccCCCCcceeEEEEEe--CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCC
Q 022887          175 KLQHRHLVRLFGCCIE--QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK  252 (290)
Q Consensus       175 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk  252 (290)
                      +++||||+++++++.+  .+..++||||+++++|.+++    ....+++.....++.|++.||.|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  56789999999999998765    2356899999999999999999999988   9999999


Q ss_pred             CCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          253 ASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       253 ~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+|||++.++.+||+|||+++.+...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~  190 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGS  190 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccc
Confidence            99999999999999999999987543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.96  E-value=1.5e-29  Score=218.36  Aligned_cols=155  Identities=29%  Similarity=0.419  Sum_probs=136.4

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC--eeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG--ENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  197 (290)
                      .++|...+.||+|+||.||+|.... ++.||||.+.... ......+.+|+.++.+++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            3678999999999999999998854 8899999997543 344677889999999999999999999998765  67999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE----cCCCCeEEeeccCce
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR  273 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DfGla~  273 (290)
                      |||+++++|.+++........+++.+++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999876544455999999999999999999999988   9999999999999    788889999999999


Q ss_pred             eeCCCc
Q 022887          274 IFGGDE  279 (290)
Q Consensus       274 ~~~~~~  279 (290)
                      .+..+.
T Consensus       165 ~~~~~~  170 (319)
T 4euu_A          165 ELEDDE  170 (319)
T ss_dssp             ECCTTC
T ss_pred             ecCCCC
Confidence            876543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=2.8e-30  Score=228.13  Aligned_cols=153  Identities=29%  Similarity=0.451  Sum_probs=135.3

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..++|...+.||+|+||.||+|.+. +++.||||.+..... ....+|.+|+.++.+++||||+++++++...+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3467888999999999999999985 688999999875422 23457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|+|.+++..  ....+++...+.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++....+
T Consensus       192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999998853  2345899999999999999999999988   999999999999999999999999999876543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.96  E-value=2.5e-30  Score=227.37  Aligned_cols=150  Identities=19%  Similarity=0.260  Sum_probs=130.5

Q ss_pred             HhcCCCccceecccCCccEEEEE------EcCCcEEEEEEeccccccCHHHHHHHHHHHcccC---CCCcceeEEEEEeC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQ  191 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~------~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  191 (290)
                      ..++|...+.||+|+||.||+|.      ..+++.||||.+...   ...++..|+.++..++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45789999999999999999994      356889999999753   3457788888877776   99999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---------
Q 022887          192 GENILIYEYMPNKSLDVFLFYP--KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---------  260 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---------  260 (290)
                      +..++||||+++|+|.+++...  .....+++..++.++.|++.||+|||+.+   |+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            9999999999999999998532  13456999999999999999999999887   999999999999998         


Q ss_pred             --CCCeEEeeccCceeeC
Q 022887          261 --DMNPKISDFGMARIFG  276 (290)
Q Consensus       261 --~~~~kl~DfGla~~~~  276 (290)
                        ++.+||+|||+|+.+.
T Consensus       217 ~~~~~~kl~DFG~a~~~~  234 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMK  234 (365)
T ss_dssp             --CTTEEECCCTTCEEGG
T ss_pred             cccCCEEEeeCchhhhhh
Confidence              8999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=1.8e-30  Score=227.56  Aligned_cols=163  Identities=28%  Similarity=0.429  Sum_probs=138.1

Q ss_pred             ccHHhHHHHhcCCCccceecccCCccEEEEEE------cCCcEEEEEEeccccc-cCHHHHHHHHHHHccc-CCCCccee
Q 022887          113 FSLASVSAATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRL  184 (290)
Q Consensus       113 ~~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l  184 (290)
                      +.....+...++|...+.||+|+||.||+|.+      .+++.||||.+..... .....+.+|+.++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34455566678999999999999999999974      2357899999975432 2346799999999999 79999999


Q ss_pred             EEEEEeCCe-eEEEEEecCCCChhhhhhCCCC------------------------------------------------
Q 022887          185 FGCCIEQGE-NILIYEYMPNKSLDVFLFYPKK------------------------------------------------  215 (290)
Q Consensus       185 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------  215 (290)
                      ++++.+.+. .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999988654 8999999999999999865432                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          216 ---------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       216 ---------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                                     ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                           122889999999999999999999988   999999999999999999999999999877544

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3e-29  Score=216.86  Aligned_cols=152  Identities=22%  Similarity=0.320  Sum_probs=134.7

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|...+.||+|+||.||++... +++.+|+|.+... ......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468899999999999999999875 4788999998643 23446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC--CCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~--~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|.+++..  ....+++.+...++.|++.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+..+
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999998843  2346899999999999999999999987   999999999999987  789999999999988654


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       158 ~  158 (321)
T 1tki_A          158 D  158 (321)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=3e-29  Score=217.25  Aligned_cols=151  Identities=28%  Similarity=0.401  Sum_probs=134.8

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc------cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      .++|...+.||+|+||.||++... +++.||+|.+.....      .....+.+|+.++..++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            457899999999999999999885 588999999865322      2357899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC----CeEEeecc
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG  270 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DfG  270 (290)
                      ++||||+++++|.+++.   ....+++.....++.|++.||.|||+.+   |+||||||+|||+++++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999884   3456899999999999999999999988   99999999999999887    79999999


Q ss_pred             CceeeCCC
Q 022887          271 MARIFGGD  278 (290)
Q Consensus       271 la~~~~~~  278 (290)
                      +++.+..+
T Consensus       164 ~a~~~~~~  171 (326)
T 2y0a_A          164 LAHKIDFG  171 (326)
T ss_dssp             TCEECCTT
T ss_pred             CCeECCCC
Confidence            99988643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=1.5e-29  Score=221.15  Aligned_cols=150  Identities=25%  Similarity=0.327  Sum_probs=134.9

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+...   .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            58999999999999999999885 5889999998643   2345678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999998843   245899999999999999999999988   999999999999999999999999999987543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=1.4e-29  Score=213.03  Aligned_cols=152  Identities=32%  Similarity=0.477  Sum_probs=137.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|+||.||++...++..||+|.+... .....++.+|+.++.+++||||+++++++...+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            4688999999999999999999988889999999753 334578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      ++++|.+++...  ...+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....+.
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            999999988432  345899999999999999999999988   9999999999999999999999999999776543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=2.8e-29  Score=213.90  Aligned_cols=149  Identities=26%  Similarity=0.433  Sum_probs=130.3

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999884 588999999975432  234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |++++.+..+..   ....+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.++.
T Consensus        82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             cCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            998755444432   2356899999999999999999999988   99999999999999999999999999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=1e-29  Score=221.80  Aligned_cols=149  Identities=26%  Similarity=0.353  Sum_probs=132.0

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||+++.. +++.||+|.+.....   .....+..|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            357899999999999999999885 478999999975432   2345678899999887 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999988843   346899999999999999999999988   9999999999999999999999999998643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.96  E-value=7.5e-30  Score=222.15  Aligned_cols=156  Identities=30%  Similarity=0.493  Sum_probs=136.4

Q ss_pred             HHHhcCCCccceecccCCccEEEEEEcC------CcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeC
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ  191 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  191 (290)
                      ....++|...+.||+|+||.||+|...+      ++.||||.+..... .....+.+|+.++.+++||||+++++++...
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            3346789999999999999999998743      47899999975432 3356799999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecC
Q 022887          192 GENILIYEYMPNKSLDVFLFYPKK---------------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRD  250 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~d  250 (290)
                      +..++||||+++|+|.+++.....                     ...+++.+++.++.|++.||.|||+.+   |+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            999999999999999998864321                     256899999999999999999999988   99999


Q ss_pred             CCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          251 LKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       251 lk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+||++++++.+||+|||+++.+..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~  226 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYS  226 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred             CCcceEEECCCCeEEEeecCCCccccc
Confidence            999999999999999999999987644

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=1.8e-29  Score=220.89  Aligned_cols=150  Identities=27%  Similarity=0.326  Sum_probs=133.2

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccc---cccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  195 (290)
                      ..++|+..+.||+|+||.||+++... ++.||||.+...   .......+..|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            35789999999999999999999854 788999999753   234556788999999888 8999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||+++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999998843   345899999999999999999999988   999999999999999999999999999865


Q ss_pred             C
Q 022887          276 G  276 (290)
Q Consensus       276 ~  276 (290)
                      .
T Consensus       172 ~  172 (353)
T 2i0e_A          172 I  172 (353)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=1.1e-29  Score=220.13  Aligned_cols=150  Identities=29%  Similarity=0.377  Sum_probs=125.0

Q ss_pred             hcCCCccceecccCCccEEEEEE----cCCcEEEEEEecccc----ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      .++|+..+.||+|+||.||+++.    .+++.||+|.+....    ......+.+|+.++..++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999987    468899999997532    2234568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++||||+++++|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999988843   345889999999999999999999988   9999999999999999999999999998


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      ....
T Consensus       170 ~~~~  173 (327)
T 3a62_A          170 ESIH  173 (327)
T ss_dssp             ----
T ss_pred             cccc
Confidence            6543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.96  E-value=4.6e-29  Score=220.82  Aligned_cols=153  Identities=25%  Similarity=0.365  Sum_probs=135.5

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|+..+.||+|+||.||+|... +++.||+|.+..........+.+|+.++..++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999874 5889999999765444556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC--CCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~--~~~~kl~DfGla~~~~~~  278 (290)
                      +++|+|.+++..  ....+++.....++.|++.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+..+
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999988743  2346899999999999999999999988   999999999999974  577999999999988654


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       205 ~  205 (387)
T 1kob_A          205 E  205 (387)
T ss_dssp             S
T ss_pred             c
Confidence            3

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=2.3e-29  Score=216.58  Aligned_cols=151  Identities=32%  Similarity=0.444  Sum_probs=131.5

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..++|+..+.||+|+||.||+|...+++.||+|++.....  .....+.+|+.++.+++||||+++++++...+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            3468999999999999999999998899999999864322  23467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++ +|..++..  ....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.++.
T Consensus        99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99985 66666543  3345899999999999999999999987   99999999999999999999999999998753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.96  E-value=4.2e-29  Score=226.35  Aligned_cols=152  Identities=30%  Similarity=0.515  Sum_probs=136.3

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|...+.||+|+||.||+|... +++.||||.+....   ......+.+|+.++..++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            368999999999999999999885 68999999996432   23456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++|+|.+++.   ....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999884   3456899999999999999999999887   99999999999999999999999999998765


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      +.
T Consensus       169 ~~  170 (476)
T 2y94_A          169 GE  170 (476)
T ss_dssp             TC
T ss_pred             cc
Confidence            43

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.96  E-value=2e-29  Score=222.97  Aligned_cols=155  Identities=30%  Similarity=0.488  Sum_probs=135.1

Q ss_pred             HhcCCCccceecccCCccEEEEEEc--------CCcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE  190 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  190 (290)
                      ..++|...+.||+|+||.||+|...        .+..||||++.... ......+.+|+.++.++ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3468999999999999999999862        23579999997543 23446789999999999 99999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEE
Q 022887          191 QGENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  257 (290)
Q Consensus       191 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nil  257 (290)
                      .+..++||||+++|+|.+++.....             ...+++.+++.++.|++.||.|||+.+   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            9999999999999999999864321             245899999999999999999999987   999999999999


Q ss_pred             EcCCCCeEEeeccCceeeCCC
Q 022887          258 LDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       258 l~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++.+||+|||+++.+...
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~  244 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHI  244 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCC
T ss_pred             EcCCCcEEEcccCcccccccc
Confidence            999999999999999977553

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.96  E-value=2.6e-29  Score=213.03  Aligned_cols=152  Identities=30%  Similarity=0.473  Sum_probs=134.3

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ..++|+..+.||+|+||.||++.+.++..||+|.+... .....++.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            45689999999999999999999988889999999754 33457899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|.+++...  ...+++.+++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++....+
T Consensus       101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A          101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999998542  345899999999999999999999988   999999999999999999999999999877543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.96  E-value=2e-29  Score=230.12  Aligned_cols=153  Identities=29%  Similarity=0.496  Sum_probs=137.1

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ..++|...+.||+|+||.||+|.+.. +..||||.+... .....+|.+|+.++.+++||||+++++++...+..++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            45678888999999999999999865 789999999754 3456889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+++|+|.+++... ....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+..+
T Consensus       297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999998542 2345899999999999999999999988   999999999999999999999999999987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=4.8e-30  Score=218.93  Aligned_cols=152  Identities=32%  Similarity=0.543  Sum_probs=131.5

Q ss_pred             hcCCCccceecccCCccEEEEEE-----cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--Cee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  194 (290)
                      .++|+..+.||+|+||.||++++     .+++.||||++..........+.+|+.++.+++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46889999999999999999984     35789999999866555567899999999999999999999998654  458


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||+++|+|.+++...  ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999998542  335899999999999999999999987   99999999999999999999999999998


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      +..+
T Consensus       164 ~~~~  167 (295)
T 3ugc_A          164 LPQD  167 (295)
T ss_dssp             ----
T ss_pred             ccCC
Confidence            7554

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.96  E-value=2.1e-29  Score=216.56  Aligned_cols=155  Identities=34%  Similarity=0.530  Sum_probs=135.2

Q ss_pred             HhcCCCccceecccCCccEEEEEE------cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      ..++|...+.||+|+||.||++..      .++..||||.+.... ......+.+|+.++.+++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            356889999999999999999986      234789999997543 2345678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCC
Q 022887          194 NILIYEYMPNKSLDVFLFYPKK---------------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK  252 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk  252 (290)
                      .++||||+++++|.+++.....                     ...+++.+++.++.|++.||.|||+.+   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999864322                     234889999999999999999999988   9999999


Q ss_pred             CCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          253 ASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       253 ~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+||++++++.+||+|||+++.+...
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~  203 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEE  203 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTT
T ss_pred             hheEEEcCCCCEEEcccccccccccc
Confidence            99999999999999999999987554

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.9e-29  Score=219.82  Aligned_cols=155  Identities=31%  Similarity=0.478  Sum_probs=132.9

Q ss_pred             HhcCCCccceecccCCccEEEEEEc------CCcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  192 (290)
                      ..++|...+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4578999999999999999999862      35679999997532 33457899999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCC
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKK--------------------RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK  252 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk  252 (290)
                      ..++||||+++|+|.+++......                    ..+++..++.++.|++.||.|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999998653321                    34899999999999999999999987   9999999


Q ss_pred             CCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          253 ASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       253 ~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+||+++.++.+||+|||+++.+..+
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~  225 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSD  225 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccC
Confidence            99999999999999999999877544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.96  E-value=1.6e-29  Score=218.43  Aligned_cols=155  Identities=31%  Similarity=0.520  Sum_probs=121.4

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCc----EEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~----~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      ..++|+..+.||+|+||.||+|......    .||||.+...  .......+.+|+.++.+++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            4568999999999999999999875432    7999998754  233457899999999999999999999999887655


Q ss_pred             ------EEEEEecCCCChhhhhhCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeE
Q 022887          195 ------ILIYEYMPNKSLDVFLFYPK---KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  265 (290)
Q Consensus       195 ------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~k  265 (290)
                            ++||||+++|+|..++....   ....+++.+++.++.|++.||.|||+.+   |+||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                  99999999999999875322   2235899999999999999999999988   99999999999999999999


Q ss_pred             EeeccCceeeCCC
Q 022887          266 ISDFGMARIFGGD  278 (290)
Q Consensus       266 l~DfGla~~~~~~  278 (290)
                      |+|||+++.+..+
T Consensus       178 l~Dfg~a~~~~~~  190 (323)
T 3qup_A          178 VADFGLSRKIYSG  190 (323)
T ss_dssp             ECCCCC-------
T ss_pred             Eeecccccccccc
Confidence            9999999877554

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.96  E-value=5e-29  Score=210.65  Aligned_cols=153  Identities=24%  Similarity=0.404  Sum_probs=137.8

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ..++|+..+.||+|+||.||+|.... +..||+|++..........+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            35679999999999999999998854 67899999987666677899999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE---cCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~~~  276 (290)
                      |+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++||||||+||++   +.++.+||+|||++..+.
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999888743   345899999999999999999999988   9999999999999   788999999999998876


Q ss_pred             CCc
Q 022887          277 GDE  279 (290)
Q Consensus       277 ~~~  279 (290)
                      .+.
T Consensus       161 ~~~  163 (277)
T 3f3z_A          161 PGK  163 (277)
T ss_dssp             TTS
T ss_pred             Ccc
Confidence            543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.96  E-value=2.9e-29  Score=219.58  Aligned_cols=155  Identities=26%  Similarity=0.374  Sum_probs=133.9

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc-----cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      .++|+..+.||+|+||.||++... +++.||||.+...     .......+.+|+.++..++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457999999999999999999874 5899999998632     1224678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC---eEEeeccC
Q 022887          196 LIYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGM  271 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~---~kl~DfGl  271 (290)
                      +||||+++++|..++.... ....+++.....++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999987764322 2345899999999999999999999988   999999999999986654   99999999


Q ss_pred             ceeeCCCc
Q 022887          272 ARIFGGDE  279 (290)
Q Consensus       272 a~~~~~~~  279 (290)
                      ++.+....
T Consensus       180 a~~~~~~~  187 (351)
T 3c0i_A          180 AIQLGESG  187 (351)
T ss_dssp             CEECCTTS
T ss_pred             eeEecCCC
Confidence            99886543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.96  E-value=7.9e-30  Score=230.06  Aligned_cols=150  Identities=25%  Similarity=0.295  Sum_probs=124.5

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||.||++.. .+++.||||.+...   .......+..|+.++..++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999987 45889999999753   233446778899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |||+++|+|..++..   ...+++.....++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+|+...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999888843   3468999999999999999999997 66   9999999999999999999999999998654


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       301 ~  301 (446)
T 4ejn_A          301 K  301 (446)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.96  E-value=1.6e-29  Score=228.53  Aligned_cols=155  Identities=31%  Similarity=0.457  Sum_probs=137.0

Q ss_pred             HHHHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          118 VSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       118 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .+...++|...+.||+|+||.||+|.+.++..||||.+.... ....+|.+|+.++.+++||||+++++++. .+..++|
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            344567889999999999999999999888899999997643 45788999999999999999999999986 5678999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++|+|.+++... ....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            9999999999998532 1235789999999999999999999987   99999999999999999999999999998754


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      +
T Consensus       337 ~  337 (454)
T 1qcf_A          337 N  337 (454)
T ss_dssp             H
T ss_pred             C
Confidence            3

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.96  E-value=4.7e-29  Score=229.57  Aligned_cols=154  Identities=28%  Similarity=0.353  Sum_probs=136.4

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|...+.||+|+||.||++... +++.||+|.+...   .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888999999999999999884 6899999999643   233456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++|+|..++... ....+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus       263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            9999999999888543 2345899999999999999999999988   99999999999999999999999999998765


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      +.
T Consensus       339 ~~  340 (576)
T 2acx_A          339 GQ  340 (576)
T ss_dssp             TC
T ss_pred             Cc
Confidence            43

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=2.1e-29  Score=218.98  Aligned_cols=151  Identities=28%  Similarity=0.474  Sum_probs=133.0

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|...+.||+|+||.||+|.. .+++.||+|.+...   .......+.+|+.++..++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36899999999999999999987 56889999998643   223346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+ +|+|.+++..   ...+++.+...++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 6788777643   345899999999999999999999988   99999999999999999999999999987755


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      +.
T Consensus       161 ~~  162 (336)
T 3h4j_B          161 GN  162 (336)
T ss_dssp             SB
T ss_pred             Cc
Confidence            43

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.96  E-value=4.9e-29  Score=218.93  Aligned_cols=153  Identities=25%  Similarity=0.421  Sum_probs=134.1

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ...++|+..+.||+|+||.||++... +++.||+|.+....  ......+.+|+.++..++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34568999999999999999999874 58899999997532  2234678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC---CCeEEeeccCce
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMAR  273 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~---~~~kl~DfGla~  273 (290)
                      ||||+++|+|.+++.   ....+++.....++.|++.||.|||+.+   |+||||||+|||++.+   +.+||+|||+++
T Consensus       106 v~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999988874   3356899999999999999999999988   9999999999999865   459999999998


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .+...
T Consensus       180 ~~~~~  184 (362)
T 2bdw_A          180 EVNDS  184 (362)
T ss_dssp             CCTTC
T ss_pred             EecCC
Confidence            87644

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.96  E-value=2.2e-30  Score=225.16  Aligned_cols=149  Identities=20%  Similarity=0.288  Sum_probs=126.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--------ccCHHHHHHHHHHHcccC---------CCCccee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--------GQGLTEFKNEMMLIAKLQ---------HRHLVRL  184 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l  184 (290)
                      .++|+..+.||+|+||.||+|+. +++.||||++....        ......+.+|+.++..++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999998 67999999997542        223478899999988885         8888888


Q ss_pred             EEEEE------------------------------eCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHH
Q 022887          185 FGCCI------------------------------EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQG  234 (290)
Q Consensus       185 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~  234 (290)
                      .+.+.                              ..+..++||||+++|++.+.+.    ...+++.....++.|++.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence            87754                              2578899999999997655552    2458999999999999999


Q ss_pred             HHHHh-hCCCCCceecCCCCCCEEEcCCC--------------------CeEEeeccCceeeCCC
Q 022887          235 LLYLH-QYSRLRIIHRDLKASNILLDSDM--------------------NPKISDFGMARIFGGD  278 (290)
Q Consensus       235 l~yLH-~~~~~~iiH~dlk~~Nill~~~~--------------------~~kl~DfGla~~~~~~  278 (290)
                      |.||| +.+   |+||||||+|||++.++                    .+||+|||+|+.....
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~  235 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG  235 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC
Confidence            99999 888   99999999999999887                    8999999999987543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.96  E-value=5.8e-29  Score=216.05  Aligned_cols=155  Identities=29%  Similarity=0.512  Sum_probs=134.3

Q ss_pred             HhcCCCccceecccCCccEEEEEEc--------CCcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEEe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE  190 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  190 (290)
                      ..++|...+.||+|+||.||+|...        ++..||+|.+.... ......+.+|+.++.++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3578999999999999999999863        46789999997543 23456789999999999 89999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEE
Q 022887          191 QGENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  257 (290)
Q Consensus       191 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nil  257 (290)
                      .+..++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+.+   |+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999865321             234899999999999999999999987   999999999999


Q ss_pred             EcCCCCeEEeeccCceeeCCC
Q 022887          258 LDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       258 l~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++.++.+||+|||+++.+...
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~  210 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNI  210 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTT
T ss_pred             EcCCCCEEEcccccccccccc
Confidence            999999999999999987654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.96  E-value=7.1e-30  Score=224.71  Aligned_cols=152  Identities=34%  Similarity=0.500  Sum_probs=131.3

Q ss_pred             hcCCCccceecccCCccEEEEEEc------CCcEEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      .++|...+.||+|+||.||+|.+.      ++..||||++... .......+.+|+.++.+++||||+++++++...+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467889999999999999999853      3568999999643 233456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC---CeEEe
Q 022887          195 ILIYEYMPNKSLDVFLFYPK----KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKIS  267 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~---~~kl~  267 (290)
                      ++||||+++|+|.+++....    ....+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999886432    2245899999999999999999999988   99999999999999554   59999


Q ss_pred             eccCceeeC
Q 022887          268 DFGMARIFG  276 (290)
Q Consensus       268 DfGla~~~~  276 (290)
                      |||+|+.+.
T Consensus       227 DFG~a~~~~  235 (367)
T 3l9p_A          227 DFGMARDIY  235 (367)
T ss_dssp             CCHHHHHHH
T ss_pred             CCccccccc
Confidence            999998653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.96  E-value=4.7e-29  Score=219.90  Aligned_cols=148  Identities=29%  Similarity=0.420  Sum_probs=126.4

Q ss_pred             ccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCC
Q 022887          127 TQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKS  205 (290)
Q Consensus       127 ~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  205 (290)
                      ..+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.++.+++||||+++++++...+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            356899999999999987 4588999999986554556789999999999999999999999999999999999999999


Q ss_pred             hhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE--cCCCCeEEeeccCceeeCCCc
Q 022887          206 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--DSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       206 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill--~~~~~~kl~DfGla~~~~~~~  279 (290)
                      |.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||+  ++++.+||+|||+++.+....
T Consensus       173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            9887743  2345899999999999999999999988   9999999999999  567899999999999886543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.96  E-value=1.3e-29  Score=218.08  Aligned_cols=151  Identities=26%  Similarity=0.389  Sum_probs=128.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccccc---CHHHHHHHHHHHcccCCCCcceeEEEEEeCCee---
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN---  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---  194 (290)
                      .++|+..+.||+|+||.||++.. .+++.||||.+......   ....+.+|+.++.+++||||+++++++...+..   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999987 56889999999754322   245788999999999999999999998876543   


Q ss_pred             -EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          195 -ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       195 -~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                       ++||||+++++|.+++..   ...+++.+.+.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             999999999999998853   346899999999999999999999988   9999999999999999999999999998


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .+...
T Consensus       165 ~~~~~  169 (311)
T 3ork_A          165 AIADS  169 (311)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            77553

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.96  E-value=3.6e-29  Score=212.94  Aligned_cols=149  Identities=28%  Similarity=0.471  Sum_probs=132.1

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|+||.||+|...+++.||+|++....  ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5788999999999999999998779999999986432  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++ +|..++...  ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.++.
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            986 787777432  345899999999999999999999987   99999999999999999999999999987653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.96  E-value=4.1e-29  Score=217.22  Aligned_cols=153  Identities=25%  Similarity=0.376  Sum_probs=134.9

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc--------cCHHHHHHHHHHHcccCCCCcceeEEEEEeC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ  191 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  191 (290)
                      ..++|+..+.||+|+||.||+|.. .+++.||||.+.....        .....+.+|+.++.+++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999986 4588999999975421        1335678899999999999999999999999


Q ss_pred             CeeEEEEEecCCC-ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          192 GENILIYEYMPNK-SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       192 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                      +..++||||+..| +|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999877 88888743   345899999999999999999999988   9999999999999999999999999


Q ss_pred             CceeeCCCc
Q 022887          271 MARIFGGDE  279 (290)
Q Consensus       271 la~~~~~~~  279 (290)
                      +++.+..+.
T Consensus       176 ~a~~~~~~~  184 (335)
T 3dls_A          176 SAAYLERGK  184 (335)
T ss_dssp             TCEECCTTC
T ss_pred             cceECCCCC
Confidence            999886543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.96  E-value=6.4e-30  Score=221.83  Aligned_cols=158  Identities=30%  Similarity=0.456  Sum_probs=135.3

Q ss_pred             HHHHhcCCCccceecccCCccEEEEEEcC-C-----cEEEEEEeccccc-cCHHHHHHHHHHHccc-CCCCcceeEEEEE
Q 022887          118 VSAATENFSTQCKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCI  189 (290)
Q Consensus       118 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~-~-----~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  189 (290)
                      .+...++|...+.||+|+||.||+|.... +     ..||+|.+..... .....+.+|+.++..+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34456789999999999999999998743 2     4799999975432 3456789999999999 8999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE
Q 022887          190 EQGENILIYEYMPNKSLDVFLFYPK-----------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  258 (290)
Q Consensus       190 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill  258 (290)
                      ..+..++||||+++|+|.+++....           ....+++...+.++.|++.||.|||+.+   |+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence            9999999999999999999875321           1345799999999999999999999987   9999999999999


Q ss_pred             cCCCCeEEeeccCceeeCCC
Q 022887          259 DSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       259 ~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++++.+||+|||+++.+..+
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~  217 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMND  217 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGC
T ss_pred             CCCCeEEECccccccccccc
Confidence            99999999999999876543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.96  E-value=4.8e-29  Score=218.97  Aligned_cols=148  Identities=24%  Similarity=0.305  Sum_probs=130.0

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|...+.||+|+||.||++... +++.||||.+.... .....+.+|+.++..++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999885 68899999997533 3346789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC--eEEeeccCceeeC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMARIFG  276 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~--~kl~DfGla~~~~  276 (290)
                      +++|+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.  +||+|||+++...
T Consensus        98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            999999988743   345899999999999999999999988   999999999999987765  9999999998543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.96  E-value=1.1e-28  Score=226.23  Aligned_cols=154  Identities=29%  Similarity=0.393  Sum_probs=136.5

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|...+.||+|+||.||+++.. +++.||+|++....   ......+..|+.++.+++||||+++++++...+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888899999999999999884 58999999996432   234577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++|+|..++.... ....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999998886433 2456999999999999999999999988   99999999999999999999999999998765


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      +.
T Consensus       342 ~~  343 (543)
T 3c4z_A          342 GQ  343 (543)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.96  E-value=5.4e-29  Score=221.27  Aligned_cols=155  Identities=29%  Similarity=0.419  Sum_probs=135.8

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC--eeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG--ENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  197 (290)
                      .++|...+.||+|+||.||+|.... ++.||||.+.... ......+.+|+.++.+++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            3578999999999999999998854 8899999997543 344677889999999999999999999998765  67999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE----cCCCCeEEeeccCce
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR  273 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DfGla~  273 (290)
                      |||+++|+|.+++........+++..++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999865444445999999999999999999999988   9999999999999    778889999999999


Q ss_pred             eeCCCc
Q 022887          274 IFGGDE  279 (290)
Q Consensus       274 ~~~~~~  279 (290)
                      .+..+.
T Consensus       165 ~~~~~~  170 (396)
T 4eut_A          165 ELEDDE  170 (396)
T ss_dssp             ECCCGG
T ss_pred             EccCCC
Confidence            876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.96  E-value=9.7e-29  Score=208.62  Aligned_cols=151  Identities=30%  Similarity=0.411  Sum_probs=134.9

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++..++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3468999999999999999999885 588999999865432 33578899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++++|.+++.   ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        85 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999998873   3346899999999999999999999987   99999999999999999999999999987653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.96  E-value=8.1e-29  Score=214.80  Aligned_cols=149  Identities=22%  Similarity=0.295  Sum_probs=132.1

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+....  ....+..|+.++..+ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46899999999999999999987 568899999986532  235789999999999 99999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC-----eEEeeccCcee
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISDFGMARI  274 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~-----~kl~DfGla~~  274 (290)
                      |+ +++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999988542  356999999999999999999999987   999999999999998887     99999999998


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      +...
T Consensus       160 ~~~~  163 (330)
T 2izr_A          160 YIDP  163 (330)
T ss_dssp             SBCT
T ss_pred             eecC
Confidence            7554

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.96  E-value=3.3e-29  Score=216.87  Aligned_cols=151  Identities=32%  Similarity=0.527  Sum_probs=129.7

Q ss_pred             cCCCccceecccCCccEEEEEEcC-CcE----EEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQE----VAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~~----vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++|+..+.||+|+||.||+|.+.. ++.    ||+|.+.... ......+.+|+..+..++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            578899999999999999998743 443    7888875432 334467889999999999999999999886 456889


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999988542  346889999999999999999999988   9999999999999999999999999999886


Q ss_pred             CCc
Q 022887          277 GDE  279 (290)
Q Consensus       277 ~~~  279 (290)
                      .+.
T Consensus       167 ~~~  169 (325)
T 3kex_A          167 PDD  169 (325)
T ss_dssp             CCT
T ss_pred             ccc
Confidence            554

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.96  E-value=7.8e-29  Score=223.76  Aligned_cols=149  Identities=30%  Similarity=0.502  Sum_probs=132.1

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-eeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-ENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  200 (290)
                      .++|+..+.||+|+||.||+|.+. ++.||||.++...  ....|.+|+.++.+++||||+++++++...+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467888899999999999999885 6799999997643  4578999999999999999999999988765 78999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++|+|.+++... ....+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++....
T Consensus       269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999998543 2334789999999999999999999988   99999999999999999999999999986543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.96  E-value=3e-29  Score=217.36  Aligned_cols=152  Identities=34%  Similarity=0.573  Sum_probs=127.9

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCc----EEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      .++|+..+.||+|+||.||+|.+. +++    +||+|.+... ......++.+|+.++.+++||||+++++++...+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            357899999999999999999863 343    4688887543 2345678999999999999999999999998754 78


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +|+||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            999999999999988542  356899999999999999999999987   999999999999999999999999999987


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      ....
T Consensus       168 ~~~~  171 (327)
T 3poz_A          168 GAEE  171 (327)
T ss_dssp             TTTC
T ss_pred             cCCc
Confidence            6544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.96  E-value=1.1e-28  Score=212.87  Aligned_cols=152  Identities=31%  Similarity=0.486  Sum_probs=119.4

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999874 58899999987543 2344678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYP---KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |++ |+|.+++...   .....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5888876432   12345899999999999999999999987   9999999999999999999999999999875


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       160 ~  160 (317)
T 2pmi_A          160 I  160 (317)
T ss_dssp             S
T ss_pred             C
Confidence            4

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.96  E-value=3.8e-29  Score=214.87  Aligned_cols=156  Identities=31%  Similarity=0.435  Sum_probs=136.1

Q ss_pred             HhcCCCccceecccCCccEEEEEE------cCCcEEEEEEeccccc-cCHHHHHHHHHHHccc-CCCCcceeEEEEEeCC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  192 (290)
                      ..++|+..+.||+|+||.||+|.+      .+++.||+|.+..... .....+.+|+.++.++ +||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            456899999999999999999985      3467899999975432 3356789999999999 9999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEE
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKK---------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  257 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nil  257 (290)
                      ..++||||+++|+|.+++.....               ...+++..++.++.|++.||.|||+.+   ++||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            99999999999999998864322               225899999999999999999999987   999999999999


Q ss_pred             EcCCCCeEEeeccCceeeCCCc
Q 022887          258 LDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       258 l~~~~~~kl~DfGla~~~~~~~  279 (290)
                      +++++.+||+|||+++....+.
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~  199 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDS  199 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCT
T ss_pred             EcCCCCEEEccccccccccccc
Confidence            9999999999999998876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=3.6e-29  Score=220.43  Aligned_cols=149  Identities=27%  Similarity=0.305  Sum_probs=123.4

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHHH-HcccCCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMML-IAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||+++.. +++.||||.+.....   .....+..|..+ +..++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            468999999999999999999885 478899999975432   233456667665 577899999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|+|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999988843   345889999999999999999999988   9999999999999999999999999998643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=7.5e-29  Score=223.10  Aligned_cols=153  Identities=27%  Similarity=0.413  Sum_probs=133.1

Q ss_pred             HHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ...++|+..+.||+|+||.||++.. .+++.+|+|.+....  ......+.+|+.++..++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            3467899999999999999999987 468899999987533  2234678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc---CCCCeEEeeccCce
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR  273 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DfGla~  273 (290)
                      ||||+++|+|.+.+..   ...+++.....++.|++.||.|||+++   |+||||||+|||++   +++.+||+|||+|+
T Consensus        88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999888753   345899999999999999999999988   99999999999998   46789999999998


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .+..+
T Consensus       162 ~~~~~  166 (444)
T 3soa_A          162 EVEGE  166 (444)
T ss_dssp             CCCTT
T ss_pred             EecCC
Confidence            87654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.96  E-value=3e-29  Score=226.63  Aligned_cols=153  Identities=32%  Similarity=0.523  Sum_probs=132.5

Q ss_pred             HHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ...++|+..+.||+|+||.||+|.+.++..||||.+.... ....+|.+|+.++.+++||||+++++++.+ +..++|||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            4457788899999999999999999888889999997543 346789999999999999999999999876 67899999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+++|+|.+++... ....+++.++..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+..+
T Consensus       259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            99999999998421 2345899999999999999999999988   999999999999999999999999999987543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.96  E-value=7.4e-29  Score=213.37  Aligned_cols=151  Identities=27%  Similarity=0.270  Sum_probs=126.9

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||+||+|... +++.||||++.....  .....+..|+..+.++ +||||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            468999999999999999999885 689999999864322  2233455566555555 899999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+ +++|..++...  ...++|..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..+.
T Consensus       136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 66887776432  346999999999999999999999987   99999999999999999999999999988765


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       210 ~  210 (311)
T 3p1a_A          210 A  210 (311)
T ss_dssp             -
T ss_pred             C
Confidence            4

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.96  E-value=1.4e-28  Score=210.12  Aligned_cols=146  Identities=29%  Similarity=0.429  Sum_probs=125.5

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcc--cCCCCcceeEEEEEeC----CeeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK--LQHRHLVRLFGCCIEQ----GENI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~  195 (290)
                      .++|+..+.||+|+||.||+|.. +++.||||.+...   ....+..|.+++..  ++||||+++++++...    +..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999988 6789999998653   23455566665555  8999999999997653    3578


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCceecCCCCCCEEEcCCCCeEEe
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                      +||||+++|+|.+++.    ...+++..++.++.|++.||.|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999983    346899999999999999999999        655   9999999999999999999999


Q ss_pred             eccCceeeCCC
Q 022887          268 DFGMARIFGGD  278 (290)
Q Consensus       268 DfGla~~~~~~  278 (290)
                      |||+|+.....
T Consensus       156 Dfg~a~~~~~~  166 (301)
T 3q4u_A          156 DLGLAVMHSQS  166 (301)
T ss_dssp             CCTTCEEEETT
T ss_pred             eCCCeeecccc
Confidence            99999887654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.96  E-value=8.9e-29  Score=216.29  Aligned_cols=150  Identities=25%  Similarity=0.384  Sum_probs=121.5

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ..++|+..+.||+|+||.||+|... +++.||||.+....  ..+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3568999999999999999999985 47889999997532  34678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---CCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGla~~~~  276 (290)
                      |+++++|.+++..   ...+++.+...++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999988843   456899999999999999999999987   999999999999975   8899999999999775


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      ..
T Consensus       203 ~~  204 (349)
T 2w4o_A          203 HQ  204 (349)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.96  E-value=1.6e-29  Score=218.27  Aligned_cols=160  Identities=29%  Similarity=0.460  Sum_probs=137.0

Q ss_pred             HhHHHHhcCCCccceecccCCccEEEEEEc------CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEE
Q 022887          116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCC  188 (290)
Q Consensus       116 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~  188 (290)
                      .+.+...++|...+.||+|+||.||+|...      ++..||+|.+..... .....+.+|+.++..++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            334455678999999999999999999764      367899999975432 2345789999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC
Q 022887          189 IEQGENILIYEYMPNKSLDVFLFYPK-------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD  261 (290)
Q Consensus       189 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~  261 (290)
                      .+.+..++||||+++|+|.+++....       ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence            99999999999999999999875321       1245789999999999999999999987   9999999999999999


Q ss_pred             CCeEEeeccCceeeCCC
Q 022887          262 MNPKISDFGMARIFGGD  278 (290)
Q Consensus       262 ~~~kl~DfGla~~~~~~  278 (290)
                      +.+||+|||+++.....
T Consensus       175 ~~~kl~Dfg~~~~~~~~  191 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYET  191 (322)
T ss_dssp             CCEEECCTTCCCGGGGG
T ss_pred             CeEEECcCccccccccc
Confidence            99999999999876543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.96  E-value=1.5e-28  Score=217.84  Aligned_cols=151  Identities=21%  Similarity=0.274  Sum_probs=134.6

Q ss_pred             hcCCCccceeccc--CCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G--~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|  +||.||++... +++.||||++....  ......+.+|+.++..++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4689999999999  99999999985 58999999997543  2334678889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|+|.+++... ....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999988543 2345899999999999999999999988   9999999999999999999999999987653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.96  E-value=3.7e-28  Score=207.00  Aligned_cols=151  Identities=30%  Similarity=0.448  Sum_probs=132.7

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      +|.....||+|+||.||+|.. .++..||||.+..........+.+|+.++..++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            455566999999999999987 4578999999987655666889999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-CCCeEEeeccCceeeCC
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGG  277 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~~  277 (290)
                      +++|.+++........+++.....++.|++.||.|||+.+   ++|+||||+||+++. ++.+||+|||+++.+..
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999865444456788999999999999999999987   999999999999987 89999999999987754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.96  E-value=5e-29  Score=211.84  Aligned_cols=151  Identities=29%  Similarity=0.453  Sum_probs=134.1

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-C-------cEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-G-------QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      .++|...+.||+|+||.||+|.... +       ..||+|.+..........+.+|+.++.+++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3678899999999999999997643 3       4699999977666667889999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC--------eE
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--------PK  265 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~--------~k  265 (290)
                      .++||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999998542  334899999999999999999999988   999999999999998887        99


Q ss_pred             EeeccCceeeCC
Q 022887          266 ISDFGMARIFGG  277 (290)
Q Consensus       266 l~DfGla~~~~~  277 (290)
                      |+|||+++....
T Consensus       162 l~Dfg~~~~~~~  173 (289)
T 4fvq_A          162 LSDPGISITVLP  173 (289)
T ss_dssp             ECCCCSCTTTSC
T ss_pred             eccCcccccccC
Confidence            999999976543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.7e-29  Score=220.10  Aligned_cols=151  Identities=28%  Similarity=0.369  Sum_probs=133.7

Q ss_pred             hcCCCccceecccCCccEEEEEE----cCCcEEEEEEecccc----ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCC
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  192 (290)
                      .++|+..+.||+|+||.||+++.    .+++.||||.+....    ......+..|+.++..+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36899999999999999999987    368899999986432    23456778899999999 6999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..++||||+++++|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999998853   345899999999999999999999987   999999999999999999999999999


Q ss_pred             eeeCCC
Q 022887          273 RIFGGD  278 (290)
Q Consensus       273 ~~~~~~  278 (290)
                      +.+..+
T Consensus       207 ~~~~~~  212 (355)
T 1vzo_A          207 KEFVAD  212 (355)
T ss_dssp             EECCGG
T ss_pred             eecccC
Confidence            977543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.96  E-value=4.6e-29  Score=225.74  Aligned_cols=149  Identities=23%  Similarity=0.391  Sum_probs=121.1

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC-----Ce
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-----GE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  193 (290)
                      .++|+..+.||+|+||.||+|... +++.||||++....  ......+.+|+.++..++||||+++++++...     +.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999874 58899999996532  22356789999999999999999999999543     46


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++||||++ ++|..++.   ....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+
T Consensus       132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            899999985 67887774   3456899999999999999999999988   9999999999999999999999999999


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      .+..
T Consensus       205 ~~~~  208 (458)
T 3rp9_A          205 TVDY  208 (458)
T ss_dssp             CTTS
T ss_pred             hccC
Confidence            8754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.96  E-value=1.3e-28  Score=220.29  Aligned_cols=153  Identities=25%  Similarity=0.354  Sum_probs=128.7

Q ss_pred             HHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--------ccCHHHHHHHHHHHcccCCCCcceeEEEEE
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLTEFKNEMMLIAKLQHRHLVRLFGCCI  189 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  189 (290)
                      ....++|...+.||+|+||.||+|... +++.||||.+....        ......+.+|+.++.+++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345689999999999999999999874 57899999986432        112346889999999999999999999975


Q ss_pred             eCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC---CCeEE
Q 022887          190 EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKI  266 (290)
Q Consensus       190 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~---~~~kl  266 (290)
                       .+..++||||+++|+|.+++.   ....+++.....++.|++.||.|||+.+   |+||||||+|||++.+   ..+||
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence             456899999999999988874   3456899999999999999999999987   9999999999999754   45999


Q ss_pred             eeccCceeeCCC
Q 022887          267 SDFGMARIFGGD  278 (290)
Q Consensus       267 ~DfGla~~~~~~  278 (290)
                      +|||+|+.++..
T Consensus       284 ~DFG~a~~~~~~  295 (419)
T 3i6u_A          284 TDFGHSKILGET  295 (419)
T ss_dssp             CCSSTTTSCC--
T ss_pred             eecccceecCCC
Confidence            999999987654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.96  E-value=7.2e-29  Score=222.89  Aligned_cols=150  Identities=25%  Similarity=0.424  Sum_probs=130.2

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC-----Ce
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-----GE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  193 (290)
                      .++|...+.||+|+||.||+|... +++.||||++....  ......+.+|+.++..++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999874 47889999997532  23356789999999999999999999999876     56


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++||||++ ++|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999987 588888743   456899999999999999999999988   9999999999999999999999999999


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .+...
T Consensus       178 ~~~~~  182 (432)
T 3n9x_A          178 TINSE  182 (432)
T ss_dssp             EC---
T ss_pred             ccccc
Confidence            87654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.96  E-value=6.2e-29  Score=216.75  Aligned_cols=150  Identities=27%  Similarity=0.371  Sum_probs=129.9

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCC--CCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||.||++...+++.||||++....  ......+.+|+.++..++|  |||+++++++...+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            46799999999999999999999889999999986432  2334678999999999976  9999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      || +.+++|.+++..   ...+++.++..++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899988853   356899999999999999999999987   99999999999997 57799999999998765


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      +.
T Consensus       160 ~~  161 (343)
T 3dbq_A          160 DT  161 (343)
T ss_dssp             --
T ss_pred             cc
Confidence            44

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.96  E-value=2.2e-28  Score=211.23  Aligned_cols=151  Identities=28%  Similarity=0.394  Sum_probs=134.9

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccccc------CHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      .++|+..+.||+|+||.||++... +++.||+|.+......      ...++.+|+.++..++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999875 5889999998754321      357899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC----CeEEeecc
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG  270 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DfG  270 (290)
                      ++||||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++||||||+||++++++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999853   346899999999999999999999987   99999999999999888    79999999


Q ss_pred             CceeeCCC
Q 022887          271 MARIFGGD  278 (290)
Q Consensus       271 la~~~~~~  278 (290)
                      +++.+..+
T Consensus       165 ~~~~~~~~  172 (321)
T 2a2a_A          165 LAHEIEDG  172 (321)
T ss_dssp             TCEECCTT
T ss_pred             cceecCcc
Confidence            99987654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.96  E-value=2e-28  Score=210.36  Aligned_cols=149  Identities=30%  Similarity=0.428  Sum_probs=132.9

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+..+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.++.+++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999885 488999999865432  224678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |+++++|..++..   ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            9999999888743   355899999999999999999999988   99999999999999999999999999988754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=1.2e-28  Score=207.13  Aligned_cols=150  Identities=31%  Similarity=0.528  Sum_probs=135.7

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|+||.||++...+++.||+|.+.... .....+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            35788899999999999999999888899999997643 34578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999988532  345899999999999999999999988   99999999999999999999999999987654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.96  E-value=2.6e-28  Score=206.39  Aligned_cols=151  Identities=30%  Similarity=0.502  Sum_probs=134.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|...+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999987 568899999986432   23457899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|..++..  ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999998853  2356899999999999999999999987   99999999999999999999999999988754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=6.6e-29  Score=216.40  Aligned_cols=157  Identities=23%  Similarity=0.317  Sum_probs=132.9

Q ss_pred             HHHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc-----cccCHHHHHHHHHHHcccCCCCcceeEEEEEeC
Q 022887          118 VSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-----SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ  191 (290)
Q Consensus       118 ~~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  191 (290)
                      +....++|...+.||+|+||.||+|.. .++..||+|.+...     .......+.+|+.++.+++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            456678999999999999999999987 45789999998643     234457899999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 022887          192 GENILIYEYMPNKSLDVFLFYPK-------------------------------------KKRLLGWQARVRIIEGIAQG  234 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~  234 (290)
                      +..++||||+++|+|.+++....                                     ....+++...+.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999998874100                                     01123567788999999999


Q ss_pred             HHHHhhCCCCCceecCCCCCCEEEcCCC--CeEEeeccCceeeCC
Q 022887          235 LLYLHQYSRLRIIHRDLKASNILLDSDM--NPKISDFGMARIFGG  277 (290)
Q Consensus       235 l~yLH~~~~~~iiH~dlk~~Nill~~~~--~~kl~DfGla~~~~~  277 (290)
                      |+|||+.+   |+||||||+||+++.++  .+||+|||+++.+..
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~  222 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK  222 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence            99999987   99999999999998776  899999999987643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.96  E-value=1.5e-28  Score=210.29  Aligned_cols=153  Identities=33%  Similarity=0.557  Sum_probs=132.0

Q ss_pred             hcCCCccceecccCCccEEEEEE-----cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--Ce
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  193 (290)
                      .+.|+..+.||+|+||.||++.+     .+++.||+|.+.... ......+.+|+.++..++||||+++++++...  +.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35688899999999999999984     357899999997533 34567899999999999999999999999877  56


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++||||+++++|.+++..  ....+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            7999999999999998843  2345899999999999999999999988   9999999999999999999999999999


Q ss_pred             eeCCCc
Q 022887          274 IFGGDE  279 (290)
Q Consensus       274 ~~~~~~  279 (290)
                      .+..+.
T Consensus       175 ~~~~~~  180 (302)
T 4e5w_A          175 AIETDK  180 (302)
T ss_dssp             ECCTTC
T ss_pred             cccCCC
Confidence            876543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.96  E-value=1.9e-28  Score=206.39  Aligned_cols=152  Identities=34%  Similarity=0.522  Sum_probs=125.1

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEecccc----ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||.||+|.+. ++.||||.+....    ......+.+|+.++..++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357889999999999999999974 7899999986432    23357889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC--------CCCeEEeec
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--------DMNPKISDF  269 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~--------~~~~kl~Df  269 (290)
                      |||+++++|..++.    ...+++...+.++.|++.||.|||+++..+++||||||+||+++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999883    346899999999999999999999987556999999999999986        778999999


Q ss_pred             cCceeeCCC
Q 022887          270 GMARIFGGD  278 (290)
Q Consensus       270 Gla~~~~~~  278 (290)
                      |+++.+...
T Consensus       161 g~~~~~~~~  169 (271)
T 3dtc_A          161 GLAREWHRT  169 (271)
T ss_dssp             CC-------
T ss_pred             Ccccccccc
Confidence            999876543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.96  E-value=3.1e-28  Score=205.99  Aligned_cols=152  Identities=36%  Similarity=0.537  Sum_probs=134.1

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ..++|+..+.||+|+||.||+|...++..||+|.+... ......+.+|+.++..++||||+++++++. .+..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            34688999999999999999999988889999999753 335678999999999999999999999886 4568999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.....
T Consensus        89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            9999999988431 1235899999999999999999999988   999999999999999999999999999987654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.96  E-value=1.8e-28  Score=231.25  Aligned_cols=151  Identities=28%  Similarity=0.326  Sum_probs=133.2

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||++... +++.||||++...   .......+..|..++..+ +||||+++++++.+.+..++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            467899999999999999999875 4788999999743   233456788899999887 79999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|+|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus       420 V~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            9999999999998853   345899999999999999999999988   9999999999999999999999999999754


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      .+
T Consensus       494 ~~  495 (674)
T 3pfq_A          494 WD  495 (674)
T ss_dssp             CT
T ss_pred             cC
Confidence            33

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.96  E-value=1.8e-28  Score=208.35  Aligned_cols=154  Identities=23%  Similarity=0.402  Sum_probs=132.8

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|...+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            467999999999999999999874 58899999987543 3356789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE---cCCCCeEEeeccCceee
Q 022887          200 YMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIF  275 (290)
Q Consensus       200 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~~  275 (290)
                      |+++|+|.+++... .....+++.....++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||+++.+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999998887432 12356899999999999999999999988   9999999999999   45678999999999877


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      ..+
T Consensus       178 ~~~  180 (285)
T 3is5_A          178 KSD  180 (285)
T ss_dssp             ---
T ss_pred             CCc
Confidence            554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.96  E-value=3.2e-28  Score=209.53  Aligned_cols=150  Identities=27%  Similarity=0.346  Sum_probs=130.5

Q ss_pred             hcCCCcc-ceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQ-CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~-~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .+.|... +.||+|+||.||++.. .+++.||||.+..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3577774 7899999999999986 46889999999876656678899999999884 7999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC---eEEeeccCceee
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARIF  275 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~---~kl~DfGla~~~  275 (290)
                      ||+++++|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||+++.+
T Consensus        91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999998853   346899999999999999999999987   999999999999998776   999999999876


Q ss_pred             CC
Q 022887          276 GG  277 (290)
Q Consensus       276 ~~  277 (290)
                      ..
T Consensus       165 ~~  166 (316)
T 2ac3_A          165 KL  166 (316)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.96  E-value=8.9e-28  Score=205.62  Aligned_cols=150  Identities=28%  Similarity=0.440  Sum_probs=135.5

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .+.|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            467899999999999999999874 58899999997543 3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+++++|.+++.    ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+...
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999999883    346899999999999999999999988   999999999999999999999999999887654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.96  E-value=1.3e-28  Score=213.23  Aligned_cols=152  Identities=30%  Similarity=0.476  Sum_probs=134.5

Q ss_pred             hcCCCccceecccCCccEEEEEE-----cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEe--CCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  194 (290)
                      .++|+..+.||+|+||.||++.+     .+++.||||.+..........+.+|+.++.+++||||+++++++..  .+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36889999999999999999984     3578999999987655556789999999999999999999999874  4568


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            8999999999999988532  235899999999999999999999987   99999999999999999999999999998


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      +...
T Consensus       177 ~~~~  180 (327)
T 3lxl_A          177 LPLD  180 (327)
T ss_dssp             CCTT
T ss_pred             cccC
Confidence            7654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.96  E-value=2.6e-28  Score=206.90  Aligned_cols=156  Identities=27%  Similarity=0.355  Sum_probs=134.6

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  196 (290)
                      ..++|+..+.||+|+||.||+|... +++.||+|.+....  .....++.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999885 68999999987532  23456788999999988 99999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---------------
Q 022887          197 IYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---------------  260 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---------------  260 (290)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+++   |+||||||+||+++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999885421 1256899999999999999999999988   999999999999984               


Q ss_pred             ----CCCeEEeeccCceeeCCCc
Q 022887          261 ----DMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       261 ----~~~~kl~DfGla~~~~~~~  279 (290)
                          ...+||+|||++.......
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~  188 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ  188 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC
T ss_pred             ccCCceEEEEcccccccccCCcc
Confidence                4479999999999876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.96  E-value=1.3e-28  Score=215.15  Aligned_cols=150  Identities=33%  Similarity=0.499  Sum_probs=130.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .+.|+..+.||+|+||.||+|.. .+++.||||++.....   ....++.+|+.++.+++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35688899999999999999987 5688999999964322   2346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||++ |++.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99998 567666532  2356899999999999999999999987   99999999999999999999999999987754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.96  E-value=6.2e-29  Score=211.17  Aligned_cols=155  Identities=29%  Similarity=0.494  Sum_probs=137.8

Q ss_pred             HHhcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ...++|+..+.||+|+||.||+|.+.. +..||+|.+... ......+.+|+.++.+++||||+++++++...+..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            345789999999999999999998854 788999999753 334578999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....+
T Consensus        89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            999999999988542 3356899999999999999999999988   999999999999999999999999999887654


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       165 ~  165 (288)
T 3kfa_A          165 T  165 (288)
T ss_dssp             S
T ss_pred             c
Confidence            3

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.96  E-value=3.5e-28  Score=207.25  Aligned_cols=150  Identities=25%  Similarity=0.347  Sum_probs=133.7

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|...+.||+|+||.||++... +++.+|+|.+....   ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468899999999999999999885 47889999986532   22356788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|.+++..   ...+++.++..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999988743   346899999999999999999999987   99999999999999999999999999988754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.95  E-value=5.9e-29  Score=229.07  Aligned_cols=153  Identities=32%  Similarity=0.523  Sum_probs=135.3

Q ss_pred             HHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ...++|+..+.||+|+||.||+|.+.++..||||.+.... ...++|.+|+.++.+++||||+++++++.+ +..++|||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            3456788899999999999999999888889999997643 346789999999999999999999999876 67899999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+++|+|.+++... ....+++.+++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+..+
T Consensus       342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            99999999998421 2245899999999999999999999988   999999999999999999999999999877543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=3.1e-28  Score=211.64  Aligned_cols=150  Identities=25%  Similarity=0.350  Sum_probs=133.9

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|...+.||+|+||.||++...+ ++.+|+|.+....   ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4689999999999999999998854 7889999986532   23356788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|.+++..   ...+++.+++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus       120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999988743   346899999999999999999999987   99999999999999999999999999998754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.95  E-value=1.3e-28  Score=218.34  Aligned_cols=149  Identities=27%  Similarity=0.373  Sum_probs=128.6

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--ccCHHHHHHHHHHHcccC--CCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQ--HRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||++...+++.||||.+....  ......+.+|+.++.+++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4699999999999999999998889999999986432  234578899999999996  599999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      | +.+++|.+++..   ...+++.++..++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+..+
T Consensus       136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 578899988853   346889999999999999999999887   99999999999995 578999999999987654


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       208 ~  208 (390)
T 2zmd_A          208 T  208 (390)
T ss_dssp             -
T ss_pred             C
Confidence            3

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=2.4e-28  Score=216.54  Aligned_cols=150  Identities=27%  Similarity=0.497  Sum_probs=122.7

Q ss_pred             HHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc--cccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCC--e
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQG--E  193 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~  193 (290)
                      ...++|+..+.||+|+||.||+|.. .+++.||||++...  .......+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3467899999999999999999987 45889999998643  2234567889999999997 999999999998654  6


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++||||++ ++|..++..    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            799999998 578877742    46889999999999999999999988   9999999999999999999999999999


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      .+..
T Consensus       158 ~~~~  161 (388)
T 3oz6_A          158 SFVN  161 (388)
T ss_dssp             ESSS
T ss_pred             cccc
Confidence            7743

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.95  E-value=8.5e-29  Score=212.96  Aligned_cols=161  Identities=28%  Similarity=0.423  Sum_probs=136.2

Q ss_pred             HHhHHHHhcCCCccceecccCCccEEEEEE------cCCcEEEEEEeccccc-cCHHHHHHHHHHHccc-CCCCcceeEE
Q 022887          115 LASVSAATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFG  186 (290)
Q Consensus       115 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~  186 (290)
                      ........++|...+.||+|+||.||+|.+      .+++.||||.+..... .....+.+|+.++.++ +||||+++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            344445568899999999999999999975      2457899999975432 2346789999999999 7999999999


Q ss_pred             EEEeCC-eeEEEEEecCCCChhhhhhCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCC
Q 022887          187 CCIEQG-ENILIYEYMPNKSLDVFLFYPKK-------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLK  252 (290)
Q Consensus       187 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk  252 (290)
                      ++...+ ..++||||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   |+|||||
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik  175 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  175 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence            998765 48999999999999999865332             123789999999999999999999987   9999999


Q ss_pred             CCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          253 ASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       253 ~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+||+++.++.+||+|||+++.+..+
T Consensus       176 p~Nil~~~~~~~kl~Dfg~~~~~~~~  201 (316)
T 2xir_A          176 ARNILLSEKNVVKICDFGLARDIYKD  201 (316)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTC
T ss_pred             cceEEECCCCCEEECCCccccccccC
Confidence            99999999999999999999877554

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=6.1e-28  Score=212.21  Aligned_cols=157  Identities=24%  Similarity=0.368  Sum_probs=137.4

Q ss_pred             HhHHHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccccc--------CHHHHHHHHHHHccc-CCCCcceeE
Q 022887          116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--------GLTEFKNEMMLIAKL-QHRHLVRLF  185 (290)
Q Consensus       116 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~l~  185 (290)
                      .......++|...+.||+|+||.||+|.+. +|+.||||.+......        ....+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334455678999999999999999999985 6899999998653311        135678899999999 799999999


Q ss_pred             EEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeE
Q 022887          186 GCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  265 (290)
Q Consensus       186 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~k  265 (290)
                      +++...+..++||||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            999999999999999999999998843   346899999999999999999999987   99999999999999999999


Q ss_pred             EeeccCceeeCCC
Q 022887          266 ISDFGMARIFGGD  278 (290)
Q Consensus       266 l~DfGla~~~~~~  278 (290)
                      |+|||++..+..+
T Consensus       241 l~DfG~~~~~~~~  253 (365)
T 2y7j_A          241 LSDFGFSCHLEPG  253 (365)
T ss_dssp             ECCCTTCEECCTT
T ss_pred             EEecCcccccCCC
Confidence            9999999987654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.95  E-value=1.4e-28  Score=222.69  Aligned_cols=148  Identities=28%  Similarity=0.394  Sum_probs=123.6

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  192 (290)
                      .++|+..+.||+|+||.||+|... +++.||||++...  .......+.+|+.++..++||||+++++++...+      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999874 5889999999753  2234567889999999999999999999997653      


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..++||||++++ +...+.     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999876 444441     23889999999999999999999988   999999999999999999999999999


Q ss_pred             eeeCCC
Q 022887          273 RIFGGD  278 (290)
Q Consensus       273 ~~~~~~  278 (290)
                      +..+..
T Consensus       212 ~~~~~~  217 (464)
T 3ttj_A          212 RTAGTS  217 (464)
T ss_dssp             -----C
T ss_pred             eecCCC
Confidence            987654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.95  E-value=2.8e-28  Score=209.68  Aligned_cols=155  Identities=30%  Similarity=0.534  Sum_probs=124.8

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC----CcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe-
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  193 (290)
                      ..++|...+.||+|+||.||+|....    +..||+|.+....  ......+.+|+.++.+++||||+++++++...+. 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            45688899999999999999997642    4479999987432  2334678999999999999999999999987653 


Q ss_pred             ----eEEEEEecCCCChhhhhhCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEE
Q 022887          194 ----NILIYEYMPNKSLDVFLFYP---KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  266 (290)
Q Consensus       194 ----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl  266 (290)
                          .++||||+++++|..++...   .....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence                49999999999999987432   23456999999999999999999999887   999999999999999999999


Q ss_pred             eeccCceeeCCC
Q 022887          267 SDFGMARIFGGD  278 (290)
Q Consensus       267 ~DfGla~~~~~~  278 (290)
                      +|||+++.+...
T Consensus       189 ~Dfg~~~~~~~~  200 (313)
T 3brb_A          189 ADFGLSKKIYSG  200 (313)
T ss_dssp             CSCSCC------
T ss_pred             eecCcceecccc
Confidence            999999877543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.95  E-value=2.2e-28  Score=208.12  Aligned_cols=149  Identities=33%  Similarity=0.503  Sum_probs=122.9

Q ss_pred             HhcCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..++|+..+.||+|+||.||+|...  ..||+|.+....  ......+.+|+.++.+++||||+++++++ ..+..++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            4578999999999999999999864  369999986433  23356799999999999999999999965 456789999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++++|.+++..  ....+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999988843  3456899999999999999999999988   99999999999999999999999999987654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.95  E-value=3.3e-28  Score=212.19  Aligned_cols=152  Identities=27%  Similarity=0.400  Sum_probs=134.8

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccC-----------------HHHHHHHHHHHcccCCCCccee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-----------------LTEFKNEMMLIAKLQHRHLVRL  184 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l  184 (290)
                      .++|...+.||+|+||.||+|.. +++.||+|.+.......                 ...+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 88999999986432211                 1789999999999999999999


Q ss_pred             EEEEEeCCeeEEEEEecCCCChhhh------hhCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCceecCCCCCCEE
Q 022887          185 FGCCIEQGENILIYEYMPNKSLDVF------LFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNIL  257 (290)
Q Consensus       185 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlk~~Nil  257 (290)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.|++.||.|||+ .+   ++||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999988      422 225679999999999999999999998 77   999999999999


Q ss_pred             EcCCCCeEEeeccCceeeCCC
Q 022887          258 LDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       258 l~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++.++.+||+|||+++.....
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~  205 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK  205 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT
T ss_pred             EcCCCcEEEeccccccccccc
Confidence            999999999999999987543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=4.8e-28  Score=208.07  Aligned_cols=152  Identities=24%  Similarity=0.293  Sum_probs=130.1

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccccc---CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ..++|...+.||+|+||.||++... +++.||+|.+......   ....+.+|+.++.+++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            4578999999999999999999875 5889999999754322   24678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999998853   345899999999999999999999988   9999999999999999999999999998775


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      ..
T Consensus       186 ~~  187 (309)
T 2h34_A          186 DE  187 (309)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.95  E-value=6.8e-28  Score=220.62  Aligned_cols=152  Identities=29%  Similarity=0.446  Sum_probs=131.9

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-------------cCHHHHHHHHHHHcccCCCCcceeEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------------QGLTEFKNEMMLIAKLQHRHLVRLFG  186 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~  186 (290)
                      ..++|...+.||+|+||.||+|... +++.||+|.+.....             .....+.+|+.++.+++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999885 478999999865321             33567899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC---C
Q 022887          187 CCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---N  263 (290)
Q Consensus       187 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~---~  263 (290)
                      ++.+.+..++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999888743   345899999999999999999999988   99999999999998775   6


Q ss_pred             eEEeeccCceeeCCC
Q 022887          264 PKISDFGMARIFGGD  278 (290)
Q Consensus       264 ~kl~DfGla~~~~~~  278 (290)
                      +||+|||+++.+..+
T Consensus       188 ~kl~Dfg~a~~~~~~  202 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKD  202 (504)
T ss_dssp             EEECCCTTCEECCTT
T ss_pred             EEEEECCCCEEcCCC
Confidence            999999999988654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.95  E-value=5.8e-28  Score=209.10  Aligned_cols=142  Identities=26%  Similarity=0.344  Sum_probs=125.1

Q ss_pred             cceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEEEecCCCC
Q 022887          128 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKS  205 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  205 (290)
                      .+.||+|+||.||++... +++.||||.+...   ....+.+|+..+..+. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999884 5889999999643   3467889999999997 9999999999999999999999999999


Q ss_pred             hhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC---CeEEeeccCceeeCCC
Q 022887          206 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARIFGGD  278 (290)
Q Consensus       206 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DfGla~~~~~~  278 (290)
                      |.+++..   ...+++.+...++.|++.||.|||+.+   |+||||||+|||++.++   .+||+|||+++....+
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9998853   356899999999999999999999988   99999999999997665   8999999999977554

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.95  E-value=4.6e-28  Score=212.58  Aligned_cols=159  Identities=26%  Similarity=0.354  Sum_probs=131.6

Q ss_pred             cHHhHHHHhcCCCccceecccCCccEEEEEEcCCcEEEEEEecccccc-----------CHHHHHHHHHHHcccCCCCcc
Q 022887          114 SLASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-----------GLTEFKNEMMLIAKLQHRHLV  182 (290)
Q Consensus       114 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~h~niv  182 (290)
                      ...++....++|...+.||+|+||.||+|...++..||||++......           ....+.+|+.++.+++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            455667788999999999999999999999888999999998643221           136789999999999999999


Q ss_pred             eeEEEEEeC-----CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEE
Q 022887          183 RLFGCCIEQ-----GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  257 (290)
Q Consensus       183 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nil  257 (290)
                      ++++++...     ...++||||++ |+|..++..  ....+++..+..++.|++.||.|||+.+   |+||||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence            999998653     35799999998 577766643  3456899999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEeeccCceeeCCC
Q 022887          258 LDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       258 l~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++.++.+||+|||+++.....
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~  187 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTAD  187 (362)
T ss_dssp             ECTTCCEEECCTTC-------
T ss_pred             EcCCCCEEEEecCcccccccc
Confidence            999999999999999865443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.95  E-value=2.7e-28  Score=213.84  Aligned_cols=162  Identities=27%  Similarity=0.291  Sum_probs=138.5

Q ss_pred             CCcccHHhHHHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccC-----CCCcce
Q 022887          110 LPLFSLASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-----HRHLVR  183 (290)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----h~niv~  183 (290)
                      ...+++.+.....++|...+.||+|+||.||+|.. .+++.||||.+... ......+..|+.++..+.     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            44455566666678999999999999999999988 45889999999742 233466788999988886     999999


Q ss_pred             eEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---
Q 022887          184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---  260 (290)
Q Consensus       184 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---  260 (290)
                      +++++...+..++||||+ +++|.+++.... ...+++.....++.|++.||+|||+.+   |+||||||+|||+++   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence            999999999999999999 899998885432 335899999999999999999999988   999999999999975   


Q ss_pred             ----------------------CCCeEEeeccCceeeCC
Q 022887          261 ----------------------DMNPKISDFGMARIFGG  277 (290)
Q Consensus       261 ----------------------~~~~kl~DfGla~~~~~  277 (290)
                                            ++.+||+|||+|+....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~  214 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD  214 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence                                  78999999999987654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=2.8e-28  Score=211.02  Aligned_cols=152  Identities=33%  Similarity=0.560  Sum_probs=133.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-----cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC--ee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG--EN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~  194 (290)
                      .++|+..+.||+|+||.||++.+     .+++.||+|.+..........+.+|+.++.+++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35788899999999999999984     357899999998765556678999999999999999999999987654  67


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999998542  345899999999999999999999987   99999999999999999999999999998


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      +..+
T Consensus       195 ~~~~  198 (326)
T 2w1i_A          195 LPQD  198 (326)
T ss_dssp             CCSS
T ss_pred             cccc
Confidence            7654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.95  E-value=4.1e-28  Score=226.67  Aligned_cols=143  Identities=30%  Similarity=0.516  Sum_probs=126.0

Q ss_pred             eecccCCccEEEEEEc---CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCCCC
Q 022887          130 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKS  205 (290)
Q Consensus       130 ~ig~G~fg~V~~~~~~---~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  205 (290)
                      .||+|+||.||+|.+.   ++..||||.++... .....+|.+|+.++.+++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999874   45679999997643 3356889999999999999999999999976 56899999999999


Q ss_pred             hhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          206 LDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       206 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |.+++..  ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+..+
T Consensus       422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            9998843  3456899999999999999999999988   999999999999999999999999999987544

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.95  E-value=1.3e-27  Score=205.18  Aligned_cols=154  Identities=31%  Similarity=0.504  Sum_probs=127.1

Q ss_pred             HHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc-----ccCHHHHHHHHHHHcccC---CCCcceeEEEEEe
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-----GQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIE  190 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  190 (290)
                      ...++|+..+.||+|+||.||+|.. .+++.||||.+....     ......+.+|+.++..++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3467999999999999999999987 568899999986422     122356777887777664   9999999999987


Q ss_pred             CC-----eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeE
Q 022887          191 QG-----ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  265 (290)
Q Consensus       191 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~k  265 (290)
                      ..     ..++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            65     4789999997 58988875432 334899999999999999999999988   99999999999999999999


Q ss_pred             EeeccCceeeCCC
Q 022887          266 ISDFGMARIFGGD  278 (290)
Q Consensus       266 l~DfGla~~~~~~  278 (290)
                      |+|||+++.+...
T Consensus       161 l~Dfg~a~~~~~~  173 (308)
T 3g33_A          161 LADFGLARIYSYQ  173 (308)
T ss_dssp             ECSCSCTTTSTTC
T ss_pred             EeeCccccccCCC
Confidence            9999999877543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.95  E-value=5.2e-28  Score=220.88  Aligned_cols=152  Identities=28%  Similarity=0.430  Sum_probs=129.6

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .++|+..+.||+|+||.||+|... ++..||+|.+....  ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999885 57899999987542  334578899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---CCCeEEeeccCceee
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARIF  275 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGla~~~  275 (290)
                      ||+++|+|.+.+..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++.+
T Consensus       116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999887743   345899999999999999999999988   999999999999976   455999999999988


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      ....
T Consensus       190 ~~~~  193 (494)
T 3lij_A          190 ENQK  193 (494)
T ss_dssp             BTTB
T ss_pred             CCCc
Confidence            6543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.95  E-value=9.6e-28  Score=207.03  Aligned_cols=147  Identities=36%  Similarity=0.570  Sum_probs=130.1

Q ss_pred             CCccceecccCCccEEEEEEc-----CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEE
Q 022887          125 FSTQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENIL  196 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  196 (290)
                      |+..+.||+|+||.||++.+.     +++.||||.+..... .....+.+|+.++.+++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999998652     578899999975432 3356789999999999999999999999984  57799


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++++|.+++..    ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999843    34899999999999999999999988   9999999999999999999999999999886


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      ..
T Consensus       186 ~~  187 (318)
T 3lxp_A          186 EG  187 (318)
T ss_dssp             TT
T ss_pred             cc
Confidence            54

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.95  E-value=5.3e-28  Score=209.75  Aligned_cols=150  Identities=29%  Similarity=0.489  Sum_probs=129.6

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccccc--CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .++|+..+.||+|+||.||++... +++.||+|++......  ....+.+|+.++.+++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            367899999999999999999885 4889999998653322  2456789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++++|..++..   ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999999887643   345899999999999999999999988   99999999999999999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.95  E-value=2.1e-28  Score=207.41  Aligned_cols=151  Identities=27%  Similarity=0.420  Sum_probs=123.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcC----CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||+|....    +..||+|.+.... ......+.+|+..+.+++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4688899999999999999998743    4569999987533 233567899999999999999999999974 567899


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+.
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999988532  345899999999999999999999987   9999999999999999999999999998875


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      ..
T Consensus       168 ~~  169 (281)
T 1mp8_A          168 DS  169 (281)
T ss_dssp             --
T ss_pred             cc
Confidence            53

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.95  E-value=7.5e-28  Score=203.95  Aligned_cols=151  Identities=27%  Similarity=0.392  Sum_probs=133.3

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc------cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      .++|+..+.||+|+||.||++... +++.||+|.+.....      .....+.+|+.++.+++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357889999999999999999885 588999999865321      2367899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC----CeEEeecc
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG  270 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DfG  270 (290)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999998843   346899999999999999999999987   99999999999998877    89999999


Q ss_pred             CceeeCCC
Q 022887          271 MARIFGGD  278 (290)
Q Consensus       271 la~~~~~~  278 (290)
                      +++.+...
T Consensus       158 ~~~~~~~~  165 (283)
T 3bhy_A          158 IAHKIEAG  165 (283)
T ss_dssp             TCEECC--
T ss_pred             cceeccCC
Confidence            99877543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.95  E-value=3.8e-28  Score=209.18  Aligned_cols=153  Identities=27%  Similarity=0.355  Sum_probs=132.4

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEe----CCeeE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGENI  195 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  195 (290)
                      ..++|+..+.||+|+||.||++.. .+++.||||.+..........+.+|+.++..++||||+++++++..    .+..+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            346899999999999999999987 5689999999876555566789999999999999999999999873    34678


Q ss_pred             EEEEecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          196 LIYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      +||||+++|+|.+++... .....+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999887542 23456899999999999999999999987   99999999999999999999999999876


Q ss_pred             eC
Q 022887          275 FG  276 (290)
Q Consensus       275 ~~  276 (290)
                      ..
T Consensus       184 ~~  185 (317)
T 2buj_A          184 AC  185 (317)
T ss_dssp             SC
T ss_pred             cc
Confidence            53

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=3.4e-28  Score=205.80  Aligned_cols=150  Identities=30%  Similarity=0.401  Sum_probs=131.9

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||.||++... ++..||+|.+...   .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            468999999999999999999875 4678999998643   223456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999988743   345899999999999999999999887   99999999999999999999999999876544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.95  E-value=1.2e-27  Score=209.17  Aligned_cols=150  Identities=29%  Similarity=0.520  Sum_probs=129.0

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC-------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-------  191 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  191 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||||++....  ......+.+|+.++..++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999988 568899999986433  22346788999999999999999999999874       


Q ss_pred             -CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          192 -GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       192 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                       +..++||||+++ ++...+..  ....+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             467999999986 55555532  2345899999999999999999999988   9999999999999999999999999


Q ss_pred             CceeeCC
Q 022887          271 MARIFGG  277 (290)
Q Consensus       271 la~~~~~  277 (290)
                      +|+.+..
T Consensus       170 ~a~~~~~  176 (351)
T 3mi9_A          170 LARAFSL  176 (351)
T ss_dssp             TCEECCC
T ss_pred             hcccccc
Confidence            9998753

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.95  E-value=5.9e-28  Score=203.86  Aligned_cols=151  Identities=28%  Similarity=0.472  Sum_probs=134.9

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|...+.||+|+||.||+|... +++.||||.+...   .......+.+|+..+..++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999985 6889999998643   233456889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999998843   245899999999999999999999988   99999999999999999999999999987755


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      +
T Consensus       164 ~  164 (276)
T 2h6d_A          164 G  164 (276)
T ss_dssp             -
T ss_pred             C
Confidence            4

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.95  E-value=4.1e-28  Score=207.47  Aligned_cols=149  Identities=28%  Similarity=0.493  Sum_probs=131.6

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ..++|+..+.||+|+||.||+|... ++..||+|.+..........+.+|+.++..++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3468999999999999999999985 488999999987666677899999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      |+++++|..++..  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            9999999988743  2345899999999999999999999987   99999999999999999999999999754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4e-28  Score=211.83  Aligned_cols=152  Identities=31%  Similarity=0.450  Sum_probs=125.7

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccccc-----CHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      ...++|...+.||+|+||.||+|... +++.||||.+......     ....+.+|+.++..++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999874 5889999998643211     13468899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++||||+++ +|..++..  ....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 77777633  3346888999999999999999999988   9999999999999999999999999998


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      .+..
T Consensus       161 ~~~~  164 (346)
T 1ua2_A          161 SFGS  164 (346)
T ss_dssp             TTTS
T ss_pred             eccC
Confidence            7754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.95  E-value=4.8e-28  Score=209.76  Aligned_cols=151  Identities=34%  Similarity=0.569  Sum_probs=125.8

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCc----EEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      .++|+..+.||+|+||.||+|.+. +++    +||+|.+... .......+.+|+.++..++||||+++++++...+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            368999999999999999999874 344    3577777543 3445688999999999999999999999998764 78


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +|+||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999988542  345899999999999999999999988   999999999999999999999999999987


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      ...
T Consensus       168 ~~~  170 (327)
T 3lzb_A          168 GAE  170 (327)
T ss_dssp             ---
T ss_pred             cCc
Confidence            554

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.9e-28  Score=210.88  Aligned_cols=151  Identities=35%  Similarity=0.554  Sum_probs=127.4

Q ss_pred             cCCCccceecccCCccEEEEEEcC-----CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++|...+.||+|+||.||+|....     +..||+|.+.... ......+.+|+.++..++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            567778999999999999998743     2359999997543 2334578999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus       124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999853  2346899999999999999999999987   9999999999999999999999999999876


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      .+
T Consensus       199 ~~  200 (333)
T 1mqb_A          199 DD  200 (333)
T ss_dssp             --
T ss_pred             cc
Confidence            54

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=1e-27  Score=203.28  Aligned_cols=152  Identities=26%  Similarity=0.436  Sum_probs=133.2

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .++|+..+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.++.+++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999874 58899999986532  223467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC---eEEeeccCceee
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARIF  275 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~---~kl~DfGla~~~  275 (290)
                      ||+++++|.+.+..   ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999887743   345899999999999999999999988   999999999999986655   999999999877


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      ....
T Consensus       159 ~~~~  162 (284)
T 3kk8_A          159 NDSE  162 (284)
T ss_dssp             CSSC
T ss_pred             ccCc
Confidence            6543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.95  E-value=2.3e-28  Score=211.87  Aligned_cols=152  Identities=30%  Similarity=0.457  Sum_probs=126.6

Q ss_pred             HHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      ....++|+..+.||+|+||.||++.. .+++.||||.+.....  .....+.+|+.++.+++||||+++++++.+.+..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            44567899999999999999999987 4588999999964332  23456789999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE-----cCCCCeEEeecc
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-----DSDMNPKISDFG  270 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill-----~~~~~~kl~DfG  270 (290)
                      +||||+++ +|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+     ++++.+||+|||
T Consensus       110 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999984 88888743   345899999999999999999999988   9999999999999     455569999999


Q ss_pred             CceeeCC
Q 022887          271 MARIFGG  277 (290)
Q Consensus       271 la~~~~~  277 (290)
                      +++.++.
T Consensus       183 ~a~~~~~  189 (329)
T 3gbz_A          183 LARAFGI  189 (329)
T ss_dssp             HHHHHC-
T ss_pred             CccccCC
Confidence            9987753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=6.6e-28  Score=209.24  Aligned_cols=152  Identities=26%  Similarity=0.389  Sum_probs=127.1

Q ss_pred             HHHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcc--cCCCCcceeEEEEEeC----C
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK--LQHRHLVRLFGCCIEQ----G  192 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~  192 (290)
                      ....++|+..+.||+|+||.||+|+.. ++.||||.+....   ...+..|.+++..  ++||||+++++++...    +
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            344578999999999999999999885 7899999986432   2444555555544  4999999999999987    6


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCceecCCCCCCEEEcCCCCeEEe
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS-----RLRIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                      ..++||||+++|+|.+++..    ..+++..++.++.|++.||.|||+..     ..+|+||||||+|||++.++.+||+
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            78999999999999999843    35899999999999999999999871     1139999999999999999999999


Q ss_pred             eccCceeeCCC
Q 022887          268 DFGMARIFGGD  278 (290)
Q Consensus       268 DfGla~~~~~~  278 (290)
                      |||+++.+..+
T Consensus       185 Dfg~a~~~~~~  195 (337)
T 3mdy_A          185 DLGLAVKFISD  195 (337)
T ss_dssp             CCTTCEECC--
T ss_pred             eCCCceeeccc
Confidence            99999877554

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.95  E-value=2.3e-28  Score=208.96  Aligned_cols=156  Identities=25%  Similarity=0.401  Sum_probs=120.6

Q ss_pred             HHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ....++|...+.||+|+||.||++.. .+++.||||.+.... .....++.+|+..+.+++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            34467899999999999999999986 457899999886432 2345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhC-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccC
Q 022887          197 IYEYMPNKSLDVFLFY-----PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl  271 (290)
                      ||||+++++|.+++..     ......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999988753     112456899999999999999999999987   99999999999999999999999999


Q ss_pred             ceeeCC
Q 022887          272 ARIFGG  277 (290)
Q Consensus       272 a~~~~~  277 (290)
                      ++.+..
T Consensus       168 ~~~~~~  173 (303)
T 2vwi_A          168 SAFLAT  173 (303)
T ss_dssp             HHHCC-
T ss_pred             hheecc
Confidence            987654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.95  E-value=1.4e-27  Score=204.39  Aligned_cols=151  Identities=25%  Similarity=0.350  Sum_probs=128.1

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc----ccCHHHHHHHHHHHcccCCCCcceeEEEEE--eCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS----GQGLTEFKNEMMLIAKLQHRHLVRLFGCCI--EQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  194 (290)
                      .++|...+.||+|+||.||++... +++.||+|.+....    ......+.+|+.++.+++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999874 57899999996432    234578999999999999999999999985  44578


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||++++ +.+++... ....+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999987 55555332 2456899999999999999999999988   99999999999999999999999999998


Q ss_pred             eCC
Q 022887          275 FGG  277 (290)
Q Consensus       275 ~~~  277 (290)
                      ...
T Consensus       159 ~~~  161 (305)
T 2wtk_C          159 LHP  161 (305)
T ss_dssp             CCT
T ss_pred             cCc
Confidence            754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.95  E-value=6.4e-28  Score=210.24  Aligned_cols=148  Identities=22%  Similarity=0.348  Sum_probs=128.1

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ..++|+..+.||+|+||.||++... +++.||+|.+.....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3568999999999999999999875 588999999975432    345678888777 7999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC----CCeEEeeccCcee
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKISDFGMARI  274 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~----~~~kl~DfGla~~  274 (290)
                      ||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+.++    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999988843   346899999999999999999999988   9999999999998543    3599999999998


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      +...
T Consensus       170 ~~~~  173 (342)
T 2qr7_A          170 LRAE  173 (342)
T ss_dssp             CBCT
T ss_pred             CcCC
Confidence            7554

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.95  E-value=4e-28  Score=213.27  Aligned_cols=152  Identities=20%  Similarity=0.335  Sum_probs=126.0

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC------CcEEEEEEeccccccC-----------HHHHHHHHHHHcccCCCCcce
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-----------LTEFKNEMMLIAKLQHRHLVR  183 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~------~~~vavK~l~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~  183 (290)
                      ..++|...+.||+|+||.||+|.+.+      ++.||||.+.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999998754      4689999986543211           123445666778889999999


Q ss_pred             eEEEEEeC----CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc
Q 022887          184 LFGCCIEQ----GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD  259 (290)
Q Consensus       184 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~  259 (290)
                      +++++...    ...++||||+ +++|.+++..  ....+++.+++.++.|++.||.|||+.+   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998875    4479999999 9999998854  2356999999999999999999999987   99999999999999


Q ss_pred             --CCCCeEEeeccCceeeCCC
Q 022887          260 --SDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       260 --~~~~~kl~DfGla~~~~~~  278 (290)
                        .++.+||+|||+|+.+..+
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~  207 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPE  207 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGG
T ss_pred             cCCCCeEEEEECCcceecccC
Confidence              8899999999999987654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.95  E-value=1.3e-27  Score=204.01  Aligned_cols=153  Identities=27%  Similarity=0.358  Sum_probs=134.6

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---------cCHHHHHHHHHHHcccC-CCCcceeEEEE
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLTEFKNEMMLIAKLQ-HRHLVRLFGCC  188 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~  188 (290)
                      ...++|+..+.||+|+||.||+|... +++.||||.+.....         .....+.+|+.++.++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999885 578999999865321         12356789999999995 99999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEee
Q 022887          189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  268 (290)
Q Consensus       189 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  268 (290)
                      ...+..++||||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence            999999999999999999998843   346899999999999999999999988   99999999999999999999999


Q ss_pred             ccCceeeCCC
Q 022887          269 FGMARIFGGD  278 (290)
Q Consensus       269 fGla~~~~~~  278 (290)
                      ||+++.+..+
T Consensus       168 fg~~~~~~~~  177 (298)
T 1phk_A          168 FGFSCQLDPG  177 (298)
T ss_dssp             CTTCEECCTT
T ss_pred             ccchhhcCCC
Confidence            9999987654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.95  E-value=1.9e-27  Score=206.86  Aligned_cols=152  Identities=26%  Similarity=0.392  Sum_probs=132.6

Q ss_pred             hHHHHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcc--cCCCCcceeEEEEEeCC--
Q 022887          117 SVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAK--LQHRHLVRLFGCCIEQG--  192 (290)
Q Consensus       117 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~--  192 (290)
                      ......++|...+.||+|+||.||+|.. +++.||||.+...   ....+..|.+++..  ++||||+++++++...+  
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            3445668999999999999999999998 5889999998643   34567788888776  79999999999998876  


Q ss_pred             --eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCceecCCCCCCEEEcCCC
Q 022887          193 --ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       193 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~iiH~dlk~~Nill~~~~  262 (290)
                        ..++||||+++|+|.+++..    ..+++.+++.++.|++.||.|||        +.+   |+||||||+|||++.++
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred             cceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence              78999999999999999843    35899999999999999999999        555   99999999999999999


Q ss_pred             CeEEeeccCceeeCCCc
Q 022887          263 NPKISDFGMARIFGGDE  279 (290)
Q Consensus       263 ~~kl~DfGla~~~~~~~  279 (290)
                      .+||+|||+++......
T Consensus       185 ~~kL~Dfg~~~~~~~~~  201 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSAT  201 (342)
T ss_dssp             CEEECCCTTCEEEETTT
T ss_pred             CEEEEECCCceeccccc
Confidence            99999999998876543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.95  E-value=4.5e-28  Score=208.08  Aligned_cols=151  Identities=28%  Similarity=0.436  Sum_probs=126.1

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|+||.||++... ++.||+|.+...  .....+.+|+.++.+++||||+++++++.  +..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            357888999999999999999884 688999998643  34578999999999999999999999876  4589999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC-eEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~-~kl~DfGla~~~~~  277 (290)
                      ++++|.+++........+++...+.++.|+++||.|||+....+|+||||||+||++++++. +||+|||+++.+..
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            99999999875544446889999999999999999999843344999999999999998886 79999999986643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=2.7e-28  Score=211.08  Aligned_cols=149  Identities=28%  Similarity=0.454  Sum_probs=127.0

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccccc-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|...+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.++..++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999885 6889999998643322 223456799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++ |+|..++..  ....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            98 477777643  2346899999999999999999999988   99999999999999999999999999987653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.95  E-value=9.7e-28  Score=203.19  Aligned_cols=151  Identities=28%  Similarity=0.466  Sum_probs=132.6

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEe--------
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--------  190 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  190 (290)
                      ...++|+..+.||+|+||.||++... +++.||+|.+....    ..+.+|+.++.+++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            34578999999999999999999985 68999999997533    467889999999999999999998865        


Q ss_pred             --------CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC
Q 022887          191 --------QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       191 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~  262 (290)
                              ....++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence                    34578999999999999998542 2356899999999999999999999987   99999999999999999


Q ss_pred             CeEEeeccCceeeCCC
Q 022887          263 NPKISDFGMARIFGGD  278 (290)
Q Consensus       263 ~~kl~DfGla~~~~~~  278 (290)
                      .+||+|||+++.+..+
T Consensus       160 ~~kl~Dfg~~~~~~~~  175 (284)
T 2a19_B          160 QVKIGDFGLVTSLKND  175 (284)
T ss_dssp             EEEECCCTTCEESSCC
T ss_pred             CEEECcchhheecccc
Confidence            9999999999987654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.3e-27  Score=203.20  Aligned_cols=150  Identities=30%  Similarity=0.510  Sum_probs=130.6

Q ss_pred             cCCCccc-eecccCCccEEEEEEc---CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~-~ig~G~fg~V~~~~~~---~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++|...+ .||+|+||.||+|.+.   ++..||+|.+.... ......+.+|+.++.+++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566666 8999999999999863   57789999997643 23456799999999999999999999999 55678999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+..
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999998843  3456899999999999999999999988   99999999999999999999999999998864


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      +
T Consensus       163 ~  163 (287)
T 1u59_A          163 D  163 (287)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.8e-28  Score=214.07  Aligned_cols=150  Identities=28%  Similarity=0.501  Sum_probs=121.7

Q ss_pred             CCCccceecccCCccEEEEEEcC--C--cEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEe-CCeeEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGENILI  197 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~--~--~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv  197 (290)
                      .|...+.||+|+||.||+|.+.+  +  ..||+|.+.... ......|.+|+.++.+++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            45667899999999999998632  2  368999986533 2345789999999999999999999999765 4578999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++|+|.+++..  ....+++...+.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999853  3345889999999999999999999988   99999999999999999999999999987754


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       245 ~  245 (373)
T 3c1x_A          245 K  245 (373)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.95  E-value=8.9e-28  Score=218.77  Aligned_cols=152  Identities=30%  Similarity=0.475  Sum_probs=135.2

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ..++|+..+.||+|+||.||++... +++.||||.+....   ......+.+|+.++.+++||||+++++++...+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3468999999999999999999885 68899999986432   3456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE---cCCCCeEEeeccCce
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMAR  273 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~  273 (290)
                      ||||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999888743   345899999999999999999999988   9999999999999   567899999999998


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .+...
T Consensus       178 ~~~~~  182 (484)
T 3nyv_A          178 HFEAS  182 (484)
T ss_dssp             HBCCC
T ss_pred             Ecccc
Confidence            77654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=1.2e-27  Score=202.92  Aligned_cols=150  Identities=27%  Similarity=0.402  Sum_probs=133.4

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|...+.||+|+||.||+|... ++..||+|.+...   .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367899999999999999999885 4778999998643   223456899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999988843   245899999999999999999999887   99999999999999999999999999987654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.95  E-value=3e-27  Score=204.70  Aligned_cols=146  Identities=22%  Similarity=0.383  Sum_probs=129.9

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEEEEe--CCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIE--QGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  197 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+..   .....+.+|+.++.+++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36799999999999999999987 5688999999864   33578999999999997 9999999999998  5678999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-CeEEeeccCceeeC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFG  276 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~  276 (290)
                      |||+++++|..++.      .+++.+...++.|++.||.|||+.+   |+||||||+|||++.++ .+||+|||+++.+.
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999998872      3889999999999999999999988   99999999999999776 89999999999876


Q ss_pred             CCc
Q 022887          277 GDE  279 (290)
Q Consensus       277 ~~~  279 (290)
                      .+.
T Consensus       183 ~~~  185 (330)
T 3nsz_A          183 PGQ  185 (330)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.95  E-value=1.6e-27  Score=206.30  Aligned_cols=150  Identities=35%  Similarity=0.570  Sum_probs=129.9

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcE--EEEEEeccc-cccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQE--VAVKRLSNQ-SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~--vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++|...+.||+|+||.||+|... ++..  +|+|.+... .......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999999874 4554  499988643 233456789999999999 899999999999999999999


Q ss_pred             EEecCCCChhhhhhCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCe
Q 022887          198 YEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  264 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~  264 (290)
                      |||+++++|.+++....             ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999986432             2346899999999999999999999987   9999999999999999999


Q ss_pred             EEeeccCceee
Q 022887          265 KISDFGMARIF  275 (290)
Q Consensus       265 kl~DfGla~~~  275 (290)
                      ||+|||+++..
T Consensus       182 kL~Dfg~~~~~  192 (327)
T 1fvr_A          182 KIADFGLSRGQ  192 (327)
T ss_dssp             EECCTTCEESS
T ss_pred             EEcccCcCccc
Confidence            99999999854

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.95  E-value=2.1e-27  Score=202.58  Aligned_cols=149  Identities=22%  Similarity=0.361  Sum_probs=131.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+....  ....+.+|+..+..+ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999986 568899999986432  335788999999999 79999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC-----eEEeeccCcee
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISDFGMARI  274 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~-----~kl~DfGla~~  274 (290)
                      |+ +++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999998542  345899999999999999999999887   999999999999987776     99999999998


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      +...
T Consensus       161 ~~~~  164 (298)
T 1csn_A          161 YRDP  164 (298)
T ss_dssp             SBCT
T ss_pred             cccc
Confidence            8654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=6e-28  Score=220.06  Aligned_cols=152  Identities=30%  Similarity=0.500  Sum_probs=134.3

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ..++|...+.||+|+||.||++... +++.||||.+...  .......+.+|+.++.+++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4578999999999999999999884 6889999998643  234567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc---CCCCeEEeeccCcee
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARI  274 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DfGla~~  274 (290)
                      |||+++|+|.+.+..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            999999999887743   346899999999999999999999988   99999999999995   456799999999987


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      +..+
T Consensus       174 ~~~~  177 (486)
T 3mwu_A          174 FQQN  177 (486)
T ss_dssp             BCCC
T ss_pred             CCCC
Confidence            7554

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.95  E-value=5.8e-28  Score=211.82  Aligned_cols=149  Identities=27%  Similarity=0.354  Sum_probs=132.9

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||.||++... ++..||+|.+.... ......+.+|+.++..++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357899999999999999999885 58899999987542 2335678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |+++++|.+++..   ...+++.....++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||+++.+.
T Consensus       112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            9999999998843   34589999999999999999999985 6   9999999999999999999999999997653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.95  E-value=1.7e-27  Score=205.66  Aligned_cols=151  Identities=25%  Similarity=0.361  Sum_probs=128.1

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--------ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ  191 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  191 (290)
                      ..++|...+.||+|+||.||+|... +++.||||.+....        ......+.+|+.++.+++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4568999999999999999999874 47899999986432        12234688999999999999999999998765


Q ss_pred             CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC---eEEee
Q 022887          192 GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISD  268 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~---~kl~D  268 (290)
                      + .++||||+++++|.+++.   ....+++.....++.|++.||.|||+.+   ++||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 899999999999988874   3456899999999999999999999987   999999999999987654   99999


Q ss_pred             ccCceeeCCC
Q 022887          269 FGMARIFGGD  278 (290)
Q Consensus       269 fGla~~~~~~  278 (290)
                      ||+++.+...
T Consensus       161 fg~~~~~~~~  170 (322)
T 2ycf_A          161 FGHSKILGET  170 (322)
T ss_dssp             CTTCEECCCC
T ss_pred             Cccceecccc
Confidence            9999987654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.95  E-value=7.2e-28  Score=206.38  Aligned_cols=151  Identities=22%  Similarity=0.366  Sum_probs=131.7

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ..++|...+.||+|+||.||++... +++.||+|.+..........+.+|+.++..++||||+++++++...+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3468899999999999999999874 688999999976544455678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE---cCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~~~  276 (290)
                      |+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++||||||+||++   ++++.+||+|||+++...
T Consensus        87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999888743   345899999999999999999999987   9999999999999   788999999999998664


Q ss_pred             C
Q 022887          277 G  277 (290)
Q Consensus       277 ~  277 (290)
                      .
T Consensus       161 ~  161 (304)
T 2jam_A          161 N  161 (304)
T ss_dssp             C
T ss_pred             C
Confidence            4

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.95  E-value=2.6e-27  Score=201.07  Aligned_cols=151  Identities=30%  Similarity=0.562  Sum_probs=128.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccccc-------CHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ-------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+......       ....+.+|+.++.+++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46899999999999999999988 46889999998643322       1267899999999999999999999986554 


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC-----eEEee
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISD  268 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~-----~kl~D  268 (290)
                       ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999887754  3456899999999999999999999764 34999999999999988776     99999


Q ss_pred             ccCceeeCC
Q 022887          269 FGMARIFGG  277 (290)
Q Consensus       269 fGla~~~~~  277 (290)
                      ||+++....
T Consensus       173 fg~~~~~~~  181 (287)
T 4f0f_A          173 FGLSQQSVH  181 (287)
T ss_dssp             CTTCBCCSS
T ss_pred             CCccccccc
Confidence            999986544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.95  E-value=5.9e-28  Score=208.76  Aligned_cols=159  Identities=29%  Similarity=0.454  Sum_probs=134.5

Q ss_pred             cHHhHHHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEe-
Q 022887          114 SLASVSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE-  190 (290)
Q Consensus       114 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  190 (290)
                      +..++....++|+..+.||+|+||.||+|.. .+++.||||.+.... .....+.+|+.++.++ +||||+++++++.. 
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3334445678899999999999999999988 468899999986532 3457889999999998 79999999999987 


Q ss_pred             -----CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeE
Q 022887          191 -----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK  265 (290)
Q Consensus       191 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~k  265 (290)
                           .+..++||||+++++|.+++... ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+|
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence                 45789999999999999988543 2356889999999999999999999987   99999999999999999999


Q ss_pred             EeeccCceeeCC
Q 022887          266 ISDFGMARIFGG  277 (290)
Q Consensus       266 l~DfGla~~~~~  277 (290)
                      |+|||++..+..
T Consensus       170 l~Dfg~~~~~~~  181 (326)
T 2x7f_A          170 LVDFGVSAQLDR  181 (326)
T ss_dssp             ECCCTTTC----
T ss_pred             EeeCcCceecCc
Confidence            999999987654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.95  E-value=8e-28  Score=205.36  Aligned_cols=152  Identities=28%  Similarity=0.491  Sum_probs=130.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcC----CcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEe-CCeeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIE-QGENI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~  195 (290)
                      ..+|...+.||+|+||.||+|...+    ...+|+|.+..... .....+.+|+.++.+++||||+++++++.. .+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3468888999999999999998643    23589999875332 345678999999999999999999999754 45779


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999854  3456899999999999999999999988   999999999999999999999999999877


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      ...
T Consensus       179 ~~~  181 (298)
T 3f66_A          179 YDK  181 (298)
T ss_dssp             SCG
T ss_pred             ccc
Confidence            554

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.95  E-value=7.7e-28  Score=213.68  Aligned_cols=151  Identities=27%  Similarity=0.446  Sum_probs=126.9

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe------eE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE------NI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~  195 (290)
                      ..+|...+.||+|+||.||+|...++..||+|++.....    ...+|+.++..++||||+++++++...+.      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            357999999999999999999997777899998865322    22469999999999999999999976543      78


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc-CCCCeEEeeccCcee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARI  274 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~  274 (290)
                      +||||++++.+............+++.....++.|++.||.|||+.+   |+||||||+|||++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999998766554433333567899999999999999999999988   99999999999999 799999999999998


Q ss_pred             eCCCc
Q 022887          275 FGGDE  279 (290)
Q Consensus       275 ~~~~~  279 (290)
                      +..+.
T Consensus       192 ~~~~~  196 (394)
T 4e7w_A          192 LIAGE  196 (394)
T ss_dssp             CCTTC
T ss_pred             ccCCC
Confidence            75543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=8.2e-28  Score=205.13  Aligned_cols=150  Identities=28%  Similarity=0.437  Sum_probs=129.0

Q ss_pred             CCCccceecccCCccEEEEEEcC-C---cEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee-EEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN-ILI  197 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~-~---~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv  197 (290)
                      .|...+.||+|+||.||+|.+.+ +   ..+|+|.+..... .....+.+|+.++..++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45566899999999999998633 2   2699999875333 3456789999999999999999999999877655 999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+.+++|.+++..  ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+..
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999998854  3456899999999999999999999988   99999999999999999999999999987654


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       177 ~  177 (298)
T 3pls_A          177 R  177 (298)
T ss_dssp             G
T ss_pred             C
Confidence            3

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.95  E-value=5.4e-28  Score=209.31  Aligned_cols=154  Identities=32%  Similarity=0.488  Sum_probs=129.9

Q ss_pred             HhcCCCccceecccCCccEEEEEE------cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      ..++|...+.||+|+||.||+|.+      .++..||||.+.... .....++.+|+.++.+++||||+++++++...+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            357899999999999999999984      246789999996432 3345678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---CCCeEE
Q 022887          194 NILIYEYMPNKSLDVFLFYPKK----KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKI  266 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl  266 (290)
                      .++||||+++++|.+++.....    ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999864321    245899999999999999999999987   999999999999984   456999


Q ss_pred             eeccCceeeCC
Q 022887          267 SDFGMARIFGG  277 (290)
Q Consensus       267 ~DfGla~~~~~  277 (290)
                      +|||+++....
T Consensus       185 ~Dfg~~~~~~~  195 (327)
T 2yfx_A          185 GDFGMARDIYR  195 (327)
T ss_dssp             CCCHHHHHHHC
T ss_pred             Ccccccccccc
Confidence            99999986543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.95  E-value=1.1e-27  Score=207.97  Aligned_cols=149  Identities=33%  Similarity=0.543  Sum_probs=122.2

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHH--HcccCCCCcceeEEEEEeC-----Cee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMML--IAKLQHRHLVRLFGCCIEQ-----GEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~-----~~~  194 (290)
                      .++|+..+.||+|+||.||+|+. +++.||||.+....   ...+..|.++  +..++||||+++++.+...     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46899999999999999999987 67899999986432   2344444444  5568999999999866532     256


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCceecCCCCCCEEEcCCCCeEEee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS------RLRIIHRDLKASNILLDSDMNPKISD  268 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~iiH~dlk~~Nill~~~~~~kl~D  268 (290)
                      ++||||+++|+|.+++..    ...++.....++.|++.||.|||+..      ..+|+||||||+|||++.++.+||+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            899999999999999843    33589999999999999999999871      11399999999999999999999999


Q ss_pred             ccCceeeCCC
Q 022887          269 FGMARIFGGD  278 (290)
Q Consensus       269 fGla~~~~~~  278 (290)
                      ||+++.+..+
T Consensus       164 FG~a~~~~~~  173 (336)
T 3g2f_A          164 FGLSMRLTGN  173 (336)
T ss_dssp             CTTCEECSSS
T ss_pred             ccceeecccc
Confidence            9999987643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.95  E-value=2.3e-27  Score=203.99  Aligned_cols=152  Identities=31%  Similarity=0.519  Sum_probs=130.0

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ...++|+..+.||+|+||.||+|... +++.||+|.+...  ....++.+|+.++..++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34578999999999999999999885 4889999999753  23578899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++++|.+++..  ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+...
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999998742  2356899999999999999999999988   999999999999999999999999999877553

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.95  E-value=8.9e-28  Score=205.09  Aligned_cols=151  Identities=32%  Similarity=0.509  Sum_probs=132.0

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEe---------
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE---------  190 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  190 (290)
                      ..++|+..+.||+|+||.||+|.. .+++.||||.+... ......+.+|+.++.+++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            356899999999999999999987 46889999998642 3345788999999999999999999999865         


Q ss_pred             ----CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEE
Q 022887          191 ----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  266 (290)
Q Consensus       191 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl  266 (290)
                          .+..++||||+++++|.+++...  ...+++...+.++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                34678999999999999998542  345788999999999999999999987   999999999999999999999


Q ss_pred             eeccCceeeCC
Q 022887          267 SDFGMARIFGG  277 (290)
Q Consensus       267 ~DfGla~~~~~  277 (290)
                      +|||+++....
T Consensus       158 ~dfg~~~~~~~  168 (303)
T 1zy4_A          158 GDFGLAKNVHR  168 (303)
T ss_dssp             CCCCCCSCTTC
T ss_pred             eeCcchhhccc
Confidence            99999987653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.95  E-value=1.4e-27  Score=212.35  Aligned_cols=148  Identities=23%  Similarity=0.300  Sum_probs=123.7

Q ss_pred             hcCCCcc-ceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHc-ccCCCCcceeEEEEEe----CCee
Q 022887          122 TENFSTQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIA-KLQHRHLVRLFGCCIE----QGEN  194 (290)
Q Consensus       122 ~~~~~~~-~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~  194 (290)
                      .++|... +.||+|+||.||++... +++.||||.+...     ..+.+|+.++. ..+||||+++++++..    .+..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3566665 68999999999999874 5889999998642     46778888764 4589999999999875    4568


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---CCCeEEeeccC
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM  271 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGl  271 (290)
                      ++||||+++|+|.+++... ....+++.....++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            9999999999999998542 2346899999999999999999999987   999999999999997   78999999999


Q ss_pred             ceeeCCC
Q 022887          272 ARIFGGD  278 (290)
Q Consensus       272 a~~~~~~  278 (290)
                      ++.....
T Consensus       211 a~~~~~~  217 (400)
T 1nxk_A          211 AKETTSH  217 (400)
T ss_dssp             CEECC--
T ss_pred             ccccCCC
Confidence            9977543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.95  E-value=2.5e-27  Score=205.23  Aligned_cols=162  Identities=29%  Similarity=0.394  Sum_probs=137.2

Q ss_pred             ccHHhHHHHhcCCCcc-ceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccC-CCCcceeEEE
Q 022887          113 FSLASVSAATENFSTQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQ-HRHLVRLFGC  187 (290)
Q Consensus       113 ~~~~~~~~~~~~~~~~-~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~  187 (290)
                      ..+...+...+.|... +.||+|+||.||++... +++.||+|.+....  .....++.+|+.++..+. ||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3444556667788877 88999999999999875 58899999987532  334678999999999984 6999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---CCCe
Q 022887          188 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNP  264 (290)
Q Consensus       188 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~~~~  264 (290)
                      +...+..++||||+++|+|.+++.. .....+++.+++.++.|++.||+|||+.+   |+||||||+|||++.   ++.+
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence            9999999999999999999988743 23456899999999999999999999988   999999999999988   7899


Q ss_pred             EEeeccCceeeCCC
Q 022887          265 KISDFGMARIFGGD  278 (290)
Q Consensus       265 kl~DfGla~~~~~~  278 (290)
                      ||+|||+++.+...
T Consensus       174 kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          174 KIVDFGMSRKIGHA  187 (327)
T ss_dssp             EECCGGGCEEC---
T ss_pred             EEeeCccccccCCc
Confidence            99999999987654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.95  E-value=1.3e-27  Score=205.69  Aligned_cols=148  Identities=28%  Similarity=0.447  Sum_probs=124.1

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEE-----------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI-----------  189 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----------  189 (290)
                      .++|...+.||+|+||.||+|.... ++.||+|.+..........+.+|+.++.+++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4689999999999999999999854 8899999997655556678999999999999999999999873           


Q ss_pred             ---eCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc-CCCCeE
Q 022887          190 ---EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPK  265 (290)
Q Consensus       190 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~-~~~~~k  265 (290)
                         +.+..++||||++ |+|.+++.    ...+++.....++.|++.||+|||+.+   |+||||||+||+++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467799999998 68988873    345889999999999999999999988   99999999999997 567999


Q ss_pred             EeeccCceeeCC
Q 022887          266 ISDFGMARIFGG  277 (290)
Q Consensus       266 l~DfGla~~~~~  277 (290)
                      |+|||+++....
T Consensus       162 l~Dfg~~~~~~~  173 (320)
T 2i6l_A          162 IGDFGLARIMDP  173 (320)
T ss_dssp             ECCCTTCBCC--
T ss_pred             EccCccccccCC
Confidence            999999997754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.95  E-value=1.5e-27  Score=204.90  Aligned_cols=154  Identities=25%  Similarity=0.447  Sum_probs=127.0

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|...+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|+.++.+++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45799999999999999999987 568899999997532   23356789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          198 YEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      |||+++++|.+++... .....+++...+.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+.
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999887532 13456899999999999999999999988   9999999999999999999999999998775


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      ..
T Consensus       188 ~~  189 (310)
T 2wqm_A          188 SK  189 (310)
T ss_dssp             --
T ss_pred             CC
Confidence            43

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.95  E-value=1.5e-27  Score=203.21  Aligned_cols=150  Identities=30%  Similarity=0.483  Sum_probs=129.3

Q ss_pred             hcCCCccc-eecccCCccEEEEEEc---CCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          122 TENFSTQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       122 ~~~~~~~~-~ig~G~fg~V~~~~~~---~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      .++|...+ .||+|+||.||+|.+.   +++.||||.+.....  ....++.+|+.++..++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35777777 9999999999999652   367899999975432  2356899999999999999999999999 567789


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999853   345899999999999999999999987   999999999999999999999999999987


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      ..+
T Consensus       168 ~~~  170 (291)
T 1xbb_A          168 RAD  170 (291)
T ss_dssp             CTT
T ss_pred             ccC
Confidence            654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.95  E-value=5.7e-28  Score=226.36  Aligned_cols=143  Identities=31%  Similarity=0.485  Sum_probs=125.4

Q ss_pred             ceecccCCccEEEEEEc---CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~---~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      +.||+|+||.||+|.+.   .+..||||.++...  .....++.+|+.++.+++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999663   35789999997543  2345789999999999999999999999864 568899999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+|.+++..   ...+++..++.|+.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            999999843   456899999999999999999999988   999999999999999999999999999987654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.95  E-value=1.2e-28  Score=217.74  Aligned_cols=152  Identities=16%  Similarity=0.236  Sum_probs=124.7

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHH---HHHcccCCCCcceeE-------EE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEM---MLIAKLQHRHLVRLF-------GC  187 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~  187 (290)
                      .++|...+.||+|+||.||+|.. .+++.||||.+...   .....+.+.+|+   ..+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999987 56899999999743   233457889999   556667899999998       66


Q ss_pred             EEeCCe-----------------eEEEEEecCCCChhhhhhCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 022887          188 CIEQGE-----------------NILIYEYMPNKSLDVFLFYPK----KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI  246 (290)
Q Consensus       188 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i  246 (290)
                      +...+.                 .++||||+ +|+|.+++....    ....+++..++.|+.|++.||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            665532                 78999999 689998885321    1223456888999999999999999988   9


Q ss_pred             eecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          247 IHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       247 iH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +||||||+|||++.++.+||+|||+|+..+.
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~  258 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA  258 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC
Confidence            9999999999999999999999999996543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.95  E-value=3.1e-27  Score=200.95  Aligned_cols=144  Identities=10%  Similarity=0.057  Sum_probs=126.7

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-CcEEEEEEecccccc---CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ---GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||.||+|.... ++.||||.+......   ....+.+|+..+.+++||||+++++++...+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            3679999999999999999999854 889999999754332   246789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      |||+++++|.+++..    . ....+..+++.|++.||.|||+++   |+||||||+|||+++++.+||+++|...
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence            999999999999832    2 355678899999999999999988   9999999999999999999999877653

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.95  E-value=9.3e-28  Score=209.43  Aligned_cols=150  Identities=17%  Similarity=0.278  Sum_probs=123.0

Q ss_pred             hcCCCccceecccCCccEEEEEEc----CCcEEEEEEecccccc-----------CHHHHHHHHHHHcccCCCCcceeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQ-----------GLTEFKNEMMLIAKLQHRHLVRLFG  186 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~  186 (290)
                      .++|...+.||+|+||.||+|...    ++..+|+|........           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999885    5678999998754321           1234667888899999999999999


Q ss_pred             EEEe----CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC
Q 022887          187 CCIE----QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       187 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~  262 (290)
                      ++..    .+..++||||+ +++|.+++..   ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    67889999999 9999998843   237899999999999999999999987   99999999999999887


Q ss_pred             --CeEEeeccCceeeCCC
Q 022887          263 --NPKISDFGMARIFGGD  278 (290)
Q Consensus       263 --~~kl~DfGla~~~~~~  278 (290)
                        .+||+|||+++.+..+
T Consensus       189 ~~~~kL~Dfg~a~~~~~~  206 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPN  206 (345)
T ss_dssp             TTSEEECCCTTCEESSGG
T ss_pred             CCcEEEEeCCCceecccc
Confidence              9999999999987543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=7.9e-28  Score=211.67  Aligned_cols=148  Identities=26%  Similarity=0.404  Sum_probs=123.6

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  192 (290)
                      .++|...+.||+|+||.||+|.. .+++.||||++....  ......+.+|+.++..++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46899999999999999999987 458999999996432  223467889999999999999999999998763      


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..++||||+ +++|..++..    ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 7899888743    45889999999999999999999988   999999999999999999999999999


Q ss_pred             eeeCC
Q 022887          273 RIFGG  277 (290)
Q Consensus       273 ~~~~~  277 (290)
                      +..+.
T Consensus       176 ~~~~~  180 (367)
T 1cm8_A          176 RQADS  180 (367)
T ss_dssp             EECCS
T ss_pred             ccccc
Confidence            98754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=1.5e-27  Score=210.95  Aligned_cols=153  Identities=24%  Similarity=0.363  Sum_probs=125.2

Q ss_pred             HHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeC------
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------  191 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  191 (290)
                      +...++|+..+.||+|+||.||+|.. .+++.||||++.....    ...+|+.++..++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999987 5689999999865322    234799999999999999999998543      


Q ss_pred             --------------------------------CeeEEEEEecCCCChhhhhhC-CCCCCCCCHHHHHHHHHHHHHHHHHH
Q 022887          192 --------------------------------GENILIYEYMPNKSLDVFLFY-PKKKRLLGWQARVRIIEGIAQGLLYL  238 (290)
Q Consensus       192 --------------------------------~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yL  238 (290)
                                                      ...++||||++ |+|...+.. ......+++.....++.|++.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            23789999998 476665532 12345689999999999999999999


Q ss_pred             hhCCCCCceecCCCCCCEEEc-CCCCeEEeeccCceeeCCCc
Q 022887          239 HQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       239 H~~~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~~~~~~  279 (290)
                      |+.+   |+||||||+|||++ +++.+||+|||+|+.+....
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  196 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE  196 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence            9887   99999999999998 68899999999999875543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.95  E-value=1.8e-27  Score=209.15  Aligned_cols=149  Identities=26%  Similarity=0.403  Sum_probs=129.9

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCC-----ee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG-----EN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  194 (290)
                      .++|+..+.||+|+||.||++... ++..||||++..... .....+.+|+.++.+++||||+++++++...+     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999874 578899999975332 23467899999999999999999999997653     67


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||++ ++|..++..    ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999998 488887732    35899999999999999999999988   99999999999999999999999999998


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      ...+
T Consensus       178 ~~~~  181 (364)
T 3qyz_A          178 ADPD  181 (364)
T ss_dssp             CCGG
T ss_pred             cCCC
Confidence            7654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.95  E-value=8.9e-28  Score=208.21  Aligned_cols=156  Identities=28%  Similarity=0.385  Sum_probs=132.6

Q ss_pred             HhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEEEEe--------
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIE--------  190 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--------  190 (290)
                      ...+|+..+.||+|+||.||++... +++.||||++..........+.+|+..+.++. ||||+++++++..        
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3468999999999999999999874 58899999987655555678899999999996 9999999999953        


Q ss_pred             CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          191 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       191 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                      ....++||||++ |+|.+++........+++.+++.++.|++.||.|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            334789999996 788887754334456999999999999999999999764 349999999999999999999999999


Q ss_pred             CceeeCCC
Q 022887          271 MARIFGGD  278 (290)
Q Consensus       271 la~~~~~~  278 (290)
                      +++.+...
T Consensus       184 ~~~~~~~~  191 (337)
T 3ll6_A          184 SATTISHY  191 (337)
T ss_dssp             TCBCCSSC
T ss_pred             cceecccc
Confidence            99887643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=2.7e-27  Score=198.97  Aligned_cols=153  Identities=24%  Similarity=0.380  Sum_probs=132.6

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  197 (290)
                      .++|...+.||+|+||.||+|.+. ++.||+|.+....  ......+.+|+.++.+++||||+++++++...  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            368999999999999999999984 7899999997542  23356799999999999999999999999887  678999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ .+++||||||+||++++++.++|.|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999999999998642 2336899999999999999999999754 3599999999999999999999999998865443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.95  E-value=2.9e-27  Score=207.15  Aligned_cols=160  Identities=24%  Similarity=0.330  Sum_probs=121.4

Q ss_pred             HhHHHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe-
Q 022887          116 ASVSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-  193 (290)
Q Consensus       116 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  193 (290)
                      .......++|+..+.||+|+||.||+|... +++.||||++.... .....+.+++..+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            344566789999999999999999999884 58899999986532 333567788888899999999999999976543 


Q ss_pred             ------eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCceecCCCCCCEEEcC-CCCe
Q 022887          194 ------NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH--QYSRLRIIHRDLKASNILLDS-DMNP  264 (290)
Q Consensus       194 ------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~iiH~dlk~~Nill~~-~~~~  264 (290)
                            .++||||++++.+............+++.....++.|++.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                  7899999997544333322234566889999999999999999999  776   999999999999996 8999


Q ss_pred             EEeeccCceeeCCCc
Q 022887          265 KISDFGMARIFGGDE  279 (290)
Q Consensus       265 kl~DfGla~~~~~~~  279 (290)
                      ||+|||+++.+....
T Consensus       172 kl~Dfg~a~~~~~~~  186 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE  186 (360)
T ss_dssp             EECCCTTCBCCCTTS
T ss_pred             EEeeCCCceecCCCC
Confidence            999999999876543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.95  E-value=1e-27  Score=203.73  Aligned_cols=153  Identities=28%  Similarity=0.391  Sum_probs=120.3

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc-c-CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-Q-GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+..... . ....+.++...+..++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46899999999999999999987 4688999999975422 1 2233445555688899999999999999999999999


Q ss_pred             EecCCCChhhhhhC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          199 EYMPNKSLDVFLFY-PKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       199 e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||+++ +|.+++.. ......+++..++.++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99984 77666532 12345699999999999999999999997 7   9999999999999999999999999998775


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      .+
T Consensus       162 ~~  163 (290)
T 3fme_A          162 DD  163 (290)
T ss_dssp             --
T ss_pred             cc
Confidence            54

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.95  E-value=1.4e-27  Score=210.11  Aligned_cols=148  Identities=29%  Similarity=0.407  Sum_probs=114.9

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC------C
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------G  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  192 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||||++....  ......+.+|+.++..++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999986 458899999996532  22356788999999999999999999998754      4


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..++|+||+ +++|..++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            579999999 678888773    246899999999999999999999988   999999999999999999999999999


Q ss_pred             eeeCC
Q 022887          273 RIFGG  277 (290)
Q Consensus       273 ~~~~~  277 (290)
                      +....
T Consensus       180 ~~~~~  184 (367)
T 2fst_X          180 RHTAD  184 (367)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            87654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.95  E-value=1.9e-27  Score=225.02  Aligned_cols=148  Identities=22%  Similarity=0.345  Sum_probs=128.1

Q ss_pred             hcCCCccceecccCCccEEEEEEc--CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe-----
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-----  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  193 (290)
                      .++|+..+.||+|+||.||++.+.  +++.||||.+.... ......+..|+.++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999885  58899999986532 2344678899999999999999999999998765     


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++||||+++++|.+++.     ..+++.+++.++.|++.||.|||+++   |+||||||+|||++++ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            699999999999988762     26899999999999999999999988   9999999999999886 89999999999


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .+...
T Consensus       230 ~~~~~  234 (681)
T 2pzi_A          230 RINSF  234 (681)
T ss_dssp             ETTCC
T ss_pred             hcccC
Confidence            87553

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.95  E-value=5.4e-27  Score=200.22  Aligned_cols=150  Identities=30%  Similarity=0.506  Sum_probs=129.8

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+..+.||+|+||.||+|... +++.||||.+....  ......+.+|+.++.+++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            57889999999999999999885 58899999986432  2234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |++ ++|.+++... ....+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.++.
T Consensus        83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  155 (299)
T 2r3i_A           83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  155 (299)
T ss_dssp             CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence            998 6888887543 2245889999999999999999999987   99999999999999999999999999987654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.95  E-value=1.9e-27  Score=212.79  Aligned_cols=148  Identities=28%  Similarity=0.459  Sum_probs=121.3

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeC----C--eeE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ----G--ENI  195 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~--~~~  195 (290)
                      .+|+..+.||+|+||.||+|.+. +++.||||++....    ....+|+.++..++||||+++++++...    +  ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999985 58999999986532    2334799999999999999999998642    2  357


Q ss_pred             EEEEecCCCChhhhhh-CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC-CCeEEeeccCce
Q 022887          196 LIYEYMPNKSLDVFLF-YPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR  273 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGla~  273 (290)
                      +||||++++ +...+. .......+++.....++.|+++||.|||+.+   |+||||||+|||++.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhccccc-HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            899999874 433332 2223456899999999999999999999887   9999999999999965 678999999999


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .+..+
T Consensus       206 ~~~~~  210 (420)
T 1j1b_A          206 QLVRG  210 (420)
T ss_dssp             ECCTT
T ss_pred             hcccC
Confidence            87554

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.95  E-value=2.7e-27  Score=208.52  Aligned_cols=148  Identities=28%  Similarity=0.379  Sum_probs=123.4

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  192 (290)
                      .++|+..+.||+|+||.||+|... +++.||||++....  ......+.+|+.++..++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999874 58899999986532  233467889999999999999999999998765      


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..++||||+++ +|...+.     ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999985 6666663     34889999999999999999999988   999999999999999999999999999


Q ss_pred             eeeCCC
Q 022887          273 RIFGGD  278 (290)
Q Consensus       273 ~~~~~~  278 (290)
                      +..+..
T Consensus       175 ~~~~~~  180 (371)
T 2xrw_A          175 RTAGTS  180 (371)
T ss_dssp             ------
T ss_pred             cccccc
Confidence            877543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.95  E-value=1.6e-27  Score=201.84  Aligned_cols=152  Identities=32%  Similarity=0.453  Sum_probs=129.5

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC----CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      ..++|...+.||+|+||.||+|.+.+    +..||+|.+.... ......+.+|+.++..++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34689999999999999999998643    2359999987542 2345789999999999999999999999765 4678


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||+++++|.+++..  ....+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999998853  2345899999999999999999999988   999999999999999999999999999877


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      ...
T Consensus       164 ~~~  166 (281)
T 3cc6_A          164 EDE  166 (281)
T ss_dssp             ---
T ss_pred             ccc
Confidence            543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.94  E-value=2e-27  Score=200.94  Aligned_cols=157  Identities=27%  Similarity=0.445  Sum_probs=130.8

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEe--CCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  196 (290)
                      .++|+..+.||+|+||.||++... +++.||+|.+....  ......+.+|+.++.+++||||+++++++..  .+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999885 58899999997532  2335678999999999999999999998865  567899


Q ss_pred             EEEecCCCChhhhhhCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          197 IYEYMPNKSLDVFLFYPK-KKRLLGWQARVRIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+++||||||+||++++++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999885422 2345899999999999999999999865  2349999999999999999999999999998


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .+..+
T Consensus       165 ~~~~~  169 (279)
T 2w5a_A          165 ILNHD  169 (279)
T ss_dssp             HC---
T ss_pred             eeccc
Confidence            77543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.94  E-value=5.2e-27  Score=199.64  Aligned_cols=152  Identities=28%  Similarity=0.420  Sum_probs=129.5

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEe----CCeeE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGENI  195 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  195 (290)
                      +.|...+.||+|+||.||+|... ++..||+|.+....  ......+.+|+.++..++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45777889999999999999874 57889999986532  2345678999999999999999999999876    34579


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc-CCCCeEEeeccCcee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARI  274 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~  274 (290)
                      +||||+++++|.+++..   ...+++...+.++.|++.||.|||+.+ .+++||||||+||+++ +++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999843   356899999999999999999999864 3599999999999998 789999999999976


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      ....
T Consensus       182 ~~~~  185 (290)
T 1t4h_A          182 KRAS  185 (290)
T ss_dssp             CCTT
T ss_pred             cccc
Confidence            6543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.94  E-value=2.1e-27  Score=200.87  Aligned_cols=149  Identities=30%  Similarity=0.522  Sum_probs=125.1

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeC-CeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-GENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  200 (290)
                      .++|+..+.||+|+||.||++.. +++.||+|.+...  .....+.+|+.++.+++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46889999999999999999987 4789999998753  3457899999999999999999999997655 468999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +++++|.+++... ....+++...+.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999988432 1223788999999999999999999987   99999999999999999999999999987654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.94  E-value=1.4e-26  Score=197.94  Aligned_cols=149  Identities=23%  Similarity=0.328  Sum_probs=128.2

Q ss_pred             hcCCCcc-ceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHH-cccCCCCcceeEEEEEe----CCee
Q 022887          122 TENFSTQ-CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLI-AKLQHRHLVRLFGCCIE----QGEN  194 (290)
Q Consensus       122 ~~~~~~~-~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~  194 (290)
                      .++|... +.||+|+||.||++.. .+++.||+|.+..     ...+.+|+..+ ...+||||+++++++..    .+..
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4577776 7899999999999987 4588999999864     24677888877 55689999999999987    5678


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---CCCeEEeeccC
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM  271 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGl  271 (290)
                      ++||||+++|+|.+++... ....+++...+.++.|++.||.|||+.+   |+||||||+||+++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            9999999999999988643 2346899999999999999999999988   999999999999998   78899999999


Q ss_pred             ceeeCCCc
Q 022887          272 ARIFGGDE  279 (290)
Q Consensus       272 a~~~~~~~  279 (290)
                      ++......
T Consensus       167 a~~~~~~~  174 (299)
T 3m2w_A          167 AKETTGEK  174 (299)
T ss_dssp             CEECTTCG
T ss_pred             cccccccc
Confidence            99876543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.94  E-value=1e-26  Score=197.62  Aligned_cols=154  Identities=31%  Similarity=0.496  Sum_probs=135.0

Q ss_pred             HHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      ....++|+..+.||+|+||.||++... +++.||+|.+....  ......+.+|+.++.+++||||+++++++...+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            345678999999999999999999885 58899999986432  345678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC---CCeEEeeccCc
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMA  272 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~---~~~kl~DfGla  272 (290)
                      +|+||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   ++|+||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            99999999999887743   345899999999999999999999987   9999999999999754   47999999999


Q ss_pred             eeeCCC
Q 022887          273 RIFGGD  278 (290)
Q Consensus       273 ~~~~~~  278 (290)
                      +....+
T Consensus       172 ~~~~~~  177 (287)
T 2wei_A          172 TCFQQN  177 (287)
T ss_dssp             GTBCCC
T ss_pred             eeecCC
Confidence            877554

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.94  E-value=1e-27  Score=206.31  Aligned_cols=156  Identities=26%  Similarity=0.361  Sum_probs=132.2

Q ss_pred             HHhHHHHhcCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--ccCHHHHHHHHHHHcccC--CCCcceeEEEEEe
Q 022887          115 LASVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQ--HRHLVRLFGCCIE  190 (290)
Q Consensus       115 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~  190 (290)
                      +..+....++|+..+.||+|+||.||++...+++.||||.+....  ......+.+|+.++.+++  ||||+++++++..
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            333444567899999999999999999998889999999986432  234577899999999997  5999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          191 QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       191 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                      .+..++||| +.+++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||++++ +.+||+|||
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             CCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence            999999999 678899988853   346899999999999999999999987   999999999999964 889999999


Q ss_pred             CceeeCCC
Q 022887          271 MARIFGGD  278 (290)
Q Consensus       271 la~~~~~~  278 (290)
                      +++.+..+
T Consensus       172 ~~~~~~~~  179 (313)
T 3cek_A          172 IANQMQPD  179 (313)
T ss_dssp             SSCC----
T ss_pred             ccccccCc
Confidence            99887554

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.4e-27  Score=220.93  Aligned_cols=140  Identities=16%  Similarity=0.216  Sum_probs=109.6

Q ss_pred             ecccCCccEEEEE-EcCCcEEEEEEecccc----------ccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEE
Q 022887          131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQS----------GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       131 ig~G~fg~V~~~~-~~~~~~vavK~l~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .+.|++|....++ ...|+.+++|.+....          ....++|.+|+++|.++ .|+||+++++++.+++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556666555543 3457889999986431          12346799999999999 7999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++++|.+.+..   ...++..   +|+.||+.||+|+|+++   ||||||||+|||+++++.+||+|||+|+.+..+
T Consensus       322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999853   3445553   58899999999999998   999999999999999999999999999987654


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       393 ~  393 (569)
T 4azs_A          393 C  393 (569)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.94  E-value=5.2e-27  Score=205.01  Aligned_cols=148  Identities=27%  Similarity=0.429  Sum_probs=129.2

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeC-----Cee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-----GEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  194 (290)
                      .++|...+.||+|+||.||+|... +++.||||.+..... .....+.+|+.++..++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999885 588999999964322 2346788999999999999999999998764     578


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++||||++ ++|..++..    ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 588887743    45899999999999999999999987   99999999999999999999999999998


Q ss_pred             eCC
Q 022887          275 FGG  277 (290)
Q Consensus       275 ~~~  277 (290)
                      +..
T Consensus       162 ~~~  164 (353)
T 2b9h_A          162 IDE  164 (353)
T ss_dssp             CC-
T ss_pred             ccc
Confidence            764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.94  E-value=3.2e-27  Score=200.76  Aligned_cols=151  Identities=32%  Similarity=0.454  Sum_probs=123.8

Q ss_pred             hcCCCccceecccCCccEEEEEEcC--Cc--EEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~--~~--~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      .++|+..+.||+|+||.||+|.+..  ++  .||+|.+...   .......+.+|+.++.+++||||+++++++...+ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            4689999999999999999998632  33  6899988653   2234578899999999999999999999998764 8


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      ++|+||+++++|.+++...  ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999988532  345889999999999999999999987   99999999999999999999999999998


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      +..+
T Consensus       171 ~~~~  174 (291)
T 1u46_A          171 LPQN  174 (291)
T ss_dssp             CCC-
T ss_pred             cccc
Confidence            7654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.94  E-value=2.1e-27  Score=207.76  Aligned_cols=147  Identities=16%  Similarity=0.255  Sum_probs=127.8

Q ss_pred             hcCCCccceecccCCccEEEEEEcC---------CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcce---------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR---------  183 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~---------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  183 (290)
                      .++|...+.||+|+||.||+|....         ++.||+|.+...     ..+.+|+.++.+++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999998753         789999998753     47889999999999999987         


Q ss_pred             ------eEEEEEe-CCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCE
Q 022887          184 ------LFGCCIE-QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNI  256 (290)
Q Consensus       184 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Ni  256 (290)
                            +++++.. .+..++||||+ +++|.+++... ....+++.+++.++.|++.||.|||+.+   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6778876 67889999999 99999998542 2356999999999999999999999987   99999999999


Q ss_pred             EEcCCC--CeEEeeccCceeeCCC
Q 022887          257 LLDSDM--NPKISDFGMARIFGGD  278 (290)
Q Consensus       257 ll~~~~--~~kl~DfGla~~~~~~  278 (290)
                      |++.++  .+||+|||+++.+..+
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~  214 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPS  214 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGG
T ss_pred             EEcCCCCceEEEecCcceeeccCC
Confidence            999998  8999999999887543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.94  E-value=7.5e-27  Score=205.70  Aligned_cols=148  Identities=24%  Similarity=0.437  Sum_probs=125.3

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee----
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN----  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----  194 (290)
                      .++|...+.||+|+||.||+|... +++.||||++....  ......+.+|+.++..++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999874 58899999997532  22346788999999999999999999999887655    


Q ss_pred             --EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          195 --ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       195 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                        ++||||++ ++|..++     ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999998 5777766     234899999999999999999999987   999999999999999999999999999


Q ss_pred             eeeCCC
Q 022887          273 RIFGGD  278 (290)
Q Consensus       273 ~~~~~~  278 (290)
                      +..+..
T Consensus       192 ~~~~~~  197 (371)
T 4exu_A          192 RHADAE  197 (371)
T ss_dssp             ------
T ss_pred             cccccC
Confidence            876543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.94  E-value=2e-26  Score=196.27  Aligned_cols=151  Identities=23%  Similarity=0.403  Sum_probs=125.8

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEE-EeCCeeEEEE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC-IEQGENILIY  198 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  198 (290)
                      ..++|+..+.||+|+||.||+|.. .+++.||||.+....  ....+..|+.++..++|++++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999987 568899999875432  224688999999999988877776665 5667889999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE---cCCCCeEEeeccCceee
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIF  275 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~~  275 (290)
                      ||+ +++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||+   ++++.+||+|||+++.+
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999988532  345899999999999999999999988   9999999999999   78899999999999988


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      ....
T Consensus       159 ~~~~  162 (296)
T 4hgt_A          159 RDAR  162 (296)
T ss_dssp             BCTT
T ss_pred             cCcc
Confidence            6543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.94  E-value=1.8e-26  Score=199.34  Aligned_cols=152  Identities=30%  Similarity=0.499  Sum_probs=127.8

Q ss_pred             HhcCCCccceecccCCccEEEEEE--cCCcEEEEEEecccc--ccCHHHHHHHHHHHccc---CCCCcceeEEEEE----
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKL---QHRHLVRLFGCCI----  189 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~--~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----  189 (290)
                      ..++|+..+.||+|+||.||++..  .+++.||+|.+....  ......+.+|+.++..+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999988  457899999886432  22234667777777666   8999999999987    


Q ss_pred             -eCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEee
Q 022887          190 -EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD  268 (290)
Q Consensus       190 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  268 (290)
                       .....++||||++ |+|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             4557899999998 68988875432 345899999999999999999999988   99999999999999999999999


Q ss_pred             ccCceeeCC
Q 022887          269 FGMARIFGG  277 (290)
Q Consensus       269 fGla~~~~~  277 (290)
                      ||+++....
T Consensus       164 fg~~~~~~~  172 (326)
T 1blx_A          164 FGLARIYSF  172 (326)
T ss_dssp             CCSCCCCCG
T ss_pred             CcccccccC
Confidence            999987754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.94  E-value=3.9e-27  Score=202.44  Aligned_cols=156  Identities=25%  Similarity=0.376  Sum_probs=124.7

Q ss_pred             HHHHhcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc------cCHHHHHHHHHHHccc----CCCCcceeEE
Q 022887          118 VSAATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKL----QHRHLVRLFG  186 (290)
Q Consensus       118 ~~~~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~~  186 (290)
                      .+...++|...+.||+|+||.||+|.. .+++.||||.+.....      .....+..|+..+.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            345567899999999999999999987 4588999999965432      1234566788888888    8999999999


Q ss_pred             EEEeCCeeEEEEEe-cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc-CCCCe
Q 022887          187 CCIEQGENILIYEY-MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNP  264 (290)
Q Consensus       187 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~-~~~~~  264 (290)
                      ++...+..++|+|| +++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++||||||+||+++ +++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence            99999999999999 789999998853   345899999999999999999999988   99999999999999 88999


Q ss_pred             EEeeccCceeeCCCc
Q 022887          265 KISDFGMARIFGGDE  279 (290)
Q Consensus       265 kl~DfGla~~~~~~~  279 (290)
                      ||+|||+++.+....
T Consensus       180 kl~dfg~~~~~~~~~  194 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP  194 (312)
T ss_dssp             EECCCSSCEECCSSC
T ss_pred             EEEEcchhhhcccCc
Confidence            999999999876543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.94  E-value=9.3e-27  Score=218.92  Aligned_cols=152  Identities=27%  Similarity=0.415  Sum_probs=130.4

Q ss_pred             HhcCCCccceecccCCccEEEEEEcC----CcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      ..++|+..+.||+|+||.||+|.+..    +..||||.+.... ......+.+|+.++.+++||||+++++++. .+..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            34567788999999999999998742    4579999987533 233467999999999999999999999985 46789


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            999999999999988532  345899999999999999999999987   999999999999999999999999999987


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      ...
T Consensus       542 ~~~  544 (656)
T 2j0j_A          542 EDS  544 (656)
T ss_dssp             CC-
T ss_pred             CCC
Confidence            544

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.94  E-value=4.4e-27  Score=207.17  Aligned_cols=150  Identities=11%  Similarity=0.116  Sum_probs=112.6

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc---cCHHHHHHHHH---HHcccCCCCcceeE-------EE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLTEFKNEMM---LIAKLQHRHLVRLF-------GC  187 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~-------~~  187 (290)
                      ..+|...+.||+|+||.||+|.+. +++.||||.+.....   .....+.+|+.   .+.. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            346889999999999999999974 688999999976432   23456777854   5555 799988754       45


Q ss_pred             EEeC-----------------CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCC
Q 022887          188 CIEQ-----------------GENILIYEYMPNKSLDVFLFYPKKKRLLGWQAR------VRIIEGIAQGLLYLHQYSRL  244 (290)
Q Consensus       188 ~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~  244 (290)
                      +...                 ...++||||++ |+|.+++...  ...+.+..+      +.++.|++.||+|||+++  
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            5433                 23799999999 8999988542  223455566      788899999999999988  


Q ss_pred             CceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       245 ~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                       |+||||||+|||++.++.+||+|||+|+..+..
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~  247 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR  247 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence             999999999999999999999999999977543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.94  E-value=1.2e-26  Score=202.91  Aligned_cols=147  Identities=24%  Similarity=0.425  Sum_probs=126.0

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe-----
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE-----  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  193 (290)
                      .++|...+.||+|+||.||+|... +++.||||.+....  ......+.+|+.++..++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            368899999999999999999874 58899999996532  2234678899999999999999999999987654     


Q ss_pred             -eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          194 -NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       194 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                       .++||||++ ++|..++.     ..+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999998 57777652     34899999999999999999999988   999999999999999999999999999


Q ss_pred             eeeCC
Q 022887          273 RIFGG  277 (290)
Q Consensus       273 ~~~~~  277 (290)
                      +..+.
T Consensus       174 ~~~~~  178 (353)
T 3coi_A          174 RHADA  178 (353)
T ss_dssp             TC---
T ss_pred             cCCCC
Confidence            87654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.94  E-value=2.6e-26  Score=205.99  Aligned_cols=150  Identities=23%  Similarity=0.267  Sum_probs=127.8

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHccc------CCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL------QHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~  194 (290)
                      ..+|+..+.||+|+||.||+|... +++.||||.+... ......+..|+.++..+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999874 4789999999753 23345677788877766      577999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC--eEEeeccCc
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMA  272 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~--~kl~DfGla  272 (290)
                      ++||||++ ++|.+++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||+|
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999997 5787777543 2345899999999999999999999987   999999999999999887  999999999


Q ss_pred             eeeCC
Q 022887          273 RIFGG  277 (290)
Q Consensus       273 ~~~~~  277 (290)
                      +....
T Consensus       250 ~~~~~  254 (429)
T 3kvw_A          250 CYEHQ  254 (429)
T ss_dssp             EETTC
T ss_pred             eecCC
Confidence            87654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.94  E-value=1.1e-26  Score=206.84  Aligned_cols=148  Identities=28%  Similarity=0.482  Sum_probs=114.3

Q ss_pred             CCCc-cceecccCCccEEEEEEc---CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEe--CCeeEEE
Q 022887          124 NFST-QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE--QGENILI  197 (290)
Q Consensus       124 ~~~~-~~~ig~G~fg~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  197 (290)
                      .|.. .++||+|+||.||+|...   ++..||||.+...  .....+.+|+.++..++||||+++++++..  ....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4554 458999999999999875   4778999999753  233578899999999999999999999965  5678999


Q ss_pred             EEecCCCChhhhhhCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE----cCCCCeEEe
Q 022887          198 YEYMPNKSLDVFLFYP------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKIS  267 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill----~~~~~~kl~  267 (290)
                      |||+++ +|..++...      .....+++..++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999975 665555321      12235899999999999999999999988   9999999999999    778899999


Q ss_pred             eccCceeeCC
Q 022887          268 DFGMARIFGG  277 (290)
Q Consensus       268 DfGla~~~~~  277 (290)
                      |||+|+.+..
T Consensus       175 Dfg~a~~~~~  184 (405)
T 3rgf_A          175 DMGFARLFNS  184 (405)
T ss_dssp             CTTCCC----
T ss_pred             ECCCceecCC
Confidence            9999998754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.94  E-value=4e-26  Score=194.49  Aligned_cols=150  Identities=23%  Similarity=0.405  Sum_probs=128.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEE-EeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC-IEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+....  ....+..|+.++..++|++++..+..+ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999987 568899999986533  235789999999999998877666655 56677899999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE---cCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~~~  276 (290)
                      |+ +++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||+   ++++.+||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999988532  346899999999999999999999988   9999999999999   488999999999999876


Q ss_pred             CCc
Q 022887          277 GDE  279 (290)
Q Consensus       277 ~~~  279 (290)
                      ...
T Consensus       160 ~~~  162 (296)
T 3uzp_A          160 DAR  162 (296)
T ss_dssp             CTT
T ss_pred             ccc
Confidence            543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.94  E-value=4.9e-26  Score=206.59  Aligned_cols=150  Identities=23%  Similarity=0.385  Sum_probs=128.6

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCC-CCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH-RHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|...+.||+|+||.||+|.. .+++.||||.+.....  ..++..|+.++..++| +++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999987 5688999998765332  3468899999999987 556666677778888999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE---cCCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~~~  276 (290)
                      |+ +++|.+++...  ...+++.+++.|+.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999988532  346899999999999999999999988   9999999999999   688999999999999886


Q ss_pred             CCc
Q 022887          277 GDE  279 (290)
Q Consensus       277 ~~~  279 (290)
                      ...
T Consensus       158 ~~~  160 (483)
T 3sv0_A          158 DTS  160 (483)
T ss_dssp             CTT
T ss_pred             CCc
Confidence            543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.93  E-value=3.6e-26  Score=197.76  Aligned_cols=153  Identities=27%  Similarity=0.412  Sum_probs=125.5

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccc-cCHHHHHHHHH-HHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLTEFKNEMM-LIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .++|...+.||+|+||.||++... +++.||||.+..... ....++..|+. ++..++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            368889999999999999999884 588999999975422 23345556665 778889999999999999999999999


Q ss_pred             EecCCCChhhhhhC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          199 EYMPNKSLDVFLFY--PKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       199 e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ||+++ +|..++..  ......+++.....++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||+++.+
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 66666532  11245689999999999999999999997 7   999999999999999999999999999877


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      ...
T Consensus       177 ~~~  179 (327)
T 3aln_A          177 VDS  179 (327)
T ss_dssp             ---
T ss_pred             ccc
Confidence            543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.93  E-value=1.9e-26  Score=204.29  Aligned_cols=135  Identities=24%  Similarity=0.321  Sum_probs=111.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccC--------CCCcceeEEEEE---
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ--------HRHLVRLFGCCI---  189 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~---  189 (290)
                      .++|...+.||+|+||.||+|.. .+++.||||.+... ......+.+|+.++..++        ||||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            46899999999999999999987 45789999999753 234567889999998885        788999999988   


Q ss_pred             -eCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEcCCC
Q 022887          190 -EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDM  262 (290)
Q Consensus       190 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~~~~  262 (290)
                       .....++||||+.++.++.+. .. ....+++...+.++.|++.||.|||++ +   |+||||||+|||++.++
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~-~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~  184 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWII-KS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHH-HT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred             CCCceEEEEEeccCccHHHHHH-hc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence             445789999999554444443 22 234689999999999999999999997 6   99999999999999775

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.93  E-value=2e-26  Score=198.92  Aligned_cols=152  Identities=24%  Similarity=0.356  Sum_probs=132.0

Q ss_pred             HhcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccccc------CHHHHHHHHHHHcccC--CCCcceeEEEEEeC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ------GLTEFKNEMMLIAKLQ--HRHLVRLFGCCIEQ  191 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~  191 (290)
                      ..++|+..+.||+|+||.||+|.. .+++.||||.+......      ....+..|+.++.+++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            456899999999999999999986 45889999999754321      2356778999999996  59999999999999


Q ss_pred             CeeEEEEEecCC-CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc-CCCCeEEeec
Q 022887          192 GENILIYEYMPN-KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDF  269 (290)
Q Consensus       192 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~-~~~~~kl~Df  269 (290)
                      +..++|+|++.+ ++|.+++..   ...+++...+.++.|++.||.|||+.+   |+||||||+|||++ +++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999986 899888743   356899999999999999999999988   99999999999999 7899999999


Q ss_pred             cCceeeCCC
Q 022887          270 GMARIFGGD  278 (290)
Q Consensus       270 Gla~~~~~~  278 (290)
                      |+++.+...
T Consensus       195 g~~~~~~~~  203 (320)
T 3a99_A          195 GSGALLKDT  203 (320)
T ss_dssp             TTCEECCSS
T ss_pred             ccccccccc
Confidence            999987654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.93  E-value=1e-26  Score=200.31  Aligned_cols=150  Identities=29%  Similarity=0.499  Sum_probs=127.5

Q ss_pred             HHHhcCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          119 SAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       119 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ....++|+..+.||+|+||.||+|...+  .+|+|.+....  ......+.+|+.++.+++||||+++++++...+..++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            3445789999999999999999998754  59999986432  2334678889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   ++||||||+||+++ ++.+||+|||+++...
T Consensus       107 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             ECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             EeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            9999999999999843  2346889999999999999999999987   99999999999998 6799999999988664

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.93  E-value=8e-26  Score=195.95  Aligned_cols=150  Identities=23%  Similarity=0.320  Sum_probs=129.2

Q ss_pred             hcCCCccceecccCCccEEEEEE--cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCC------cceeEEEEEeCCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH------LVRLFGCCIEQGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~--~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  193 (290)
                      .++|+..+.||+|+||.||++..  .+++.||||.+... ......+.+|+.++..++|+|      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999987  35789999999753 234567889999998887654      9999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-------------
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------------  260 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-------------  260 (290)
                      .++||||+ +++|.+++... ....+++.....++.|++.||+|||+.+   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88888887543 2346889999999999999999999987   999999999999987             


Q ss_pred             ------CCCeEEeeccCceeeCC
Q 022887          261 ------DMNPKISDFGMARIFGG  277 (290)
Q Consensus       261 ------~~~~kl~DfGla~~~~~  277 (290)
                            ++.+||+|||+++....
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~  189 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE  189 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS
T ss_pred             ccccccCCCceEeeCcccccCcc
Confidence                  67899999999987654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.93  E-value=3.6e-26  Score=205.43  Aligned_cols=149  Identities=26%  Similarity=0.317  Sum_probs=119.6

Q ss_pred             CCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      .|...+.||+|+||+||.+...+++.||||++...   ....+.+|+.++.++ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            44556889999999998776678999999998643   235678899999876 89999999999999999999999996


Q ss_pred             CCChhhhhhCCCCCC----CCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC-------------CCeE
Q 022887          203 NKSLDVFLFYPKKKR----LLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-------------MNPK  265 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~-------------~~~k  265 (290)
                       |+|.+++.......    ..++...+.++.|++.||+|||+.+   |+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999886432211    1133445789999999999999987   9999999999999754             4899


Q ss_pred             EeeccCceeeCCCc
Q 022887          266 ISDFGMARIFGGDE  279 (290)
Q Consensus       266 l~DfGla~~~~~~~  279 (290)
                      |+|||+++.+..+.
T Consensus       169 L~DFG~a~~~~~~~  182 (434)
T 2rio_A          169 ISDFGLCKKLDSGQ  182 (434)
T ss_dssp             ECCCTTCEECCC--
T ss_pred             EcccccceecCCCC
Confidence            99999999886643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.93  E-value=9.2e-27  Score=216.77  Aligned_cols=155  Identities=28%  Similarity=0.369  Sum_probs=131.7

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEe------CCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE------QGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  193 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+... .......+.+|+.++.+++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999987 45889999998653 23345678999999999999999999998765      567


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCC---eEEeecc
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFG  270 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~---~kl~DfG  270 (290)
                      .++||||+++|+|.+++........+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            7999999999999999876555556899999999999999999999987   999999999999997664   9999999


Q ss_pred             CceeeCCCc
Q 022887          271 MARIFGGDE  279 (290)
Q Consensus       271 la~~~~~~~  279 (290)
                      +++.+....
T Consensus       170 ~a~~~~~~~  178 (676)
T 3qa8_A          170 YAKELDQGE  178 (676)
T ss_dssp             CCCBTTSCC
T ss_pred             ccccccccc
Confidence            999876543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.93  E-value=3.5e-26  Score=205.19  Aligned_cols=148  Identities=24%  Similarity=0.382  Sum_probs=120.6

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ..+|...+.||+|+||+|+.....+++.||||++....   ...+.+|+.++..+ +||||+++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            34688889999999999766555678999999996532   23467899999998 799999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-----CCCeEEeeccCceee
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARIF  275 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~DfGla~~~  275 (290)
                      ++ |+|.+++....  ....+.....++.|++.||.|||+.+   |+||||||+|||++.     ...+||+|||+|+.+
T Consensus       100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            97 58888885432  23444556789999999999999988   999999999999953     336889999999987


Q ss_pred             CCC
Q 022887          276 GGD  278 (290)
Q Consensus       276 ~~~  278 (290)
                      ..+
T Consensus       174 ~~~  176 (432)
T 3p23_A          174 AVG  176 (432)
T ss_dssp             ---
T ss_pred             cCC
Confidence            644

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.93  E-value=2.4e-25  Score=193.51  Aligned_cols=150  Identities=23%  Similarity=0.279  Sum_probs=120.9

Q ss_pred             HhcCCCccc-eecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEe----CCee
Q 022887          121 ATENFSTQC-KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGEN  194 (290)
Q Consensus       121 ~~~~~~~~~-~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  194 (290)
                      ..++|...+ .||+|+||.||+|... +++.||||.+....    ....+....+..++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356888854 6999999999999885 58999999986521    222223334566799999999999876    3457


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---CCCeEEeeccC
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM  271 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGl  271 (290)
                      ++||||+++|+|.+++... ....+++.+++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            9999999999999998643 2346899999999999999999999988   999999999999976   45699999999


Q ss_pred             ceeeCCC
Q 022887          272 ARIFGGD  278 (290)
Q Consensus       272 a~~~~~~  278 (290)
                      ++.....
T Consensus       178 ~~~~~~~  184 (336)
T 3fhr_A          178 AKETTQN  184 (336)
T ss_dssp             CEEC---
T ss_pred             ceecccc
Confidence            9877543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.93  E-value=1.2e-25  Score=193.47  Aligned_cols=151  Identities=24%  Similarity=0.373  Sum_probs=115.1

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccccc-C-HHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-G-LTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .++|+..+.||+|+||.||+|... +++.||||.+...... . ...+.++..++..++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467888999999999999999885 6889999999754321 2 233445556788889999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+ ++.+..+...  ....+++.....++.|++.||.|||++ +   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 4445444321  235689999999999999999999985 7   99999999999999999999999999987654


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      +
T Consensus       178 ~  178 (318)
T 2dyl_A          178 D  178 (318)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.92  E-value=5.2e-25  Score=194.64  Aligned_cols=154  Identities=27%  Similarity=0.342  Sum_probs=127.5

Q ss_pred             HHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccC-CC-----CcceeEEEEEeCC
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HR-----HLVRLFGCCIEQG  192 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~  192 (290)
                      ...++|+..+.||+|+||.||+|... +++.||||.+... .....++..|+.++..++ |+     +++++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34578999999999999999999875 5788999999753 233466778888888775 44     4999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc--CCCCeEEeecc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFG  270 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~--~~~~~kl~DfG  270 (290)
                      ..++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+|||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            9999999996 48888875432 24589999999999999999999953 23499999999999994  57889999999


Q ss_pred             CceeeCC
Q 022887          271 MARIFGG  277 (290)
Q Consensus       271 la~~~~~  277 (290)
                      +|+.++.
T Consensus       207 ~a~~~~~  213 (382)
T 2vx3_A          207 SSCQLGQ  213 (382)
T ss_dssp             TCEETTC
T ss_pred             Cceeccc
Confidence            9998754

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=6.5e-25  Score=201.90  Aligned_cols=136  Identities=18%  Similarity=0.244  Sum_probs=108.8

Q ss_pred             CccceecccCCccEEEEEEcCCcEEEEEEecccccc--------CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          126 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       126 ~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ...+.||+|+||.||++.. .+..+++|+.......        ..+.+.+|+.++.+++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4457899999999999955 5678999987542211        134589999999999999999777777788888999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++++|.+++..           +..++.|+++||.|||+++   |+||||||+|||+++  .+||+|||+|+....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999998832           5689999999999999988   999999999999999  999999999998866


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       482 ~  482 (540)
T 3en9_A          482 D  482 (540)
T ss_dssp             H
T ss_pred             c
Confidence            4

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.92  E-value=4.3e-25  Score=192.62  Aligned_cols=150  Identities=24%  Similarity=0.319  Sum_probs=125.9

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CC-cEEEEEEeccccccCHHHHHHHHHHHcccCCCC------cceeEEEEEeCCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NG-QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH------LVRLFGCCIEQGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  193 (290)
                      .++|...+.||+|+||.||++... ++ +.||+|.+... ......+..|+.++..++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999874 33 68999999753 234567888999999887766      8999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE---------------
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---------------  258 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill---------------  258 (290)
                      .++||||+. +++..++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||+               
T Consensus        97 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELLG-KNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEeccC-CChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            999999994 5555555332 2346899999999999999999999887   9999999999999               


Q ss_pred             ----cCCCCeEEeeccCceeeCC
Q 022887          259 ----DSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       259 ----~~~~~~kl~DfGla~~~~~  277 (290)
                          +.++.+||+|||+++....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~  194 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE  194 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS
T ss_pred             cccccCCCcEEEeecCccccccc
Confidence                5688999999999987544

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.92  E-value=2.3e-25  Score=195.96  Aligned_cols=150  Identities=23%  Similarity=0.389  Sum_probs=127.1

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccC-----------CCCcceeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-----------HRHLVRLFGCCI  189 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  189 (290)
                      .++|...+.||+|+||.||+|.. .+++.||||.+... ......+.+|+.++.+++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36899999999999999999987 56889999999742 233467888999888876           899999999998


Q ss_pred             eCC----eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEc-----
Q 022887          190 EQG----ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLD-----  259 (290)
Q Consensus       190 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~-----  259 (290)
                      ..+    ..++||||+ +++|.+++.... ...+++.....++.|++.||.|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            754    678999999 889988875432 34589999999999999999999997 7   99999999999994     


Q ss_pred             -CCCCeEEeeccCceeeCC
Q 022887          260 -SDMNPKISDFGMARIFGG  277 (290)
Q Consensus       260 -~~~~~kl~DfGla~~~~~  277 (290)
                       ..+.+||+|||+++....
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~  190 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDE  190 (373)
T ss_dssp             TTEEEEEECCCTTCEETTB
T ss_pred             cCcceEEEcccccccccCC
Confidence             445899999999987754

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=3e-25  Score=188.10  Aligned_cols=141  Identities=19%  Similarity=0.169  Sum_probs=113.3

Q ss_pred             HHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccc------------------cCHHHHHHHHHHHcccCCCCc
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLTEFKNEMMLIAKLQHRHL  181 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~e~~~l~~l~h~ni  181 (290)
                      .....|+..+.||+|+||.||+|...+++.||+|.+.....                  .....+.+|+.++.+++  | 
T Consensus        87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-  163 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-  163 (282)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred             hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence            34456777799999999999999997789999999864321                  12356889999999998  4 


Q ss_pred             ceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC
Q 022887          182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD  261 (290)
Q Consensus       182 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~  261 (290)
                      +++.+++.. +..++||||+++++|.. +..         .....++.|++.||.|||+.+   |+||||||+|||++ +
T Consensus       164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~  228 (282)
T 1zar_A          164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred             CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence            555554433 56699999999999987 411         223479999999999999888   99999999999999 9


Q ss_pred             CCeEEeeccCceeeCCC
Q 022887          262 MNPKISDFGMARIFGGD  278 (290)
Q Consensus       262 ~~~kl~DfGla~~~~~~  278 (290)
                      +.+||+|||+|+.....
T Consensus       229 ~~vkl~DFG~a~~~~~~  245 (282)
T 1zar_A          229 EGIWIIDFPQSVEVGEE  245 (282)
T ss_dssp             TEEEECCCTTCEETTST
T ss_pred             CcEEEEECCCCeECCCC
Confidence            99999999999977543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.89  E-value=2.6e-23  Score=185.60  Aligned_cols=152  Identities=16%  Similarity=0.211  Sum_probs=113.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc---ccCHHHHHHHHHHHcccCC-CCcc---------eeE--
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQH-RHLV---------RLF--  185 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h-~niv---------~l~--  185 (290)
                      ..+|...+.||+|+||.||+|.+ .+++.||||++....   ....+.+.+|+.++..++| +|..         ...  
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34577788999999999999996 468999999987332   2235789999999999987 3211         111  


Q ss_pred             ----------EEEEe-----CCeeEEEEEecCCCChhhhhhC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 022887          186 ----------GCCIE-----QGENILIYEYMPNKSLDVFLFY----PKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRI  246 (290)
Q Consensus       186 ----------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i  246 (290)
                                .+...     ....+++|++ ..++|.+++..    ......+++..++.++.|++.||+|||+++   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                      11111     1134566665 46788877631    123456788999999999999999999988   9


Q ss_pred             eecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          247 IHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       247 iH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +||||||+|||++.++.+||+|||+++..+.
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~  263 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA  263 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC
Confidence            9999999999999999999999999987643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=5.8e-23  Score=171.94  Aligned_cols=139  Identities=16%  Similarity=0.178  Sum_probs=107.0

Q ss_pred             CCccceecccCCccEEEEEE-cCCcE--EEEEEecccccc------------------------CHHHHHHHHHHHcccC
Q 022887          125 FSTQCKLGEGGFGPVYKGRL-LNGQE--VAVKRLSNQSGQ------------------------GLTEFKNEMMLIAKLQ  177 (290)
Q Consensus       125 ~~~~~~ig~G~fg~V~~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~e~~~l~~l~  177 (290)
                      |+..+.||+|+||.||+|.. .+|+.  ||||.++.....                        ....+..|+..+.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999988 67888  999987542111                        0136889999999998


Q ss_pred             CCCc--ceeEEEEEeCCeeEEEEEecCC-C----ChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCceec
Q 022887          178 HRHL--VRLFGCCIEQGENILIYEYMPN-K----SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH-QYSRLRIIHR  249 (290)
Q Consensus       178 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~iiH~  249 (290)
                      |+++  ..++..    +..++||||+.+ |    +|.+....      .++.....++.|++.||.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8864  334432    356899999952 4    55554321      224456789999999999999 877   9999


Q ss_pred             CCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          250 DLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       250 dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||||+|||+++  .++|+|||+|...+..
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             CCCHHHEEEcC--cEEEEECcccccCCCc
Confidence            99999999998  9999999999877543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=6.4e-20  Score=160.11  Aligned_cols=139  Identities=13%  Similarity=0.123  Sum_probs=99.5

Q ss_pred             CCCccceecccCCccEEEEEEcCCcEEEEEEeccccc--------------cCHHH--------HHHHHHHHcccCCCCc
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------------QGLTE--------FKNEMMLIAKLQHRHL  181 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~--------------~~~~~--------~~~e~~~l~~l~h~ni  181 (290)
                      -|++.+.||+|+||.||+|...+|+.||||.++....              .....        ...|...+.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3889999999999999999998899999998753210              00111        2345555666654443


Q ss_pred             ceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCC
Q 022887          182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD  261 (290)
Q Consensus       182 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~  261 (290)
                      ....-+..  ...++||||+++++|..+...         .....++.|++.+|.|||+.+   ||||||||.|||++++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence            22211111  234799999999888654311         123467899999999999887   9999999999999887


Q ss_pred             C----------CeEEeeccCceeeC
Q 022887          262 M----------NPKISDFGMARIFG  276 (290)
Q Consensus       262 ~----------~~kl~DfGla~~~~  276 (290)
                      +          .+.|+||+=+.-.+
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCcccccccccceEEEEeCCcccCC
Confidence            6          38999999876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.55  E-value=3.7e-14  Score=118.39  Aligned_cols=147  Identities=16%  Similarity=0.085  Sum_probs=114.9

Q ss_pred             HHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEE
Q 022887          120 AATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       120 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  198 (290)
                      .....|.....++.|+.+.||+.... ++.+++|............+.+|+.++..+. +..+.++++++...+..++||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            44567887778888888999999754 6799999986532233456889999998884 677889999999988999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS------------------------------------  242 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------  242 (290)
                      ||+++.++.....        +......++.+++++|..||+..                                    
T Consensus        90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999876531        11223477889999999999811                                    


Q ss_pred             --------------------CCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          243 --------------------RLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       243 --------------------~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                                          +..++|+|++|.||+++++..+.|+||+.+..-
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                                134899999999999987766789999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.42  E-value=7.8e-13  Score=109.90  Aligned_cols=138  Identities=17%  Similarity=0.192  Sum_probs=102.6

Q ss_pred             CCCccceec-ccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCC--cceeEEEEEeCCeeEEEEEe
Q 022887          124 NFSTQCKLG-EGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       124 ~~~~~~~ig-~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++.. ..++ .|..+.||+....+++.+++|.....   ....+..|+.++..+.+.+  +.+++++....+..++||||
T Consensus        21 ~~~~-~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           21 GYDW-AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TCEE-EECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCce-EecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            4444 3444 55569999998777788999987643   2356888999988886545  45688888887788999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS--------------------------------------  242 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--------------------------------------  242 (290)
                      +++.++.  ..  .    .+   ...++.++++.|..||+..                                      
T Consensus        97 i~G~~l~--~~--~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SS--H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TS--C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cC--c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9998874  21  0    11   2356777888888888643                                      


Q ss_pred             -----------------CCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          243 -----------------RLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       243 -----------------~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                                       +..++|+|++|.||+++++..++|+||+.+..-+
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~  216 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD  216 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence                             1229999999999999887777899999998654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.31  E-value=1.4e-11  Score=107.57  Aligned_cols=143  Identities=13%  Similarity=0.225  Sum_probs=107.2

Q ss_pred             ccceecccCCccEEEEEEcCCcEEEEEEec--ccc-ccCHHHHHHHHHHHcccC--CCCcceeEEEEEeC---CeeEEEE
Q 022887          127 TQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQS-GQGLTEFKNEMMLIAKLQ--HRHLVRLFGCCIEQ---GENILIY  198 (290)
Q Consensus       127 ~~~~ig~G~fg~V~~~~~~~~~~vavK~l~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  198 (290)
                      ..+.++.|.++.+|+....+ ..+++|+..  ... ......+.+|..++..+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            35688999999999988754 678888765  322 123457888999988886  45678889888776   4579999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS------------------------------------  242 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------  242 (290)
                      ||+++..+.+..     ...++..++..++.++++.|..||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998774321     233678888999999999999999731                                    


Q ss_pred             -------------------CCCceecCCCCCCEEEcCCCC--eEEeeccCceee
Q 022887          243 -------------------RLRIIHRDLKASNILLDSDMN--PKISDFGMARIF  275 (290)
Q Consensus       243 -------------------~~~iiH~dlk~~Nill~~~~~--~kl~DfGla~~~  275 (290)
                                         +..++|+|+++.||++++++.  +.|.||+++..-
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                               246999999999999997753  699999999854

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.86  E-value=5.9e-09  Score=88.68  Aligned_cols=139  Identities=21%  Similarity=0.219  Sum_probs=99.3

Q ss_pred             cceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCC--cceeEEEEEeCC---eeEEEEEec
Q 022887          128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRH--LVRLFGCCIEQG---ENILIYEYM  201 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~  201 (290)
                      .+.++.|....||+..    ..+++|.....  .....+..|..++..+ .+..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568899999999853    56888876432  2346788999998877 3333  334554443332   348999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------------
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY----------------------------------------  241 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------------------------------------  241 (290)
                      ++.++.....     ..++..++..++.++++.+..||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865331     2356777788888888888888851                                        


Q ss_pred             ---------------CCCCceecCCCCCCEEEcC--CCCeEEeeccCceeeCC
Q 022887          242 ---------------SRLRIIHRDLKASNILLDS--DMNPKISDFGMARIFGG  277 (290)
Q Consensus       242 ---------------~~~~iiH~dlk~~Nill~~--~~~~kl~DfGla~~~~~  277 (290)
                                     .+..++|+|++|.||++++  +..+.|+||+.+..-++
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~  226 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP  226 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh
Confidence                           1234799999999999998  55689999999986543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.77  E-value=9.1e-08  Score=81.44  Aligned_cols=138  Identities=22%  Similarity=0.198  Sum_probs=94.6

Q ss_pred             cceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCC---CcceeEEEEE-eCCeeEEEEEecCC
Q 022887          128 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR---HLVRLFGCCI-EQGENILIYEYMPN  203 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  203 (290)
                      .+.++.|....||+.    +..+++|....  ......+..|..++..+.+.   .+.+.+.+.. ..+..++||||+++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456778888889987    46788887532  23346788999999988652   2556666664 34567899999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------------------
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY------------------------------------------  241 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------------------------------------------  241 (290)
                      ..+.....     ..++..++..++.++++.|..||+.                                          
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            88765321     1134445555555555555555532                                          


Q ss_pred             ---------------CCCCceecCCCCCCEEEcC---CCC-eEEeeccCceeeC
Q 022887          242 ---------------SRLRIIHRDLKASNILLDS---DMN-PKISDFGMARIFG  276 (290)
Q Consensus       242 ---------------~~~~iiH~dlk~~Nill~~---~~~-~kl~DfGla~~~~  276 (290)
                                     .+..++|+|+.|.||+++.   ++. +.|.||+.+..-+
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                           2234699999999999987   455 5899999998654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.67  E-value=1e-07  Score=82.83  Aligned_cols=80  Identities=8%  Similarity=-0.004  Sum_probs=54.9

Q ss_pred             ccee-cccCCccEEEEEEc-------CCcEEEEEEecccc---ccCHHHHHHHHHHHcccC-C--CCcceeEEEEEeC--
Q 022887          128 QCKL-GEGGFGPVYKGRLL-------NGQEVAVKRLSNQS---GQGLTEFKNEMMLIAKLQ-H--RHLVRLFGCCIEQ--  191 (290)
Q Consensus       128 ~~~i-g~G~fg~V~~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--  191 (290)
                      .+.| +.|....+|+....       +++.+++|......   ......+..|..++..+. +  ..+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999988764       25678888765422   111246788888887774 2  3466788877655  


Q ss_pred             -CeeEEEEEecCCCChh
Q 022887          192 -GENILIYEYMPNKSLD  207 (290)
Q Consensus       192 -~~~~lv~e~~~~g~L~  207 (290)
                       +..++||||+++..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.64  E-value=2e-07  Score=77.56  Aligned_cols=137  Identities=19%  Similarity=0.157  Sum_probs=95.2

Q ss_pred             eecccCCc-cEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          130 KLGEGGFG-PVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       130 ~ig~G~fg-~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      .+..|..+ .||+.... ++..+.+|.-...   ...++..|...+..+. +--+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 58987764 4567888876432   3457888888887774 33366789999999999999999999877


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------------
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS--------------------------------------------  242 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--------------------------------------------  242 (290)
                      ......       .......+..+++..|.-||...                                            
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            654311       11222345555556666665321                                            


Q ss_pred             -----------CCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          243 -----------RLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       243 -----------~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                                 +..++|+|+.+.||+++++..+-|.||+.+..-+
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd  225 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD  225 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence                       1237899999999999988878899999998654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.33  E-value=4.1e-06  Score=73.75  Aligned_cols=75  Identities=13%  Similarity=0.194  Sum_probs=49.2

Q ss_pred             cceecccCCccEEEEEEc-CCcEEEEEEeccccc-------cCHHHHHHHHHHHcccCC--CCc-ceeEEEEEeCCeeEE
Q 022887          128 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------QGLTEFKNEMMLIAKLQH--RHL-VRLFGCCIEQGENIL  196 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~h--~ni-v~l~~~~~~~~~~~l  196 (290)
                      .+.+|.|.++.||++... +++.+++|.......       .....+..|...+..+..  |.. .+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999999764 467899997653211       123456778888877642  333 345543  4456789


Q ss_pred             EEEecCCC
Q 022887          197 IYEYMPNK  204 (290)
Q Consensus       197 v~e~~~~g  204 (290)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.32  E-value=4.1e-06  Score=71.91  Aligned_cols=142  Identities=15%  Similarity=0.150  Sum_probs=80.5

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHccc-----CCCCcceeE-E--EEEeCCeeEEEEEe
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-----QHRHLVRLF-G--CCIEQGENILIYEY  200 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lv~e~  200 (290)
                      +.|+.|....||+....++ .+++|.....    ..++..|..++..+     ..|.++... |  +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4565567889999987554 5889988652    23334444444433     234444310 1  12345678999999


Q ss_pred             cCCCChhh--------------hhhC--C----CC-----CCCCCHHHHH------------------------------
Q 022887          201 MPNKSLDV--------------FLFY--P----KK-----KRLLGWQARV------------------------------  225 (290)
Q Consensus       201 ~~~g~L~~--------------~l~~--~----~~-----~~~l~~~~~~------------------------------  225 (290)
                      +++..+..              .++.  .    ..     .....|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99865420              0110  0    00     0112343211                              


Q ss_pred             -HHHHHHHHHHHHHhh----------CCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          226 -RIIEGIAQGLLYLHQ----------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       226 -~i~~~i~~~l~yLH~----------~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                       .+..++..++.+|+.          ..+..++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g  253 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD  253 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence             011123345666653          12456999999999999988889999999998743

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.18  E-value=1.9e-05  Score=67.16  Aligned_cols=140  Identities=20%  Similarity=0.131  Sum_probs=92.9

Q ss_pred             CccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccC---CCCcceeEEEEEeCCeeEEEEEecC
Q 022887          126 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ---HRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       126 ~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      ...+.|+.|....+|+... ++..+++|.....   ....+..|...+..+.   ...+.+++.++...+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3456789999999999876 4678888876542   3567888988888774   3567888888888888999999999


Q ss_pred             CCChhh-----------hhhCCCC-------------------CCCCCHHHHH---HHHH----------------HHHH
Q 022887          203 NKSLDV-----------FLFYPKK-------------------KRLLGWQARV---RIIE----------------GIAQ  233 (290)
Q Consensus       203 ~g~L~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~~----------------~i~~  233 (290)
                      +..+..           .++....                   ...-+|....   ++..                .+..
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            886521           1121111                   0012564332   1111                1111


Q ss_pred             H-HHHHhh-CCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          234 G-LLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       234 ~-l~yLH~-~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                      . ...|.. ..++.++|+|+.+.|++++.++ +.|.|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 123421 2356799999999999999887 8999983

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.18  E-value=9.9e-06  Score=68.03  Aligned_cols=81  Identities=16%  Similarity=0.218  Sum_probs=59.3

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCC---CCcceeEEEEEeCCeeEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH---RHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~  198 (290)
                      .......+.+|.|..+.||+.+..+|+.+.+|+...........|..|...|..+.-   --+.+++++    +..++||
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~   89 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM   89 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred             CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence            345666788999999999999999999999998765444444568889888877742   223445544    2347899


Q ss_pred             EecCCCCh
Q 022887          199 EYMPNKSL  206 (290)
Q Consensus       199 e~~~~g~L  206 (290)
                      ||++.+..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.01  E-value=4e-05  Score=67.93  Aligned_cols=74  Identities=12%  Similarity=0.189  Sum_probs=45.8

Q ss_pred             ccceecccCCccEEEEEEcCCcEEEEEEeccc----cc--c---CHHHHHHHHHHHc-ccCCCCcceeEEEEEeCCeeEE
Q 022887          127 TQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----SG--Q---GLTEFKNEMMLIA-KLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       127 ~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~----~~--~---~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ..+.+|.|....||+... ++..++||...+.    ..  .   ....+..|+..+. ......+.+++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            346789999999999965 4678999944321    01  1   2234444444332 22234556666654  567799


Q ss_pred             EEEec-CC
Q 022887          197 IYEYM-PN  203 (290)
Q Consensus       197 v~e~~-~~  203 (290)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.86  E-value=8.7e-05  Score=63.09  Aligned_cols=159  Identities=14%  Similarity=0.124  Sum_probs=86.1

Q ss_pred             ccHHhHHHHhcCCCc-----cceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccC-----CCCcc
Q 022887          113 FSLASVSAATENFST-----QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-----HRHLV  182 (290)
Q Consensus       113 ~~~~~~~~~~~~~~~-----~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----h~niv  182 (290)
                      ++..++......|..     .+.|+.|....+|+....++ .+++|......  ....+..|..++..+.     -|.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            344455555555543     34566677788999887655 67888876521  1234556666665553     23333


Q ss_pred             eeE-E--EEEeCCeeEEEEEecCCCChhhh--------------hhC--CC---CC----CCCCHHHHHHH---------
Q 022887          183 RLF-G--CCIEQGENILIYEYMPNKSLDVF--------------LFY--PK---KK----RLLGWQARVRI---------  227 (290)
Q Consensus       183 ~l~-~--~~~~~~~~~lv~e~~~~g~L~~~--------------l~~--~~---~~----~~l~~~~~~~i---------  227 (290)
                      ... |  +....+..+++++|+++..+...              ++.  ..   ..    ....|...+.-         
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            210 1  11234567899999998654210              111  00   00    01123321110         


Q ss_pred             ---HHHHHHHHHHHhhC----CCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          228 ---IEGIAQGLLYLHQY----SRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       228 ---~~~i~~~l~yLH~~----~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                         ...+...+++++..    .+..++|+|+.+.||+++++..+.|+||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               11234455555432    234599999999999999876678999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.80  E-value=0.00018  Score=60.72  Aligned_cols=142  Identities=11%  Similarity=0.088  Sum_probs=76.5

Q ss_pred             CccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCc-ceeEEEEEeCCeeEEEEEec-CC
Q 022887          126 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIYEYM-PN  203 (290)
Q Consensus       126 ~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~  203 (290)
                      ...+.|+.|....+|+.     ..+++|........ ..+...|...+..+...++ .++++.  ..+..++++||+ ++
T Consensus        21 ~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           21 TGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA   92 (301)
T ss_dssp             CSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred             cceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence            33678888999999998     56888877543221 1233567777666643333 355543  344467899999 55


Q ss_pred             CChhhh------------------hhCCCC--CCCCCHH-HHHHHHH--------------HHHHHHH----HHhh-CCC
Q 022887          204 KSLDVF------------------LFYPKK--KRLLGWQ-ARVRIIE--------------GIAQGLL----YLHQ-YSR  243 (290)
Q Consensus       204 g~L~~~------------------l~~~~~--~~~l~~~-~~~~i~~--------------~i~~~l~----yLH~-~~~  243 (290)
                      .++...                  ++....  ....+.. ....+..              .+.+.+.    .+.. ..+
T Consensus        93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~  172 (301)
T 3dxq_A           93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP  172 (301)
T ss_dssp             EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence            444210                  111110  0011111 1111110              0111111    1111 223


Q ss_pred             CCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       244 ~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ..++|+|+.+.||+ .+++.+.++||..+..-+
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~  204 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMND  204 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence            45899999999999 566678999999987543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.66  E-value=0.00037  Score=59.55  Aligned_cols=34  Identities=26%  Similarity=0.405  Sum_probs=28.9

Q ss_pred             CCCceecCCCCCCEEEcCC----CCeEEeeccCceeeC
Q 022887          243 RLRIIHRDLKASNILLDSD----MNPKISDFGMARIFG  276 (290)
Q Consensus       243 ~~~iiH~dlk~~Nill~~~----~~~kl~DfGla~~~~  276 (290)
                      +..++|+|+.+.||+++.+    ..+.|.||+.+..-+
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            4569999999999999875    678999999998543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.60  E-value=0.00017  Score=64.09  Aligned_cols=73  Identities=23%  Similarity=0.383  Sum_probs=48.7

Q ss_pred             cceecccCCccEEEEEEcC--------CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCc-ceeEEEEEeCCeeEEEE
Q 022887          128 QCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIY  198 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  198 (290)
                      .+.|+.|-...+|+....+        +..+.+|+....  .....+..|..++..+...++ .++++.+.  +  .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            3567778889999998753        467888877431  122456678888887754444 45666543  2  3899


Q ss_pred             EecCCCCh
Q 022887          199 EYMPNKSL  206 (290)
Q Consensus       199 e~~~~g~L  206 (290)
                      ||+++.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.52  E-value=0.0016  Score=55.27  Aligned_cols=143  Identities=15%  Similarity=0.154  Sum_probs=81.1

Q ss_pred             ceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCC--cceeEEE-----EEeCCeeEEEEEec
Q 022887          129 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH--LVRLFGC-----CIEQGENILIYEYM  201 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~  201 (290)
                      ..++ |....||+....+|+.+++|...... .....+..|..++..+....  +.+++..     ....+..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 77788998877677789999886421 23456667777776664222  3333332     22345668899999


Q ss_pred             CCCChhh-----h---------hhC----CC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHhh--
Q 022887          202 PNKSLDV-----F---------LFY----PK--KKRLLGWQAR----VRI---------------IEGIAQGLLYLHQ--  240 (290)
Q Consensus       202 ~~g~L~~-----~---------l~~----~~--~~~~l~~~~~----~~i---------------~~~i~~~l~yLH~--  240 (290)
                      ++..+..     .         ++.    ..  .....++...    ..+               ...+...+..+..  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8754421     0         110    00  0112232211    001               1111122223221  


Q ss_pred             --CCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          241 --YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       241 --~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                        ..+..++|+|+++.||+++ + .+.|.||+.+..-
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence              1234589999999999999 4 8999999988754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.48  E-value=0.00088  Score=59.96  Aligned_cols=74  Identities=11%  Similarity=0.128  Sum_probs=46.8

Q ss_pred             cceecccCCccEEEEEEcC-CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCc-ceeEEEEEeCCeeEEEEEecCCCC
Q 022887          128 QCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIYEYMPNKS  205 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  205 (290)
                      .+.|+.|-...+|+....+ +..+++|........ .-+-..|..++..+...++ .++++.+.  +  .+||||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3578778889999998765 467888876432211 1122578888887765555 45676652  2  35999998755


Q ss_pred             h
Q 022887          206 L  206 (290)
Q Consensus       206 L  206 (290)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.37  E-value=0.00041  Score=60.22  Aligned_cols=73  Identities=12%  Similarity=0.145  Sum_probs=42.7

Q ss_pred             ceecccCCccEEEEEEcC---------CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCc-ceeEEEEEeCCeeEEEE
Q 022887          129 CKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIY  198 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~---------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  198 (290)
                      +.++.|....+|+....+         +..+++|........ ..+...|..++..+...++ .++++..  .  .++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            467777788899987654         257888876542221 1234667777777653343 3566543  2  37899


Q ss_pred             EecCCCCh
Q 022887          199 EYMPNKSL  206 (290)
Q Consensus       199 e~~~~g~L  206 (290)
                      ||+++..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.28  E-value=0.002  Score=56.11  Aligned_cols=142  Identities=21%  Similarity=0.257  Sum_probs=82.9

Q ss_pred             ceecccCCccEEEEEEcC--------CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCc-ceeEEEEEeCCeeEEEEE
Q 022887          129 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIYE  199 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  199 (290)
                      +.+..|-...+|+....+        ++.+.+|+.-. .........+|..++..+.-.++ .++++.+..    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            467667778899987642        46788887533 22345667789888877753333 456665543    28999


Q ss_pred             ecCCCChhhh-----------------hhCC--CCCCCCC--HHHHHHHHHHHHH-------------------HHHHHh
Q 022887          200 YMPNKSLDVF-----------------LFYP--KKKRLLG--WQARVRIIEGIAQ-------------------GLLYLH  239 (290)
Q Consensus       200 ~~~~g~L~~~-----------------l~~~--~~~~~l~--~~~~~~i~~~i~~-------------------~l~yLH  239 (290)
                      |+++.++..-                 ++..  ...+...  |.+..++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9997665321                 1111  1112222  4444445443321                   223332


Q ss_pred             ----h-CCCCCceecCCCCCCEEEcCC----CCeEEeeccCceee
Q 022887          240 ----Q-YSRLRIIHRDLKASNILLDSD----MNPKISDFGMARIF  275 (290)
Q Consensus       240 ----~-~~~~~iiH~dlk~~Nill~~~----~~~kl~DfGla~~~  275 (290)
                          . ..+..++|+|+.+.||+++.+    +.+.++||..|..-
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence                2 123458999999999999876    78999999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.08  E-value=0.0071  Score=51.76  Aligned_cols=35  Identities=20%  Similarity=0.332  Sum_probs=30.1

Q ss_pred             CCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       243 ~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      +..++|+|+.+.||++++++.+.|.||+.+..-+.
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~  239 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPK  239 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEECT
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCH
Confidence            34699999999999999888899999998876543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.02  E-value=0.059  Score=47.56  Aligned_cols=141  Identities=16%  Similarity=0.181  Sum_probs=82.7

Q ss_pred             ceecccCCccEEEEEEcC--------CcEEEEEEeccccccCHHHHHHHHHHHcccCCCCc-ceeEEEEEeCCeeEEEEE
Q 022887          129 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-VRLFGCCIEQGENILIYE  199 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  199 (290)
                      +.+..|-...+|+....+        +..+++|+..... ...-+-.+|..++..+.-.++ .++++.+  .  .++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence            466667788899988753        5778888764322 222234577777777743333 4555533  2  378999


Q ss_pred             ecCCCChhhh-----------------hhC--------CC--CCCCCCHHHHHHHHHHH-------------------HH
Q 022887          200 YMPNKSLDVF-----------------LFY--------PK--KKRLLGWQARVRIIEGI-------------------AQ  233 (290)
Q Consensus       200 ~~~~g~L~~~-----------------l~~--------~~--~~~~l~~~~~~~i~~~i-------------------~~  233 (290)
                      |+++..+..-                 ++.        ..  ...+.-|.+..++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            9998664210                 010        00  11122244433333222                   12


Q ss_pred             HHHHHh---------------------hCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          234 GLLYLH---------------------QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       234 ~l~yLH---------------------~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      .+.+|.                     ...+..++|+|+.+.||+ ++++.+.++||..|..-
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            233332                     112345899999999999 88889999999999754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.74  E-value=0.17  Score=40.05  Aligned_cols=91  Identities=9%  Similarity=0.016  Sum_probs=64.3

Q ss_pred             cCCCCcceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCC
Q 022887          176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN  255 (290)
Q Consensus       176 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~N  255 (290)
                      ..||+++.. .+-.+.+...+.|+.-  .+...|-    .-+.++...+++++.+++....+++.     =+|--+.|+|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcC--cccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            368888866 4555555555544443  3333322    12447789999999999988766653     4678899999


Q ss_pred             EEEcCCCCeEEeeccCceeeCCC
Q 022887          256 ILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       256 ill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++++.++.+++.-.|+-..+.+.
T Consensus       110 L~f~~~~~p~i~~RGik~~l~P~  132 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVDPL  132 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBSCC
T ss_pred             EEEcCCCCEEEEEccCccCCCCC
Confidence            99999999999999987666554

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=93.73  E-value=0.24  Score=39.24  Aligned_cols=90  Identities=10%  Similarity=0.067  Sum_probs=62.2

Q ss_pred             CCCCcceeEEEEEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCceecCCCCCC
Q 022887          177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL-YLHQYSRLRIIHRDLKASN  255 (290)
Q Consensus       177 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-yLH~~~~~~iiH~dlk~~N  255 (290)
                      .||.+  --.+-.+.+...+.|+.-+++.-...+      +.++...+++++.+++.... +++.     -+|--+.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            67887  233335555655555554333211122      34778999999999888776 5543     5778889999


Q ss_pred             EEEcCCCCeEEeeccCceeeCCCc
Q 022887          256 ILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       256 ill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      ++++.++.+++.-.|+-..+.+.+
T Consensus       115 L~f~~~~~p~i~hRGi~~~lpP~e  138 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESLPPDE  138 (219)
T ss_dssp             EEECTTCCEEESCCEETTTBSSCS
T ss_pred             EEEeCCCcEEEEEcCCcccCCCCC
Confidence            999999999999999877665544

>2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M*

Probab=93.36  E-value=0.092  Score=34.53  Aligned_cols=33  Identities=24%  Similarity=0.536  Sum_probs=27.0

Q ss_pred             CChhhHHHHHhhccCeeeEeeccccCCCcceeEeec
Q 022887            1 MNLNQCQAKCLKNCSCRAYANSKLTGGGSGCLMWFG   36 (290)
Q Consensus         1 ~~~~~C~~~c~~~c~C~a~~~~~~~~g~~~c~~~~~   36 (290)
                      .++++|++.|+.+-.|.+|.|..   ....|+++.+
T Consensus        30 ~sl~~Cq~aC~a~~~C~aFTyN~---~s~~CflKs~   62 (82)
T 2ll3_A           30 SSLSECRARCQAEKECSHYTYNV---KSGLCYPKRG   62 (82)
T ss_dssp             SSHHHHHHHHHHCTTEEEEEEET---TTTEEEEEES
T ss_pred             CCHHHHHHHhhccCCCCeEEecc---CCCceEcccC
Confidence            47899999999999999999863   3346998765

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.12  E-value=0.15  Score=29.05  Aligned_cols=7  Identities=57%  Similarity=0.866  Sum_probs=2.6

Q ss_pred             hhhhhhc
Q 022887           85 YIFRRRR   91 (290)
Q Consensus        85 ~~~~~~~   91 (290)
                      ++++|+|
T Consensus        32 ~~~~RRr   38 (44)
T 2ks1_B           32 GLFMRRR   38 (44)
T ss_dssp             HHHHHTT
T ss_pred             HHHhhhh
Confidence            3333333

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.03  E-value=0.18  Score=28.68  Aligned_cols=7  Identities=29%  Similarity=0.767  Sum_probs=2.6

Q ss_pred             hhhhhhc
Q 022887           85 YIFRRRR   91 (290)
Q Consensus        85 ~~~~~~~   91 (290)
                      ++++|+|
T Consensus        31 ~~~~RRR   37 (44)
T 2l2t_A           31 AVYVRRK   37 (44)
T ss_dssp             HHHHHTT
T ss_pred             HHHhhhh
Confidence            3333333

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.93  E-value=0.056  Score=48.29  Aligned_cols=60  Identities=10%  Similarity=0.104  Sum_probs=17.6

Q ss_pred             cceecccCCccEEEEEEcC-CcEEEE------EEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEe
Q 022887          128 QCKLGEGGFGPVYKGRLLN-GQEVAV------KRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE  190 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~-~~~vav------K~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  190 (290)
                      .+.+|   ||.||+|.+.. ..+|||      |......  .+....|.+|..++..++|||+++.+++-..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            35565   99999998854 468888      7665322  2234568888888888999999999887654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=84.09  E-value=0.55  Score=40.91  Aligned_cols=30  Identities=27%  Similarity=0.370  Sum_probs=25.6

Q ss_pred             ceecCCCCCCEEE------cCCCCeEEeeccCceee
Q 022887          246 IIHRDLKASNILL------DSDMNPKISDFGMARIF  275 (290)
Q Consensus       246 iiH~dlk~~Nill------~~~~~~kl~DfGla~~~  275 (290)
                      ++|+|+.+.|||+      +++..++++||-.|..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            5799999999999      45677999999998754

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=82.87  E-value=0.66  Score=26.35  Aligned_cols=9  Identities=44%  Similarity=0.656  Sum_probs=3.4

Q ss_pred             Hhhhhhhhc
Q 022887           83 SFYIFRRRR   91 (290)
Q Consensus        83 ~~~~~~~~~   91 (290)
                      .+++|.|||
T Consensus        30 ~~~~~~RRR   38 (44)
T 2jwa_A           30 VFGILIKRR   38 (44)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHhheehh
Confidence            333333333

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=80.91  E-value=0.062  Score=48.28  Aligned_cols=32  Identities=16%  Similarity=-0.058  Sum_probs=26.1

Q ss_pred             cCHHHHHHHHHHHcccCCCCcceeEEEEEeCC
Q 022887          161 QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG  192 (290)
Q Consensus       161 ~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  192 (290)
                      ....+|..|++.+++++|+|+|+++|||....
T Consensus       321 ~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          321 QGSETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             ----CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             ccHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            34678999999999999999999999998754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	290
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-46
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-45
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-44
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-44
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-43
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-43
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-41
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-41
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-41
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-40
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-40
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-39
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-39
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-39
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-38
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-38
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-38
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-34
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-33
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-33
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-29
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-28
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-27
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-48
 Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 6/168 (3%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
              +   ++G G FG VYKG+      V +  ++  + Q L  FKNE+ ++ K +H +++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
              G      +  ++ ++    SL   L   + K        + I    AQG+ YLH   
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA-- 122

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              IIHRDLK++NI L  D+  KI DFG+A +          +++ G+
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 4e-48
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 11/172 (6%)

Query: 121 ATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGL-TEFKNEMMLIAKLQH 178
             ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            ++V  +G     GE  +  E+M   SLD  L   KK   +  Q   ++   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
               + +I+HRD+K SNIL++S    K+ DFG++               VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGT 166

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-46
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 6/164 (3%)

Query: 122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRH 180
            + +    +LG+G FG VYK +        A K +  +S + L ++  E+ ++A   H +
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V+L      +    ++ E+    ++D  +   + +R L       + +     L YLH 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
               +IIHRDLKA NIL   D + K++DFG++        + ++
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 6e-46
 Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 16/173 (9%)

Query: 122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---NQSGQGLTEFKNEMMLIAKLQ 177
            + FS   ++G G FG VY  R + N + VA+K++S    QS +   +   E+  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H + ++  GC + +    L+ EY    + D+       K+ L       +  G  QGL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           LH      +IHRD+KA NILL      K+ DFG A I             VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGT 174

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-45
 Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 6/162 (3%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E      +LG G FG V+ G      +VAVK L  Q       F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           RL+    +     +I EYM N SL  FL  P   +L      + +   IA+G+ ++ +  
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
               IHRDL+A+NIL+   ++ KI+DFG+AR+   +E     
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 6e-45
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 7/168 (4%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
              +   ++G G FG V+ G  LN  +VA+K +  +      +F  E  ++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L+G C+EQ    L++E+M +  L    +   ++ L   +  + +   + +G+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              +IHRDL A N L+  +   K+SDFGM R    D+   ++      
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (381), Expect = 1e-44
 Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 6/163 (3%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
            + + + KLG G +G VY+G        VAVK L   + + + EF  E  ++ +++H +L
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V+L G C  +    +I E+M   +L  +L    ++  +     + +   I+  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
            +   IHRDL A N L+  +   K++DFG++R+  GD    + 
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-44
 Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 8/170 (4%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHR 179
           E++     +G G +G   K R   +G+ +  K L   + +        +E+ L+ +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 180 HLVRLFGCCIEQGENIL--IYEYMPNKSLDVFLF-YPKKKRLLGWQARVRIIEGIAQGLL 236
           ++VR +   I++    L  + EY     L   +    K+++ L  +  +R++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 237 YLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
             H+ S     ++HRDLK +N+ LD   N K+ DFG+ARI   D      
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  150 bits (380), Expect = 2e-44
 Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 19/191 (9%)

Query: 113 FSLASVSAATENFSTQC---------KLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQ 158
           F+    + A   F+ +           +G G FG V  G L         VA+K L S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 159 SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL 218
           + +   +F +E  ++ +  H +++ L G   +    ++I E+M N SLD FL     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 219 LGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
                 V ++ GIA G+ YL        +HRDL A NIL++S++  K+SDFG++R    D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 279 ELQGNTKRIVG 289
                    +G
Sbjct: 182 TSDPTYTSALG 192

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 4e-44
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 8/170 (4%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHRH 180
           E++     LGEG +G V         + VAVK +  +      E  K E+ +   L H +
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V+ +G   E     L  EY     L   +   +    +      R    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              + I HRD+K  N+LLD   N KISDFG+A +F  +  +    ++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 7e-44
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 7/168 (4%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           ++ +   +LG G FG V  G+     +VA+K +   S     EF  E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L+G C +Q    +I EYM N  L  +L   + +     Q  + + + + + + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES-- 118

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
             + +HRDL A N L++     K+SDFG++R    DE   +       
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-43
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 6/162 (3%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           E+   + KLG+G FG V+ G       VA+K L   +      F  E  ++ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
           +L+     +    ++ EYM   SL       +  + L     V +   IA G+ Y+ +  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 132

Query: 243 RLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
               +HRDL+A+NIL+  ++  K++DFG+AR+   +E     
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 5e-43
 Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 8/163 (4%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +       +G+G FG V  G    G +VAVK + N +      F  E  ++ +L+H +LV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 183 RLFGCCIEQGENI-LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           +L G  +E+   + ++ EYM   SL  +L   + + +LG    ++    + + + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 242 SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
                +HRDL A N+L+  D   K+SDFG+ +     +  G  
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 5e-43
 Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 17/172 (9%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCI 189
            +G+G FG V++G+   G+EVAVK  S++  +     + E+     L+H +++       
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67

Query: 190 EQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ----- 240
           +         L+ +Y  + SL  +L     +  +  +  +++    A GL +LH      
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF--GGDELQGNTKRIVGT 290
             +  I HRDLK+ NIL+  +    I+D G+A       D +       VGT
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-41
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 12/176 (6%)

Query: 121 ATENFS-TQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLTE-FKNEMMLIAK 175
             +N      +LG G FG V +G         +VA+K L   + +  TE    E  ++ +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L + ++VRL G C +    +L+ E      L  FL    K+  +       ++  ++ G+
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGM 122

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR-IVGT 290
            YL +      +HRDL A N+LL +    KISDFG+++  G D+     +      
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (357), Expect = 5e-41
 Identities = 47/196 (23%), Positives = 77/196 (39%), Gaps = 31/196 (15%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-TEFKNEMMLIAK 175
            N      +GEG FG V++ R            VAVK L  ++   +  +F+ E  L+A+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLF---------------------YPK 214
             + ++V+L G C       L++EYM    L+ FL                         
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 215 KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
               L    ++ I   +A G+ YL +    + +HRDL   N L+  +M  KI+DFG++R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 275 FGGDELQGNTKRIVGT 290
               +           
Sbjct: 190 IYSADYYKADGNDAIP 205

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 8e-41
 Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 14/172 (8%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLTEFKNEMMLIAKLQH 178
           E+F     LG+G FG VY  R   +   +A+K L     +      + + E+ + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
            +++RL+G   +     LI EY P  ++   L   +K      Q     I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           H     R+IHRD+K  N+LL S    KI+DFG +              + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 9e-41
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 16/169 (9%)

Query: 130 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFG 186
           ++G G F  VYKG       EVA   L ++  +      FK E  ++  LQH ++VR + 
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 187 CCIEQGEN----ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
                 +     +L+ E M + +L  +L   K+ +++  +        I +GL +LH  +
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 243 RLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGDELQGNTKRIVGT 290
              IIHRDLK  NI +     + KI D G+A +          K ++GT
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 176

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 1e-40
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 10/178 (5%)

Query: 114 SLASVSAATENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMML 172
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q         NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 173 IAKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIA 232
           + + ++ ++V      +   E  ++ EY+   SL   +     +  +       +     
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECL 126

Query: 233 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG       +  Q     +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-40
 Identities = 48/191 (25%), Positives = 68/191 (35%), Gaps = 26/191 (13%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LTEFKNEMMLIAK 175
              S    LG G FG V +              VAVK L   +         +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 176 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL---------------L 219
           L  H ++V L G C   G  ++I EY     L  FL   +   +               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 220 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +  +     +A+G+ +L        IHRDL A NILL      KI DFG+AR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 280 LQGNTKRIVGT 290
                      
Sbjct: 200 NYVVKGNARLP 210

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-40
 Identities = 47/196 (23%), Positives = 73/196 (37%), Gaps = 31/196 (15%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LTEFKNEMMLIAK 175
           EN      LG G FG V               +VAVK L  ++         +E+ ++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 176 L-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKK------------------ 216
           L  H ++V L G C   G   LI+EY     L  +L   ++K                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 217 --RLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 274
              +L ++  +     +A+G+ +L        +HRDL A N+L+      KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 275 FGGDELQGNTKRIVGT 290
              D            
Sbjct: 214 IMSDSNYVVRGNARLP 229

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-39
 Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 12/174 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-NQSGQGLTEFKNEMMLIAKL 176
             F     LG G FG VYKG  +   E     VA+K L    S +   E  +E  ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
            + H+ RL G C+      LI + MP   L    +  + K  +G Q  +     IA+G+ 
Sbjct: 69  DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           YL      R++HRDL A N+L+ +  + KI+DFG+A++ G +E + + +     
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-39
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 13/167 (7%)

Query: 130 KLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQG--LTEFKNEMMLIAKLQHRHLVRL 184
           +LG G FG V KG        + VAVK L N++       E   E  ++ +L + ++VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 185 FGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
            G C E    +L+ E      L+ +L    + R +  +  + ++  ++ G+ YL +    
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE---S 126

Query: 245 RIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTK-RIVGT 290
             +HRDL A N+LL +    KISDFG+++    DE     +      
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  138 bits (349), Expect = 2e-39
 Identities = 36/170 (21%), Positives = 67/170 (39%), Gaps = 8/170 (4%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           +++    +LG G FG V++      G   A K +           + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           V L     +  E ++IYE+M    L   +    +   +     V  +  + +GL ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMH-- 141

Query: 242 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARIFGGDELQGNTKRIVG 289
                +H DLK  NI+  +  +   K+ DFG+       +    T     
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-39
 Identities = 47/171 (27%), Positives = 70/171 (40%), Gaps = 10/171 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
              V+L+    +  +      Y  N  L    +  K         R       A+ +  L
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTR----FYTAEIVSAL 121

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVG 289
                  IIHRDLK  NILL+ DM+ +I+DFG A++   +  Q      VG
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 1e-38
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 11/163 (6%)

Query: 130 KLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQG-LTEFKNEMMLIAKLQHRHLVRL 184
            +G G FG VY G LL+        AVK L+  +  G +++F  E +++    H +++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 185 FGCCIE-QGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
            G C+  +G  +++  YM +  L    F   +      +  +     +A+G+      + 
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR 286
            + +HRDL A N +LD     K++DFG+AR     E      +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  136 bits (344), Expect = 2e-38
 Identities = 44/166 (26%), Positives = 68/166 (40%), Gaps = 13/166 (7%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNE---MMLIAK 175
            +FS    +G GGFG VY  R    G+  A+K L  +     QG T   NE   + L++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
                +V +        +   I + M    L   L    +  +            I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
            ++H      +++RDLK +NILLD   + +ISD G+A  F   +  
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  136 bits (343), Expect = 2e-38
 Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 8/161 (4%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           + +    +LG G FG V++      G+    K ++          KNE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           + L     ++ E +LI E++    L  F     +   +     +  +    +GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 242 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARIFGGDEL 280
               I+H D+K  NI+ ++      KI DFG+A     DE+
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 3e-38
 Identities = 48/175 (27%), Positives = 73/175 (41%), Gaps = 13/175 (7%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAK 175
           ++     KLG+G FG V +G           VAVK L        + + +F  E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
           L HR+L+RL+G  +      ++ E  P  SL       K +         R    +A+G+
Sbjct: 68  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            YL      R IHRDL A N+LL +    KI DFG+ R    ++     +     
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 5e-38
 Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 24/186 (12%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNG---QEVAVKRLS-NQSGQGLTEFKNEMMLIAKL-Q 177
            +   Q  +GEG FG V K R+       + A+KR+    S     +F  E+ ++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFL-------------FYPKKKRLLGWQAR 224
           H +++ L G C  +G   L  EY P+ +L  FL                     L  Q  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 225 VRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           +     +A+G+ YL Q    + IHRDL A NIL+  +   KI+DFG++R           
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183

Query: 285 KRIVGT 290
                 
Sbjct: 184 TMGRLP 189

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-37
 Identities = 46/182 (25%), Positives = 75/182 (41%), Gaps = 17/182 (9%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLTEFKNEMMLIAK 175
           E  +   +LG+G FG VY+G             VA+K ++   S +   EF NE  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 176 LQHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------LGWQARVRII 228
               H+VRL G   +    ++I E M    L  +L   +                 +++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 229 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIV 288
             IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 289 GT 290
             
Sbjct: 197 LP 198

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 8e-37
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 11/168 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSGQG-LTEFKNEMMLIAKL 176
              + Q  +G G FG VYKG L          VA+K L     +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 177 QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
            H +++RL G   +    ++I EYM N +  +  F  +K         V ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 237 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
           YL     +  +HRDL A NIL++S++  K+SDFG++R+   D     T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  129 bits (326), Expect = 3e-36
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 10/160 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
           ++F     LG G FG V+  R   NG+  A+K L  +     + +    +E ++++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
             ++R++G   +  +  +I +Y+    L  F    K +R     A+       A+  L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYA----AEVCLAL 117

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
                  II+RDLK  NILLD + + KI+DFG A+     
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 3e-36
 Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 12/173 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQ 177
           E       +GEG FG V++G  ++       VA+K   N +   + E F  E + + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H H+V+L G   E     +I E      L    F   +K  L   + +     ++  L Y
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           L      R +HRD+ A N+L+ S+   K+ DFG++R            +    
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLP 172

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 4e-36
 Identities = 39/165 (23%), Positives = 73/165 (44%), Gaps = 5/165 (3%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
              ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           +++ +           +   Y+    +   L+   K + L        +  I +GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
                 ++HRDLK SN+LL++  + KI DFG+AR+   D      
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-36
 Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 15/169 (8%)

Query: 124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +++    +G G FG VY+ +L  +G+ VA+K++             E+ ++ KL H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76

Query: 183 RLFGCCIEQGEN------ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLL 236
           RL       GE        L+ +Y+P     V   Y + K+ L        +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 237 YLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIFGGDELQGNT 284
           Y+H      I HRD+K  N+LLD D    K+ DFG A+     E   + 
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-35
 Identities = 45/190 (23%), Positives = 68/190 (35%), Gaps = 25/190 (13%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLTE--FKNEMMLIA 174
           +       LG G FG V +            + VAVK L   +             +LI 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 175 KLQHRHLVRLFGCCIEQGENILI-YEYMPNKSLDVFLFYPKK-------------KRLLG 220
              H ++V L G C + G  +++  E+    +L  +L   +              K  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 221 WQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL 280
            +  +     +A+G+ +L      + IHRDL A NILL      KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 281 QGNTKRIVGT 290
                     
Sbjct: 190 YVRKGDARLP 199

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  126 bits (317), Expect = 3e-35
 Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 20/179 (11%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE---------FKNEMML 172
           EN+  +  LG G    V +       +E AVK +    G   +             E+ +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 173 IAKLQ-HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           + K+  H ++++L           L+++ M    L  +L    +K  L  +   +I+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
            + +  LH   +L I+HRDLK  NILLD DMN K++DFG +      E     + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 172

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  123 bits (308), Expect = 5e-34
 Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 8/164 (4%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHRH 180
           E +    K+GEG +G VYK +   G+  A+K  RL  +     +    E+ ++ +L+H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +V+L+     +   +L++E++      +       +  L        +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 241 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNT 284
               R++HRDLK  N+L++ +   KI+DFG+AR FG    +   
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (311), Expect = 5e-34
 Identities = 33/160 (20%), Positives = 66/160 (41%), Gaps = 9/160 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL 181
           E +     LG G FG V++     + +    K +  + G      K E+ ++   +HR++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63

Query: 182 VRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY 241
           + L        E ++I+E++    +   +        L  +  V  +  + + L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 242 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARIFGGDE 279
               I H D++  NI+  +  +   KI +FG AR     +
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 7e-34
 Identities = 50/191 (26%), Positives = 82/191 (42%), Gaps = 26/191 (13%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLTEFKNEMMLI 173
           +       LGEG FG V     +           +VAVK L S+ + + L++  +EM ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 174 AKL-QHRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRL-------------L 219
             + +H++++ L G C + G   +I EY    +L  +L   +   L             L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 220 GWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
             +  V     +A+G+ YL      + IHRDL A N+L+  D   KI+DFG+AR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 280 LQGNTKRIVGT 290
               T      
Sbjct: 190 YYKKTTNGRLP 200

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-33
 Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 12/155 (7%)

Query: 130 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLTE-----FKNEMMLIAKLQHRHLVR 183
            LGEG F  VYK R  N  Q VA+K++         +        E+ L+ +L H +++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 184 LFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSR 243
           L      +    L++++M                +L        +    QGL YLHQ+  
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119

Query: 244 LRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
             I+HRDLK +N+LLD +   K++DFG+A+ FG  
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 2e-33
 Identities = 45/173 (26%), Positives = 68/173 (39%), Gaps = 13/173 (7%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKN----EMMLIAKLQ 177
           E+F     LG+G FG V+        Q  A+K L         + +     + +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 178 HRHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLY 237
           H  L  +F     +     + EY+    L   +   +                I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118

Query: 238 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           LH      I++RDLK  NILLD D + KI+DFGM +     + + NT    GT
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (301), Expect = 1e-32
 Identities = 35/171 (20%), Positives = 68/171 (39%), Gaps = 8/171 (4%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTE-FKNEMMLIAKLQHR 179
            + +  +  LG G F  V         + VA+K ++ ++ +G     +NE+ ++ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++V L       G   LI + +    L   +    +K     +   R+I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
               +    +        LD D    ISDFG++++     +        GT
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 2e-32
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 8/160 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           ENF    K+GEG +G VYK R  L G+ VA+K  RL  ++    +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++V+L      + +  L++E++                 +        +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
            +   R++HRDLK  N+L++++   K++DFG+AR FG   
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-31
 Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 19/181 (10%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHR 179
             +    K+G+G FG V+K R    GQ+VA+K++   N+          E+ ++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 180 HLVRLFGCCIEQ--------GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGI 231
           ++V L   C  +        G   L++++  +    +      K          R+++ +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126

Query: 232 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKR--IVG 289
             GL Y+H+    +I+HRD+KA+N+L+  D   K++DFG+AR F   +     +    V 
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 290 T 290
           T
Sbjct: 184 T 184

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  115 bits (289), Expect = 3e-31
 Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 15/178 (8%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LTEFKNEMMLIAKLQ 177
           ++ +     LG GG   V+  R L   ++VAVK L     +       F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 178 HRHLVRLFGCCIEQGENI----LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           H  +V ++     +        ++ EY+   +L   +        +  +  + +I    Q
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG-GDELQGNTKRIVGT 290
            L + H   +  IIHRD+K +NI++ +    K+ DFG+AR           T  ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 8e-31
 Identities = 40/172 (23%), Positives = 66/172 (38%), Gaps = 12/172 (6%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQH 178
            +F     LG+G FG V   R    G+  A+K L  +   +   +     E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 179 RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
             L  L            + EY     L   L     +  +  + R R     A+ +  L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEIVSAL 118

Query: 239 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
                  +++RD+K  N++LD D + KI+DFG+ +    D      K   GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 168

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-30
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 9/160 (5%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLTEFKNEMMLIAKLQHR 179
           + +    K+GEG +G V+K +     + VA+K  RL +      +    E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 180 HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH 239
           ++VRL        +  L++E+        F          G      +   + Q L  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115

Query: 240 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE 279
                 ++HRDLK  N+L++ +   K+++FG+AR FG   
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 3e-30
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 16/180 (8%)

Query: 121 ATENFSTQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQSGQGLTEFK-----NEMMLI 173
           A + +    ++GEG +G V+K R L   G+ VA+KR+  Q+G+             +  +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 174 AKLQHRHLVRLFGCCIEQGENILIYEYMPNKSLD---VFLFYPKKKRLLGWQARVRIIEG 230
              +H ++VRLF  C     +      +  + +D           +  +  +    ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 231 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           + +GL +LH     R++HRDLK  NIL+ S    K++DFG+ARI+     Q     +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  111 bits (278), Expect = 4e-29
 Identities = 45/194 (23%), Positives = 77/194 (39%), Gaps = 11/194 (5%)

Query: 90  RRRKHKEKDGEGNDKSKDSWLPLFSLASVSAAT-ENFSTQCKLGEGGFGPVYKGR-LLNG 147
           ++   +E   E   K+K+ +L  +   S + A  + F     LG G FG V   +   +G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 148 QEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPNK 204
              A+K L  Q     + +    NE  ++  +    LV+L     +     ++ EY+   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 205 SLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 264
            +   L    +               I     YLH    L +I+RDLK  N+L+D     
Sbjct: 127 EMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYI 180

Query: 265 KISDFGMARIFGGD 278
           +++DFG A+   G 
Sbjct: 181 QVTDFGFAKRVKGR 194

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  110 bits (275), Expect = 4e-29
 Identities = 33/180 (18%), Positives = 72/180 (40%), Gaps = 20/180 (11%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHR-H 180
            ++    ++GEG FG +++G  LLN Q+VA+K    +S     + ++E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           +  ++    E   N+L+ + +      +        R    +      + +   +  +H+
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 241 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARIFGGDELQGN-----TKRIVGT 290
                +++RD+K  N L+    +       + DFGM + +     + +      K + GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 1e-28
 Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 20/172 (11%)

Query: 130 KLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLTEFKNEMMLIAKLQHRHLV 182
           +LG G F  V K R    G + A K +      S++ G    + + E+ ++ ++QH +++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 183 RLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS 242
            L      + + ILI E +    L     +  +K  L  +     ++ I  G   ++   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG---VYYLH 130

Query: 243 RLRIIHRDLKASNILLDSDMNP----KISDFGMARIFGGDELQGNTKRIVGT 290
            L+I H DLK  NI+L     P    KI DFG+A            K I GT
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 5e-28
 Identities = 37/171 (21%), Positives = 63/171 (36%), Gaps = 19/171 (11%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG------LTEFKNEMMLIAKLQHRH-- 180
            LG GGFG VY G  + +   VA+K +              T    E++L+ K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 181 LVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ 240
           ++RL          +LI E            +  ++  L  +        + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDL--FDFITERGALQEELARSFFWQVLEAVRHCHN 128

Query: 241 YSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIFGGDELQGNTKRIVGT 290
                ++HRD+K  NIL+D +    K+ DFG   +              GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGT 172

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 9e-28
 Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 17/165 (10%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLTEFKNEMMLIAKLQHR 179
             +     +G G +G V        G +VA+K+L    QS         E+ L+  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 180 HLVRLFGCCIEQG------ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           +++ L              +  L+  +M      +      K   LG      ++  + +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD 278
           GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR    +
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (266), Expect = 1e-27
 Identities = 36/170 (21%), Positives = 67/170 (39%), Gaps = 16/170 (9%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCC 188
           K+G G FG +Y G  +  G+EVA+K    ++     +   E  +   +Q    +     C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 189 IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH 248
             +G+  ++   +   SL+    +    R    +  + + + +   + Y+H       IH
Sbjct: 72  GAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126

Query: 249 RDLKASNIL---LDSDMNPKISDFGMARIFGGDELQGN-----TKRIVGT 290
           RD+K  N L           I DFG+A+ +       +      K + GT
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 1e-27
 Identities = 34/158 (21%), Positives = 63/158 (39%), Gaps = 18/158 (11%)

Query: 131 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCC 188
           LG G  G V +       ++ A+K L +       + + E+ L  +  Q  H+VR+    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVY 74

Query: 189 IEQGEN----ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRL 244
                     +++ E +    L   +   +  +    +    I++ I + + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130

Query: 245 RIIHRDLKASNILLDSDMNP---KISDFGMARIFGGDE 279
            I HRD+K  N+L  S       K++DFG A+      
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 4e-27
 Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 15/168 (8%)

Query: 123 ENFSTQCKLGEGGFGPVYKGRLL----NGQEVAVKRLS----NQSGQGLTEFKNEMMLIA 174
           ENF     LG G +G V+  R +     G+  A+K L      Q  +     + E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 175 KLQHR-HLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
            ++    LV L      + +  LI +Y+    L   L   +++R    + ++ +     +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYV----GE 137

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQ 281
            +L L    +L II+RD+K  NILLDS+ +  ++DFG+++ F  DE +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  104 bits (260), Expect = 1e-26
 Identities = 34/173 (19%), Positives = 75/173 (43%), Gaps = 20/173 (11%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRH 180
           +++    KLG G +  V++   + N ++V VK L     +   + K E+ ++  L+   +
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 181 LVRLFGCCIEQGEN--ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYL 238
           ++ L     +       L++E++ N            + L  +  R   +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALDYC 145

Query: 239 HQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIFGGDELQGNTKRIVGT 290
           H    + I+HRD+K  N+++D +    ++ D+G+A  +   +        V +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVAS 192

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 98.3 bits (244), Expect = 1e-25
 Identities = 28/158 (17%), Positives = 56/158 (35%), Gaps = 28/158 (17%)

Query: 130 KLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQ--------GLTEFKNEMMLIAKLQHR 179
            +GEG    V+        E  VK  ++ + S +        G   F    +  A+ + R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 180 HLVRLFGCCI----EQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGL 235
            L +L G  +        N ++ E +            K+   +  +    +++ I + +
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMELI----------DAKELYRVRVENPDEVLDMILEEV 116

Query: 236 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 273
              +      I+H DL   N+L+  +    I DF  + 
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (248), Expect = 6e-25
 Identities = 44/177 (24%), Positives = 72/177 (40%), Gaps = 21/177 (11%)

Query: 123 ENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQHR 179
           + +     +G G  G V      +  + VA+K+LS   Q+         E++L+  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 180 HLVRLFGCCIEQG------ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
           +++ L      Q       +  L+ E M      V             +    ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT 290
           G+ +LH      IIHRDLK SNI++ SD   KI DFG+AR  G   +       V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVT 181

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.7 bits (242), Expect = 4e-24
 Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 15/163 (9%)

Query: 122 TENFSTQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLTEFKNEMMLIAKLQH 178
            E +     +G G +G V        G  VAVK+LS   QS         E+ L+  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 179 RHLVRLFGCC-----IEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQ 233
            +++ L         +E+  ++ +  ++    L+       K + L       +I  I +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILR 132

Query: 234 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG 276
           GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR   
Sbjct: 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 85.1 bits (209), Expect = 2e-19
 Identities = 35/175 (20%), Positives = 68/175 (38%), Gaps = 18/175 (10%)

Query: 130 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH---------- 178
           KLG G F  V+  + ++N   VA+K +           ++E+ L+ ++            
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 179 -RHLVRLFGCCIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGW--QARVRIIEGIAQGL 235
             H+++L      +G N +    +     +  L   KK    G       +I + +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 236 LYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIFGGDELQGNTKRIVG 289
            Y+H+  R  IIH D+K  N+L++  D    +    +A +        +    + 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	290
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.98
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.97
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.97
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.97
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.96
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.96
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.87
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.44
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.84
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.38
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.97
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.71
d1dmca_	31	Metallothionein {Crab (Callinectes sapidus), alpha	81.81

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-38  Score=264.91  Aligned_cols=163  Identities=29%  Similarity=0.412  Sum_probs=140.1

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||+||+|.. .+++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            35799999999999999999987 458999999986543 2345679999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      |+++|+|.+++.   ....+++.+...++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999883   3456999999999999999999999988   9999999999999999999999999999886654


Q ss_pred             cccCcceeecC
Q 022887          280 LQGNTKRIVGT  290 (290)
Q Consensus       280 ~~~~~~~~~Gt  290 (290)
                      ........+||
T Consensus       158 ~~~~~~~~~GT  168 (271)
T d1nvra_         158 RERLLNKMCGT  168 (271)
T ss_dssp             EECCBCCCCSC
T ss_pred             ccccccceeeC
Confidence            44444455676

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-38  Score=266.55  Aligned_cols=158  Identities=28%  Similarity=0.475  Sum_probs=140.2

Q ss_pred             HHHHhcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          118 VSAATENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       118 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++...++|+..+.||+|+||.||+|.+. +++.||||+++.. ....++|.+|+.++++++|||||++++++.+.+..++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3344578899999999999999999885 4889999998753 3456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|+|..++... ....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence            99999999999988543 3456899999999999999999999987   9999999999999999999999999999886


Q ss_pred             CCcc
Q 022887          277 GDEL  280 (290)
Q Consensus       277 ~~~~  280 (290)
                      .+..
T Consensus       167 ~~~~  170 (287)
T d1opja_         167 GDTY  170 (287)
T ss_dssp             SSSS
T ss_pred             CCCc
Confidence            6543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-37  Score=260.10  Aligned_cols=151  Identities=25%  Similarity=0.403  Sum_probs=137.7

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|+..+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            35799999999999999999987 56899999999766556677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      +++|+|..++..    ..+++.+...++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus        99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            999999987732    45899999999999999999999988   9999999999999999999999999999886543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-37  Score=260.09  Aligned_cols=151  Identities=32%  Similarity=0.556  Sum_probs=131.2

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      ++|+..+.||+|+||.||+|.+.+++.||||++... ....++|.+|+.++.+++|||||+++|+|...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            578889999999999999999988889999999753 4456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      +|+|.+++..  ....++|..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+|+.+....
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence            9999998754  3456899999999999999999999987   9999999999999999999999999999876543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-37  Score=261.47  Aligned_cols=152  Identities=36%  Similarity=0.542  Sum_probs=135.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|+||.||+|.+.+++.||||+++.. ....++|.+|+.++.+++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            4688889999999999999999988889999999753 3456789999999999999999999998754 5679999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      ++|+|.+++... ....++|..++.|+.|+++||.|||+++   |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence            999999876432 2335899999999999999999999987   9999999999999999999999999999886654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-37  Score=258.13  Aligned_cols=161  Identities=32%  Similarity=0.482  Sum_probs=131.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||.||+|++.  ..||||+++..  .....+.|.+|+.++.+++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            468999999999999999999864  36999998643  23446789999999999999999999998754 56899999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      |+++|+|.+++...  ...+++..+..++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999988542  345899999999999999999999987   9999999999999999999999999999886544


Q ss_pred             cccCcceeecC
Q 022887          280 LQGNTKRIVGT  290 (290)
Q Consensus       280 ~~~~~~~~~Gt  290 (290)
                      .........||
T Consensus       159 ~~~~~~~~~gt  169 (276)
T d1uwha_         159 GSHQFEQLSGS  169 (276)
T ss_dssp             -------CCCC
T ss_pred             CcccccccccC
Confidence            33333344454

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-37  Score=261.05  Aligned_cols=151  Identities=32%  Similarity=0.522  Sum_probs=124.1

Q ss_pred             CCCccceecccCCccEEEEEEcC-C---cEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      +|+..+.||+|+||+||+|.+.. +   ..||||.+.... ....++|.+|+.++++++|||||+++|++.+.+..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            45567899999999999998743 2   258999886543 334568999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|+|..++..  ....++|.+++.++.|+++||.|||+++   |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus       107 Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         107 EFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             ECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999998753  3456899999999999999999999987   999999999999999999999999999988654


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       182 ~  182 (299)
T d1jpaa_         182 T  182 (299)
T ss_dssp             -
T ss_pred             C
Confidence            3

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-37  Score=260.14  Aligned_cols=150  Identities=27%  Similarity=0.422  Sum_probs=136.7

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      +.|+..+.||+|+||.||+|+. .+++.||||.+........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            5689999999999999999987 458899999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ++|+|..++..  ....+++.+...++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+....
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            99999988643  2356999999999999999999999988   99999999999999999999999999987644

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-36  Score=250.84  Aligned_cols=152  Identities=30%  Similarity=0.483  Sum_probs=138.1

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecC
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMP  202 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  202 (290)
                      ++|+..+.||+|+||.||+|++.++++||||.++.. ....++|.+|+.++.+++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            689999999999999999999988889999999764 3456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCcc
Q 022887          203 NKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDEL  280 (290)
Q Consensus       203 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~  280 (290)
                      +|+|..++..  ....+++..+.+++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            9999988643  3456889999999999999999999987   99999999999999999999999999998765443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-37  Score=257.25  Aligned_cols=162  Identities=30%  Similarity=0.416  Sum_probs=137.3

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||+||+|.. .+++.||||.+...   .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999987 46889999998642   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|+|.+++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999888743   356899999999999999999999988   999999999999999999999999999998765


Q ss_pred             ccccCcceeecC
Q 022887          279 ELQGNTKRIVGT  290 (290)
Q Consensus       279 ~~~~~~~~~~Gt  290 (290)
                      .........+||
T Consensus       162 ~~~~~~~~~~GT  173 (288)
T d1uu3a_         162 SKQARANSFVGT  173 (288)
T ss_dssp             --------CCCC
T ss_pred             CcccccccccCC
Confidence            444334445565

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-36  Score=251.21  Aligned_cols=151  Identities=30%  Similarity=0.403  Sum_probs=135.7

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.+...   .......+.+|+.++.+++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57899999999999999999884 5889999998642   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|+|..++..   ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+....+
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999998843   346899999999999999999999988   999999999999999999999999999877654


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       160 ~  160 (263)
T d2j4za1         160 R  160 (263)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-36  Score=261.04  Aligned_cols=150  Identities=27%  Similarity=0.351  Sum_probs=134.7

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++++++|||||++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46899999999999999999987 468899999997543 2335678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |+++|+|.+++..   ...+++.....++.|++.||.|||++ +   |+||||||+|||+++++.+||+|||+|+.+..
T Consensus        85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            9999999998853   34589999999999999999999974 6   99999999999999999999999999997743

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-36  Score=252.93  Aligned_cols=152  Identities=32%  Similarity=0.526  Sum_probs=131.6

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      .++|+..+.||+|+||+||+|.+.+++.||||++... ....++|.+|+.++.+++|||||+++|++. .+..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            3689999999999999999999988889999999753 445678999999999999999999999985 45689999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      ++|+|..++... ....++|.+++.++.||+.||+|||+++   |+||||||+|||+++++++||+|||+|+.+..+.
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            999998887432 2345999999999999999999999988   9999999999999999999999999999876544

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.9e-35  Score=254.61  Aligned_cols=153  Identities=23%  Similarity=0.387  Sum_probs=136.9

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++.+++|||||++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            36899999999999999999987 46899999999765555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc--CCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~--~~~~~kl~DfGla~~~~~~  278 (290)
                      +++|+|.+++..  ....+++.....++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+|+.++..
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999988743  2346899999999999999999999988   99999999999996  4678999999999988665


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       180 ~  180 (350)
T d1koaa2         180 Q  180 (350)
T ss_dssp             S
T ss_pred             c
Confidence            4

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.4e-35  Score=253.68  Aligned_cols=152  Identities=25%  Similarity=0.370  Sum_probs=136.3

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEec
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYM  201 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  201 (290)
                      ++|+..+.||+|+||.||+|.. .+++.||||.+..........+.+|+.++.+++|||||++++++.+++..++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999987 468999999997655445567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc--CCCCeEEeeccCceeeCCCc
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~--~~~~~kl~DfGla~~~~~~~  279 (290)
                      ++|+|.+++..  ....+++.+...|+.||+.||.|||+.+   |+||||||+|||++  .++.+||+|||+|+.+..+.
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999876632  3446899999999999999999999988   99999999999998  67899999999999987654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-36  Score=251.52  Aligned_cols=158  Identities=27%  Similarity=0.450  Sum_probs=126.2

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC--CeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ--GENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  196 (290)
                      .++|+..+.||+|+||+||+|+. .+++.||||.+....  ......+.+|+.++.+++|||||++++++.+.  +..++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            36899999999999999999987 458899999987542  22346789999999999999999999998753  45789


Q ss_pred             EEEecCCCChhhhhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          197 IYEYMPNKSLDVFLFYP-KKKRLLGWQARVRIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      ||||+++|+|.+++... .....+++...+.++.|++.||.|||+++  ..+|+||||||+|||+++++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999987532 23456999999999999999999999864  2359999999999999999999999999999


Q ss_pred             eeCCCc
Q 022887          274 IFGGDE  279 (290)
Q Consensus       274 ~~~~~~  279 (290)
                      .+..+.
T Consensus       163 ~~~~~~  168 (269)
T d2java1         163 ILNHDT  168 (269)
T ss_dssp             HC----
T ss_pred             ecccCC
Confidence            886543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-35  Score=254.75  Aligned_cols=156  Identities=30%  Similarity=0.462  Sum_probs=132.1

Q ss_pred             hcCCCccceecccCCccEEEEEEcC-C-----cEEEEEEeccc-cccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSNQ-SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~-~-----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  193 (290)
                      .++|+..+.||+|+||+||+|++.. +     ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4688999999999999999998743 2     26999998643 334456899999999998 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCC
Q 022887          194 NILIYEYMPNKSLDVFLFYPKK--------------------KRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKA  253 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~  253 (290)
                      .++||||+++|+|.+++.....                    ...++|..++.++.|+++||+|||+++   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999865321                    245899999999999999999999987   99999999


Q ss_pred             CCEEEcCCCCeEEeeccCceeeCCCcc
Q 022887          254 SNILLDSDMNPKISDFGMARIFGGDEL  280 (290)
Q Consensus       254 ~Nill~~~~~~kl~DfGla~~~~~~~~  280 (290)
                      +|||++.++.+||+|||+|+.......
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~  219 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSN  219 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTT
T ss_pred             hccccccCCeEEEeeccccccccCCCc
Confidence            999999999999999999998765443

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-35  Score=252.48  Aligned_cols=149  Identities=33%  Similarity=0.512  Sum_probs=132.9

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      +.|+.++.||+|+||.||+|+. .+++.||||.+.....   .....+.+|+.++.+++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4589999999999999999987 4688999999875432   23457899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++|++..++..   ...+++.++..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+|+....
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            99999999876532   356899999999999999999999988   99999999999999999999999999987654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-35  Score=249.71  Aligned_cols=153  Identities=35%  Similarity=0.548  Sum_probs=128.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcCC-----cEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~-----~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      .+.|+..++||+|+||.||+|.+.+.     ..||||++..... ....+|.+|+.++.+++|||||+++|++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35788889999999999999987542     3699999965432 33457999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||+.++++..++..  ....++|.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence            99999999999887643  3356999999999999999999999987   999999999999999999999999999987


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      ..+.
T Consensus       161 ~~~~  164 (283)
T d1mqba_         161 EDDP  164 (283)
T ss_dssp             ----
T ss_pred             cCCC
Confidence            6543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-35  Score=247.53  Aligned_cols=151  Identities=30%  Similarity=0.506  Sum_probs=130.1

Q ss_pred             cCCCccc-eecccCCccEEEEEEc---CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~-~ig~G~fg~V~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++|...+ +||+|+||.||+|.+.   ++..||||.++.... ...++|.+|+.++.+++|||||+++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 4999999999999763   345799999975432 345789999999999999999999999865 568999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++|+|.+++..  ....+++.++..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+..
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999998743  3456899999999999999999999987   99999999999999999999999999998865


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      ..
T Consensus       162 ~~  163 (285)
T d1u59a_         162 DD  163 (285)
T ss_dssp             CS
T ss_pred             cc
Confidence            43

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.5e-36  Score=253.22  Aligned_cols=162  Identities=30%  Similarity=0.481  Sum_probs=139.2

Q ss_pred             hHHHHhcCCCccceecccCCccEEEEEEc------CCcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEE
Q 022887          117 SVSAATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCI  189 (290)
Q Consensus       117 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~  189 (290)
                      +++.+.++|+..+.||+|+||.||+|++.      +++.||||++..... ....+|.+|+.++++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34446688999999999999999999864      356899999975433 23567999999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcee
Q 022887          190 EQGENILIYEYMPNKSLDVFLFYPK---------------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIH  248 (290)
Q Consensus       190 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH  248 (290)
                      ..+..+++|||+++|+|.+++....                     ....+++..++.|+.|++.||+|||+++   ++|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence            9999999999999999999885321                     1234899999999999999999999988   999


Q ss_pred             cCCCCCCEEEcCCCCeEEeeccCceeeCCCccc
Q 022887          249 RDLKASNILLDSDMNPKISDFGMARIFGGDELQ  281 (290)
Q Consensus       249 ~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~  281 (290)
                      |||||+|||++.++.+||+|||+|+.+..+...
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~  196 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYY  196 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccc
Confidence            999999999999999999999999987655433

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-35  Score=252.35  Aligned_cols=161  Identities=26%  Similarity=0.319  Sum_probs=140.1

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      .++|+..+.||+|+||.||+|+. .+++.||||++.+.   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36799999999999999999987 56899999999743   234567889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++|+|..++..   ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999988743   456889999999999999999999988   99999999999999999999999999997754


Q ss_pred             CccccCcceeecC
Q 022887          278 DELQGNTKRIVGT  290 (290)
Q Consensus       278 ~~~~~~~~~~~Gt  290 (290)
                      ....  ....+||
T Consensus       158 ~~~~--~~~~~GT  168 (337)
T d1o6la_         158 DGAT--MKTFCGT  168 (337)
T ss_dssp             TTCC--BCCCEEC
T ss_pred             CCcc--cccceeC
Confidence            3322  2334565

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-35  Score=245.01  Aligned_cols=149  Identities=29%  Similarity=0.430  Sum_probs=127.2

Q ss_pred             CccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEe----CCeeEEEE
Q 022887          126 STQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIE----QGENILIY  198 (290)
Q Consensus       126 ~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  198 (290)
                      +..+.||+|+||+||+|.+. +++.||+|.+....  ......|.+|+.++++++|||||++++++..    .+..++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999874 57899999986532  2335678999999999999999999999875    34578999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc-CCCCeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~~~~  277 (290)
                      ||+++|+|.+++..   ...+++.+...++.|++.||+|||+++ .+|+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999998843   356899999999999999999999864 4599999999999996 578999999999987644


Q ss_pred             C
Q 022887          278 D  278 (290)
Q Consensus       278 ~  278 (290)
                      .
T Consensus       168 ~  168 (270)
T d1t4ha_         168 S  168 (270)
T ss_dssp             T
T ss_pred             C
Confidence            3

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.4e-35  Score=245.25  Aligned_cols=151  Identities=28%  Similarity=0.372  Sum_probs=135.1

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEecccccc---------CHHHHHHHHHHHcccC-CCCcceeEEEEEeC
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ---------GLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQ  191 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  191 (290)
                      ++|+..+.||+|+||+||+|+. .+++.||||++......         ....+.+|+.++.+++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999987 56889999998653221         1235889999999997 99999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccC
Q 022887          192 GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM  271 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl  271 (290)
                      +..++||||+++|+|.+++..   ...+++.+...++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999843   446899999999999999999999988   99999999999999999999999999


Q ss_pred             ceeeCCCc
Q 022887          272 ARIFGGDE  279 (290)
Q Consensus       272 a~~~~~~~  279 (290)
                      |+.++.+.
T Consensus       157 a~~~~~~~  164 (277)
T d1phka_         157 SCQLDPGE  164 (277)
T ss_dssp             CEECCTTC
T ss_pred             eeEccCCC
Confidence            99887653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-35  Score=249.56  Aligned_cols=152  Identities=25%  Similarity=0.352  Sum_probs=122.9

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .+.|+..+.||+|+||+||+|+.. +++.||||.+.... ......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            457999999999999999999874 58899999997543 2234568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc---CCCCeEEeeccCceeeC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARIFG  276 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DfGla~~~~  276 (290)
                      |+++|+|.+++..   ...+++.+...++.|++.||+|||+++   |+||||||+|||+.   +++.+||+|||+|+..+
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999998843   456999999999999999999999988   99999999999994   57899999999999876


Q ss_pred             CCc
Q 022887          277 GDE  279 (290)
Q Consensus       277 ~~~  279 (290)
                      .+.
T Consensus       162 ~~~  164 (307)
T d1a06a_         162 PGS  164 (307)
T ss_dssp             ---
T ss_pred             CCC
Confidence            554

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-35  Score=244.19  Aligned_cols=144  Identities=31%  Similarity=0.490  Sum_probs=124.8

Q ss_pred             ceecccCCccEEEEEEcC---CcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEecCC
Q 022887          129 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEYMPN  203 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~---~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  203 (290)
                      ++||+|+||+||+|.+.+   ++.||||+++...  ....++|.+|+.++.+++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998643   4679999996532  2235689999999999999999999999864 567899999999


Q ss_pred             CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          204 KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       204 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      |+|.+++..   ...++|..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+....
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            999998843   456999999999999999999999987   9999999999999999999999999999886543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-34  Score=247.66  Aligned_cols=150  Identities=29%  Similarity=0.423  Sum_probs=134.7

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999997 45899999999643   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+++|++..++.   ....+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999988874   3455788899999999999999999887   999999999999999999999999999987543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-34  Score=242.71  Aligned_cols=152  Identities=29%  Similarity=0.408  Sum_probs=135.0

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc------ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCee
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS------GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGEN  194 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  194 (290)
                      .++|+..+.||+|+||.||+|.. .+|+.||||.+....      ....+.+.+|+.++.+++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35799999999999999999988 468999999986432      12357899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC----CeEEeecc
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG  270 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DfG  270 (290)
                      ++||||+++|+|.+++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            999999999999998843   346999999999999999999999988   99999999999998776    49999999


Q ss_pred             CceeeCCCc
Q 022887          271 MARIFGGDE  279 (290)
Q Consensus       271 la~~~~~~~  279 (290)
                      +|+.+..+.
T Consensus       163 ~a~~~~~~~  171 (293)
T d1jksa_         163 LAHKIDFGN  171 (293)
T ss_dssp             TCEECTTSC
T ss_pred             hhhhcCCCc
Confidence            999886543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-34  Score=246.18  Aligned_cols=162  Identities=32%  Similarity=0.519  Sum_probs=131.2

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCc----EEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      ++|+..+.||+|+||+||+|.+. +++    +||+|++... ..+..++|.+|+.++.+++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999874 333    6899988643 345678899999999999999999999999865 5678


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ++||+.+|+|.+++..  ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999887643  3456899999999999999999999987   9999999999999999999999999999887


Q ss_pred             CCccccCcceeecC
Q 022887          277 GDELQGNTKRIVGT  290 (290)
Q Consensus       277 ~~~~~~~~~~~~Gt  290 (290)
                      .+.....+....||
T Consensus       163 ~~~~~~~~~~~~gt  176 (317)
T d1xkka_         163 AEEKEYHAEGGKVP  176 (317)
T ss_dssp             TTCC--------CC
T ss_pred             cccccccccccccC
Confidence            65544333334444

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=241.46  Aligned_cols=152  Identities=21%  Similarity=0.306  Sum_probs=133.8

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++|++.+.||+|+||+||+|... +++.||||.++... .....+.+|+.++..++||||+++++++.+.+..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            368999999999999999999874 58899999997543 3345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC--CCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~--~~~~kl~DfGla~~~~~~  278 (290)
                      +++|+|.+++..  ....+++.+...++.|++.||+|||+.+   |+||||||+|||++.  ...+||+|||+++....+
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999998843  2346899999999999999999999988   999999999999985  458999999999987654


Q ss_pred             c
Q 022887          279 E  279 (290)
Q Consensus       279 ~  279 (290)
                      .
T Consensus       158 ~  158 (321)
T d1tkia_         158 D  158 (321)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.5e-34  Score=245.19  Aligned_cols=150  Identities=25%  Similarity=0.326  Sum_probs=135.2

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  198 (290)
                      ++|+.++.||+|+||.||+|+. .+++.||||.+...   .......+.+|+.++..++||||+++++++...+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999987 46899999998642   2345577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ||+.+|+|..++..   ...+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999888743   346899999999999999999999988   999999999999999999999999999987543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.7e-34  Score=247.02  Aligned_cols=151  Identities=28%  Similarity=0.348  Sum_probs=131.0

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc---ccCHHHHHH---HHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLTEFKN---EMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      ++|+..+.||+|+||.||+|+.. +|+.||||.+....   ......+.+   ++.++..++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            68999999999999999999874 58999999986421   222333444   467788889999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||+++|+|..++..   ...+++.....++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999998843   356889999999999999999999988   999999999999999999999999999988


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      ....
T Consensus       158 ~~~~  161 (364)
T d1omwa3         158 SKKK  161 (364)
T ss_dssp             SSSC
T ss_pred             CCCc
Confidence            6653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-34  Score=243.58  Aligned_cols=157  Identities=29%  Similarity=0.464  Sum_probs=135.7

Q ss_pred             HhcCCCccceecccCCccEEEEEEc------CCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE  193 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  193 (290)
                      ..++|...+.||+|+||.||+|.+.      +++.||||+++... ......|.+|+.++.+++||||++++|++...+.
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            3478889999999999999999763      25689999997543 2334568999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEE
Q 022887          194 NILIYEYMPNKSLDVFLFYP-------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI  266 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl  266 (290)
                      .++||||+++|+|..++...       .....+++..+..++.|+++||.|||+++   |+||||||+|||+++++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence            99999999999999887532       22345799999999999999999999987   999999999999999999999


Q ss_pred             eeccCceeeCCCcc
Q 022887          267 SDFGMARIFGGDEL  280 (290)
Q Consensus       267 ~DfGla~~~~~~~~  280 (290)
                      +|||+|+.+.....
T Consensus       175 ~DFGla~~~~~~~~  188 (308)
T d1p4oa_         175 GDFGMTRDIYETDY  188 (308)
T ss_dssp             CCTTCCCGGGGGGC
T ss_pred             eecccceeccCCcc
Confidence            99999998765443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-34  Score=240.19  Aligned_cols=151  Identities=32%  Similarity=0.457  Sum_probs=123.8

Q ss_pred             cCCCccceecccCCccEEEEEEcC--C--cEEEEEEeccc---cccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQ---SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~--~--~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  195 (290)
                      ++|+..+.||+|+||.||+|++..  +  .+||||++...   .....++|.+|+.++.+++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            579999999999999999998632  2  37899988653   23345689999999999999999999999965 5678


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      +||||+++|++.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999887643  2345899999999999999999999987   999999999999999999999999999988


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      ....
T Consensus       162 ~~~~  165 (273)
T d1u46a_         162 PQND  165 (273)
T ss_dssp             CC-C
T ss_pred             ccCC
Confidence            6654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=239.77  Aligned_cols=151  Identities=29%  Similarity=0.481  Sum_probs=130.4

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+..+.||+|+||+||+|.. .+++.||||+++...  ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999987 568999999996432  2345789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      |+.++.+.....  .....+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+....+
T Consensus        82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence            998765544332  23456999999999999999999999988   999999999999999999999999999877543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-34  Score=242.65  Aligned_cols=170  Identities=26%  Similarity=0.366  Sum_probs=128.9

Q ss_pred             HHHHhcCCCccceecccCCccEEEEEEc------CCcEEEEEEecccc-ccCHHHHHHHHHHHccc-CCCCcceeEEEEE
Q 022887          118 VSAATENFSTQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKL-QHRHLVRLFGCCI  189 (290)
Q Consensus       118 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  189 (290)
                      .+...++|+..+.||+|+||.||+|.+.      +++.||||++.... ....+.+..|...+.++ +||||+.+++++.
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            3344578999999999999999999863      24579999997533 23356788888887776 6899999999987


Q ss_pred             eCC-eeEEEEEecCCCChhhhhhCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCC
Q 022887          190 EQG-ENILIYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASN  255 (290)
Q Consensus       190 ~~~-~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~N  255 (290)
                      ..+ ..++||||+++|+|.+++....             ....+++.+++.++.|+++||.|||+++   |+||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccc
Confidence            654 5789999999999999986432             1345899999999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEeeccCceeeCCCccccCcceeecC
Q 022887          256 ILLDSDMNPKISDFGMARIFGGDELQGNTKRIVGT  290 (290)
Q Consensus       256 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~Gt  290 (290)
                      ||+++++.+||+|||+|+..........+....||
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt  199 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  199 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeC
Confidence            99999999999999999987655443333344554

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=239.70  Aligned_cols=150  Identities=27%  Similarity=0.372  Sum_probs=125.5

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC----eeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG----ENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  198 (290)
                      ++|...+.||+|+||.||+|++ +|+.||||++..... .......|+..+..++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4677788999999999999997 678999999864321 1122334555667889999999999998764    578999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      ||+++|+|..++..    ..++|.+++.++.|++.||+|||+.     ...+|+||||||+|||+++++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999953    3589999999999999999999974     13459999999999999999999999999999


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .+...
T Consensus       157 ~~~~~  161 (303)
T d1vjya_         157 RHDSA  161 (303)
T ss_dssp             EEETT
T ss_pred             cccCC
Confidence            88654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-33  Score=239.67  Aligned_cols=151  Identities=27%  Similarity=0.372  Sum_probs=132.3

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEeccc---cccCHHHHHHHHHHHc-ccCCCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLTEFKNEMMLIA-KLQHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++|...+.||+|+||+||+|+.. +++.||||.+.+.   .......+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999884 5889999999643   2334556777777665 68999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCC
Q 022887          198 YEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGG  277 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~  277 (290)
                      |||+++|+|..++..   ...+++.+...++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999998843   345889999999999999999999988   99999999999999999999999999997755


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      ..
T Consensus       156 ~~  157 (320)
T d1xjda_         156 GD  157 (320)
T ss_dssp             TT
T ss_pred             cc
Confidence            43

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-33  Score=239.16  Aligned_cols=152  Identities=34%  Similarity=0.550  Sum_probs=131.6

Q ss_pred             cCCCccceecccCCccEEEEEEcC-Cc--EEEEEEeccc-cccCHHHHHHHHHHHccc-CCCCcceeEEEEEeCCeeEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQGENILI  197 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  197 (290)
                      ++|+..+.||+|+||.||+|.+.+ +.  .||||++... .....++|.+|+.++.++ +|||||+++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            688889999999999999998744 43  5788888643 334556899999999998 799999999999999999999


Q ss_pred             EEecCCCChhhhhhCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCe
Q 022887          198 YEYMPNKSLDVFLFYP-------------KKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP  264 (290)
Q Consensus       198 ~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~  264 (290)
                      |||+++|+|.+++...             .....++|..++.++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998643             23467999999999999999999999987   9999999999999999999


Q ss_pred             EEeeccCceeeCC
Q 022887          265 KISDFGMARIFGG  277 (290)
Q Consensus       265 kl~DfGla~~~~~  277 (290)
                      ||+|||+|+....
T Consensus       167 kl~DfG~a~~~~~  179 (309)
T d1fvra_         167 KIADFGLSRGQEV  179 (309)
T ss_dssp             EECCTTCEESSCE
T ss_pred             EEccccccccccc
Confidence            9999999987643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-33  Score=237.30  Aligned_cols=151  Identities=27%  Similarity=0.429  Sum_probs=123.2

Q ss_pred             hcCCCccceecccCCccEEEEEEcC----CcEEEEEEeccccc-cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  196 (290)
                      .++|+..+.||+|+||.||+|.+..    +..||||.+..... .....|.+|+.++++++||||++++|++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4678899999999999999998743    34689999865433 33567999999999999999999999985 467899


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeC
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFG  276 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~  276 (290)
                      ||||+++|++..++..  ....+++..++.++.|+++||.|||+++   ++||||||+||++++++.+||+|||+|+.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999887643  3456899999999999999999999988   9999999999999999999999999999876


Q ss_pred             CC
Q 022887          277 GD  278 (290)
Q Consensus       277 ~~  278 (290)
                      ..
T Consensus       160 ~~  161 (273)
T d1mp8a_         160 DS  161 (273)
T ss_dssp             --
T ss_pred             CC
Confidence            54

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.2e-33  Score=236.96  Aligned_cols=150  Identities=26%  Similarity=0.447  Sum_probs=134.6

Q ss_pred             cCCCccceecccCCccEEEEEEcCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|+||+||+|+..+++.||||++....  ......+.+|+.++++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999999889999999996532  33357899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +.++.+..+.   .....+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||+|......
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            9988777665   33466999999999999999999999987   999999999999999999999999999887543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-33  Score=239.01  Aligned_cols=147  Identities=31%  Similarity=0.417  Sum_probs=125.7

Q ss_pred             ccceecccCCccEEEEEE-cCCcEEEEEEecccccc-----CHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEEe
Q 022887          127 TQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ-----GLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYEY  200 (290)
Q Consensus       127 ~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  200 (290)
                      .++.||+|+||+||+|+. .+++.||||++......     ....+.+|+.++.+++|||||++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999987 45899999998643221     235688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      ++++++..+.   .....+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            9998776654   33456888999999999999999999988   9999999999999999999999999998776543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-33  Score=236.49  Aligned_cols=147  Identities=29%  Similarity=0.512  Sum_probs=127.4

Q ss_pred             cceecccCCccEEEEEEcCC----cEEEEEEeccc-cccCHHHHHHHHHHHcccCCCCcceeEEEEEeC-CeeEEEEEec
Q 022887          128 QCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQ-SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-GENILIYEYM  201 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~~----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~  201 (290)
                      .++||+|+||+||+|.+.++    ..||||+++.. ......+|.+|+.++++++||||++++|++... +..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999987442    25899999743 334457899999999999999999999998764 5889999999


Q ss_pred             CCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCCc
Q 022887          202 PNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGDE  279 (290)
Q Consensus       202 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~  279 (290)
                      ++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            99999998754  3445788999999999999999999987   9999999999999999999999999999876543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-33  Score=240.26  Aligned_cols=157  Identities=31%  Similarity=0.426  Sum_probs=135.9

Q ss_pred             HhcCCCccceecccCCccEEEEEE------cCCcEEEEEEeccccc-cCHHHHHHHHHHHccc-CCCCcceeEEEEEeCC
Q 022887          121 ATENFSTQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQG  192 (290)
Q Consensus       121 ~~~~~~~~~~ig~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  192 (290)
                      ..++|+..+.||+|+||.||+|++      .++..||||+++.... ....+|.+|+.++.++ +|||||++++++.+.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            457888999999999999999986      2356899999975433 3456789999999999 6999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEE
Q 022887          193 ENILIYEYMPNKSLDVFLFYPK---------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL  257 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nil  257 (290)
                      ..++||||+++|+|..++....               ....+++..+..++.||++||+|||+++   ++||||||+||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence            9999999999999999886432               2336899999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEeeccCceeeCCCcc
Q 022887          258 LDSDMNPKISDFGMARIFGGDEL  280 (290)
Q Consensus       258 l~~~~~~kl~DfGla~~~~~~~~  280 (290)
                      ++.++.+|++|||+++.......
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~  200 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSN  200 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTT
T ss_pred             ccccCcccccccchheeccCCCc
Confidence            99999999999999998865443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-33  Score=235.27  Aligned_cols=150  Identities=30%  Similarity=0.518  Sum_probs=126.0

Q ss_pred             hcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeC-CeeEEEEEe
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-GENILIYEY  200 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  200 (290)
                      .++|+..+.||+|+||.||+|.+ .+++||||+++..  ...++|.+|+.++++++||||++++|+|.+. +..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            35788889999999999999998 4679999999753  3457899999999999999999999999764 567999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      +++|+|.+++... ....++|..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence            9999999998532 2235899999999999999999999987   999999999999999999999999999987554

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.9e-33  Score=232.42  Aligned_cols=151  Identities=26%  Similarity=0.373  Sum_probs=131.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc---cCHHHHHHHHHHHcccCCCCcceeEEEEEeCCe----
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG---QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGE----  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  193 (290)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+.....   .....|.+|+.++..++||||+++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36799999999999999999987 5688999999975432   234578999999999999999999999987643    


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++||||+++++|..++..   ...+++.+...++.|++.||+|||+++   |+||||||+|||++.++..+++|||+++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999988743   346899999999999999999999988   9999999999999999999999999998


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .....
T Consensus       160 ~~~~~  164 (277)
T d1o6ya_         160 AIADS  164 (277)
T ss_dssp             ECC--
T ss_pred             hhccc
Confidence            77543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=5.5e-33  Score=235.79  Aligned_cols=156  Identities=30%  Similarity=0.490  Sum_probs=130.2

Q ss_pred             hcCCCccceecccCCccEEEEEEcC--------CcEEEEEEeccccc-cCHHHHHHHHHHHccc-CCCCcceeEEEEEeC
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSG-QGLTEFKNEMMLIAKL-QHRHLVRLFGCCIEQ  191 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  191 (290)
                      .++|...+.||+|+||.||+|+..+        +..||||+++.... ....++.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4688889999999999999997632        24799999975433 3457888999988888 799999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEE
Q 022887          192 GENILIYEYMPNKSLDVFLFYPK-------------KKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL  258 (290)
Q Consensus       192 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill  258 (290)
                      +..++||||+++|+|.+++....             ....+++.+++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999986432             1345899999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEeeccCceeeCCCcc
Q 022887          259 DSDMNPKISDFGMARIFGGDEL  280 (290)
Q Consensus       259 ~~~~~~kl~DfGla~~~~~~~~  280 (290)
                      +.++.+||+|||+++.......
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~  190 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDY  190 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCT
T ss_pred             cCCCCeEeccchhhcccccccc
Confidence            9999999999999998866543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.3e-32  Score=233.48  Aligned_cols=149  Identities=23%  Similarity=0.314  Sum_probs=127.1

Q ss_pred             hcCCCccc-eecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHccc-CCCCcceeEEEEEe----CCee
Q 022887          122 TENFSTQC-KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKL-QHRHLVRLFGCCIE----QGEN  194 (290)
Q Consensus       122 ~~~~~~~~-~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~  194 (290)
                      .++|.+.. .||+|+||.||+|.. .+++.||||+++..     ..+.+|+.++.++ +|||||++++++.+    .+..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46888765 599999999999987 56899999998642     4678899886654 89999999999875    3567


Q ss_pred             EEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC---CCCeEEeeccC
Q 022887          195 ILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM  271 (290)
Q Consensus       195 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGl  271 (290)
                      ++||||+++|+|.+++... ....+++.+...|+.|++.||+|||+.+   |+||||||+|||+++   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999998542 2356999999999999999999999988   999999999999985   56799999999


Q ss_pred             ceeeCCCc
Q 022887          272 ARIFGGDE  279 (290)
Q Consensus       272 a~~~~~~~  279 (290)
                      |+......
T Consensus       161 a~~~~~~~  168 (335)
T d2ozaa1         161 AKETTSHN  168 (335)
T ss_dssp             CEECCCCC
T ss_pred             eeeccCCC
Confidence            99876644

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-32  Score=229.80  Aligned_cols=150  Identities=25%  Similarity=0.364  Sum_probs=128.2

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc------cCHHHHHHHHHHHcccC--CCCcceeEEEEEeCCe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG------QGLTEFKNEMMLIAKLQ--HRHLVRLFGCCIEQGE  193 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  193 (290)
                      ++|++.+.||+|+||.||+|.. .+++.||||++.....      .....+.+|+.++.+++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999987 4689999999864321      12245778999999886  8999999999999999


Q ss_pred             eEEEEEecCC-CChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-CCCeEEeeccC
Q 022887          194 NILIYEYMPN-KSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGM  271 (290)
Q Consensus       194 ~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGl  271 (290)
                      .++||||+.+ +++.+++.   ....+++.+...++.|++.||+|||+++   |+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 56666653   2356899999999999999999999988   999999999999985 47999999999


Q ss_pred             ceeeCCC
Q 022887          272 ARIFGGD  278 (290)
Q Consensus       272 a~~~~~~  278 (290)
                      |+.....
T Consensus       158 a~~~~~~  164 (273)
T d1xwsa_         158 GALLKDT  164 (273)
T ss_dssp             CEECCSS
T ss_pred             ceecccc
Confidence            9977544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.1e-32  Score=234.78  Aligned_cols=149  Identities=30%  Similarity=0.492  Sum_probs=125.2

Q ss_pred             CCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC------eeEE
Q 022887          124 NFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------ENIL  196 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l  196 (290)
                      +|+..++||+|+||+||+|+.. +++.||||++.....    ...+|+.++.+++||||+++++++....      ..++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6888899999999999999984 589999999975432    2347999999999999999999986532      4689


Q ss_pred             EEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-CeEEeeccCceee
Q 022887          197 IYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIF  275 (290)
Q Consensus       197 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~  275 (290)
                      ||||++++.+..+.........+++.+...++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999998765555433334567999999999999999999999887   99999999999999775 8999999999987


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      ..+.
T Consensus       174 ~~~~  177 (350)
T d1q5ka_         174 VRGE  177 (350)
T ss_dssp             CTTS
T ss_pred             cCCc
Confidence            6543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.1e-31  Score=224.21  Aligned_cols=150  Identities=26%  Similarity=0.425  Sum_probs=134.3

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCCeeEEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  199 (290)
                      ++|+.++.||+|+||+||+|+. .+++.||||+++...  ......+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999987 468899999986433  2335788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceeeCCC
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIFGGD  278 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~  278 (290)
                      ++.++++..++.   ....+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence            999999887764   3456789999999999999999999988   999999999999999999999999999987654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.97  E-value=3.9e-31  Score=227.28  Aligned_cols=145  Identities=22%  Similarity=0.394  Sum_probs=127.5

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEEEEeC--CeeEEEE
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQ--GENILIY  198 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  198 (290)
                      ++|+.++.||+|+||+||+|+. .+++.||||+++..   ..+++.+|+.++..++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999987 56889999998643   3568899999999995 99999999999854  4689999


Q ss_pred             EecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCC-CeEEeeccCceeeCC
Q 022887          199 EYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIFGG  277 (290)
Q Consensus       199 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~~  277 (290)
                      ||+++++|..+.      +.+++.....++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999987653      35899999999999999999999988   99999999999998655 699999999998865


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      +.
T Consensus       183 ~~  184 (328)
T d3bqca1         183 GQ  184 (328)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-31  Score=231.85  Aligned_cols=151  Identities=25%  Similarity=0.400  Sum_probs=127.3

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc-ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC----eeE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG----ENI  195 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  195 (290)
                      +++|+.++.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.++..++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35799999999999999999986 568999999997543 233567899999999999999999999997653    335


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                      ++++|+.+|+|.+++..    ..+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            66677889999998843    35899999999999999999999988   999999999999999999999999999987


Q ss_pred             CCCc
Q 022887          276 GGDE  279 (290)
Q Consensus       276 ~~~~  279 (290)
                      ....
T Consensus       160 ~~~~  163 (345)
T d1pmea_         160 DPDH  163 (345)
T ss_dssp             CGGG
T ss_pred             cCCC
Confidence            6543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8e-31  Score=224.36  Aligned_cols=151  Identities=28%  Similarity=0.508  Sum_probs=128.3

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccc--cccCHHHHHHHHHHHcccCCCCcceeEEEEEeC-------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-------  191 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  191 (290)
                      .++|+..+.||+|+||+||+|+. .+++.||||++...  .......+.+|+.++.+++|||++++++.+...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999997 46899999998543  233457789999999999999999999998653       


Q ss_pred             -CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeecc
Q 022887          192 -GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG  270 (290)
Q Consensus       192 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG  270 (290)
                       +..++||||++++++..+.   .....++......++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence             4578999999988776554   33456888999999999999999999988   9999999999999999999999999


Q ss_pred             CceeeCCC
Q 022887          271 MARIFGGD  278 (290)
Q Consensus       271 la~~~~~~  278 (290)
                      +++.+...
T Consensus       163 ~~~~~~~~  170 (318)
T d3blha1         163 LARAFSLA  170 (318)
T ss_dssp             TCEECCC-
T ss_pred             eeeecccc
Confidence            99887653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.8e-31  Score=227.26  Aligned_cols=151  Identities=28%  Similarity=0.375  Sum_probs=132.6

Q ss_pred             cCCCccceecccCCccEEEEEE----cCCcEEEEEEeccc----cccCHHHHHHHHHHHcccCC-CCcceeEEEEEeCCe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQ----SGQGLTEFKNEMMLIAKLQH-RHLVRLFGCCIEQGE  193 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~----~~~~~vavK~l~~~----~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  193 (290)
                      ++|+..+.||+|+||+||+|..    .+|+.||||.+...    .......+.+|+.++.+++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999975    24789999998643    22345678899999999977 899999999999999


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .+++|||+.+|+|..++..   ...+.......++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999988743   345678888999999999999999988   9999999999999999999999999999


Q ss_pred             eeCCCc
Q 022887          274 IFGGDE  279 (290)
Q Consensus       274 ~~~~~~  279 (290)
                      .+....
T Consensus       178 ~~~~~~  183 (322)
T d1vzoa_         178 EFVADE  183 (322)
T ss_dssp             ECCGGG
T ss_pred             hhcccc
Confidence            876543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-30  Score=226.13  Aligned_cols=149  Identities=26%  Similarity=0.413  Sum_probs=122.8

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeCC------
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQG------  192 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  192 (290)
                      .++|+.++.||+|+||+||+|.. .+++.||||++....  ....+.+.+|+.+++.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999987 458999999997532  223467889999999999999999999998765      


Q ss_pred             eeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCc
Q 022887          193 ENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA  272 (290)
Q Consensus       193 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla  272 (290)
                      ..++||||+ +.+|..+..    ...+++.....++.|++.||.|||+++   |+||||||+|||++.++.+|++|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 456666552    345899999999999999999999988   999999999999999999999999999


Q ss_pred             eeeCCC
Q 022887          273 RIFGGD  278 (290)
Q Consensus       273 ~~~~~~  278 (290)
                      +..+..
T Consensus       169 ~~~~~~  174 (346)
T d1cm8a_         169 RQADSE  174 (346)
T ss_dssp             EECCSS
T ss_pred             eccCCc
Confidence            987553

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.96  E-value=5.7e-30  Score=216.42  Aligned_cols=149  Identities=22%  Similarity=0.357  Sum_probs=128.2

Q ss_pred             hcCCCccceecccCCccEEEEEEc-CCcEEEEEEeccccccCHHHHHHHHHHHcccCC-CCcceeEEEEEeCCeeEEEEE
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH-RHLVRLFGCCIEQGENILIYE  199 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  199 (290)
                      .++|++.+.||+|+||.||+|++. +++.||||.+....  ....+.+|+..+..++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            468999999999999999999874 58899999886432  23467888899988875 899999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcC-----CCCeEEeeccCcee
Q 022887          200 YMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARI  274 (290)
Q Consensus       200 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~DfGla~~  274 (290)
                      |+ +++|..++..  ....+++.+...++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 5788877643  2346899999999999999999999888   999999999999974     56799999999998


Q ss_pred             eCCC
Q 022887          275 FGGD  278 (290)
Q Consensus       275 ~~~~  278 (290)
                      +...
T Consensus       156 ~~~~  159 (293)
T d1csna_         156 YRDP  159 (293)
T ss_dssp             SBCT
T ss_pred             cccC
Confidence            7653

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.4e-30  Score=220.09  Aligned_cols=152  Identities=30%  Similarity=0.473  Sum_probs=125.0

Q ss_pred             hcCCCccceecccCCccEEEEEEc-C-CcEEEEEEecccc--ccCHHHHHHHHHHHccc---CCCCcceeEEEEEeC---
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQS--GQGLTEFKNEMMLIAKL---QHRHLVRLFGCCIEQ---  191 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~~-~-~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~---  191 (290)
                      .++|+.++.||+|+||+||+|... + ++.||||++....  ......+.+|+.++..+   +||||+++++++...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999873 4 5679999986432  22334566777776655   799999999998642   


Q ss_pred             --CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeec
Q 022887          192 --GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF  269 (290)
Q Consensus       192 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  269 (290)
                        ...+++|||++++++.....  .....+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence              36789999999987765543  23456889999999999999999999988   999999999999999999999999


Q ss_pred             cCceeeCCC
Q 022887          270 GMARIFGGD  278 (290)
Q Consensus       270 Gla~~~~~~  278 (290)
                      |+++....+
T Consensus       161 g~~~~~~~~  169 (305)
T d1blxa_         161 GLARIYSFQ  169 (305)
T ss_dssp             CSCCCCCGG
T ss_pred             hhhhhhccc
Confidence            999876544

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.6e-30  Score=221.72  Aligned_cols=149  Identities=28%  Similarity=0.390  Sum_probs=126.0

Q ss_pred             hcCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccc--cCHHHHHHHHHHHcccCCCCcceeEEEEEeC-----Ce
Q 022887          122 TENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ-----GE  193 (290)
Q Consensus       122 ~~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  193 (290)
                      +++|+..+.||+|+||+||+|+. .+++.||||++.....  .....+.+|+.++.+++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46899999999999999999987 5689999999975322  2345788999999999999999999998643     34


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .+++++|+.+|+|.+++.    ...+++.+...++.|++.||+|||+++   |+||||||+|||++.++.+|++|||+|.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            577788899999999883    245999999999999999999999988   9999999999999999999999999998


Q ss_pred             eeCC
Q 022887          274 IFGG  277 (290)
Q Consensus       274 ~~~~  277 (290)
                      ....
T Consensus       170 ~~~~  173 (348)
T d2gfsa1         170 HTDD  173 (348)
T ss_dssp             CCTG
T ss_pred             ccCc
Confidence            7643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=2.2e-29  Score=213.54  Aligned_cols=149  Identities=23%  Similarity=0.396  Sum_probs=121.9

Q ss_pred             cCCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCcce-eEEEEEeCCeeEEEEEe
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLVR-LFGCCIEQGENILIYEY  200 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~  200 (290)
                      ++|+..+.||+|+||.||+|.+ .+++.||||.+....  ...++..|++++..++|+|++. +.++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999987 458899999886533  2356889999999998776555 45556777888999999


Q ss_pred             cCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEc---CCCCeEEeeccCceeeCC
Q 022887          201 MPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARIFGG  277 (290)
Q Consensus       201 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DfGla~~~~~  277 (290)
                      +++ ++...+..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+.+..
T Consensus        85 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            955 44444322  3456899999999999999999999988   99999999999986   355799999999998865


Q ss_pred             Cc
Q 022887          278 DE  279 (290)
Q Consensus       278 ~~  279 (290)
                      ..
T Consensus       159 ~~  160 (299)
T d1ckia_         159 AR  160 (299)
T ss_dssp             TT
T ss_pred             cc
Confidence            43

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.6e-29  Score=218.04  Aligned_cols=147  Identities=29%  Similarity=0.392  Sum_probs=120.8

Q ss_pred             cCCCccceecccCCccEEEEEEc-CCcEEEEEEecccc--ccCHHHHHHHHHHHcccCCCCcceeEEEEEeC------Ce
Q 022887          123 ENFSTQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLTEFKNEMMLIAKLQHRHLVRLFGCCIEQ------GE  193 (290)
Q Consensus       123 ~~~~~~~~ig~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  193 (290)
                      ++|+.++.||+|+||+||+|.+. +++.||||++....  ......+.+|+.++++++||||+++++++...      +.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999875 58999999997532  22345788999999999999999999999643      57


Q ss_pred             eEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEeeccCce
Q 022887          194 NILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR  273 (290)
Q Consensus       194 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~  273 (290)
                      .++||||+.++++..+.      ..+++.....++.|++.||.|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            79999999877665442      34889999999999999999999988   9999999999999999999999999998


Q ss_pred             eeCCC
Q 022887          274 IFGGD  278 (290)
Q Consensus       274 ~~~~~  278 (290)
                      .....
T Consensus       168 ~~~~~  172 (355)
T d2b1pa1         168 TAGTS  172 (355)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            77654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=4e-25  Score=174.89  Aligned_cols=135  Identities=20%  Similarity=0.222  Sum_probs=105.6

Q ss_pred             CccceecccCCccEEEEEEcCCcEEEEEEecccccc------------------CHHHHHHHHHHHcccCCCCcceeEEE
Q 022887          126 STQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ------------------GLTEFKNEMMLIAKLQHRHLVRLFGC  187 (290)
Q Consensus       126 ~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~l~~~  187 (290)
                      ...+.||+|+||.||+|...+|++||||.++.....                  .......|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            356899999999999999988999999987532100                  01234567888899999999988765


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCceecCCCCCCEEEcCCCCeEEe
Q 022887          188 CIEQGENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS  267 (290)
Q Consensus       188 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~  267 (290)
                      .    ..+++|||+++..+..          +++.....++.|++.++.|||+.+   |+||||||+|||+++++ ++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence            3    2379999998876543          223334678999999999999988   99999999999998655 8999


Q ss_pred             eccCceeeCCC
Q 022887          268 DFGMARIFGGD  278 (290)
Q Consensus       268 DfGla~~~~~~  278 (290)
                      |||+|+..+.+
T Consensus       145 DFG~a~~~~~~  155 (191)
T d1zara2         145 DFPQSVEVGEE  155 (191)
T ss_dssp             CCTTCEETTST
T ss_pred             ECCCcccCCCC
Confidence            99999877543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.90  E-value=2.9e-24  Score=186.34  Aligned_cols=150  Identities=22%  Similarity=0.302  Sum_probs=119.5

Q ss_pred             CCCccceecccCCccEEEEEE-cCCcEEEEEEeccccccCHHHHHHHHHHHcccC-----------CCCcceeEEEEEeC
Q 022887          124 NFSTQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-----------HRHLVRLFGCCIEQ  191 (290)
Q Consensus       124 ~~~~~~~ig~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~  191 (290)
                      +|++.++||+|+||+||+|+. .+++.||||+++... .....+.+|+.++..++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            599999999999999999987 568999999997532 23457788888887765           57899999888654


Q ss_pred             --CeeEEEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCceecCCCCCCEEEcCCCC-----
Q 022887          192 --GENILIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMN-----  263 (290)
Q Consensus       192 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlk~~Nill~~~~~-----  263 (290)
                        ...+++++++..+..............+++.....++.|++.||+|||+ .+   |+||||||+|||++.++.     
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence              4566777777665543333333445668889999999999999999997 55   999999999999986653     


Q ss_pred             -eEEeeccCceeeCC
Q 022887          264 -PKISDFGMARIFGG  277 (290)
Q Consensus       264 -~kl~DfGla~~~~~  277 (290)
                       +|++|||.|+....
T Consensus       170 ~~kl~dfg~s~~~~~  184 (362)
T d1q8ya_         170 QIKIADLGNACWYDE  184 (362)
T ss_dssp             EEEECCCTTCEETTB
T ss_pred             eeeEeeccccccccc
Confidence             99999999987644

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.87  E-value=1.5e-08  Score=82.04  Aligned_cols=150  Identities=16%  Similarity=0.098  Sum_probs=100.9

Q ss_pred             hHHHHhcCCCccceecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccC-CCCcceeEEEEEeCCeeE
Q 022887          117 SVSAATENFSTQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQ-HRHLVRLFGCCIEQGENI  195 (290)
Q Consensus       117 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  195 (290)
                      ++....+.|+..+..+-++...||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+....+..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            3445556777655444344568998865 45677888886655445556788888877663 333567888888888999


Q ss_pred             EEEEecCCCChhhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------
Q 022887          196 LIYEYMPNKSLDVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLHQYS---------------------------------  242 (290)
Q Consensus       196 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------  242 (290)
                      +||+++++.++.......        .....++.++++.+..||+..                                 
T Consensus        87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            999999998875443110        112234445555555555321                                 


Q ss_pred             -----------------------CCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          243 -----------------------RLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       243 -----------------------~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                                             ...++|+|+.|.||+++++..+.|.||+.+..-
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                                   112789999999999998877789999998754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.44  E-value=8.3e-07  Score=71.09  Aligned_cols=132  Identities=18%  Similarity=0.186  Sum_probs=86.0

Q ss_pred             eecccCC-ccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCC--CCcceeEEEEEeCCeeEEEEEecCCCCh
Q 022887          130 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQH--RHLVRLFGCCIEQGENILIYEYMPNKSL  206 (290)
Q Consensus       130 ~ig~G~f-g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L  206 (290)
                      .+..|.. ..||+....++..+.+|......   ...+..|...+..+..  -.+.+++.+..+.+..++|||++++-++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4445543 67899988788888888765432   2356777777766643  3356678888888889999999987665


Q ss_pred             hhhhhCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 022887          207 DVFLFYPKKKRLLGWQARVRIIEGIAQGLLYLH-----------------------------------------------  239 (290)
Q Consensus       207 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-----------------------------------------------  239 (290)
                      ....        ...   ...+.++++.|.-||                                               
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            3311        000   111122222222222                                               


Q ss_pred             ----hC----CCCCceecCCCCCCEEEcCCCCeEEeeccCceee
Q 022887          240 ----QY----SRLRIIHRDLKASNILLDSDMNPKISDFGMARIF  275 (290)
Q Consensus       240 ----~~----~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~  275 (290)
                          ..    .+..++|+|+.|.||+++++..+.|.||+.+..-
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g  206 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  206 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence                11    1123799999999999998877889999998763

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.84  E-value=4.4e-05  Score=64.96  Aligned_cols=76  Identities=12%  Similarity=0.156  Sum_probs=47.3

Q ss_pred             cceecccCCccEEEEEEcC-CcEEEEEEeccc-------cccCHHHHHHHHHHHcccC-C--CCcceeEEEEEeCCeeEE
Q 022887          128 QCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-------SGQGLTEFKNEMMLIAKLQ-H--RHLVRLFGCCIEQGENIL  196 (290)
Q Consensus       128 ~~~ig~G~fg~V~~~~~~~-~~~vavK~l~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l  196 (290)
                      .+.||.|....||+....+ ++.+++|.-.+.       .+........|...+..+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4578999999999998754 678899965431       1112334556777666552 2  234455544  4556789


Q ss_pred             EEEecCCCC
Q 022887          197 IYEYMPNKS  205 (290)
Q Consensus       197 v~e~~~~g~  205 (290)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.38  E-value=0.00079  Score=55.38  Aligned_cols=135  Identities=16%  Similarity=0.190  Sum_probs=77.7

Q ss_pred             ccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCc-----cee--EEEEEeCCeeEEEEEecCCCChhh-
Q 022887          137 GPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-----VRL--FGCCIEQGENILIYEYMPNKSLDV-  208 (290)
Q Consensus       137 g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~l--~~~~~~~~~~~lv~e~~~~g~L~~-  208 (290)
                      -.||+....+|+.+++|...+. .....++..|...+..|...++     +..  -......+..+.+++++++..++. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            5799999989999999987653 2345677888887776643222     111  112234566788999997654321 


Q ss_pred             ----h------h---h----CC--CCCCCCCHHH-------------------HHHHHHHHHHHHHHHh----hCCCCCc
Q 022887          209 ----F------L---F----YP--KKKRLLGWQA-------------------RVRIIEGIAQGLLYLH----QYSRLRI  246 (290)
Q Consensus       209 ----~------l---~----~~--~~~~~l~~~~-------------------~~~i~~~i~~~l~yLH----~~~~~~i  246 (290)
                          +      +   +    ..  ......++..                   +..+...+.+.++.+.    +..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                0      0   0    00  0111122211                   1111112222233332    2234568


Q ss_pred             eecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          247 IHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       247 iH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                      +|+|+.+.|||++++  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.97  E-value=0.00092  Score=56.51  Aligned_cols=72  Identities=21%  Similarity=0.328  Sum_probs=47.1

Q ss_pred             ceecccCCccEEEEEEcCC--------cEEEEEEeccccccCHHHHHHHHHHHcccCCCCcc-eeEEEEEeCCeeEEEEE
Q 022887          129 CKLGEGGFGPVYKGRLLNG--------QEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHLV-RLFGCCIEQGENILIYE  199 (290)
Q Consensus       129 ~~ig~G~fg~V~~~~~~~~--------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e  199 (290)
                      +.|+.|-.-.+|+....++        ..|.++..- . .....+..+|..++..+.-.+++ ++++++..    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            5677777888999987543        345555543 2 23344566788888877544554 67776642    68999


Q ss_pred             ecCCCCh
Q 022887          200 YMPNKSL  206 (290)
Q Consensus       200 ~~~~g~L  206 (290)
                      |+++..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.71  E-value=0.014  Score=47.22  Aligned_cols=159  Identities=13%  Similarity=0.019  Sum_probs=81.1

Q ss_pred             ccHHhHHHHhcCCCccce-----ecccCCccEEEEEEcCCcEEEEEEeccccccCHHHHHHHHHHHcccCCCCc-----c
Q 022887          113 FSLASVSAATENFSTQCK-----LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLTEFKNEMMLIAKLQHRHL-----V  182 (290)
Q Consensus       113 ~~~~~~~~~~~~~~~~~~-----ig~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-----v  182 (290)
                      .+.++++...++|...+.     |..|---+.|+...+++ .+++|......  ...++..|+.++..+...++     +
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            355667777778866443     33455567898887665 58888876432  22345556666655543222     2


Q ss_pred             ee---EEEEEeCCeeEEEEEecCCCChhhh--------------hh------CCC-CCCCCCH-H---------------
Q 022887          183 RL---FGCCIEQGENILIYEYMPNKSLDVF--------------LF------YPK-KKRLLGW-Q---------------  222 (290)
Q Consensus       183 ~l---~~~~~~~~~~~lv~e~~~~g~L~~~--------------l~------~~~-~~~~l~~-~---------------  222 (290)
                      ..   ..+.........++.+..+......              ++      ... ......+ .               
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            11   0012234455667777665433110              00      000 0000000 0               


Q ss_pred             -HHHHHHHHHHHHHHHHh-hCCCCCceecCCCCCCEEEcCCCCeEEeeccCcee
Q 022887          223 -ARVRIIEGIAQGLLYLH-QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI  274 (290)
Q Consensus       223 -~~~~i~~~i~~~l~yLH-~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~  274 (290)
                       .....+......+.-.+ ..-+.++||+|+.++|++++++...-|.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence             01111111222222222 12244699999999999999988889999999863

>d1dmca_ g.46.1.1 (A:) Metallothionein {Crab (Callinectes sapidus), alpha and beta domains [TaxId: 6763]}

class: Small proteins
fold: Metallothionein
superfamily: Metallothionein
family: Metallothionein
domain: Metallothionein
species: Crab (Callinectes sapidus), alpha and beta domains [TaxId: 6763]

Probab=81.81  E-value=0.25  Score=23.19  Aligned_cols=16  Identities=38%  Similarity=0.997  Sum_probs=13.9

Q ss_pred             ChhhHHHHHhhccCee
Q 022887            2 NLNQCQAKCLKNCSCR   17 (290)
Q Consensus         2 ~~~~C~~~c~~~c~C~   17 (290)
                      +.+||...|-..|+|-
T Consensus        14 tkeecsktctkpcscc   29 (31)
T d1dmca_          14 TKEECSKTCTKPCSCC   29 (31)
T ss_dssp             SHHHHHHHCSSCCSSS
T ss_pred             cHHHHhhhcCCCcccC
Confidence            5689999999999983